0001038133-21-000011.txt : 20210226 0001038133-21-000011.hdr.sgml : 20210226 20210226103041 ACCESSION NUMBER: 0001038133-21-000011 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 111 CONFORMED PERIOD OF REPORT: 20201231 FILED AS OF DATE: 20210226 DATE AS OF CHANGE: 20210226 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HESKA CORP CENTRAL INDEX KEY: 0001038133 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 770192527 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-22427 FILM NUMBER: 21684819 BUSINESS ADDRESS: STREET 1: 3760 ROCKY MOUNTAIN AVENUE CITY: LOVELAND STATE: CO ZIP: 80538 BUSINESS PHONE: 9704937272 MAIL ADDRESS: STREET 1: 3760 ROCKY MOUNTAIN AVENUE CITY: LOVELAND STATE: CO ZIP: 80538 10-K 1 hska-20201231.htm 10-K hska-20201231
0001038133falseFY20201867691051920.010.012,500,0002,500,0000.010.0110,250,00013,250,0000.010.0110,250,00013,250,0007,881,9289,475,8457,881,9289,475,845P3Y104321037355150.2111114.507.367.3732.2132.2262.5062.5169.7769.78108.254.50108.2500P1Y0.011543468 months, 15 daysP12MP12M00010381332020-01-012020-12-31iso4217:USD00010381332020-06-30xbrli:shares00010381332021-02-2500010381332020-12-3100010381332019-12-31iso4217:USDxbrli:shares0001038133us-gaap:CommonStockMember2019-12-310001038133us-gaap:CommonStockMember2020-12-310001038133hska:PublicCommonStockMember2019-12-310001038133hska:PublicCommonStockMember2020-12-3100010381332019-01-012019-12-3100010381332018-01-012018-12-310001038133us-gaap:PreferredStockMember2017-12-310001038133hska:PublicAndCommonStockMember2017-12-310001038133us-gaap:AdditionalPaidInCapitalMember2017-12-310001038133us-gaap:ComprehensiveIncomeMember2017-12-310001038133us-gaap:RetainedEarningsMember2017-12-3100010381332017-12-310001038133us-gaap:RetainedEarningsMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2017-12-310001038133srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2017-12-310001038133us-gaap:PreferredStockMembersrt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember2017-12-310001038133hska:PublicAndCommonStockMembersrt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember2017-12-310001038133srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMemberus-gaap:AdditionalPaidInCapitalMember2017-12-310001038133srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMemberus-gaap:ComprehensiveIncomeMember2017-12-310001038133srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMemberus-gaap:RetainedEarningsMember2017-12-310001038133srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember2017-12-310001038133us-gaap:RetainedEarningsMember2018-01-012018-12-310001038133hska:PublicAndCommonStockMember2018-01-012018-12-310001038133us-gaap:AdditionalPaidInCapitalMember2018-01-012018-12-310001038133us-gaap:ComprehensiveIncomeMember2018-01-012018-12-310001038133us-gaap:PreferredStockMember2018-12-310001038133hska:PublicAndCommonStockMember2018-12-310001038133us-gaap:AdditionalPaidInCapitalMember2018-12-310001038133us-gaap:ComprehensiveIncomeMember2018-12-310001038133us-gaap:RetainedEarningsMember2018-12-3100010381332018-12-310001038133us-gaap:RetainedEarningsMember2019-01-012019-12-310001038133hska:PublicAndCommonStockMember2019-01-012019-12-310001038133us-gaap:AdditionalPaidInCapitalMember2019-01-012019-12-310001038133us-gaap:ComprehensiveIncomeMember2019-01-012019-12-310001038133us-gaap:PreferredStockMember2019-12-310001038133hska:PublicAndCommonStockMember2019-12-310001038133us-gaap:AdditionalPaidInCapitalMember2019-12-310001038133us-gaap:ComprehensiveIncomeMember2019-12-310001038133us-gaap:RetainedEarningsMember2019-12-310001038133us-gaap:RetainedEarningsMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2019-12-310001038133srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2019-12-310001038133us-gaap:PreferredStockMembersrt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember2019-12-310001038133hska:PublicAndCommonStockMembersrt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember2019-12-310001038133srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMemberus-gaap:AdditionalPaidInCapitalMember2019-12-310001038133srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMemberus-gaap:ComprehensiveIncomeMember2019-12-310001038133srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMemberus-gaap:RetainedEarningsMember2019-12-310001038133srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember2019-12-310001038133us-gaap:RetainedEarningsMember2020-01-012020-12-310001038133hska:PublicAndCommonStockMember2020-01-012020-12-310001038133us-gaap:AdditionalPaidInCapitalMember2020-01-012020-12-310001038133us-gaap:PreferredStockMember2020-01-012020-12-310001038133us-gaap:ComprehensiveIncomeMember2020-01-012020-12-310001038133us-gaap:PreferredStockMember2020-12-310001038133hska:PublicAndCommonStockMember2020-12-310001038133us-gaap:AdditionalPaidInCapitalMember2020-12-310001038133us-gaap:ComprehensiveIncomeMember2020-12-310001038133us-gaap:RetainedEarningsMember2020-12-310001038133hska:CVMMember2020-01-012020-12-310001038133hska:CVMMember2019-01-012019-12-310001038133hska:CVMMember2018-01-012018-12-310001038133hska:ScilAnimalCareCompanyMember2020-01-012020-12-310001038133hska:ScilAnimalCareCompanyMember2019-01-012019-12-310001038133hska:ScilAnimalCareCompanyMember2018-01-012018-12-31xbrli:pure0001038133us-gaap:AccountsReceivableMemberhska:HenryScheinMemberus-gaap:CustomerConcentrationRiskMember2020-01-012020-12-310001038133us-gaap:AccountsReceivableMemberhska:HenryScheinMemberus-gaap:CustomerConcentrationRiskMember2019-01-012019-12-31iso4217:EURiso4217:CHFiso4217:CADiso4217:AUDiso4217:MYR0001038133srt:MinimumMemberus-gaap:SoftwareDevelopmentMember2020-01-012020-12-310001038133us-gaap:SoftwareDevelopmentMembersrt:MaximumMember2020-01-012020-12-310001038133srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMemberhska:NoncashDebtInterestExpenseCalculationMember2019-01-012019-12-310001038133srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMemberhska:NoncashDebtInterestExpenseCalculationMember2020-04-012020-06-300001038133srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMemberhska:NoncashDebtInterestExpenseCalculationMember2020-01-012020-03-310001038133srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMemberhska:NoncashDebtInterestExpenseCalculationMember2020-07-012020-09-300001038133srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMemberhska:NoncashDebtInterestExpenseCalculationMember2019-12-310001038133srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMemberhska:NoncashDebtInterestExpenseCalculationMember2020-03-310001038133srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMemberhska:NoncashDebtInterestExpenseCalculationMember2020-06-300001038133srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMemberhska:NoncashDebtInterestExpenseCalculationMember2020-09-300001038133srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMemberhska:NoncashDebtInterestExpenseCalculationMember2020-10-012020-12-310001038133srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMemberhska:NoncashDebtInterestExpenseCalculationMember2020-12-310001038133hska:AccountingStandardsUpdate202006Memberus-gaap:RetainedEarningsMemberus-gaap:SubsequentEventMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2021-01-010001038133us-gaap:BuildingMembersrt:MinimumMember2020-01-012020-12-310001038133us-gaap:BuildingMembersrt:MaximumMember2020-01-012020-12-310001038133srt:MinimumMemberus-gaap:MachineryAndEquipmentMember2020-01-012020-12-310001038133srt:MaximumMemberus-gaap:MachineryAndEquipmentMember2020-01-012020-12-310001038133hska:OfficeFurnitureAndEquipmentMembersrt:MinimumMember2020-01-012020-12-310001038133hska:OfficeFurnitureAndEquipmentMembersrt:MaximumMember2020-01-012020-12-310001038133hska:ComputerHardwareAndSoftwareMembersrt:MinimumMember2020-01-012020-12-310001038133hska:ComputerHardwareAndSoftwareMembersrt:MaximumMember2020-01-012020-12-310001038133hska:LeaseholdandBuildingImprovementsMembersrt:MinimumMember2020-01-012020-12-310001038133hska:LeaseholdandBuildingImprovementsMembersrt:MaximumMember2020-01-012020-12-31hska:segment0001038133us-gaap:OperatingSegmentsMemberhska:NorthAmericaSegmentMemberhska:PointOfCareLaboratoryRevenueLabInstrumentsAndOtherMember2020-01-012020-12-310001038133us-gaap:OperatingSegmentsMemberhska:NorthAmericaSegmentMemberhska:PointOfCareLaboratoryRevenueLabInstrumentsAndOtherMember2019-01-012019-12-310001038133us-gaap:OperatingSegmentsMemberhska:NorthAmericaSegmentMemberhska:PointOfCareLaboratoryRevenueLabInstrumentsAndOtherMember2018-01-012018-12-310001038133us-gaap:OperatingSegmentsMemberhska:NorthAmericaSegmentMemberhska:PointOfCareLaboratoryRevenueSalesTypeLeasesMember2020-01-012020-12-310001038133us-gaap:OperatingSegmentsMemberhska:NorthAmericaSegmentMemberhska:PointOfCareLaboratoryRevenueSalesTypeLeasesMember2019-01-012019-12-310001038133us-gaap:OperatingSegmentsMemberhska:NorthAmericaSegmentMemberhska:PointOfCareLaboratoryRevenueSalesTypeLeasesMember2018-01-012018-12-310001038133us-gaap:OperatingSegmentsMemberhska:NorthAmericaSegmentMemberhska:PointOfCareLaboratoryRevenueConsumablesMember2020-01-012020-12-310001038133us-gaap:OperatingSegmentsMemberhska:NorthAmericaSegmentMemberhska:PointOfCareLaboratoryRevenueConsumablesMember2019-01-012019-12-310001038133us-gaap:OperatingSegmentsMemberhska:NorthAmericaSegmentMemberhska:PointOfCareLaboratoryRevenueConsumablesMember2018-01-012018-12-310001038133us-gaap:OperatingSegmentsMemberhska:NorthAmericaSegmentMemberhska:PointOfCareLaboratoryRevenueImagingMember2020-01-012020-12-310001038133us-gaap:OperatingSegmentsMemberhska:NorthAmericaSegmentMemberhska:PointOfCareLaboratoryRevenueImagingMember2019-01-012019-12-310001038133us-gaap:OperatingSegmentsMemberhska:NorthAmericaSegmentMemberhska:PointOfCareLaboratoryRevenueImagingMember2018-01-012018-12-310001038133us-gaap:OperatingSegmentsMemberhska:OtherRevenueOtherPharmaceuticalsVaccinesAndDiagnosticTestsMemberhska:NorthAmericaSegmentMember2020-01-012020-12-310001038133us-gaap:OperatingSegmentsMemberhska:OtherRevenueOtherPharmaceuticalsVaccinesAndDiagnosticTestsMemberhska:NorthAmericaSegmentMember2019-01-012019-12-310001038133us-gaap:OperatingSegmentsMemberhska:OtherRevenueOtherPharmaceuticalsVaccinesAndDiagnosticTestsMemberhska:NorthAmericaSegmentMember2018-01-012018-12-310001038133us-gaap:OperatingSegmentsMemberhska:NorthAmericaSegmentMemberhska:OVPMember2020-01-012020-12-310001038133us-gaap:OperatingSegmentsMemberhska:NorthAmericaSegmentMemberhska:OVPMember2019-01-012019-12-310001038133us-gaap:OperatingSegmentsMemberhska:NorthAmericaSegmentMemberhska:OVPMember2018-01-012018-12-310001038133us-gaap:OperatingSegmentsMemberhska:NorthAmericaSegmentMember2020-01-012020-12-310001038133us-gaap:OperatingSegmentsMemberhska:NorthAmericaSegmentMember2019-01-012019-12-310001038133us-gaap:OperatingSegmentsMemberhska:NorthAmericaSegmentMember2018-01-012018-12-310001038133us-gaap:OperatingSegmentsMemberhska:InternationalSegmentMemberhska:PointOfCareLaboratoryRevenueLabInstrumentsAndOtherMember2020-01-012020-12-310001038133us-gaap:OperatingSegmentsMemberhska:InternationalSegmentMemberhska:PointOfCareLaboratoryRevenueLabInstrumentsAndOtherMember2019-01-012019-12-310001038133us-gaap:OperatingSegmentsMemberhska:InternationalSegmentMemberhska:PointOfCareLaboratoryRevenueLabInstrumentsAndOtherMember2018-01-012018-12-310001038133us-gaap:OperatingSegmentsMemberhska:InternationalSegmentMemberhska:PointOfCareLaboratoryRevenueSalesTypeLeasesMember2020-01-012020-12-310001038133us-gaap:OperatingSegmentsMemberhska:InternationalSegmentMemberhska:PointOfCareLaboratoryRevenueSalesTypeLeasesMember2019-01-012019-12-310001038133us-gaap:OperatingSegmentsMemberhska:InternationalSegmentMemberhska:PointOfCareLaboratoryRevenueSalesTypeLeasesMember2018-01-012018-12-310001038133us-gaap:OperatingSegmentsMemberhska:PointOfCareLaboratoryRevenueOperatingLeasesMemberhska:InternationalSegmentMember2020-01-012020-12-310001038133us-gaap:OperatingSegmentsMemberhska:PointOfCareLaboratoryRevenueOperatingLeasesMemberhska:InternationalSegmentMember2019-01-012019-12-310001038133us-gaap:OperatingSegmentsMemberhska:PointOfCareLaboratoryRevenueOperatingLeasesMemberhska:InternationalSegmentMember2018-01-012018-12-310001038133us-gaap:OperatingSegmentsMemberhska:InternationalSegmentMemberhska:PointOfCareLaboratoryRevenueConsumablesMember2020-01-012020-12-310001038133us-gaap:OperatingSegmentsMemberhska:InternationalSegmentMemberhska:PointOfCareLaboratoryRevenueConsumablesMember2019-01-012019-12-310001038133us-gaap:OperatingSegmentsMemberhska:InternationalSegmentMemberhska:PointOfCareLaboratoryRevenueConsumablesMember2018-01-012018-12-310001038133us-gaap:OperatingSegmentsMemberhska:PointOfCareLaboratoryRevenueImagingMemberhska:InternationalSegmentMember2020-01-012020-12-310001038133us-gaap:OperatingSegmentsMemberhska:PointOfCareLaboratoryRevenueImagingMemberhska:InternationalSegmentMember2019-01-012019-12-310001038133us-gaap:OperatingSegmentsMemberhska:PointOfCareLaboratoryRevenueImagingMemberhska:InternationalSegmentMember2018-01-012018-12-310001038133us-gaap:OperatingSegmentsMemberhska:OtherRevenueOtherPharmaceuticalsVaccinesAndDiagnosticTestsMemberhska:InternationalSegmentMember2020-01-012020-12-310001038133us-gaap:OperatingSegmentsMemberhska:OtherRevenueOtherPharmaceuticalsVaccinesAndDiagnosticTestsMemberhska:InternationalSegmentMember2019-01-012019-12-310001038133us-gaap:OperatingSegmentsMemberhska:OtherRevenueOtherPharmaceuticalsVaccinesAndDiagnosticTestsMemberhska:InternationalSegmentMember2018-01-012018-12-310001038133us-gaap:OperatingSegmentsMemberhska:OVPMemberhska:InternationalSegmentMember2020-01-012020-12-310001038133us-gaap:OperatingSegmentsMemberhska:OVPMemberhska:InternationalSegmentMember2019-01-012019-12-310001038133us-gaap:OperatingSegmentsMemberhska:OVPMemberhska:InternationalSegmentMember2018-01-012018-12-3100010381332021-01-012020-12-3100010381332022-01-012020-12-3100010381332023-01-012020-12-3100010381332024-01-012020-12-3100010381332025-01-012020-12-3100010381332026-01-012020-12-310001038133hska:ScilAnimalCareCompanyMember2020-04-010001038133hska:ScilAnimalCareCompanyMember2020-04-012020-04-010001038133hska:InternationalSegmentMemberhska:ScilAnimalCareCompanyMember2020-04-010001038133hska:NorthAmericaSegmentMemberhska:ScilAnimalCareCompanyMember2020-04-010001038133hska:ScilAnimalCareCompanyMember2020-12-310001038133us-gaap:CustomerRelationshipsMemberhska:ScilAnimalCareCompanyMember2020-04-012020-04-010001038133us-gaap:SoftwareDevelopmentMemberhska:ScilAnimalCareCompanyMember2020-04-012020-04-010001038133us-gaap:OrderOrProductionBacklogMemberhska:ScilAnimalCareCompanyMember2020-04-012020-04-010001038133us-gaap:NoncompeteAgreementsMemberhska:ScilAnimalCareCompanyMember2020-04-012020-04-010001038133us-gaap:TradeNamesMemberhska:ScilAnimalCareCompanyMember2020-04-012020-04-010001038133us-gaap:TradeNamesMemberhska:ScilAnimalCareCompanyMember2020-04-012020-04-010001038133hska:ScilAnimalCareCompanyMember2020-04-012020-09-300001038133hska:CVMMember2019-12-050001038133hska:CVMMember2019-12-052019-12-050001038133hska:CVMMemberus-gaap:CustomerRelationshipsMember2019-12-052019-12-050001038133hska:CVMMemberus-gaap:TradeNamesMember2019-12-052019-12-050001038133hska:CVMMemberus-gaap:DevelopedTechnologyRightsMember2019-12-052019-12-050001038133hska:CVMMember2019-12-062019-12-310001038133hska:OptomedMember2019-02-220001038133hska:OptomedMember2019-02-222019-02-220001038133hska:OptomedMember2020-10-050001038133hska:OptomedMember2020-10-052020-10-050001038133hska:CuattroLLCMember2018-12-212018-12-2100010381332018-12-210001038133hska:HeskaImagingMemberhska:CuattroLLCMember2020-01-012020-12-310001038133hska:HeskaImagingMemberhska:CuattroLLCMember2019-01-012019-12-310001038133hska:HeskaImagingMemberhska:CuattroLLCMember2018-01-012018-12-310001038133srt:AffiliatedEntityMemberhska:CVMPracticeMember2020-01-012020-12-310001038133srt:AffiliatedEntityMemberhska:CVMPracticeMember2020-12-310001038133srt:AffiliatedEntityMemberhska:CVMPracticeMember2019-01-012019-12-310001038133srt:AffiliatedEntityMemberhska:CVMPracticeMember2019-12-310001038133hska:GeneralFluidicsCorporationMember2018-09-242018-09-240001038133hska:GeneralFluidicsCorporationMember2020-12-310001038133hska:GeneralFluidicsCorporationMember2018-09-242018-09-240001038133hska:MBioDiagnosticsInc.Member2018-08-082018-08-080001038133hska:OptomedMember2020-01-012020-12-310001038133hska:OptomedMember2019-01-012019-12-310001038133hska:OptomedMember2018-01-012018-12-310001038133us-gaap:DomesticCountryMember2020-01-012020-12-310001038133us-gaap:ForeignCountryMember2020-01-012020-12-310001038133us-gaap:DomesticCountryMember2019-01-012019-12-310001038133us-gaap:ForeignCountryMember2019-01-012019-12-310001038133us-gaap:DomesticCountryMember2018-01-012018-12-310001038133us-gaap:DomesticCountryMember2020-12-310001038133us-gaap:ForeignCountryMember2020-12-310001038133us-gaap:DomesticCountryMemberus-gaap:ResearchMember2020-12-310001038133hska:TaxYears2018through2022Member2020-12-310001038133hska:TaxYears2024Through2025Member2020-12-310001038133hska:TaxYear2027Member2020-12-310001038133us-gaap:ConvertiblePreferredStockMember2020-01-012020-12-310001038133us-gaap:ConvertiblePreferredStockMember2019-01-012019-12-310001038133us-gaap:ConvertiblePreferredStockMember2018-01-012018-12-310001038133hska:SeniorConvertibleNoteMember2020-01-012020-12-310001038133hska:SeniorConvertibleNoteMember2019-01-012019-12-310001038133hska:SeniorConvertibleNoteMember2018-01-012018-12-310001038133hska:StockOptionsAndRestrictedUnitsMember2020-01-012020-12-310001038133hska:StockOptionsAndRestrictedUnitsMember2019-01-012019-12-310001038133hska:StockOptionsAndRestrictedUnitsMember2018-01-012018-12-310001038133us-gaap:ConvertibleDebtMemberhska:SeniorConvertibleNoteMember2019-09-170001038133hska:SeriesXConvertiblePreferredStockMember2020-04-142020-04-140001038133us-gaap:CommonStockMember2020-04-142020-04-140001038133us-gaap:OperatingSegmentsMemberhska:NorthAmericaSegmentMember2018-12-310001038133us-gaap:OperatingSegmentsMemberhska:InternationalSegmentMember2018-12-310001038133us-gaap:OperatingSegmentsMemberhska:InternationalSegmentMember2019-01-012019-12-310001038133us-gaap:OperatingSegmentsMemberhska:NorthAmericaSegmentMember2019-12-310001038133us-gaap:OperatingSegmentsMemberhska:InternationalSegmentMember2019-12-310001038133us-gaap:OperatingSegmentsMemberhska:InternationalSegmentMember2020-01-012020-12-310001038133us-gaap:OperatingSegmentsMemberhska:NorthAmericaSegmentMember2020-12-310001038133us-gaap:OperatingSegmentsMemberhska:InternationalSegmentMember2020-12-310001038133hska:CustomerRelationshipsAndOtherMember2020-12-310001038133hska:CustomerRelationshipsAndOtherMember2019-12-310001038133us-gaap:DevelopedTechnologyRightsMember2020-12-310001038133us-gaap:DevelopedTechnologyRightsMember2019-12-310001038133us-gaap:TradeNamesMember2020-12-310001038133us-gaap:TradeNamesMember2019-12-310001038133us-gaap:TradeNamesMember2020-12-310001038133us-gaap:TradeNamesMember2019-12-310001038133us-gaap:LandMember2020-12-310001038133us-gaap:LandMember2019-12-310001038133us-gaap:BuildingMember2020-12-310001038133us-gaap:BuildingMember2019-12-310001038133us-gaap:MachineryAndEquipmentMember2020-12-310001038133us-gaap:MachineryAndEquipmentMember2019-12-310001038133hska:OfficeFurnitureAndEquipmentMember2020-12-310001038133hska:OfficeFurnitureAndEquipmentMember2019-12-310001038133hska:ComputerHardwareAndSoftwareMember2020-12-310001038133hska:ComputerHardwareAndSoftwareMember2019-12-310001038133hska:LeaseholdandBuildingImprovementsMember2020-12-310001038133hska:LeaseholdandBuildingImprovementsMember2019-12-310001038133us-gaap:ConstructionInProgressMember2020-12-310001038133us-gaap:ConstructionInProgressMember2019-12-310001038133srt:MinimumMemberhska:InventoryTransferredToMachineryAndEquipmentMember2020-01-012020-12-310001038133hska:InventoryTransferredToMachineryAndEquipmentMembersrt:MaximumMember2020-01-012020-12-310001038133hska:LeasedEquipmentMember2020-12-310001038133hska:LeasedEquipmentMember2019-12-31hska:plans0001038133hska:SharePurchasePlan1997Member2012-05-012012-05-310001038133hska:SharePurchasePlan1997Member2016-05-012016-05-310001038133hska:SharePurchasePlan1997Member2018-05-012018-05-310001038133hska:SharePurchasePlan1997Member2020-04-012020-04-300001038133hska:SharePurchasePlan2003Member2003-05-310001038133hska:SharePurchasePlan1997Member2020-12-310001038133hska:IncentiveStockOptionsMember2020-01-012020-12-310001038133us-gaap:EmployeeStockOptionMember2019-12-310001038133us-gaap:EmployeeStockOptionMember2020-01-012020-12-310001038133us-gaap:EmployeeStockOptionMember2020-12-310001038133hska:ExercisePriceRangeOneMember2020-12-310001038133hska:ExercisePriceRangeOneMember2020-01-012020-12-310001038133hska:ExercisePriceRangeTwoMember2020-12-310001038133hska:ExercisePriceRangeTwoMember2020-01-012020-12-310001038133hska:ExercisePriceRangeThreeMember2020-12-310001038133hska:ExercisePriceRangeThreeMember2020-01-012020-12-310001038133hska:ExercisePriceRangeFourMember2020-12-310001038133hska:ExercisePriceRangeFourMember2020-01-012020-12-310001038133hska:ExercisePriceRangeFiveMember2020-12-310001038133hska:ExercisePriceRangeFiveMember2020-01-012020-12-310001038133hska:ExercisePriceRangeSixMember2020-12-310001038133hska:ExercisePriceRangeSixMember2020-01-012020-12-310001038133us-gaap:PerformanceSharesMember2020-04-162020-04-160001038133us-gaap:ShareBasedCompensationAwardTrancheOneMemberus-gaap:PerformanceSharesMember2020-04-162020-04-160001038133us-gaap:PerformanceSharesMember2020-01-012020-12-310001038133us-gaap:PerformanceSharesMember2020-12-310001038133srt:MaximumMemberus-gaap:RestrictedStockMember2020-01-012020-12-310001038133us-gaap:RestrictedStockUnitsRSUMember2019-12-310001038133us-gaap:RestrictedStockUnitsRSUMember2020-01-012020-12-310001038133us-gaap:RestrictedStockUnitsRSUMember2020-12-310001038133us-gaap:RestrictedStockUnitsRSUMember2019-01-012019-12-310001038133us-gaap:RestrictedStockUnitsRSUMember2018-01-012018-12-310001038133us-gaap:RestrictedStockMember2020-12-310001038133us-gaap:EmployeeStockMember2020-01-012020-12-310001038133us-gaap:EmployeeStockMember2019-01-012019-12-310001038133us-gaap:EmployeeStockMember2018-01-012018-12-310001038133us-gaap:PreferredStockMember2020-03-300001038133us-gaap:PreferredStockMember2020-03-302020-03-300001038133hska:ScilAnimalCareCompanyMember2020-03-302020-03-300001038133srt:MinimumMemberus-gaap:RestrictedStockMember2020-01-012020-12-310001038133us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2018-12-310001038133us-gaap:AccumulatedTranslationAdjustmentMember2018-12-310001038133hska:AccumulatedForeignCurrencyGainOnIntraEntityTransactionsMember2018-12-310001038133us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-12-310001038133us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-01-012019-12-310001038133us-gaap:AccumulatedTranslationAdjustmentMember2019-01-012019-12-310001038133hska:AccumulatedForeignCurrencyGainOnIntraEntityTransactionsMember2019-01-012019-12-310001038133us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-01-012019-12-310001038133us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-12-310001038133us-gaap:AccumulatedTranslationAdjustmentMember2019-12-310001038133hska:AccumulatedForeignCurrencyGainOnIntraEntityTransactionsMember2019-12-310001038133us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310001038133us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-01-012020-12-310001038133us-gaap:AccumulatedTranslationAdjustmentMember2020-01-012020-12-310001038133hska:AccumulatedForeignCurrencyGainOnIntraEntityTransactionsMember2020-01-012020-12-310001038133us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-12-310001038133us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-12-310001038133us-gaap:AccumulatedTranslationAdjustmentMember2020-12-310001038133hska:AccumulatedForeignCurrencyGainOnIntraEntityTransactionsMember2020-12-310001038133us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-3100010381332019-02-282019-02-280001038133us-gaap:ConvertibleDebtMemberhska:SeniorConvertibleNoteMemberhska:InitialPurchasersMember2019-09-170001038133hska:SeniorConvertibleNoteMember2019-09-172019-09-170001038133us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2020-01-012020-12-310001038133us-gaap:LineOfCreditMemberus-gaap:LetterOfCreditMember2020-12-310001038133us-gaap:ConvertibleDebtMemberhska:SeniorConvertibleNoteMember2019-09-172019-09-17hska:day0001038133us-gaap:ConvertibleDebtMemberus-gaap:DebtInstrumentRedemptionPeriodOneMemberhska:SeniorConvertibleNoteMember2019-09-172019-09-170001038133us-gaap:ConvertibleDebtMemberus-gaap:DebtInstrumentRedemptionPeriodTwoMemberhska:SeniorConvertibleNoteMember2019-09-172019-09-170001038133us-gaap:ConvertibleDebtMemberus-gaap:DebtInstrumentRedemptionPeriodThreeMemberhska:SeniorConvertibleNoteMember2019-09-172019-09-170001038133us-gaap:ConvertibleDebtMember2019-09-170001038133us-gaap:ConvertibleDebtMemberhska:SeniorConvertibleNoteMember2020-12-310001038133us-gaap:ConvertibleDebtMemberhska:SeniorConvertibleNoteMember2020-01-012020-12-310001038133us-gaap:ConvertibleDebtMemberhska:SeniorConvertibleNoteMember2019-12-310001038133us-gaap:ConvertibleDebtMemberhska:SeniorConvertibleNoteMember2019-01-012019-12-310001038133us-gaap:FairValueInputsLevel2Memberhska:SeniorConvertibleNoteMember2020-12-310001038133hska:SeniorConvertibleNoteMember2020-01-012020-12-310001038133hska:ConvertibleNoteReceivableMemberus-gaap:EquityMethodInvesteeMember2020-12-310001038133hska:ConvertibleNoteReceivableMemberus-gaap:EquityMethodInvesteeMember2020-12-092020-12-090001038133us-gaap:OperatingSegmentsMemberhska:InternationalSegmentMember2018-01-012018-12-310001038133country:US2020-01-012020-12-310001038133country:US2019-01-012019-12-310001038133country:US2018-01-012018-12-310001038133country:CA2020-01-012020-12-310001038133country:CA2019-01-012019-12-310001038133country:CA2018-01-012018-12-310001038133country:DE2020-01-012020-12-310001038133country:DE2019-01-012019-12-310001038133country:DE2018-01-012018-12-310001038133country:FR2020-01-012020-12-310001038133country:FR2019-01-012019-12-310001038133country:FR2018-01-012018-12-310001038133country:ES2020-01-012020-12-310001038133country:ES2019-01-012019-12-310001038133country:ES2018-01-012018-12-310001038133country:IT2020-01-012020-12-310001038133country:IT2019-01-012019-12-310001038133country:IT2018-01-012018-12-310001038133country:CH2020-01-012020-12-310001038133country:CH2019-01-012019-12-310001038133country:CH2018-01-012018-12-310001038133hska:OtherInternationalMember2020-01-012020-12-310001038133hska:OtherInternationalMember2019-01-012019-12-310001038133hska:OtherInternationalMember2018-01-012018-12-310001038133country:US2020-12-310001038133country:US2019-12-310001038133country:US2018-12-310001038133country:CA2020-12-310001038133country:CA2019-12-310001038133country:CA2018-12-310001038133country:DE2020-12-310001038133country:DE2019-12-310001038133country:DE2018-12-310001038133country:FR2020-12-310001038133country:FR2019-12-310001038133country:FR2018-12-310001038133country:ES2020-12-310001038133country:ES2019-12-310001038133country:ES2018-12-310001038133country:IT2020-12-310001038133country:IT2019-12-310001038133country:IT2018-12-310001038133country:CH2020-12-310001038133country:CH2019-12-310001038133country:CH2018-12-310001038133hska:OtherInternationalMember2020-12-310001038133hska:OtherInternationalMember2019-12-310001038133hska:OtherInternationalMember2018-12-310001038133hska:CovetrusMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2020-01-012020-12-310001038133hska:CovetrusMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2019-01-012019-12-310001038133hska:CovetrusMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2018-01-012018-12-310001038133srt:NorthAmericaMemberhska:CovetrusMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2020-01-012020-12-310001038133srt:NorthAmericaMemberhska:CovetrusMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2019-01-012019-12-310001038133srt:NorthAmericaMemberhska:CovetrusMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2018-01-012018-12-310001038133hska:InternationalMemberhska:CovetrusMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2020-01-012020-12-310001038133hska:MerckMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2020-01-012020-12-310001038133hska:MerckMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2019-01-012019-12-310001038133hska:MerckMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2018-01-012018-12-310001038133hska:LacunaDiagnosticsIncMemberus-gaap:SubsequentEventMember2021-02-012021-02-010001038133hska:LacunaDiagnosticsIncMemberhska:PerformanceMetricEarnOutInitialPeriodMemberus-gaap:SubsequentEventMember2021-02-010001038133hska:LacunaDiagnosticsIncMemberhska:PerformanceMetricEarnOutInitialPeriodMemberus-gaap:SubsequentEventMember2021-02-012021-02-010001038133hska:LacunaDiagnosticsIncMemberus-gaap:SubsequentEventMemberhska:PerformanceMetricEarnOutSubsequentPeriodMember2021-02-012021-02-010001038133us-gaap:SubsequentEventMemberus-gaap:EquityMethodInvesteeMember2021-02-012021-02-01hska:payment0001038133us-gaap:SubsequentEventMemberus-gaap:EquityMethodInvesteeMember2021-02-01


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
(Mark One)
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2020
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from _________________ to _______________________
Commission file number: 000-22427
hska-20201231_g1.jpg
HESKA CORPORATION
(Exact name of registrant as specified in its charter)
Delaware77-0192527
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification Number)
3760 Rocky Mountain Avenue Loveland, Colorado
80538
(Address of principal executive offices)(Zip Code)
Registrant's telephone number, including area code: (970493-7272
Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading SymbolName of each exchange on which registered
Common stock, $0.01 par valueHSKAThe Nasdaq Stock Market LLC
Securities registered pursuant to Section 12(g) of the Act: None


Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes No

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes    No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes   No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.



Large Accelerated filer
Accelerated filer
Non-accelerated filer
Smaller Reporting Company
Emerging Growth Company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C.7262(b)) by the registered public accounting firm that prepared or issued its audit report.                            

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).  Yes   No 

The aggregate market value of voting common stock held by non-affiliates of the Registrant was approximately $806,427,745 as of June 30, 2020 based upon the closing price on the Nasdaq Capital Market reported for such date. This calculation does not reflect a determination that certain persons are affiliates of the Registrant for any other purpose.

9,477,240 shares of the Registrant's Public Common Stock, $.01 par value, were outstanding at February 25, 2021.
___________________________________
DOCUMENTS INCORPORATED BY REFERENCE
Items 10, 11, 12, 13 and 14 of Part III incorporate by reference information from the Registrant's definitive proxy statement to be filed with the Securities and Exchange Commission in connection with the solicitation of proxies for the Registrant's 2021 Annual Meeting of Stockholders to be held on or about May 5, 2021.



TABLE OF CONTENTS
 
   Page
 
 Item 1.
 Item 1A.
 Item 1B.
 Item 2.
 Item 3.
 Item 4.
 Item 5.
 Item 7.
 Item 7A.
 Item 8.
 Item 9.
 Item 9A.
 Item 9B.
 Item 10.
 Item 11.
 Item 12.
 Item 13.
 Item 14.
 
 Item 15.
Item 16.
 

HESKA, scil, ALLERCEPT, HemaTrue, Solo Step, Element DC, Element HT5, Element POC, Element i, Element i+, Element COAG, Element DC5X and Element RC, Element RCX, Element RCX3 and scil vet, scil academy, scil vIP, scil ABC are registered trademarks of Heska Corporation. DRI-CHEM is a registered trademark of FUJIFILM Corporation. TRI-HEART is a registered trademark of Intervet Inc., d/b/a Merck Animal Health, formerly known as Schering-Plough Animal Health Corporation ("Merck Animal Health"), which is a unit of Merck & Co., Inc., in the United States and is a registered trademark of Heska Corporation in other countries. This Annual Report on Form 10-K also refers to trademarks and trade names of other organizations.


-i-


Statement Regarding Forward Looking Statements
This Form 10-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). For this purpose, any statements contained herein that are not statements of current or historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, words such as "scheduled," "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Therefore, actual results could differ materially from those expressed or forecasted in any such forward-looking statements as a result of certain factors. Such factors are set forth in "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations," "Business" and elsewhere in this Form 10-K and include, among others, risks and uncertainties related to:
the impact of the COVID-19 pandemic on consumer demand, our global supply chain and our financial and operational results;
the success of third parties in marketing our products;
outside business interests of our Chief Executive Officer;
our reliance on third party suppliers and collaborative partners;
our dependence on key personnel;
our dependence upon a number of significant customers;
competitive conditions in our industry;
our dependence on third parties to successfully develop new products;
our ability to market and sell our products successfully;
expansion of our international operations;
the impact of regulation on our business;
the success of our acquisitions and other strategic development opportunities;
our ability to develop, commercialize and gain market acceptance of our products;
cybersecurity incidents and related disruptions and our ability to protect our stakeholders’ privacy;
product returns or liabilities;
volatility of our stock price;
our ability to service our convertible notes and comply with their terms.
Readers are cautioned not to place undue reliance on these forward-looking statements.
Although we believe that expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect the passage of time, any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based, except as otherwise required by applicable securities laws. These forward-looking statements apply only as of the date of this Form 10-K or for statements incorporated by reference from our 2021 proxy statement on Schedule 14A, as of the date of the Schedule 14A.
PART I
Item 1. Business
Unless we state otherwise or the context otherwise requires, the terms "Heska," "we," "our," "us" and the "Company" refer to Heska Corporation and its consolidated subsidiaries.
-1-


Our Certificate of Incorporation, as amended (the “Charter”), authorizes three classes of stock: Original Common Stock, Public Common Stock, and Preferred Stock.  Pursuant to an NOL Protective Amendment to the Charter adopted in 2010, all shares of Original Common Stock then outstanding were automatically reclassified into shares of Public Common Stock.  Our Public Common Stock trades on the Nasdaq Stock Market LLC.  In this Annual Report on Form 10-K, references to “Public Common Stock” and “common stock” are references to our Public Common Stock, unless the context otherwise requires.
Overview
We sell veterinary and animal health diagnostic and specialty products. Our offerings include Point of Care diagnostic laboratory instruments and consumables; Point of Care digital imaging diagnostic products; digital cytology services; vaccines; local and cloud-based data services; allergy testing and immunotherapy; and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. Our core focus is on supporting veterinarians in the canine and feline healthcare space.
On February 24, 2013, the Company acquired a majority interest in Cuattro Veterinary USA, LLC which was subsequently renamed Heska Imaging US, LLC ("U.S. Imaging"). The remaining minority position in U.S. Imaging was purchased on May 31, 2017.
On May 31, 2016, the Company acquired Cuattro Veterinary, LLC ("Cuattro International"), which was subsequently renamed Heska Imaging International, LLC ("International Imaging"). As of this date the Company's interest in both International Imaging and U.S. Imaging was transferred to the Company's wholly owned subsidiary, Heska Imaging Global, LLC ("Global Imaging").
On June 1, 2017, the Company consolidated its assets and liabilities in the U.S. Imaging and International Imaging companies into Global Imaging, which was re-named Heska Imaging, LLC ("Heska Imaging"). Heska Imaging was subsequently dissolved on March 31, 2020.
    
On June 13, 2017, the Company incorporated Heska Canada Limited in the province of British Columbia, in order to expand our footprint into more of the North American veterinary market.

On July 26, 2018, the Company incorporated Heska Australia Pty Ltd in the state of Victoria, in order to expand our footprint into the Australian veterinary market.

On February 22, 2019, the Company acquired 70% of the equity of Optomed. Optomed designs, develops, manufactures and distributes veterinary imaging solutions, with a primary focus and expertise in endoscopy technologies and has a direct sales presence in France. On November 4, 2019 the Company acquired A. DUCHENE IMMO ("SCI Duchene"). SCI Duchene owns real estate in which Optomed operates.

On December 5, 2019, the Company acquired CVM Diagnostico Veterinario, S.L. and CVM Ecografia, jointly known as the CVM Companies ("CVM"). CVM is a Spanish company that primarily sells and performs marketing of medical equipment to veterinary clinics.

On April 1, 2020, the Company completed the acquisition of scil animal care company GmbH ("scil") from Covetrus, Inc. scil represents a key milestone in the Company's long-term strategic plan creating a global veterinary diagnostics company with leadership positions in key geographic markets. Scil has operations in Germany, France, Italy, Spain, Canada, and Malaysia.

On October 5, 2020 the Company acquired the remaining 30% minority interest in Optomed. The Company had previously acquired 70% of the equity of Optomed in February 2019. The purchase allows the Company to assume full control of the business operations.
-2-



On February 1, 2021 the Company acquired Lacuna Diagnostics, Inc. ("Lacuna"). Lacuna is a United States based company that specializes in digital cytology services. The purchase allows the Company to broaden our point of care diagnostics offering.
Products and Services
Our business is composed of two operating and reportable segments: North America and International. North America consists of the United States, Canada and Mexico. International consists of geographies outside of North America, primarily our operations in Australia, France, Germany, Italy, Malaysia, Spain and Switzerland. Point of Care laboratory and imaging products, which are the Company's core strategic focus, are included in both segments. The North America segment also includes the contract manufacturing of vaccines and pharmaceutical products.
Our major product categories sold in both segments include: Point of Care laboratory instruments and consumables; digital imaging diagnostic instruments, software and services; digital cytology services; local and cloud-based data services; allergy testing and immunotherapy; and single use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production, which are sold by third parties under third party labels.
For the year ended December 31, 2020, our North America and International segments represent approximately 66% and 34% of our total revenue, respectively.
Point of Care Laboratory and Imaging Diagnostics
We offer a line of veterinary Point of Care (stationary and portable) laboratory diagnostic instruments for testing blood and other biological materials, for use in diagnostic imaging and for other uses, some of which are described below. We also market and sell consumable supplies and services for these instruments. Our line of veterinary instruments includes the following:
Blood Chemistry. Element DC® Veterinary Chemistry Analyzer (the "Element DC") is an easy-to-use, robust system that uses dry slide technology for blood chemistry and electrolyte analysis and has the ability to run 22 tests at a time with a single blood sample. Test slides are available as both pre-packaged panels as well as individual slides. The Element DC5x® Veterinary Chemistry Analyzer (the "Element DC5x"), launched during 2018, delivers faster run times, higher throughput, and allows simultaneous staging of five patient samples. The Element DC and Element DC5x utilize the same test slides. We are supplied with the Element DC and Element DC5x, as well as the affiliated test slides and supplies, under a contractual agreement with FUJIFILM Corporation.
We also market and distribute the Element RC® and Element RCXTM, easy-to-use, compact chemistry systems that utilize load-and-go rotors for blood chemistry and electrolyte analysis. A small volume of whole blood can be loaded on the rotor, eliminating the need for external centrifugation. Rotors of various test menus are available, providing results in some cases for up to 21 measured tests, including additional calculated values. The Element RC3XTM launched during 2020 and delivers a three-bay rotor solution for higher throughput and additional testing parameters. We are supplied with the Element RC and the Element RCX and RC3X under contractual agreements with various suppliers.

Hematology. The Element HT5® Hematology Analyzer (the "HT5") is a true 5-part hematology analyzer which measures key parameters such as white blood cell count, red blood cell count, platelet count and hemoglobin levels in animals. The HT5 can generate results in less than a minute with 15 µL of sample. We are supplied with the HT5 and affiliated reagents and supplies under a contractual agreement with Shenzen
-3-


Mindray Bio-Medical Electronics Co., Ltd. ("Mindray"). We also market the scil Vet abc Plus +TM, a 4-part hematology analyzer that provides results in less than a minute with 10 µL of sample.
Blood Gases and Electrolytes. The Element POC® Blood Gas & Electrolyte Analyzer (the "EPOC") is a handheld, wireless analyzer which delivers rapid blood gas, electrolyte, metabolite and basic blood chemistry testing. The EPOC features test cards with room temperature storage which can offer results with less than 100 µL of sample as well as WiFi and Bluetooth connectivity.
Immunodiagnostics. The Element i® Immunodiagnostic Analyzer (the "Element i") utilizes fluorescence immunoassay technology to ensure sensitivity for accurate in-clinic detection of Total T4, TSH, Cortisol, Bile Acids, and Progesterone. The Element i is a benchtop technology with a test time of 10 minutes or less per analyte. Along with confidence in results, this measurement principle allows for simplified reagents and testing protocols. The Element i+® Immunodiagnostic Analyzer (the "Element i+"), launched during 2020, utilizes patented fluorescence waveguide immunoassay technology with laser evanescent illumination for accurate in-clinic detection of Total T4 and Cortisol. The Element i+ delivers results in as little as 5 minutes from a sample volume of 100ul, using microfluidic cartridges stored at room temperature. The Element i+ analyzer system has capability of high sensitivity and specificity multiplexed assays in a single microfluidic cartridge, offering future menu expansions in endocrine, inflammatory, infectious disease, and other diagnostic target areas. The Cube-VetTM is a compact benchtop analyzer used for the determination of the parameters fibrinogen, cCRP, SAA, T4, fructosamine, pancreas-specific lipase (dog / cat), ammonia, GLDH, lactate, progesterone, bile acids, phenobarbital and SDMA.
Coagulation. The Element COAG® Veterinary Analyzer (the "Element COAG") is a compact benchtop, cartridge-based system used for coagulation and specialty testing. There are five test cartridges offered: the PT/aPTT Coag Combo, Equine Fibrinogen, Canine Fibrinogen, Canine DEA 1 Blood Typing and Feline A and B Blood Typing. Each of these cartridges perform accurate, automated analysis using less than 100 µL of sample in just minutes.
IV Pumps. The VET/IV 2.2TM infusion pump is a compact, affordable IV pump that allows veterinarians to easily provide regulated infusion of fluids for their patients.
Digital Radiography. We sell hardware, including digital radiography detectors, acquisition workstation equipment, positioning aides, viewing computers, radiographic generators, anti-scatter grids and other accessories for use in digital radiography imaging diagnostics. With this hardware, we also provide licensed embedded software, support, data hosting, warranty and other services. CloudDRTM solutions combine flat panel digital radiography detectors, acquisition workstations and acquisition software to produce, review, archive and share radiographic image studies, primarily in fixed location companion animal veterinary settings.

We also sell mobile digital radiography products, primarily for equine use, such as the Cuattro Uno, a full powered, portable digital radiography generator integrated with an embedded touchscreen acquisition and review function. In addition to Cuattro Uno, we sell the Cuattro Hub, a mobile digital radiography acquisition console that is capable of operating as a general full field wireless x-ray imager and as the control and display for DentiPodTM, a large format equine intraoral dental sensor, and SonoPod TM, a wireless ultrasound.

In Europe, we sell radiography solutions, including flat panel or image plate x-ray scanners, acquisition workstations and acquisition software to produce, review, and archive radiographic image studies, primarily in fixed location companion animal veterinary settings.
Ultrasound Systems. We sell ultrasound products, including affiliated probes and peripherals, with varying features and corresponding price points from various suppliers.
-4-



Diagnostic Data and Support. CloudbankTM is an automatic, secure, web-based image storage solution designed to interface with the imaging products we sell. HeskaView+TM is a Picture Archival and Communications Systems (PACS) for web or local viewing, reporting, planning and email sharing of studies on Internet devices, including personal computers, tablet devices and smartphones. SupportCloudTM is a support package including call center voice and remote diagnostics, recovery and other services, such as the provision of warranty-related loaner units, to support customers. Access and operation between our imaging devices, CloudbankTM and SupportCloudTM is supported by the acquisition software used in the equipment we sell. On December 21, 2018, we closed on the purchase of the acquisition software previously provided by Cuattro in the amount of $8.2 million and terminated a supply and license agreement. See Note 3 to the financial statements included under Item 8 of this Annual Report on Form 10-K for related party and acquisition disclosures.

HeskaView and Heska’s Data Capture Utility (DCU) are modern and intuitively operated practice information software applications for point of care devices. The HeskaView software can be used as independent practice information reporting software for Heska analyzers. HeskaView and the DCU can be used as a middleware to bi-directionally connect Heska’s analyzers to a wide variety of Veterinary Practice Management Software platforms used throughout North America.

scil vIP® is a modern and intuitively operated practice information software for point of care devices. The software can be used as independent practice information software or as middleware to connect POC equipment throughout Europe. It further provides a web interface allowing the users to access the software even more easily.
Point of Care Heartworm Diagnostic Tests
Heartworm infections of dogs and cats are caused by the parasite Dirofilaria immitis. This parasitic worm is transmitted in larval form to dogs and cats through the bite of an infected mosquito. Larvae develop into adult worms that live in the pulmonary arteries and heart of the host, where they can cause serious cardiovascular, pulmonary, liver and kidney disease. Our canine and feline heartworm diagnostic tests use monoclonal antibodies or a recombinant heartworm antigen, respectively, to detect heartworm antigens or antibodies circulating in the blood of an infected animal.
Heartworm Preventive Products
We have an agreement with Merck Animal Health, a unit of Merck & Co., Inc., granting Merck Animal Health the exclusive distribution and marketing rights for our canine heartworm prevention product, Tri-Heart® Plus Chewable Tablets, ultimately sold to or through veterinarians in the U.S. Tri-Heart Plus Chewable Tablets (ivermectin/pyrantel) are indicated for use as a monthly preventive treatment of canine heartworm infection and for treatment and control of ascarid and hookworm infections. We manufacture Tri-Heart Plus Chewable Tablets at our Des Moines, Iowa production facility.
Allergy Products and Services
Allergy is common in companion animals. Clinical symptoms of allergy are variable, but are often manifested as persistent and serious skin disease in dogs and cats. Clinical management of allergic disease is problematic, as there are a large number of allergens that may give rise to these conditions. Although skin testing is often regarded as the most accurate diagnostic procedure, such tests can be painful, subjective and inconvenient. The effectiveness of the immunotherapy that is prescribed to treat symptoms of allergic disease is inherently limited by inaccuracies in the diagnostic process.
-5-



We believe that our ALLERCEPT® Definitive Allergen Panels provide the most accurate determination of which we are aware of the specific allergens to which an animal, such as a dog, cat or horse, is reacting. The panels use a highly specific recombinant version of the natural IgE receptor to test the serum of potentially allergic animals for IgE directed against a panel of known allergens. A typical test panel consists primarily of various pollen, grass, mold, insect and mite allergens. The test results serve as the basis for prescription ALLERCEPT® Therapy Shots and ALLERCEPT® Therapy Drops. We operate veterinary laboratories in Loveland, Colorado and Fribourg, Switzerland which both offer blood testing using our ALLERCEPT® Definitive Allergen Panels.

We sell kits to conduct blood testing using our ALLERCEPT® Definitive Allergen Panels to third party veterinary diagnostic laboratories outside of the U.S. We also sell products to screen for the presence of allergen-specific IgE to these customers. Animals testing positive for allergen-specific IgE using these screening tests are candidates for further evaluation using our ALLERCEPT® Definitive Allergen Panels.

Veterinarians who use our ALLERCEPT® Definitive Allergen Panels often purchase our ALLERCEPT® Therapy Shots or ALLERCEPT® Therapy Drops. These prescription immunotherapy treatment sets are formulated specifically for each allergic animal and contain only the allergens to which the animal has significant levels of IgE antibodies. The prescription formulations are administered in a series of subcutaneous injections (Shots) or by daily sublingual (under the tongue) administration (Drops), with doses increasing over several months, to ameliorate the allergic condition of the animal. Immunotherapy is generally continued for an extended time. We offer canine, feline and equine subcutaneous and sublingual immunotherapy treatment products. We believe our ALLERCEPT® Therapy Drops offer a convenient alternative to subcutaneous injection, thereby increasing the likelihood of pet owner compliance.
Other Vaccines and Pharmaceuticals ("OVP")
We developed a line of bovine vaccines that are licensed by the U.S. Department of Agriculture ("USDA"). In January 2015, we signed a long-term Master Supply Agreement related to these vaccines with Eli Lilly operating through Elanco.
We manufacture biological and pharmaceutical products for a number of other animal health companies. We manufacture products for animals other than cattle including horses, pigs, chickens, cats and dogs. Our offerings range from providing complete turnkey services which include research, licensing, production, labeling and packaging of products to providing any one of these services as needed by our customers as well as validation support and distribution services.
Marketing, Sales and Customer Support
We currently market our products to veterinarians through an outside field organization, a telephone sales force and independent third-party distributors, as well as through trade shows, print advertising and through other distribution relationships, such as Merck Animal Health in the case of our heartworm preventive. As of December 31, 2020, our customer facing sales, installed base support and utilization organization consisted of 144 and 124 individuals in various parts of our North America and International segments, respectively.
Veterinarians may obtain our products directly from us or indirectly through others. All of our products ultimately are sold primarily to or through veterinarians. The acceptance of our products by veterinarians is critical to our success. Internationally, we market our products to veterinarians primarily through third-party veterinary diagnostic laboratories and independent third party distributors, but through our recent acquisitions of scil, Optomed and CVM, and organic efforts in Australia, we have begun to market directly.
-6-



We have a staff dedicated to customer and product support including veterinarians, technical support specialists and service technicians. Individuals from our product development group may also be used as a resource in responding to certain product inquiries.
All OVP products are marketed and sold by third-parties under third-party labels.
We grant third parties rights to our intellectual property as well as our products, with our compensation often taking the form of royalties and/or milestone payments.
Manufacturing
The majority of our revenue is from proprietary products manufactured by third parties. Third parties manufacture our veterinary instruments, including affiliated consumables and supplies, as well as other products including key components of our heartworm point-of-care diagnostic tests.
Our facility in Des Moines, Iowa is a USDA, Food and Drug Administration ("FDA") and Drug Enforcement Agency ("DEA") licensed biological and pharmaceutical manufacturing facility. This facility currently has the capacity to manufacture more than 50 million doses of vaccine each year. We expect that we will, for the foreseeable future, manufacture most, or all of our pharmaceutical and biological products at this facility, as well as most, or all, of our recombinant proteins and other proprietary reagents for our diagnostic tests. We currently manufacture our canine heartworm prevention product, our allergy treatment products and all our OVP products at this facility.
The OVP products for our North America segment are purchased in both finished and bulk format, and we perform all phases of manufacturing, including growth of the active bacterial and viral agents, sterile filling, lyophilization and packaging at this facility. We manufacture our various allergy products at our Des Moines facility, our Loveland facility and our Fribourg facility. We believe the raw materials for most of the products we manufacture are readily available from more than one source.
Product Development
We are committed to providing innovative products to address the health needs of companion animals. We may obtain such products from external sources, external collaboration or internal research and development.
We are committed to identifying external product opportunities and creating business and technical collaborations that lead to high value veterinary products. We believe that our active participation in scientific networks and our reputation for investing in research enhances our ability to acquire external product opportunities. We have collaborated, and intend to continue to do so, with a number of companies and universities.
Internal research and development is managed on a case-by-case basis. We employ individuals with expertise in various applicable areas and will form multidisciplinary product-associated teams as appropriate.
Intellectual Property
We believe that patents, trademarks, copyrights and other proprietary rights represent opportunities to grow our business and maintain or enhance our competitive position. We also rely upon trade secrets, know-how, continuing technological innovations and licensing opportunities to develop and maintain our competitive position. The proprietary technologies of our OVP products are primarily protected through trade secret protection of, for example, our manufacturing processes in this area.
-7-



We actively seek patent protection both in the U.S. and abroad. Our issued patent portfolios primarily relate to allergy, diagnostic and detection tests, and vaccine delivery technologies. As of December 31, 2020, we owned, co-owned or had rights to 5 issued U.S. patents expiring at various dates from April 2021 to April 2024 and had 2 pending U.S. patent application. Our corresponding foreign patent portfolio as of December 31, 2020 included 7 issued patents in various foreign countries expiring at various dates from February 2021 to August 2024 and no pending applications.
We also have obtained exclusive and non-exclusive licenses for numerous other patents held by academic institutions and for-profit companies.
Seasonality
While we do not experience significant seasonal fluctuations in our sales throughout the year, we generally experience higher sales in the fourth quarter due to industry trade shows and other similar activities.
Government Regulation
Although the majority of our revenue is from the sale of unregulated items, many of our products or products that we may develop are, or may be, subject to extensive regulation by governmental authorities in the U.S., including the USDA and the FDA and by similar agencies in other countries. These regulations govern, among other things, the development, testing, manufacturing, labeling, storage, pre-market approval, advertising, promotion, sale and distribution of our products. Satisfaction of these requirements can take several years to achieve and the time needed to satisfy them may vary substantially, based on the type, complexity and novelty of the product. Any product that we develop must receive all relevant regulatory approval or clearances, if required, before it may be marketed in a particular country. The following summarizes the major U.S. government agencies that regulate animal health products:

USDA.  Vaccines and certain single use, point-of-care diagnostics are considered veterinary biologics and are therefore regulated by the Center for Veterinary Biologics, or CVB, of the USDA. In contrast to vaccines, single use, point-of-care diagnostics can typically be licensed by the USDA in about two years, at considerably less cost. However, vaccines or diagnostics that use innovative materials, such as those resulting from recombinant DNA technology, usually require additional time to license. The USDA licensing process involves the submission of several data packages. These packages include information on how the product will be manufactured, information on the efficacy and safety of the product in laboratory and target animal studies and information on performance of the product in field conditions.

FDA.  Pharmaceutical products, which typically include synthetic compounds, are approved and monitored by the Center for Veterinary Medicine of the FDA. Under the Federal Food, Drug and Cosmetic Act, the same statutory standard for FDA approval applies to both human and animal drugs: demonstrated safety, efficacy and compliance with FDA manufacturing standards. However, unlike human drugs, neither preclinical studies nor a sequential phase system of studies are required. Rather, for animal drugs, studies for safety and efficacy may be conducted immediately in the species for which the drug is intended. Thus, there is no required phased evaluation of drug performance, and the Center for Veterinary Medicine will review data at appropriate times in the drug development process. The time and cost for developing companion animal drugs may be significantly less than for drugs for livestock animals, which generally have enhanced standards designed to ensure safety in the food chain.

-8-


EPA.  Products that are applied topically to animals or to premises to control external parasites are regulated by the Environmental Protection Agency, or EPA.
After we have received regulatory licensing or approval for our products, numerous regulatory requirements typically apply. Among the conditions for certain regulatory approvals is the requirement that our manufacturing facilities or those of our third-party manufacturers conform to current Good Manufacturing Practices or other manufacturing regulations, which include requirements relating to quality control and quality assurance as well as maintenance of records and documentation. The USDA, FDA and foreign regulatory authorities strictly enforce manufacturing regulatory requirements through periodic inspections and/or reports.
A number of our animal health products are not regulated. For example, certain products such as our ALLERCEPT® panels are not regulated by either the USDA or FDA. Similarly, none of our veterinary instruments requires regulatory approval to be marketed and sold in the U.S.
We have pursued CE Marking for imaging equipment and regulatory approval outside the U.S. based on market demographics of foreign countries. For marketing outside the U.S., we are subject to foreign regulatory requirements governing regulatory licensing and approval for many of our products. Licensing and approval by comparable regulatory authorities of foreign countries must be obtained before we can market products in those countries. Product licensing approval processes and requirements vary from country to country and the time required for such approvals may differ substantially from that required in the U.S. We cannot be certain that approval of any of our products in one country will result in approvals in any other country.
To date, we or our distributors have sought regulatory approval for certain of our products from the Canadian Center for Veterinary Biologics, or CCVB (Canada); the Japanese Ministry of Agriculture, Forestry and Fisheries, or MAFF (Japan); the Australian Department of Agriculture, Fisheries and Forestry, or ADAFF (Australia); the Republic of South Africa Department of Agriculture, or RSADA (South Africa); the Agriculture, Fisheries and Conservation Department, or ADCD (Hong Kong); the Macau Animal Health Division of Animal Control and Inspection, or IACM (Macau); the Spanish Ministry for Agriculture, Fisheries and Food; and from the relevant regulatory authorities in certain other countries requiring such approval.
The heartworm and allergy products previously discussed which have received regulatory approval in the U.S. and/or elsewhere are summarized below:
ProductsCountryRegulatedAgencyStatus
ALLERCEPT Allergy Treatment SetsU.S.
Canada
Yes
Yes
USDA
CCVB
Licensed
Licensed
SOLO STEP CHU.S.
EU
Canada
Yes
No-in most countries
Yes
USDA
  CCVB

Licensed
 
Licensed
SOLO STEP FHU.S.
Canada
Yes
Yes
USDA
CCVB
Licensed
Licensed
TRI-HEART Plus Heartworm PreventiveU.S.
Hong Kong
Macau
Yes
Yes
Yes
FDA
AFCD
IACM
Licensed
Licensed
Licensed

-9-



Customer Concentration

The information concerning our significant customers included in our Risk Factors section of this Annual Report under the caption “The loss of significant customers who, for example, are historically large purchasers or who are considered leaders in their field could damage our business and financial results” is incorporated herein by reference thereto.
Competition
Our market is intensely competitive. Our competitors include independent animal health companies and major pharmaceutical companies that have animal health divisions. We also compete with independent, third party distributors, including distributors who sell products under their own private labels. In the Point of Care diagnostic testing market, our major competitors include IDEXX Laboratories, Inc. ("IDEXX") and Zoetis Inc. ("Zoetis"). Idexx has a larger veterinary product and service offering than we do and a large sales infrastructure network and a well-established brand name. Zoetis also has a large sales infrastructure network.
In our North America segment, the OVP products we manufacture for sale by third parties compete with similar products offered by a number of other companies, some of which have substantially greater financial, technical, research and other resources than us and may have more established marketing, sales, distribution and service organizations than we do. Companies with a significant presence in the animal health market such as CEVA Santé Animale, Elanco, Merck, Sanofi, Vétoquinol S.A., Virbac S.A. and Zoetis may be marketing or developing products that compete with our products or would compete with them if successfully developed. These and other competitors and potential competitors may have substantially greater financial, technical, research and other resources and larger, more established marketing, sales, distribution and service organizations than we do. Our competitors may offer broader product lines and have greater name recognition than we do.
Environmental Regulation
In connection with our product development activities and manufacturing of our biological, pharmaceutical, diagnostic and detection products, we are subject to federal, state and local laws, rules, regulations and policies governing the use, generation, manufacture, storage, handling and disposal of certain materials, biological specimens and wastes. Although we believe that we have complied with these laws, regulations and policies in all material respects and have not been required to take any significant action to correct any noncompliance, we may be required to incur significant costs to comply with environmental and health and safety regulations in the future. Although we believe that our safety procedures for handling and disposing of such materials comply with the standards prescribed by state and federal regulations, the risk of accidental contamination or injury from these materials cannot be eliminated. In the event of such an accident, we could be held liable for any damages that result and any such liability could exceed our resources.
-10-



Human Capital Resources
As of December 31, 2020, we employed approximately 602 persons, 360 of which resided in North America and 242 internationally. We employ temporary workers on a need only basis to maintain business flexibility and a dynamic workforce. We are committed to employee diversity and inclusion and the support of traditionally underrepresented groups in management. Our workforce is approximately 50% women and 50% men with 40% of our management team (defined as Director, Vice President and Executive Vice President) represented by women. In 2020, we experienced an employee turnover rate of approximately 13% globally.
We believe that the current and future success of our company’s ability to execute on its strategic initiatives is highly dependent upon our ability to recruit, retain and reward our employees. We engage in targeted recruitment strategies to fill highly skilled positions. Our employees enjoy competitive compensation plans including market rate targeted salaries, robust benefits including retirement plans and employee stock purchase plan opportunities, and the opportunity for participation in short and long term incentive programs. Our compensation philosophy is designed to provide an appealing, market-based and rewarding compensation program that encourages high personal and company performance, strong cultural and ethical behavior, and incentives aligned with shareholder interests. Our aim is to attract, engage and retain highly qualified, motivated, and creative people who will fulfill our mission to be the “voice of the pet,” while delivering on Heska goals in a healthy, honest, and sustainable manner.

We are committed to providing a workplace that protects the health and well-being of our employees. All employees are required to abide by our Code of Conduct and Ethics, company health and safety parameters and contribute to a positive and friendly company culture. Due to the COVID-19 pandemic and in consideration of our employees’ safety, in March 2020, we implemented strict work from home policies for all employees with the ability to work remotely at all of our locations. At our Des Moines, Iowa manufacturing facility, we instituted staggered start times, designated building entry/exit protocols and closed common areas to maximize “social distancing” guidelines. As of December 31, 2020, we continue to enforce these safety precautions and abide by Center for Disease Control (“CDC”) guidelines, while tentatively planning limited return to work procedures in the second half of 2021.

Our Chief Administrative Officer is responsible for developing and executing the Company’s human capital strategy and updates the Board on human capital matters.
Where You Can Find Additional Information
Our principal executive offices are located at 3760 Rocky Mountain Avenue, Loveland, Colorado 80538. Our telephone number is 970-493-7272 and our Internet address is www.heska.com. References to our website in this Annual Report on Form 10-K are inactive textual references only and the content of our website should not be deemed incorporated by reference for any purpose.
Because we believe it provides useful information in a cost-effective manner to interested investors, we make available free of charge, via a link on our website, our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, current reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act as soon as reasonably practical after we electronically file such material with, or furnish it to, the Securities and Exchange Commission (the "SEC").
In addition, you may also review and download a copy of this Annual Report on Form 10-K, including any exhibits and any schedules filed therewith, and our other periodic and current reports, proxy and information statements, and other information that we file with the SEC, without charge, by visiting the SEC's website (http://www.sec.gov).

-11-


Information About Our Executive Officers
Our executive officers and their ages as of February 26, 2021 are as follows:
 
NameAgePosition
Kevin S. Wilson48Chief Executive Officer and President
Catherine Grassman45Executive Vice President, Chief Financial Officer
Nancy Wisnewski, Ph.D.58Executive Vice President, Chief Operating Officer
Steven M. Eyl55Executive Vice President, Chief Commercial Officer, and President, scil animal care company
Christopher Sveen38Executive Vice President, Chief Administrative Officer, General Counsel and Corporate Secretary, Heska and President, Diamond Animal Health
Eleanor Baker36Executive Vice President, Managing Director and Chief Operating Officer scil animal care company
Kevin S. Wilson was appointed President and Chief Executive Officer effective March 31, 2014. He previously served as our President and Chief Operating Officer from February 2013. Mr. Wilson became a member of our Board of Directors in May 2014. Mr. Wilson is a founder, member and officer of Cuattro, LLC, an imaging diagnostic company. Since 2008, he has been involved in developing technologies for radiographic imaging with Cuattro, LLC and as a founder of Cuattro Software, LLC, Cuattro Medical, LLC and Cuattro Veterinary, LLC. Mr. Wilson served on the board of various private, non-profit and educational organizations from 2005 to 2011. He was a founder of Sound Technologies, Inc., a diagnostic imaging company, in 1996. After Sound Technologies, Inc. was sold to VCA Antech, Inc. in 2004, Mr. Wilson served as Chief Strategy Officer for VCA Antech, Inc. until 2006. Mr. Wilson attended Saddleback College. 
Catherine Grassman, CPA, was appointed Executive Vice President, Chief Financial Officer on May 6, 2019. She previously served as Vice President and Chief Accounting Officer from December 2017 to May 2019 and as Corporate Controller from January 2017 to December 2017. Ms. Grassman has been a central figure in the Company’s accounting and finance leadership. Prior to joining Heska, Ms. Grassman was Corporate Controller of KeyPoint Government Solutions, a mid-sized private-equity backed, background investigation services company. She also spent more than 15 years with PricewaterhouseCoopers, LLP as a senior manager in the audit practice. She is licensed in Colorado as a Certified Public Accountant and possesses a Master of Accountancy and a Bachelor of Business Administration from Stetson University.
Nancy Wisnewski, Ph.D. was appointed Executive Vice President, Chief Operating Officer in August 2019. She previously served as Executive Vice President, Diagnostic Operations and Product Development from September 2016 to August 2019, as Executive Vice President, Product Development and Customer Service from April 2011 to September 2016 and as Vice President, Product Development and Technical Customer Service from December 2006 to April 2011. From January 2006 to November 2006, Dr. Wisnewski was Vice President, Research and Development. Dr. Wisnewski held various positions in Heska's Research and Development organization between 1993 and 2005. She holds a Ph.D. in Parasitology/Biochemistry from the University of Notre Dame and a BS in Biology from Lafayette College.
Steven M. Eyl was appointed Executive Vice President, Global Sales and Marketing in September 2016. He previously served as our Executive Vice President, Commercial Operations from May 2013 to September 2016. Mr. Eyl was a principal of Eyl Business Services, a consulting firm, from January 2012 to May 2013. He was President of Sound Technologies, Inc. ("Sound") from 2000 to 2011, including after Sound's acquisition by VCA Antech, Inc. in 2004. Mr. Eyl has an extensive background in medical technology sales. He is a graduate of Indiana University.
-12-


Christopher Sveen, Esq. was appointed Executive Vice President, Chief Administrative Officer, General Counsel and Corporate Secretary of Heska Corporation and President, Diamond Animal Health in April 2020, previously serving as Vice President, General Counsel from December 2018 to April 2020. Before joining Heska, Mr. Sveen served as a Private Banker at J.P. Morgan Private Bank in Chicago from August 2015 to May 2018 and prior to that as a civil litigation and trial attorney at a boutique litigation firm. Mr. Sveen received his Juris Doctor from Chicago-Kent College of Law in 2009 and his Master of Business Administration (MBA) from the Kelley School of Business at Indiana University in 2015. He is licensed to practice law in Illinois and Colorado.

Eleanor Baker, Esq. was appointed Executive Vice President, Managing Director of scil in April 2020, previously serving as Vice President, General Counsel since November 2017. Previously, Ms. Baker worked at KPMG, LLP as a technology and innovation solutions consultant from 2015 to November 2017. Ms. Baker received her Juris Doctor from Wake Forest School of Law, a Master of Laws from University of Houston and her undergraduate degree from Texas A&M University. She is licensed to practice law in Texas and Colorado.
Item 1A.Risk Factors

Risk Factors Summary

Pursuant to Item 105(b) of Regulation S-K, the following represents a summary of the principal factors that make an investment in our common stock speculative or risky. This summary does not address all of the risks that we face. Additional discussion of the risks summarized in this risk factor summary, and other risks that we face, can be found below under the heading “Risk Factors” and should be carefully considered, together with other information in this Form 10-K and our other filings with the SEC, before making an investment decision regarding our common stock.

Risks related to our business and industry

The COVID-19 pandemic is adversely impacting consumer demand, our global supply chain and our financial and operational results.
If the third parties that have substantial marketing rights for certain of our historical products, existing products or future products under development are not successful in marketing those products, then our sales and financial position may suffer.
Our Chief Executive Officer has acknowledged outside business interests which may occupy a portion of his time.
We rely substantially on third party suppliers. The loss of products or delays in product availability from one or more third party suppliers could substantially harm our business.
We depend on key personnel for our future success. If we lose our key personnel or are unable to attract and retain additional personnel, we may be unable to achieve our goals.
The loss of significant customers who, for example, are historically large purchasers or who are considered leaders in their field could damage our business and financial results.
We operate in a highly competitive industry, which could render our products obsolete or substantially limit the volume of products that we sell. This would limit our ability to compete and maintain sustained profitability.
We often depend on third parties for products we intend to introduce in the future. If our current relationships and collaborations are not successful, we may not be able to introduce the products we intend to introduce in the future.
We may be unable to market and sell our products successfully.
We face risks associated with our international operations and our international expansion may not generate the results we anticipate.
-13-


We may face costly legal disputes, including disputes related to our intellectual property or technology or that of our suppliers or collaborators.
Interpretation of existing legislation, regulations and rules, including financial accounting standards, or implementation of future legislation, regulations and rules could cause our costs to increase or could harm us in other ways.
We are currently evaluating, and we intend to pursue, acquisitions and other strategic development opportunities, which may not have desired results and could be detrimental to our financial position.
Obtaining and maintaining regulatory approvals in order to market our products may be costly and could delay the marketing and sales of our products. Failure to meet all regulatory requirements could cause significant losses from affected inventory and the loss of market share.
Our future revenues depend on successful product development, commercialization and/or market acceptance, any of which can be slower than we expect or may not occur.
Many of our expenses are fixed and if factors beyond our control cause our revenue to fluctuate, this fluctuation could cause greater than expected losses, cash flow and liquidity shortfalls.
Cyberattack related breaches of our information technology systems could have an adverse effect on our business.
We may be unable to protect our stakeholders’ privacy or we may fail to comply with privacy laws.
We may not be able to achieve sustained profitability or increase profitability on a quarterly or annual basis.
We may face product returns and product liability litigation in excess of, or not covered by, our insurance coverage or indemnities and/or warranties from our suppliers. If we become subject to product liability claims resulting from defects in our products, we may fail to achieve market acceptance of our products and our sales could substantially decline.
We may be held liable for the release of hazardous materials, which could result in extensive remediation costs or otherwise harm our business.

Risks related to our common stock

Our stock price has historically experienced high volatility, and could do so in the future, including experiencing a material price decline resulting from a large sale in a short period of time. This volatility could affect the value of our common stock.
Our NOL Protective Amendment could adversely impact the value and trading liquidity of our common stock.
If securities analysts do not publish research or reports about our business, or if they downgrade our stock, the price of our stock could decline.
We have not declared or paid any dividends on our common stock since 2012 and we do not anticipate paying any cash dividends in the foreseeable future.
We have fewer than 300 holders of record, which could allow us to terminate voluntarily the registration of our common stock with the SEC and after which we would no longer be eligible to maintain the listing of our common stock on The Nasdaq Capital Market. We may also be unable to otherwise maintain our listing on The Nasdaq Capital Market.
Provisions in our Certificate of Incorporation and bylaws and under Delaware law might discourage, delay or prevent a change of control of our company or changes in our management and, therefore, depress the trading price of our common stock.

Risks related to the outstanding Notes

Servicing our debt will require a significant amount of cash, and we may not have sufficient cash flow from our business to pay our substantial debt.
-14-


We may not have the ability to raise the funds necessary to settle conversions of our convertible notes (the "Notes") in cash or to repurchase the Notes upon a fundamental change, and our future debt may contain, limitations on our ability to pay cash upon conversion or repurchase of the Notes.
The conditional conversion feature of the Notes, if triggered, may adversely affect our financial condition and operating results.

Risk Factors

Our future operating results may vary substantially from period to period due to a number of factors, many of which are beyond our control. The following discussion highlights the material factors and the possible impact of these factors on future results of operations. If any of the following factors actually occur, our business, financial condition or results of operations could be harmed. In that case, the price of our Public Common Stock could decline and investors in our Public Common Stock could experience losses on their investment.

Risks related to our business and industry

The COVID-19 pandemic is adversely impacting consumer demand, our global supply chain and our financial and operational results.

With the recent acquisition of scil, our worldwide operations make us vulnerable to risks from a global public health crisis, such as the COVID-19 pandemic. We expect a future adverse impact to our financial results as the pandemic spreads through domestic and foreign markets and if local governmental authorities institute or extend “shelter at home” protective measures. While the pace and ability of governmental authorities to contain the COVID-19 pandemic remains uncertain, we expect this global public health crisis to have an adverse impact on our financial results, including revenues, earnings and cash flows through at least the first half of 2021; specifically as a result of:

Temporary closure or reduced hours of veterinary clinics where we sell our products and services, resulting in decreased visits and testing;
Reduction in consumer discretionary spending on their pets’ health and wellbeing;
Potential supply chain disruption caused by customs restrictions of cross border trade, and other factors related to COVID-19 pandemic;
Potential supply chain disruption as suppliers consider focusing research and development efforts on human health away from animal health;
Governmental orders that create an array of restrictions on our customers, our employees and the pets they serve to limit the spread of the COVID-19 pandemic;
Lower productivity due to reduced travel, work from home policies or shelter in place orders; and
Overall slowdown in foreign and domestic economies resulting in stagnating wage growth, reduced discretionary spending and temporary or permanent staffing layoffs.

As a result of the COVID-19 pandemic, we have implemented strict work from home policies for all employees with the ability to work remotely at all of our locations. At our Des Moines, Iowa manufacturing facility, production schedules remain on track for order fulfillment but we have instituted staggered start times, designated building entry/exit protocols and closed common areas to maximize “social distancing” guidelines. Companywide, we enacted travel restrictions. The restricted travel policies for our sales force may adversely affect our customers' ability or willingness to purchase our products and services, delay customer capital spending and reduce our ability to provide on-site customer service. While we are unable to predict the duration of the financial and operational impact due to the COVID-19 pandemic, we expect it could have
-15-


minimal adverse impact on our business through at least the first half of 2021. The COVID-19 pandemic could also have the effect of heightening other risk factors described in this report.

If third parties that have substantial marketing rights for certain of our historical products, existing products or future products under development are not successful in marketing those products, then our sales and financial position may suffer.

We are party to agreements with Merck Animal Health (“MAH”) for our canine heartworm preventive product, TRI-HEART Plus Chewable Tablets, and Elanco for certain bovine vaccines, which have been sold primarily under the Titanium and MasterGuard brands. Either of these marketing partners may not devote sufficient resources to marketing our products and our sales and financial position could suffer significantly as a result. For example, in 2020, MAH failed to market, sell and support our heartworm preventive product, which resulted in depressed OVP product annual revenue in our North America segment. Furthermore, there may be nothing to prevent these partners from pursuing alternative technologies, products or supply arrangements, including as part of mergers, acquisitions or divestitures. Third party marketing assistance may not be available in the future on reasonable terms, if at all. If the third parties with marketing rights for our products were to merge or go out of business, the sale and promotion of our products could be diminished.

Our Chief Executive Officer has acknowledged outside business interests which may occupy a portion of his time.

Mr. Wilson’s employment agreement with us acknowledges that Mr. Wilson has business interests in Cuattro, LLC, Cuattro Software, LLC and Cuattro Medical, LLC which may require a portion of his time, resources and attention during his working hours. If Mr. Wilson is distracted by these or other business interests, he may not contribute as much as he otherwise would have to enhancing our business, to the detriment of our shareholder value.

Cuattro, LLC charged Heska Imaging $0, $6.0 thousand, and $4.6 million during 2020, 2019, and 2018, respectively, primarily related to digital imaging products, for which there was an underlying supply contract with minimum purchase obligations, software and services as well as other operating expenses.

We rely substantially on third party suppliers. The loss of products or delays in product availability from one or more third party suppliers could substantially harm our business.

To be successful, we must contract for the supply of, or manufacture ourselves, current and future products of appropriate quantity, quality and cost. Such products must be available on a timely basis and be in compliance with any regulatory requirements. Similarly, we must provide ourselves, or contract for the supply of, certain services. Such services must be provided in a timely and appropriate manner. Failure to do any of the above could substantially harm our business.

We rely on third party suppliers to manufacture those products we do not manufacture ourselves and to provide services we do not provide ourselves. Proprietary products provided by these suppliers represent a majority of our revenue. We currently rely on these suppliers for our point of care laboratory instruments and consumable supplies for these instruments, for our imaging products and related software and services, for key components of our point-of-care diagnostic tests as well as for the manufacture of other products.

The loss of access to products from one or more suppliers could have a significant, negative impact on our business. Major suppliers that sell us proprietary products are FUJIFILM Corporation and Shenzen Mindray Bio-Medical Electronics Co., Ltd. We often purchase products from our suppliers under agreements that are of limited duration or potentially can be terminated on short notice subsequent to unfavorable legal action. In the case of our point of care laboratory instruments and our digital radiography solutions, post-termination,
-16-


we are typically entitled to non-exclusive access to consumable supplies, or ongoing non-exclusive access to products and services to meet the needs of an existing customer base, respectively, for a defined period upon expiration of exclusive rights, which could subject us to competitive pressures in the period of non-exclusive access. There can be no assurance that our suppliers will meet their obligations under any agreements we may have in place with them or that we will be able to compel them to do so. Risks of relying on suppliers include:

Inability to meet minimum obligations. Current agreements, or agreements we may negotiate in the future, may commit us to certain minimum purchase or other spending obligations. It is possible we will not be able to create the market demand to meet such obligations, which could create a drain on our financial resources and liquidity. Some agreements may require minimum purchases and/or sales to maintain product rights and we may be significantly harmed if we are unable to meet such requirements and lose product rights.
Loss of exclusivity. In the case of our point of care laboratory instruments, if we are entitled to non-exclusive access to consumable supplies for a defined period upon expiration of exclusive rights, we may face increased competition from a third party with similar non-exclusive access or our former supplier, which could cause us to lose customers and/or significantly decrease our margins and could significantly affect our financial results. In addition, current agreements, or agreements we may negotiate in the future, with suppliers may require us to meet minimum annual sales levels to maintain our position as the exclusive distributor of these products. We may not meet these minimum sales levels and maintain exclusivity over the distribution and sale of these products. If we are not the exclusive distributor of these products, competition may increase significantly, reducing our revenues and/or decreasing our margins.
Changes in economics. An underlying change in the economics with a supplier, such as a large price increase or new requirement of large minimum purchase amounts, could have a significant, adverse effect on our business, particularly if we are unable to identify and implement an alternative source of supply in a timely manner.
The loss of product rights upon expiration or termination of an existing agreement. Unless we are able to find an alternate supply of a similar product, we would not be able to continue to offer our customers the same breadth of products and our sales and operating results would likely suffer. In the case of an instrument supplier, we could also potentially suffer the loss of sales of consumable supplies, which would be significant in cases where we have built a significant installed base, further harming our sales prospects and opportunities. Even if we were able to find an alternate supply for a product to which we lost rights, we would likely face increased competition from the product whose rights we lost being marketed by a third party or the former supplier and it may take us additional time and expense to gain the necessary approvals and launch an alternative product.
High switching costs. In our point of care laboratory instrument products, we could face significant competition and lose all or some of the consumable revenues from the installed base of those instruments if we were to switch to a competitive instrument. If we need to change to other commercial manufacturing contractors for certain of our regulated products, additional regulatory licenses or approvals generally must be obtained for these contractors prior to our use. This would require new testing and compliance inspections prior to sale, thus resulting in potential delays. Any new manufacturer would have to be educated in, or develop, substantially equivalent processes necessary for the production of our products. We likely would have to train our sales force, distribution network employees and customer support organization on the new product and spend significant funds marketing the new product to our customer base.
-17-


The involuntary or voluntary discontinuation of a product line. Unless we are able to find an alternate supply of a similar product in this or similar circumstances with any product, we would not be able to continue to offer our customers the same breadth of products and our sales would likely suffer. Even if we are able to identify an alternate supply, it may take us additional time and expense to gain the necessary approvals and launch an alternative product, especially if the product is discontinued unexpectedly.
Inconsistent or inadequate quality control. We may not be able to control or adequately monitor the quality of products we receive from our suppliers. Poor quality items could damage our reputation with our customers.
Limited capacity or ability to scale capacity. If market demand for our products increases suddenly, our current suppliers might not be able to fulfill our commercial needs, which would require us to seek new manufacturing arrangements and may result in substantial delays in meeting market demand. If we consistently generate more demand for a product than a given supplier is capable of handling, it could lead to large backorders and potentially lost sales to competitive products that are readily available. This could require us to seek or fund new sources of supply, which may be difficult to find or may require terms that are less advantageous if available at all.
Regulatory risk. Our manufacturing facility and those of some of our third party suppliers are subject to ongoing periodic unannounced inspection by regulatory authorities, including the FDA, USDA and other federal, state and foreign agencies for compliance with strictly enforced Good Manufacturing Practices, regulations and similar foreign standards. We do not have control over our suppliers’ compliance with these regulations and standards. Regulatory violations could potentially lead to interruptions in supply that could cause us to lose sales to readily available competitive products. If one of our suppliers is unable to provide a raw material or finished product due to regulatory issues, it could have a material adverse financial impact on our business and could expose us to legal action if we are unable to perform on contracts to our customers involving related products.
Developmental delays. We may experience delays in the scale-up quantities needed for product development that could delay regulatory submissions and commercialization of our products in development, causing us to miss key opportunities.
Limited geographic rights. We typically do not have global geographic rights to products supplied by third parties. If we were to determine a market opportunity in a geography where we did not have distribution rights and were unable to obtain such rights from the supplier, it might hamper our ability to succeed in such geography and our sales and profits would be lower than they otherwise would have been.
Limited intellectual property rights. We typically do not have intellectual property rights, or may have to share intellectual property rights, to the products supplied by third parties and any improvements to the manufacturing processes or new manufacturing processes for these products.
Changes to United States tariff and import/export regulations. Changes to United States trade policies, treaties and tariffs could have a material adverse effect on global trade. These changes could result in increased costs of goods imported into the United States for the Company and our third party suppliers. Our third party suppliers may limit their trade with companies in the United States, including us.
Global human and animal health risk. Several of our suppliers have operations in areas that may be susceptible to public health emergencies that could restrict global trade generally, and our access to consumables and product, specifically. The risk of infectious disease in humans and animals may limit trade and product access with third party suppliers with companies inside and outside the United States,
-18-


including us. In particular, the use of animal bi-product may affect our consumable supply as a result of global animal health risks.
Potential problems with suppliers such as those discussed above could substantially decrease sales, lead to higher costs and/or damage our reputation with our customers due to factors such as poor quality goods or delays in order fulfillment, resulting in our being unable to sell our products effectively and substantially harming our business.
We depend on key personnel for our future success. If we lose our key personnel or are unable to attract and retain additional personnel, we may be unable to achieve our goals.

Our future success is substantially dependent on the efforts of our senior management and other key personnel, including our Chief Executive Officer (“CEO”) and President, Kevin Wilson. The loss of the services of members of our senior management or other key personnel may significantly delay or prevent the achievement of our business objectives. Although we have employment agreements with many of these individuals, all are at-will employees, which means that either the employee or Heska may terminate employment at any time without prior notice. If we lose the services of, or fail to recruit, key personnel, the growth of our business could be substantially impaired. We do not maintain key person life insurance for any of our senior management or key personnel.

The loss of significant customers who, for example, are historically large purchasers or who are considered leaders in their field could damage our business and financial results.

We are dependent upon a number of significant customers. Revenue from Covetrus, Inc., formerly known as Henry Schein Animal Health ("Covetrus"), represented approximately 6%, 14% and 15% of our consolidated revenue for the years ended December 31, 2020, 2019 and 2018, respectively. Revenue from Merck entities, including Merck Animal Health, represented approximately 5%, 1% and 12% of our consolidated revenue for the years ended December 31, 2020, 2019 and 2018, respectively. No other customer accounted for more than 10% of our consolidated revenue for the years ended December 31, 2020, 2019 or 2018.

Covetrus represented 9% and 19% of our consolidated accounts receivable at December 31, 2020 and 2019, respectively. No other customer accounted for more than 10% of our consolidated accounts receivable at December 31, 2020 or 2019. The loss of, or material reduction in business from, any of our significant customers could adversely affect our business and financial results.

We operate in a highly competitive industry, which could render our products obsolete or substantially limit the volume of products that we sell. This would limit our ability to compete and maintain sustained profitability.

The market in which we compete is intensely competitive. Our competitors include independent animal health companies and major pharmaceutical companies that have animal health divisions. We also compete with independent, third party distributors, including distributors that sell products under their own private labels. In the point-of-care diagnostic testing market, our major competitors include IDEXX Laboratories, Inc. and Zoetis Inc.. The OVP products manufactured by our North America segment for sale by third parties compete with similar products offered by a number of other companies, some of which have substantially greater financial, technical, research and other resources than us and may have more established marketing, sales, distribution and service organizations than those of our OVP product customers. Competitors may have facilities with similar capabilities to our Des Moines, Iowa facility, which they may operate and sell at a lower unit price to customers than we sell our OVP products for, which could cause us to lose customers. Companies with a significant presence in the companion animal health market, such as CEVA Sante´ Animale, Elanco, Merck, Sanofi, Vétoquinol S.A. and Virbac S.A. may be marketing or developing products
-19-


that compete with our products or would compete with them if developed. These and other competitors and potential competitors may have substantially greater financial, technical, research and other resources and larger, more established marketing, sales and service organizations than we do. For example, if Zoetis devotes its significant commercial and financial resources to growing its market share in the veterinary allergy market, our allergy-related sales could suffer significantly. Our competitors may offer broader product lines and have greater name recognition than we do. Our competitors may also develop or market technologies or products that are more effective or commercially attractive than our current or future products or that would render our technologies and products obsolete. Further, additional competition could come from new entrants to the animal health care market. Moreover, we may not have the financial resources, technical expertise or marketing, sales or support capabilities to compete successfully. Zoetis has recently launched allergy products which may diminish the competitiveness and sales prospects for our own allergy immunotherapy products. IDEXX has recently launched an SDMA test in its point of care laboratory chemistry line, which may cause veterinary customers to prefer IDEXX products to ours.

If we fail to compete successfully, our ability to achieve sustained profitability will be limited and sustained profitability, or profitability at all, may not be possible.

We benefit from relationships or collaboration with third parties, including but not limited to, companies, buying groups, veterinary hospital groups and reference laboratory entities that operate in our markets. Beneficial third party, semi-competitive, directly competitive and cooperative relationships that affect how we go to market, develop products, generate leads and other commercial efforts of Heska may be negatively affected as a result of consolidation, acquisition, merger, exclusive arrangement or other agreements or activities between and amongst those third parties and others.

We may depend on third parties for products we intend to introduce in the future. If our current relationships and collaborations are not successful, we may not be able to introduce the products we intend to introduce in the future.

We are occasionally dependent on third parties and collaborative partners to perform research and development activities to successfully develop new products. We routinely discuss Heska marketing in the veterinary market instruments being developed by third parties for use in the human health care market. In the future, one or more of these third parties or collaborative partners may not complete research and development activities in a timely fashion, or at all. Even if these third parties are successful in their research and development activities, we may not be able to come to an economic agreement with them. If these third parties or collaborative partners fail to complete research and development activities or fail to complete them in a timely fashion, or if we are unable to negotiate economic agreements with such third parties or collaborative partners, our ability to introduce new products may be impacted negatively and our revenues may decline.
We may be unable to market and sell our products successfully.

We may not develop and maintain marketing and/or sales capabilities successfully, and we may not be able to make arrangements with third parties to perform these activities on satisfactory terms, or at all. If our marketing and sales strategy is unsuccessful, our ability to sell our products will be negatively impacted and our revenues will decrease. This could result in the loss of distribution rights for products or failure to gain access to new products and could cause damage to our reputation and adversely affect our business and future prospects. The market for companion animal healthcare products is highly fragmented. Because our proprietary products are generally available only to veterinarians or by prescription and our medical instruments require technical training to operate, we ultimately sell all our products primarily to or through veterinarians. The acceptance of our products by veterinarians is critical to our success. Changes in our ability
-20-


to obtain or maintain such acceptance or changes in veterinary medical practice could significantly decrease our anticipated sales. As the vast majority of cash flow to veterinarians ultimately is funded by pet owners without private insurance or government support, our business may be more susceptible to severe economic downturns than other health care businesses that rely less on individual consumers.

For our Point of Care laboratory blood diagnostics products, we primarily rely on contracts with our veterinary customers for their use of our owned equipment and our consumable supplies over a multiple year period. If veterinarians under these contracts experience a significant downturn in their business, they may not fulfill their use and financial obligations under these contracts. If veterinarians breach our contracts, and we are unable to collect on default payment provisions or otherwise enforce the terms of our contracts, our business will be adversely affected. If we have to litigate against customer(s) to enforce our contracts, our expenses may increase, our sales may decrease to those customers, and our reputation may suffer. If significant numbers of our customers under contracts for use of our equipment and consumable supplies do not renew their contracts, our business will be adversely affected.

We have entered into agreements with independent third party distributors who we anticipate will market and sell our products to a greater degree than in the recent past. Independent third party distributors may be effective in increasing sales of our products to veterinarians, although we would expect a corresponding lower gross margin as such distributors typically buy products from us at a discount to end user prices. It is possible new or existing independent third party distributors could cannibalize our direct sales efforts and lower our total gross margin. For us to be effective when working with an independent third party distributor, the distributor must agree to market and/or sell our products and we must provide proper economic incentives to the distributor as well as contend effectively for the time, energy and focus of the employees of such distributor given other products the distributor may be carrying, potentially including those of our competitors. If we fail to be effective with new or existing independent third party distributors, our financial performance may suffer.

We face risks associated with our international operations and our international expansion may not generate the results we anticipate.

A core component of our future growth strategy is international expansion. As we continue to expand our international footprint, we will be increasingly susceptible to the risks associated with international operations including, but not limited to, the following:

uncertain political and economic climates and fluctuations in exchange rates that may increase the volatility of foreign-based revenue and expenses;
burdens of complying with and unexpected changes in foreign laws, accounting and legal standards, regulatory requirements, taxes, tariffs and other barriers or trade restrictions;
lack of experience in connection with the customs, cultures, languages and sales cycle;
reduced or altered protection for intellectual property rights; and
data privacy laws in foreign countries, which require that data storage and processing be subject to laws different than the United States.

As a result of these and other factors, international expansion may be more difficult and not generate the results we anticipate, which could negatively impact our business.

-21-


We may face costly legal disputes, including disputes related to our intellectual property or technology or that of our suppliers or collaborators.

We may face legal disputes related to our business. Even if meritless, these disputes may require significant expenditures on our part and could entail a significant distraction to members of our management team or other key employees. For example, it took us until October 10, 2018, to reach an agreement in principle to settle the complaint that was filed against the Company by Shaun Fauley on March 12, 2015 in the United States District Court for the Northern District of Illinois alleging our transmittal of unauthorized faxes in violation of the federal Telephone Consumer Protection Act of 1991, as amended by the Junk Fax Prevention Act of 2005, as a class action (the “Fauley class action”). The settlement, which was approved by the court on February 28, 2019, required us, among other things, to pay $6.75 million to class members, as well as to pay attorneys’ fees and expenses to legal counsel to the class, which we paid in full on April 3, 2019. Insurance coverage may not cover any costs required to litigate a legal dispute or an unfavorable ruling or settlement. We did not have insurance coverage for the settlement arrangement regarding the Fauley class action and had to borrow under our Credit Facility to fund the settlement. A legal dispute leading to an unfavorable ruling or settlement, whether or not insurance coverage may be available for any portion thereof, could have material adverse consequences on our business. Moreover, we may have to use legal means and incur affiliated costs to secure the benefits to which we are entitled under third party agreements, such as to collect payment for goods shipped to third parties, which would reduce our income as compared to what it otherwise would have been.

We may become subject to patent infringement claims and litigation in the United States or other countries or interference proceedings conducted in the United States Patent and Trademark Office, or USPTO, to determine the priority of inventions. The defense and prosecution of intellectual property suits, USPTO interference proceedings and related legal and administrative proceedings are likely to be costly, time-consuming and distracting. As is typical in our industry, from time to time we and our collaborators and suppliers have received, and may in the future receive, notices from third parties claiming infringement and invitations to take licenses under third-party patents. Any legal action against us or our collaborators or suppliers may require us or our collaborators or suppliers to obtain one or more licenses in order to market or manufacture affected products or services. We or our collaborators or suppliers may not, however, be able to obtain licenses for technology patented by others on commercially reasonable terms, or at all, or to develop alternative approaches to access or replace such technology if we or they are unable to obtain such licenses or if current and future licenses prove inadequate, any of which could substantially harm our business.

We may also need to pursue litigation to enforce any patents issued to us or our collaborative partners, to protect trade secrets or know-how owned by us or our collaborative partners, or to determine the enforceability, scope and validity of the proprietary rights of others. Any litigation or interference proceedings will likely result in substantial expense to us and significant diversion of the efforts of our technical and management personnel. Any adverse determination in litigation or interference proceedings could subject us to significant liabilities to third parties. Further, as a result of litigation or other proceedings, we may be required to seek licenses from third parties which may not be available on commercially reasonable terms, or at all.

Interpretation of existing legislation, regulations and rules, including financial accounting standards, or implementation of future legislation, regulations and rules could cause our costs to increase or could harm us in other ways.

As a public company, we have incurred and will continue to incur significant legal, accounting and other expenses due to our compliance with regulations and disclosure obligations applicable to us, including compliance with the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act, as well as rules implemented
-22-


by the SEC and the Nasdaq Stock Market. We prepare our financial statements in conformance with GAAP. These accounting principles are established by and are subject to interpretation by the SEC, the FASB and others which interpret and create accounting policies. These rules and regulations will continue to cause us to incur significant legal and financial compliance costs and will make some activities more time-consuming and costly. A change in those policies or how those policies are interpreted can have a significant effect on our reported results and may affect our reporting of transactions completed before a change is made effective. Such changes may require us to incur additional compliance costs, adversely affect our reported financial results and the way we conduct our business or have a negative impact on us if we fail to track such changes.

If our regulators and/or auditors adopt or interpret more stringent standards than we anticipate, we could experience unanticipated changes in our reported financial statements, including but not limited to restatements, which could adversely affect our business due to litigation and investor confidence in our financial statements. In addition, changes in the underlying circumstances to which we apply given accounting standards and principles may affect our results of operations and have a negative impact on us. For example, we review goodwill recognized on our consolidated balance sheets at least annually and if we were to conclude there was an impairment of goodwill, we would reduce the corresponding goodwill to its estimated fair value and recognize a corresponding expense in our statement of operations. This impairment and corresponding expense could be as large as the total amount of goodwill recognized on our consolidated balance sheets, which was $88.3 million at December 31, 2020 and $36.2 million at December 31, 2019. There can be no assurance that future goodwill impairments will not occur if projected financial results are not met, or otherwise.

We are currently evaluating, and we intend to pursue, acquisitions and other strategic development opportunities, which may not have desired results and could be detrimental to our financial position.

We continue to evaluate, and we intend to pursue, acquisitions and other strategic development opportunities, including minority investments where strategic, such as our acquisition of scil in 2020. The ultimate business and financial performance of these opportunities may not create, and may end up adversely affecting materially, the value we hope to enhance by pursuing them. Any acquisition may significantly underperform relative to our financial expectations and may serve to diminish rather than enhance shareholder value. We may also diminish our cash resources or dilute stockholders in order to finance any such acquisition or other strategic transaction.

The success of any acquisition will depend on, among other things, our ability to integrate assets and personnel acquired in these transactions and to apply our internal controls process to these acquired businesses. The integration of acquisitions is likely to require significant attention from our management, and the diversion of management’s attention and resources could have a material adverse effect on our ability to manage our business. Furthermore, we may not realize the degree or timing of benefits we anticipated when we first entered into the acquisition transaction. If actual integration costs are higher than amounts originally anticipated, if we are unable to integrate the assets and personnel acquired in an acquisition as anticipated, or if we are unable to fully benefit from anticipated synergies, our business, financial condition, results of operations and cash flows could be materially adversely affected. Furthermore, it is possible we will use management time and resources to pursue opportunities we ultimately are unable or decide not to consummate, in which case, we may not be able to utilize such management time and resources on what may have proved to be more productive matters in other areas of our business.

-23-


Obtaining and maintaining regulatory approvals in order to market our products may be costly and could delay the marketing and sales of our products. Failure to meet all regulatory requirements could cause significant losses from affected inventory and the loss of market share.

Many of the products we develop, market or manufacture may subject us to extensive regulation by one or more of the USDA, the FDA, the EPA and foreign and other regulatory authorities. These regulations govern, among other things, the development, testing, manufacturing, labeling, storage, pre-market approval, advertising, promotion and sale of some of our products. Satisfaction of these requirements can take several years and time needed to satisfy them may vary substantially, based on the type, complexity and novelty of the product. The decision by a regulatory authority to regulate a currently non-regulated product or product area could significantly impact our revenue and have a corresponding adverse impact on our financial performance and position while we attempt to comply with the new regulation, if such compliance is possible at all.

The effect of government regulation may be to delay or to prevent marketing of our products for a considerable period of time and to impose costly procedures upon our activities. We may not be able to estimate the time to obtain required regulatory approvals accurately and such approvals may require significantly more time than we anticipate. We have experienced in the past, and may experience in the future, difficulties that could delay or prevent us from obtaining the regulatory approval or license necessary to introduce or market our products. Such delays in approval may cause us to forego a significant portion of a new product’s sales in its first year due to seasonality and advanced booking periods associated with certain products. Regulatory approval of our products may also impose limitations on the indicated or intended uses for which our products may be marketed.

Difficulties in making established products to all regulatory specifications may lead to significant losses related to affected inventory as well as market share. Among the conditions for certain regulatory approvals is the requirement that our facilities and/or the facilities of our third party manufacturers conform to current Good Manufacturing Practices and other analogous or additional requirements. If any regulatory authority determines that our manufacturing facilities or those of our third party manufacturers do not conform to appropriate manufacturing requirements, we or the manufacturers of our products may be subject to sanctions, including, but not limited to, warning letters, manufacturing suspensions, product recalls or seizures, injunctions, refusal to permit products to be imported into or exported out of the United States, refusals of regulatory authorities to grant approval or to allow us to enter into government supply contracts, withdrawals of previously approved marketing applications, civil fines and criminal prosecutions. Furthermore, third parties may perceive procedures required to obtain regulatory approval objectionable and may attempt to disrupt or otherwise damage our business as a result. In addition, certain of our agreements may require us to pay penalties if we are unable to supply products, including for failure to maintain regulatory approvals.

Any of these events, alone or in combination with others, could significantly damage our business or results of operations.

-24-


Our future revenues depend on successful product development, commercialization and/or market acceptance, any of which can be slower than we expect or may not occur.

The product development and regulatory approval process for many of our potential products is extensive and may take substantially longer than we anticipate. Research projects may fail. New products that we may be developing for the veterinary marketplace may not perform consistently within our expectations. Because we have limited resources to devote to product development and commercialization, any delay in the development of one product or reallocation of resources to product development efforts that prove unsuccessful may delay or jeopardize the development of other product candidates. If we fail to successfully develop new products and bring them to market in a timely manner, our ability to generate additional revenue will decrease.

Even if we are successful in the development of a product or obtain rights to a product from a third party supplier, we may experience delays or shortfalls in commercialization and/or market acceptance of the product. For example, veterinarians may be slow to adopt a product, a product may not achieve the anticipated technical performance in field use or there may be delays in producing large volumes of a product. The former is particularly likely where there is no comparable product available or historical precedent for such a product. The ultimate adoption of a new product by veterinarians, the rate of such adoption and the extent veterinarians choose to integrate such a product into their practice are all important factors in the economic success of any new products and are factors that we do not control to a large extent. If our products do not achieve a significant level of market acceptance, demand for our products will not develop as expected and our revenues will be lower than we anticipate.

Many of our expenses are fixed and if factors beyond our control cause our revenue to fluctuate, this fluctuation could cause greater than expected losses, cash flow and liquidity shortfalls.

We believe that our future operating results will fluctuate on a quarterly basis due to a variety of factors which are generally beyond our control, including:

supply of products, including minimum purchase agreements, from third party suppliers or termination, cancellation or expiration of such relationships;
competition and pricing pressures from competitive products;
the introduction of new products or services by our competitors or by us;
large customers failing to purchase at historical levels;
fundamental shifts in market demand;
manufacturing delays;
shipment problems;
information technology problems, which may prevent us from conducting our business effectively, or at all, and may also raise our costs;
regulatory and other delays in product development;
product recalls or other issues which may raise our costs;
changes in our reputation and/or market acceptance of our current or new products; and
changes in the mix of products sold.

We have high operating expenses, including those related to personnel. Many of these expenses are fixed in the short term and may increase over time. If any of the factors listed above cause our revenues to decline, our operating results could be substantially harmed.

-25-


Cyberattack related breaches of our information technology systems could have an adverse effect on our business.

Cyberattacks are increasing in their frequency, sophistication and intensity, and have become increasingly difficult to detect and defend against, notwithstanding our ongoing evaluation of and improvements to the preventive measures we take on to reduce the risks associated with these threats based on our own experience and those observed in the broader market. Cyberattacks, ranging from the use of malware, computer viruses, dedicated denial of services attacks, credential harvesting, social engineering and other means for obtaining unauthorized access to our Company's confidential information or assets or disrupting our Company’s ability to operate normally, could have a material adverse effect on our business. Cyberattacks may cause equipment failures, loss of information or assets, including sensitive personal information of third-party vendors, customers or employees, or valuable technical and marketing information, as well as disruptions to our or our vendor or customers’ operations. These attacks may be committed by company employees or external actors operating in any geography, including jurisdictions where law enforcement measures to address such attacks are unavailable or ineffective. Cyberattacks may occur alone or in conjunction with physical attacks, especially where disruption of service is an objective of the attacker. The preventive actions we take on an ongoing basis to reduce the risks and mitigate the potential damages associated with cyberattacks, including protection of our systems, networks and assets and the retention of cybersecurity insurance policies, may be insufficient to repel or mitigate entirely the effects of a cyberattack.

We devote significant resources to network security, data encryption and other security measures to protect our systems and data, but these security measures cannot provide absolute security. To the extent we were to experience a breach of our systems and were unable to protect sensitive data in the wake of the breach, such a breach could materially damage business partner and customer relationships and reduce or otherwise negatively impact access to online services. Moreover, if a computer security breach affects our systems or results in the unauthorized release of Personally Identifiable Information (“PII”), our reputation and brand could be materially damaged; use of our products and services could decrease, we could suffer from reputational harm impacting sales revenue, and we could be faced with unforeseen regulatory investigation, remediation and litigation costs. Our cybersecurity insurance policies may not cover the full extent, or any, of the potential financial harm that could be caused by a breach of our systems, including in respect of theft or possible damages claims that may be brought against us by our business partners and customers in respect of any such breach.

The frequently changing attack techniques, along with the increased volume and sophistication of the attacks, create additional potential for us to be adversely impacted by this activity. This impact could result in reputational, competitive, operational or other business harm as well as management distraction, financial losses and costs, and regulatory action.

We may be unable to protect our stakeholders’ privacy or we may fail to comply with privacy laws.

The protection of customer, employee, supplier and company data is critical and the regulatory environment surrounding information security, storage, use, processing, disclosure and privacy is demanding, with the frequent imposition of new and changing requirements. In addition, our customers, employees and suppliers expect that we will protect their personal information. Any actual or perceived significant breakdown, intrusion, interruption, cyberattack or corruption of customer, employee or supplier data or our failure to comply with federal, state, local and foreign privacy laws, including the European Union’s General Data Protection Regulation (“GDPR”) and the Health Insurance Portability and Accountability Act, could result in lost sales, remediation costs, and legal liability including severe penalties, regulatory action and reputational harm. GDPR became effective in 2018, for example, and requires companies to meet new and enhanced requirements regarding the handling of personal data, including its use, protection and the rights of data
-26-


subjects to request correction or deletion of their personal data. Failure to meet GDPR requirements could result in penalties of up to 4% of worldwide revenue. Despite our efforts and investments in technology to secure our computer network, security could be compromised, confidential information could be misappropriated or system disruptions could occur. Failure to comply with the security requirements or rectify a security issue may result in fines and the imposition of restrictions on our ability to accept payment by credit or debit cards. In addition, the payment card industry (“PCI”) is controlled by a limited number of vendors that have the ability to impose changes in PCI’s fee structure and operational requirements on us without negotiation. Such changes in fees and operational requirements may result in our failure to comply with PCI security standards, as well as significant unanticipated expenses. Such failures could materially adversely affect our operating results and financial condition. Furthermore, we maintain cybersecurity insurance coverage at levels that we believe are appropriate for our business. The costs related to significant security breaches or disruptions, however, could be material and exceed the limits of the cybersecurity insurance we maintain against such risks. If the amounts of our insurance coverage are inadequate to satisfy any damages and losses in the event of a cybersecurity incident, we may have to expend significant resources to mitigate the impact of such an incident, and to develop and implement protections to prevent future incidents of this nature from occurring. Such financial exposure could have a material adverse effect on our business.
    
We may not be able to achieve sustained profitability or increase profitability on a quarterly or annual basis.

Prior to 2005, we incurred net losses on an annual basis since our inception in 1988 and, as of December 31, 2020, we had an accumulated deficit of $150.9 million. Relatively small differences in our performance metrics may cause us to generate an operating or net loss in future periods. Our ability to be profitable in future periods will depend, in part, on our ability to increase sales, including maintaining and growing our installed base of instruments and related consumables, to maintain or increase gross margins and to limit the increase in our operating expenses to a reasonable level as well as avoid or effectively manage any unanticipated issues. We may not be able to generate, sustain or increase profitability on a quarterly or annual basis. If we cannot achieve or sustain profitability for an extended period, we may not be able to fund our expected cash needs, including the repayment of debt as it comes due, or continue our operations.

We may face product returns and product liability litigation in excess of, or not covered by, our insurance coverage or indemnities and/or warranties from our suppliers. If we become subject to product liability claims resulting from defects in our products, we may fail to achieve market acceptance of our products and our sales could substantially decline.

The testing, manufacturing and marketing of our current products as well as those currently under development entail an inherent risk of product liability claims and associated adverse publicity. Following the introduction of a product, adverse side effects may be discovered. Adverse publicity regarding such effects could affect sales of our other products for an indeterminate time period. To date, we have not experienced any material product liability claims, but any claim arising in the future could substantially harm our business. Potential product liability claims may exceed the amount of our insurance coverage or may be excluded from coverage under the terms of the policy. We may not be able to continue to obtain adequate insurance at a reasonable cost, if at all. In the event that we are held liable for a claim against which we are not indemnified or for damages exceeding the $10 million limit of our insurance coverage or which results in significant adverse publicity against us, we may lose revenue, be required to make substantial payments which could exceed our financial capacity and/or lose or fail to achieve market acceptance.
-27-


We may be held liable for the release of hazardous materials, which could result in extensive remediation costs or otherwise harm our business.
Certain of our products and development programs produced at our Des Moines, Iowa facility involve the controlled use of hazardous and biohazardous materials, including chemicals and infectious disease agents. We cannot eliminate the risk of accidental contamination or injury from these materials. In the event of such an accident, we could be held liable for any fines, penalties, remediation costs or other damages that result. Our liability for the release of hazardous materials could exceed our resources, which could lead to a shutdown of our operations, significant remediation costs and potential legal liability. In addition, we may incur substantial costs to comply with environmental regulations if we choose to expand our manufacturing capacity.

Risks related to our common stock

Our stock price has historically experienced high volatility, and could do so in the future, including experiencing a material price decline resulting from a large sale in a short period of time. This volatility could affect the value of our common stock.

Should a relatively large stockholder decide to sell a large number of shares in a short period of time, it could lead to an excess supply of our shares available for sale and correspondingly result in a significant decline in our stock price.

The securities markets have experienced significant price and volume fluctuations and the market prices of securities of many small cap companies have in the past been, and can in the future be expected to be, especially volatile. During the twelve months ended December 31, 2020, the closing stock price of our common stock has ranged from a low of $52.17 to a high of $151.18, and the closing sale price of our common stock on February 25, 2021 was $190.51 per share. Fluctuations in the trading price or liquidity of our common stock may adversely affect our ability to raise capital through future equity financings. Factors that may have a significant impact on the market price and marketability of our common stock include:

stock sales by large stockholders or by insiders;
changes in the outlook for our business;
our quarterly operating results, including as compared to expected revenue or earnings and in comparison to historical results;
termination, cancellation or expiration of our third-party supplier relationships;
announcements of technological innovations or new products by our competitors or by us;
litigation;
regulatory developments, including delays in product introductions;
developments or disputes concerning patents or proprietary rights;
availability of our revolving line of credit and compliance with debt covenants;
releases of reports by securities analysts;
economic and other external factors;
issuances of equity or equity-linked securities by us; and
general market conditions

In the past, following periods of volatility in the market price of a company’s securities, securities class action litigation has often been instituted. If a securities class action suit is filed against us, it is likely we would incur substantial legal fees and our management’s attention and resources would be diverted from operating our business in order to respond to the litigation.

-28-


Our NOL Protective Amendment could adversely impact the value and trading liquidity of our common stock.

On May 4, 2010, our stockholders approved an amendment (the “NOL Protective Amendment”) to our Certificate of Incorporation. The NOL Protective Amendment places restrictions on the transfer of our common stock that could adversely affect our ability to use our domestic Federal Net Operating Loss carryforward (“NOL”). In particular, the NOL Protective Amendment prevents the transfer of shares without the approval of our board of directors if, as a consequence, an individual, entity or groups of individuals or entities would become a 5-percent holder under Section 382 of the Internal Revenue Code of 1986, as amended, and the related Treasury regulations, and also prevents any existing 5-percent holder from increasing his or her ownership position in the Company without the approval of our board of directors. Any transfer of shares in violation of the NOL Protective Amendment (a “Transfer Violation”) shall be void ab initio under the our Certificate of Incorporation and our board of directors has procedures under our Certificate of Incorporation to remedy a Transfer Violation including requiring the shares causing such Transfer Violation to be sold and any profit resulting from such sale to be transferred to a charitable entity chosen by the Company’s board of directors in specified circumstances. The NOL Protective Amendment could have an adverse impact on the value and trading liquidity of our stock if certain buyers who would otherwise have bid on or purchased our stock, including buyers who may not be comfortable owning stock with transfer restrictions, do not bid on or purchase our stock as a result of the NOL Protective Amendment. In addition, because some corporate takeovers occur through the acquirer’s purchase, in the public market or otherwise, of sufficient shares to give it control of a company, any provision that restricts the transfer of shares can have the effect of preventing a takeover. The NOL Protective Amendment could discourage or otherwise prevent accumulations of substantial blocks of shares in which our stockholders might receive a substantial premium above market value and might tend to insulate management and the board of directors against the possibility of removal to a greater degree than had the NOL Protective Amendment not passed.

In February 2018, our board of directors granted a waiver to a non-affiliated stockholder to allow the purchase, subject to certain limitations, of up to 730,000 shares of our common stock without causing a Transfer Violation. This waiver can be withdrawn by our board of directors at any time, in which case the non-affiliated stockholder is to only sell our stock until the non-affiliated stockholder ceases to be a Five Percent Shareholder (as defined in our Certificate of Incorporation). On August 7, 2019, our board of directors determined to waive the application of any NOL transfer restrictions contained in our Certificate of Incorporation with respect to the issuance and transfer of our Notes, any issuance of shares of the Company’s common stock upon conversion of any of the Notes, and any subsequent and further transfer of any such common stock, to the extent such restrictions would otherwise have been applicable thereto. In January 2020, our board of directors waived the application of any NOL transfer restrictions contained in our Certificate of Incorporation with respect to the issuance and sale of the shares of preferred stock and underlying common stock issued in connection with the financing of the scil acquisition. These waivers, and any similar waivers that our board of directors may grant in the future, may make it more likely that we have a “change of ownership” as defined under the provisions of Section 382 of the Internal Revenue Code of 1986, as amended, which could place a significant restriction on our ability to utilize our domestic Federal NOL in the future and materially adversely affect our results of operations. State net operating loss carryforwards may be similarly or more stringently limited. Any limitations on our ability to use our pre-change of ownership net operating losses to offset taxable income could potentially result in increased future tax liability to us.

If securities analysts do not publish research or reports about our business, or if they downgrade our stock, the price of our stock could decline.

The trading market for our common stock will likely be influenced by research and reports that securities or industry analysts publish about us or our business. In the event securities or industry analysts cover our company and one or more of these analysts downgrades our stock, lowers their price target, or publishes
-29-


unfavorable or inaccurate research about our business, our stock price would likely decline. If one or more of these analysts ceases coverage of our company or fails to publish reports on us regularly, demand for our stock could decrease, which could cause our stock price and trading volume to decline.

We have not declared or paid any dividends on our common stock since 2012 and we do not anticipate paying any cash dividends in the foreseeable future.

We have not declared or paid any dividends on our common stock since October 2012. We intend to retain any earnings to finance the operation and expansion of our business, and we do not anticipate paying any cash dividends in the future. As a result, investors in our common stock may only receive a return on their investment in our common stock if the market price of our common stock increases.

We have fewer than 300 holders of record, which could allow us to terminate voluntarily the registration of our common stock with the SEC and after which we would no longer be eligible to maintain the listing of our common stock on The Nasdaq Capital Market. We may also be unable to otherwise maintain our listing on The Nasdaq Capital Market.

We have fewer than 300 holders of record as of our latest information, a fact which could make us eligible to terminate voluntarily the registration of our common stock with the SEC and therefore suspend our reporting obligations with the SEC under the Exchange Act and become a non-reporting company. If we were to cease reporting with the SEC, we would no longer be eligible to maintain the listing of our common stock on The Nasdaq Capital Market, which we would expect to materially adversely affect the liquidity and market price for our common stock. The Nasdaq Capital Market has several additional quantitative and qualitative requirements companies must comply with to maintain this listing. While we believe we are currently in compliance with all Nasdaq requirements, there can be no assurance we will continue to meet Nasdaq listing requirements, that Nasdaq will interpret these requirements in the same manner we do if we believe we meet the requirements, or that Nasdaq will not change such requirements or add new requirements to include requirements we do not meet in the future.

If we were delisted from The Nasdaq Capital Market, our common stock may be considered a penny stock under the regulations of the SEC and would therefore be subject to rules that impose additional sales practice requirements on broker-dealers who sell our securities. The additional burdens imposed upon broker-dealers may discourage broker-dealers from effecting transactions in our common stock, which could severely limit market liquidity of the common stock and any stockholder’s ability to sell our securities in the secondary market. This lack of liquidity would also likely make it more difficult for us to raise capital in the future.

Provisions in our Certificate of Incorporation and bylaws and under Delaware law might discourage, delay or prevent a change of control of our company or changes in our management and, therefore, depress the trading price of our common stock.

Our Certificate of Incorporation and bylaws contain provisions that could depress the trading price of our common stock by acting to discourage, delay or prevent a change of control of our company or changes in our management that the stockholders of our company may deem advantageous. These provisions:

place restrictions on the transfer of our common stock that could adversely affect our ability to use our domestic NOL, which can have an effect of preventing a takeover;
provide that our board of directors may, without stockholder approval, issue shares of preferred stock with special voting or economic rights;
prohibit stockholders from calling a special meeting of our stockholders;
provide that the board of directors is expressly authorized to make, alter or repeal our bylaws; and
-30-


establish advance notice requirements for nominations for elections to our board of directors or for proposing matters that can be acted upon by stockholders at stockholder meetings.

Additionally, we are subject to Section 203 of the Delaware General Corporation Law, which generally prohibits a Delaware corporation from engaging in any of a broad range of business combinations with any “interested” stockholder for a period of three years following the date on which the stockholder became an “interested’ stockholder and which may discourage, delay, or prevent a change of control of our company.
Any provision of our Certificate of Incorporation, bylaws or Delaware law that has the effect of delaying or deterring a change in control could limit the opportunity for our stockholders to receive a premium for their shares of our common stock, and could also negatively affect the price that some investors are willing to pay for our common stock.

Risks related to the outstanding Notes

Servicing our debt will require a significant amount of cash, and we may not have sufficient cash flow from our business to pay our substantial debt.

Our ability to make scheduled payments of the principal of, to pay interest on or to refinance our indebtedness, including the amounts payable under the Notes, depends on our future performance, which is subject to economic, financial, competitive and other factors beyond our control. Our business may not continue to generate cash flow from operations in the future sufficient to service our debt and make necessary capital expenditures. If we are unable to generate such cash flow, we may be required to adopt one or more alternatives, such as selling assets, restructuring debt or obtaining additional equity capital on terms that may be onerous or highly dilutive. Our ability to refinance our indebtedness will depend on the capital markets and our financial condition at such time. We may not be able to engage in any of these activities or engage in these activities on desirable terms, which could result in a default on our debt obligations.

We may not have the ability to raise the funds necessary to settle conversions of the Notes in cash or to repurchase the Notes upon a fundamental change, and our future debt may contain, limitations on our ability to pay cash upon conversion or repurchase of the Notes.

Holders of the Notes will have the right to require us to repurchase their notes upon the occurrence of a fundamental change at a fundamental change repurchase price equal to 100% of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest, if any. In addition, upon conversion of the Notes, unless we elect to deliver solely shares of our common stock to settle such conversion (other than paying cash in lieu of delivering any fractional share), we will be required to make cash payments in respect of the Notes being converted. However, we may not have enough available cash or be able to obtain financing at the time we are required to make repurchases of Notes surrendered therefor or Notes being converted. In addition, our ability to repurchase the Notes or to pay cash upon conversions of the Notes may be limited by law, by regulatory authority or by agreements governing our existing and future indebtedness. Our failure to repurchase Notes at a time when the repurchase is required by the indenture or to pay any cash payable on future conversions of the Notes as required by the indenture would constitute a default under the indenture. If a fundamental change occurs, or if the Notes are accelerated due to an event of default under the indenture, such events may lead to a default under agreements governing our future indebtedness. Any future indebtedness of ours may contain restrictions on our ability to pay cash upon conversion or repurchase of the Notes. If the repayment of the related indebtedness were to be accelerated after any applicable notice or grace periods, we may not have sufficient funds to repay the indebtedness and repurchase the Notes or make cash payments upon conversions thereof.

-31-


The conditional conversion feature of the Notes, if triggered, may adversely affect our financial condition and operating results.

In the event the conditional conversion feature of the Notes is triggered, holders of Notes will be entitled to convert the Notes at any time during specified periods at their option. If one or more holders elect to convert their Notes, unless we elect to satisfy our conversion obligation by delivering solely shares of our common stock (other than paying cash in lieu of delivering any fractional share) or by electing an exchange process for the Notes and a designated financial institution delivers the applicable conversion consideration, we would be required to settle a portion or all of our conversion obligation through the payment of cash, which could adversely affect our liquidity. In addition, even if holders of Notes do not elect to convert their Notes, we could be required under applicable accounting rules to reclassify all or a portion of the outstanding principal of the Notes as a current rather than long-term liability, which would result in a material reduction of our net working capital.

Item 1B.Unresolved Staff Comments    
None.
Item 2.Properties
Our principal administrative and research and development activities are located in Loveland, Colorado. We lease approximately 60,000 square feet at a facility in Loveland, Colorado under an agreement that expires in 2023. Our principal production facility located in Des Moines, Iowa, consists of approximately 160,000 square feet of buildings on 34 acres of land, which we own.
In December 2019, we entered into lease agreements for two warehouses in Tudela, Spain for the development of the business activities of the CVM companies.
On April 1, 2020, we acquired scil, which included property in Germany, France, Spain, Canada, Italy and Malaysia. In Germany, we own an office space that is approximately 45,000 square feet, and a warehouse that is approximately 15,000 square feet. In France, Spain and Malaysia, we lease office spaces and warehouses. In Canada, we lease an office space and in Italy, we own an office space, a warehouse, and a showroom.
Item 3.Legal Proceedings

From time to time, the Company may be involved in litigation relating to claims arising out of its operations. The Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred, and the amount can be reasonably estimated.
As of December 31, 2020, we were not a party to any legal proceedings that are expected, individually or in the aggregate, to have a material adverse effect on our business, financial condition or operating results.
Item 4. Mine Safety Disclosures

Not applicable.
-32-



PART II

Item 5.Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Our Public Common Stock is quoted on the Nasdaq Capital Market under the symbol "HSKA".
As of February 25, 2021, there were approximately 250 holders of record of our Public Common Stock, and approximately 4,000 beneficial stockholders. We do not anticipate any dividend payments in the foreseeable future.
Issuer Purchases of Equity Securities
The following table sets forth information about the Company's purchases of our outstanding Public Common Stock during the quarter ended December 31, 2020:
PeriodTotal Number of Shares Purchased (1)Average Price Paid per Share (1)Total Number of Shares Purchased as Part of Publicly Announced Plans or ProgramsApproximate Dollar Value of Shares that May Yet be Purchased Under Plans or Programs
October 2020— $— — $— 
November 20203,127 $121.83 — $— 
December 20202,825 $133.13 — $— 
5,952 $127.19 — $— 
 (1) Shares of Public Common Stock we purchased between October 1, 2020 and December 31, 2020 were solely for the cancellation of shares of stock withheld for related tax obligations.

-33-


STOCK PRICE PERFORMANCE GRAPH
The following graph provides a comparison over the five-year period ended December 31, 2020 of the cumulative total shareholder return from a $100 investment in the Company's common stock with the NASDAQ Medical Supplies Index and the NASDAQ Composite Total Return:

hska-20201231_g2.jpg

Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20
Heska Corporation$100 $395 $442 $475 $529 $803 
NASDAQ Medical Supplies Index$100 $126 $165 $177 $234 $297 
NASDAQ Composite Total Return Index$100 $116 $151 $147 $200 $291 

-34-



Item 7.Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the Consolidated Financial Statements and related Notes included in Item 8 of this Form 10-K. This discussion contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Rule 175 promulgated thereunder, and Section 21E of the Securities Exchange Act of 1934, as amended, that involve risks and uncertainties, and can generally be identified by our use of the words "scheduled," "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," and variations of such words and similar expressions. Such statements, which include statements concerning future revenue sources and concentration, international market expansion, gross profit margins, selling and marketing expenses, remaining minimum performance obligations, research and development expenses, general and administrative expenses, capital resources, financings or borrowings and additional losses, are subject to risks and uncertainties, including, but not limited to, those discussed below and elsewhere in this Form 10-K, particularly in Item 1A. "Risk Factors," that could cause actual results to differ materially from those projected. The forward-looking statements set forth in this Form 10-K are as of the close of business on February 25, 2021, and we undertake no duty and do not intend to update this information, except as required by applicable securities laws. If we updated one or more forward looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements set forth above. See "Statement Regarding Forward Looking Statements."
Overview
We sell advanced veterinary diagnostic and specialty products. Our offerings include Point of Care laboratory instruments and consumables; Point of Care digital imaging diagnostic instruments; digital cytology services; vaccines; local and cloud-based data services; allergy testing and immunotherapy; and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. Our core focus is on supporting veterinarians in the canine and feline healthcare space.
Point of Care laboratory instruments and other sales include outright instrument sales, revenue recognized from sales-type lease treatment, and other revenue sources, such as charges for repairs. Revenue from Point of Care laboratory consumables primarily involves placing an instrument under contract in the field and generating future revenue from testing consumables, such as cartridges and reagents, as that instrument is used. Instruments placed under subscription agreements are considered operating or sales-type
leases, depending on the duration and other factors of the underlying agreement. A loss of, or disruption in, the supply of consumables we are selling to an installed base of instruments could substantially harm our business. All of our Point of Care laboratory and other non-imaging instruments and consumables are supplied by third parties, who typically own the product rights and supply the product to
us under marketing and/or distribution agreements. In many cases, we have collaborated with a third party to adapt a human instrument for veterinary use. Major products in this area include our instruments for chemistry, hematology, blood gas and immunodiagnostic testing and their affiliated operating consumable.

Radiography is the largest product offering in Point of Care imaging, which includes digital and computed radiography and ultrasound instruments. Radiography solutions typically consist of a combination of hardware and software placed with a customer, often combined with an ongoing service and support contract. Our experience has been that most of the revenue is generated at the time of sale in this area, in contrast to the Point of Care diagnostic laboratory placements discussed above where ongoing consumable revenue is often a larger component of economic value as a given instrument is used.

-35-


Pharmaceuticals, Vaccines and Diagnostic ("PVD") revenue, includes single use diagnostic and other tests, pharmaceuticals and biologicals as well as research and development, licensing and royalty revenue. Since items in this area are often single use by their nature, our typical aim is to build customer satisfaction and loyalty for each product, generate repeat annual sales from existing customers and expand our customer base in the future. Products in this area are both supplied by third parties and provided by us. Major products and services in this area include heartworm diagnostic tests and preventives, and allergy test kits, allergy
immunotherapy and testing.

Other Vaccines and Pharmaceuticals ("OVP") revenue is generated in our USDA, FDA and DEA licensed production facility in Des Moines, Iowa. We view this facility as an asset which could allow us to control our cost of goods on any pharmaceuticals and vaccines that we may commercialize in the future. We have increased integration of this facility with our operations elsewhere. For example, virtually all of our U.S. inventory, excluding our imaging products, is stored at this facility and related fulfillment logistics are managed there. Our OVP revenue includes vaccines and pharmaceuticals produced for third parties. OVP is attributable only to the North America segment.

All of our products are ultimately sold primarily to or through veterinarians. In many cases, veterinarians will mark up their costs to their customers. The acceptance of our products by veterinarians is critical to our success. These products are sold directly to end users by us as well as through distribution relationships, such as the sale of kits to conduct blood testing to third-party veterinary diagnostic laboratories and sales to independent third-party distributors. Revenue from direct sales and distribution relationships represented 72% and 28%, respectively, of revenue for the year ended December 31, 2020 compared to 64% and 36%, respectively, for the year ended December 31, 2019.

Segment Change

During the second quarter of 2020, following the scil acquisition, the chief operating decision maker (“CODM”) changed how he assesses performance and allocates resources based on geographic regions. As a result, the Company determined it has two operating and reportable segments: North America and International. North America consists of the United States, Canada and Mexico. International consists of geographies outside of North America, primarily our operations in Australia, France, Germany, Italy, Malaysia, Spain and Switzerland. The Company's core strategic focus on point of care laboratory and imaging products is included in both segments. The North America segment also includes the contract manufacturing
of vaccines and pharmaceutical products. The Company revised prior comparative periods to conform to the current period segment presentation. Refer to Note 18 - Segment Reporting to the consolidated financial statements included in Part II. Item 8 of this Annual Report on Form 10-K for further information.

Impact of COVID-19 Pandemic and Current Economic Environment

Beginning in the first quarter of 2020, to limit the spread of COVID-19, governments took various actions including the issuance of stay-at-home policies and social distancing procedures and guidelines, causing some businesses to adjust, reduce or suspend business and operating activities. Veterinary care is widely recognized as an "essential" service for pet owners, and veterinarians continued to deliver essential medical care for sick and injured pets. The stay-at-home policies deployed early in 2020 to combat the spread of COVID-19 resulted in a decrease in companion animal clinical visits, including delay of elective procedures and wellness visits and as a result lower demand for diagnostic testing services. During the second and third quarters of 2020, certain local, state and federal governments began to ease the stay-at-home policies and allowed more businesses and facilities to re-open, leading to a recovery in companion animal clinical visits and associated demand for our diagnostic products. Finally, during the fourth quarter, increased restrictions, mainly in the European Union, certain parts of Canada and Australia, in which we operate, re-emerged. The extent to which
-36-


the continuation, or another wave outbreak of COVID-19, or an outbreak of other health epidemics could impact our business, results of operations and financial condition, including the potential for write-offs or impairments of assets and suspension of capital investments, will depend on future developments. We are unable to predict with certainty the effects of the COVID-19 pandemic on our customers, suppliers and vendors, as well as the actions of governments, and when and to what extent normal economic and operating conditions can resume; these effects may differ from those assumed in our projected estimates. Even after the COVID-19 pandemic has subsided, we may continue to experience adverse impacts, mainly in our ability to place new capital equipment, to our business as a result of any economic impact that has occurred or may occur in the future.

As a result of social distancing measures, on-site installations of POC Lab and Imaging equipment continue to experience intermittent delays. While not significant to the overall results of the of the year, on-site installations of equipment have been impacted since March. However, our financial position remains strong. On April 1, 2020, we closed our acquisition of scil; the transaction was fully financed by a preferred stock offering. We have sufficient liquidity to sustain our operations and do not anticipate a need to access additional capital outside of the various programs available to our overseas subsidiaries.

While we have experienced some intermittent delays in receiving supply and a slight increase in shipping costs, our supply chain has not been significantly impacted. Our major research and development projects are continuing to progress substantially as planned but we have experienced sporadic delays in receiving validation samples and device components as well as inefficiencies in remote collaboration and field-testing.

We do not know how long COVID-19 related challenges will continue. The ultimate impact on our business will depend on many factors substantially beyond our control and difficult to predict. In the near-term and with asynchronous variation across geographies, we anticipate veterinary hospitals may temporarily delay capital equipment investments as a result of heightened conservatism and the effects of social distancing on in-clinic demonstrations and installations. Despite these headwinds, we believe we are well positioned because: (1) our customers and products are essential, (2) our main Point of Care laboratory business continues to show healthy consumables use and margin, (3) our subscriptions model metrics continue to show solid performance, (4) our vaccines and pharmaceuticals business continues to perform with minimal disruption, (5) our balance sheet is strong, and (6) our employees, logistics, supply chain, and operations continue to operate well in the current environment and they are fully prepared for both a phased return and an instant return to full capacity.

Critical Accounting Estimates
Note 1 - Summary of Significant Accounting Policies to the consolidated financial statements included in Part II. Item 8 of this Annual Report on Form 10-K describes the significant accounting policies used in preparation of these consolidated financial statements. We believe the following critical accounting estimates and assumptions may have a material impact on reported financial condition and operating performance and involve significant levels of judgment to account for highly uncertain matters or are susceptible to significant change. In each of these areas, management makes estimates based on historical results, current trends and future projections.



-37-


Deferred Tax Assets – Valuation Allowance
    
We evaluate our ability to realize the tax benefits associated with a deferred tax asset (“DTA”) by analyzing our forecasted taxable income using both historical and projected future operating results, the reversal of existing temporary differences, taxable income in prior carry back years (if permitted) and the availability of tax planning strategies. A valuation allowance is required to be established unless management determines that it is more likely than not that we will ultimately realize the tax benefit associated with a deferred tax asset. As of December 31, 2020 and 2019, we had valuation allowances of approximately $6.4 million and $5.7 million, respectively.     

Business Combinations

We account for transactions that represent business combinations under the acquisition method of accounting, which requires us to allocate the total consideration paid for each acquisition to the assets we acquire and liabilities we assume based on their fair values as of the date of acquisition, including identifiable intangible assets. The allocation of the purchase price utilizes significant estimates in determining the fair values of identifiable assets acquired and liabilities assumed, especially with respect to intangible assets. We may refine our estimates and make adjustments to the assets acquired and liabilities assumed over a measurement period, not to exceed one year. 

Valuation of Goodwill and Intangibles

A significant portion of the purchase price for acquired businesses is generally assigned to intangible assets. Intangible assets other than goodwill are initially valued at fair value. If a quoted price in an active market for the identical asset is not readily available at the measurement date, the fair value of the intangible asset is estimated based on discounted cash flows using market participant assumptions, which are assumptions that are not specific to Heska. The selection of appropriate valuation methodologies and the estimation of discounted cash flows require significant assumptions about the timing and amounts of future cash flows, risks, appropriate discount rates, and the useful lives of intangible assets. When material, we utilize independent valuation experts to advise and assist us in determining the fair values of the identified intangible assets acquired in connection with a business acquisition and in determining appropriate amortization methods and periods for those intangible assets. Goodwill is initially valued based on the excess of the purchase price of a business combination over the fair value of acquired net assets recognized and represents the future economic benefits arising from other assets acquired that could not be individually identified and separately recognized.

We assess goodwill for impairment annually, at the reporting unit level, in the fourth quarter and whenever events or circumstances indicate impairment may exist. In evaluating goodwill for impairment, we have the option to first assess the qualitative factors to determine whether it is more-likely-than-not that the estimated fair value of the reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the comparison of the estimated fair value of the reporting unit to the carrying value. The more-likely-than-not threshold is defined as having a likelihood of more than 50 percent. If, after assessing the totality of events or circumstances, we determine that is it more-likely-than-not that the estimated fair value of a reporting is less than its carrying amount, we would then estimate the fair value of the reporting unit and compare it to the carrying value. If the carrying value exceeds the estimated fair value we would recognize an impairment for the difference; otherwise, no further impairment test would be required. In contrast, we can opt to bypass the qualitative assessment for any reporting unit in any period and proceed directly to quantitative analysis. Doing so does not preclude us from performing the qualitative assessment in any subsequent period.

-38-


As part of our goodwill testing process, we evaluate factors specific to a reporting unit as well as industry and macroeconomic factors that are reasonably likely to have a material impact on the fair value of a reporting unit. Examples of the factors considered in assessing the fair value of a reporting unit include: the results of the most recent impairment test, the competitive environment, the regulatory environment, anticipated changes in product or labor costs, revenue growth trends, the consistency of operating margins and cash flows and current and long-range financial forecasts. The long-range financial forecasts of the reporting units, which are based upon management’s long-term view of our markets, are used by senior management and the Board of Directors to evaluate operating performance.
We performed qualitative assessments in the fourth quarters of 2020, 2019 and 2018 and determined that no indications of impairment existed.

We assess the realizability of intangible assets other than goodwill whenever events or changes in circumstances indicate that the carrying value may not be recoverable. If an impairment review is triggered, we evaluate the carrying value of intangible assets based on estimated undiscounted future cash flows over the remaining useful life of the primary asset of the asset group and compare that value to the carrying value of the asset group. The cash flows that are used contain our best estimates, using appropriate and customary assumptions and projections at the time. If the net carrying value of an intangible asset exceeds the related estimated undiscounted future cash flows, an impairment to adjust the intangible asset to its fair value would be reported as a non-cash charge to earnings. If necessary, we would calculate the fair value of an intangible asset using the present value of the estimated future cash flows to be generated by the intangible asset, and applying a risk-adjusted discount rate. We had no impairments of our intangible assets during the years ended December 31, 2020, 2019 and 2018.

These valuations require the use of management’s assumptions, which would not reflect unanticipated events and circumstances that may occur.

Share-Based Compensation Expense

We utilize share-based compensation arrangements as part of our long-term incentive plan. Our share-based compensation programs provide for grants of many types of awards, but we currently grant stock options, including performance stock options, and restricted stock awards, along with the issuance of employee stock purchase rights. The total fair value of future awards may vary significantly from past awards based on a number of factors, including our share-based award practices. Therefore, share-based compensation expense is likely to fluctuate, possibly significantly, from year to year.

The majority of our currently issued restricted stock awards and performance stock options are tied to Company and market-related performance metrics and generally include a time vesting component. We also grant stock options and restricted stock awards tied to time vesting to employees and directors. All significant inputs into the determination of expense as well as the related expense are discussed further in Note 12 - Capital Stock to the consolidated financial statements included in Part II. Item 8 of this Annual Report on Form 10-K.

Restricted Stock Awards (Time Vesting)

The fair value of restricted stock awards with only time-based vesting terms used in our expense recognition method is measured based on the number of shares granted and the closing market price of our common stock on the date of grant. Such value is recognized as an expense over the corresponding requisite service period. Forfeitures are accounted for as they occur.

-39-


Performance-Based Stock Compensation Awards

We also grant restricted stock awards and performance stock options subject to performance vesting criteria, in addition to service, to our executive officers and other key employees. This type of grant consists of the right to receive shares of, or options to purchase, common stock, subject to achievement of time-based criteria and certain Company and market performance-related goals over a specified period, as established by the Compensation Committee of our Board of Directors. We recognize any related share-based compensation expense ratably over the requisite service period based on the probability assessment on the outcome of the performance condition related to company performance metrics. The fair value used in our expense recognition method is measured based on the number of shares granted and the closing market price of our common stock on the date of grant for restricted stock awards and the Black-Scholes model for performance stock options. The amount of share-based compensation expense recognized in any one period can vary based on the attainment or expected attainment of the performance goals. If such performance goals are not ultimately met, no compensation expense is recognized and any previously recognized compensation expense is reversed. We recognize any related share-based compensation expense ratably over the service period based on the most probable outcome of the performance condition related to market performance metrics. For awards related to market performance, the fair value used in our expense recognition method is measured based on the number of shares granted, and a Monte Carlo simulation model, which incorporates the probability of the achievement of the market-related performance goals as part of the grant date fair value. If such performance goals are not ultimately met, the expense is not reversed.

Recent Accounting Pronouncements
From time to time, the FASB or other standard setting bodies issue new accounting pronouncements. Updates to the FASB ASC are communicated through issuance of an ASU. Unless otherwise discussed, we believe that recently issued guidance, whether adopted or to be adopted in the future, is not expected to have a material impact on our Consolidated Financial Statements upon adoption.
To understand the impact of recently issued guidance, whether adopted or to be adopted, please review the information provided in Note 1 - Operations and Summary of Significant Accounting Policies to the consolidated financial statements included in Part II. Item 8 of this Annual Report on Form 10-K.
-40-


Results of Operations
Our analysis presented below is organized to provide the information we believe will facilitate an understanding of our historical performance and relevant trends going forward. This discussion should be read in conjunction with our consolidated financial statements, including the notes thereto, in Part II. Item 8 of this Annual Report on Form 10-K. A discussion of significant changes from the periods ending December 31, 2019 compared to December 31, 2018 can be found in Part II. Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Annual Report on Form 10-K for the year ended December 31, 2019.
The following table sets forth, for the periods indicated, certain data derived from our Consolidated Statements of (Loss) Income (in thousands):

Year Ended December 31,
20202019
Revenue, net$197,323 $122,661 
Gross profit81,290 54,449 
Operating expenses89,482 54,122 
Operating (loss) income(8,192)327 
Interest and other expense, net5,601 2,910 
Income before income taxes and equity in losses of unconsolidated affiliates(13,793)(2,583)
Income tax expense (benefit)239 (1,446)
Net loss before equity in losses of unconsolidated affiliates(14,032)(1,137)
Equity in losses of unconsolidated affiliates(720)(594)
Net loss, after equity in losses of unconsolidated affiliates(14,752)(1,731)
Net loss attributable to non-controlling interest(353)(266)
Net loss attributable to Heska Corporation$(14,399)$(1,465)
Diluted loss per share attributable to Heska Corporation(1)
$(1.66)$(0.20)
Non-GAAP net income per diluted share (1)(2)
$0.74 $0.49 
Adjusted EBITDA (2)
$22,319 $10,382 
Net loss margin (2)
(7.1)%(0.9)%
Adjusted EBITDA margin (2)
11.3 %8.5 %
(1) Shares used in the diluted per share calculation for diluted loss per share attributable to Heska Corporation are (in thousands) 8,653 for the year ended December 31, 2020 and 7,446 for the year ended December 31, 2019. Shares used in the diluted per share calculation for non-GAAP net income per diluted share are (in thousands): 9,451 for the year ended December 31, 2020 compared to 7,977 for the year ended December 31, 2019.
(2) See “Non-GAAP Financial Measures” for a reconciliation of Adjusted EBITDA to net income, Non-GAAP net income (loss) per diluted share to Diluted (loss) earnings per share attributable to Heska Corporation, and Adjusted EBITDA margin to Net loss margin, the closest comparable GAAP measures, for each of the periods presented.

Revenue
Total revenue increased 61% to $197.3 million in 2020 compared to $122.7 million in 2019. The significant increase in revenue is driven mainly by the acquisitions of CVM and scil, which represented an increase of $68.2 million of revenue for the twelve months ended December 31, 2020, which was not included in the
-41-


prior year period. The remaining increase is a result of sales of POC Lab Consumables, contract manufactured product for third parties, including TriHeart, and immunotherapy products.
Gross Profit
Gross profit increased 49.3% to $81.3 million in 2020 compared to $54.4 million in 2019.  Gross margin percent declined to 41.2% in 2020 compared to 44.4% in 2019. The increase in gross profit is due to recent acquisitions of CVM and scil, which represented an increase of $21.3 million increase in gross profit in the twelve months ended December 31, 2020, which was not included in the prior year period. Remaining increase in gross profit is due to increased sales of higher margin products such as POC Lab Consumables and contract manufacturing production increases. The decrease in gross margin percentage is due to lower margin in our newly acquired businesses.
Operating Expenses
Selling and marketing expenses increased 39% to $38.5 million in 2020 compared to $27.7 million in 2019. The increase is a direct result of international expansion related to recent acquisitions and is in line with management expectations.
Research and development expenses increased 6% to $8.8 million in 2020, compared to $8.2 million in 2019. The increase was primarily driven by spending on product development for a urine and fecal diagnostic analyzer and enhanced immunodiagnostic offerings. As we invest in future growth of the Company, the increased research and development expenses is consistent with the spending initiatives of management.
General and administrative expenses increased 132% to $42.2 million in 2020, compared to $18.2 million in 2019. The increase is driven primarily by additional expenses related to the impact of international acquisitions compared to the prior year of $11.4 million, as well as one-time costs primarily related to the acquisition of scil, which were $9.5 million in 2020 compared to $1.0 million in 2019. In addition, stock-based and other compensation expenses increased by $4.5 million.
Interest and Other (Income) Expense, Net
Interest and other expense, net, was $5.6 million in 2020, compared to $2.9 million in 2019. The increase was primarily driven by interest expense as a result of the Notes. Refer to Note 16 - Convertible Notes and Credit Facility to the consolidated financial statements included in Part II, Item 8 of this Annual Report on Form 10-K.
Income Tax (Benefit) Expense

In 2020, we had total income tax expense of $0.2 million compared to a total income tax benefit in 2019 of $1.4 million. See Note 5 - Income Taxes to the consolidated financial statements included in Part II. Item 8 of this Annual Report on Form 10-K for additional information regarding our income taxes.

Net (Loss) Income Attributable to Heska Corporation
Net loss attributable to Heska Corporation was $14.4 million in 2020, compared to net loss attributable to Heska Corporation of $1.5 million in 2019. The difference between this line item and "Net (loss) income after equity in losses of unconsolidated affiliates" is the net income or loss attributable to the minority interest in our French subsidiary, Optomed, which we purchased in February 2019. The difference between these line items was a gain of $0.4 million for 2020, and a gain of $0.3 million for 2019. In October 2020, the Company acquired the remaining 30% minority interest in Optomed.
-42-



Adjusted EBITDA
Adjusted EBITDA in the twelve months ended December 31, 2020 was $22.3 million (11.3% adjusted EBITDA margin), compared to $10.4 million (8.5% adjusted EBITDA margin) in the twelve months ended December 31, 2019. The increase is driven by increased revenue and gross profit as discussed above. The increases in operating expenses are excluded from adjusted EBITDA. See “Non-GAAP Financial Measures” for a reconciliation of adjusted EBITDA to net income and adjusted EBITDA margin to net loss margin, the closest comparable GAAP measures, for each of the periods presented.
Earnings Per Share
Loss per share attributable to Heska was $1.66 per diluted share in the twelve months ended December 31, 2020 compared to loss of $0.20 per diluted share in the twelve months ended December 31, 2019. The decline is primarily due to increases in operating expenses as discussed above, interest and amortization charges relating to the Notes, and increased deferred income tax expense.
Non-GAAP Earnings Per Share
Non-GAAP EPS was income of $0.74 per diluted share in the twelve months ended December 31, 2020 compared to income of $0.49 per diluted share in the twelve months ended December 31, 2019. The decline is primarily due to cash interest related to the Notes and increased deferred income taxes. See “Non-GAAP Financial Measures" for a reconciliation of non-GAAP EPS to net (loss) income attributable to Heska per diluted share, the closest comparable U.S. GAAP measure, in each of the periods presented.

Non-GAAP Financial Measures

In addition to financial measures presented on the basis of accounting principles generally accepted in the U.S. (“U.S. GAAP”), we also present EBITDA, adjusted EBITDA, adjusted EBITDA margin, and non-GAAP net income (loss) per diluted share, which are non-GAAP measures.
These measures should be viewed as a supplement to, not substitute for, our results of operations presented under U.S. GAAP. The non-GAAP financial measures presented may not be comparable to similarly titled measures of other companies because they may not calculate their measures in the same manner. Management uses EBITDA, adjusted EBITDA, adjusted EBITDA margin and non-GAAP net income (loss) per diluted share as key profitability measures, which are included in our quarterly analyses of our operating results to our senior management team, our annual budget and related goal setting and other performance measurements. We believe these non-GAAP measures enhance our investors' understanding of our business performance and that not adjusting for the items included in the reconciliations below would hinder comparison of the performance of our businesses on a period-over-period basis or with other businesses.
-43-


The following tables reconcile our most directly comparable as-reported financial measures calculated in accordance with GAAP to our non-GAAP financial measures (in thousands, except percentages and per share amounts):
 Year Ended
December 31,
 20202019
Net loss (1)
$(14,032)$(1,137)
Income tax expense (benefit)239 (1,446)
Interest expense5,767 2,428 
Depreciation and amortization$11,385 4,916 
EBITDA$3,359 $4,761 
Acquisition-related and other one-time costs (2)
$9,837 981 
Stock-based compensation9,490 4,968 
Equity in losses of unconsolidated affiliates(720)(594)
Net loss attributable to non-controlling interest353 266 
Adjusted EBITDA$22,319 $10,382 
Net loss margin (3)
(7.1)%(0.9)%
Adjusted EBITDA margin (3)
11.3 %8.5 %

(1) Net loss used for reconciliation represents the "Net loss before equity in losses of unconsolidated affiliates."

(2) To exclude the effect of one-time charges of $9.8 million for the year ended December 31, 2020 compared to $1.0 million for the year ended December 31, 2019. These costs were incurred primarily as part of the acquisition of scil.

(3) Net loss margin and adjusted EBITDA margin are calculated as the ratio of net loss and adjusted EBITDA, respectively, to revenue.


 Year Ended
December 31,
 20202019
GAAP net income attributable to Heska per diluted share$(1.66)$(0.20)
Acquisition-related costs and other one-timed costs(1)
1.04 0.12 
Amortization of acquired intangibles(2)
0.55 0.16 
Purchase accounting adjustments related to inventory and fixed asset step-up(3)
0.08 — 
Amortization of debt discount and issuance costs0.33 0.23 
Stock-based compensation1.00 0.62 
Loss on equity investee transactions0.08 0.07 
Estimated income tax effect of non-GAAP adjustments(4)
(0.68)(0.51)
Non-GAAP net income per diluted share$0.74 $0.49 
Shares used in diluted per share calculations9,451 7,977 

(1) To exclude the effect of one-time charges of $9.8 million for the year ended December 31, 2020 compared to $1.0 million for the year ended December 31, 2019. These costs were incurred primarily as part of the acquisition of scil.

(2) To exclude the effect of amortization of acquired intangibles of $5.2 million in the year ended December 31, 2020, compared to $1.3 million in the year ended December 31, 2019. These costs were incurred as part of the purchase accounting adjustments for the acquisitions of scil, Optomed and CVM.

-44-


(3) To exclude the effect of purchase accounting adjustments for inventory step up amortization and depreciation related to the step-up of fixed assets of $0.7 million for the year ended December 31, 2020.

(4) Represents income tax expense utilizing an estimated effective tax rate that adjusts for non-GAAP measures including: acquisition-related and other one-time costs (excluding items which are not deductible for tax of $4.0 million for the year ended December 31, 2020), amortization of acquired intangibles, purchase accounting adjustments, amortization of debt discount and issuance costs, and stock-based compensation. This incorporates the tax benefit related to stock-based compensation of $0.2 million for the year ended December 31, 2020 compared to $1.7 million for the year ended December 31, 2019. Adjusted effective tax rates are approximately 25% for the year ended December 31, 2020 and 24% for the year ended December 31, 2019.
Analysis by Segment
The North America segment includes sales and costs from the United States, Canada and Mexico. The International segment includes sales and costs from Australia, France, Germany, Italy, Malaysia, Spain and Switzerland.
The North America segment represented 66.4% of our revenue for the twelve months ended December 31, 2020, and the International segment represented 33.6% of our revenue for the twelve months ended December 31, 2020.

The following sections and tables set forth, for the periods indicated, certain data derived from our Consolidated Statements of (Loss) Income (in thousands).

North America Segment
Twelve Months Ended December 31,Change
20202019Dollar Change% Change
Point of Care laboratory:$72,910 $66,713 $6,197 9.3 %
Instruments & Other13,663 13,446 217 1.6 %
Consumables59,247 53,267 5,980 11.2 %
Point of Care imaging20,651 21,654 (1,003)(4.6)%
PVD19,810 10,966 8,844 80.6 %
OVP17,695 16,090 1,605 10.0 %
Total North America revenue$131,066 $115,423 $15,643 13.6 %
North America Gross Profit$60,903 $52,334 $8,569 16.4 %
North America Gross Margin46.5 %45.3 %
North America Operating (Loss) Income$(4,977)$1,426 $(6,403)(449.0)%
North America Operating (Loss) Income Margin(3.8)%1.2 %

North America segment revenue increased 13.6% to $131.1 million for the twelve months ended December 31, 2020, compared to $115.4 million for the twelve months ended December 31, 2019. The $15.6 million increase was driven by a $8.4 million in Tri-Heart sales, an 11.2% increase in POC Lab Consumables, and a $1.6 million increase related to OVP. These increases were partially offset by a 4.6% decrease in sales from Point of Care Imaging, which was largely expected as a result of the government restrictions in place relating to COVID-19.

-45-


Gross profit was $60.9 million compared to $52.3 million for the twelve months ended December 31, 2020 and 2019, respectively. The increase in gross profit for both periods is primarily driven by increased revenue in the current year, specifically related to PVD and POC Lab Consumables. Gross margin was 46.5% for the twelve months ended December 31, 2020, compared to 45.3% in the twelve months ended December 31, 2019. The increase is due to increased revenue and margins for consumables, Tri-Heart and OVP, which had reduced production in the twelve months ended December 31, 2019.
North America operating loss increased $6.4 million to $5.0 million in the twelve months ended December 31, 2020 from income of $1.4 million for the twelve months ended December 31, 2019. While we experienced increased revenue and gross margin in 2020, the increase in operating loss is driven by one-time transaction related costs primarily relating to the acquisition of scil and increased stock-based and other compensation expenses in 2020.

International Segment

Twelve Months Ended December 31,Change
20202019Dollar
Change
%
Change
Point of Care laboratory:$40,136 $419 $39,717 9,479.0 %
Instruments & Other7,782 96 7,686 8,006.3 %
Consumables32,354 323 32,031 9,916.7 %
Point of Care imaging22,537 3,998 18,539 463.7 %
PVD3,584 2,821 763 27.0 %
Total International revenue$66,257 $7,238 $59,019 815.4 %
International Gross Profit$20,387 $2,115 $18,272 863.9 %
International Gross Margin30.8 %29.2 %
International Operating (Loss)$(3,215)$(1,099)$(2,116)(192.5)%
International Operating (Loss) Margin(4.9)%(15.2)%
International revenue was $66.3 million compared to $7.2 million for the twelve months ended December 31, 2020 and 2019, respectively. The increase is due to the acquisitions of CVM and scil, which contributed approximately $57.8 million of revenue in the twelve months ended December 31, 2020, that was not included in the comparable period.
Gross profit was $20.4 million compared to $2.1 million for the twelve months ended December 31, 2020 and 2019, respectively. Gross margin for the International segment was 30.8% for the year ended December 31, 2020, compared to 29.2% for the year ended December 31, 2019. The increase in gross profit and gross margin is driven by increased revenue from the acquisitions of CVM and scil, which contributed approximately $18.1 million of gross profit that was not included in the comparable period.
International operating loss increased $2.1 million for the year ended December 31, 2020, compared to the prior year. The increase in operating loss in is driven by increased depreciation and amortization and one-time transaction related costs in the current year; partially offset by increased International revenue and gross profit discussed above.
-46-


Liquidity, Capital Resources and Financial Condition
We believe that adequate liquidity and cash generation is important to the execution of our strategic initiatives. Our ability to fund our operations, acquisitions, capital expenditures, and product development efforts may depend on our ability to generate cash from operating activities, which is subject to future operating performance, as well as general economic, financial, competitive, legislative, regulatory, and other conditions, some of which may be beyond our control. Our primary source of liquidity is our available cash of $86.3 million, which includes net proceeds from the issuance of the Notes and cash generated from current operations. In January 2020, the Company transferred $14.6 million of consideration for the purchase of the CVM companies. Refer to Note 3 - Acquisitions and Related Party Items to the consolidated financial statements included in Item II. Part 8 of this Annual Report on Form 10-K. Additionally, we financed the acquisition of scil through a private placement of convertible preferred equity from which we raised $122 million, while we transferred approximately $110 million in purchase price, netting a remaining $11 million of liquidity. Refer to Note 12 - Capital Stock to the consolidated financial statements included in Item II. Part 8 of this Annual Report on Form 10-K.

For the year ended December 31, 2020, we had a net loss after equity in losses of unconsolidated affiliates of $14.8 million and net cash used by operations of $0.7 million. At December 31, 2020, we had $86.3 million of cash and cash equivalents and working capital of $129.2 million. A discussion of significant changes from the periods ending December 31, 2019 compared to December 31, 2018 can be found in Part II. Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2019.
A summary of our cash provided by and used in operating, investing and financing activities is as follows (in thousands):
Year Ended December 31,
20202019
Net cash (used in) provided by operating activities$(656)$3,296 
Net cash used in investing activities(126,597)(1,923)
Net cash provided by financing activities123,764 74,264 
Effect of currency translation on cash793 
Increase (decrease) in cash and cash equivalents(2,696)75,641 
Cash and cash equivalents, beginning of the period89,030 13,389 
Cash and cash equivalents, end of the period$86,334 $89,030 

Net cash used by operating activities was $0.7 million in 2020, compared to net cash provided by operating activities of $3.3 million in 2019, a decrease of approximately $4.0 million. The decrease in cash from operating activities is primarily due to the $13.0 million decrease in net income after equity in losses of unconsolidated affiliates for the twelve months ended December 31, 2020 compared to the twelve months ended December 31, 2019. Net cash also decreased due to significant working capital fluctuations such as a $9.4 million decrease in cash from accounts receivable driven primarily by increased sales, and a $6.3 million decrease in cash provided by inventories, due to the timing of purchases and sales. These decreases are partially offset by an increase cash from the aggregate of accounts payable and other liabilities of $8.4 million (driven by a settlement payment and related legal fees in 2019) and an increase in cash from other assets of $3.3 million. In addition, the net cash used by operating activities is offset by non-cash transactions, including a $6.5 million increase in depreciation and amortization driven by the acquisition of scil, a $4.5 million increase in stock-based compensation expense, and a $1.2 million increase related to amortization of the debt discount.

Net cash used in investing activities was $126.6 million in 2020, compared to net cash used in investing activities of $1.9 million in 2019, an increase of approximately $124.7 million. The increase in cash used
-47-


for investing activities was driven by a $104.4 million investment for the scil acquisition, net of cash acquired, a $14.4 million payment of consideration for the December 2019 acquisition of CVM, and a $6.7 million convertible note receivable.

Net cash provided by financing activities was $123.8 million in 2020, compared to net cash provided by financing activities of $74.3 million in 2019, an increase of approximately $49.5 million. The change was driven primarily by the issuance of preferred stock resulting in $122.0 million in proceeds, primarily used for financing the acquisition of scil, while our Notes financing in 2019 generated net proceeds of $77.1 million, which is net of debt issuance and the repayment of a pre-existing credit facility, resulting in a financing change year over year of $44.9 million. Additionally, net proceeds from issuance of common stock yielded $4.4 million more in 2020 as compared to 2019.

We believe that our cash, cash equivalents and marketable securities balances, as well as the cash flows generated by our operations, will be sufficient to satisfy our anticipated cash needs for working capital and capital expenditures, including selling and marketing team expansion and product development initiatives, for at least the next 12 months. Our belief may prove to be incorrect, however, and we could utilize our available financial resources sooner the we currently expect. For example, we are actively seeking acquisitions that are consistent with our strategic direction, which may require additional capital. Our future capital requirements and the adequacy of available funds will depend on many factors, including those set forth in Part I, Item 1A, "Risk Factors", of this Form 10-K. We may be required to seek additional equity or debt financing in order to meet these future capital requirements, even in the absence of any acquisitions. In the event that additional financing is required from outside sources, we may not be able to raise it on terms acceptable to us, or at all. If we are unable to raise additional capital when desired, our business, results of operations and financial condition would be adversely affected.
Effect of currency translation on cash
Net effect of foreign currency translations on cash changed $789 thousand to a $793 thousand positive impact in 2020, compared to a $4 thousand positive impact in 2019. The net effect of foreign currency translation on cash changed $14 thousand to a $4 thousand positive impact in 2019 from a $10 thousand negative impact in 2018. These effects are related to changes in exchange rates between the U.S. Dollar and the Swiss Franc, Euro, Canadian Dollar, Australian Dollar, and Malaysian Ringgit which are the functional currencies of our subsidiaries.
Material Cash Requirements
The Company has not entered into any transactions with unconsolidated entities whereby the Company has financial guarantees, subordinated retained interests, derivative instruments, or other contingent arrangements that expose the Company to material continuing risks, contingent liabilities, or any other obligation under a variable interest in an unconsolidated entity that provided financing, liquidity, market risk or credit risk support to the Company, or engages in leasing, hedging or research and development services with the Company.
Purchase obligations represent contractual agreements to purchase goods or services that are legally binding; specify a fixed, minimum or range of quantities; specify a fixed, minimum, variable, or indexed price provision; and specify approximate timing of the transaction.

-48-


The following table presents certain future payments due by the Company as of December 31, 2020 (in thousands):
TotalLess Than 1 Year1 - 3 Years3 - 5 YearsAfter 5 Years
Purchase obligations$24,991 $10,053 $10,551 $4,387 $— 
Operating lease obligations6,355 2,158 3,783 282 132 
Finance lease obligations574 294 198 64 18 
Other long term borrowings554 — 222 222 110 
Convertible senior notes (1)
86,250 — — — 86,250 
Future interest obligations (2)
18,492 3,235 6,484 6,480 2,293 
Total$137,216 $15,740 $21,238 $11,435 $88,803 
(1) Includes the principal amount of the convertible senior notes. Although the notes mature in 2026, they can be converted into cash and shares of our common stock prior to maturity if certain conditions are met. Any conversion prior to maturity can result in repayments of the principal amounts sooner than the scheduled repayments as indicated in the table. For additional information, refer to Note 16 - Convertible Notes and Credit Facility to the consolidated financial statements included in Part II, Item 8 of this Annual Report on Form 10-K.
(2) Includes interest payments for both the convertible senior notes and other long term borrowings.
Net Operating Loss Carryforwards
 
As of December 31, 2020, we had a net operating loss carryforward (“NOL”) and domestic research and development tax credit carryforward. See Note 5 - Income Taxes to the consolidated financial statements included in Part II, Item 8 of this Annual Report on Form 10-K for additional information regarding our carryforwards.

-49-


Item 7A.Quantitative and Qualitative Disclosures about Market Risk
Market risk represents the risk of loss that may impact the financial position, results of operations or cash flows due to adverse changes in financial and commodity market prices and rates. We are exposed to market risk in the areas of changes in U.S. and foreign interest rates and changes in foreign currency exchange rates as measured against the U.S. Dollar. These exposures are directly related to our normal operating and funding activities.
Interest Rate Risk

In September 2019, we issued $86.25 million aggregate principal amount of Notes. The fair market value of the Notes is affected by our common stock price. The fair value of the Notes will generally increase as our common stock price increases and will generally decrease as our common stock price declines in value. In addition, the fair market value of the Notes is exposed to interest rate risk. Generally, the fair market value of our fixed interest rate Notes will increase as interest rates fall and decrease as interest rates rise. Additionally, on our balance sheet we carry the Notes at face value less unamortized discount and debt issuance cost and we present the fair value for required disclosure purposes only. For additional information, refer to Note 16 - Convertible Notes and Credit Facility to the consolidated financial statements included in Part II, Item 8 of this Annual Report on Form 10-K and to our consolidated financial statements included herein. We had no interest rate hedge transactions in place on December 31, 2020.
Foreign Currency Risk
Foreign currency risk may impact our results of operations. In cases where we purchase inventory in one currency and sell corresponding products in another, our gross margin percentage is typically at risk based on foreign currency exchange rates. In addition, in cases where we may be generating operating income in foreign currencies, the magnitude of such operating income when translated into U.S. dollars will be at risk based on foreign currency exchange rates. We had no foreign currency hedge transactions in place on December 31, 2020. We do not currently consider foreign currency risk to be material to our business.
-50-



Item 8.     Financial Statements and Supplementary Data
HESKA CORPORATION
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
 Page
       Note 2, Revenue
       Note 5, Income Taxes
       Note 6, Leases
       Note 10, Inventories

-51-



REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


Board of Directors and Shareholders
Heska Corporation


Opinion on the financial statements
We have audited the accompanying consolidated balance sheet of Heska Corporation and subsidiaries (the “Company”) as of December 31, 2020, the related consolidated statements of loss, comprehensive loss, stockholders’ equity, and cash flows for the year ended December 31, 2020, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2020 and the results of its operations and its cash flows for the year ended December 31, 2020, in conformity with accounting principles generally accepted in the United States of America.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”), the Company’s internal control over financial reporting as of December 31, 2020, based on criteria established in the 2013 Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”), and our report dated February 26, 2021 expressed an unqualified opinion.

Basis for opinion
These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical audit matters
The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

Stock-based compensation - assessment of probability related to stock-based compensation subject to performance based vesting requirements
As described further in Note 12 to the financial statements, the Company granted restricted stock awards and stock options. Certain of the restricted stock awards and stock options have performance based vesting periods, which vest based on when performance targets are met. Performance based awards are recognized as

-52-


an expense based on the probability of achieving the underlying performance targets. We identified the probability assessment of achieving the performance targets as a critical audit matter.

The principal consideration for our determination that the probability of achieving the performance targets is a critical audit matter is that the probability is based on a subjective assessment of the Company’s prospective financial information. The probability assessment requires management to estimate the successful development and market acceptance of future product introductions, future sales targets, operating performance, and EBITDA. Changes in the subjective probability assessment can materially affect the amount and timing of the recognition of stock-based compensation expense and require significant auditor subjectivity in evaluating the reasonableness of those judgments and estimates.

Our audit procedures related to the probability of achieving the performance targets included the following, among others.

We tested the design and operating effectiveness of internal controls relating to management’s determination of stock-based compensation expense, including testing management’s review controls over the identification of the terms of the performance conditions and the key inputs used in determining the probability of achieving the performance targets.
We evaluated the reasonableness of management’s prospective financial information by comparing management’s previous forecasts to actual results to assess management’s ability to accurately forecast actual results. We also evaluated the reasonableness of forecasted revenue by comparing sales growth to current market and industry trends; operating performance and EBITDA by comparing to current market and industry trends, historical information, and inquiring of individuals outside of the finance department; and future product introductions by evaluating the status of development, recent placement history, and inquiring of individuals outside of the finance department. We also evaluated the consistency of forecasts used in the probability assessment with other elements of the financial statements that use the forecast as an input.

Business combination of scil animal care company GmbH
As described further in Note 3 to the financial statements, the Company completed the acquisition of scil animal care company GmbH (“scil”) on April 1, 2020. The Company paid approximately $110.3 million in cash to acquire 100% of the capital stock of scil, which resulted in the identification and recognition of $44.5 million of other intangible assets. We identified the Company’s determination of the fair value of customer relationships and the trademarks and trade names not subject to amortization (“trade name”) intangible assets acquired as a critical audit matter.

The principal considerations for our determination that the Company’s valuation of the customer relationships and the trade name intangible assets acquired is a critical audit matter due to the high degree of management subjectivity in the related fair value estimates. This requires management to evaluate historical results and expectations of future operating performance based on relevant information available to them regarding expectations of industry performance, as well as, expectations for company-specific performance. Significant assumptions (assumed revenue growth rates, discount rates, and operating margin) utilized to determine the fair value are subject to estimation uncertainty and require significant auditor subjectivity in evaluating the reasonableness of those judgments and estimates.

Our audit procedures related to the business combination of scil included the following, among others.

We tested the design and operating effectiveness of internal controls relating to management’s valuation of the customer relationships and trade name intangible assets, which includes management’s review of the preliminary valuation report for reasonableness of significant assumptions used in the fair value calculations.
We evaluated the reasonableness of management’s forecasted revenue growth rate and operating margin by comparing to current market and industry trends, historical data, and strategic business plans. We performed a sensitivity analysis on the assumed revenue growth rate and operating margin assumptions. We utilized a valuation specialist to assist in evaluating the appropriateness of the Company’s selection of valuation methodology and evaluating the reasonableness of the discount rate.

-53-



/s/ GRANT THORNTON LLP

We have served as the Company’s auditor since 2020.

Denver, Colorado
February 26, 2021



-54-


REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Board of Directors and Shareholders
Heska Corporation

Opinion on internal control over financial reporting
We have audited the internal control over financial reporting of Heska Corporation and subsidiaries (the “Company”) as of December 31, 2020, based on criteria established in the 2013 Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2020, based on criteria established in the 2013 Internal Control—Integrated Framework issued by COSO.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”), the consolidated financial statements of the Company as of and for the year ended December 31, 2020, and our report dated February 26, 2021 expressed an unqualified opinion on those financial statements.

Basis for opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control Over Financial Reporting (“Management’s Report”). Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

Our audit of, and opinion on, the Company’s internal control over financial reporting does not include the internal control over financial reporting of scil animal care company GmbH, a wholly-owned subsidiary, whose financial statements reflect total assets and revenues constituting 45% and 30% , respectively, of the related consolidated financial statement amounts as of and for the year ended December 31, 2020. As indicated in Management’s Report, scil animal care company GmbH was acquired during 2020. Management’s assertion on the effectiveness of the Company’s internal control over financial reporting excluded internal control over financial reporting of scil animal care company GmbH.

Definition and limitations of internal control over financial reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that: (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized

-55-


acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ GRANT THORNTON LLP

Denver, Colorado
February 26, 2021


-56-


REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Shareholders and Board of Directors of Heska Corporation

 
Opinion on the Financial Statements

We have audited the accompanying balance sheet of Heska Corporation and subsidiaries (the “Company”) as of December 31, 2019, and the related statements of income, comprehensive income, stockholders' equity, and cash flows for the years ended December 31, 2019 and 2018, and the related notes (collectively referred to as the “financial statements”).

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2019 and the results of its operations and its cash flows for the years ended December 31, 2019 and 2018, in conformity with accounting principles generally accepted in the United States of America.

Change in Accounting Principle

As discussed in Note 1 to the financial statements, the Company adopted the Accounting Standards Codification (ASC) Topic 842, “Leases,” using the modified retrospective adoption method on January 1, 2019.

Basis for Opinion

The Company's management is responsible for these financial statements. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits of the financial statements included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.


/s/ Plante & Moran, PLLC


We served as the Company’s auditor from 2006-2020.

Denver, Colorado

February 28, 2020, except for the effects of the change in segments described in Notes 2 and 18, as to which the date is February 26, 2021


-57-


HESKA CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share amounts)

 December 31,
 20202019
ASSETS
Current assets:  
Cash and cash equivalents$86,334 $89,030 
Accounts receivable, net of allowance for losses of $769 and $186, respectively31,080 15,161 
Inventories40,037 26,601 
Net investment in leases, current, net of allowance for losses of $192 and $105, respectively
4,794 3,856 
Prepaid expenses3,875 2,219 
Other current assets5,155 3,000 
Total current assets171,275 139,867 
Property and equipment, net35,542 15,469 
Operating lease right-of-use assets
5,457 5,726 
Goodwill 88,276 36,204 
Other intangible assets, net55,992 11,472 
Deferred tax asset, net5,694 6,429 
Net investment in leases, non-current
15,789 14,307 
Investments in unconsolidated affiliates 6,704 7,424 
Related party convertible note receivable, net 6,671  
Other non-current assets8,439 7,526 
Total assets$399,839 $244,424 
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:  
Accounts payable$15,119 $6,600 
Accrued liabilities18,055 6,345 
Accrued purchase consideration payable 14,579 
Operating lease liabilities, current
2,087 1,745 
Deferred revenue, current, and other6,854 2,930 
Total current liabilities42,115 32,199 
Convertible note, non-current, net
48,459 45,348 
Deferred revenue, non-current4,667 5,966 
Other long-term borrowings554 1,121 
Operating lease liabilities, non-current3,858 4,413 
Deferred tax liability11,856 691 
Other liabilities1,277 152 
Total liabilities112,786 89,890 
Redeemable non-controlling interest and mezzanine equity 170 
Stockholders' equity:  
Preferred stock, $.01 par value, 2,500,000 shares authorized, none issued or outstanding  
Common stock, $.01 par value, 13,250,000 and 10,250,00 shares authorized, respectively, none issued or outstanding  
Public common stock, $.01 par value, 13,250,000 and 10,250,000 shares authorized, 9,475,845 and 7,881,928 shares issued and outstanding, respectively95 79 
Additional paid-in capital423,650 290,216 
Accumulated other comprehensive income14,169 513 
Accumulated deficit(150,861)(136,444)
Total stockholders' equity287,053 154,364 
Total liabilities, mezzanine equity and stockholders' equity$399,839 $244,424 
See accompanying notes to consolidated financial statements.
-58-


HESKA CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF (LOSS) INCOME
(in thousands, except per share amounts)

 Year Ended December 31,
 202020192018
Revenue, net$197,323 $122,661 $127,446 
Cost of revenue116,033 68,212 70,808 
Gross profit81,290 54,449 56,638 
Operating expenses:   
Selling and marketing38,468 27,678 24,663 
Research and development8,772 8,240 3,334 
General and administrative42,242 18,204 24,847 
Total operating expenses89,482 54,122 52,844 
Operating income (loss)(8,192)327 3,794 
Interest and other expense (income), net5,601 2,910 (13)
Income (loss) before income taxes and equity in losses of unconsolidated affiliates(13,793)(2,583)3,807 
Income tax expense (benefit):   
Current income tax expense1,780 359 140 
Deferred income tax benefit(1,541)(1,805)(2,255)
Total income tax expense (benefit)239 (1,446)(2,115)
Net (loss) income before equity in losses of unconsolidated affiliates(14,032)(1,137)5,922 
Equity in losses of unconsolidated affiliates(720)(594)(72)
Net (loss) income after equity in losses of unconsolidated affiliates(14,752)(1,731)5,850 
Net loss attributable to redeemable non-controlling interest(353)(266) 
Net (loss) income attributable to Heska Corporation$(14,399)$(1,465)$5,850 
Basic (loss) earnings per share attributable to Heska Corporation$(1.66)$(0.20)$0.81 
Diluted (loss) earnings per share attributable to Heska Corporation$(1.66)$(0.20)$0.74 
Weighted average outstanding shares used to compute basic (loss) earnings per share attributable to Heska Corporation8,653 7,446 7,220 
Weighted average outstanding shares used to compute diluted (loss) earnings per share attributable to Heska Corporation8,653 7,446 7,856 
See accompanying notes to consolidated financial statements.

-59-


HESKA CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME
(in thousands) 

 Year Ended December 31,
 202020192018
Net (loss) income after equity in losses of unconsolidated affiliates$(14,752)$(1,731)$5,850 
Other comprehensive (loss) income:   
Minimum pension liability(40)73 70 
Translation adjustments and gains (losses) from intra-entity transactions13,696 163 (25)
Comprehensive (loss) income(1,096)(1,495)5,895 
Comprehensive loss attributable to redeemable non-controlling interest(353)(266) 
Comprehensive (loss) income attributable to Heska Corporation$(743)$(1,229)$5,895 
 
See accompanying notes to consolidated financial statements.

-60-


HESKA CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(in thousands)

 Preferred Stock 
 
Common Stock
 
Additional
Paid-in
Capital
Accumulated
Other
Comprehensive
Income
 
 
Accumulated
Deficit
 
Total
Stockholders'
Equity
 SharesAmountSharesAmount
Balances, December 31, 2017 $ 7,303 $73 $243,598 $232 $(143,463)$100,440 
Adoption of accounting standards— — — — — — 2,634 2,634 
Balances, January 1, 2018, as adjusted  7,303 73 243,598 232 (140,829)103,074 
Net income attributable to Heska Corporation— — — — — — 5,850 5,850 
Issuance of common stock, net of shares withheld for employee taxes— — 318 3 2,759 — — 2,762 
Issuance of common stock related to acquisition of assets from Cuattro, LLC— — 55 1 5,450 — — 5,451 
Stock-based compensation— — — — 5,227 — — 5,227 
Other comprehensive income— — — — — 45 — 45 
Balances, December 31, 2018  7,676 77 257,034 277 (134,979)122,409 
Net loss attributable to Heska Corporation— — — — — — (1,465)(1,465)
Issuance of common stock, net of shares withheld for employee taxes— — 206 2 (1,620)— — (1,618)
Stock-based compensation— — — — 4,968 — — 4,968 
Convertible notes, equity— — — — 29,834 — — 29,834 
Other comprehensive income— — — — — 236 — 236 
Balances, December 31, 2019  7,882 79 290,216 513 (136,444)154,364 
Adoption of accounting standards— — — — — — (18)(18)
Balances, January 1, 2020  7,882 79 290,216 513 (136,462)154,346 
Net loss attributable to Heska Corporation— — — — — — (14,399)(14,399)
Issuance of common stock, net of shares withheld for employee taxes— — 85 1 2,795 — — 2,796 
Issuance of preferred stock122 1 — — 121,785 — — 121,786 
Conversion to common stock(122)(1)1,509 15 (14)— —  
Stock-based compensation— — — — 9,490 — — 9,490 
Purchase of minority interest— — — — (622)— — (622)
Other comprehensive income— — — — — 13,656 — 13,656 
Balances, December 31, 2020 $ 9,476 $95 $423,650 $14,169 $(150,861)$287,053 
 
See accompanying notes to consolidated financial statements.
 
-61-


HESKA CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
 Year Ended December 31,
 202020192018
CASH FLOWS FROM OPERATING ACTIVITIES:   
Net (loss) income after equity in losses from unconsolidated affiliates$(14,752)$(1,731)$5,850 
Adjustments to reconcile net (loss) income to cash (used in) provided by operating activities:  
Depreciation and amortization11,385 4,916 4,595 
Non-cash impact of operating leases
1,985 1,565 — 
Deferred income tax benefit(1,541)(1,805)(2,255)
Stock-based compensation9,490 4,968 5,227 
Equity in losses of unconsolidated affiliates720 594 72 
Accretion of discounts and issuance costs
3,090 1,842  
Provision for credit losses 614 113 104 
Other (gains) losses(91)560 8 
Changes in operating assets and liabilities (net of effect of acquisitions):   
Accounts receivable(5,755)3,683 (1,180)
Inventories(5,409)918 6,046 
Other assets(271)(3,580)(4,590)
Accounts payable(280)(1,686)(2,020)
Due to related parties (226)(1,477)
Other liabilities159 (6,835)2,907 
Net cash (used in) provided by operating activities(656)3,296 13,287 
CASH FLOWS FROM INVESTING ACTIVITIES:   
Investment in subsidiary, net of cash acquired
 (622) 
Acquisition of CVM(14,420)927  
Convertible note receivable issuance(6,650)  
Purchase of minority interest(450)  
Acquisition of scil, net of cash acquired (104,401)  
Acquisition of intangible asset  (2,750)
Investments in unconsolidated affiliates  (8,091)
Real estate asset acquisition (1,184) 
Purchases of property and equipment(686)(1,044)(1,358)
Proceeds from disposition of property and equipment10  25 
Net cash used in investing activities(126,597)(1,923)(12,174)
CASH FLOWS FROM FINANCING ACTIVITIES:   
Proceeds from issuance of common stock4,273 1,829 4,034 
Repurchase of common stock(1,477)(3,447)(1,271)
Payment of preferred stock issuance costs(214)  
Preferred Stock Proceeds122,000   
Distributions to non-controlling interest members  (126)
Convertible debt proceeds
 86,250  
Payments of related party debts(1,140)  
Borrowing on line of credit 6,750 3,000 
Repayments of line of credit borrowings (12,750)(3,000)
Borrowings of other debts613   
Repayments of other debt(291)(1,191)(10)
Payment of debt issuance costs (3,177) 
Net cash provided by financing activities123,764 74,264 2,627 
NET EFFECT OF EXCHANGE RATE CHANGES ON CASH793 4 (10)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS(2,696)75,641 3,730 
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR89,030 13,389 9,659 
CASH AND CASH EQUIVALENTS, END OF YEAR$86,334 $89,030 $13,389 
-62-


NON-CASH TRANSACTIONS:
Transfers of equipment between inventory and property and equipment, net $4,437 $827 $1,449 
Non-cash conversion of preferred stock to common stock$122,000 $ $ 
Consideration payable for CVM Acquisition (See Note 3)$ $14,420 $ 
Common stock issued as partial consideration of Cuattro acquisition transactions (See Note 3)$ $ $5,450 
See accompanying notes to consolidated financial statements.
-63-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


1.    OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Heska Corporation and its wholly-owned subsidiaries ("Heska", the "Company", "we" or "our") sell veterinary and animal health diagnostic and specialty products. Our offerings include Point of Care diagnostic laboratory instruments and supplies; digital imaging diagnostic products, software and services; digital cytology services; vaccines; local and cloud-based data services; allergy testing and immunotherapy; and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. Our core focus is on supporting veterinarians in the canine and feline healthcare space.
Basis of Presentation and Consolidation
In the opinion of management, the accompanying Consolidated Financial Statements contain all adjustments, consisting of normal, recurring adjustments, necessary to present fairly the financial position of the Company as of December 31, 2020 and 2019, as well as the results of our operations, statements of stockholders' equity and cash flows for the twelve months ended December 31, 2020, 2019 and 2018.
The audited Consolidated Financial Statements included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Our audited Consolidated Financial Statements include our accounts and the accounts of our wholly-owned subsidiaries since their respective dates of acquisitions. All intercompany accounts and transactions have been eliminated in consolidation. Where our ownership of a subsidiary was less than 100%, the non-controlling interest is reported on our consolidated balance sheets. The non-controlling interest in our consolidated net income is reported as "Net loss attributable to non-controlling interest" on our Consolidated Statements of (Loss) Income. Our audited Consolidated Financial Statements are stated in U.S. Dollars and have been prepared in accordance with accounting principles generally accepted in the U.S. ("GAAP").
Beginning in the first quarter of 2020, to limit the spread of COVID-19, governments took various actions including the issuance of stay-at-home policies and social distancing procedures and guidelines, causing some businesses to adjust, reduce or suspend business and operating activities. Veterinary care is widely recognized as an "essential" service for pet owners, and veterinarians continued to deliver essential medical care for sick and injured pets. The stay-at-home policies deployed early in 2020 to combat the spread of COVID-19 resulted in a decrease in companion animal clinical visits, including delay of elective procedures and wellness visits and as a result lowers demand for diagnostic testing services. Beginning in the second quarter of 2020, certain local, state and federal governments began to ease the stay-at-home policies and allowed more businesses and facilities to re-open, leading to a recovery in companion animal clinical visits and associated demand for our diagnostic products. The extent to which the continuation, or a possible second-wave outbreak of COVID-19, or an outbreak of other health epidemics could impact our business, results of operations and financial condition, including the potential for write-offs or impairments of assets and suspension of capital investments, will depend on future developments. We are unable to predict with certainty the effects of the COVID-19 pandemic on our customers, suppliers and vendors, as well as the actions of governments, and when and to what extent normal economic and operating conditions can resume; these effects may differ from those assumed in our projected estimates. Even after the COVID-19 pandemic has subsided, we may continue to experience adverse impacts to our business as a result of any economic impact that has occurred or may occur in the future.
Reclassification
To maintain consistency and comparability, certain amounts in the financial statements have been reclassified to conform to current year presentation.
-64-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates are required when establishing the allowance for doubtful accounts and the net realizable value of inventory; determining future costs associated with warranties provided; determining the period over which our obligations are fulfilled under agreements to license product rights and/or technology rights; evaluating long-lived and intangible assets and investments for estimated useful lives and impairment; estimating the useful lives and standalone selling prices of instruments under leasing arrangements; determining the allocation of purchase price under purchase accounting; estimating the expense associated with the granting of stock; determining the need for, and the amount of a valuation allowance on deferred tax assets; determining the fair value of our embedded derivative; and determining the fair value of the liability component associated with the issuance of convertible debt. Our actual results may differ from these estimates and there may be changes to those estimates in future periods.
Concentration of Credit Risk
Financial instruments that potentially subject us to a concentration of credit risk consist of cash and cash equivalents and accounts receivable. We maintain the majority of our cash and cash equivalents with financial institutions that management believes are creditworthy in the form of demand deposits. We have no off-balance-sheet concentrations of credit risk such as foreign exchange contracts, options contracts or other foreign currency hedging arrangements. Our accounts receivable balances are due largely from distribution partners, domestic veterinary clinics and individual veterinarians and other animal health companies.

Covetrus represented 9% and 19% of our consolidated accounts receivable at December 31, 2020 and 2019, respectively. No other customer accounted for more than 10% of our consolidated accounts receivable at December 31, 2020 or 2019.
We have established an allowance for credit losses based upon factors surrounding the credit risk of specific customers, historical trends and other information.
Accounts Receivable and Allowance for Credit Losses
Accounts receivable are recorded net of an allowance for credit losses. From time to time, our customers are unable to meet their payment obligations. We continuously monitor our customers' credit worthiness and establish allowances for estimated credit losses related to our accounts receivable, net investment in leases, contract assets, and promissory notes. Our allowances are established based on factors surrounding the credit risk of specific customers, historical experience including collections and write-off history, and current economic conditions. Account balances are considered past due if payments have not been received within agreed upon invoice and/or contract terms and the Company may employ collection agencies and legal counsel to pursue recovery of defaulted amounts. Account balances are written off against the allowance after all collection efforts have been exhausted and it is probable the receivable will not be recovered. The Company also performs a qualitative assessment, on a quarterly basis, to monitor economic factors and other uncertainties that may require additional adjustments for the expected credit loss allowance. While such credit losses have historically been within our expectations and the provisions established, there is no assurance that we will continue to experience the same credit loss rates that we have in the past. A significant change in the liquidity or financial position of our customers could have a material adverse impact on the collectability of accounts receivable and our future operating results. The Company will continue to actively monitor the impact of the COVID-19 pandemic on expected credit losses. In 2020, the Company adopted Accounting
-65-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

Standards Update ("ASU") 2016-13, Financial Instruments - Credit Losses (Topic 326). See "Adoption of New Accounting Standards" below for impacts of adoption.
Changes in the allowance for credit losses are summarized as follows (in thousands):

Years Ended December 31,
202020192018
Balances at beginning of period$186 $245 $215 
Additions from acquisition90   
Additions - charged to expense614 113 104 
Deductions - write offs, net of recoveries(121)(172)(74)
Balances at end of period$769 $186 $245 
Cash and Cash Equivalents
Cash and cash equivalents are stated at cost, which approximates market value, and include short-term, highly liquid investments with original maturities of less than three months. We valued our foreign cash accounts at the spot market foreign exchange rate as of each balance sheet date, with changes due to foreign exchange fluctuations recorded in Accumulated other comprehensive income in the Consolidated Balance Sheets. The majority of our cash and cash equivalents are held in accounts not insured by governmental entities. The foreign cash balances are summarized as follows (denominated in foreign currency, in thousands):

As of December 31,
20202019
European Union Euros8,520 1,773 
Swiss Francs138 124 
Canadian Dollars2,993 88 
Australian Dollars159 54 
Malaysian Ringgit364  
Fair Value of Financial Instruments
In accordance with ASC 820, Fair Value Measurements (“ASC 820”), the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. Fair value is defined as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:
Level 1: Quoted market prices in active markets for identical assets or liabilities.
Level 2: Quoted prices in active markets for similar assets and liabilities, quoted prices for identically similar assets or liabilities in markets that are not active and models for which all significant inputs are observable either directly or indirectly.
Level 3: Unobservable inputs reflecting the reporting entity’s own assumptions or external inputs for inactive markets.
-66-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

The Company's financial instruments consist of cash and cash equivalents, short-term trade receivables and payables, a long-term note receivable with an embedded derivative asset, and its 3.75% Convertible Senior Notes due 2026 (the "Notes"). The carrying values of cash and cash equivalents and short-term trade receivables and payables approximate fair value because of the short-term nature of the instruments.
The estimated fair value of the Notes disclosed at each reporting period is evaluated through Level 2 inputs with consideration of quoted market prices in less active markets. For additional information regarding the Company's accounting treatment for the issuance of the Notes, including the fair value measurement of the liability component, refer to Note 16. Convertible Notes.
The Company determined the redemption features of its convertible note receivable represents an embedded derivative. The estimated fair value of the embedded derivative asset is evaluated through Level 3 inputs. The carrying amount of the derivative is recorded at fair value at issuance and will be remeasured each reporting period, with the mark-to-market adjustments to be included in other expense (income). For additional information regarding the Company's accounting treatment for the convertible note receivable, including the fair value measurement of the embedded derivative, refer to Note 17. Convertible Note Receivable.
Property and Equipment
Property and equipment is stated at cost, net of accumulated depreciation. The costs of additions and improvements are capitalized, while maintenance and repairs are charged to expense as incurred. When an item is sold or retired, the cost and related accumulated depreciation is relieved and the resulting gain or loss, if any, is recognized in the Consolidated Statements of (Loss) Income. We provide for depreciation primarily using the straight-line method by charges to income in amounts that allocate the cost of property and equipment over their estimated useful lives as follows:
Asset ClassificationEstimated
Useful Life
Building10 to 43 years
Machinery and equipment2 to 10 years
Office furniture and equipment3 to 7 years
Computer hardware and software3 to 7 years
Leasehold and building improvements5 to 15 years

We capitalize certain costs incurred in connection with developing or obtaining software designated for internal use based on three distinct stages of development. Qualifying costs incurred during the application development stage, which consist primarily of internal payroll and direct fringe benefits and external direct project costs, including labor and travel, are capitalized and amortized on a straight-line basis over the estimated useful life of the asset, which range from three to seven years. Costs incurred during the preliminary project and post-implementation and operation phases are expensed as incurred. These costs are general and administrative in nature and related primarily to the determination of performance requirements, data conversion and training.
Inventories
Inventories are stated at the lower of cost or net realizable value using the first-in, first-out method. Inventory we manufacture includes the cost of material, labor and overhead. We write down the carrying value of inventory for estimated obsolescence by an amount equal to the difference between the cost of inventory and the estimated market value when warranted based on assumptions of future demand, market conditions, remaining shelf life, or product functionality.
-67-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

Investments in Unconsolidated Affiliates
Investments in unconsolidated affiliates are measured and recorded as either non-marketable equity securities or equity method investments. Non-marketable equity securities are equity securities without readily determinable fair value that are measured and recorded using a measurement alternative which measures the securities at cost minus impairment, if any, plus or minus changes from qualifying observable price changes. Equity method investments are equity securities in investees we do not control but over which we have the ability to exercise significant influence. When the equity method of accounting is determined to be appropriate, the initial measurement of the investment includes the cost of the investment and all direct transaction costs incurred to acquire the investment. Equity method investments are measured at cost minus impairment, if any, plus or minus our share of equity method investee income or loss, which is recorded as a separate line on the income statement. Both types of investments are evaluated for impairment if a triggering event occurs.
Goodwill, Intangible and Other Long-Lived Assets

Goodwill is initially valued based on the excess of the purchase price of a business combination over the fair value of acquired net assets recognized and represents the future economic benefits arising from other assets acquired that could not be individually identified and separately recognized. Intangible assets other than goodwill are initially valued at fair value. If a quoted price in an active market for the identical asset is not readily available at the measurement date, the fair value of the intangible asset is estimated based on discounted cash flows using market participant assumptions, which are assumptions that are not specific to the Company. The selection of appropriate valuation methodologies and the estimation of discounted cash flows require significant assumptions about the timing and amounts of future cash flows, risks, appropriate discount rates, and the useful lives of intangible assets. When material, we utilize independent valuation experts to advise and assist us in determining the fair values of the identified intangible assets acquired in connection with a business acquisition and in determining appropriate amortization methods and periods for those intangible assets.

We assess goodwill for impairment annually, at the reporting unit level, in the fourth quarter and whenever events or circumstances indicate impairment may exist. In evaluating goodwill for impairment, we have the option to first assess the qualitative factors to determine whether it is more-likely-than-not that the estimated fair value of the reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the comparison of the estimated fair value of the reporting unit to the carrying value. The more-likely-than-not threshold is defined as having a likelihood of more than 50 percent. If, after assessing the totality of events or circumstances, we determine that it is more-likely-than-not that the estimated fair value of a reporting is less than its carrying amount, we would then estimate the fair value of the reporting unit and compare it to the carrying value. If the carrying value exceeds the estimated fair value we would recognize an impairment for the difference; otherwise, no further impairment test would be required. In contrast, we can opt to bypass the qualitative assessment for any reporting unit in any period and proceed directly to quantitative analysis. Doing so does not preclude us from performing the qualitative assessment in any subsequent period. Following the acquisition of scil in April 2020, we restructured our operating segments based on how the Chief Operating Decision Maker (“CODM”) manages the business, allocates resources, makes operating decisions and evaluates operating performance. As further discussed in Note 18, our new reporting segments are North America and International. As a result of the change in operating segments, we also revised our reporting units to aggregate our legal entities based on similarities in economic characteristics. Our new reporting units consist of the following: (1) Heska Corporation and Heska Canada, (2) Diamond Animal Health, (3) scil animal care company GmbH, Optomed, CVM, and Heska Australia, and (4) Heska AG.
As a result of the recent global economic disruption and uncertainty due to the COVID-19 pandemic, the
-68-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

Company performed a qualitative assessment during the first quarter of 2020. Based on the interim assessment performed, we concluded that there was no triggering event and additionally, no indications of impairment existed. We performed qualitative assessments in the fourth quarters of 2020, 2019, and 2018 and determined that no indications of impairment existed.

We assess the realizability of intangible assets other than goodwill whenever events or changes in circumstances indicate that the carrying value may not be recoverable. If an impairment review is triggered, we evaluate the carrying value of intangible assets based on estimated undiscounted future cash flows over the remaining useful life of the primary asset of the asset group and compare that value to the carrying value of the asset group. The cash flows that are used contain our best estimates, using appropriate and customary assumptions and projections at the time. If the net carrying value of an intangible asset exceeds the related estimated undiscounted future cash flows, an impairment to adjust the intangible asset to its fair value would be reported as a non-cash charge to earnings. If necessary, we would calculate the fair value of an intangible asset using the present value of the estimated future cash flows to be generated by the intangible asset, and applying a risk-adjusted discount rate. We had no impairments of our intangible assets during the years ended December 31, 2020, 2019, and 2018.
Revenue Recognition

We generate revenue through the sale of products, either by outright purchase by our customers or through a subscription agreement whereby our customers receive instruments and pay us a monthly fee for the consumables needed to conduct testing. Subscription placement is the majority of our Point of Care laboratory transactions while outright sales to customers are the majority of both Point of Care imaging diagnostic transactions and the sale of pharmaceuticals and vaccines.

For outright sales of products, revenue is recognized when control of the promised product or service is transferred to our customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products or services (the transaction price). Taxes assessed by governmental authorities and collected from the customer are excluded from our revenue recognition. A performance obligation is a promise in a contract to transfer a distinct product or service to a customer and is the unit of account under ASC 606. For instruments, consumables and most software licenses sold by the Company, control transfers to the customer at a point in time. To indicate the transfer of control, the Company must have a present right to payment, legal title must have passed to the customer, the customer must have the significant risks and rewards of ownership and where acceptance is not a formality, the customer must have accepted the product or service. Heska’s principal terms of sale are FOB Shipping Point, or equivalent, and, as such, we primarily transfer control and record revenue for product sales upon shipment. If a performance obligation to the customer with respect to a sales transaction remains unfulfilled following shipment (typically owed installation), revenue recognition for that performance obligation is deferred until such commitments have been fulfilled. For extended warranty and service plans, control transfers to the customer over the term of the arrangement and as such the revenue is recognized ratably based upon the period of time elapsed under the arrangement.

Our revenue under subscription agreements relates to operating-type lease ("OTL") arrangements or sales-type lease ("STL") arrangements. Determination of an OTL or STL is primarily determined as a result of the length of the contract as compared to the estimated useful life of the instrument, among other factors. Leases are outside of the scope of ASC 606 and are therefore accounted for in accordance with ASC 842, Leases. A STL would result in earlier recognition of instrument revenue as compared to an OTL, which is generally upon installation of the instruments. Instrument lease revenue for our OTL subscription agreements is recognized on a straight-line basis over the life of the lease and is included with the predominant non-lease components in consumables revenue. For instrument only OTL agreements, operating lease income is
-69-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

recognized on a straight-line basis over the term of the lease. The cash collected under both arrangements is over the term of the contract. The OTLs and STLs are not cancellable until after an initial term. See below for additional information on our lease accounting policies.
For contracts with both lease and non-lease components, the Company allocates the contracts' transaction price for each component on a relative standalone selling price basis using our best estimate of the standalone selling price of each distinct product or service in the contract. When available, the method used to estimate the standalone selling price is the price observed in standalone sales to customers. When prices in standalone sales are not available, we use a cost-plus margin approach. Changes in these values can impact the amount of consideration allocated to each component of the contract. Allocation of the transaction price is determined at the contracts' inception. The Company does not adjust the transaction price for the effects of a significant financing component when the period between the transfer of the promised good or service to the customer and payment for that good or service by the customer is expected to be one year or less.

To the extent the transaction price includes variable consideration, such as future payments based on consumable usage over time, we apply judgment to determine if the variable consideration should be constrained. As the variable consideration is highly susceptible to factors outside of the Company’s influence, and the potential values contain a broad range of possible outcomes given all potential amounts of consumption that could occur, it is likely that a significant revenue reversal would occur should the variable consideration be estimated at an amount greater than the minimum stated amount until such a time as the uncertainty is resolved. For our subscription agreements with variable consideration based on consumable usage over time, the variable consideration is allocated to the non-lease components upon resolution of the uncertainty and is included in consumables revenue.

We generate OVP revenue through contract manufacturing agreements with customers. Revenue from these customer contracts is generally recognized upon shipment or acceptance by our customer, under the same guidelines noted above for other outright product sales. Heska assessed the over-time criteria within ASC 606 and concluded that while products within this segment have no alternative use to Heska, as Heska is contractually prohibited to redirect the product to other customers, Heska does not have right to payment for performance to date. Therefore, point in time revenue recognition has been determined to be appropriate.
Recording revenue from the sale of products involves the use of estimates and management's judgment. We must make a determination at the time of sale whether the customer has the ability and intent to make payments in accordance with arrangements. For contracts with multiple performance obligations, we exercise judgment in allocating the transaction price for each performance obligation based on an estimated standalone selling price for each distinct product or service. We do not generally allow return of products or instruments. Distributor rebates are recorded as a reduction to revenue.

Refer to Note 2 for additional disclosures required by ASC 606.

Leases

The Company acts as a lessee and a lessor. As a lessee, the Company leases buildings, office equipment, and vehicles. As a lessor, the Company enters into sales-type and operating leases as part of its subscription agreements.

The Company determines if an arrangement is a lease at inception based on whether control of an identified asset is transferred. For leases where the Company is the lessee, ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based
-70-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The lease terms used to calculate the ROU asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense while the expense for finance leases is recognized as amortization expense and interest expense. The Company has lease agreements which require payments for lease and non-lease components and has elected to account for these as a single lease component for our building and office equipment leases, but as separate components for our vehicle leases.

As a lessor, our subscription agreements relate to both OTL arrangements and STL arrangements. For a STL, instrument revenue is generally recorded upon installation of the instruments and the cost of the customer-leased instruments is removed from inventory and recognized in the Consolidated Statements of (Loss) Income. There is no residual value taken into consideration as it does not meet our capitalization requirements. For our OTL agreements that include both lease and non-lease components, revenue is recognized on a straight-line basis over the term of the lease and is included with the predominant non-lease components in consumables revenue. For instrument only OTL agreements, operating lease income is recognized on a straight-line basis over the term of the lease. For an OTL, the costs of customer-leased instruments are recorded within property and equipment in the accompanying Consolidated Balance Sheets and depreciated over the instrument’s estimated useful life. The depreciation expense is reflected in cost of revenue in the accompanying Consolidated Statements of (Loss) Income.

For leases that commenced before the January 1, 2019 effective date of ASC 842, the Company elected the permitted practical expedients to not reassess the following: (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) initial direct costs for any existing leases. The Company also elected to exclude leases with a term of 12 months or less from the recognized ROU assets and lease liabilities.
Stock-based Compensation
Stock-based compensation expense is measured at the grant date based upon the estimated fair value of the portion of the award that is ultimately expected to vest and is recognized as expense over the applicable requisite service period of the award generally using the straight-line method.
Advertising Costs
Advertising costs are expensed as incurred and are included in sales and marketing expenses. Advertising expenses were $0.4 million for the year ended December 31, 2020, $0.3 million for the year ended December 31, 2019, and $0.2 million for the year ended December 31, 2018.
-71-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

Income Taxes

The Company records a current provision for income taxes based on estimated amounts payable or refundable on tax returns filed or to be filed each year. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates, in each tax jurisdiction, expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date. The overall change in deferred tax assets and liabilities for the period measures the deferred tax expense or benefit for the period. Deferred tax assets are reduced by a valuation allowance based on a judgmental assessment of available evidence if the Company is unable to conclude that it is more likely than not that some or all of the deferred tax assets will be realized.
Earnings Per Share
Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued.
Foreign Currency Translation

The functional currency of certain foreign subsidiaries is the local currency. Accordingly, assets and liabilities of these subsidiaries are translated using the exchange rate in effect at the balance sheet date. Revenue and expense accounts and cash flows are translated using an average of exchange rates in effect during the period. Cumulative translation gains and losses are shown in the Consolidated Balance Sheets as a separate component of stockholders' equity. Exchange gains and losses arising from transactions denominated in foreign currencies (i.e., transaction gains and losses) are recognized as a component of other income (expense) in current operations, as are exchange gains and losses on intercompany transactions expected to be settled in the near term. Gains and losses arising from intercompany foreign currency transactions that are of a long-term investment nature are reported as a component of Accumulated other comprehensive income in the Consolidated Balance Sheets.
Warranty Costs
The Company generally provides for the estimated cost of hardware and software warranties in the period the related revenue is recognized. The Company assesses the adequacy of its accrued warranty liabilities and adjusts the amounts as necessary based on actual experience and changes in future estimates. Should product failure rates differ from our estimates, actual costs could vary significantly from our expectations. Extended warranties are sold to our customers and revenue is recognized over the term of the warranty agreement, as expected costs are incurred.

-72-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

Correction of an Immaterial Error
During the fourth fiscal quarter of 2020, the Company recorded an out-of-period adjustment that impacted the Consolidated Balance Sheets, Consolidated Statements of (Loss) Income and Consolidated Statements of Comprehensive (Loss) Income. The adjustment related to an error in the calculation of non-cash interest expense relating to the Company's Notes. This error resulted in an overstatement of non-cash interest expense of $0.7 million in 2019, $0.6 million in each of the first and second fiscal quarters of 2020 and $0.5 million in the third fiscal quarter of 2020. The error also resulted in an overstatement of Convertible Notes, net, and Deferred Tax Liability of $0.7 million and $0.2 million, respectively as of December 31, 2019; $1.4 million and $0.3 million, respectively, as of March 31, 2020; $2.0 million and $0.4 million, respectively, as of June 30, 2020; and $2.5 million and $0.6 million, respectively, as of September 30, 2020. The Company assessed the materiality of these errors on the previously issued interim and annual financial statements in accordance with SEC Staff Accounting Bulletin No. 99 and No. 108. The Company concluded that the errors were not material to any of the previously issued consolidated financial statements and the impact of correcting these errors in the year ended December 31, 2020 is not material to the consolidated financial statements.
The impact of this adjustment resulted in a fourth quarter period decrease in interest expense of $2.5 million and a decrease in income tax benefit of $0.6 million. The Company also recorded a decrease in Convertible Notes, net, of $2.5 million, and a reduction in Deferred Tax Liability of $0.6 million as of December 31, 2020.
Adoption of New Accounting Pronouncements
In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2016-13, Financial Instruments - Credit Losses (Topic 326), which requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected. The income statement reflects the measurement of credit losses for newly recognized financial assets, as well as the increases or decreases of expected credit losses that have taken place during the period. The measurement of expected credit losses is based upon historical experience, current conditions and reasonable and supportable forecasts that affect the collectability of the reported amount. Subsequent to the issuance of ASU 2016-13, the FASB issued ASU 2018-19, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, in November 2018. This ASU clarifies that receivables from operating leases are accounted for using the lease guidance and not as financial instruments. In April 2019, the FASB issued ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments, which further clarifies and improves guidance related to accounting for credit losses. In May 2019, the FASB issued ASU 2019-05, Financial Instruments - Credit Losses (Topic 326). This ASU provides relief to certain entities adopting ASU 2016-13. The amendment provides entities with an option to irrevocably elect the fair value option for certain financial assets. The Company adopted ASU 2016-13 with a cumulative-effect adjustment in retained earnings as of January 1, 2020. The impact of the adoption was not material to the Company's consolidated financial statements.

-73-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

Accounting Pronouncements Not Yet Adopted    

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which is intended to simplify various aspects related to the accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740, and also clarifies and amends existing guidance to improve consistent application. This guidance will be effective for interim and annual periods beginning after December 15, 2020, and early adoption is permitted. We evaluated the impact of the standard on our consolidated financial statements and do not expect the standard to have a material impact on our consolidated financial statements and disclosures.

In January 2020, the FASB issued ASU 2020-01, Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815). The amendments in this ASU clarify the interaction between the accounting for investments in equity securities, investment in equity method and certain derivatives instruments. The ASU is expected to reduce diversity in practice and increase comparability of the accounting for these interactions. This guidance will be effective for fiscal years beginning after December 15, 2020. We evaluated the impact of the standard on our consolidated financial statements and do not expect the standard to have a material impact on our consolidated financial statements and disclosures.

In August 2020, the FASB issued ASU 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40), which simplifies the accounting for certain convertible instruments. The update reduces the number of accounting models for convertible debt instruments and convertible preferred stock. Convertible debt will be accounted for as a single liability measured at its amortized cost and convertible preferred stock will be accounted for as a single equity instrument measured at its historical cost, as long as no other features require bifurcation and recognition as derivatives. The update also requires the if-converted method to be used for convertible instruments and the effect of potential share settlement be included in the diluted earnings per share calculation when an instrument may be settled in cash or shares. The amendments in this update are effective for public business entities for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. The guidance may be early adopted for fiscal years beginning after December 15, 2020,
and interim periods within those fiscal years.

The Company has elected to early adopt ASU 2020-06 as of January 1, 2021. The Notes are a convertible instrument with a cash-conversion feature that is accounted for within the scope of ASC 470-20 and will be impacted by adopting ASU 2020-06. The Company has elected to apply the modified retrospective method wherein the Company will recognize a cumulative-effect adjustment to the opening balance of retained earnings (January 1, 2021). Further, the Company will not restate EPS in the prior periods. The Company calculated the cumulative-effect adjustment as of January 1, 2021 by comparing (i) the historical amortization schedule for the Notes through December 31, 2020 and (ii) an updated amortization schedule wherein the conversion feature within the Notes would not be separated as an equity component and subsequently recognized as non-cash interest expense under ASC 835-30. As a result of ASU 2020-06, while cash interest expense is not impacted, non-cash interest accretion is limited to the amortization of debt issuance costs under ASC 835-30. Therefore, the Company prepared its transition journal entries by (i) reversing the conversion feature amount recorded in APIC and (ii) reversing the difference in non-cash interest expense via retained earnings. The expected impact on retained earnings is $4.3 million.

In October 2020, the FASB issued ASU 2020-10, Codification Improvements, which updates various codification topics by clarifying or improving disclosure requirements to align with the SEC's regulations. This guidance will be effective for annual periods beginning after December 15, 2020, for public entities. The Company will adopt as of the reporting period beginning January 1, 2021. We evaluated the impact of the
-74-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

standard on our consolidated financial statements and do not expect the standard to have a material impact on our consolidated financial statements and disclosures.
2.     REVENUE

We separate our goods and services among two reportable segments, North America and International. The two segments consist of revenue originating from:

North America: including the United States, Canada and Mexico
International: all geographies outside North America, currently consisting primarily of Australia, France, Germany, Italy, Malaysia, Spain and Switzerland

Refer to Note 18 for further detail regarding the change in reportable segments which required recast of prior period presentation.
The following table summarizes our segment revenue (in thousands):

Year Ended December 31,
202020192018
North America Revenue:
    POC Lab Instruments & Other$8,433 $6,556 $6,375 
    POC Sales-type leases5,230 6,890 5,888 
    POC Lab Consumables59,247 53,267 45,111 
    POC Imaging20,651 21,655 22,832 
    PVD19,810 10,965 25,663 
    OVP17,695 16,090 18,522 
    Total North America Revenue$131,066 $115,423 $124,391 
International Revenue:
    POC Lab Instruments & Other$6,383 $96 $ 
    POC Sales-type leases387   
    POC Operating Leases1,012   
    POC Lab Consumables32,354 323  
    POC Imaging22,537 3,998  
    PVD3,584 2,821 3,055 
    Total International Revenue$66,257 $7,238 $3,055 
Total Revenue$197,323 $122,661 $127,446 

Remaining Performance Obligations

Remaining performance obligations represent the aggregate transaction price allocated to performance obligations with an original contract term greater than one year which are fully or partially unsatisfied at the end of the period. Remaining performance obligations include noncancelable purchase orders, the non-lease portion of minimum purchase commitments under long-term supply arrangements, extended warranty, service and other long-term contracts. Remaining performance obligations do not include revenue from contracts with customers with an original term of one year or less, revenue from long-term supply arrangements with no minimum purchase requirements, revenue expected from purchases made in excess of the minimum purchase
-75-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

requirements, or revenue from instruments leased to customers. While the remaining performance obligation disclosure is similar in concept to backlog, the definition of remaining performance obligations excludes leases and contracts that provide the customer with the right to cancel or terminate for convenience with no substantial penalty, even if historical experience indicates the likelihood of cancellation or termination is remote. Additionally, the Company has elected to exclude contracts with customers with an original term of one year or less from remaining performance obligations.

As of December 31, 2020, the aggregate amount of the transaction price allocated to remaining minimum performance obligations was approximately $144.6 million. As of December 31, 2020, the Company expects to recognize revenue as follows (in thousands):

Year Ending December 31,Revenue
2021$32,976 
202230,089 
202326,992 
202422,668 
202516,713 
Thereafter15,129 
$144,567 

Contract Balances

The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled contract assets, deferred revenue, and customer deposits and billings in excess of revenue recognized. In addition, the Company defers certain costs incurred to obtain contracts.

Contract Assets

Certain unbilled amounts related to long-term contracts for which we provide a free term to the customer are recorded in "Other current assets" and "Other non-current assets" on the accompanying Consolidated Balance Sheets. The collection of these balances occurs over the term of the underlying contract. The balances as of December 31, 2020 were $1.2 million and $4.1 million for current and non-current assets, respectively, shown net of related unearned interest. The balances as of December 31, 2019 were $1.1 million and $3.7 million for current and non-current assets, respectively, shown net of related unearned interest.

-76-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

Contract Liabilities

The Company receives cash payments from customers for licensing fees or other arrangements that extend for a specified term. These contract liabilities are classified as either current or long-term in the Consolidated Balance Sheets based on the timing of when the Company expects to recognize revenue. As of December 31, 2020 and 2019, contract liabilities were $8.9 million and $8.7 million, respectively, and are included within "Deferred revenue, current, and other" and "Deferred revenue, non-current" in the accompanying Consolidated Balance Sheets. The decrease in the contract liability balance during the year ended December 31, 2020 is approximately $4.2 million of revenue recognized during the period, offset by approximately $3.8 million of additional deferred sales in 2020 and the acquisition of scil contract liabilities of $0.6 million. The decrease in the contract liability balance during the year ended December 31, 2019 is $3.1 million of revenue recognized during the period, offset by $2.2 million of additional deferred sales. Contract liabilities are reported on the accompanying Consolidated Balance Sheets on a contract-by-contract basis.

Contract Costs

The Company capitalizes certain direct incremental costs incurred to obtain customer contracts, typically sales-related commissions, where the recognition period for the related revenue is greater than one year. Contract costs are classified as current or non-current, and are included in "Other current assets" and "Other non-current assets" in the Consolidated Balance Sheets based on the timing of when the Company expects to recognize the expense. Contract costs are generally amortized into selling and marketing expense with a certain percentage recognized immediately based upon placement of the instrument with the remainder recognized on a straight-line basis (which is consistent with the transfer of control for the related goods or services) over the average term of the underlying contracts, approximately 6 years. Management assesses these costs for impairment at least quarterly on a portfolio basis and as “triggering” events occur that indicate it is more-likely-than-not that an impairment exists. The balance of contract costs as of December 31, 2020 and December 31, 2019 was $3.0 million and $2.7 million, respectively. Amortization expense for the year ended December 31, 2020 was approximately $1.0 million, offset by approximately $1.2 million of additional contract cost capitalization and $0.1 million of the acquisition of scil contract costs. Amortization expense for the year ended December 31, 2019 was approximately $0.9 million, offset by approximately $1.1 million of additional contract costs capitalized. Contract costs are calculated and reported on a portfolio basis.

3.    ACQUISITION AND RELATED PARTY ITEMS
scil Acquisition
On April 1, 2020, the Company completed the acquisition of scil animal care company GmbH (“scil”) from Covetrus, Inc. The Company purchased 100% of the capital stock of scil for an aggregate purchase price of $110.3 million in cash. The acquisition represents a key milestone in the Company's long-term strategic plan, creating a global veterinary diagnostics company with leadership positions in key geographic markets. The purchase price exceeded the identifiable net assets, resulting in goodwill of $46.0 million, primarily attributable to the synergies expected from the expanded market opportunities with our offerings and the experienced workforce acquired. Of the goodwill acquired, $37.3 million is allocated to our International segment and $8.7 million is allocated to our North America segment. All of the goodwill is tax deductible for purposes of calculating Controlled Foreign Corporation ("CFC") tested income, which may result in a decrease to the Company's future U.S. federal tax liability.

-77-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

The acquisition was accounted for using the acquisition method of accounting in accordance with ASC 805, Business Combinations, which requires, among other things, that assets acquired and liabilities assumed be recognized at their fair values as of the acquisition date. As such, the total purchase consideration was allocated to the assets acquired and liabilities assumed based on a preliminary estimate of their fair values as of April 1, 2020.

The information below represents the preliminary purchase price allocation of scil (in thousands):


April 1, 2020
Total purchase consideration$110,290 
Cash and cash equivalents5,889 
Accounts receivable 10,707 
Inventories11,278 
Net investment in leases, current311 
Prepaid expenses1,692 
Other current assets1,338 
Property and equipment, net19,320 
Operating lease right-of-use assets877 
Other intangible assets, net44,517 
Net investment in leases, non-current1,027 
Investments in unconsolidated affiliates55 
Other non-current assets291 
    Total assets acquired97,302 
Accounts payable8,221 
Accrued liabilities7,067 
Operating lease liabilities, current356 
Deferred revenue, current, and other3,220 
Deferred revenue, non-current94 
Operating lease liabilities, non-current529 
Deferred tax liability13,249 
Other liabilities276 
    Net assets acquired64,290 
Goodwill46,000 
Total fair value of consideration transferred$110,290 

The Company's preliminary estimates of fair values of the assets acquired and the liabilities assumed are based on the information currently available, and the Company is continuing to evaluate the underlying inputs and assumptions used in its valuations. Accordingly, these preliminary estimates are subject to change during the measurement period, which is up to one year from the date of the acquisition. A decrease in the fair value of assets acquired or an increase in the fair value of liabilities assumed in the acquisition from those valuations would result in a corresponding change in the amount of goodwill from the acquisition. During the fourth quarter, the Company made certain valuation adjustments to provisional amounts previously recognized. These adjustments resulted in a net increase of $0.2 million in goodwill, primarily due to changes in estimated taxes and an increase in accrued liabilities assumed.
-78-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


Per the tax indemnification included in the purchase agreement of scil animal care company GmbH, the seller has indemnified the Company for $1.1 million related to uncertain tax positions taken in prior years. The outcome of this arrangement will either be settled or expire due to lapse of statute of limitations by 2027. As of December 31, 2020, approximately $0.8 million of the indemnification agreement remains outstanding.
Intangible assets acquired, amortization method and estimated useful life as of April 1, 2020, was as follows (dollars in thousands):

Useful LifeAmortization MethodFair Value
Customer relationships10 yearsStraight-line$36,272 
Internally developed software7 yearsStraight-line353
Backlog0.2 yearsStraight-line210
Non-compete agreements2 yearsStraight-line60
Trade name subject to amortization0.8 yearsStraight-line66
Trademarks and trade names not subject to amortizationn/aIndefinite7,556
Total intangible assets acquired$44,517 

scil generated net revenue of $61.3 million and a net loss of $1.1 million for the period from April 1, 2020 to December 31, 2020.

The Company incurred acquisition related costs of approximately $6.3 million and $0.7 million for the years ended December 31, 2020 and 2019, respectively, which are included within general and administrative expenses on our Consolidated Statements of (Loss) Income.

Unaudited Pro Forma Financial Information

The following tables present unaudited supplemental pro forma financial information as if the acquisition had occurred on January 1, 2019 (in thousands):
Year Ended December 31,
20202019
Revenue, net$215,874 $201,700 
Net (loss) income before equity in losses of unconsolidated affiliates$(14,848)$(2,159)
Net (loss) income attributable to Heska Corporation$(15,215)$(2,487)

The pro forma financial information presented above has been prepared by combining our historical results and the historical results of scil and further reflects the effect of purchase accounting adjustments, including: (i) amortization of acquired intangible assets, (ii) the impact of certain fair value adjustments such as depreciation on the acquired property, plant and equipment, and (iii) historical intercompany sales between the Company and scil. The unaudited pro forma results are presented for informational purposes only and are not necessarily indicative of what actual results of operations would have been if the acquisition had occurred as the beginning of the period presented, nor are they indicative of future results of operations.

CVM
On December 5, 2019, Heska entered into a definitive agreement to purchase 100% of the outstanding shares of CVM Diagnostico Veternario S.L. and CVM Ecografia S.L. (“CVM”, collectively), primarily to expand international operations in Europe. CVM is headquartered in Tudela, outside of Madrid, Spain. CVM mainly
-79-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

operates in Spain. The terms of the agreement transferred control of CVM upon signing, and the transfer of the purchase price of approximately $14.4 million and shares occurred in January 2020. The purchase price exceeded the fair value of the identifiable net assets and, accordingly, $9.0 million was allocated to goodwill within the International segment based on the purchase price allocation, all of which is tax deductible for purposes of calculating CFC tested income.
The fair values allocated to CVM's assets and liabilities as of the acquisition date, as well as the purchase price, are reflected in the table below (in thousands):

Purchase PriceDecember 5, 2019
Consideration paid to former owners$14,420 
Cash and cash equivalents1,226 
Accounts receivable583 
Inventories1,621 
Other current assets1,186 
Property and equipment345 
Other intangible assets2,608 
Other non-current assets460 
    Total assets acquired8,029 
Accounts payable(94)
Accrued liabilities(471)
Current portion of deferred revenue, and other(54)
Deferred tax liability(683)
Other long-term borrowings(1,109)
Other liabilities(157)
    Net assets acqiured5,461 
Goodwill8,959 
Total fair value of consideration transferred$14,420 

During the year ended December 31, 2020, the Company made certain valuation adjustments to provisional amounts previously recognized. These measurement period adjustments resulted in a net $110 thousand increase of goodwill, primarily due to fair value adjustments resulting in a decrease in net identifiable assets acquired. The Company finalized the accounting for the CVM acquisition in the fourth quarter of 2020.
Intangible assets acquired, amortization method and estimated useful life as of December 5, 2019, were as follows (dollars in thousands):
Useful LifeAmortization MethodFair Value
Customer relationships6 yearsStraight-line$2,440 
Trade name4 yearsStraight-line111 
Developed technologyn/aIndefinite57 
$2,608 
-80-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

CVM generated net revenue of $0.8 million and net income of $0.1 million, for the period from December 6, 2019 to December 31, 2019.
The Company incurred acquisition related costs of approximately $0.6 million and $0.1 million for the years ended December 31, 2020 and 2019, respectively, which are included within general and administrative expenses on our Consolidated Statements of (Loss) Income.
Unaudited Pro Forma Financial Information

The following table presents unaudited supplemental pro forma financial information as if the CVM acquisition had occurred on January 1, 2018 (in thousands):
Year Ended December 31,
20192018
Revenue, net$130,434 $135,344 
Net (loss) income before equity in losses of unconsolidated affiliates$(460)$6,042 
Net (loss) income attributable to Heska Corporation$(788)$5,970 

The pro forma financial information presented above has been prepared by combining our historical results and the historical results of CVM and further reflects the effect of purchase accounting adjustments. The unaudited pro forma results are presented for informational purposes only and are not necessarily indicative of what actual results of operations would have been if the acquisition had occurred as the beginning of the period presented, nor are they indicative of future results of operations.
Optomed
On February 22, 2019, Heska acquired 70% of the equity of Optomed, a French-based endoscopy company, in exchange for approximately $0.2 million in cash and the assumption of approximately $0.4 million in debt. On October 5, 2020, the Company acquired the remaining 30% minority interest in Optomed for a purchase price of $0.5 million, allowing the Company to assume full control of the business operations.
Purchase Agreement for Certain Assets
Cuattro, LLC ("Cuattro") is owned by Kevin S. Wilson, the CEO and President of the Company. On December 21, 2018, the Company closed a transaction (the "Asset Acquisition") to acquire certain assets from Cuattro, all related to the North America segment. Pursuant to the Asset Acquisition, dated November 26, 2018, the Company issued 54,763 shares of the Company's common stock, $0.01 par value per share (the "Common Stock"), to Cuattro on the Closing Date, at an aggregate value equal to approximately $5.4 million based on the adjusted closing price per share of the Common Stock as reported on the Nasdaq Stock Market on the Asset Acquisition agreement date. These shares were issued to Cuattro in a private placement in reliance upon an exemption from the registration requirements of the Securities Act pursuant to Section 4(a)(2) thereof and the safe harbor provided by Rule 506 of Regulation D promulgated thereunder. In addition to the Common Stock, the Company paid cash in the amount of $2.8 million to Cuattro as part of the transaction. The total purchase price was determined based on a valuation report from an independent third party. Part of the Asset Acquisition was an agreement to terminate the supply and license agreement that Heska had been operating under since the acquisition of Cuattro Veterinary USA, LLC.
The Company evaluated the acquisition of the purchased assets under ASC 805, Business Combinations and ASU 2017-01, Business Combinations (Topic 805) and concluded that as substantially all of the fair value of the gross assets acquired is concentrated in an identifiable group of similar assets, the transaction did not meet the requirements to be accounted for as a business combination and therefore was accounted for as an asset
-81-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

acquisition. Accordingly, the $8.2 million purchase price of the purchased assets was allocated entirely to an identifiable intangible asset amortizing on a straight-line basis over a 10-year useful life.
Related Party Activities
Cuattro charged the Company $0, $6 thousand and $4.6 million during 2020, 2019 and 2018, respectively, primarily related to digital imaging products, pursuant to an underlying supply contract that contained minimum purchase obligations, software and services as well as other operating expenses. Pursuant to the Asset Acquisition, Cuattro was obligated, without further compensation, to assist the Company with the implementation of a third-party image hosting platform and necessary data migration. The implementation and migration were completed, and as of December 31, 2020 there will be no further related party activities with Cuattro.

CVM management conducts related party activities with Practice Clinicas Veterinarias Moviles, S.L. ("CVM Practice"), which is owned by CVM's management. During the year ended December 31, 2020, the Company fully paid the balance of a loan due to CVM Practice of approximately $1.1 million, which is included in "Payments of related party debt" on the Consolidated Statements of Cash Flows. CVM also leases two warehouses from CVM Practice. CVM Practice charged CVM $31 thousand and $0 during the year ended December 31, 2020 and 2019, respectively, all of which is related to lease payments. The right-of-use asset and lease liability amounts related to the warehouse leases were approximately $0.2 million and $0 as of December 31, 2020 and 2019, respectively. The change from December 31, 2019 to December 31, 2020 is due to a reorganization regarding CVM management and the control that they exercise subsequent to the scil acquisition.
4.    INVESTMENTS IN UNCONSOLIDATED AFFILIATES
The carrying values of investments in unconsolidated affiliates, categorized by type of investment, is as follows (in thousands):
December 31, 2020December 31, 2019
Equity method investment$3,686 $4,406 
Non-marketable equity security investment3,018 3,018 
Investment in Unconsolidated Affiliates$6,704 $7,424 
Equity Method Investment
On September 24, 2018, we invested approximately $5.1 million, including costs, to acquire an equity interest in a business as part of our product development strategy. As of December 31, 2020, our ownership interest in the business was 29.1%. In connection with the investment, the Company entered into a Manufacturing Supply Agreement that grants the Company global exclusivity to specified products to be delivered under the agreement for a 15-year period that begins upon the Company's receipt and acceptance of an initial order under the agreement. The Company accounts for this investment using the equity method of accounting. Under the equity method, the carrying value of the investment is adjusted for the Company's proportionate share of the investee's reported earnings or losses with the corresponding share of earnings or losses reported as Equity in losses of unconsolidated affiliates, listed below Net income before equity in losses of unconsolidated affiliates within the Consolidated Statements of (Loss) Income.
Non-Marketable Equity Security Investment
-82-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

On August 8, 2018, the Company invested approximately $3.0 million, including costs, in exchange for preferred stock. The Company's investment is a non-marketable equity security, recorded using the measurement alternative of cost minus impairment, if any, plus or minus changes resulting from qualifying observable price changes.
As part of the agreement, the Company entered into a Supply and License Agreement, which provides that the investee produce and commercialize products that will enhance the Company's diagnostic portfolio. As part of this agreement, the Company made upfront payment of $1.0 million related to a worldwide exclusive license agreement over a 20-year period, recorded in both short and long-term other assets. In addition, the agreement provides for an additional contingent payment of $10.0 million, relating to the successful achievement of sales milestones. This potential future milestone payment has not yet been accrued as it is not deemed by the Company to be probable at this time.
Both parties in this arrangement are active participants and are exposed to significant risks and rewards dependent on the commercial success of the activities of the collaboration. The parties are actively working on developing and testing the product as well as funding the research and development. Heska classifies the amounts paid for research and development work within the North America segment research and development operating expenses. Expense is recognized ratably when incurred and in accordance with the development plan.
Our investments are evaluated for impairment if a triggering event occurs. The Company evaluated both its equity method investment and non-marketable equity security investment for losses other than temporary as of December 31, 2020, and determined that no indications of an impairment existed.

5.    INCOME TAXES

The components of income before income taxes were as follows (in thousands):

 Year Ended December 31,
 202020192018
Domestic$(9,441)$(1,872)$3,602 
Foreign(4,352)(711)205 
 $(13,793)$(2,583)$3,807 
-83-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

Temporary differences that give rise to the components of net deferred tax assets (liabilities) are as follows (in thousands):

 December 31,
 20202019
Inventory$2,993 $2,005 
Accrued compensation295 122 
Stock options2,322 1,858 
Research and development tax credit1,308 990 
Research and development expense2,571 1,417 
Deferred revenue1,441 2,052 
Property and equipment298 3,469 
Net operating loss carryforwards8,757 11,676 
Foreign tax credit carryforward64 64 
Sales-type leases1,324 (1,968)
Convertible debt equity component(8,691)(9,421)
Foreign intangible(11,311)(691)
Other(1,124)(179)
247 11,394 
Valuation allowance(6,409)(5,656)
Total net deferred tax assets (liabilities)$(6,162)$5,738 

The components of the income tax expense (benefit) are as follows (in thousands):

 Year Ended December 31,
 202020192018
Current income tax expense:   
Federal$(24)$ $(115)
State339 189 192 
Foreign1,465 170 63 
Total current expense$1,780 $359 $140 
Deferred income tax (benefit) expense:   
Federal$369 $(1,610)$(1,877)
State289 (307)(378)
Foreign(2,199)112  
Total deferred (benefit) expense(1,541)(1,805)(2,255)
Total income tax expense (benefit)$239 $(1,446)$(2,115)
-84-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

The Company's income tax (benefit) expense relating to income (loss) for the periods presented differs from the amounts that would result from applying the federal statutory rate to that income (loss) as follows:

Year Ended December 31,
202020192018
Statutory federal tax rate21 %21 %21 %
State income taxes, net of federal benefit(4)%9 %(8)%
Non-controlling interest in Optomed1 %(2)% %
Foreign income inclusion(12)% % %
Non-temporary stock option benefit6 %48 %(50)%
Meals and entertainment permanent difference %(2)%1 %
GILTI permanent difference %2 %1 %
Other permanent differences1 %(1)%1 %
Foreign tax rate differences2 %6 % %
Change in tax rate1 %(6)% %
Change in valuation allowance(4)%(17)% %
Other deferred differences(2)%(9)%(21)%
Transaction costs(6)%(6)% %
Executive compensation limit(6)%(7)% %
Research & development credit2 %20 % %
Equity Investment(4)% % %
Change in uncertain tax benefits3 % % %
Other(1)% %(1)%
Effective income tax rate(2)%56 %(56)%

In 2020, we had total income tax expense of $0.2 million, including $0.6 million in domestic deferred income tax expense and $2.2 million in foreign deferred income tax benefit, and $1.8 million in current income tax expense. In 2019, we had total income tax benefit of $1.4 million, including approximately $1.9 million in domestic deferred income tax benefit and $0.1 million of foreign deferred income tax expense, a non-cash benefit, and approximately $0.4 million in current income tax expense. In 2018, we had total income tax benefit of $2.1 million, including $2.3 million in domestic deferred income tax benefit, a non-cash benefit, and $0.1 million in current income tax expense. Income tax expense increased in 2020 from 2019 due to foreign income inclusion, executive compensation limitations and acquisition related costs. Income tax benefit decreased in 2019 from 2018 due to executive compensation limitations and lower excess tax benefits related to stock-based compensation deductions.

Cash paid for income taxes for the years ended December 31, 2020, 2019 and 2018 was $993 thousand, $128 thousand and $36 thousand, respectively.

-85-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

The Company is subject to income taxes in the U.S. federal jurisdiction, and various foreign, state and local jurisdictions. Tax regulations within each jurisdiction are subject to the interpretation of the related tax laws and regulations and require significant judgment to apply. Although the U.S. and many states generally have statutes of limitations ranging from 3 to 5 years, those statutes could be extended due to the Company’s net operating loss and tax credit carryforward positions in several of the Company's tax jurisdictions. In the U.S., the tax years 2017 - 2019 remain open to examination by the Internal Revenue Service.

As of December 31, 2020, the Company had net operating loss carryforwards ("NOL") of approximately $35.0 million, a foreign tax credit of $64 thousand and a domestic research and development tax credit carryforward of approximately $1.3 million. Our federal NOL is expected to expire as follows if unused: $22 million in 2021 through 2022, $5.4 million in 2024 through 2025 and $0.5 million in 2027 and later. Our foreign NOL of $7.1 million does not have an expiration date.

The Company considered multiple factors in assessing the need for an increase in the partial valuation allowance against the Company’s deferred tax assets as of December 31, 2020. Significant factors such as employee stock compensation expenses from achievement of Company performance metrics, executive compensation limitations and required capitalization of research and development expenses beginning in 2022 have negatively impacted our future taxable income projections. These future projections indicate a larger portion of the Company’s deferred tax assets will likely expire unrealized. As a result, the Company recorded an additional $0.8 million tax effected increase to the current partial valuation allowance against the Company's worldwide net operating losses and tax credits for the year ended December 31, 2020. As of December 31, 2020, the Company had a deferred tax asset of approximately $10.1 million from net operating losses and tax credits and a net partial valuation allowance of approximately $6.4 million recorded against these deferred tax assets. The Company will continue to closely monitor the need for an additional valuation allowance against its deferred tax assets in each subsequent reporting period which can be impacted by actual operating results compared to the Company's forecast.

ASC Topic 740 prescribes the accounting for uncertainty in income taxes recognized in the financial statements in accordance with the other provisions contained within this guidance. This topic prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by the taxing authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50% likely or being realized upon ultimate audit settlement. In the normal course of business, the Company's tax returns are subject to examination by various taxing authorities. Such examination may result in future tax and interest assessments by these taxing authorities for uncertain tax positions taken in respect to certain matters.

The following provides a reconciliation of unrecognized tax benefits which are included in Other liabilities within the Consolidated Balance Sheets (in thousands):
Year Ended December 31,
20202019
Balance at beginning of period$ $ 
Acquired additions based on prior year tax positions
(1,072) 
Reductions from lapse in statutes of limitations
358  
Currency Translation Adjustment$(94) 
Balance at the end of period
$(808)$ 

-86-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

The total amount of unrecognized tax benefits, which are included in other liabilities within the combined balance sheets as of December 31, 2020 was approximately $0.8 million, which may impact the effective tax rate if recognized. These unrecognized tax benefits were recognized as part of the acquisition of scil animal care company GmbH. Per the tax indemnification included in the purchase agreement, the seller has indemnified the Company for these other liabilities, which would reduce the economic impact to the Company if these positions were settled with tax authorities. It is expected that the amount of unrecognized tax benefits will change in the next 12 months; however, the Company does not expect the change to have a material impact on the combined financial statements. The Company recognizes interest and penalties related to uncertain tax positions in income tax (benefit)/expense. Interest and penalties accrued as of December 31, 2020 are $19.0 thousand.

As of December 31, 2020, the Company had accumulated undistributed earnings generated by foreign subsidiaries of approximately $2.9 million, which would be subject to U.S. taxes and foreign withholding taxes of approximately $145 thousand if repatriated. The Company had previously considered these earnings as a possible cash source through repatriation to the U.S. As of December 31, 2020, the Company has changed its assertion on these earnings and now considers them to be indefinitely reinvested and expects the future U.S. cash generation to be sufficient to meet future U.S. cash needs. If the Company decides to repatriate these foreign earnings, it would need to adjust its income tax provision in the period it determined that the earnings would no longer be indefinitely invested outside the United States.

6.     LEASES

Lessee Accounting

The Company leases buildings, office equipment, and vehicles. The following table summarizes the Company's operating and finance lease balances (in thousands):

LeasesBalance Sheet LocationDecember 31, 2020December 31, 2019
Assets
OperatingOperating lease right-of-use assets$5,457 $5,726 
FinanceProperty and equipment, net1,907 81 
Total Leased Assets$7,364 $5,807 
Liabilities
OperatingOperating lease liabilities, current$2,087 $1,745 
Operating lease liabilities, non-current3,858 4,413 
FinanceDeferred revenue, current, and other295 47 
Other liabilities261 37 
Total Lease Liabilities$6,501 $6,242 

For the twelve months ended December 31, 2020, operating lease expense was approximately $2.8 million, including immaterial variable lease costs. For the twelve months ended December 31, 2019, operating lease expense was approximately $2.4 million, including immaterial variable lease costs. The Company had building and other rent expense of $1.9 million for the twelve months ended December 31, 2018 under ASC 840, Leases.
-87-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


For the years ended December 31, 2020 and 2019, finance lease amortization expense was $0.3 million and $44 thousand, respectively. For the years ended December 31, 2020 and 2019, finance lease interest expense was $10 thousand and $3 thousand, respectively. The Company's finance leases were not material as of December 31, 2018 and for the twelve month period then ended.     


Supplemental cash flow information related to the Company's operating and finance leases for the years ended December 31, 2020 and 2019, respectively, was as follows (in thousands):
Twelve Months Ended
December 31,
20202019
Cash paid for amounts included in the measurement of lease liabilities:
    Operating cash outflows - operating leases$2,213 $1,800 
    Operating cash outflows - finance leases$10 $3 
    Financing cash outflows - finance leases$250 $36 
ROU assets obtained in exchange for new lease obligations:
    Operating leases$788 $604 
    Finance leases$159 $11 

The following table presents the weighted average remaining lease term and weighted average discount rate related to the Company's leases:

December 31,
20202019
Weighted average remaining lease term:
    Operating3.1 years3.8 years
    Finance2.9 years2.0 years
Weighted average discount rate:
    Operating4.2 %4.4 %
    Finance2.1 %4.0 %

-88-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

The following table presents the maturity of the Company's lease liabilities as of December 31, 2020 (in thousands):

Year Ending December 31,Operating LeasesFinance Leases
2021$2,158 $294 
20221,834 139 
20231,949 59 
2024144 38 
2025138 26 
Thereafter132 18 
Total lease payments6,355 574 
Less: imputed interest410 18 
Total lease liabilities$5,945 $556 

Lessor Accounting
The Company enters into sales-type leases as part of our subscription agreements. The following table presents the maturity of the Company's lease receivables as of December 31, 2020 (in thousands):

Year Ending December 31,Sales-Type Leases
2021$4,834 
20224,872 
20234,220 
20243,291 
20252,033 
Thereafter1,424 
Total undiscounted future maturities20,674 
Less: interest91 
Total lease receivables$20,583 


-89-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

The following table summarizes the profit recognized on the commencement date for sales-type leases and lease income for equipment-only operating leases (in thousands):


Twelve Months Ended
December 31,
20202019
Sales-type lease revenue$5,617 $6,890 
Sales-type lease cost of revenue3,951 5,099 
Profit recognized at commencement for sales-type leases$1,666 $1,791 
Operating lease income$1,012 $ 

-90-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

7.    EARNINGS PER SHARE
Basic earnings per share ("EPS") is computed by dividing net income attributable to the Company by the weighted-average number of common shares outstanding during the period. The computation of diluted EPS is similar to the computation of basic EPS except that the numerator is increased to exclude charges that would not have been incurred, and the denominator is increased to include the number of additional common shares that would have been outstanding (using the if-converted and treasury stock methods), if securities containing potentially dilutive common shares (stock options and restricted stock awards but excluding options to purchase fractional shares resulting from the Company's December 2010 1-for-10 reverse stock split) had been converted to common shares, and if such assumed conversion is dilutive.
The following is a reconciliation of the weighted-average shares outstanding used in the calculation of basic and diluted earnings per share ("EPS") for the years ended December 31, 2020, 2019 and 2018 (in thousands, except per share data):

Years ended December 31,
202020192018
Net (loss) income attributable to Heska Corporation$(14,399)$(1,465)$5,850 
Basic weighted-average common shares outstanding8,653 7,446 7,220 
Assumed exercise of dilutive stock options and restricted shares  636 
Diluted weighted-average common shares outstanding8,653 7,446 7,856 
Basic (loss) earnings per share attributable to Heska Corporation$(1.66)$(0.20)$0.81 
Diluted (loss) earnings per share attributable to Heska Corporation$(1.66)$(0.20)$0.74 
The following potentially outstanding common shares from convertible preferred stock, convertible senior notes, stock options and restricted stock awards were excluded from the computation of diluted EPS because the effect would have been antidilutive (in thousands):

Years ended December 31,
202020192018
Convertible preferred stock458   
Convertible senior notes118   
Stock options and restricted shares328 300 111 
904 300 111 

As more fully described in Note 16, our Notes are convertible under certain circumstances, as defined in the indenture, into a combination of cash and shares of our common stock. The Company intends to settle the principal value of the Notes in cash and issue shares of our common stock to settle the intrinsic value of the conversion feature. The Company will use the treasury stock method when calculating the potential dilutive effect of the conversion feature on earnings per share, if any. Potential dilution upon conversion of the Notes occurs when the average market price per share of our common stock is greater than the conversion price of the Notes of $86.63. For the periods presented, all potentially dilutive shares relating to the Notes were not included in the computation of diluted EPS as the effect would have been antidilutive.
-91-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

As discussed in Note 12, the Company issued and sold an aggregate of 122,000 shares of its Preferred Stock to certain investors in a private placement offering. The shares were converted into 1,508,964 shares of Public Common Stock, effective on April 21, 2020. The potential dilutive effect of the convertible preferred stock was calculated using the if-converted method for the period the preferred shares were outstanding. For the twelve months ended December 31, 2020, these shares were excluded from the computation of diluted EPS because the effect would have been antidilutive.
8.    GOODWILL AND OTHER INTANGIBLES

The following summarizes the changes in goodwill during the years ended December 31, 2020 and 2019 (in thousands):
North AmericaInternationalTotal
Carrying amount, December 31, 2018$25,724 $955 $26,679 
Goodwill attributable to acquisitions 9,396 9,396 
Foreign currency adjustments 129 129 
Carrying amount, December 31, 2019$25,724 $10,480 $36,204 
Goodwill attributable to acquisitions (subject to change)8,742 37,258 46,000 
Measurement period adjustment to prior year acquisition 110 110 
Foreign currency adjustments948 5,014 5,962 
Carrying amount, December 31, 2020$35,414 $52,862 $88,276 

Other intangibles assets, net consisted of the following as of December 31, 2020 and 2019 (in thousands):

20202019
Gross Carrying AmountAccumulated AmortizationNet Carrying AmountGross Carrying AmountAccumulated AmortizationNet Carrying Amount
Intangible assets subject to amortization:
Customer relationships and other$46,989 $(6,436)$40,553 $6,205 $(2,226)$3,979 
Developed technology8,669 (1,696)6,973 8,200 (819)7,381 
Trade names197 (105)92 112  112 
Intangible assets not subject to amortization:
Trade names8,374 — 8,374  —  
Total intangible assets$64,229 $(8,237)$55,992 $14,517 $(3,045)$11,472 

Amortization expense relating to other intangibles is as follows (in thousands):

Years Ended December 31,
202020192018
Amortization expense$5,196 $1,278 $388 
    
The remaining weighted-average amortization period for intangible assets is approximately 8.7 years.


-92-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


Estimated amortization expense related to intangibles for each of the five years from 2021 through 2025 and thereafter is as follows (in thousands):

Year Ending December 31,
2021$5,905 
20225,868 
20235,506 
20245,376 
20255,347 
Thereafter19,616 
Total amortization related to finite-lived intangible assets47,618 
Indefinite-lived intangible assets8,374 
Net intangible assets$55,992 

9.    PROPERTY AND EQUIPMENT, NET
Property and equipment, net, consisted of the following (in thousands):
 December 31,
 20202019
Land$2,590 $694 
Building12,737 3,845 
Machinery and equipment40,411 28,777 
Office furniture and equipment2,047 1,345 
Computer hardware and software4,773 3,408 
Leasehold and building improvements10,728 10,558 
Construction in progress4 671 
Property and equipment, gross73,290 49,298 
Less accumulated depreciation(37,748)(33,829)
Total property and equipment, net$35,542 $15,469 
The Company has subscription agreements whereby its instruments in inventory may be placed at a customer's location on a rental basis. For instruments classified as operating leases, the cost of these instruments is transferred to machinery and equipment and depreciated, typically over a 5 to 7 year period depending on the circumstance under which the instrument is placed with the customer. Our cost of instruments under operating leases as of December 31, 2020 and 2019 was $13.6 million and $8.1 million, respectively, before accumulated depreciation of $4.7 million and $4.6 million, respectively.
Depreciation expense for property and equipment was $6.2 million, $3.6 million and $4.2 million for the years ended December 31, 2020, 2019 and 2018, respectively.
-93-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

10.    INVENTORIES

Inventories consisted of the following (in thousands):
December 31,
20202019
Raw materials$14,454 $14,597 
Work in process4,262 2,730 
Finished goods21,321 9,274 
Total inventories$40,037 $26,601 

Inventories are measured on a first-in, first-out basis and stated at lower of cost or net realizable value.
11.    ACCRUED LIABILITIES
Accrued liabilities consisted of the following (in thousands):
December 31,
20202019
Accrued payroll and employee benefits$7,949 $1,175 
Accrued property taxes659 681 
Accrued purchase orders1,549 739 
Accrued taxes3,731 586 
Other4,167 3,164 
Total accrued liabilities$18,055 $6,345 

Other accrued liabilities consist of items that are individually less than 5% of total current liabilities.
12.    CAPITAL STOCK
Stock Plans
We have two stock option plans which authorize granting of stock options, restricted stock awards and stock purchase rights to our employees, officers, directors and consultants. In 1997, the board of directors adopted the 1997 Stock Incentive Plan (the "1997 Plan"), which was later amended in December 2018 to be renamed the "Stock Incentive Plan." In May 2012, stockholders approved an amendment allowing for an increase of 250,000 shares and an annual increase through 2016 based on the number of non-employee directors serving as of our Annual Meeting of Stockholders, subject to a maximum of 45,000 shares per year. The plan was further amended in May 2016, May 2018, and April 2020 to increase the number of shares authorized for issuance by 500,000, 250,000, and 300,000 shares, respectively. In May 2003, the stockholders approved a new plan, the 2003 Equity Incentive Plan (the "2003 Plan"), which allows for the granting of stock options/restricted stock for up to 239,050 shares of the Company's common stock. The number of shares reserved for issuance under both plans as of December 31, 2020 was 151,605.
Stock Options
The stock options granted by the Board of Directors may be either incentive stock options ("ISOs") or non-qualified stock options ("NQs") and may include time-based vesting terms and/or be tied to Company and market-related performance metrics. The exercise price for options under all of the plans may be no less than
-94-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

100% of the fair value of the underlying common stock. Options granted will expire no later than the tenth anniversary subsequent to the date of grant or three months following termination of employment, except in cases of death or disability, in which case the options will remain exercisable for up to twelve months. Under the terms of the Stock Incentive Plan, in the event we are sold or merged, outstanding options will either be assumed by the surviving corporation or vest immediately.
We use the Black-Scholes option-pricing model to estimate the fair value of time-vested and performance stock options granted, which includes four key inputs: expected term, expected volatility, risk-free interest rate and expected dividends. Our expected term is estimated based on historical exercise patterns. Our expected volatility input was estimated based on our historical stock price volatility. Our risk-free interest rate input was determined based on the U.S. Treasury yield curve at the time of option issuance. Our expected dividends inputs were zero in all periods as we did not anticipate paying dividends in the foreseeable future. For options tied to market performance, the fair value used in our expense recognition method is measured based on the number of shares granted, and a Monte Carlo simulation model, which incorporates the probability of the achievement of the market-related performance goals as part of the grant date fair value. We recognize forfeitures as they occur.

Time Vesting Stock Options
The fair value of each time vesting option grant was estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions:

 202020192018
Risk-free interest rate3.64%1.62%2.66%
Expected lives5.3 years4.7 years4.9 years
Expected volatility46%40%40%
Expected dividend yield0%0%0%

A summary of our time vesting stock option activity is as follows:

 Year Ended December 31,
 2020
  OptionsWeighted Average Exercise Price
Outstanding at beginning of period536,315 $54.86 
Granted at market83,250 $69.27 
Forfeited(42,307)$76.24 
Expired(28,691)$69.25 
Exercised(84,335)$40.64 
Outstanding at end of period464,232 $57.18 
Exercisable at end of period291,334 $46.53 

The total estimated fair value of time vesting stock options granted was computed to be approximately $2.4 million, $2.6 million and $4.4 million during the years ended December 31, 2020, 2019 and 2018, respectively. The amounts are amortized ratably over the vesting periods of the options. The weighted average estimated fair value of options granted was computed to be approximately $28.66, $29.89 and $28.81 during the years ended December 31, 2020, 2019 and 2018, respectively. The total intrinsic value of options
-95-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

exercised was $5.0 million, $12.8 million and $10.5 million during the years ended December 31, 2020, 2019 and 2018, respectively. The cash proceeds from options exercised were $3.4 million, $1.0 million and $3.2 million during the years ended December 31, 2020, 2019 and 2018, respectively.
The following table summarizes information about time vesting stock options outstanding and exercisable at December 31, 2020.
Options OutstandingOptions Exercisable
Exercise PricesNumber of
Options
Outstanding
at
December 31,
2020
Weighted
Average
Remaining
Contractual
Life in Years
Weighted
Average
Outstanding
Price
Number of
Options
Exercisable
at
December 31,
2020
Weighted
Average
Remaining
Contractual
Life in Years
Weighted
Average
Exercise
Price
$6.23 - $12.7886,166 2.20$7.59 86,166 2.20$7.59 
$12.79 - $39.7663,197 4.57$30.11 63,197 4.57$30.11 
$39.77 - $60.9465,000 9.29$60.94  0$ 
$60.95 - $71.84120,666 7.59$70.21 71,334 7.47$70.03 
$71.85 - $108.25129,203 7.82$89.45 70,637 6.89$84.98 
$6.23 - $108.25464,232 6.48$57.18 291,334 5.14$46.53 
As of December 31, 2020, there was approximately $3.6 million of total unrecognized compensation cost related to outstanding stock options. That cost is expected to be recognized over a weighted-average period of 1.63 years with all cost to be recognized by the end of August 2023, assuming all options vest according to the vesting schedules in place at December 31, 2020. As of December 31, 2020, the aggregate intrinsic value of outstanding options was approximately $41.1 million and the aggregate intrinsic value of exercisable options was approximately $28.9 million.
Performance Stock Options
On April 16, 2020, the Company granted a total of 240,000 performance-based stock options all with an exercise price of $60.94. Of the options granted,10,000 are tied to market-related vesting conditions and 230,000 are tied to Company performance metrics, including future product launches, future sales targets, operating performance, and EBITDA. Performance and market conditions must be achieved by December 31, 2023 otherwise the stock options are forfeited. All vested but unexercised options will expire April 15, 2030.
During the year ended December 31, 2020, 20,000 of the performance-based stock options were forfeited, leaving a total of 220,000 options outstanding as of December 31, 2020. The outstanding options had a weighted-average exercise price of $60.94, a weighted-average remaining contractual term of 9.29 years, and an aggregate intrinsic value of approximately $18.6 million. No options were exercisable as of December 31, 2020. For the year ended December 31, 2020, the weighted-average estimated fair value of the options granted was computed to be approximately $25.04 and the total estimated fair value was approximately $6.0 million. As of December 31, 2020, there was approximately $2.4 million of total unrecognized compensation cost that is expected to be recognized over a weighted average period of 1.80 years.
As of December 31, 2020, we reviewed each of the underlying corporate performance targets and determined that approximately 80,000 shares were related to corporate performance targets in which we did not deem achievement probable. No compensation expense had been recorded at any period prior to December 31, 2020. The unrecognized compensation cost associated with the performance options not deemed probable, based on grant date fair value, is approximately $2.0 million. Any change in the probability determination could accelerate the recognition of this expense.
-96-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

Restricted Stock Awards
We have granted unvested restricted stock awards (“restricted stock”) to management and directors pursuant to the Stock Incentive Plan. The restricted stock awards have varying vesting periods, but generally become fully vested between one and four years after the grant date, depending on the specific award, performance targets met for performance based awards granted to management, and vesting period for time based awards. Management performance based awards are granted at the target amount of shares that may be earned and are tied to future sales targets, operating performance, and/or EBITDA. We valued the restricted stock awards related to service and/or company performance targets based on grant date fair value and expense over the period when achievement of those conditions is deemed probable. For restricted stock awards related to market conditions, we utilize a Monte Carlo simulation model to estimate grant date fair value and expense over the requisite period. We recognize forfeitures as they occur.
The following table summarizes restricted stock transactions for the year ended December 31, 2020:

Restricted StockWeighted-Average Grant Date Fair Value Per Award
Non-vested as of December 31, 2019335,667 $74.29 
Granted69,823 $87.29 
Vested(46,140)$68.80 
Forfeited(67,830)$73.27 
Non-vested as of December 31, 2020291,520 $78.44 
The weighted average grant date fair value of awards granted during the year was $87.29, $74.93, and $71.77 for the years ended December 31, 2020, 2019 and 2018, respectively. Fair value of restricted stock vested was $5.0 million, $0.3 million, and $4.4 million for the years ended December 31, 2020, 2019 and 2018, respectively.
As of December 31, 2020, there was approximately $5.5 million of total unrecognized compensation cost related to restricted stock awards with probable Company performance targets, as well as market and time vesting conditions. The Company expects to recognize this expense over a weighted average period of 1.4 years. As of December 31, 2020, we reviewed each of the underlying corporate performance targets and determined that approximately 129,000 shares of common stock were related to corporate performance targets in which we did not deem achievement probable. No compensation expense had been recorded at any period prior to December 31, 2020. The unrecognized compensation cost associated with the restricted stock awards not deemed probable, based on grant date fair value, is approximately $10.6 million. Any change in the probability determination could accelerate the recognition of this expense.
Employee Stock Purchase Plan
Under the 2020 Employee Stock Purchase Plan (the "ESPP"), we are authorized to issue up to 200,000 shares of common stock to our employees, of which 3,859 had been issued as of December 31, 2020. The ESPP provides for the issuance of shares of our common stock to participating employees. At the end of each designated offering period, which occurs every six months on June 30 and December 31, employees can elect to purchase shares of our common stock with contributions of up to 10% of their base pay, accumulated via payroll deductions, at an amount equal to 85% of the lower of our stock price on (i) the first trading day of the offering period, or (ii) the last trading day of the offering period.

-97-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

We issued 10,069, 10,698 and 10,078 shares under the ESPP for the years ended December 31, 2020, 2019 and 2018, respectively. The weighted-average fair value of the purchase rights granted was $16.19, $18.10 and $18.14 per share for the years ended December 31, 2020, 2019 and 2018, respectively.
Series X Convertible Preferred Stock
On March 30, 2020, the Company completed a private placement offering in which the Company issued and sold an aggregate of 122,000 shares of its Series X Convertible Preferred Stock, par value $0.01 per share (the "Preferred Stock"). The shares of Preferred Stock issued and sold were priced at $1,000 per share (the “Stated Value”), resulting in gross proceeds of $122.0 million, less issuance costs of $0.2 million. The Company used approximately $111.0 million of the proceeds from the offering to fund the April 1, 2020 acquisition of scil and plans to use the remaining proceeds for working capital and general corporate purposes.

The offering was made pursuant to the Securities Purchase Agreement (the “Securities Purchase Agreement”), dated as of January 12, 2020, by and among the Company and certain investors, and subsequent amendment (the “Securities Purchase Agreement Amendment”) to the Securities Purchase Agreement, entered into by the Company and each investor on March 30, 2020 (the Securities Purchase Agreement as amended by the Securities Purchase Agreement Amendment, the “Amended Securities Purchase Agreement”).

The shares of Preferred Stock were convertible into shares of the Company’s Common Stock at an initial ratio of approximately 12.4 shares of Common Stock for each share of Preferred Stock (equivalent to a conversion price of approximately $80.85 per share of common stock), at the option of the holders of the Preferred Stock or the Company, subject to the Company possessing sufficient unissued and otherwise unreserved shares of Common Stock under the Company’s Restated Certificate of Incorporation, as amended (the “Certificate of Incorporation”). On April 14, 2020, the Company gave notice of its exercise of its right to convert the 122,000 shares of Preferred Stock into 1,508,964 shares of Public Common Stock (the "Conversion Shares") and the conversion was effective on April 21, 2020. The conversion resulted in dilution of less than 20% of total shares of the Company’s Public Common Stock currently issued and outstanding. A registration statement on Form S-3 (File No. 333-238005) registering the Conversion Shares for resale was filed by us with the SEC on May 5, 2020.

-98-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

13.    ACCUMULATED OTHER COMPREHENSIVE INCOME
Accumulated other comprehensive income (loss) consisted of the following (in thousands):

Pension Adjustments
Foreign Currency Translation1
Foreign Currency Gain on Intra-Entity Transactions2
Total Accumulated Other Comprehensive Income
Balances at December 31, 2018$(419)$696 $ $277 
Other comprehensive income73 163  236 
Balances at December 31, 2019(346)859  513 
Other comprehensive (loss) income(40)5,013 8,683 13,656 
Balances at December 31, 2020$(386)$5,872 $8,683 $14,169 
1 Foreign currency gains and losses related to translation of foreign subsidiary financial statements.
2 The Company has intercompany loans of a long-term investment nature that are denominated in a foreign currency. These transactions are considered to be of a long-term nature if settlement is not planned or anticipated in the foreseeable future.

14.    COMMITMENTS AND CONTINGENCIES
Warranties
The Company's current terms and conditions of sale include a limited warranty that its products and services will conform to published specifications at the time of shipment and a more extensive warranty related to certain products. The Company also sells a renewal warranty for certain of its products. The typical remedy for breach of warranty is to correct or replace any defective product, and if not possible or practical, the Company will accept the return of the defective product and refund the amount paid. Historically, the Company has incurred minimal warranty costs. The Company's warranty reserve was $0.5 million and $0.3 million as of December 31, 2020 and 2019.

Litigation
From time to time, the Company may be involved in litigation relating to claims arising out of its operations. The Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred, and the amount can be reasonably estimated.
On February 18, 2020, a former managing director of scil filed a claim disputing the effective date of the termination of his management service agreement and the validity of the Company´s waiver of his two-year post-contractual non-compete obligation. The Company intends to defend itself against the claim. Whether or not this will be successful depends on complex facts and circumstances. The Company is, based on the advice of its legal counsel, confident that it will be successful in evidencing the effective date of the termination of the management service agreement and as such, no accrual has been recorded for this ongoing litigation. Additionally, we are indemnified by the scil acquisition agreement for this claim.

On October 10, 2018, we reached an agreement in principle to settle the complaint that was filed against the Company by Shaun Fauley on March 12, 2015 in the U.S. District Court Northern District of Illinois (the "Court") alleging our transmittal of unauthorized faxes in violation of the federal Telephone Consumer Protection Act of 1991, as amended by the Junk Fax Prevention Act of 2005, as a class action (the "Fauley Complaint"). The settlement, which received the Court's approval on February 28, 2019 and was not
-99-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

subsequently appealed by a class member, required us to make available a total of $6.8 million to pay class members, as well as to pay attorneys' fees and expenses to legal counsel to the class. The Company recorded the loss provision in the third quarter of 2018 in connection with the settlement agreement and does not have insurance coverage for the Fauley Complaint. The payment in respect of the settlement was made in full on April 3, 2019, and all activity related to the Fauley Complaint has ceased.
At December 31, 2020, the Company was not a party to any other legal proceedings that were expected, individually or in the aggregate, to have a material adverse effect on our business, financial condition or operating results.
Off-Balance Sheet Commitments
We have no off-balance sheet arrangements or variable interest entities.

Purchase Obligations

The Company has contractual obligations with suppliers for unconditional annual minimum inventory purchases in the amounts of $25.0 million as of December 31, 2020.

15.    INTEREST AND OTHER EXPENSE (INCOME), NET
Interest and other expense (income), net, consisted of the following (in thousands):

 Year Ended December 31,
 202020192018
Interest income$(607)$(661)$(261)
Interest expense1
6,374 3,089 310 
Other (income) expense, net(166)482 (62)
Interest and other expense (income), net$5,601 $2,910 $(13)
1 Refer to Note 1. Summary of Significant Accounting Policies relating to an immaterial out of period error correction of non-cash interest identified and recorded during the fourth fiscal quarter of 2020.
Cash paid for interest was $3.2 million, $0.4 million and $0.2 million for the years ended December 31, 2020, 2019 and 2018, respectively.
16.    CONVERTIBLE NOTES

Convertible Notes

On September 17, 2019, the Company issued $86.25 million aggregate principal amount of 3.750% Convertible Senior Notes due 2026, which included the exercise in full of an $11.25 million purchase option, to certain financial institutions as the initial purchasers of the Notes (the "Initial Purchasers"). The Notes are senior unsecured obligations of the Company. The Notes were issued pursuant to an Indenture, dated September 17, 2019 (the “Indenture”), between the Company and U.S. Bank National Association, as trustee.

The net proceeds from the sale of the Notes were approximately $83.7 million after deducting the initial purchasers’ discounts and the offering expenses payable by the Company. The Company used approximately $12.8 million of the net proceeds from the Notes to repay all outstanding indebtedness on its
-100-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

existing Credit Facility with JPMorgan Chase Bank, N.A., and an additional $2.0 million to fully fund a cash collateralized, letter of credit facility under a new Credit Facility. The Company subsequently terminated the Credit Facility with JPMorgan Chase Bank, N.A. on December 31, 2019. The Company expects to use the remainder of the net proceeds from the sale of the Notes to fund our intended expansion efforts, including through acquisitions of complementary businesses or technologies or other strategic transactions, and for working capital and other general corporate purposes.

The Notes are senior unsecured obligations of the Company and will rank senior in right of payment to any of our indebtedness that is expressly subordinated in right of payment to the Notes; equal in right of payment to any of our unsecured indebtedness that is not so subordinated; effectively junior in right of payment to any of our secured indebtedness to the extent of the value of assets securing such indebtedness; and structurally junior to all indebtedness and other liabilities (including trade payables) of our subsidiaries.

The Company pays interest on the Notes semiannually in arrears at a rate of 3.750% per annum on March 15 and September 15 of each year. The Notes are convertible based upon an initial conversion rate of 11.5434 shares of the Company’s common stock per $1,000 principal amount of Notes (equivalent to a conversion price of approximately $86.63 per share of common stock). The Notes would convert in full into 995,618 shares of common stock based on the initial conversion rate. The conversion rate will be subject to standard anti-dilution adjustments upon the occurrence of certain events but will not be adjusted for accrued and unpaid interest. The interest rate on the Notes may be increased by up to 0.50% upon the occurrence of certain events of default or non-timely filings until such matter has been cured.

The Indenture includes customary covenants, but no financial or operating covenants or restrictions on the payments of dividends, the incurrence of indebtedness or the issuance or repurchase of securities, and sets forth certain events of default and certain types of bankruptcy or insolvency events of default involving the Company after which the Notes become automatically due and payable. The Company can settle any conversions of the Notes in cash, shares of the Company’s common stock or a combination thereof, with the form of consideration determined at the Company’s election. The Company intends to settle the principal value of the Notes in cash and issue shares of the Company’s common stock to settle the intrinsic value of the conversion feature. There can be no guarantee, however, that any settlement will be affected by the Company as currently intended, and the timing and other factors of any settlement, many of which may be outside the Company's control, could impact the actual amounts to be settled in either cash or common stock.

The Notes will mature on September 15, 2026, unless earlier repurchased, redeemed or converted. Prior to March 15, 2026, holders may convert all or a portion of their Notes only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on December 31, 2019 (and only during such calendar quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the 5 business day period after any 5 consecutive trading day period (the "Notes measurement period") in which the trading price per $1,000 principal amount of Notes for each trading day of the Notes measurement period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate on each such trading day; (3) with respect to any Notes called for redemption by the Company, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or (4) upon the occurrence of specified corporate events. On and after March 15, 2026 until the close of business on the scheduled trading day immediately preceding the maturity date, holders may convert their Notes at any time, regardless of the foregoing circumstances. Holders of Notes who convert their Notes in connection with a notice of a redemption or a make-whole fundamental change (each as defined in the Indenture) may be entitled to a premium in the form of an increase in the conversion rate of the Notes.
-101-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)


The Company may not redeem the Notes prior to September 20, 2023. On or after September 20, 2023, the Company may redeem for cash all or part of the Notes if the last reported sale price of the Company’s common stock equals or exceeds 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of the redemption. The redemption price will be 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest, if any. No sinking fund is provided for the Notes.

Upon the occurrence of a fundamental change (as defined in the Indenture), holders may require the Company to repurchase all or a portion of their Notes for cash at a price equal to 100% of the principal amount of the Notes to be repurchased plus any accrued but unpaid interest to, but excluding, the fundamental change repurchase date.

In accounting for the issuance of the Notes, the Company separated the Notes into liability and equity components. The carrying amount of the liability component was calculated by measuring the fair value of a similar liability that does not have an associated convertible feature. The carrying amount of the equity component, representing the conversion option, which does not meet the criteria for separate accounting as a derivative as it is indexed to the Company's own stock, was determined by deducting the fair value of the liability component from the par value of the Notes. The difference between the principal amount of the Notes and the liability component represents the debt discount, which is recorded as a direct deduction from the related debt liability in the Consolidated Balance Sheet and amortized to interest expense using the effective interest method over the term of the Notes. The effective interest rate of the Notes is 15.3% per annum. The equity component of the Notes is approximately $39.5 million, net of allocated issuance costs of $1.5 million. This is included in additional paid-in capital in the Consolidated Balance Sheet, net of deferred tax impacts of $9.7 million, and is not remeasured as long as it continues to meet the conditions for equity classification. The Company allocated transaction costs related to the Notes using the same proportions as the proceeds from the Notes. Transaction costs attributable to the liability component were recorded as a direct deduction from the related debt liability in the Consolidated Balance Sheet and amortized to interest expense over the term of the Notes, and transaction costs attributable to the equity component were netted with the equity component in shareholders’ equity.

In addition, the Company determined that the additional interest that could be due to the holders of the Notes upon an event of default or non-timely filing represented an embedded derivative feature that should be bifurcated from the Notes. The Company concluded that the fair value of this embedded derivative feature was de minimis upon the issuance of the Notes and at December 31, 2020.

During the years ended December 31, 2020 and 2019, no portion of the Notes was converted and the liability component was classified as long-term debt on the Company's Consolidated Balance Sheet as of December 31, 2020.

The following table summarizes the net carrying amount of the Notes as of December 31, 2020 (in thousands):

December 31, 2020December 31, 2019
Principal amount of the Notes$86,250 $86,250 
Unamortized debt discount(37,791)(40,902)
Net carrying amount$48,459 $45,348 

-102-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

Interest expense related to the Notes is comprised of the amortization of debt discount and debt issuance costs and the contractual coupon interest as follows (in thousands):

Twelve Months Ended December 31, 2020Twelve Months Ended December 31, 2019
Interest expense related to contractual coupon interest$3,234 $925 
Interest expense related to amortization of the debt discount1
3,111 1,744 
Total interest expense$6,345 $2,669 
1 Refer to Note 1. Summary of Significant Accounting Policies relating to an immaterial out of period error correction of non-cash interest identified and recorded during the fourth fiscal quarter of 2020.

As of December 31, 2020, the remaining period over which the unamortized discount will be amortized is 68.5 months.

The estimated fair value of the Notes was $156.9 million as of December 31, 2020, determined through consideration of quoted market prices in less active markets. The fair value measurement is classified as Level 2 in the fair value hierarchy, which is defined in ASC 820 as inputs other than quoted prices in active markets that are either directly or indirectly observable. Based on our closing stock price of $145.65 on December 31, 2020, the if-converted value exceeded the aggregate principal amount of the Notes by $58.8 million.

-103-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

17.    CONVERTIBLE NOTE RECEIVABLE
The carrying value of the note receivable, included in Related party convertible note receivable, net on the Consolidated Balance Sheets, is as follows (in thousands):
December 31, 2020
Principal amount$6,650 
Unamortized discount(977)
Net carrying amount$5,673 

On December 9, 2020, our equity method investee (the “Investee”), issued a Convertible Promissory Note to the Company (the “Convertible Promissory Note”) with a principal amount of $6.65 million and a stated interest rate of 3.0% per annum that is payable monthly. The Convertible Promissory Note has a maturity date of December 9, 2023, or otherwise upon qualified redemption event or in the event of a default. Refer to Note 4 for additional information on our equity method investment.

The conversion of the Convertible Promissory Note is contingent upon certain events. Due to the convertible debt features included in the Convertible Promissory Note, it is not an equity security and is therefore not considered an additional investment in our equity method investee. The Company accounted for the transaction as a note receivable, included in Related party convertible note receivable, net on the Consolidated Balance Sheets. The note receivable will be measured at amortized cost, and evaluated for credit losses each reporting period. The Company determined that the redemption features described above met the definition of an embedded derivative that requires bifurcation from the note receivable host. The Company measured the redemption features at fair value, with the residual proceeds paid allocated to the note receivable host, creating a discount to the note receivable. The discount will be amortized over the contractual term of the Promissory Note using the effective interest method. The effective interest rate of the Convertible Promissory Note is 8.69%, and the amortization of the discount will be included as interest income within Interest and other expense (income), net on the Consolidated Statements of Income.

The fair value of the embedded derivative was $1.0 million at issuance and as of December 31, 2020, and is included in Related party convertible note receivable, net on our Consolidated Balance Sheets. The fair value of the derivative will be remeasured each reporting period, with the mark-to-market adjustment to be included in other expense (income) on the Consolidated Statements of Income.
18.    SEGMENT REPORTING
On April 1, 2020, Heska completed the acquisition of scil. Following this acquisition, the Company restructured its operating segments based on how the Chief Operating Decision Maker (“CODM”) manages the business, allocates resources, makes operating decisions and evaluates operating performance. The CODM changed how he assesses performance and allocates resources based on geographic regions in order to better align with the global operations of the Company. Based on this change, the Company determined it has two reportable segments and revised prior comparative periods to conform to the current period segment presentation. The Company’s two segments are North America and International.
The North America segment is comprised of the Company's operations in the United States, Canada and Mexico and the International segment is comprised of geographies outside of North America, which are the Company's operations primarily in Australia, France, Germany, Italy, Malaysia, Spain and Switzerland. Certain expenses incurred at the Company’s headquarters located in the North America segment are allocated to each segment in a manner consistent with where the benefits from the expenses are derived. However, there
-104-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

are certain corporate expenses included in the North America segment that we do not allocate. Such expenses include research and development, certain selling, marketing, general, and administrative costs that support the global organization. Sales and transfers between operating segments are accounted for at market-based transaction prices and are eliminated in consolidation. The Company's sales are determined by the country of origin where the sale occurred. For a description of Heska's previous operating segments, refer to Note 17 to the consolidated financial statements included in Part II. Item 8 of Heska's Annual Report on Form 10-K for the year ended December 31, 2019.

Our CODM continues to evaluate segment performance and allocate resources based on Revenue, Cost of Revenue, Gross Profit, Gross Margin and Operating Income. The CODM does not evaluate operating segments using asset information; however, we have included total asset information by segment below as there was a material change in total assets by segment as of December 31, 2020 due to the acquisition of scil.

Summarized financial information concerning the Company's reportable segments is shown in the following tables (in thousands):
Year Ended December 31, 2020North AmericaInternational
 
 
Total
Total revenue$131,066 $66,257 $197,323 
Cost of revenue70,163 45,870 116,033 
Gross profit60,903 20,387 81,290 
   Gross margin46%31%41%
Operating loss(4,977)(3,215)(8,192)
Income (loss) before income taxes(7,871)(5,922)(13,793)
Investments in unconsolidated affiliates6,704  6,704 
Total Assets238,550 161,289 399,839 
Net Assets156,931 130,122 287,053 
Capital Expenditures443 243 686 
Depreciation and Amortization4,735 6,650 11,385 

Year Ended December 31, 2019North AmericaInternational 
 
Total
Total revenue$115,423 $7,238 $122,661 
Cost of revenue63,089 5,123 68,212 
Gross profit52,334 2,115 54,449 
   Gross margin45%29%44%
Operating income (loss)1,426 (1,099)327 
Income (loss) before income taxes(1,343)(1,240)(2,583)
Investments in unconsolidated affiliates7,424  7,424 
Total Assets219,402 25,022 244,424 
Net Assets133,835 20,699 154,534 
Capital Expenditures1,005 39 1,044 
Depreciation and Amortization4,788 128 4,916 

-105-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

Year Ended December 31, 2018North AmericaInternational 
 
Total
Total revenue$124,391 $3,055 $127,446 
Cost of revenue68,555 2,253 70,808 
Gross profit55,836 802 56,638 
   Gross margin45%26%44%
Operating income3,622 172 3,794 
Income before income taxes3,717 90 3,807 
Investments in unconsolidated affiliates8,018  8,018 
Total Assets152,663 3,789 156,452 
Net Assets118,770 3,639 122,409 
Capital Expenditures1,329 29 1,358 
Depreciation and Amortization4,586 9 4,595 

The Company measures its geographic revenue information based on the country of origin where the sale occurred. The geographic classification is independent of where the customer resides or where the customer is physically located while using the Company's product. Total revenue by principal geographic area was as follows (in thousands):
 For the Year Ended December 31,
 202020192018
United States$120,244 $113,485 $123,965 
Canada10,822 1,938 425 
Germany29,543   
France12,615 3,473  
Spain12,995 759  
Italy5,850   
Switzerland3,343 2,820 3,056 
Other International1,911 186  
Total$197,323 $122,661 $127,446 
Total long-lived assets by principal geographic areas were as follows (in thousands):
 As of December 31,
 202020192018
United States$11,805 $14,712 $15,933 
Canada643  11 
Germany14,630   
France4,205 152  
Spain1,209 391  
Italy1,944   
Switzerland46 33 37 
Other International1,060 181  
Total$35,542 $15,469 $15,981 

-106-


HESKA CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

Revenue from Covetrus represented approximately 6%, 14% and 15% of our consolidated revenue for the years ended December 31, 2020, 2019 and 2018, respectively. Consolidated revenue from Covetrus attributable to our North America segment represented approximately 5%, 14% and 15%, respectively, whereas revenue from Covetrus attributable to our International segment represented 1% for 2020. Revenue from Merck entities, including Merck Animal Health, represented approximately 5%, 1% and 12% for the years ended December 31, 2020, 2019 and 2018, respectively, all included in our North America Segment. No other customer accounted for more than 10% of our consolidated revenue for the years ended December 31, 2020, 2019 or 2018.
19.    SUBSEQUENT EVENTS
Lacuna Diagnostics, Inc.
On February 1, 2021 the Company completed the acquisition of Lacuna Diagnostics, Inc. ("Lacuna"), a veterinary digital cytology company, to broaden the Company's point of care diagnostic offering. In exchange for all the outstanding shares of Lacuna, the Company paid total consideration of $4.3 million upon closing. The Company expects to account for this transaction as a business combination however, does not have that accounting complete as of the date of this filing due to the limited time that has passed since the date of transaction.
As additional consideration for the shares, the Company agreed to a contingent earn-out of an additional $2 million based on the achievement of certain performance metrics within a twelve month period ("Initial Earn Out Period"), reducing to $1 million if such metrics were met in a twelve month period subsequent to the Initial Earn Out Period.
Note Receivable
On February 1, 2021, one of our equity investees ("Investee"), for which we account for as a nonmarketable equity security, issued a Promissory Note to the Company (the “Promissory Note”) with a principal amount of $9.0 million and a stated interest rate of 10.0% per annum that is payable monthly. The Promissory Note has a maturity date of December 1, 2024. The Promissory Note provides for interest only payments through December 1, 2023. Beginning on January 1, 2024, the Promissory Note requires repayment of the principal and interest over twelve consecutive monthly payments. Additionally, the Investee issued a warrant to the Company to acquire securities. The warrant expires December 31, 2034. Refer to Note 4 for additional information on our equity investments.

Item 9.Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
None.
Item 9A. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our principal executive officer and our principal financial officer, evaluated the effectiveness of our disclosure controls and procedures, as defined by Rule 13a-15 of the Exchange Act, as of December 31, 2020. Based on this evaluation, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures were effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time period specified in the SEC's rules and forms and that such information is accumulated and communicated to our management,
-107-



including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding disclosure.
Management's Report on Internal Control over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, the Company conducted an evaluation of the effectiveness of its internal control over financial reporting based on criteria set forth in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on this evaluation, the Company's management has concluded that the Company's internal control over financial reporting was effective as of December 31, 2020.
We acquired scil animal care company GmbH on April 1, 2020 as discussed in Note 3. Acquisition and Related Party Items in Item 8 "Financial Statements and Supplementary Data". The objectives of scil's established internal controls over financial reporting are consistent, in all material respects, with Heska's objectives. Given the significance of the scil acquisition and the complexity of systems and business processes, we have excluded certain acquired scil processes and internal controls from our evaluation of internal control over financial reporting, in accordance with guidance issued by the staff of the US Securities and Exchange Commission. scil accounted for approximately 45% of Heska's total assets at December 31, 2020 and approximately 30% of total net revenue for the fiscal year ended December 31, 2020.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risks that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. Accordingly, even an effective system of internal control will provide only reasonable assurance that the objectives of the internal control system are met.
Grant Thornton, an independent registered public accounting firm, has audited our Consolidated Financial Statements included in this Form 10-K, and as part of the audit, has issued a report, included herein, on the effectiveness of our internal control over financial reporting as of December 31, 2020.
Changes in Internal Control over Financial Reporting
We evaluated our internal controls over financial reporting in relation to recurring performance, realigned business segments, and changes to the control environment due to COVID-19. Based on the assessment, we determined there was no change in our internal control over financial reporting that occurred during the fourth quarter of 2020 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Item 9B.Other Information
None.




PART III
Certain information required by Part III is incorporated by reference to our definitive Proxy Statement to be filed with the SEC in connection with the solicitation of proxies for our 2021 Annual Meeting of Stockholders.
Item 10.Directors, Executive Officers and Corporate Governance
Executive Officers
The information required by this item with respect to executive officers is incorporated by reference to Item 1 of this report and can be found under the caption "Information About Our Executive Officers."
Directors
The information required by this section with respect to our directors will be incorporated by reference to the information in the sections entitled Proposal No. 1 "Election of Directors" in the Proxy Statement.
Code of Ethics
Our Board of Directors has adopted a code of conduct and ethics for our senior executive and financial officers (including our principal executive officer, principal financial officer and principal accounting officer). The code of conduct and ethics is available on our website at www.heska.com under the Corporate Governance section under the Company Information section under the "Investors" tab. We intend to disclose any amendments to or waivers from the code of conduct and ethics at that location.
Audit Committee
The information required by this section with respect to our Audit Committee will be incorporated by reference to the information in the section entitled "Board Structure and Committees" in the Proxy Statement.
Item 11.Executive Compensation
The information required by this section will be incorporated by reference to the information in the sections entitled "Director Compensation," "Executive Compensation," "Compensation Committee Report" in the Proxy Statement.
Item 12.Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
The other information required by this section will be incorporated by reference to the information in the section entitled "Ownership of Securities - Common Stock Ownership of Certain Beneficial Owners and Management" in the Proxy Statement.
-109-



Equity Compensation Plan Information
The following table sets forth information about our common stock that may be issued upon exercise of options and rights under all of our equity compensation plans as of December 31, 2020, including the Stock Incentive Plan, as amended and restated, the 2003 Stock Incentive Plan, as amended and the 2020 Employee Stock Purchase Plan. Our stockholders have approved all of these plans.
Plan Category(a) Number of Securities to be Issued Upon Exercise of Outstanding Options and Rights(b) Weighted-Average Exercise Price of Outstanding Options and Rights(c) Number of Securities
Remaining Available for Future
Issuance Under Equity
Compensation Plans (excluding securities reflected in column (a))
Equity Compensation Plans Approved by Stockholders
684,232$58.39347,746
Equity Compensation Plans Not Approved
by Stockholders
NoneNoneNone
Total684,232$58.39347,746

Item 13. Certain Relationships and Related Transactions and Director Independence
The information required by this section will be incorporated by reference to the information in the sections entitled "Board Structure and Committees" and "Significant Relationships and Transactions with Directors, Officers or Principal Stockholders" in the Proxy Statement.
Item 14.Principal Accountant Fees and Services
The information required by this section will be incorporated by reference to the information in the section entitled "Auditor Fees and Services" in the Proxy Statement.
The information required by Part III to the extent not set forth herein, will be incorporated herein by reference to our definitive Proxy Statement for the 2021 Annual Meeting of Stockholders.
-110-




PART IV
Item 15.Exhibits and Financial Statement Schedules
(a)    The following documents are filed as a part of this Form 10-K.
    (1) Financial Statements:
Reference is made to the Index to Consolidated Financial Statements under Item 8 in Part II of this Form 10-K.
    (2) Financial Statement Schedules:
NOTE: All schedules have been omitted because they are either not required or the information is included in the financial statements and notes thereto.
(3)    Exhibits:
The exhibits listed below are required by Item 601 of Regulation S-K. Each management contract or compensatory plan or arrangement required to be filed as an exhibit to this Form 10-K has been identified.
Exhibit Number 
Notes
 
Description of Document
2.1#++(20)
2.2#(23)
3(i)(4)
3(ii)(4)
3(iii)(4)
3(iv)(9)
3(v)(10)
3(vi)(13)
3(vii)(16)
3(viii)(21)
3(ix)#(23)
3(x)(16)
4.1(19)
4.2
-111-



10.1*(21)
10.2*(18)
10.3*(18)
10.4*(18)
10.5*(18)
10.6*(18)
10.7*(18)
10.8*(3)
10.09*(9)
10.10*(9)
10.11*(9)
10.12*(9)
10.13*(9)
10.14*(21)
10.15*
10.16*(20)
10.17*(2)
10.18*(12)
10.19*(5)
10.20*(7)
10.21*(11)
10.22*(12)
10.23*(14)
10.24*(17)
10.25*(1)
10.26*(2)
10.27*(22)
10.28*(14)
10.29*(15)
-112-




10.30
10.31*
10.32*
10.33*(12)
10.34*(12)
10.35+(6)
10.36(8)
10.37++(20)
10.38+(11)
10.39++(22)
10.40+(22)
10.41+(11)
10.42#(23)
21.1
23.1
23.2 
24.1
31.1 
31.2
32.1**
101.INS XBRL Instance Document.
101.SCH XBRL Taxonomy Extension Schema Document.
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF XBRL Taxonomy Extension Definition Linkbase Document.
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document.
-113-




101.LAB XBRL Taxonomy Extension Label Linkbase Document.
104.0Cover Page Interactive Data File (embedded within the Inline XBRL document contained in Exhibit 101)

Notes 
*
Indicates management contract or compensatory plan or arrangement.
+Portions of the exhibit have been omitted pursuant to a request for confidential treatment.
++Certain confidential information contained in this exhibit has been omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.
#Certain personally identifiable information has been omitted from this exhibit pursuant to Item 601(a)(6) under Regulation S-K.
**Furnished herewith but not filed.
(1)Filed with the Registrant's Form 10-K for the year ended December 31, 2006.
(2)Filed with the Registrant's Form 10-K for the year ended December 31, 2007.
(3)Filed with the Registrant's Form 10-K for the year ended December 31, 2008.
(4)Filed with the Registrant's Form 10-K for the year ended December 31, 2012.
(5)Filed with the Registrant's Form 10-K for the year ended December 31, 2013.
(6)Filed with the Registrant's Form 10-Q for the quarter ended June 30, 2014.
(7)Filed with the Registrant's Form 10-K for the year ended December 31, 2014.
(8)Filed with the Registrant's Form 10-Q for the quarter ended March 31, 2015.
(9)Filed with the Registrant's Form 10-K for the year ended December 31, 2016.
(10)Filed with the Registrant's Form 10-Q for the quarter ended March 31, 2017.
(11)Filed with the Registrant's Form 10-K for the year ended December 31, 2017.
(12)Filed with the Registrant's Form 10-Q for the quarter ended March 31, 2018.
(13)Filed with the Registrant's Form 8-K on May 9, 2018.
(14)Filed with the Registrant's Form 10-Q for the quarter ended June 30, 2018.
(15)Filed with the Registrant's Form 10-Q for the quarter ended September 30, 2018.
(16)Filed with the Registrant's Form 10-Q for the quarter ended June 30, 2019.
(17)Filed with the Registrant's Form 8-K on June 1, 2019.
(18)Filed with the Registrant's Form 10-K for the year ended December 31, 2018.
(19)Filed with the Registrant's Form 8-K on September 17, 2019.
(20)Filed with the Registrant's Form 10-K for the year ended December 31, 2019.
(21)Filed with the Registrant’s Form 10-Q for the quarter ended March 31, 2020.
(22)Filed with the Registrant’s Form 10-Q for the quarter ended June 30, 2020.
(23)
Filed with the Registrant’s Form 8-K on April 1, 2020.

-114-




Item 16.    Form 10-K Summary
Registrants may voluntarily include a summary of information required by Form 10-K under this Item 16. The Registrant has elected not to include such summary information.

-115-




SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on February 26, 2021.
 
 HESKA CORPORATION
 
By: /s/ KEVIN S. WILSON   
Kevin S. Wilson
Chief Executive Officer and President
 
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Catherine Grassman his or her true and lawful attorneys-in-fact, with full power of substitution, for him or her in any and all capacities, to sign any amendments to this report on Form 10-K and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all of said attorney-in-fact or their substitute may do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated:
 
SignatureTitleDate
/s/ KEVIN S. WILSON
Kevin S. Wilson
Chief Executive Officer, President and Director (Principal Executive Officer)February 26, 2021
/s/ CATHERINE GRASSMAN
Catherine Grassman
Executive Vice President, Chief Financial Officer (Principal Financial and Accounting Officer)February 26, 2021
/s/ SCOTT HUMPHREY
Scott Humphrey
ChairFebruary 26, 2021
/s/ ROBERT L. ANTIN
Robert L. Antin
DirectorFebruary 26, 2021
/s/ STEPHEN L. DAVIS
Stephen L. Davis
DirectorFebruary 26, 2021
/s/ MARK F. FURLONG
Mark F. Furlong
DirectorFebruary 26, 2021
/s/ JOACHIM HASENMAIER
Joachim Hasenmaier
DirectorFebruary 26, 2021
/s/ SHARON J. LARSON
Sharon J. Larson
DirectorFebruary 26, 2021
/s/ DAVID E. SVEEN
David E. Sveen, Ph.D.
DirectorFebruary 26, 2021
/s/ BONNIE J. TROWBRIDGE
Bonnie J. Trowbridge
DirectorFebruary 26, 2021

-116-

EX-4.2 2 heska-12312020xex42.htm EX-4.2 Document

Exhibit 4.2
HESKA CORPORATION
DESCRIPTION OF SECURITIES

DESCRIPTION OF COMMON STOCK
General
The following description summarizes important terms of our common stock. Because it is only a summary, it does not contain all the information that may be important to you. For a complete description of the matters set forth herein, you should refer to our Certificate of Incorporation and our bylaws, both of which are filed as exhibits to our Annual Report on Form 10-K, and to the applicable provisions of Delaware law.
On May 4, 2010, our stockholders approved an amendment to our Certificate of Incorporation (the “NOL Protective Amendment”). The NOL Protective Amendment places restrictions on the transfer of our common stock that could adversely affect our ability to use our domestic Federal Net Operating Loss carryforward (“NOL”). The NOL Protective Amendment reclassified our capital stock into shares of Traditional common stock and common stock, which together we refer to as our “common stock.” These restrictions on transfer prohibit certain future transfers our capital stock that could adversely affect our ability to utilize our NOL and certain income tax credits to reduce our federal income taxes, which we refer to as the “Tax Benefits.” Pursuant to the NOL Protective Amendment, each share of Traditional common stock was automatically reclassified into one share of common stock.
After giving effect to the amendments to our Certificate of Incorporation adopted subsequent to the NOL Protective Amendment, our authorized capital stock consists of 29,000,000 shares of capital stock, par value $0.01 per share, of which:
13,250,000 shares of original common stock are designated as Traditional common stock;
13,250,000 shares of NOL restricted common stock are designated as Public common stock; and
2,500,000 shares are designated as preferred stock.
All outstanding shares of common stock are validly issued, fully paid, and nonassessable.
Voting rights
Each holder of common stock is entitled to one vote for each share of common stock held of record on the applicable record date on all matters submitted to a vote of stockholders. There are no cumulative voting rights for the election of directors in our Certificate of Incorporation. The directors elected at each annual meeting of stockholders shall be elected for a term of office expiring at the next annual meeting of stockholders.



Dividend rights; rights upon liquidation
The holders of common stock are entitled to receive dividends out of assets legally available for dividends at times and in amounts as our board of directors may determine. These dividend rights are subject to any preferential dividend rights that may be granted to holders of outstanding preferred stock.
In the event of our liquidation, dissolution or winding up, each share of common stock is entitled to share pro rata in any distribution of our assets after payment or providing for the payment of liabilities and the liquidation preference of any then outstanding preferred stock.
Preemptive and other rights
Other than as set forth under the caption “Conversion” below, holders of common stock have no preemptive or other rights to purchase, subscribe for or otherwise acquire any unissued or treasury shares or other of our securities. There are no redemption or sinking fund provisions applicable to the common stock securities.
Conversion
Each share of Public common stock will automatically be converted into the equivalent number of shares of Traditional common stock on the earliest of January 1, 2026, the date our board of directors determines that the transfer restrictions described below are no longer necessary or advisable to preserve the Tax Benefits due to changes in tax laws, or the date our board of directors determines in good faith that it is in the best interests of the Company and our stockholders to terminate the transfer restrictions.
NOL transfer restrictions
As a result of the NOL Protective Amendment, the shares of common stock are subject to transfer restrictions such that holders of common stock are restricted from attempting to transfer (which includes any direct or indirect acquisition, sale, transfer, assignment, conveyance, pledge or other disposition) any of the shares of common stock (or options, warrants or other rights to acquire common stock, or securities convertible or exchangeable into common stock), to the extent that such transfer would (i) create or result in an individual or entity becoming a five-percent stockholder of the common stock for purposes of Section 382 of the Internal Revenue Code of 1986, as amended, and the related Treasury Regulations, which individual or entity is referred to as a “five-percent stockholder,” or (ii) increase the stock ownership percentage of any existing five-percent stockholder.
Transfers that violate the provisions of the NOL Protective Amendment shall be null and void ab initio and shall not be effective to transfer any record, legal, beneficial or any other ownership of the number of shares which result in the violation of the NOL Protective Amendment, which shares are referred to as “Excess Securities.” The purported transferee shall not be entitled to any rights as a Company stockholder with respect to the Excess Securities. Instead, the purported transferee would be required, upon demand by us, to transfer the Excess
2


Securities to an agent designated by us for the limited purpose of consummating an orderly arm’s-length sale of such Excess Securities. The net proceeds of the sale will be distributed first to reimburse the agent for any costs associated with the sale, second to the purported transferee to the extent of the price it paid, and finally to the purported transferor to the extent there is any additional amount, or, if the purported transferor cannot readily be identified to us, to cover the costs incurred by us as a result of such prohibited transfer, with the remainder, if any, to be donated to a charity designated by our board of directors.
With respect to any transfer that does not involve a transfer of our “securities” within the meaning of Delaware law but which would cause any five-percent stockholder to violate the transfer restrictions, the following procedure would apply in lieu of those described above. In such case, no such five-percent stockholder would be required to dispose of any interest that is not a security of the Company, but such five-percent stockholder and/or any person whose ownership of our securities is attributed to such five-percent stockholder, would be deemed to have disposed of (and would be required to dispose of) sufficient securities (which securities shall be disposed of in the inverse order in which they were acquired), simultaneously with the transfer, to cause such five-percent stockholder not to be in violation of the transfer restrictions, and such securities would be treated as Excess Securities to be disposed of through the agent under the provisions summarized above, with the maximum amount payable to such five-percent stockholder or such other person that was the direct holder of such Excess Securities from the proceeds of sale by the agent being the fair market value of such Excess Securities at the time of the prohibited transfer.
The NOL Protective Amendment also provides us with various remedies to prevent or respond to a purported transfer that violates its provisions, including that any person who knowingly violates it, together with any persons in the same control group with such person, are jointly and severally liable to us for such amounts as will put us in the same financial position as it would have been in had such violation not occurred.
The foregoing transfer restriction provisions may only be amended or repealed by the affirmative vote of the holders of at least two-thirds of the shares entitled to vote thereon. This summary description of the NOL Protective Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the NOL Protective Amendment.
Anti-takeover provisions in Delaware law and our certificate of incorporation
The NOL Protective Amendment may have an “anti-takeover” effect because, among other things, the common stock restricts the ability of a person, entity or group to accumulate more than five percent of the common stock and the ability of persons, entities or groups now owning more than five percent of the outstanding shares of common stock from acquiring additional shares of common stock without the approval of our board of directors.
We are subject to Section 203 of the Delaware General Corporation Law, an anti-takeover law. In general, the statute prohibits a publicly held Delaware corporation from engaging in a business combination with an “interested stockholder” for a period of three years after the date of the transaction in which the person became an interested stockholder, unless the
3


business combination is approved in a prescribed manner. A “business combination” includes a merger, asset sale or other transaction resulting in financial benefit to the stockholder. An “interested stockholder” is a person who, together with affiliates and associates, owns (or within three years prior, did own) 15% or more of the corporation’s voting stock.
The Certificate of Incorporation provides that special meetings of stockholders may be called only at the request of our chairman of the board of directors, our chief executive officer or president, or by a resolution adopted by a majority of our board of directors.
The provisions described above, together with the ability of our board of directors to issue preferred stock without stockholder approval, could have the effect of delaying, deferring or preventing a change in control, delaying, deferring or preventing the removal of existing management, deterring potential acquirers from making an offer to our stockholders, and limiting any opportunity of our stockholders to realize premiums over prevailing market prices of our common stock in connection with offers by potential acquirers.
The above-described effects could occur even if a majority of our stockholders might benefit from such a change in control or offer.
Listing
Our common stock is listed on The Nasdaq Capital Market under the symbol “HSKA”.

4
EX-10.15 3 heska-12312020xex1015.htm EX-10.15 Document

Exhibit 10.15
Heska Corporation
 Management Incentive Plan Master Document
 Amended and Restated as of February 17, 2021
This Management Incentive Plan Master Document (“MIP”) is intended to provide incentives to the senior management of Heska Corporation (“Heska” or the “Company”) for the achievement of goals and objectives that are essential to the growth and continued success of the Company. This MIP is to act as a master document for future plans and replaces in its entirety any and all previous management incentive plans of the Company. All employees of the Company and its affiliates are eligible for participation in the MIP.
Article I.
DEFINITIONS
Section i.CEO” means the Chief Executive Officer of the Company.
Section ii.Committee” means the Compensation Committee of the Board of Directors of the Company or such other committee designated by the Board of Directors of the Company to administer the MIP. Any actions permitted under the MIP by the CEO may at any time in the Committee’s discretion instead be taken by the Committee.
Section iii.Incentive Target” means the designated percentage of the Participant’s base salary or base wages (but excluding commissions, bonuses, relocation payments or other forms of compensation not considered part of the Participants’ base pay) earned during the Plan Year, as determined by the Committee or, for non-executive officer employees, the CEO. For individuals becoming Participants after the beginning of the applicable Plan Year, the Incentive Target shall be based on the amount of base salary or base wages earned while a Participant and excludes any earnings prior to becoming a Participant.
Section iv.MIP Payout” means all payments made under the MIP.
Section v.Participant” means any employee of the Company or its affiliates that is designated by the Committee or the CEO as eligible to receive a MIP Payout.
Section vi.Performance Measures” means the corporate, business unit, individual, or other designated performance measures, as determined by the Committee.
Section vii.Plan Year” means the applicable period of time during which a MIP Payout may be earned, as determined by the Committee.
Article II.
MIP AWARD OPPORTUNITIES
104385268.3


Section i.Establishment of MIP Award Opportunities. The Committee or, for non-executive officer employees, the CEO shall designate the Participants, each Participant’s Incentive Target, if applicable, and the applicable Performance Measures for each Plan Year under the MIP. The Committee or the CEO, as applicable, may establish any threshold or maximum opportunities for MIP Payouts with respect to each Plan Year.
Section ii.Award Determination. The Committee has the sole discretion in determining whether and to the extent to which the Performance Measures established for the Plan Year have been achieved.
Article III.
PAYMENTS
Section i.Payment to Individual Participants. The Committee will determine any MIP Payout to the CEO. Any individual MIP Payouts to other executive officers will generally be recommended to the Committee by the CEO, although the Committee will make the final determination of any individual MIP Payouts to executive officers of the Company other than the CEO. Any individual MIP Payouts to other non-executive officer Participants will be determined by the CEO.
Section ii.Medium of Payment. In the sole and absolute discretion of the Committee, the MIP Payout may be made in cash, in stock of the Company, in unsecured notes, or in any other alternative forms of compensation.
Section iii.Time of Payment. Unless otherwise determined by the Committee, all MIP Payouts earned shall be paid only after the Committee has reviewed management’s calculations of the achievement of the Performance Measures for the Plan Year and the resulting MIP Payouts. MIP Payouts shall be made by no later than March 15th of the year following the end of any Plan Year.
Section iv.Employment Required. Except in the case of the Participant’s death or as otherwise determined by the Committee or the CEO, as applicable, Participants must remain active employees of Heska or one of its affiliates in a position which qualifies for MIP participation through the end of a given Plan Year in order to be eligible to earn any MIP Payouts.
Section v.Change in Control. If the Company experiences a Change in Control (as defined in the Heska Corporation Stock Incentive Plan or such successor plan as in effect from time to time) during any Plan Year, unless otherwise determined by the Committee, each Participant will receive a MIP Payout equal to such Participant’s Incentive Target, prorated from the beginning of the Plan Year until the date of such Change in Control. Unless otherwise determined by the Committee, MIP Payouts will occur at a time as close as commercially reasonably practicable to the date of the closing of such Change in Control and in all events within 60 days thereafter.
Section vi.Disability. Employees who are on short-term disability will continue to be treated as active employees for purposes of MIP participation. Employees who are on long-term disability will not be treated as active employees for purposes of MIP participation and will not be eligible
2


for a MIP Payout unless otherwise determined by the Committee. The participation of employees on other personal leave will be considered by the Committee or its designee on a case by case basis.
Section vii.Death. Upon the death of a Participant, a prorated portion of any earned MIP Payout will be made to the Participant’s designated beneficiary (or estate, in the absence of a proper designated beneficiary) at the normal payment time of the MIP Payouts for such Plan Year.
Section viii.Partial Payments or Exceptions. The Committee must approve partial payments or exceptions to any major provision of this MIP.
Article IV.
MISCELLANEOUS
Section i.Parachute Payments. To the extent that any of the payments and benefits provided for under the MIP or any other agreement or arrangement between the Company and a Participant (collectively, the “Payments”) (i) constitute a “parachute payment” within the meaning of Section 280G of the Internal Revenue Code of 1986, as amended (the “Code”) and (ii) but for this paragraph would be subject to the excise tax imposed by Section 4999 of the Code, then the Payments shall be payable either (i) in full or (ii) as to such lesser amount which would result in no portion of such Payments being subject to excise tax under Section 4999 of the Code (determined in accordance with the reduction of payments and benefits in the paragraph set forth below); whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the excise tax imposed by Section 4999, results in the Participant’s receipt on an after-tax basis of the greatest amount of the Payments, notwithstanding that all or some portion of such Payments may be taxable under Section 4999 of the Code. Except to the extent, if any, otherwise agreed in writing between a Participant and the Company, any determination required under this provision will be made by accountants selected by the Company, whose determination shall be conclusive and binding upon the Participant and the Company for all purposes.
Section ii.No Right to Employment. Nothing in this document is to be construed as a contract of employment of a defined period of time or otherwise altering the status of employee as an at-will employee of the Company. Either party may elect to terminate the employment relationship at any time, without cause or advance notice.
a.Amendment; Termination. The Committee reserves the right to interpret, modify, suspend or terminate this MIP at any time as determined in its sole discretion.
b.Unfunded Plan. No amounts awarded or accrued under this MIP will be funded, set aside or otherwise segregated prior to payment. The obligation to pay the bonuses awarded hereunder will at all times be an unfunded and unsecured obligation of Heska. Participants shall have the status of general creditors and shall look solely to the general assets of Heska for the payment of their bonus awards.
3


c.No Assignment. No Participant will have the right to alienate, assign, encumber, hypothecate or pledge his or her interest in any award under the MIP, voluntarily or involuntarily, and any attempt to so dispose of any such interest will be void. During the lifetime of any Participant, payment of a bonus award under the MIP will only be made to such Participant.
d.Governing Law. This MIP shall be construed in accordance with and governed by the laws of the State of Delaware, excluding any conflicts or choice of law rule or principle that might otherwise refer construction or interpretation of this MIP to the substantive law of another jurisdiction.




4
EX-10.30 4 heska-12312020xexx1030.htm EX-10.30 Document

Exhibit 10.30
SEPARATION AND RELEASE AGREEMENT

This Separation and Release Agreement (the "Agreement") is made between (i) Jason Aroesty ("Employee") and (ii) Heska Corporation (the "Company"). Employee and the Company are referred to collectively as the "Parties" and individually as a "Party."

RECITALS

WHEREAS, Employee was employed at the Company's Loveland facility;

,
WHEREAS, Employee's employment with the Company terminated effective December 4th
2020 (the "Termination Date");

WHEREAS, Employee's termination is without "Cause" under Section 6(a), entitling Employee to certain payments and benefits under Section 6(a)(i) of the Employment Agreement;

WHEREAS, Employee resigns all board seats, observation rights and actual, titles and appointments that are conditioned upon continued employment with the Company;

WHEREAS, the Parties wish to resolve fully and finally any potential disputes regarding Employee's employment with the Company and any other potential disputes between the Parties, and

WHEREAS, in order to accomplish this end, the Parties are willing to enter into this Agreement.

NOW THEREFORE, in consideration of the mutual promises and undertakings contained herein, the sufficiency of which is acknowledged by the Parties, the Parties to this Agreement agree as follows:

TERMS

1.Effective Date. This Agreement shall become effective on the eighth day after Employee signs this Agreement (the "Effective Date"), so long as Employee does not revoke this Agreement pursuant to Paragraph 10 below. Employee's Termination Date will not change regardless of whether this Agreement becomes effective on the "Effective Date."

2.Consideration for Release and Payment Terms.

a.Pursuant to this Agreement, the Company shall, as consideration for Employee's release and promises set forth in this Agreement, pay Employee additional compensation that Employee would not be entitled to otherwise.

b.After the Effective Date and on the express condition that Employee has not revoked this Agreement, the Company will pay Employee a severance payment in the total sum of three hundred thousand dollars ($300,000.00), less applicable deductions and withholdings , to be paid within three business days of the Effective Date, so long as Employee does not revoke this



Agreement pursuant to Paragraph 10 below. This payment is inclusive of the severance pay described under Section 6(a)(i) of the Employment Agreement and this Agreement supersedes the Company's obligations under the Employment Agreement. Notwithstanding the Employment Agreement, under this Agreement, Employee agrees to receive the entire twelve months' payment in one lump sum, to be paid in accordance with the terms herein. Payment will be mailed to Employee's residence address payable to "Jason Aroesty" or directly deposited to the Employee's financial institution as soon as is administratively feasible.

c.Medical and Dental Benefits. From the Termination Date through the earlier of (i) the twelve month anniversary of the Termination Date or (ii) the date on which Employee is provided or obtains medical or dental insurance coverage from another employer or entity, the Company shall reimburse Employee for the difference between the cost of any COBRA premiums paid by Employee for continued medical and dental coverage under the Company's group health plans for himself and his dependents and the active employee rates for coverage under such plans. The foregoing is subject to Employee's timely enrollment in COBRA and payment of applicable premiums.

d.Reporting and Withholding. Reporting of and withholding on any payment under this Agreement for tax purposes shall be at the discretion of the Company in conformance with applicable tax laws. If a claim is made against the Company for any additional tax or withholding in connection with or arising out of any payment pursuant to this Agreement, Employee shall pay any such claim within thirty (30) days of being notified by the Company and agrees to indemnify the Company and hold it harmless against such claims, including, but not limited to, any taxes, attorneys' fees, penalties, and/or interest, which are or become due from the Company.

3.General Release.

a.    Employee, for Employee, and for Employee's affiliates, successors, heirs, subrogees, assigns, principals, agents, partners, employees, associates, attorneys, and representatives, voluntarily, knowingly, unequivocally, unconditionally and intentionally releases and discharges (i) the Company and its predecessors, successors, parents, subsidiaries, affiliates, and assigns, and (ii) each of their respective officers, directors, principals, shareholders, agents, attorneys, board members, and employees (the "Released Parties") from any and all claims, actions, liabilities, demands, rights, damages, costs, expenses, and attorneys' fees (including, but not limited to, any claim of entitlement for attorneys' fees under any contract, statute, or rule of law allowing a prevailing party or plaintiff to recover attorneys' fees), of every kind and description from the beginning of time through the Effective Date (the "Released Claims").

b.The Released Claims include, but are not limited to, those which arise out of, relate to, or are based upon: (i) Employee's employment with the Company or the termination thereof; (ii) statements, acts, or omissions by the Released Parties whether in their individual or representative capacities; (iii) express or implied agreements between the Parties and claims under any severance plan (except as provided herein); (iv) any stock or


- 2 -




stock option grant, agreement, or plan, except as set forth below; (v) all federal, state, and municipal statutes, ordinances, and regulations, including, but not limited to, claims of discrimination based on race, color, national origin, age, sex, sexual orientation, religion, disability, veteran status, whistleblower status, public policy, or any other characteristic of Employee under the Age Discrimination in Employment Act, the Older Workers Benefit Protection Act, the Americans with Disabilities Act, the Equal Pay Act, Title VII of the Civil Rights Act of 1964 (as amended), the Employee Retirement Income Security Act of 1974, the Rehabilitation Act of 1973, the Family and Medical Leave Act, the Worker Adjustment and Retraining Notification Act, the Colorado Anti-Discrimination in Employment Act, or any other federal, state, or municipal law prohibiting discrimination or termination for any reason; (vi) state and federal common law; (vii) the failure of this Agreement, or of any other employment, severance, profit sharing, bonus, equity incentive or other compensatory plan to which Employee and the Company are or were parties, to comply with, or to be operated in compliance with, Section 409A of the Internal Revenue Code of 1986, as amended ("Section 409A"), or any similar provision of state or local income tax law; and (viii) any claim which was or could have been raised by Employee. Released Claims do not include claims with respect to any vested equity awards, which shall continue to be governed by the terms of the applicable
Company stock plan and award agreements.
a.Employee understands that nothing contained in this Agreement limits Employee's ability to file a charge or complaint with any federal, state or local governmental agency or commission (each a "Government Agency"). Employee further understands that this Release does not limit Employee's ability to communicate with any Government Agency or otherwise participate in any investigation or proceeding that may be conducted by any Government Agency, including providing documents or other information, without notice to the Company. However, to the maximum extent permitted by law, Employee agrees that if such a charge or complaint is made, Employee shall not be entitled to recover any individual monetary relief or other individual remedies. This Release does not limit or prohibit Employee's right to receive an award for information provided to any Government Agency to the extent that such limitation or prohibition is a violation of law.

b.The General Release in this Agreement does not apply to claims under federal, state, or local law (statutory, regulatory, or otherwise) that may not be lawfully waived and released, including but not limited to vested retirement benefits (if any), COBRA rights, unemployment compensation, and workers' compensation.

1.Confidential Information.

a.For the purposes of this Agreement, "Confidential Information" shall include, without limitation, any non-public information relating to or pertaining to the Company, such as the whole or any portion or phase of (i) any proprietary information or Trade Secrets (defined below); (ii) any scientific, technical, business, or financial information; (iii) any marketing information, business development information, prospect information, or marketing analysis or plans; (iv) any customer information, lists, contacts, or needs; (v) any contracts, agreements, or leases; (vi) any discoveries, inventions, products, designs, methods, know-how, techniques, systems, processes, software programs, works of authorship, projects, or plans; (vii) any proposals, strategies, concepts, analyses, surveys,

- 3 -



ideas, research, data, databases, reports, manuals, manuscripts, articles, or records; and
(viii) any other business or corporate documents related to Company Business. The Company' s "Trade Secrets" include, without limitation, the Company's non-public marketing strategies, financial information, customer and client information, projects, plans, proposals, business strategies (including potential new business opportunities and divisions). All Confidential Information identified above shall be treated as Confidential Information regardless of whether it pertains to the Company, its affiliates, subsidiaries, or parents, or their customers. The list set forth above is not intended by the Company to be a comprehensive list of Confidential Information.

a.Employee acknowledges the success of the Company depends in large part on the protection of the Company's Confidential Information. Employee further acknowledges that, in the course of Employee's employment with the Company, Employee became familiar with the Company's Confidential Information. Employee recognizes and acknowledges that the Company's Confidential Information is a valuable, special, and unique asset of the Company's business, access to and knowledge of which were essential to the performance of Employee's duties. Employee acknowledges use or disclosure of the Confidential Information outside the performance of Employee's job duties for the Company would cause harm and/or damage to the Company.

b.· Employee agrees that Employee will not, directly or indirectly, disclose any Confidential Information to any person, firm, business, company, corporation, association, or any other entity for any reason or purpose whatsoever except as otherwise required by law. Employee also agrees that Employee has not and will not use, directly or indirectly, any Confidential Information for Employee's own purposes or for the benefit of any person, firm, business, company, corporation, or any other entity (except the Company) under any circumstances. Employee has considered and treated and shall consider and treat as confidential all Confidential Information in any way relating to the Company's business and affairs, whether created by Employee or otherwise coming into Employee's possession before, during, or after the Termination Date. Employee shall not use or attempt to use any Confidential Information in any manner which has the possibility of injuring or causing loss, whether directly or indirectly, to the Company, its affiliates, subsidiaries, parents, or customers. Employee agrees all such Confidential Information shall be and remain the sole and exclusive property of the Company.

1.Remedies.

a.Injunctive Relief. Employee acknowledges that any breach of Paragraph 4 or the surviving provisions of the Employment Agreement referenced in Paragraphs 6, 8, 12 and 13 below will cause the Company to suffer immediate and irreparable harm and damage for which money alone cannot fully compensate the Company. Employee agrees that upon breach or threat of imminent breach of any obligation under Paragraphs 4, 6, 8, 12, and/or 13 of this Agreement, the Company shall be entitled to a temporary restraining order, preliminary injunction, permanent injunction, or other injunctive relief without posting any bond or other security, and that Employee shall not oppose entry of any of these measures. This Paragraph shall not be construed as an election of any remedy, or as a waiver of any right available to the Company under this Agreement or the Colorado law governing this Agreement, including the right to seek damages from Employee.

b.Attorneys' Fees. In the event of any controversy, claim, or dispute between the parties affecting or relating to Paragraphs 4, 6, 8, 12, and/or 13 of this Agreement, if the Company is required to defend its actions or seek enforcement of the Agreement, the Company shall be entitled to
- 9 -



recover all of its attorneys' fees and costs if the Company is successful in its defense or enforcement action.

c.Separate Provisions. Employee agrees the provisions of Paragraphs 4, 6, 8, 12, and 13 of this Agreement are separate from and independent of the remainder of this Agreement and that these provisions are specifically enforceable by the Company notwithstanding any claim by Employee that the Company has violated or breached this Agreement.

2.Return of Company Property. Employee represents and warrants that Employee returned all Company property to the designated Company representative on or before Employee's Termination Date, unless otherwise agreed upon. This property includes, but is not limited to, Company documents and files (in any recorded media, such as papers, computer disks, copies, transparencies, and microfiche), materials, keys, credit cards, laptops, cellular phone(s), computer disks, and badges. Employee agrees that, to the extent that Employee possesses any files, data, or information relating in any way to the Company or the Company's business on any personal computer, Employee will delete the data, files, or information (and will retain no copies in any form).

3.Unknown Facts. The releases in this Agreement include, but are not limited to, claims of every nature and kind, known or unknown, suspected or unsuspected. Employee hereby acknowledges that Employee may hereafter discover facts different from, or in addition to, those which Employee now knows to be or believes to be true with respect to this Agreement, and Employee agrees that this Agreement and the releases contained herein shall be and remain effective in all respects, notwithstanding such different or additional facts or the discovery thereof.

4.Confidentiality of Agreement. Employee agrees to keep this Agreement confidential and will not disclose the existence or the terms of this Agreement to anyone except to Employee's immediate family, accountants, legal or financial advisors, as part of an investigation or proceeding conducted by any Government Agency, or as otherwise appropriate or necessary as required by law or court order. To the extent that Employee discloses the existence or terms of this Agreement to Employee's immediate family, accountants, or legal or financial advisors, Employee must advise them that they must not disclose the existence or terms of this Agreement to any person or entity. However, nothing contained herein precludes any individual from communicating with any Government Agency. If compulsory disclosure is required by a Government Agency, Employee shall provide the Company immediate notice of the compulsory process and affording the Company the opportunity to obtain any necessary or appropriate protective orders. Otherwise, in response to inquiries about Employee's employment and this matter, Employee shall state, "My employment with the Company has ended" and nothing more. The Company agrees to keep this Agreement confidential and will not disclose the existence or the terms of this Agreement to anyone except the Company's Human Resources Department, Legal Department, Executive Management Team and Board of Directors, or as otherwise appropriate or necessary as required by law or court order. To the extent that Company chooses to disclose the existence or terms of this Agreement to the Company's Human Resources Department, Legal Department, Executive Management Team and Board of Directors, the Company must advise them that they must not disclose the existence or terms of this Agreement to any person or entity. However, nothing contained herein precludes any individual from communicating with any Government Agency. If compulsory disclosure is required by a Government Agency, Company shall provide the Employee immediate notice of the compulsory process and affording the Employee the opportunity to obtain any necessary or appropriate protective orders.

5.No Admission of Liability. The Parties agree that nothing contained herein, and no action taken by any Party hereto with regard to this Agreement, shall be construed as an admission by any Party of liability or of any fact that might give rise to liability for any purpose whatsoever.

6.ADEA and Older Workers Benefit Protection Act Release
- 9 -




In addition to the General Release contained in Section 3, Employee knowingly, voluntarily, and irrevocably discharges and releases Releasees from any claims arising under the Age Discrimination in Employment Act (ADEA). Employee acknowledges that Employee has been informed pursuant to the federal Older Workers Benefit Protection Act of 1990 as follows:

You are advised to consult with an attorney before signing this Agreement.

You do not waive rights or claims under the federal Age Discrimination in Employment Act that may arise after the date this Agreement is executed.

You have twenty-one (21) days from the date of receipt of this Agreement to consider this Agreement. You acknowledge that if you sign this Agreement before the end of the twenty-one (21)-day period, it will be your personal, voluntary decision to do so and that you have not been pressured to make a decision sooner.

You have seven (7) days after signing this Agreement to revoke the Agreement, and the Agreement will not be effective until that revocation period has expired. If mailed, the rescission must be postmarked within the seven-day period, properly addressed to:

Heska Corporation
Attn: Human Resources Department 3760 Rocky Mountain Avenue Loveland, CO 80538

This agreement shall not be effective or enforceable, and no payments or benefits under this Agreement shall be provided to you, until after the seven (7) day revocation period has expired. You understand that you will not receive any settlement payment if you void your signature or revoke this Agreement.

7.Representations and Warranties. Employee represents and warrants as follows:

a.Employee has read this Agreement and agrees to the conditions and obligations set forth in it;

b.Employee voluntarily executes this Agreement (i) after having been advised to consult with legal counsel, (ii) after having had opportunity to consult with legal counsel, and (iii) without being pressured or influenced by any statement or representation or omission of any person acting on behalf of the Company including, without limitation, the officers, directors, board members, committee members, employees, agents, and attorneys for the Company;

c.Employee has no knowledge of the existence of any lawsuit, charge, or proceeding against the Company or any of its officers, directors, board members, committee members, employees, or agents arising out of or otherwise connected with any of the matters herein released. In the event that any such lawsuit, charge, or proceeding has been filed, Employee immediately will take all actions necessary to withdraw or terminate that lawsuit, charge, or proceeding;

d.Employee has not previously disclosed any information which would be a violation of the confidentiality provisions set forth herein if such disclosure were to be made after the execution of this Agreement;

e.Employee has full and complete legal capacity to enter into this Agreement;

- 9 -



f.Employee admits, acknowledges, and agrees that Employee is not otherwise entitled to the amounts and other consideration set forth in Paragraph 2, which are good and valuable consideration for this Agreement; and

g.Employee further admits, acknowledges, and agrees that Employee has been fully and finally paid all wages, compensation, vacation, bonuses, stock, stock options, or other benefits from the Company which are or could be due to Employee under the terms of Employee's employment with the Company or otherwise.

8.Non-Disparagement. Employee agrees not to make to any person any statement that disparages the Company or reflects negatively upon the Company, including, without limitation, statements regarding the Company's financial condition, business practices, employment practices, or its predecessors, successors, parents, subsidiaries, officers, directors, employees, affiliates, agents, or representatives. Company agrees not to make to any person any statement that disparages Employee or reflects negatively upon the Employee.

9.Cooperation. Employee agrees to cooperate with and assist the Company with any investigation, lawsuit, arbitration, or other proceeding to which the Company is subjected. Employee will beavailable for preparation for, and attendance of, hearings, proceedings, or trial, including pretrial discovery and trial preparation. Employee further agrees to perform all acts and execute any documents that may be necessary to carry out the provisions of this Paragraph.

10.Section 409A. This Agreement is intended to comply with Section 409A of the Internal Revenue Code and shall be construed accordingly. It is the intention of the Parties that payments or benefits payable under this Agreement not be subject to the additional tax or interest imposed pursuant to Section 409A. To the extent such potential payments or benefits are or could become subject to Section 409A, the Parties shall cooperate to amend this Agreement with the goal of giving Employee the economic benefits described herein in a manner that does not result in such tax or interest being imposed. Employee shall, at the request of the Company, take any reasonable action (or refrain from taking any action), required to comply with any correction procedure promulgated pursuant to Section 409A.

11.Severability. If any provision of this Agreement is held illegal, invalid, or unenforceable, such holding shall not affect any other provisions hereof. In the event any provision is held illegal, invalid or unenforceable, such provision shall be limited so as to effect the intent of the parties to the fullest extent permitted by applicable law. Any claim by Employee against the Company shall not constitute a defense to enforcement by the Company of this Agreement.

12.Enforcement. The Release contained herein does not release any claims for enforcement of the terms, conditions, or warranties contained in this Agreement. The Parties shall be free to pursue any remedies available to them to enforce this Agreement.

13.Entire Agreement. This Agreement constitutes the entire agreement between the Parties and supersedes and modifies any and all prior agreements. This Agreement cannot be modified except in a writing signed by all Parties.

14.Venue. Applicable Law. and Submission to Jurisdiction. This Agreement shall be interpreted and construed in accordance with the laws of the State of Colorado, without regard to its conflicts of law provisions. Venue and jurisdiction will be in the Colorado state or federal courts.

15.Interpretation. The determination of the terms, and the drafting, of this Agreement has been by mutual agreement after negotiation, with consideration by and participation of all Parties. Accordingly, the
- 9 -



Parties agree that rules relating to the interpretation of contracts against the drafter of any particular clause shall not apply in the case of this Agreement. The term "Paragraph" shall refer to the enumerated paragraphs of this Agreement. The headings contained in this Agreement are for convenience of reference only and are not intended to limit the scope or affect the interpretation of any provision of this Agreement.

16.Assignment. The. Company may assign its rights under this Agreement. Employee cannot assign Employee's rights under this Agreement without the written consent of the Company. No other assignment is permitted except by written permission of the Parties

17.Counterparts. This Agreement may be executed in counterparts.

IN WITNESS WHEREOF, the Parties have executed this Separation and Release Agreement on the dates written below.

Employee has carefully read the above and executes it voluntarily, fully understanding and accepting the provisions of this Agreement in its entirety and without reservation after having had sufficient time and opportunity to consult with legal advisors prior to executing this Agreement. Employee has been advised to consult with an attorney prior to executing this Agreement. In agreeing to sign this Agreement, Employee has not relied on any statements or explanation made by the Company. Employee has had at least twenty-one (21) days to consider this Agreement. Employee understands that if he does not return this Agreement signed by him to the Company upon the expiration of the twenty-one-day consideration period, this offer will expire. Employee understands that he may revoke and cancel the Agreement within seven (7) days after signing it by serving written notice upon Company as set forth in Paragraph 10 above.

EMPLOYEE    HESKA CORPORATION


/s/ Jason Aroesty                        /s/ Christopher Sveen
Jason Aroesty                            Christopher Sveen
General Counsel


December 2, 2020                        December 3, 2020

- 9 -



Date
Date
- 9 -

EX-10.31 5 heska-12312020xex10x31.htm EX-10.31 Document

Exhibit 10.31

EMPLOYMENT AGREEMENT

This Employment Agreement (the "Agreement") is made effective on April 15th, 2020
(the "Effective Date") between Heska Corporation, a Delaware corporation ("Heska"),
and Christopher Sveen ("Executive"). Heska and Executive collectively are referred to as the
"Parties" and individually as a "Party."

RECITALS

WHEREFORE, Executive is currently the Executive Vice President, General Counsel and Chief Administrative Officer, Heska and President, Diamond Animal Health, a wholly- owned subsidiary of Heska.

WHEREFORE, Executive and Heska now wish to enter into this Agreement regarding
the terms of Executive's employment, which shall become effective upon execution.

NOW, THEREFORE, in consideration of the foregoing and of the mutual promises, covenants, and agreements contained herein, the legal sufficiency of which is acknowledged by the Parties, and intending to be legally bound, the Parties agree as follows:

TERMS

1.Duties and Scope of Employment.

a.Position and Duties. As of April 15th, 2020, Executive will serve as Executive Vice President, General Counsel and Chief Administrative Officer, Heska and President, Diamond Animal Health. Executive will render such business and professional services in the performance of Executive's duties, consistent with Executive's position within Heska and/or its subsidiaries, as will reasonably be assigned to
Executive by Heska's Board of Directors, Chief Executive Officer, or Executive's supervisor. Executive's duties will be subject to review and adjustments will be made at the discretion of the Executive's supervisor and superiors.

b.Obligations. During the Term of Agreement (as defined below), Executive will devote Executive's full attention, skills, time and business efforts to Heska and/or its subsidiaries. For the duration of the Term of Agreement, Executive agrees not to actively engage in any other employment, occupation, or consulting activity, for any direct or indirect remuneration, without the prior approval of the Board or the Corporate Governance Committee of the Board; provided, however, that Executive may, without the approval of the Board or the Corporate Governance Committee of the Board, serve in any capacity with any civic, educational, or charitable organization, provided such services do not interfere with Executive's obligations to Heska.

2.Term of Agreement.




a.The period of Executive's employment under this Agreement is referred to herein as the "Term of Agreement." Subject to the provisions for earlier termination of employment in Section 6 below, this Agreement will have an initial term of twelve
(12) months commencing on the Effective Date. On the 1st anniversary of the Effective Date, and on each annual anniversary of the Effective Date thereafter, this Agreement automatically will renew for an additional twelve-month term unless Heska provides Executive with notice of non-renewal at least 120 days prior to the date of automatic renewal; provided, however, that either Heska or Executive may
terminate Executive's employment immediately at any time subject to the provisions
in Section 6 below.

b.Executive may be entitled to severance benefits pursuant to Section 6 below, depending upon the circumstances of Executive's termination of employment. Upon the termination of Executive's employment for any reason, Executive will be entitled to payment of all expense reimbursements, and other benefits due to Executive through Executive's termination date under any Heska-provided or paid plans, policies, and arrangements. Executive agrees to resign from all positions that Executive holds with Heska and its subsidiaries, without limitation, immediately following the termination of Executive's employment if the Board so requests.

1.Compensation.

a.Base Salary. Heska will pay Executive an annual salary of $300,000.00 as compensation for Executive's services (the "Base Salary"). The Base Salary will be paid periodically in accordance with Heska's normal payroll practices and will be subject to the usual, required withholdings and deductions. Executive's salary will be subject to review, and adjustments will be made at the sole discretion of the Compensation Committee of the Board (the "Committee") and based upon Heska's standard practices.

b.Annual Bonus. During the Term of Agreement, Executive will be eligible to
participate in the Management Incentive Plan ("MIP"), a compensation plan intended to reward near term performance (i.e. no longer than the coming year) which may be available from time to time at the discretion of the Committee. MIP Payouts, if any, will accrue and become payable in accordance with the Committee's standard practices for paying executive incentive compensation, provided, however, that any bonus payable under this subsection will be payable within two-and-one-half (2-1/2) months after the end of the taxable year to which it relates or such longer period as may be permitted or required by Treasury regulations in order to avoid application of Section 409A of the Internal Revenue Code of 1986, as amended (the "Code") to such MIP Payouts. Any MIP Payouts paid pursuant to this Section will be subject to applicable withholdings and deductions.

2.Expenses.




a.In addition to the foregoing, Heska will reimburse Executive for Executive's reasonable out-of-pocket travel, entertainment, and other expenses, in accordance with Heska's expense reimbursement policies and practices in effect at the time of the reimbursement request. Executive shall submit such requests within forty-five (45) days of incurring such expenses.

1.Employee Benefits.

a.During the Term of Agreement, Executive will be eligible to participate in the benefits offered to other executives of Heska, in accordance with benefit plans, policies, and arrangements that may exist from time to time.

2.Termination and Severance.

a.Termination without Cause or for Good Reason other than In Connection with a Change of Control. If, at any time, Executive's employment is terminated by Heska without Cause (as defined below), by Executive for Good Reason (as defined below), or due to Executive's death or Disability (as defined below) or pursuant to Heska's delivery of notice of non-renewal pursuant to Section 2(a) above, and the termination is not In Connection with a Change of Control (as defined below), Executive will receive the following, subject to conditions and limitations set forth in Section 7:

i.A payment of an amount equal to six (6) months of Executive's Base Salary, payable in accordance with Heska's standard payroll practices over the shorter of the following periods (A) in equal installments over the period beginning on the date of such termination and ending on the one-year anniversary thereof, or (B) in equal installments on a monthly basis corresponding to the amount Executive would normally receive as salary each month if Executive were still employed with Heska, with a lump sum of any remaining balance of the amount specified above on March 15 of the year following the year of termination.

ii.Provided that, within thirty (30) days of termination date, Executive elects continuation coverage under the Consolidated Omnibus Budget
Reconciliation Act of 1985, as amended ("COBRA"), Heska shall pay the COBRA premium for coverage for Executive and Executive's eligible dependents under Heska's Benefit Plans (as defined below) for six (6) months, or if earlier, until Executive becomes employed by another employer and
eligible for coverage under such other employer's welfare benefit plans (e.g., payments for medical COBRA premiums will cease when Executive becomes eligible for another employer's medical plan.) For the balance of the period during which Executive and Executive's eligible dependents are entitled to coverage under COBRA, Executive shall be entitled to maintain coverage for Executive and Executive's eligible dependents at Executive's sole expense.




Executive shall notify Heska immediately upon Executive's acceptance of
employment with another employer.

a.Termination without Cause or for Good Reason In Connection with a Change of Control. If, at any time, Executive's employment is terminated by Heska without Cause or by Executive for Good Reason or pursuant to Heska's delivery of notice of non-renewal pursuant to Section 2(a) above, and the termination is In Connection with a Change of Control (as defined below), then, subject to the limitations set forth in this Section 7, Executive will receive:

i.A payment of an amount equal to twelve (12) months of Executive's Base Salary, payable in equal installments in accordance with the standard payroll schedule over the shorter of the following periods (A) the period beginning on the date of such termination and ending on the one-year anniversary thereof, or (B) the period beginning on the date of such termination and ending on March 15 of the year following the year of termination.

ii.Provided that, within thirty (30) days of termination date, Executive elects continuation coverage under COBRA, Heska shall pay the COBRA premium for coverage for Executive and Executive's eligible dependents under Heska's Benefit Plans (as defined below) for twelve (12) months, or if earlier, until Executive becomes employed by another employer and eligible for coverage under such other employer's welfare benefit plans (e.g., payments for medical COBRA premiums will cease when Executive becomes eligible for another employer's medical plan). For the balance of the period during which
Executive and Executive's eligible dependents are entitled to coverage under COBRA, Executive shall be entitled to maintain coverage for Executive and Executive's eligible dependents at Executive's sole expense. Executive shall notify Heska immediately upon Executive's acceptance of employment with another employer.

b.Termination without Good Reason; Termination for Cause. If, at any time, Executive's employment with Heska terminates voluntarily by Executive without Good Reason or is terminated for Cause by Heska, then (i) all further vesting of
Executive's outstanding equity awards will terminate immediately, (ii) all payments of compensation by Heska to Executive hereunder will terminate immediately (except as to amounts already earned), but Executive will be paid all expense
reimbursements, and other benefits due to Executive through Executive's termination date under any Company-provided or paid plans, policies, and arrangements, and (iii) Executive will not be entitled to any severance.

c.Excise Tax. In the event that any benefits payable to Executive pursuant to Section 6 of this Agreement ("Termination Benefits") (i) constitute "parachute payments" within the meaning of Section 280G of the Code, or any comparable successor provisions, and (ii) but for this Section 6(d), would be subject to the excise tax




imposed by Section 4999 of the Code, or any comparable successor provisions (the "Excise Tax"), then Executive's Termination Benefits hereunder shall be either (A) provided to Executive in full, or (B) provided to Executive as to such lesser extent which would result in no portion of such benefits being subject to the Excise Tax, whichever of the foregoing amounts, when taking into account applicable federal, state, local, and foreign income and employment taxes, the Excise Tax, and any other applicable taxes, results in the receipt by Executive, on an after-tax basis, of the greatest amount of benefits, notwithstanding that all or some portion of such benefits may be taxable under the Excise Tax. Unless Heska and Executive otherwise agree in writing, any determination required under this Section 6(d) shall be made in
writing in good faith by Heska's independent accountants. In the event of a reduction of benefits hereunder, Executive shall be given the choice of which benefits to reduce. If Executive does not provide written identification to Heska of which benefits Executive chooses to reduce within ten (10) days after written notice of the accountants' determination, and Executive has not disputed the accountants' determination, then Heska shall select the benefits to be reduced. For purposes of making the calculations required by this Section 6(d), the accountants may make reasonable assumptions and approximations concerning the applicable taxes and may rely on reasonable, good faith interpretations concerning the application of the Code and other applicable legal authority. Heska and Executive shall furnish to the accountants such information and documents as the accountants may reasonably request in order to make a determination under this Section 6(d). Heska shall bear all costs the accountants may reasonably incur in connection with any calculations contemplated by this Section 6(d).

1.Conditions to Receipt of Severance; No Duty to Mitigate; Covenants.

a.Separation Agreement and Release of Claims. The receipt of any severance pursuant to Section 6 will be subject to Executive signing and not revoking a confidential separation agreement and release of claims in a form reasonably acceptable to Heska. Such agreement will provide (among other things) that Executive will not disparage Heska, its affiliates, parents, subsidiaries, directors, executive officers, employees, agents, or representatives. No severance will be paid or provided until the confidential separation agreement and release agreement becomes effective. No severance will be paid or provided if the Executive's confidential separation agreement and release agreement is not signed and irrevocable within forty-five (45) days after the Executive's termination date. If Executive's date of termination and the last day of any applicable statutory revocation period could fall in two separate taxable years, regardless of when Executive actually executes and delivers the release, payments will not commence until the later taxable year.

b.Non-Competition. In the event of a termination of Executive's employment that would entitle Executive to the receipt of severance pursuant to Sections 6(a) or 6(b), or a termination for Cause by Heska, Executive agrees not to engage in Competition (as defined below) for six (6) months following the termination date. The geographic




scope of this Section 7(b) is the United States of America and Europe. If Executive engages in Competition within such period, all continuing payments and benefits to which Executive otherwise may be entitled pursuant to Section 6 will cease immediately.

a.Non-Solicitation. In the event of a termination of Executive's employment that would entitle Executive to the receipt of severance pursuant to Sections 6(a) or 6(b), or a termination for Cause by Heska, Executive agrees that, for twelve (12) months following the termination date, Executive, directly or indirectly, whether as employee, owner, sole proprietor, partner, director, member, consultant, agent, founder, co-venturer, or otherwise, (i) will not solicit, induce, or influence any person to modify his or her employment or consulting relationship with Heska (the "No-
Inducement"), and (ii) not intentionally divert business away from Heska by soliciting business from any of Heska's customers and users who would otherwise
have placed the solicited order with Heska (the "No Solicit"). The geographic scope of this Section 7(c) is the United States of America and Europe. If Executive breaches the No-Inducement or No Solicit, all continuing payments and benefits to which Executive otherwise may be entitled pursuant to Section 6 will cease immediately.

b.Remedies. In the event of Executive's breach of Sections 7(b) or 7(c), Heska shall have any and all remedies available to it in law or in equity, including without limitation the right to seek recovery of any amounts paid under Section 6 of this Agreement and injunctive relief, specific performance, or any other equitable relief to prevent a breach and to secure the enforcement of this Section. Injunctive relief may be granted immediately upon the commencement of any such action, and Heska need not post a bond to obtain temporary or permanent injunctive relief.

c.No Duty to Mitigate. Executive is under no duty or requirement to mitigate the amount of any payment contemplated by this Agreement, nor will any earnings that Executive may receive from any other source reduce any such payment.


1.Definitions.

a.Benefit Plans. For purposes of this Agreement, "Benefit Plans" means plans,
policies, or arrangements that Heska sponsors (or participates in) and that
immediately prior to Executive's termination of employment provide Executive and Executive's eligible dependents with medical, dental, or vision benefits. Benefit Plans do not include any other type of benefit (including, but not limited to, financial counseling, disability, life insurance, or retirement benefits). A requirement that Heska provide Executive and Executive's eligible dependents with coverage under the Benefit Plans will not be satisfied unless the coverage is no less favorable than




that provided to Executive and Executive's eligible dependents immediately prior to Executive's termination of employment.

a.Cause. For purposes of this Agreement, "Cause" shall mean the occurrence of one or more of the following: (i) conviction of, or an entry of a plea of nolo contendere to, any crime (including one involving moral turpitude), whether a felony or misdemeanor, or any crime which reflects so negatively on Heska to be detrimental to Heska's image or interests, or any act of fraud or dishonesty that has such negative reflection upon Heska; (ii) the repeated commitment of insubordination or refusal to comply with any reasonable request of Heska's Board of Directors, Chief Executive Officer, or Executive's supervisor related to the scope or performance of Executive's duties; (iii) possession of any illegal drug on Heska premises or being under the influence of illegal drugs or abusing prescription drugs or alcohol while on Heska business, attending Heska-sponsored functions, or on Heska premises; (iv) the gross misconduct or gross negligence in the performance of Executive's responsibilities which, based upon good faith and reasonable factual investigation of the Board,
demonstrates Executive's unfitness to serve; (v) material breach of Executive's obligations under this Agreement; or (vi) material breach of any fiduciary duty of Executive to Heska or its subsidiaries,; provided, however, that if any occurrence under subsections (ii), (iv), (v), and (vi) is reasonably capable of being cured, Heska will provide notice to Executive describing the nature of such event and Executive will thereafter have thirty (30) days to cure such event, and if such event is cured within that 30-day period, then grounds will no longer exist for terminating
Executive's employment for Cause; and provided, further, that such cure period will not apply to any subsequent occurrence of the same event.

b.Change of Control. For purposes of this Agreement, "Change of Control" means
(i) a sale of all or substantially all of Heska's assets, (ii) any merger, consolidation, or other business combination transaction of Heska with or into another corporation, entity, or person, other than a transaction in which the holders of at least a majority of the shares of voting capital stock of Heska outstanding immediately prior to such transaction continue to hold (either by such shares remaining outstanding or by their being converted into shares of voting capital stock of the surviving entity) a majority of the total voting power represented by the shares of voting capital stock of Heska (or the surviving entity) outstanding immediately after such transaction, (iii) the direct or indirect acquisition (including by way of a tender or exchange offer) by any person, or persons acting as a group, of beneficial ownership or a right to acquire beneficial ownership of shares representing a majority of the voting power of the then outstanding shares of capital stock of Heska, (iv) a contested election of Directors, as a result of which or in connection with which the persons who were Directors before such election or their nominees cease to constitute a majority of the Board, or (v) a dissolution or liquidation of Heska.

c.Competition. For purposes of this Agreement, Executive will be deemed to have engaged in "Competition" if Executive, without the written consent of the Board or




an authorized officer of any successor company to Heska, directly or indirectly (1) provides services or assistance in any form to any individual, entity, or company providing veterinary products for the companion animal health industry or imaging products or services for the veterinary market (a "Restricted Company"), whether such services or assistance is provided as an employee, consultant, agent, corporate officer, director, or otherwise or (2) participates in the financing, operation, management, or control of, a Restricted Company. A Restricted Company includes, without limitation, Zoetis, Inc. Abaxis, Inc. (currently a wholly-owned subsidiary of Zoetis, Inc.), IDEXX Laboratories, Inc., Sound Technologies, Inc. (currently a unit of Mars, Incorporated), and Zoetis, Inc. Notwithstanding the foregoing, nothing contained in this Section 8(d) or in Section 7(b) above shall prohibit Executive from being employed or engaged in a corporate function or senior management position (and holding commensurate equity interests) in a division of a Restricted Company, so long as such division is not in any way engaged in providing veterinary products for the companion animal health industry or imaging products or services for the veterinary market and Executive does not directly or indirectly provide services or assistance to any division that does provide veterinary products for the companion animal health industry or imaging products or services for the veterinary market.

a.Disability. For purposes of this Agreement, "Disability" shall mean that, by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than twelve (12) months, the Executive either (i) is unable to engage in any gainful activity, or (ii) is receiving income replacement benefits for a period of not less than three (3) months under an accident and health plan covering Heska employees.

b.Good Reason.

i.For purposes of this Agreement, "Good Reason" means the occurrence of any of the following without Executive's express written consent:

1.Executive's officer level with Heska is, or Executive's duties or responsibilities are, materially diminished relative to Executive's officer level, duties, and responsibilities as in effect immediately prior to such change;

2.a material diminution in Executive's Base Salary as in effect immediately prior to such diminution; provided, that an across-the- board reduction in the base compensation and benefits of all other executive officers of Heska by the same percentage amount (or under the same terms and conditions) as part of a general base compensation reduction and/or benefit reduction shall not constitute such a qualifying material diminution;




1.a material change in the geographic location of Executive's principal place of employment such that the new location is greater than fifty (50) road miles each way from Executive's place of employment on the Effective Date;

2.any material breach by Heska of any provision of this Agreement; and

3.any acquiring company fails to assume or be bound by the terms of this Agreement in Connection with a Change of Control;

i.The aforementioned occurrences shall not be deemed Good Reason unless Executive gives Heska written notice of the existence of the condition which Executive believes constitutes Good Reason (which notice must be given within ninety (90) days of the initial existence of the condition) and such condition remains uncured for a period of thirty (30) days after the date of such notice. An event of Good Reason shall occur automatically at the expiration of such 30-day period if the relevant condition remains uncured at such time.

a.In Connection with a Change of Control. For purposes of this Agreement, a
termination of Executive's employment with Heska is "In Connection with a Change of Control" if Executive's employment is terminated without Cause or for Good Reason during the period beginning three (3) months prior to a Change of Control and ending eighteen (18) months following a Change of Control.

1.Confidential Information.

a.Executive acknowledges that Executive has executed Heska's standard employee Confidential Information and Invention Agreement (the "Confidentiality Agreement"). During the Term of Agreement, and for twenty-four (24) months after termination of Executive's employment, Executive agrees, if requested by Heska, to execute any updated versions of Heska's form of employee confidential information agreement as may be required of substantially all of Heska's executive officers.

2. Executive's Representations and Warranties.

a.Executive represents and warrants that Executive is not a party to any other employment, non-competition, or other agreement or restriction which could interfere with the Executive's employment with Heska or Executive's or Heska's rights and obligations hereunder and that Executive's acceptance of employment with Heska and the performance of Executive's duties hereunder will not breach the provisions of any contract, agreement, or understanding to which the Executive is party or any duty owed by the Executive to any other person.




1.Notices.

a.All notices, requests, demands, and other communications called for hereunder will be in writing and will be deemed given:
i.on the date of delivery if delivered personally,
ii.one (1) day after being delivered through a nationally recognized overnight courier service, or
iii.five (5) business days after the date of mailing if sent certified or registered mail.
iv.Notice to Heska shall be sent to its principal place of business with a copy provided by facsimile or electronic communication to the Chair of the Board of Directors, and notice to Executive will be delivered personally or sent to Executive's last known address provided to Heska.

2.Successors and Assigns.

a.This Agreement will be binding upon and inure to the benefit of (a) the heirs,
executors, and legal representatives of Executive upon Executive's death and
(b) any successor of Heska. Any such Successor (as defined below) of Heska will be deemed substituted for Heska under the terms of this Agreement for all purposes. For purposes of this Section, "Successor" means any person, firm, corporation, or other business entity which at any time, whether by purchase, merger, or otherwise, directly or indirectly, acquires all or substantially all of the assets or business of Heska. None of the rights of Executive to receive any form of compensation payable pursuant to this Agreement may be assigned or transferred except by will or the laws of descent and distribution. Any other attempted assignment, transfer, conveyance, or other disposition of Executive's right to compensation or other benefits will be null and void.

3.Integration.

a.This Agreement, together with the Confidentiality Agreement, Heska's stock plans, and Executive's stock option and restricted stock agreements, represents the entire agreement and understanding between the Parties as to the subject matter herein and supersedes all prior or contemporaneous agreements whether written or oral, including the Prior Agreement. No waiver, alteration, or modification of any of the provisions of this Agreement will be binding unless in writing that specifically references this Section and is signed by duly authorized representatives of the Parties hereto.

4.Interpretation.

a.Article titles and section headings contained herein are inserted for convenience of reference only and are not intended to be a part of or to affect the meaning or interpretation of this Agreement. The determination of the terms of, and the drafting of, this Agreement has been by mutual agreement after negotiation, with




consideration by and participation of all Parties. Accordingly, the Parties agree that rules relating to the interpretation of contracts against the drafter of any particular clause shall not apply in the case of this Agreement.

1.Waivers.

a.Any term or provision of this Agreement may be waived, or the time for its performance may be extended, by the Party or Parties entitled to the benefit thereof. Any such waiver shall be validly and sufficiently authorized for the purposes of this Agreement if, as to any Party, it is authorized in writing by an authorized representative of such Party. The failure of any Party hereto to enforce at any time any provision of this Agreement shall not be construed to be a waiver of such provision, nor in any way to affect the validity of this Agreement or any part hereof or the right of any Party thereafter to enforce each and every such provision. No waiver of any breach of this Agreement shall be held to constitute a waiver of any other or subsequent breach.

2.Severability.

a.If any provision of this Agreement is held illegal, invalid, or unenforceable, such holding shall not affect any other provisions hereof. In the event any provision is held illegal, invalid, or unenforceable, such provision shall be limited so as to give effect to the intent of the Parties to the fullest extent permitted by applicable law. Any claim by Executive against Heska shall not constitute a defense to enforcement by Heska.

3.Tax Matters.

a.Except as provided in Section 6(d) above, Executive agrees that Executive is responsible for any applicable taxes of any nature (including any penalties or interest that may apply to such taxes) that are reasonably determined to apply to any payment made to Executive hereunder (or any arrangement contemplated hereunder), that
Executive's receipt of any benefit hereunder is conditioned on Executive's satisfaction of any applicable withholding or similar obligations that apply to such benefit, and that any cash payment owed to Executive hereunder will be reduced to satisfy any such withholding or similar obligations that may apply thereto.

b.Executive acknowledges that no representative or agent of Heska has provided Executive with any tax advice of any nature, and Executive has consulted with Executive's own legal, tax, and financial advisor(s) as to tax and related matters concerning the compensation to be received under this Agreement.

4.Section 409A.

a.This Agreement is intended to comply with Section 409A of the Code, as amended
("Section 409A") and shall be construed accordingly. It is the intention of the parties




that payments or benefits payable under this Agreement not be subject to the additional tax or interest imposed pursuant to Section 409A. To the extent such potential payments or benefits are or could become subject to Section 409A, the parties shall cooperate to amend this Agreement with the goal of giving Executive the economic benefits described herein in a manner that does not result in such tax or interest being imposed; provided, however, that no such amendment shall materially increase the cost to, or impose any liability on Heska with respect to any benefits contemplated or provided hereunder. Executive shall, at the request of Heska, take any reasonable action (or refrain from taking any action), required to comply with any correction procedure promulgated pursuant to Section 409A.

a.If a payment that could be made under this Agreement would be subject to additional taxes and interest under Section 409A, Heska in its sole discretion may accelerate some or all of a payment otherwise payable under the Agreement to the time at which such amount is includible in the income of Executive, provided that such acceleration shall only be permitted to the extent permitted under Treasury Regulation § 1.409A- 3(j)(4)(vii) and the amount of such acceleration does not exceed the amount permitted under Treasury Regulation § 1.409A-3(j)(vii).

b.No payment to be made under this Agreement shall be made at a time earlier than that provided for in this Agreement unless such payment is (i) an acceleration of payment permitted to be made under Treasury Regulation § 1.409A-3(j)(4) or (ii) a payment that would otherwise not be subject to additional taxes and interest under Section 409A.

c.The right to each payment described in this Agreement shall be treated as a right to a series of separate payments and a separately identifiable payment for purposes of Section 409A.

d.For purposes of Section 6 of this Agreement, "termination" (or any similar term) when used in reference to Executive's employment shall mean "separation from service" with Heska within the meaning of Section 409A(a)(2)(A)(i) of the Code and applicable administrative guidance issued thereunder, and Executive shall be considered to have terminated employment with Heska when, and only when,
Executive incurs a "separation from service" with Heska within the meaning of Section 409A(a)(2)(A)(i) of the Code and applicable administrative guidance issued thereunder.

e.If Executive qualifies as a "specified employee" within the meaning of Section
409A(a)(2)(B)(i) of the Code and would receive any payment sooner than six
(6) months after Executive's separation from service that, absent the application of this Section 19(f), would be subject to additional tax imposed pursuant to Section 409A as a result of such status as a specified employee, then such payment shall instead be payable on the date that is the earliest of (i) six (6) months after




Executive's separation from service, (ii) Executive's death, or (iii) such other date as will not result in such payment being subject to such additional tax.

1.Governing Law; Waiver of Jury Trial.

a.This Agreement shall be governed by and construed in accordance with the internal laws of the State of Colorado without regard to conflict of law principles. The Parties hereto each waive their respective rights to a jury trial of any and all such claims and causes of action.

2.Counterparts.

a.This Agreement may be executed in counterparts, and each counterpart will have the same force and effect as an original and will constitute an effective, binding agreement on the part of each of the undersigned.


[signature page follows]




IN WITNESS WHEREOF, Heska has caused this Employment Agreement to be duly executed by an officer thereunto duly authorized, and Executive has hereunto set Executive's hand, all as of the day and year first above written.


EXECUTIVE:



/s/ Christopher Sveen
Christopher Sveen
Executive Vice President, General Counsel and Chief Administrative Officer, Heska and President, Diamond Animal Health



HESKA CORPORATION:



/s/ Kevin Wilson
Kevin Wilson
Chief Executive Officer and President

EX-10.32 6 heska-12312020xex1032.htm EX-10.32 Document

Exhibit 10.32
EMPLOYMENT AGREEMENT

This Employment Agreement (the “Agreement”) is made effective on April 9th, 2020 (the “Effective Date”) between Heska Corporation, a Delaware corporation (“Heska”), and Eleanor Baker (“Executive”). Heska and Executive collectively are referred to as the “Parties” and individually as a “Party.”

RECITALS

WHEREFORE, Executive is currently the Executive Vice President, Managing Director and Chief Operating Officer, scil animal care company, a wholly-owned subsidiary of Heska.

WHEREFORE, Executive and Heska now wish to enter into this Agreement regarding the terms of Executive’s employment, which shall become effective upon execution.

NOW, THEREFORE, in consideration of the foregoing and of the mutual promises, covenants, and agreements contained herein, the legal sufficiency of which is acknowledged by the Parties, and intending to be legally bound, the Parties agree as follows:

TERMS
1.
Duties and Scope of Employment.
a.Position and Duties. As of April 9th, 2020, Executive will serve as Executive Vice President, Managing Director and Chief Operating Officer, scil animal care company. Executive will render such business and professional services in the performance of Executive’s duties, consistent with Executive’s position within Heska and/or its subsidiaries, as will reasonably be assigned to Executive by Heska’s Board of Directors, Chief Executive Officer, or Executive’s supervisor. Executive’s duties will be subject to review and adjustments will be made at the discretion of the Executive’s supervisor and superiors.

b.Obligations. During the Term of Agreement (as defined below), Executive will devote Executive’s full attention, skills, time and business efforts to Heska and/or its subsidiaries. For the duration of the Term of Agreement, Executive agrees not to actively engage in any other employment, occupation, or consulting activity, for any direct or indirect remuneration, without the prior approval of the Board or the Corporate Governance Committee of the Board; provided, however, that Executive may, without the approval of the Board or the Corporate Governance Committee of the Board, serve in any capacity with any civic, educational, or charitable organization, provided such services do not interfere with Executive’s obligations to Heska.




2.    Term of Agreement.
a.The period of Executive’s employment under this Agreement is referred to herein as the “Term of Agreement.” Subject to the provisions for earlier termination of employment in Section 6 below, this Agreement will have an initial term of twelve (12) months commencing on the Effective Date. On the 1st anniversary of the Effective Date, and on each annual anniversary of the Effective Date thereafter, this Agreement automatically will renew for an additional twelve-month term unless Heska provides Executive with notice of non-renewal at least 120 days prior to the date of automatic renewal; provided, however, that either Heska or Executive may terminate Executive’s employment immediately at any time subject to the provisions in Section 6 below.

b.Executive may be entitled to severance benefits pursuant to Section 6 below, depending upon the circumstances of Executive’s termination of employment. Upon the termination of Executive’s employment for any reason, Executive will be entitled to payment of all expense reimbursements, and other benefits due to Executive through Executive’s termination date under any Heska-provided or paid plans, policies, and arrangements. Executive agrees to resign from all positions that Executive holds with Heska and its subsidiaries, without limitation, immediately following the termination of Executive’s employment if the Board so requests.

3.    Compensation.

a.Base Salary.  Heska will pay Executive an annual salary of $300,000.00 as compensation for Executive’s services (the “Base Salary”). The Base Salary will be paid periodically in accordance with Heska’s normal payroll practices and will be subject to the usual, required withholdings and deductions. Executive’s salary will be subject to review, and adjustments will be made at the sole discretion of the Compensation Committee of the Board (the “Committee”) and based upon Heska’s standard practices.

b.Annual Bonus.  During the Term of Agreement, Executive will be eligible to participate in the Management Incentive Plan (“MIP”), a compensation plan intended to reward near term performance (i.e. no longer than the coming year) which may be available from time to time at the discretion of the Committee. MIP Payouts, if any, will accrue and become payable in accordance with the Committee’s standard practices for paying executive incentive compensation, provided, however, that any bonus payable under this subsection will be payable within two-and-one-half (2-1/2) months after the end of the taxable year to which it relates or such longer period as may be permitted or required by Treasury regulations in order to avoid application of Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”) to such MIP Payouts. Any MIP Payouts paid pursuant to this Section will be subject to applicable withholdings and deductions.

4.    Expenses. 




a.In addition to the foregoing, Heska will reimburse Executive for Executive’s reasonable out-of-pocket travel, entertainment, and other expenses, in accordance with Heska’s expense reimbursement policies and practices in effect at the time of the reimbursement request. Executive shall submit such requests within forty-five (45) days of incurring such expenses.

5.    Employee Benefits. 

a.During the Term of Agreement, Executive will be eligible to participate in the benefits offered to other executives of Heska, in accordance with benefit plans, policies, and arrangements that may exist from time to time.

6.    Termination and Severance.

a.Termination without Cause or for Good Reason other than In Connection with a Change of Control. If, at any time, Executive’s employment is terminated by Heska without Cause (as defined below), by Executive for Good Reason (as defined below), due to Executive’s death or Disability (as defined below) or pursuant to Heska’s delivery of notice of non-renewal pursuant to Section 2(a) above, and the termination is not In Connection with a Change of Control (as defined below), Executive will receive the following, subject to conditions and limitations set forth in Section 7:

i.A payment of an amount equal to six (6) months of Executive’s Base Salary, payable in accordance with Heska’s standard payroll practices over the shorter of the following periods (A) in equal installments over the period beginning on the date of such termination and ending on the one-year anniversary thereof, or (B) in equal installments on a monthly basis corresponding to the amount Executive would normally receive as salary each month if Executive were still employed with Heska, with a lump sum of any remaining balance of the amount specified above on March 15 of the year following the year of termination.

ii.Provided that, within thirty (30) days of termination date, Executive elects continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”), Heska shall pay the COBRA premium for coverage for Executive and Executive’s eligible dependents under Heska’s Benefit Plans (as defined below) for six (6) months, or if earlier, until Executive becomes employed by another employer and eligible for coverage under such other employer’s welfare benefit plans (e.g., payments for medical COBRA premiums will cease when Executive becomes eligible for another employer’s medical plan.) For the balance of the period during which Executive and Executive’s eligible dependents are entitled to coverage under COBRA, Executive shall be entitled to maintain coverage for Executive and Executive’s eligible dependents at Executive’s sole expense.



Executive shall notify Heska immediately upon Executive’s acceptance of employment with another employer.

iii.If Executive’s principal place of employment is outside the United States on the termination date, Heska will pay or reimburse the reasonable out-of-pocket costs of Executive’s relocation to the United States, if Executive so elects within thirty (30) days of the termination date.

b.Termination without Cause or for Good Reason In Connection with a Change of Control. If, at any time, Executive’s employment is terminated by Heska without Cause or by Executive for Good Reason, or pursuant to Heska’s delivery of notice of non-renewal pursuant to Section 2(a) above, and the termination is In Connection with a Change of Control (as defined below), then, subject to the limitations set forth in this Section 7, Executive will receive:

i.A payment of an amount equal to twelve (12) months of Executive’s Base Salary, payable in equal installments in accordance with the standard payroll schedule over the shorter of the following periods (A) the period beginning on the date of such termination and ending on the one-year anniversary thereof, or (B) the period beginning on the date of such termination and ending on March 15 of the year following the year of termination.

ii.Provided that, within thirty (30) days of termination date, Executive elects continuation coverage under COBRA, Heska shall pay the COBRA premium for coverage for Executive and Executive’s eligible dependents under Heska’s Benefit Plans (as defined below) for twelve (12) months, or if earlier, until Executive becomes employed by another employer and eligible for coverage under such other employer’s welfare benefit plans (e.g., payments for medical COBRA premiums will cease when Executive becomes eligible for another employer’s medical plan). For the balance of the period during which Executive and Executive’s eligible dependents are entitled to coverage under COBRA, Executive shall be entitled to maintain coverage for Executive and Executive’s eligible dependents at Executive’s sole expense. Executive shall notify Heska immediately upon Executive’s acceptance of employment with another employer.

iii.If Executive’s principal place of employment is outside the United States on the termination date, Heska will pay or reimburse the reasonable out-of-pocket costs of Executive’s relocation to the United States, if Executive so elects within thirty (30) days of the termination date.

c.Termination without Good Reason; Termination for Cause.  If, at any time, Executive’s employment with Heska terminates voluntarily by Executive without Good Reason or is terminated for Cause by Heska, then (i) all further vesting of Executive’s outstanding equity awards will terminate immediately, (ii) all payments



of compensation by Heska to Executive hereunder will terminate immediately (except as to amounts already earned), but Executive will be paid all expense reimbursements, and other benefits due to Executive through Executive’s termination date under any Company-provided or paid plans, policies, and arrangements, and (iii) Executive will not be entitled to any severance.

d.Excise Tax.  In the event that any benefits payable to Executive pursuant to Section 6 of this Agreement (“Termination Benefits”) (i) constitute “parachute payments” within the meaning of Section 280G of the Code, or any comparable successor provisions, and (ii) but for this Section 6(d), would be subject to the excise tax imposed by Section 4999 of the Code, or any comparable successor provisions (the “Excise Tax”), then Executive’s Termination Benefits hereunder shall be either (A) provided to Executive in full, or (B) provided to Executive as to such lesser extent which would result in no portion of such benefits being subject to the Excise Tax, whichever of the foregoing amounts, when taking into account applicable federal, state, local, and foreign income and employment taxes, the Excise Tax, and any other applicable taxes, results in the receipt by Executive, on an after-tax basis, of the greatest amount of benefits, notwithstanding that all or some portion of such benefits may be taxable under the Excise Tax. Unless Heska and Executive otherwise agree in writing, any determination required under this Section 6(d) shall be made in writing in good faith by Heska’s independent accountants. In the event of a reduction of benefits hereunder, Executive shall be given the choice of which benefits to reduce. If Executive does not provide written identification to Heska of which benefits Executive chooses to reduce within ten (10) days after written notice of the accountants’ determination, and Executive has not disputed the accountants’ determination, then Heska shall select the benefits to be reduced. For purposes of making the calculations required by this Section 6(d), the accountants may make reasonable assumptions and approximations concerning the applicable taxes and may rely on reasonable, good faith interpretations concerning the application of the Code and other applicable legal authority. Heska and Executive shall furnish to the accountants such information and documents as the accountants may reasonably request in order to make a determination under this Section 6(d). Heska shall bear all costs the accountants may reasonably incur in connection with any calculations contemplated by this Section 6(d).
7.
Conditions to Receipt of Severance; No Duty to Mitigate; Covenants.
a.Separation Agreement and Release of Claims.  The receipt of any severance pursuant to Section 6 will be subject to Executive signing and not revoking a confidential separation agreement and release of claims in a form reasonably acceptable to Heska. Such agreement will provide (among other things) that Executive will not disparage Heska, its affiliates, parents, subsidiaries, directors, executive officers, employees, agents, or representatives. No severance will be paid or provided until the confidential separation agreement and release agreement



becomes effective. No severance will be paid or provided if the Executive’s confidential separation agreement and release agreement is not signed and irrevocable within forty-five (45) days after the Executive’s termination date. If Executive's date of termination and the last day of any applicable statutory revocation period could fall in two separate taxable years, regardless of when Executive actually executes and delivers the release, payments will not commence until the later taxable year.

b.Non-Competition.  In the event of a termination of Executive’s employment that would entitle Executive to the receipt of severance pursuant to Sections 6(a) or 6(b), or a termination for Cause by Heska, Executive agrees not to engage in Competition (as defined below) for six (6) months following the termination date. The geographic scope of this Section 7(b) is the United States of America and Europe. If Executive engages in Competition within such period, all continuing payments and benefits to which Executive otherwise may be entitled pursuant to Section 6 will cease immediately.

c.Non-Solicitation.  In the event of a termination of Executive’s employment that would entitle Executive to the receipt of severance pursuant to Sections 6(a) or 6(b), or a termination for Cause by Heska, Executive agrees that, for twelve (12) months following the termination date, Executive, directly or indirectly, whether as employee, owner, sole proprietor, partner, director, member, consultant, agent, founder, co-venturer, or otherwise, (i) will not solicit, induce, or influence any person to modify his or her employment or consulting relationship with Heska (the “No-Inducement”), and (ii) not intentionally divert business away from Heska by soliciting business from any of Heska’s customers and users who would otherwise have placed the solicited order with Heska (the “No Solicit”). The geographic scope of this Section 7(c) is the United States of America and Europe. If Executive breaches the No-Inducement or No Solicit, all continuing payments and benefits to which Executive otherwise may be entitled pursuant to Section 6 will cease immediately.

d.Remedies.  In the event of Executive’s breach of Sections 7(b) or 7(c), Heska shall have any and all remedies available to it in law or in equity, including without limitation the right to seek recovery of any amounts paid under Section 6 of this Agreement and injunctive relief, specific performance, or any other equitable relief to prevent a breach and to secure the enforcement of this Section. Injunctive relief may be granted immediately upon the commencement of any such action, and Heska need not post a bond to obtain temporary or permanent injunctive relief.

e.No Duty to Mitigate. Executive is under no duty or requirement to mitigate the amount of any payment contemplated by this Agreement, nor will any earnings that Executive may receive from any other source reduce any such payment.

8.    Definitions.




a.Benefit Plans.  For purposes of this Agreement, “Benefit Plans” means plans, policies, or arrangements that Heska sponsors (or participates in) and that immediately prior to Executive’s termination of employment provide Executive and Executive’s eligible dependents with medical, dental, or vision benefits. Benefit Plans do not include any other type of benefit (including, but not limited to, financial counseling, disability, life insurance, or retirement benefits). A requirement that Heska provide Executive and Executive’s eligible dependents with coverage under the Benefit Plans will not be satisfied unless the coverage is no less favorable than that provided to Executive and Executive’s eligible dependents immediately prior to Executive’s termination of employment.

b.Cause.  For purposes of this Agreement, “Cause” shall mean the occurrence of one or more of the following: (i) conviction of, or an entry of a plea of nolo contendere to, any crime (including one involving moral turpitude), whether a felony or misdemeanor, or any crime which reflects so negatively on Heska to be detrimental to Heska’s image or interests, or any act of fraud or dishonesty that has such negative reflection upon Heska; (ii) the repeated commitment of insubordination or refusal to comply with any reasonable request of Heska’s Board of Directors, Chief Executive Officer, or Executive’s supervisor related to the scope or performance of Executive’s duties; (iii) possession of any illegal drug on Heska premises or being under the influence of illegal drugs or abusing prescription drugs or alcohol while on Heska business, attending Heska-sponsored functions, or on Heska premises; (iv) the gross misconduct or gross negligence in the performance of Executive’s responsibilities which, based upon good faith and reasonable factual investigation of the Board, demonstrates Executive’s unfitness to serve; (v) material breach of Executive’s obligations under this Agreement; or (vi) material breach of any fiduciary duty of Executive to Heska or its subsidiaries,; provided, however, that if any occurrence under subsections (ii), (iv), (v), and (vi) is reasonably capable of being cured, Heska will provide notice to Executive describing the nature of such event and Executive will thereafter have thirty (30) days to cure such event, and if such event is cured within that 30-day period, then grounds will no longer exist for terminating Executive’s employment for Cause; and provided, further, that such cure period will not apply to any subsequent occurrence of the same event.

c.Change of Control.  For purposes of this Agreement, “Change of Control” means (i) a sale of all or substantially all of Heska’s assets, (ii) any merger, consolidation, or other business combination transaction of Heska with or into another corporation, entity, or person, other than a transaction in which the holders of at least a majority of the shares of voting capital stock of Heska outstanding immediately prior to such transaction continue to hold (either by such shares remaining outstanding or by their being converted into shares of voting capital stock of the surviving entity) a majority of the total voting power represented by the shares of voting capital stock of Heska (or the surviving entity) outstanding immediately after such transaction, (iii) the direct or indirect acquisition (including by way of a tender or exchange offer) by any



person, or persons acting as a group, of beneficial ownership or a right to acquire beneficial ownership of shares representing a majority of the voting power of the then outstanding shares of capital stock of Heska, (iv) a contested election of Directors, as a result of which or in connection with which the persons who were Directors before such election or their nominees cease to constitute a majority of the Board, or (v) a dissolution or liquidation of Heska.

d.Competition.  For purposes of this Agreement, Executive will be deemed to have engaged in “Competition” if Executive, without the written consent of the Board or an authorized officer of any successor company to Heska, directly or indirectly (1) provides services or assistance in any form to any individual, entity, or company providing veterinary products for the companion animal health industry or imaging products or services for the veterinary market (a “Restricted Company”), whether such services or assistance is provided as an employee, consultant, agent, corporate officer, director, or otherwise or (2) participates in the financing, operation, management, or control of, a Restricted Company. A Restricted Company includes, without limitation, Zoetis, Inc. Abaxis, Inc. (currently a wholly-owned subsidiary of Zoetis, Inc.), IDEXX Laboratories, Inc., Sound Technologies, Inc. (currently a unit of Mars, Incorporated), and Zoetis, Inc. Notwithstanding the foregoing, nothing contained in this Section 8(d) or in Section 7(b) above shall prohibit Executive from being employed or engaged in a corporate function or senior management position (and holding commensurate equity interests) in a division of a Restricted Company, so long as such division is not in any way engaged in providing veterinary products for the companion animal health industry or imaging products or services for the veterinary market and Executive does not directly or indirectly provide services or assistance to any division that does provide veterinary products for the companion animal health industry or imaging products or services for the veterinary market.

e.Disability.  For purposes of this Agreement, “Disability” shall mean that, by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than twelve (12) months, the Executive either (i) is unable to engage in any gainful activity, or (ii) is receiving income replacement benefits for a period of not less than three (3) months under an accident and health plan covering Heska employees.

f.Good Reason.

i.For purposes of this Agreement, “Good Reason” means the occurrence of any of the following without Executive’s express written consent:

1.Executive’s officer level with Heska is, or Executive’s duties or responsibilities are, materially diminished relative to Executive’s officer level, duties, and responsibilities as in effect immediately prior to such change;




2.a material diminution in Executive’s Base Salary as in effect immediately prior to such diminution; provided, that an across-the-board reduction in the base compensation and benefits of all other executive officers of Heska by the same percentage amount (or under the same terms and conditions) as part of a general base compensation reduction and/or benefit reduction shall not constitute such a qualifying material diminution;

3.a material change in the geographic location of Executive's principal place of employment such that the new location is greater than fifty (50) road miles each way from Executive's place of employment on the Effective Date;

4.any material breach by Heska of any provision of this Agreement; and

5.any acquiring company fails to assume or be bound by the terms of this Agreement In Connection with a Change of Control;

ii.The aforementioned occurrences shall not be deemed Good Reason unless Executive gives Heska written notice of the existence of the condition which Executive believes constitutes Good Reason (which notice must be given within ninety (90) days of the initial existence of the condition) and such condition remains uncured for a period of thirty (30) days after the date of such notice. An event of Good Reason shall occur automatically at the expiration of such 30-day period if the relevant condition remains uncured at such time.

g.In Connection with a Change of Control. For purposes of this Agreement, a termination of Executive’s employment with Heska is “In Connection with a Change of Control” if Executive’s employment is terminated without Cause or for Good Reason during the period beginning three (3) months prior to a Change of Control and ending eighteen (18) months following a Change of Control.

9.    Confidential Information. 

a.Executive acknowledges that Executive has executed Heska’s standard employee Confidential Information and Invention Agreement (the “Confidentiality Agreement”). During the Term of Agreement, and for twenty-four (24) months after termination of Executive’s employment, Executive agrees, if requested by Heska, to execute any updated versions of Heska’s form of employee confidential information agreement as may be required of substantially all of Heska’s executive officers.

10.    Executive’s Representations and Warranties

a.Executive represents and warrants that Executive is not a party to any other employment, non-competition, or other agreement or restriction which could interfere with the Executive’s employment with Heska or Executive’s or Heska’s rights and



obligations hereunder and that Executive’s acceptance of employment with Heska and the performance of Executive’s duties hereunder will not breach the provisions of any contract, agreement, or understanding to which the Executive is party or any duty owed by the Executive to any other person.

11.    Notices. 

a.All notices, requests, demands, and other communications called for hereunder will be in writing and will be deemed given:
i.on the date of delivery if delivered personally,
ii.one (1) day after being delivered through a nationally recognized overnight courier service, or
iii.five (5) business days after the date of mailing if sent certified or registered mail.
iv.Notice to Heska shall be sent to its principal place of business with a copy provided by facsimile or electronic communication to the Chair of the Board of Directors, and notice to Executive will be delivered personally or sent to Executive’s last known address provided to Heska.

12.    Successors and Assigns. 

a.This Agreement will be binding upon and inure to the benefit of (a) the heirs, executors, and legal representatives of Executive upon Executive’s death and 
(b) any successor of Heska. Any such Successor (as defined below) of Heska will be deemed substituted for Heska under the terms of this Agreement for all purposes. For purposes of this Section, “Successor” means any person, firm, corporation, or other business entity which at any time, whether by purchase, merger, or otherwise, directly or indirectly, acquires all or substantially all of the assets or business of Heska. None of the rights of Executive to receive any form of compensation payable pursuant to this Agreement may be assigned or transferred except by will or the laws of descent and distribution. Any other attempted assignment, transfer, conveyance, or other disposition of Executive’s right to compensation or other benefits will be null and void.

13.    Integration. 

a.This Agreement, together with the Confidentiality Agreement, Heska’s stock plans, and Executive’s stock option and restricted stock agreements, represents the entire agreement and understanding between the Parties as to the subject matter herein and supersedes all prior or contemporaneous agreements whether written or oral, including the Prior Agreement. No waiver, alteration, or modification of any of the provisions of this Agreement will be binding unless in writing that specifically references this Section and is signed by duly authorized representatives of the Parties hereto.

14.    Interpretation. 

a.Article titles and section headings contained herein are inserted for convenience of reference only and are not intended to be a part of or to affect the meaning or interpretation of this Agreement. The determination of the terms of, and the drafting of, this Agreement has been by mutual agreement after negotiation, with



consideration by and participation of all Parties. Accordingly, the Parties agree that rules relating to the interpretation of contracts against the drafter of any particular clause shall not apply in the case of this Agreement.

15.    Waivers. 

a.Any term or provision of this Agreement may be waived, or the time for its performance may be extended, by the Party or Parties entitled to the benefit thereof. Any such waiver shall be validly and sufficiently authorized for the purposes of this Agreement if, as to any Party, it is authorized in writing by an authorized representative of such Party. The failure of any Party hereto to enforce at any time any provision of this Agreement shall not be construed to be a waiver of such provision, nor in any way to affect the validity of this Agreement or any part hereof or the right of any Party thereafter to enforce each and every such provision. No waiver of any breach of this Agreement shall be held to constitute a waiver of any other or subsequent breach.

16.    Severability. 

a.If any provision of this Agreement is held illegal, invalid, or unenforceable, such holding shall not affect any other provisions hereof. In the event any provision is held illegal, invalid, or unenforceable, such provision shall be limited so as to give effect to the intent of the Parties to the fullest extent permitted by applicable law. Any claim by Executive against Heska shall not constitute a defense to enforcement by Heska.

17.    Tax Matters.

a.Except as provided in Section 6(d) above, Executive agrees that Executive is responsible for any applicable taxes of any nature (including any penalties or interest that may apply to such taxes) that are reasonably determined to apply to any payment made to Executive hereunder (or any arrangement contemplated hereunder), that Executive’s receipt of any benefit hereunder is conditioned on Executive’s satisfaction of any applicable withholding or similar obligations that apply to such benefit, and that any cash payment owed to Executive hereunder will be reduced to satisfy any such withholding or similar obligations that may apply thereto.

b.Executive acknowledges that no representative or agent of Heska has provided Executive with any tax advice of any nature, and Executive has consulted with Executive’s own legal, tax, and financial advisor(s) as to tax and related matters concerning the compensation to be received under this Agreement.

18.    Section 409A.

a.This Agreement is intended to comply with Section 409A of the Code, as amended (“Section 409A”) and shall be construed accordingly. It is the intention of the parties that payments or benefits payable under this Agreement not be subject to the additional tax or interest imposed pursuant to Section 409A. To the extent such potential payments or benefits are or could become subject to Section 409A, the



parties shall cooperate to amend this Agreement with the goal of giving Executive the economic benefits described herein in a manner that does not result in such tax or interest being imposed; provided, however, that no such amendment shall materially increase the cost to, or impose any liability on Heska with respect to any benefits contemplated or provided hereunder. Executive shall, at the request of Heska, take any reasonable action (or refrain from taking any action), required to comply with any correction procedure promulgated pursuant to Section 409A.

b.If a payment that could be made under this Agreement would be subject to additional taxes and interest under Section 409A, Heska in its sole discretion may accelerate some or all of a payment otherwise payable under the Agreement to the time at which such amount is includible in the income of Executive, provided that such acceleration shall only be permitted to the extent permitted under Treasury Regulation § 1.409A-3(j)(4)(vii) and the amount of such acceleration does not exceed the amount permitted under Treasury Regulation § 1.409A-3(j)(vii).

c.No payment to be made under this Agreement shall be made at a time earlier than that provided for in this Agreement unless such payment is (i) an acceleration of payment permitted to be made under Treasury Regulation § 1.409A-3(j)(4) or (ii) a payment that would otherwise not be subject to additional taxes and interest under Section 409A.

d.The right to each payment described in this Agreement shall be treated as a right to a series of separate payments and a separately identifiable payment for purposes of Section 409A.

e.For purposes of Section 6 of this Agreement, “termination” (or any similar term) when used in reference to Executive’s employment shall mean “separation from service” with Heska within the meaning of Section 409A(a)(2)(A)(i) of the Code and applicable administrative guidance issued thereunder, and Executive shall be considered to have terminated employment with Heska when, and only when, Executive incurs a “separation from service” with Heska within the meaning of Section 409A(a)(2)(A)(i) of the Code and applicable administrative guidance issued thereunder.

f.If Executive qualifies as a “specified employee” within the meaning of Section 409A(a)(2)(B)(i) of the Code and would receive any payment sooner than six (6) months after Executive’s separation from service that, absent the application of this Section 19(f), would be subject to additional tax imposed pursuant to Section 409A as a result of such status as a specified employee, then such payment shall instead be payable on the date that is the earliest of (i) six (6) months after Executive’s separation from service, (ii)  Executive’s death, or (iii) such other date as will not result in such payment being subject to such additional tax.

19.    Governing Law; Waiver of Jury Trial. 




a.This Agreement shall be governed by and construed in accordance with the internal laws of the State of Colorado without regard to conflict of law principles. The Parties hereto each waive their respective rights to a jury trial of any and all such claims and causes of action.

20.    Counterparts. 

a.This Agreement may be executed in counterparts, and each counterpart will have the same force and effect as an original and will constitute an effective, binding agreement on the part of each of the undersigned.


[signature page follows]




IN WITNESS WHEREOF, Heska has caused this Employment Agreement to be duly executed by an officer thereunto duly authorized, and Executive has hereunto set Executive’s hand, all as of the day and year first above written.

                
EXECUTIVE:


/s/ Eleanor Baker
Eleanor Baker
Executive Vice President, Managing Director and Chief Operating Officer, scil animal care company



HESKA CORPORATION:



/s/ Kevin Wilson
Kevin Wilson
Chief Executive Officer and President


EX-21.1 7 heska-12312020xex211.htm EX-21.1 Document


Exhibit 21.1

SUBSIDIARIES OF COMPANY


Diamond Animal Health, Inc., an Iowa corporation

Heska AG, a corporation incorporated under the laws of Switzerland

Heska Canada, Limited, a limited company organized under the laws of British Columbia, Canada

Heska Australia Pty Ltd, a proprietary company organized under the laws of Australia and registered in Victoria

Optomed SAS, a corporation incorporated under the laws of France

CVM Diagnostico Veterinario, S.L., a corporation incorporated under the laws of Spain

CVM Ecografia, S.L., a corporation incorporated under the laws of Spain

SCI A. Duchene Immo, a real estate company formed under the laws of France

Heska GmbH, a corporation incorporated under the laws of Germany

scil animal care company GmbH, a corporation incorporated under the laws of Germany

scil animal care company France sarl, a limited liability company organized under the laws of France

scil animal care company SL., a limited liability company organized under the laws of Spain

scil animal care company Ltd., a limited company organized under the laws of the United Kingdom

scil animal care company Srl, a limited liability company organized under the laws of Italy

scil Diagnostics Sdn Bhd, a public limited company organized under the laws of Malaysia


EX-23.1 8 heska-12312020xex231.htm EX-23.1 Document
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our report dated February 26, 2021, with respect to the consolidated financial statements and internal control over financial reporting included in the Annual Report of Heska Corporation and subsidiaries on Form 10-K for the year ended December 31, 2020. We consent to the incorporation by reference of said reports in the Registration Statements of Heska Corporation on Forms S-8 (File Nos. 333‑30951, 333-34111, 333-47129, 333-72155, 333-38138, 333-39448, 333-55112, 333-82096, 333-89738, 333-102871, 333-106679, 333-112701, 333-115995, 333-123196, 333-132916, 333-141737, 333-194120, 333-194122, 333-195734, 333-204036, 333-211567, 333-225112, 333-238006, 333-238008) and on Form S-3 (File No. 333-238005).

/s/ Grant Thornton LLP

Denver, Colorado
February 26, 2021



EX-23.2 9 heska-12312020xex232.htm EX-23.2 Document
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in Heska Corporation’s Registration Statements on Form S-8 (File Nos. 333-30951, 333-34111, 333-47129, 333-72155, 333-38138, 333-39448, 333-55112, 333-82096, 333-89738, 333-102871, 333-106679, 333-112701, 333-115995, 333-123196, 333-132916, 333-141737, 333-194120, 333-194122, 333-195734, 333-204036, 333-211567, 333-225112, 333-238006, and 333-238008) and Form S-3 (File No. 333-238005) of our report dated February 28, 2020, except for the effects of the change in segments described in Notes 2 and 18, as to which the date is February 26, 2021, relating to accompanying balance sheet as of December 31, 2019 and the related statements of income, comprehensive income, stockholders' equity, and cash flows for the years ended December 31, 2019 and 2018, the related notes (collectively referred to as the “financial statements”) of Heska Corporation, which appears in this Annual Report on Form 10-K.
/s/ Plante & Moran, PLLC
Denver, Colorado
February 26, 2021


EX-31.1 10 heska-12312020xex31x1.htm EX-31.1 Document

Exhibit 31.1
 
 
CERTIFICATION
 
I, Kevin S. Wilson, certify that:
 
1.I have reviewed this annual report on Form 10-K of Heska Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; and
c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
 
Dated: February 26, 2021/s/ Kevin S. Wilson                    
 KEVIN S. WILSON
 Chief Executive Officer and President
 (Principal Executive Officer)


EX-31.2 11 heska-12312020xexx31x2.htm EX-31.2 Document

Exhibit 31.2
 
CERTIFICATION
 
I, Catherine Grassman, certify that:

1.I have reviewed this annual report on Form 10-K of Heska Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; and
c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
 
 
Dated: February 26, 2021/s/ Catherine Grassman
 CATHERINE GRASSMAN
 Executive Vice President, Chief Financial Officer
 (Principal Financial and Accounting Officer)



EX-32.1 12 heska-12312020xexx32x1.htm EX-32.1 Document

Exhibit 32.1
 
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
I, Kevin S. Wilson, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of Heska Corporation on Form 10-K for the year ended December 31, 2020 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-K fairly presents in all material respects the financial condition and results of operations of Heska Corporation, to the best of my knowledge.
 

Dated: February 26, 2021By:/s/ Kevin S. Wilson
 Name:KEVIN S. WILSON
 Title:Chief Executive Officer and President
 
 
I, Catherine Grassman, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of Heska Corporation on Form 10-K for the year ended December 31, 2020 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-K fairly presents in all material respects the financial condition and results of operations of Heska Corporation, to the best of my knowledge.
 
Dated: February 26, 2021By:/s/ Catherine Grassman
 Name:CATHERINE GRASSMAN
 Title:Executive Vice President, Chief Financial Officer
 
A signed original of this written statement required by Section 906 has been provided to Heska Corporation and will be retained by Heska Corporation and furnished to the Securities and Exchange Commission or its staff upon request.

EX-101.SCH 13 hska-20201231.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 1001002 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 1002003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1003004 - Statement - CONSOLIDATED STATEMENTS OF INCOME link:presentationLink link:calculationLink link:definitionLink 1004005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 1005006 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 1006007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 2101101 - Disclosure - OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 2202201 - Disclosure - OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 2303301 - Disclosure - OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 2404401 - Disclosure - OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 2105102 - Disclosure - REVENUE link:presentationLink link:calculationLink link:definitionLink 2306302 - Disclosure - REVENUE (Tables) link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - REVENUE (Details) link:presentationLink link:calculationLink link:definitionLink 2408403 - Disclosure - REVENUE - Performance Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 2408403 - Disclosure - REVENUE - Performance Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 2109103 - Disclosure - ACQUISITION AND RELATED PARTY ITEMS link:presentationLink link:calculationLink link:definitionLink 2310303 - Disclosure - ACQUISITION AND RELATED PARTY ITEMS ACQUISITION AND RELATED PARTY ITEMS (Tables) link:presentationLink link:calculationLink link:definitionLink 2411404 - Disclosure - ACQUISITION AND RELATED PARTY ITEMS - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 2412405 - Disclosure - ACQUISITION AND RELATED PARTY ITEMS - Fair Values of Assets and Liabilties at Scil Acquisition Date (Details) link:presentationLink link:calculationLink link:definitionLink 2413406 - Disclosure - ACQUISITION AND RELATED PARTY ITEMS - Fair Value of Assets and Liabilities at CVM Acquisition Date (Details) link:presentationLink link:calculationLink link:definitionLink 2414407 - Disclosure - ACQUISITION AND RELATED PARTY ITEMS - Intangible Assets Acquired, Amortization Method (Details) link:presentationLink link:calculationLink link:definitionLink 2415408 - Disclosure - ACQUISITION AND RELATED PARTY ITEMS - Unaudited Pro Forma Financial Information (Details) link:presentationLink link:calculationLink link:definitionLink 2116104 - Disclosure - INVESTMENTS IN UNCONSOLIDATED AFFILIATES link:presentationLink link:calculationLink link:definitionLink 2317304 - Disclosure - INVESTMENTS IN UNCONSOLIDATED AFFILIATES (Tables) link:presentationLink link:calculationLink link:definitionLink 2418409 - Disclosure - INVESTMENTS IN UNCONSOLIDATED AFFILIATES (Details) link:presentationLink link:calculationLink link:definitionLink 2119105 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 2320305 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 2421410 - Disclosure - INCOME TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 2422411 - Disclosure - INCOME TAXES - COMPONENTS OF INCOME (LOSS) BEFORE TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 2423412 - Disclosure - INCOME TAXES - TEMPORARY DIFFERENCES TO THE COMPONENTS OF DEFERRED TAX ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 2424413 - Disclosure - INCOME TAXES - COMPONENTS OF INCOME TAX EXPENSE (BENEFIT) (Details) link:presentationLink link:calculationLink link:definitionLink 2425414 - Disclosure - INCOME TAXES - EFFECTIVE INCOME TAX RECONCILIATION (Details) link:presentationLink link:calculationLink link:definitionLink 2426415 - Disclosure - INCOME TAXES - UNRECOGNIZED TAX BENEFITS ROLL FORWARD (Details) link:presentationLink link:calculationLink link:definitionLink 2127106 - Disclosure - LEASES link:presentationLink link:calculationLink link:definitionLink 2328306 - Disclosure - LEASES (Tables) link:presentationLink link:calculationLink link:definitionLink 2429416 - Disclosure - LEASES - Operating and Financing Lease Balances (Details) link:presentationLink link:calculationLink link:definitionLink 2430417 - Disclosure - LEASES - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 2431418 - Disclosure - LEASES - Supplemental Cash Flow Information (Details) link:presentationLink link:calculationLink link:definitionLink 2432419 - Disclosure - LEASES - Weighted Average Remaining Lease Term and Weighted Average Discount Rate (Details) link:presentationLink link:calculationLink link:definitionLink 2433420 - Disclosure - LEASES - Lessee Accounting (Details) link:presentationLink link:calculationLink link:definitionLink 2433420 - Disclosure - LEASES - Lessee Accounting (Details) link:presentationLink link:calculationLink link:definitionLink 2434421 - Disclosure - LEASES - Lessor Accounting (Details) link:presentationLink link:calculationLink link:definitionLink 2434421 - Disclosure - LEASES - Lessor Accounting (Details) link:presentationLink link:calculationLink link:definitionLink 2435422 - Disclosure - LEASES - Sales-type Leases and Lease Income (Details) link:presentationLink link:calculationLink link:definitionLink 2136107 - Disclosure - EARNINGS PER SHARE link:presentationLink link:calculationLink link:definitionLink 2337307 - Disclosure - EARNINGS PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 2438423 - Disclosure - EARNINGS PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 2139108 - Disclosure - GOODWILL AND OTHER INTANGIBLES link:presentationLink link:calculationLink link:definitionLink 2340308 - Disclosure - GOODWILL AND OTHER INTANGIBLES (Tables) link:presentationLink link:calculationLink link:definitionLink 2441424 - Disclosure - GOODWILL AND OTHER INTANGIBLES (Details) link:presentationLink link:calculationLink link:definitionLink 2441424 - Disclosure - GOODWILL AND OTHER INTANGIBLES (Details) link:presentationLink link:calculationLink link:definitionLink 2142109 - Disclosure - PROPERTY AND EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 2343309 - Disclosure - PROPERTY AND EQUIPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 2444425 - Disclosure - PROPERTY AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 2145110 - Disclosure - INVENTORIES link:presentationLink link:calculationLink link:definitionLink 2346310 - Disclosure - INVENTORIES (Tables) link:presentationLink link:calculationLink link:definitionLink 2447426 - Disclosure - INVENTORIES (Details) link:presentationLink link:calculationLink link:definitionLink 2148111 - Disclosure - ACCRUED LIABILITIES link:presentationLink link:calculationLink link:definitionLink 2349311 - Disclosure - ACCRUED LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 2450427 - Disclosure - ACCRUED LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 2151112 - Disclosure - CAPITAL STOCK link:presentationLink link:calculationLink link:definitionLink 2352312 - Disclosure - CAPITAL STOCK (Tables) link:presentationLink link:calculationLink link:definitionLink 2453428 - Disclosure - CAPITAL STOCK - NARRATIVE (Details) link:presentationLink link:calculationLink link:definitionLink 2454429 - Disclosure - CAPITAL STOCK - OPTION ACTIVITY (Details) link:presentationLink link:calculationLink link:definitionLink 2455430 - Disclosure - CAPITAL STOCK- SUMMARY OF INFORMATION BY EXERCISE PRICE RANGE (Details) link:presentationLink link:calculationLink link:definitionLink 2456431 - Disclosure - CAPITAL STOCK CAPITAL STOCK - RESTRICTED STOCK (Details) link:presentationLink link:calculationLink link:definitionLink 2157113 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 2358313 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables) link:presentationLink link:calculationLink link:definitionLink 2459432 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (Details) link:presentationLink link:calculationLink link:definitionLink 2160114 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 2461433 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) link:presentationLink link:calculationLink link:definitionLink 2162115 - Disclosure - INTEREST AND OTHER (INCOME) EXPENSE, NET link:presentationLink link:calculationLink link:definitionLink 2363314 - Disclosure - INTEREST AND OTHER (INCOME) EXPENSE, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 2464434 - Disclosure - INTEREST AND OTHER (INCOME) EXPENSE, NET (Details) link:presentationLink link:calculationLink link:definitionLink 2165116 - Disclosure - CREDIT FACILITY AND LONG-TERM DEBT link:presentationLink link:calculationLink link:definitionLink 2366315 - Disclosure - CREDIT FACILITY AND LONG-TERM DEBT CREDIT FACILITY AND LONG-TERM DEBT (Tables) link:presentationLink link:calculationLink link:definitionLink 2467435 - Disclosure - CREDIT FACILITY AND LONG-TERM DEBT CREDIT FACILITY AND LONG-TERM DEBT - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2468436 - Disclosure - CREDIT FACILITY AND LONG-TERM DEBT CREDIT FACILITY AND LONG-TERM DEBT - Carrying Amount of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2469437 - Disclosure - CREDIT FACILITY AND LONG-TERM DEBT CREDIT FACILITY AND LONG-TERM DEBT - Interest Expense Related to the Notes (Details) link:presentationLink link:calculationLink link:definitionLink 2170117 - Disclosure - CONVERTIBLE NOTE RECEIVABLE link:presentationLink link:calculationLink link:definitionLink 2371316 - Disclosure - CONVERTIBLE NOTE RECEIVABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 2472438 - Disclosure - CONVERTIBLE NOTE RECEIVABLE (Details) link:presentationLink link:calculationLink link:definitionLink 2473439 - Disclosure - CONVERTIBLE NOTE RECEIVABLE - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 2174118 - Disclosure - SEGMENT REPORTING link:presentationLink link:calculationLink link:definitionLink 2375317 - Disclosure - SEGMENT REPORTING (Tables) link:presentationLink link:calculationLink link:definitionLink 2476440 - Disclosure - SEGMENT REPORTING (Details) link:presentationLink link:calculationLink link:definitionLink 2177119 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 2478441 - Disclosure - SUBSEQUENT EVENTS (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 14 hska-20201231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 15 hska-20201231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 16 hska-20201231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Revision of Prior Period [Axis] Revision of Prior Period [Axis] Intrinsic value of options outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Common stock issued as partial consideration of Cuattro acquisition transactions (See Note 3) Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Shares Issued, Value Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Shares Issued, Value Related Party [Axis] Related Party [Axis] Germany GERMANY Interest expense related to amortization of the debt discount Amortization of Debt Discount (Premium) Deferred tax liability Deferred tax liability Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Foreign intangible Deferred Tax Liabilities, Foreign Intangible Deferred Tax Liabilities, Foreign Intangible Increase in number of share to be repurchased Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized Measurement period adjustment to prior year acquisition Goodwill, Purchase Accounting Adjustments Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] Incentive Stock Options Incentive Stock Options [Member] Incentive Stock Options [Member] Range [Domain] Statistical Measurement [Domain] LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities and Equity [Abstract] 2025 Lessor, Operating Lease, Payment to be Received, Year Five Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Finance lease amortization expense Finance Lease, Right-of-Use Asset, Amortization Convertible notes, equity Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt Preferred Stock Preferred Stock [Member] Security Exchange Name Security Exchange Name Offering period Share-based Compensation Arrangement by Share-based Payment Award, Offering Period Share-based Compensation Arrangement by Share-based Payment Award, Offering Period Total current liabilities Liabilities, Current Accounts Receivable and Allowance for Doubtful Accounts Accounts Receivable [Policy Text Block] Performance Shares Performance Shares [Member] Nonvested, at period start (in dollars per share) Nonvested, at period end (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Total lease payments Finance Lease, Liability, Payment, Due Change in valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent INTEREST AND OTHER (INCOME) EXPENSE, NET Interest and Other Income [Text Block] Operating lease liabilities, current Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Liability, Current Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Liability, Current ASSETS Assets [Abstract] Investment, Name [Axis] Investment, Name [Axis] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Accounting Policies [Abstract] Accounting Policies [Abstract] International International [Member] International Issuance of common stock, net of shares withheld for employee taxes Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture Cash paid for amounts included in the measurement of lease liabilities: Operating Lease, Payments Sales-type Lease, Lease Income Sales-type Lease, Lease Income [Table Text Block] ACCUMULATED OTHER COMPREHENSIVE INCOME Comprehensive Income (Loss) Note [Text Block] Share Purchase Plan 2003 Share Purchase Plan 2003 [Member] Share Purchase Plan 2003 [Member] ACCRUED LIABILITIES Accounts Payable and Accrued Liabilities Disclosure [Text Block] Other International Other International [Member] Other International Acquired finite-lived intangible assets, weighted average useful life Acquired Finite-lived Intangible Assets, Weighted Average Useful Life 2021 Lessee, Operating Lease, Liability, to be Paid, Year One Monthly withholding for compensation payment Share-based Compensation Arrangement By Share-based Payment Award, Monthly Withholding For Compensation Payment Share-based Compensation Arrangement By Share-based Payment Award, Monthly Withholding For Compensation Payment Options outstanding (in shares) Outstanding at beginning of period Outstanding at end of period Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 2024 Lessee, Operating Lease, Liability, to be Paid, Year Four Number of shares authorized to be repurchased annually Share-based Compensation Arrangement by Share-based Payment Award, Number Of Shares Authorized To Be Purchased Annually Share-based Compensation Arrangement by Share-based Payment Award, Number Of Shares Authorized To Be Purchased Annually Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Canada CANADA State Current State and Local Tax Expense (Benefit) Beginning balance (in shares) Ending balance (in shares) Shares, Outstanding Preferred stock, $.01 par value, 2,500,000 shares authorized, none issued or outstanding Preferred Stock, Value, Issued Switzerland SWITZERLAND Exercise price, lower range limit Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit Supply commitment term Supply Commitment, Term Supply Commitment, Term Total operating expenses Operating Expenses Building Building [Member] Other comprehensive (loss) income: Other Comprehensive Income (Loss), Net of Tax [Abstract] Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Other liabilities Other Liabilities, Noncurrent Business Acquisition, Pro Forma Net Income (Loss), Including Portion Attributable To Noncontrolling Interest Business Acquisition, Pro Forma Net Income (Loss), Including Portion Attributable To Noncontrolling Interest Business Acquisition, Pro Forma Net Income (Loss), Including Portion Attributable To Noncontrolling Interest Financing cash outflows - finance leases Finance Lease, Principal Payments Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] Related party - amount of transaction Related Party Transaction, Amounts of Transaction Inventories Total inventory, net Inventory, Net Concentration risk, percentage Concentration Risk, Percentage Asset acquisition, consideration transferred Asset Acquisition, Consideration Transferred Asset Acquisition, Consideration Transferred Statement [Line Items] Statement [Line Items] Convertible preferred stock, shares issuable upon conversion (in shares) Convertible Preferred Stock, Shares Issuable Upon Conversion Convertible Preferred Stock, Shares Issuable Upon Conversion Weekly hours requirement for plan eligibility Share-based Compensation Arrangement by Share-based Payment Award, Weekly Requirement For Plan Eligibility Share-based Compensation Arrangement by Share-based Payment Award, Weekly Requirement For Plan Eligibility Schedule of antidilutive securities excluded from computation of earnings per share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Class of Stock [Domain] Class of Stock [Domain] Tax Period [Axis] Tax Period [Axis] Executive compensation limit Effective Income Tax Rate Reconciliation, Executive Compensation Limit, Percent Effective Income Tax Rate Reconciliation, Executive Compensation Limit, Percent Transaction costs Effective Income Tax Rate Reconciliation, Transaction Costs, Percent Effective Income Tax Rate Reconciliation, Transaction Costs, Percent Statement [Table] Statement [Table] Warranty Costs Standard Product Warranty, Policy [Policy Text Block] Range [Axis] Statistical Measurement [Axis] Other current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other Change in tax rate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent Convertible note, non-current, net Convertible Debt, Noncurrent Schedule of interest expense (income) and other income, net Interest Expense (Income) and Other Income, Net [Table Text Block] Interest Expense (Income) and Other Income, Net Purchase of minority interest Payments to Acquire Additional Interest in Subsidiaries Entity Small Business Entity Small Business Henry Schein Henry Schein [Member] Henry Schein [Member] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] CREDIT FACILITY AND LONG-TERM DEBT Debt Disclosure [Text Block] Prepaid expenses Prepaid Expense, Current Cost of revenue Cost of Revenue Covetrus Covetrus [Member] Covetrus Amendment Flag Amendment Flag Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Number of shares authorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Other Other Accrued Liabilities, Current Purchase commitment, remaining minimum amount committed Purchase Commitment, Remaining Minimum Amount Committed Spain SPAIN Payments of related party debts Repayments of related party debt Repayments of Related Party Debt Machinery and equipment Inventory Transferred To Machinery And Equipment [Member] Inventory Transferred To Machinery And Equipment [Member] Accrued settlement Loss Contingency, Accrual, Current PVD Other Revenue, Other Pharmaceuticals, Vaccines And Diagnostic Tests [Member] Other Revenue, Other Pharmaceuticals, Vaccines And Diagnostic Tests [Member] Business combination, contingent consideration arrangements, change in range of outcomes, contingent consideration, liability, value, low Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, Low Investments in Unconsolidated Affiliates Equity Method Investments [Policy Text Block] Debt Instrument, Redemption, Period Three Debt Instrument, Redemption, Period Three [Member] General Fluidics Corporation General Fluidics Corporation [Member] General Fluidics Corporation [Member] Business combination, earn-out period Business Combination, Earn-out Period Business Combination, Earn-out Period $6.23 - $108.25 Exercise Price Range Six [Member] Exercise Price Range Six Capital Expenditures Capital Expenditures Incurred but Not yet Paid SUBSEQUENT EVENTS Subsequent Events [Text Block] Shares issued during period Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period France FRANCE Total unrecognized compensation expense related to outstanding stock options Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Lessor, Leases Lessor, Leases [Policy Text Block] Assumed exercise of dilutive stock options and restricted stock awards (in shares) Weighted Average Number Diluted Shares Outstanding Adjustment Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Employee Stock Employee Stock [Member] Schedule of restricted stock transactions Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Issuance of common stock related to acquisition of assets from Cuattro, LLC Stock Issued During Period, Value, Acquisitions Non-temporary stock option benefit Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent Payments for asset acquisition Payments For Asset Acquisitions Payments For Asset Acquisitions 2022 Lessee, Operating Lease, Liability, to be Paid, Year Two CASH FLOWS FROM FINANCING ACTIVITIES: Net Cash Provided by (Used in) Financing Activities [Abstract] Maximum percent of annual base earnings withholding for purchases of stock Share-based Compensation Arrangement by Share-based Payment Award, Maximum Percent Of Annual Base Earnings Withholding For Purchases Of Stock Share-based Compensation Arrangement by Share-based Payment Award, Maximum Percent Of Annual Base Earnings Withholding For Purchases Of Stock Deferred revenue Deferred Tax Assets, Deferred Income Lease, Cost Lease, Cost [Table Text Block] 2023 Lessee, Operating Lease, Liability, to be Paid, Year Three Other non-current assets Other Assets, Noncurrent Plan Name [Axis] Plan Name [Axis] Total assets Total Assets Assets CONVERTIBLE NOTE RECEIVABLE Related Party Transactions Disclosure [Text Block] Interest income Interest Income, Deposits with Financial Institutions Preferred stock, convertible, conversion price (in dollars per share) Preferred Stock, Convertible, Conversion Price Preferred Stock, Convertible, Conversion Price Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain] Exercise Price Range [Domain] Interest expense, debt Total interest expense related to debt Interest Expense, Debt Non-vested, period start (in shares) Non-vested, period end (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Backlog Order or Production Backlog [Member] Finance Leases Finance Lease, Liability, Payment, Due [Abstract] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Antidilutive Securities [Axis] Antidilutive Securities [Axis] LEASES Lessor, Operating Leases [Text Block] Other (gains) losses Unrealized (gain) loss on foreign currency translation Unrealized gain loss on foreign currency transactions Concentration of Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Eli Lilly Eli Lilly [Member] Eli Lilly [Member] Options Exercisable - Weighted Average Exercise Price (in dollars per share) Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price Revenue, Initial Application Period Cumulative Effect Transition [Line Items] Revenue, Initial Application Period Cumulative Effect Transition [Line Items] Cash and cash equivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Total liabilities Liabilities Income Tax Contingency [Line Items] Income Tax Contingency [Line Items] Expected volatility (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Italy ITALY POC Lab Consumables Point Of Care Laboratory Revenue, Consumables [Member] Point Of Care Laboratory Revenue, Consumables [Member] $71.85 - $108.25 Exercise Price Range Five [Member] Exercise Price Range Five [Member] Public Common Stock Public Common Stock [Member] Public Common Stock [Member] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Unrecognized tax benefits, income tax penalties and interest expense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense Inventories Increase (Decrease) in Inventories Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Valuation allowance, deferred tax asset, increase (decrease), amount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount POC Operating Leases Point Of Care Laboratory Revenue, Operating Leases [Member] Point Of Care Laboratory Revenue, Operating Leases   Additional Paid-in Capital Additional Paid-in Capital [Member] Reverse stock split conversion ratio Stockholders' Equity Note, Stock Split, Conversion Ratio Finance lease, interest expense Finance Lease, Interest Expense Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Machinery and equipment Machinery and Equipment [Member] Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Investments in unconsolidated affiliates Equity Method Investments Common stock, shares outstanding Common Stock, Shares, Outstanding Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract]     Common Stock Public And Common Stock [Member] Public And Common Stock [Member] Revolving Credit Facility Revolving Credit Facility [Member] Income (loss) before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Business combination, achievement of performance metrics subsequent to contingent earn-out Business Combination, Achievement Of Performance Metrics Subsequent To Contingent Earn-out Business Combination, Achievement Of Performance Metrics Subsequent To Contingent Earn-out Other Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Net investment in leases, non-current Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Investment In Leases Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Investment In Leases Acquisition of scil, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Common stock, shares authorized Common Stock, Shares Authorized Percentage of voting interest acquired Business Acquisition, Percentage of Voting Interests Acquired Proceeds from stock options exercised Proceeds from Stock Options Exercised Property and equipment, gross Property, Plant and Equipment, Gross Federal Deferred Federal Income Tax Expense (Benefit) Operating lease liabilities, non-current Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Operating Lease, Liability Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Operating Lease, Liability Senior Convertible Note Senior Convertible Note [Member] Senior Convertible Note [Member] Due to related parties Increase (Decrease) in Due to Related Parties Income Statement [Abstract] Income Statement [Abstract] Total Accumulated Other Comprehensive Income AOCI Attributable to Parent [Member] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Cash paid for interest Interest Paid, Including Capitalized Interest, Operating and Investing Activities Debt instrument, debt issuance costs, net Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Use of Estimates Use of Estimates, Policy [Policy Text Block] Business combination, achievement of performance metrics contingent earn-out Business Combination, Achievement Of Performance Metrics Contingent Earn-out Business Combination, Achievement Of Performance Metrics Contingent Earn-out Schedule of intangible assets acquired Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block] Schedule of pricing models Fair Value Option, Disclosures [Table Text Block] Income Tax Authority [Domain] Income Tax Authority [Domain] Accounts payable Increase (Decrease) in Accounts Payable, Trade Capitalized contract costs Capitalized Contract Cost, Net Debt instrument, shares issuable upon conversion (in shares) Debt Instrument, Shares Issuable Upon Conversion Debt Instrument, Shares Issuable Upon Conversion Counterparty Name [Domain] Counterparty Name [Domain] Consolidation Items [Domain] Consolidation Items [Domain] Business combination, contingent consideration, liability Business Combination, Contingent Consideration, Liability GOOWILL AND OTHER INTANGIBLES Goodwill and Intangible Assets Disclosure [Text Block] Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Remaining number of shares authorized to be repurchased Common Stock, Capital Shares Reserved for Future Issuance Equity in losses of unconsolidated affiliates Equity in losses of unconsolidated affiliates Income (Loss) from Equity Method Investments Income (loss) before income taxes and equity in losses of unconsolidated affiliates Income (loss) before income taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Other deferred differences Effective Income Tax Rate Reconciliation, Other Deferred Differences, Percent Effective Income Tax Rate Reconciliation, Other Deferred Differences, Percent Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Table] Schedule of inventory Schedule of Inventory, Current [Table Text Block] Net operating loss carryforwards – domestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic Entity [Domain] Entity [Domain] Goodwill attributable to acquisitions (subject to change) Goodwill, Acquired During Period Lessor, Operating Lease, Payments, Fiscal Year Maturity [Abstract] Lessor, Operating Lease, Payments, Fiscal Year Maturity [Abstract] Debt instrument, convertible, if-converted value in excess of principal Debt Instrument, Convertible, If-converted Value in Excess of Principal Property plant and equipment, useful life Property, Plant and Equipment, Useful Life Affiliated Entity Affiliated Entity [Member] Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table] Share-based Payment Arrangement, Option, Exercise Price Range [Table] Total net deferred tax assets (liabilities) Deferred Tax Assets, Net Restricted Stock Restricted Stock [Member] Accounts receivable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Share-based Payment Arrangement [Abstract] Land Land [Member] Operating lease liabilities, current Operating Lease, Liability, Current Warranty reserve Standard and Extended Product Warranty Accrual Finance leases Right-of-Use Asset Obtained in Exchange for Finance Lease Liability Debt instrument, convertible, threshold business trading days Debt Instrument, Convertible, Threshold Business Trading Days Debt Instrument, Convertible, Threshold Business Trading Days Forfeited (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Accounts Receivable Accounts Receivable [Member] Finite-lived intangible assets, remaining amortization period Finite-Lived Intangible Assets, Remaining Amortization Period Customer [Domain] Customer [Domain] Cumulative Effect, Period of Adoption, Adjustment Cumulative Effect, Period of Adoption, Adjustment [Member] Foreign Currency Gain on Intra-Entity Transactions Accumulated Foreign Currency Gain On Intra-Entity Transactions [Member] Accumulated Foreign Currency Gain On Intra-Entity Transactions Entity Registrant Name Entity Registrant Name Subsequent Event Type [Domain] Subsequent Event Type [Domain] Business Acquisition [Line Items] Business Acquisition [Line Items] Operating Operating Lease, Weighted Average Discount Rate, Percent Other liabilities Increase (Decrease) in Other Operating Liabilities POC Sales-type leases Point Of Care Laboratory Revenue, Sales-Type Leases [Member] Point Of Care Laboratory Revenue, Sales-Type Leases [Member] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Less: imputed interest Finance Lease, Liability, Undiscounted Excess Amount Consideration transferred shares issued Asset Acquisition, Consideration Transferred, Equity Instruments Issued Or Issuable Asset Acquisition, Consideration Transferred, Equity Instruments Issued Or Issuable Conversion to common stock Stock Issued During Period, Value, Conversion of Convertible Securities Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Less: interest Lessor, Operating Lease, Payment to be Received, Undiscounted Excess Amount Lessor, Operating Lease, Payment to be Received, Undiscounted Excess Amount Depreciation and amortization Depreciation and Amortization Depreciation, Depletion and Amortization, Nonproduction Adjustments for New Accounting Pronouncements [Axis] Accounting Standards Update [Axis] Schedule of cash and cash equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Operating Loss Carryforwards [Line Items] Operating Loss Carryforwards [Line Items] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Debt Instrument, Redemption, Period Two Debt Instrument, Redemption, Period Two [Member] Goodwill Goodwill Carrying amount Carrying amount Goodwill Deferred revenue, non-current Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Deferred Revenue Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Deferred Revenue Number of consecutive monthly payments Related Party Transaction, Number Of Consecutive Monthly Payments Related Party Transaction, Number Of Consecutive Monthly Payments Deferred tax assets, operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards Face amount Principal amount of the Notes Debt Instrument, Face Amount Other current assets Other Assets, Current Schedule of changes in goodwill Schedule of Goodwill [Table Text Block] Forfeitures in period (in shares) Forfeited Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Optomed Optomed [Member] Optomed [Member] Equity [Abstract] Equity [Abstract] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Indefinite-lived intangible assets acquired Indefinite-lived Intangible Assets Acquired Net investment in leases, current Net Investment in Lease, Current Deferred revenue, current, and other Contract with Customer, Liability, Current Business combination, subsequent to initial earn-out period Business Combination, Subsequent To Initial Earn-out Period Business Combination, Subsequent To Initial Earn-out Period Granted at Market (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Customer Concentration Risk Customer Concentration Risk [Member] Schedule of estimated future amortization expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Weighted average outstanding shares used to compute diluted (loss) earnings per share attributable to Heska Corporation Diluted weighted-average common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Diluted Letter of Credit Letter of Credit [Member] Intangible asset acquired Non-Marketable Equity Security Investment, Intangible Assets Acquired Non-Marketable Equity Security Investment, Intangible Assets Acquired Other Income and Expenses [Abstract] Other Income and Expenses [Abstract] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Selling and marketing Selling and Marketing Expense Accretion of discounts and issuance costs Amortization of Debt Issuance Costs and Discounts Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Schedule of shares authorized under stock options plans by exercise price range Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block] Remaining performance obligation Revenue, Remaining Performance Obligation, Amount Tax Credit Carryforward, Name [Domain] Tax Credit Carryforward, Name [Domain] Unrecognized tax benefits Balance at beginning of period Balance at the end of period Unrecognized Tax Benefits Counterparty Name [Axis] Counterparty Name [Axis] Common stock, $.01 par value, 13,250,000 and 10,250,00 shares authorized, respectively, none issued or outstanding Common Stock, Value, Issued Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Document Fiscal Year Focus Document Fiscal Year Focus 2022 Finite-Lived Intangible Asset, Expected Amortization, Year Two Entity Current Reporting Status Entity Current Reporting Status Sale of stock, price per share (in dollars per share) Sale of Stock, Price Per Share Related Party Transaction [Axis] Related Party Transaction [Axis] Earnings Per Share Earnings Per Share, Policy [Policy Text Block] Comprehensive (loss) income Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Inventory Disclosure [Abstract] Common stock, shares issued Common Stock, Shares, Issued Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Number of Options Outstanding at December 31, 2020 Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding Operating lease liability Operating Lease, Liability Total net deferred tax assets (liabilities) Deferred Tax Liabilities, Net Intangible assets acquired, useful life Non-Marketable Equity Security Investment, Intangible Assets Acquired, Useful Life Non-Marketable Equity Security Investment, Intangible Assets Acquired, Useful Life Segment Reporting [Abstract] Segment Reporting [Abstract] Debt Instrument [Line Items] Debt Instrument [Line Items] Total stockholders' equity Stockholders' Equity Attributable to Parent Purchase price Total fair value of consideration transferred Business Combination, Consideration Transferred Raw materials Inventory, Raw Materials, Gross Entity Address, City or Town Entity Address, City or Town Accrued payroll and employee benefits Employee-related Liabilities, Current Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Acquisition of intangible asset Payments to Acquire Intangible Assets Restricted Stock Restricted Stock Units (RSUs) [Member] 2025 Lessee, Operating Lease, Liability, to be Paid, Year Five Type of Adoption [Domain] Accounting Standards Update [Domain] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets [Axis] Contract cost average term Capitalized Contract Costs, Average Term Capitalized Contract Costs, Average Term Sales-type leases Deferred Tax Liabilities, Leasing Arrangements Deferred tax assets, valuation allowance Valuation allowance Deferred Tax Assets, Valuation Allowance Liabilities Liabilities [Abstract] Construction in progress Construction in Progress [Member] 2023 Finite-Lived Intangible Asset, Expected Amortization, Year Three Performance Metric Earn Out, Initial Period Performance Metric Earn Out, Initial Period [Member] Performance Metric Earn Out, Initial Period Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Other liabilities Finance Lease, Liability, Noncurrent Other comprehensive (loss) income Other Comprehensive Income (Loss), Net of Tax Investment, Name [Domain] Investment, Name [Domain] Work in process Inventory, Work in Process, Gross Leases [Abstract] Leases [Abstract] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Investments in unconsolidated affiliates Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Investment In Unconsolidated Investments Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Investment In Unconsolidated Investments Total current assets Assets, Current Comprehensive loss attributable to redeemable non-controlling interest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Operating loss carryforwards Operating Loss Carryforwards Earnings Per Share [Abstract] Earnings Per Share [Abstract] Temporary differences to the components of deferred tax assets Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] State income taxes, net of federal benefit Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Pension Adjustments Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Stockholders' equity: Stockholders' Equity Attributable to Parent [Abstract] 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Five Document Fiscal Period Focus Document Fiscal Period Focus Equity Investment Effective Income Tax Rate Reconciliation, Equity Method Investment Effective Income Tax Rate Reconciliation, Equity Method Investment Software Development Software Development [Member] Sales-type lease revenue Sales-type Lease, Revenue Operating lease right-of-use assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Right-Of-Use Asset Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Right-Of-Use Asset Foreign earnings repatriated Foreign Earnings Repatriated Capitalized contract costs during the period Capitalized Contract Costs During The Period Capitalized Contract Costs During The Period Debt instrument, redemption price, percentage Debt Instrument, Redemption Price, Percentage Series X Convertible Preferred Stock Series X Convertible Preferred Stock [Member] Series X Convertible Preferred Stock [Member] Customer relationships and other Customer Relationships And Other [Member] Customer Relationships And Other [Member] Number of warehouses Number Of Warehouses Number Of Warehouses Entity Filer Category Entity Filer Category Common Stock Common Stock [Member] Foreign Currency Translation Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Product and Service [Domain] Product and Service [Domain] Office furniture & equipment Office Furniture And Equipment [Member] Office Furniture And Equipment [Member] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Related party convertible note receivable, net Net carrying amount Notes Receivable, Related Parties Finance Finance Lease, Weighted Average Discount Rate, Percent Net investment in leases, current Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Investment In Leases Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Investment In Leases Transfers of equipment between inventory and property and equipment, net Property, Plant and Equipment, Transfers and Changes 2021 Lessor, Operating Lease, Payment to be Received, Year One Convertible debt equity component Deferred Tax Liabilities, Convertible Debt Equity Component Deferred Tax Liabilities, Convertible Debt Equity Component Noncash Debt Interest Expense Calculation Noncash Debt Interest Expense Calculation [Member] Noncash Debt Interest Expense Calculation Sales Revenue, Net Revenue Benchmark [Member] Initial Purchasers Initial Purchasers [Member] Initial Purchasers [Member] Schedule of Equity Method Investments [Line Items] Schedule of Equity Method Investments [Line Items] Revision of Prior Period [Domain] Revision of Prior Period [Domain] Debt instrument, interest rate, stated percentage Debt Instrument, Interest Rate, Stated Percentage Expected timing of satisfaction Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Foreign tax credit carryforward Deferred Tax Assets, Tax Credit Carryforwards, Foreign Schedule of Related Party Transactions Schedule of Related Party Transactions [Table Text Block] Contract liabilities, increase due to additional deferred sales Contract with Customer, Liability, Increase Due To Additional Deferred Sales Contract with Customer, Liability, Increase Due To Additional Deferred Sales Exercises in period (in shares) Exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Research and development tax credit Deferred Tax Assets, Tax Credit Carryforwards, Research $12.79 - $39.76 Exercise Price Range Two [Member] Exercise Price Range Two [Member] Employee Stock Purchase Plan, Purchase Price, Greater Of Employee Stock Purchase Plan, Purchase Price, Greater Of [Member] Employee Stock Purchase Plan, Purchase Price, Greater Of [Member] NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Interest and other expense (income) Nonoperating Income (Expense) ACQUISITION AND RELATED PARTY ITEMS Business Combination Disclosure [Text Block] Public common stock, $.01 par value, 13,250,000 and 10,250,000 shares authorized, 9,475,845 and 7,881,928 shares issued and outstanding, respectively Public Common Stock, Value, Issued Public Common Stock, Value, Issued Stock options and restricted shares Share-based Payment Arrangement, Option [Member] Subsequent Events [Abstract] Subsequent Events [Abstract] Translation adjustments and gains (losses) from intra-entity transactions Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax State Deferred State and Local Income Tax Expense (Benefit) Domestic Income (Loss) from Continuing Operations before Income Taxes, Domestic Deferred tax assets, operating loss carryforwards, not subject to expiration Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration Tax Period [Domain] Tax Period [Domain] Related party transaction, effective interest rate Related Party Transaction, Effective Interest Rate Related Party Transaction, Effective Interest Rate Foreign income inclusion Effective Income Tax Rate Reconciliation, Foreign Income Inclusion, Percent Effective Income Tax Rate Reconciliation, Foreign Income Inclusion, Percent Beginning balance Ending balance Stockholders' equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Additional paid-in capital Additional Paid in Capital 2021 Finite-Lived Intangible Asset, Expected Amortization, Year One Profit recognized at commencement for sales-type leases Sales-type Lease, Selling Profit (Loss) Class of Stock [Axis] Class of Stock [Axis] Impairment of intangible assets (excluding goodwill) Impairment of Intangible Assets (Excluding Goodwill) Increase in authorized repurchase amount Stock Repurchase Program, Increase In Remaining Authorized Repurchase Amount Stock Repurchase Program, Increase In Remaining Authorized Repurchase Amount Accrued liabilities Accrued liabilities Accrued Liabilities, Current Preferred Stock Proceeds Proceeds from Issuance of Preferred Stock and Preference Stock Diluted earnings per share attributable to Heska Corporation (in dollars per share) Earnings Per Share, Diluted Schedule of revenue from external customers and long-lived assets, by geographical areas Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] Schedule of unrecognized tax benefits roll forward Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] Goodwill, Intangible and Other Long-Lived Assets Goodwill and Intangible Assets, Policy [Policy Text Block] Weighted Average Remaining Contractual Life in Years Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term Entity Address, Address Line One Entity Address, Address Line One Non-compete agreements Noncompete Agreements [Member] Entity Emerging Growth Company Entity Emerging Growth Company Indefinite-lived intangible assets Indefinite-lived Intangible Assets (Excluding Goodwill) Debt instrument, convertible, threshold consecutive trading days Debt Instrument, Convertible, Threshold Consecutive Trading Days Revenue, net Business Acquisition, Pro Forma Revenue Deferred income tax benefit Deferred income tax benefit Total deferred (benefit) expense Deferred Income Tax Expense (Benefit) Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Maximum Maximum [Member] Preferred stock, shares authorized Preferred Stock, Shares Authorized Convertible Note Receivable Convertible Note Receivable [Member] Convertible Note Receivable Stock and Stock Options Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost Repayments of other debt Repayments of Other Debt Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] 2023 Lessor, Operating Lease, Payment to be Received, Year Three Allowance for doubtful accounts Balances at beginning of period Balances at end of period Accounts Receivable, Allowance for Credit Loss Sales-type lease cost of revenue Cost of Goods Sold, Sales-type Lease Trading Symbol Trading Symbol Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Revenue, Initial Application Period Cumulative Effect Transition [Table] Revenue, Initial Application Period Cumulative Effect Transition [Table] Schedule of Timing of Revenue Expected to be Recognized Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block] Foreign Income (Loss) from Continuing Operations before Income Taxes, Foreign Entity Shell Company Entity Shell Company Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] 2022 Finance Lease, Liability, to be Paid, Year Two Expired (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Current percentage of total liabilities Percentage Of Total Liabilities, Current Percentage Of Total Liabilities, Current Entity Public Float Entity Public Float Real estate asset acquisition Payments to Acquire Real Estate Document Type Document Type ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Other (income) expense, net Other Nonoperating Income (Expense) Segment Reporting, Other Significant Reconciling Item [Line Items] Segment Reporting, Other Significant Reconciling Item [Line Items] Grants in period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Payables and Accruals [Abstract] Payables and Accruals [Abstract] Segments [Axis] Segments [Axis] Schedule of accumulated other comprehensive income (loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Vested (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Lessee, Leases Lessee, Leases [Policy Text Block] Contingent consideration on milestones Non-Marketable Equity Security Investment, Consideration Transferred, Contingent Consideration Amount Non-Marketable Equity Security Investment, Consideration Transferred, Contingent Consideration Amount Tax Years 2024 Through 2025 Tax Years 2024 Through 2025 [Member] Tax Years 2024 Through 2025 [Member] Line of Credit Line of Credit [Member] Thereafter Lessor, Operating Lease, Payment to be Received, after Year Five Deferred tax liability Deferred Income Tax Liabilities, Net Net intangible assets Net intangible assets Intangible Assets, Net (Excluding Goodwill) Unamortized discount Notes Receivable, Related Parties, Unamortized Discount Notes Receivable, Related Parties, Unamortized Discount Convertible debt proceeds Proceeds from convertible debt Proceeds from Convertible Debt Operating income (loss) Operating income (loss) Operating Income (Loss) Payment of debt issuance costs Payments of Debt Issuance Costs Outstanding exercise price (in dollars per share) Outstanding at beginning of period (in dollars per share) Outstanding at ending of period (in dollars per share) Options Outstanding - Weighted Average Exercise Price (in dollars per share) Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price Other long-term borrowings Other Long-term Debt, Noncurrent Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Repurchase of common stock Payments for Repurchase of Common Stock Award vesting period (in years) Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Thereafter Lessee, Operating Lease, Liability, to be Paid, after Year Five Entity Address, State or Province Entity Address, State or Province Vested (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Accounts payable Accounts Payable, Current Foreign currency adjustments Goodwill, Foreign Currency Translation Gain (Loss) POC Lab Instruments & Other Point Of Care Laboratory Revenue, Lab Instruments And Other [Member] Point Of Care Laboratory Revenue, Lab Instruments And Other Accumulated deficit Retained Earnings (Accumulated Deficit) Repayments of line of credit borrowings Repayments of Lines of Credit Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Error Correction, Type [Domain] Error Correction, Type [Domain] Net investment in leases, non-current Loans And Leases Receivable, Net Of Deferred Income, Noncurrent Loans And Leases Receivable, Net Of Deferred Income, Noncurrent Unamortized debt discount Debt Instrument, Unamortized Discount Convertible Debt Convertible Debt [Table Text Block] Cash paid for income taxes Income Taxes Paid 2021 Finance Lease, Liability, to be Paid, Year One Property and equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Deductions - write offs, net of recoveries Allowance for Doubtful Accounts Receivable, Write-offs Net of Recoveries Allowance for Doubtful Accounts Receivable, Write-offs Net of Recoveries Customer [Axis] Customer [Axis] Currency Translation Adjustment Unrecognized Tax Benefits, Decrease Resulting from Foreign Currency Translation Income Taxes Income Tax, Policy [Policy Text Block] Investments in unconsolidated affiliates Payments to acquire equity method investments Payments to Acquire Equity Method Investments Exercisable at end of period Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Weighted average remaining lease term: Weighted Average Remaining Lease Term [Abstract] Weighted Average Remaining Lease Term Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract] Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract] Convertible note receivable issuance Principal amount Origination of Notes Receivable from Related Parties Stock-based compensation APIC, Share-based Payment Arrangement, Increase for Cost Recognition North America North America [Member] Cumulative Effect, Period of Adoption, Adjusted Balance Cumulative Effect, Period of Adoption, Adjusted Balance [Member] Revenue, net Total revenue Revenue from Contract with Customer, Excluding Assessed Tax Advertising expense Advertising Expense Share price (in dollars per share) Share Price Business Acquisition [Axis] Business Acquisition [Axis] Geographical [Domain] Geographical [Domain] Capitalized contract costs, amortization Capitalized Contract Cost, Amortization Embedded derivative, fair value of embedded derivative asset Embedded Derivative, Fair Value of Embedded Derivative Asset Debt instrument, convertible, conversion ratio Debt Instrument, Convertible, Conversion Ratio Current portion of deferred revenue, and other Current portion of deferred revenue, and other Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue Issuance of common stock related to acquisition of assets from Cuattro, LLC (in shares) Stock Issued During Period, Shares, Acquisitions Foreign Deferred Foreign Income Tax Expense (Benefit) Payments to acquire non-marketable securities Payments To Acquire Non-Marketable Securities Payments To Acquire Non-Marketable Securities Entity Voluntary Filers Entity Voluntary Filers Acquisition related costs Business Combination, Acquisition Related Costs Tax Credit Carryforward [Axis] Tax Credit Carryforward [Axis] Thereafter Finite-Lived Intangible Asset, Expected Amortization, after Year Five Credit Facility [Axis] Credit Facility [Axis] Acquired additions based on prior year tax positions Acquired additions based on prior year tax positions Unrecognized Tax Benefits, Decrease Resulting from Acquisition Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Total undiscounted future maturities Lessor, Operating Lease, Payments to be Received Additions from acquisition Accounts Receivable, Allowance For Credit Loss, Increase From Acquisition Accounts Receivable, Allowance For Credit Loss, Increase From Acquisition Foreign Tax Authority Foreign Tax Authority [Member] Deferred tax asset, net Deferred Tax Assets, Net, Excluding Foreign Intangible Deferred Tax Assets, Net, Excluding Foreign Intangible Earnings or loss of acquiree since acquisition date Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual Operating Leases Lessee, Operating Lease, Liability, Payment, Due [Abstract] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Proceeds from issuance of common stock Proceeds from Issuance of Common Stock Debt Instrument, Redemption, Period One Debt Instrument, Redemption, Period One [Member] Goodwill, period increase (decrease) Goodwill, Period Increase (Decrease) Goodwill [Roll Forward] Goodwill [Roll Forward] Reconciliation of basic and diluted earnings per share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Contingent Consideration Type [Domain] Contingent Consideration Type [Domain] Repayments of debt Repayments of Debt Inventories Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Carrying values of investments in unconsolidated entities Equity Method Investments [Table Text Block] Net cash (used in) provided by operating activities Net Cash Provided by (Used in) Operating Activities Entity Central Index Key Entity Central Index Key Related Party [Domain] Related Party [Domain] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Interest and other expense (income), net Interest and other (income) expense, net Table of interest and other income expense Cuattro, LLC Cuattro, LLC [Member] Cuattro, LLC [Member] Schedule of other intangible assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Geographical [Axis] Geographical [Axis] Segments [Domain] Segments [Domain] Other long-term borrowings Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Long-term Debt, Other Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Long-term Debt, Other Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] North America Segment North America Segment [Member] North America Segment Net (loss) income attributable to Heska Corporation Business Acquisition, Pro Forma Net Income (Loss) NET EFFECT OF EXCHANGE RATE CHANGES ON CASH Effect of Exchange Rate on Cash and Cash Equivalents Weighted Average Remaining Contractual Life in Years Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Debt instrument, debt default, maximum rate increase Debt Instrument, Debt Default, Maximum Rate Increase Debt Instrument, Debt Default, Maximum Rate Increase Accumulated Other Comprehensive Income Comprehensive Income [Member] Indefinite-lived Intangible Assets [Line Items] Indefinite-lived Intangible Assets [Line Items] Federal Current Federal Tax Expense (Benefit) Amortization expense Amortization of Intangible Assets Other permanent differences Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent Percent of fair value for options granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants, Exercise Price, Percent of Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants, Exercise Price, Percent of Fair Value INVESTMENTS IN UNCONSOLIDATED AFFILIATES Equity Method Investments and Joint Ventures Disclosure [Text Block] Debt instrument, convertible, threshold percentage of stock price trigger Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger SEGMENT REPORTING Segment Reporting Disclosure [Text Block] Issuance of preferred stock Stock Issued During Period, Value, New Issues Operating cash outflows - finance leases Finance Lease, Interest Payment on Liability Purchases of property and equipment Payments to Acquire Other Property, Plant, and Equipment Title of 12(b) Security Title of 12(b) Security Schedule of accrued liabilities Schedule of Accrued Liabilities [Table Text Block] $6.23 - $12.78 Exercise Price Range One [Member] Exercise Price Range One [Member] Other intangible assets, net Net Carrying Amount Finite-Lived Intangible Assets, Net Total long-lived assets Long-Lived Assets Weighted average grant date fair value Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Performance shares not meeting performance targets (in shares) Share-Based Compensation Arrangement By Share-based Payment Award, Options, Shares Not Meeting Performance Targets Share-Based Compensation Arrangement By Share-based Payment Award, Options, Shares Not Meeting Performance Targets 2022 Lessor, Operating Lease, Payment to be Received, Year Two Vesting [Domain] Vesting [Domain] Interest expense Interest Expense Reconciliation of other significant reconciling items from segments to consolidated Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table Text Block] Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Research Tax Credit Carryforward Research Tax Credit Carryforward [Member] Schedule of components of income tax expense Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Product and Service [Axis] Product and Service [Axis] Assets and Liabilities, Lessee Assets and Liabilities, Lessee [Table Text Block] Assets and Liabilities, Lessee Period for recognition of unrecognized compensation expense Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition 2025 Finance Lease, Liability, to be Paid, Year Five Fair value of stock options granted during period Shares Granted, Value, Share-based Payment Arrangement, before Forfeiture Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table] Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table] Contract liabilities, revenue recognized Contract with Customer, Liability, Revenue Recognized Debt Instrument [Axis] Debt Instrument [Axis] Schedule of aggregate consideration and allocation of purchase price Schedule of Business Acquisitions, by Acquisition [Table Text Block] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Operating Segments Operating Segments [Member] Contingent Consideration by Type [Axis] Contingent Consideration by Type [Axis] Performance Metric Earn Out, Subsequent Period Performance Metric Earn Out, Subsequent Period [Member] Performance Metric Earn Out, Subsequent Period Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Inventory Deferred Tax Assets, Inventory Convertible debt, fair value disclosures Convertible Debt, Fair Value Disclosures Number of Options Exercisable at December 31, 2020 Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable Adjustments to reconcile net (loss) income to cash (used in) provided by operating activities: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Research and development Research and Development Expense Subsequent Event Subsequent Event [Member] Domestic Tax Authority Domestic Tax Authority [Member] Reclassification, Comparability Adjustment Reclassification, Comparability Adjustment [Policy Text Block] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Scil Animal Care Company Scil Animal Care Company [Member] Scil Animal Care Company Shares not meeting performance targets Share-Based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Shares Not Meeting Performance Targets Share-Based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Shares Not Meeting Performance Targets International Segment International Segment [Member] International Segment Debt assumed in acquisition Business Combination, Consideration Transferred, Liabilities Incurred Interest expense related to contractual coupon interest Interest Expense, Debt, Excluding Amortization Related party transaction, rate Related Party Transaction, Rate Operating lease liabilities, non-current Operating Lease, Liability, Noncurrent 2024 Finite-Lived Intangible Asset, Expected Amortization, Year Four Minimum pension liability Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Change in uncertain tax benefits Effective Income Tax Rate Reconciliation, Tax Contingency, Percent Research & development credit Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent Current assets: Assets, Current [Abstract] ASU 2020-06 Accounting Standards Update 2020-06 [Member] Accounting Standards Update 2020-06 Depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant and Equipment, Period Increase (Decrease) $39.77 - $60.94 Exercise Price Range Three [Member] Exercise Price Range Three [Member] Comprehensive (loss) income attributable to Heska Corporation Comprehensive Income (Loss), Net of Tax, Attributable to Parent 2023 Finance Lease, Liability, to be Paid, Year Three Expected dividend rate (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Effective income tax rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Income tax expense (benefit): Income Tax Expense (Benefit), Intraperiod Tax Allocation [Abstract] Annual month requirement for plan eligibility Share-based Compensation Arrangement by Share-based Payment Award, Annual Requirement For Plan Eligibility Share-based Compensation Arrangement by Share-based Payment Award, Annual Requirement For Plan Eligibility Legal Entity [Axis] Legal Entity [Axis] City Area Code City Area Code Income Tax Authority [Axis] Income Tax Authority [Axis] Document Period End Date Document Period End Date Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Unrecognized compensation costs, not probable Employee Service Share-Based Compensation, Nonvested Awards, Compensation Not Yet Recognized, Equity Instruments Other Than Options, Not Probable Awards Employee Service Share-Based Compensation, Nonvested Awards, Compensation Not Yet Recognized, Equity Instruments Other Than Options, Not Probable Awards Purchase Price Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination [Abstract] Purchase of minority interest Adjustments To Additional Paid In Capital, Purchase Of Minority Interest Adjustments To Additional Paid In Capital, Purchase Of Minority Interest Net (loss) income after equity in losses of unconsolidated affiliates Net (loss) income after equity in losses of unconsolidated affiliates Net (loss) income after equity in losses from unconsolidated affiliates Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Computer hardware & software Computer Hardware And Software [Member] Computer Hardware And Software [Member] Tax Years 2018 Through 2022 Tax Years 2018 through 2022 [Member] Tax Years 2018 through 2022 [Member] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Stock-based compensation Share-based Payment Arrangement, Noncash Expense Stock Options And Restricted Units Stock Options And Restricted Units [Member] Stock Options And Restricted Units [Member] Property and equipment Deferred Tax Assets, Property, Plant and Equipment Intangible Assets, Net (Excluding Goodwill) [Abstract] Intangible Assets, Net (Excluding Goodwill) [Abstract] Cover [Abstract] Heska Imaging Heska Imaging [Member] Heska Imaging [Member] POC Imaging Point Of Care Laboratory Revenue, Imaging [Member] Point Of Care Laboratory Revenue, Imaging Accounts payable Accounts payable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable Equity Method Investee Equity Method Investee [Member] Total lease receivables Lessor, Operating Leases, Receivables Lessor, Operating Leases, Receivables Debt instrument, convertible, remaining discount amortization period Debt Instrument, Convertible, Remaining Discount Amortization Period Net carrying amount Long-term Debt LEASES Lessee, Operating Leases [Text Block] Investments in unconsolidated affiliates Investments Investments Customer Relationships Customer Relationships [Member] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Equity Components [Axis] Equity Components [Axis] Sale of stock, consideration received per transaction Sale of Stock, Consideration Received Per Transaction Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Deferred tax assets, gross Deferred Tax Assets, Gross Shares issued as consideration, value Asset Acquisition, Consideration Transferred, Equity Issued, Value Asset Acquisition, Consideration Transferred, Equity Issued, Value Minimum Minimum [Member] Total assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Cash paid for amounts included in the measurement of lease liabilities: Cash Flow, Lessee [Abstract] Cash Flow, Lessee Net loss attributable to redeemable non-controlling interest Net Income (Loss) Attributable to Noncontrolling Interest Equity Method Investments and Joint Ventures [Abstract] Equity Method Investments and Joint Ventures [Abstract] Gross margin Gross Margin Gross Margin Contract receivables, noncurrent Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent Entity Interactive Data Current Entity Interactive Data Current United States UNITED STATES Exercised (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Accrued compensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation Revenues [Abstract] Revenues [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Net Cash Provided by (Used in) Operating Activities [Abstract] Number of stock option plans Share-based Compensation Arrangement by Share-based Payment Award, Number Of Option Plans Share-based Compensation Arrangement by Share-based Payment Award, Number Of Option Plans Schedule of stock options plans Share-based Payment Arrangement, Option, Activity [Table Text Block] MBio Diagnostics, Inc. MBio Diagnostics, Inc. [Member] MBio Diagnostics, Inc. [Member] Stock-Based Compensation Share-based Payment Arrangement [Policy Text Block] Foreign Current Foreign Tax Expense (Benefit) Share Purchase Plan 1997 Share Purchase Plan 1997 [Member] Share Purchase Plan 1997 [Member] Litigation settlement, amount awarded to other party Litigation Settlement, Amount Awarded to Other Party Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Allowance for Doubtful Accounts Receivable [Roll Forward] Accounts Receivable, Allowance for Credit Loss [Roll Forward] Advertising Costs Advertising Cost [Policy Text Block] Proceeds from disposition of property and equipment Proceeds from Sale of Property, Plant, and Equipment Total intangible assets acquired Intangible Assets, Gross (Excluding Goodwill) OVP OVP [Member] OVP Number of reportable segments Number of Reportable Segments Consideration payable for CVM Acquisition Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Exercise Price Range [Axis] Exercise Price Range [Axis] Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Table] Debt instrument, interest rate, effective percentage Debt Instrument, Interest Rate, Effective Percentage Consolidation Items [Axis] Consolidation Items [Axis] Investment in subsidiary, net of cash acquired Payments to Acquire Other Investments Other comprehensive income Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax Accounts receivable, net of allowance for losses of $769 and $186, respectively Accounts Receivable, after Allowance for Credit Loss, Current Finished goods Inventory, Finished Goods, Gross Total lease payments Lessee, Operating Lease, Liability, to be Paid Debt instrument, convertible, threshold trading days Debt Instrument, Convertible, Threshold Trading Days Operating lease income Operating Lease, Lease Income Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period [Domain] Foreign Currency Translation Foreign Currency Transactions and Translations Policy [Policy Text Block] Document Transition Report Document Transition Report Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Axis] Schedule of weighted average valuation assumptions Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block] Deferred income tax (benefit) expense: Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract] Accrued purchase consideration payable Business Combination, Contingent Consideration, Liability, Current Other liabilities Other liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other CVM Practice CVM Practice [Member] CVM Practice Fair Value, Inputs, Level 2 Fair Value, Inputs, Level 2 [Member] Vesting [Axis] Vesting [Axis] Current income tax expense: Current Income Tax Expense (Benefit), Continuing Operations [Abstract] Subsequent Event [Line Items] Subsequent Event [Line Items] Cumulative Effect, Period of Adoption [Axis] Cumulative Effect, Period of Adoption [Axis] Credit Facility [Domain] Credit Facility [Domain] Debt instrument, convertible, conversion price (in dollars per share) Debt Instrument, Convertible, Conversion Price Basic earnings per share attributable to Heska Corporation (in dollars per share) Earnings Per Share, Basic Expected lives (in years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Schedule of Indefinite-Lived Intangible Assets [Table] Schedule of Indefinite-Lived Intangible Assets [Table] Entity File Number Entity File Number Expired Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Accrued property taxes Accrual for Taxes Other than Income Taxes, Current Operating Operating Lease, Weighted Average Remaining Lease Term Fair Value Finite-lived Intangible Assets Acquired Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] 2024 Lessor, Operating Lease, Payment to be Received, Year Four Debt instrument, collateral amount Debt Instrument, Collateral Amount ROU assets obtained in exchange for new lease obligations: Right-Of-Use Asset Obtained In Exchange For Lease Liability [Abstract] Right-Of-Use Asset Obtained In Exchange For Lease Liability GILTI permanent difference Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act, Percent Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Document Annual Report Document Annual Report Non-cash impact of operating leases Operating Lease, Non-cash Impacts Operating Lease, Non-cash Impacts Asset Acquisition [Axis] Asset Acquisition [Axis] Asset Acquisition [Axis] Changes in allowance for doubtful accounts Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Prepaid expenses Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Prepaid Expenses Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Prepaid Expenses 2024 Finance Lease, Liability, to be Paid, Year Four Borrowings of other debts Proceeds from Other Debt Subsequent Event [Table] Subsequent Event [Table] Issuance of common stock, net of shares withheld for employee taxes (in shares) Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Net assets acqiured Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Principal amount Notes Receivable, Related Parties, Face Amount Notes Receivable, Related Parties, Face Amount Weighted average purchase price of shares purchased Granted (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value CASH FLOWS FROM INVESTING ACTIVITIES: Net Cash Provided by (Used in) Investing Activities [Abstract] Other Deferred Tax Liabilities, Other Non-controlling interest in Optomed Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Percent CVM CVM [Member] CVM [Member] Leased Equipment Leased Equipment [Member] Leased Equipment [Member] Sales-type leases Deferred Tax Assets, Leasing Arrangements Deferred Tax Assets, Leasing Arrangements Accounts receivable Increase (Decrease) in Accounts Receivable Payment of preferred stock issuance costs Payments of stock issuance costs Payments of Stock Issuance Costs Concentration Risk Type [Domain] Concentration Risk Type [Domain] Total liabilities, mezzanine equity and stockholders' equity Liabilities and Equity Accumulated other comprehensive income Accumulated Other Comprehensive Income (Loss), Net of Tax INCOME TAXES Income Tax Disclosure [Text Block] Operating lease, expense Operating Lease, Cost Reductions from lapse in statutes of limitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations Total fair value of consideration transferred Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net General and administrative General and Administrative Expense Convertible Promissory Note Convertible Promissory Note [Member] Convertible Promissory Note Undistributed earnings of foreign subsisdiaries Undistributed Earnings of Foreign Subsidiaries Stock options and restricted units excluded from computation of earnings per share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Foreign tax rate differences Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent Current income tax expense Current income tax expense (benefit) Total current expense Current Income Tax Expense (Benefit) Finance Finance Lease, Weighted Average Remaining Lease Term Tax Year 2027 and later Tax Year 2027 [Member] Tax Year 2027 [Member] Equity Component [Domain] Equity Component [Domain] Gross profit Gross profit Gross Profit Property and equipment, net Total property and equipment, net Property, Plant and Equipment, Net Entity Tax Identification Number Entity Tax Identification Number Accrued taxes Accrued Purchases, Current Accrued Purchases, Current Total Leased Assets Lease, Right-of-Use Asset Lease, Right-of-Use Asset CAPITAL STOCK Share-based Payment Arrangement [Text Block] Net (loss) income attributable to Heska Corporation Net (loss) income attributable to Heska Corporation Net Income (Loss) Attributable to Parent Changes in operating assets and liabilities (net of effect of acquisitions): Increase (Decrease) in Operating Capital [Abstract] Debt instrument, convertible, carrying amount of equity component Debt Instrument, Convertible, Carrying Amount of Equity Component Distributions to non-controlling interest members Payments to Noncontrolling Interests INVENTORIES Inventory Disclosure [Text Block] Provision for credit losses Financing Receivable, Credit Loss, Expense (Reversal) Trade names Trade Names [Member] Net Assets Net Assets Total Lease Liabilities Lease, Liability Lease, Liability Current Fiscal Year End Date Current Fiscal Year End Date Operating expenses: Operating Expenses [Abstract] Error Correction, Type [Axis] Error Correction, Type [Axis] Total lease liabilities Finance Lease, Liability Other intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Developed technology Developed Technology Rights [Member] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Convertible notes Convertible Debt Net (loss) income before equity in losses of unconsolidated affiliates Income (Loss) From Continuing Operations Before Equity Method Investments, Income Taxes, Noncontrolling Interest, Net Of Taxes Income (Loss) From Continuing Operations Before Equity Method Investments, Income Taxes, Noncontrolling Interest, Net Of Taxes Thereafter Finance Lease, Liability, to be Paid, after Year Five Deferred revenue, non-current Contract with Customer, Liability, Noncurrent $60.95 - $71.84 Exercise Price Range Four [Member] Exercise Price Range Four [Member] Granted at market Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures NON-CASH TRANSACTIONS: Supplemental Cash Flow Information [Abstract] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Accumulation period Share-based Compensation Arrangement by Share-based Payment Award, Accumulation Period Share-based Compensation Arrangement by Share-based Payment Award, Accumulation Period Business Combinations and Related Party Disclosure [Abstract] Business Combinations and Related Party Disclosure [Abstract] Convertible Debt Convertible Debt [Member] Schedule of property and equipment Property, Plant and Equipment [Table Text Block] Issuance of preferred stock (in shares) Stock Issued During Period, Shares, New Issues Gross Carrying Amount Finite-Lived Intangible Assets, Gross Finite-Lived Intangible Assets, Net [Abstract] Finite-Lived Intangible Assets, Net [Abstract] Conversion to common stock (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Additions - charged to expense Accounts Receivable, Credit Loss Expense (Reversal) Less accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Contract receivables, current Contract with Customer, Asset, after Allowance for Credit Loss, Current Property and equipment, net Finance Lease, Right-of-Use Asset, after Accumulated Amortization Lessee, Operating Lease, Liability, Maturity Lessee, Operating Lease, Liability, Maturity [Table Text Block] Basis of Presentation and Consolidation Basis of Accounting, Policy [Policy Text Block] Weighted average outstanding shares used to compute basic (loss) earnings per share attributable to Heska Corporation Basic weighted-average common shares outstanding (In shares) Weighted Average Number of Shares Outstanding, Basic Meals and entertainment permanent difference Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Percent Risk-free interest rate (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Forfeited (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Lacuna Diagnostics, Inc. Lacuna Diagnostics, Inc. [Member] Lacuna Diagnostics, Inc. Plan Name [Domain] Plan Name [Domain] Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Ownership percentage Equity Method Investment, Ownership Percentage REVENUE Revenue from Contract with Customer [Text Block] Weighted average discount rate: Leases, Weighted Average Discount Rate [Abstract] Leases, Weighted Average Discount Rate ROU assets obtained in exchange for new lease obligations: Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Merck Merck [Member] Merck [Member] Total income tax expense (benefit) Income tax expense (benefit) Income Tax Expense (Benefit) CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR CASH AND CASH EQUIVALENTS, END OF YEAR Cash and cash equivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Non-marketable equity security investment Non-Marketable Equity Security Investment Non-Marketable Equity Security Investment Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] Deferred revenue, current, and other Finance Lease, Liability, Current Local Phone Number Local Phone Number Payments to acquire business Payments to Acquire Businesses, Gross Business acquisition, pro forma information Business Acquisition, Pro Forma Information [Table Text Block] Leasehold and building improvements Leasehold and Building Improvements [Member] Leasehold and Building Improvements [Member] Cumulative Effect, Period of Adoption [Domain] Cumulative Effect, Period of Adoption [Domain] Schedule of amortization expense on intangible assets Finite-lived Intangible Assets Amortization Expense [Table Text Block] Share-based Payment Arrangement, Tranche One Share-based Payment Arrangement, Tranche One [Member] Intrinsic value of options exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value Revenue of acquiree since acquisition date Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual Exercise price, upper range limit Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit Current portion of deferred revenue, and other Contract with Customer, Liability Related Party Transaction [Domain] Related Party Transaction [Domain] Other assets Increase (Decrease) in Other Operating Assets Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Convertible Preferred Stock Convertible Preferred Stock [Member] Award Type [Axis] Award Type [Axis] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Revision of Prior Period, Error Correction, Adjustment Revision of Prior Period, Error Correction, Adjustment [Member] Restricted stock vested, fair value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Other non-current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets     Accumulated Deficit Retained Earnings [Member] Preferred stock, shares outstanding Preferred Stock, Shares Outstanding OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Weighted average remaining contractual term (in years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Equity Award [Domain] Award Type [Domain] Lessor, Operating Lease, Payments to be Received, Maturity Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Table Text Block] Research and development expense Deferred Tax Assets, in Process Research and Development Non-cash conversion of preferred stock to common stock Accrued Debt Issuance Costs Accrued Debt Issuance Costs Exercisable at end of period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Net investment in leases, current, net of allowance for losses of $192 and $105, respectively Loans and Leases Receivable, Net of Deferred Income PROPERTY AND EQUIPMENT Property, Plant and Equipment Disclosure [Text Block] Accrued liabilities Accrued liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities EARNINGS PER SHARE Earnings Per Share [Text Block] Asset Acquisition [Domain] Asset Acquisition [Domain] [Domain] for Asset Acquisition [Axis] Redeemable non-controlling interest and mezzanine equity Redeemable Noncontrolling Interest, Equity, Carrying Amount Current liabilities: Liabilities, Current [Abstract] Statutory federal tax rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Income Tax Contingency [Table] Income Tax Contingency [Table] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Borrowing on line of credit Proceeds from Lines of Credit Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] EX-101.PRE 17 hska-20201231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 18 hska-20201231_g1.jpg LOGO begin 644 hska-20201231_g1.jpg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hska-20201231_g2.jpg CHART begin 644 hska-20201231_g2.jpg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˩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end XML 20 hska-20201231_htm.xml IDEA: XBRL DOCUMENT 0001038133 2020-01-01 2020-12-31 0001038133 2020-06-30 0001038133 2021-02-25 0001038133 2020-12-31 0001038133 2019-12-31 0001038133 us-gaap:CommonStockMember 2019-12-31 0001038133 us-gaap:CommonStockMember 2020-12-31 0001038133 hska:PublicCommonStockMember 2019-12-31 0001038133 hska:PublicCommonStockMember 2020-12-31 0001038133 2019-01-01 2019-12-31 0001038133 2018-01-01 2018-12-31 0001038133 us-gaap:PreferredStockMember 2017-12-31 0001038133 hska:PublicAndCommonStockMember 2017-12-31 0001038133 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001038133 us-gaap:ComprehensiveIncomeMember 2017-12-31 0001038133 us-gaap:RetainedEarningsMember 2017-12-31 0001038133 2017-12-31 0001038133 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2017-12-31 0001038133 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2017-12-31 0001038133 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:PreferredStockMember 2017-12-31 0001038133 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember hska:PublicAndCommonStockMember 2017-12-31 0001038133 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001038133 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:ComprehensiveIncomeMember 2017-12-31 0001038133 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:RetainedEarningsMember 2017-12-31 0001038133 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2017-12-31 0001038133 us-gaap:RetainedEarningsMember 2018-01-01 2018-12-31 0001038133 hska:PublicAndCommonStockMember 2018-01-01 2018-12-31 0001038133 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-12-31 0001038133 us-gaap:ComprehensiveIncomeMember 2018-01-01 2018-12-31 0001038133 us-gaap:PreferredStockMember 2018-12-31 0001038133 hska:PublicAndCommonStockMember 2018-12-31 0001038133 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001038133 us-gaap:ComprehensiveIncomeMember 2018-12-31 0001038133 us-gaap:RetainedEarningsMember 2018-12-31 0001038133 2018-12-31 0001038133 us-gaap:RetainedEarningsMember 2019-01-01 2019-12-31 0001038133 hska:PublicAndCommonStockMember 2019-01-01 2019-12-31 0001038133 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-12-31 0001038133 us-gaap:ComprehensiveIncomeMember 2019-01-01 2019-12-31 0001038133 us-gaap:PreferredStockMember 2019-12-31 0001038133 hska:PublicAndCommonStockMember 2019-12-31 0001038133 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001038133 us-gaap:ComprehensiveIncomeMember 2019-12-31 0001038133 us-gaap:RetainedEarningsMember 2019-12-31 0001038133 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2019-12-31 0001038133 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0001038133 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:PreferredStockMember 2019-12-31 0001038133 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember hska:PublicAndCommonStockMember 2019-12-31 0001038133 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001038133 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:ComprehensiveIncomeMember 2019-12-31 0001038133 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:RetainedEarningsMember 2019-12-31 0001038133 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0001038133 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001038133 hska:PublicAndCommonStockMember 2020-01-01 2020-12-31 0001038133 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001038133 us-gaap:PreferredStockMember 2020-01-01 2020-12-31 0001038133 us-gaap:ComprehensiveIncomeMember 2020-01-01 2020-12-31 0001038133 us-gaap:PreferredStockMember 2020-12-31 0001038133 hska:PublicAndCommonStockMember 2020-12-31 0001038133 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001038133 us-gaap:ComprehensiveIncomeMember 2020-12-31 0001038133 us-gaap:RetainedEarningsMember 2020-12-31 0001038133 hska:CVMMember 2020-01-01 2020-12-31 0001038133 hska:CVMMember 2019-01-01 2019-12-31 0001038133 hska:CVMMember 2018-01-01 2018-12-31 0001038133 hska:ScilAnimalCareCompanyMember 2020-01-01 2020-12-31 0001038133 hska:ScilAnimalCareCompanyMember 2019-01-01 2019-12-31 0001038133 hska:ScilAnimalCareCompanyMember 2018-01-01 2018-12-31 0001038133 hska:HenryScheinMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001038133 hska:HenryScheinMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-12-31 0001038133 srt:MinimumMember us-gaap:SoftwareDevelopmentMember 2020-01-01 2020-12-31 0001038133 srt:MaximumMember us-gaap:SoftwareDevelopmentMember 2020-01-01 2020-12-31 0001038133 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember hska:NoncashDebtInterestExpenseCalculationMember 2019-01-01 2019-12-31 0001038133 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember hska:NoncashDebtInterestExpenseCalculationMember 2020-04-01 2020-06-30 0001038133 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember hska:NoncashDebtInterestExpenseCalculationMember 2020-01-01 2020-03-31 0001038133 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember hska:NoncashDebtInterestExpenseCalculationMember 2020-07-01 2020-09-30 0001038133 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember hska:NoncashDebtInterestExpenseCalculationMember 2019-12-31 0001038133 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember hska:NoncashDebtInterestExpenseCalculationMember 2020-03-31 0001038133 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember hska:NoncashDebtInterestExpenseCalculationMember 2020-06-30 0001038133 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember hska:NoncashDebtInterestExpenseCalculationMember 2020-09-30 0001038133 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember hska:NoncashDebtInterestExpenseCalculationMember 2020-10-01 2020-12-31 0001038133 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember hska:NoncashDebtInterestExpenseCalculationMember 2020-12-31 0001038133 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember hska:AccountingStandardsUpdate202006Member us-gaap:RetainedEarningsMember us-gaap:SubsequentEventMember 2021-01-01 0001038133 srt:MinimumMember us-gaap:BuildingMember 2020-01-01 2020-12-31 0001038133 srt:MaximumMember us-gaap:BuildingMember 2020-01-01 2020-12-31 0001038133 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2020-01-01 2020-12-31 0001038133 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2020-01-01 2020-12-31 0001038133 srt:MinimumMember hska:OfficeFurnitureAndEquipmentMember 2020-01-01 2020-12-31 0001038133 srt:MaximumMember hska:OfficeFurnitureAndEquipmentMember 2020-01-01 2020-12-31 0001038133 srt:MinimumMember hska:ComputerHardwareAndSoftwareMember 2020-01-01 2020-12-31 0001038133 srt:MaximumMember hska:ComputerHardwareAndSoftwareMember 2020-01-01 2020-12-31 0001038133 srt:MinimumMember hska:LeaseholdandBuildingImprovementsMember 2020-01-01 2020-12-31 0001038133 srt:MaximumMember hska:LeaseholdandBuildingImprovementsMember 2020-01-01 2020-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:PointOfCareLaboratoryRevenueLabInstrumentsAndOtherMember hska:NorthAmericaSegmentMember 2020-01-01 2020-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:PointOfCareLaboratoryRevenueLabInstrumentsAndOtherMember hska:NorthAmericaSegmentMember 2019-01-01 2019-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:PointOfCareLaboratoryRevenueLabInstrumentsAndOtherMember hska:NorthAmericaSegmentMember 2018-01-01 2018-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:PointOfCareLaboratoryRevenueSalesTypeLeasesMember hska:NorthAmericaSegmentMember 2020-01-01 2020-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:PointOfCareLaboratoryRevenueSalesTypeLeasesMember hska:NorthAmericaSegmentMember 2019-01-01 2019-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:PointOfCareLaboratoryRevenueSalesTypeLeasesMember hska:NorthAmericaSegmentMember 2018-01-01 2018-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:PointOfCareLaboratoryRevenueConsumablesMember hska:NorthAmericaSegmentMember 2020-01-01 2020-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:PointOfCareLaboratoryRevenueConsumablesMember hska:NorthAmericaSegmentMember 2019-01-01 2019-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:PointOfCareLaboratoryRevenueConsumablesMember hska:NorthAmericaSegmentMember 2018-01-01 2018-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:PointOfCareLaboratoryRevenueImagingMember hska:NorthAmericaSegmentMember 2020-01-01 2020-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:PointOfCareLaboratoryRevenueImagingMember hska:NorthAmericaSegmentMember 2019-01-01 2019-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:PointOfCareLaboratoryRevenueImagingMember hska:NorthAmericaSegmentMember 2018-01-01 2018-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:OtherRevenueOtherPharmaceuticalsVaccinesAndDiagnosticTestsMember hska:NorthAmericaSegmentMember 2020-01-01 2020-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:OtherRevenueOtherPharmaceuticalsVaccinesAndDiagnosticTestsMember hska:NorthAmericaSegmentMember 2019-01-01 2019-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:OtherRevenueOtherPharmaceuticalsVaccinesAndDiagnosticTestsMember hska:NorthAmericaSegmentMember 2018-01-01 2018-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:OVPMember hska:NorthAmericaSegmentMember 2020-01-01 2020-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:OVPMember hska:NorthAmericaSegmentMember 2019-01-01 2019-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:OVPMember hska:NorthAmericaSegmentMember 2018-01-01 2018-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:NorthAmericaSegmentMember 2020-01-01 2020-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:NorthAmericaSegmentMember 2019-01-01 2019-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:NorthAmericaSegmentMember 2018-01-01 2018-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:PointOfCareLaboratoryRevenueLabInstrumentsAndOtherMember hska:InternationalSegmentMember 2020-01-01 2020-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:PointOfCareLaboratoryRevenueLabInstrumentsAndOtherMember hska:InternationalSegmentMember 2019-01-01 2019-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:PointOfCareLaboratoryRevenueLabInstrumentsAndOtherMember hska:InternationalSegmentMember 2018-01-01 2018-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:PointOfCareLaboratoryRevenueSalesTypeLeasesMember hska:InternationalSegmentMember 2020-01-01 2020-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:PointOfCareLaboratoryRevenueSalesTypeLeasesMember hska:InternationalSegmentMember 2019-01-01 2019-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:PointOfCareLaboratoryRevenueSalesTypeLeasesMember hska:InternationalSegmentMember 2018-01-01 2018-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:PointOfCareLaboratoryRevenueOperatingLeasesMember hska:InternationalSegmentMember 2020-01-01 2020-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:PointOfCareLaboratoryRevenueOperatingLeasesMember hska:InternationalSegmentMember 2019-01-01 2019-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:PointOfCareLaboratoryRevenueOperatingLeasesMember hska:InternationalSegmentMember 2018-01-01 2018-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:PointOfCareLaboratoryRevenueConsumablesMember hska:InternationalSegmentMember 2020-01-01 2020-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:PointOfCareLaboratoryRevenueConsumablesMember hska:InternationalSegmentMember 2019-01-01 2019-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:PointOfCareLaboratoryRevenueConsumablesMember hska:InternationalSegmentMember 2018-01-01 2018-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:PointOfCareLaboratoryRevenueImagingMember hska:InternationalSegmentMember 2020-01-01 2020-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:PointOfCareLaboratoryRevenueImagingMember hska:InternationalSegmentMember 2019-01-01 2019-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:PointOfCareLaboratoryRevenueImagingMember hska:InternationalSegmentMember 2018-01-01 2018-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:OtherRevenueOtherPharmaceuticalsVaccinesAndDiagnosticTestsMember hska:InternationalSegmentMember 2020-01-01 2020-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:OtherRevenueOtherPharmaceuticalsVaccinesAndDiagnosticTestsMember hska:InternationalSegmentMember 2019-01-01 2019-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:OtherRevenueOtherPharmaceuticalsVaccinesAndDiagnosticTestsMember hska:InternationalSegmentMember 2018-01-01 2018-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:OVPMember hska:InternationalSegmentMember 2020-01-01 2020-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:OVPMember hska:InternationalSegmentMember 2019-01-01 2019-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:OVPMember hska:InternationalSegmentMember 2018-01-01 2018-12-31 0001038133 2021-01-01 2020-12-31 0001038133 2022-01-01 2020-12-31 0001038133 2023-01-01 2020-12-31 0001038133 2024-01-01 2020-12-31 0001038133 2025-01-01 2020-12-31 0001038133 2026-01-01 2020-12-31 0001038133 hska:ScilAnimalCareCompanyMember 2020-04-01 0001038133 hska:ScilAnimalCareCompanyMember 2020-04-01 2020-04-01 0001038133 hska:ScilAnimalCareCompanyMember hska:InternationalSegmentMember 2020-04-01 0001038133 hska:ScilAnimalCareCompanyMember hska:NorthAmericaSegmentMember 2020-04-01 0001038133 hska:ScilAnimalCareCompanyMember 2020-12-31 0001038133 hska:ScilAnimalCareCompanyMember us-gaap:CustomerRelationshipsMember 2020-04-01 2020-04-01 0001038133 hska:ScilAnimalCareCompanyMember us-gaap:SoftwareDevelopmentMember 2020-04-01 2020-04-01 0001038133 hska:ScilAnimalCareCompanyMember us-gaap:OrderOrProductionBacklogMember 2020-04-01 2020-04-01 0001038133 hska:ScilAnimalCareCompanyMember us-gaap:NoncompeteAgreementsMember 2020-04-01 2020-04-01 0001038133 hska:ScilAnimalCareCompanyMember us-gaap:TradeNamesMember 2020-04-01 2020-04-01 0001038133 hska:ScilAnimalCareCompanyMember us-gaap:TradeNamesMember 2020-04-01 2020-04-01 0001038133 hska:ScilAnimalCareCompanyMember 2020-04-01 2020-09-30 0001038133 hska:CVMMember 2019-12-05 0001038133 hska:CVMMember 2019-12-05 2019-12-05 0001038133 hska:CVMMember us-gaap:CustomerRelationshipsMember 2019-12-05 2019-12-05 0001038133 hska:CVMMember us-gaap:TradeNamesMember 2019-12-05 2019-12-05 0001038133 hska:CVMMember us-gaap:DevelopedTechnologyRightsMember 2019-12-05 2019-12-05 0001038133 hska:CVMMember 2019-12-06 2019-12-31 0001038133 hska:OptomedMember 2019-02-22 0001038133 hska:OptomedMember 2019-02-22 2019-02-22 0001038133 hska:OptomedMember 2020-10-05 0001038133 hska:OptomedMember 2020-10-05 2020-10-05 0001038133 hska:CuattroLLCMember 2018-12-21 2018-12-21 0001038133 2018-12-21 0001038133 hska:HeskaImagingMember hska:CuattroLLCMember 2020-01-01 2020-12-31 0001038133 hska:HeskaImagingMember hska:CuattroLLCMember 2019-01-01 2019-12-31 0001038133 hska:HeskaImagingMember hska:CuattroLLCMember 2018-01-01 2018-12-31 0001038133 hska:CVMPracticeMember srt:AffiliatedEntityMember 2020-01-01 2020-12-31 0001038133 hska:CVMPracticeMember srt:AffiliatedEntityMember 2020-12-31 0001038133 hska:CVMPracticeMember srt:AffiliatedEntityMember 2019-01-01 2019-12-31 0001038133 hska:CVMPracticeMember srt:AffiliatedEntityMember 2019-12-31 0001038133 hska:GeneralFluidicsCorporationMember 2018-09-24 2018-09-24 0001038133 hska:GeneralFluidicsCorporationMember 2020-12-31 0001038133 hska:GeneralFluidicsCorporationMember 2018-09-24 2018-09-24 0001038133 hska:MBioDiagnosticsInc.Member 2018-08-08 2018-08-08 0001038133 hska:OptomedMember 2020-01-01 2020-12-31 0001038133 hska:OptomedMember 2019-01-01 2019-12-31 0001038133 hska:OptomedMember 2018-01-01 2018-12-31 0001038133 us-gaap:DomesticCountryMember 2020-01-01 2020-12-31 0001038133 us-gaap:ForeignCountryMember 2020-01-01 2020-12-31 0001038133 us-gaap:DomesticCountryMember 2019-01-01 2019-12-31 0001038133 us-gaap:ForeignCountryMember 2019-01-01 2019-12-31 0001038133 us-gaap:DomesticCountryMember 2018-01-01 2018-12-31 0001038133 us-gaap:DomesticCountryMember 2020-12-31 0001038133 us-gaap:ForeignCountryMember 2020-12-31 0001038133 us-gaap:DomesticCountryMember us-gaap:ResearchMember 2020-12-31 0001038133 hska:TaxYears2018through2022Member 2020-12-31 0001038133 hska:TaxYears2024Through2025Member 2020-12-31 0001038133 hska:TaxYear2027Member 2020-12-31 0001038133 us-gaap:ConvertiblePreferredStockMember 2020-01-01 2020-12-31 0001038133 us-gaap:ConvertiblePreferredStockMember 2019-01-01 2019-12-31 0001038133 us-gaap:ConvertiblePreferredStockMember 2018-01-01 2018-12-31 0001038133 hska:SeniorConvertibleNoteMember 2020-01-01 2020-12-31 0001038133 hska:SeniorConvertibleNoteMember 2019-01-01 2019-12-31 0001038133 hska:SeniorConvertibleNoteMember 2018-01-01 2018-12-31 0001038133 hska:StockOptionsAndRestrictedUnitsMember 2020-01-01 2020-12-31 0001038133 hska:StockOptionsAndRestrictedUnitsMember 2019-01-01 2019-12-31 0001038133 hska:StockOptionsAndRestrictedUnitsMember 2018-01-01 2018-12-31 0001038133 hska:SeniorConvertibleNoteMember us-gaap:ConvertibleDebtMember 2019-09-17 0001038133 hska:SeriesXConvertiblePreferredStockMember 2020-04-14 2020-04-14 0001038133 us-gaap:CommonStockMember 2020-04-14 2020-04-14 0001038133 us-gaap:OperatingSegmentsMember hska:NorthAmericaSegmentMember 2018-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:InternationalSegmentMember 2018-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:InternationalSegmentMember 2019-01-01 2019-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:NorthAmericaSegmentMember 2019-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:InternationalSegmentMember 2019-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:InternationalSegmentMember 2020-01-01 2020-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:NorthAmericaSegmentMember 2020-12-31 0001038133 us-gaap:OperatingSegmentsMember hska:InternationalSegmentMember 2020-12-31 0001038133 hska:CustomerRelationshipsAndOtherMember 2020-12-31 0001038133 hska:CustomerRelationshipsAndOtherMember 2019-12-31 0001038133 us-gaap:DevelopedTechnologyRightsMember 2020-12-31 0001038133 us-gaap:DevelopedTechnologyRightsMember 2019-12-31 0001038133 us-gaap:TradeNamesMember 2020-12-31 0001038133 us-gaap:TradeNamesMember 2019-12-31 0001038133 us-gaap:TradeNamesMember 2020-12-31 0001038133 us-gaap:TradeNamesMember 2019-12-31 0001038133 us-gaap:LandMember 2020-12-31 0001038133 us-gaap:LandMember 2019-12-31 0001038133 us-gaap:BuildingMember 2020-12-31 0001038133 us-gaap:BuildingMember 2019-12-31 0001038133 us-gaap:MachineryAndEquipmentMember 2020-12-31 0001038133 us-gaap:MachineryAndEquipmentMember 2019-12-31 0001038133 hska:OfficeFurnitureAndEquipmentMember 2020-12-31 0001038133 hska:OfficeFurnitureAndEquipmentMember 2019-12-31 0001038133 hska:ComputerHardwareAndSoftwareMember 2020-12-31 0001038133 hska:ComputerHardwareAndSoftwareMember 2019-12-31 0001038133 hska:LeaseholdandBuildingImprovementsMember 2020-12-31 0001038133 hska:LeaseholdandBuildingImprovementsMember 2019-12-31 0001038133 us-gaap:ConstructionInProgressMember 2020-12-31 0001038133 us-gaap:ConstructionInProgressMember 2019-12-31 0001038133 srt:MinimumMember hska:InventoryTransferredToMachineryAndEquipmentMember 2020-01-01 2020-12-31 0001038133 srt:MaximumMember hska:InventoryTransferredToMachineryAndEquipmentMember 2020-01-01 2020-12-31 0001038133 hska:LeasedEquipmentMember 2020-12-31 0001038133 hska:LeasedEquipmentMember 2019-12-31 0001038133 hska:SharePurchasePlan1997Member 2012-05-01 2012-05-31 0001038133 hska:SharePurchasePlan1997Member 2016-05-01 2016-05-31 0001038133 hska:SharePurchasePlan1997Member 2018-05-01 2018-05-31 0001038133 hska:SharePurchasePlan1997Member 2020-04-01 2020-04-30 0001038133 hska:SharePurchasePlan2003Member 2003-05-31 0001038133 hska:SharePurchasePlan1997Member 2020-12-31 0001038133 hska:IncentiveStockOptionsMember 2020-01-01 2020-12-31 0001038133 us-gaap:EmployeeStockOptionMember 2019-12-31 0001038133 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-12-31 0001038133 us-gaap:EmployeeStockOptionMember 2020-12-31 0001038133 hska:ExercisePriceRangeOneMember 2020-12-31 0001038133 hska:ExercisePriceRangeOneMember 2020-01-01 2020-12-31 0001038133 hska:ExercisePriceRangeTwoMember 2020-12-31 0001038133 hska:ExercisePriceRangeTwoMember 2020-01-01 2020-12-31 0001038133 hska:ExercisePriceRangeThreeMember 2020-12-31 0001038133 hska:ExercisePriceRangeThreeMember 2020-01-01 2020-12-31 0001038133 hska:ExercisePriceRangeFourMember 2020-12-31 0001038133 hska:ExercisePriceRangeFourMember 2020-01-01 2020-12-31 0001038133 hska:ExercisePriceRangeFiveMember 2020-12-31 0001038133 hska:ExercisePriceRangeFiveMember 2020-01-01 2020-12-31 0001038133 hska:ExercisePriceRangeSixMember 2020-12-31 0001038133 hska:ExercisePriceRangeSixMember 2020-01-01 2020-12-31 0001038133 us-gaap:PerformanceSharesMember 2020-04-16 2020-04-16 0001038133 us-gaap:PerformanceSharesMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2020-04-16 2020-04-16 0001038133 us-gaap:PerformanceSharesMember 2020-01-01 2020-12-31 0001038133 us-gaap:PerformanceSharesMember 2020-12-31 0001038133 srt:MaximumMember us-gaap:RestrictedStockMember 2020-01-01 2020-12-31 0001038133 us-gaap:RestrictedStockUnitsRSUMember 2019-12-31 0001038133 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-12-31 0001038133 us-gaap:RestrictedStockUnitsRSUMember 2020-12-31 0001038133 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-12-31 0001038133 us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-12-31 0001038133 us-gaap:RestrictedStockMember 2020-12-31 0001038133 us-gaap:EmployeeStockMember 2020-01-01 2020-12-31 0001038133 us-gaap:EmployeeStockMember 2019-01-01 2019-12-31 0001038133 us-gaap:EmployeeStockMember 2018-01-01 2018-12-31 0001038133 us-gaap:PreferredStockMember 2020-03-30 0001038133 us-gaap:PreferredStockMember 2020-03-30 2020-03-30 0001038133 hska:ScilAnimalCareCompanyMember 2020-03-30 2020-03-30 0001038133 srt:MinimumMember us-gaap:RestrictedStockMember 2020-01-01 2020-12-31 0001038133 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-31 0001038133 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0001038133 hska:AccumulatedForeignCurrencyGainOnIntraEntityTransactionsMember 2018-12-31 0001038133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001038133 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-12-31 0001038133 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-12-31 0001038133 hska:AccumulatedForeignCurrencyGainOnIntraEntityTransactionsMember 2019-01-01 2019-12-31 0001038133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-12-31 0001038133 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-31 0001038133 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0001038133 hska:AccumulatedForeignCurrencyGainOnIntraEntityTransactionsMember 2019-12-31 0001038133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001038133 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-12-31 0001038133 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-12-31 0001038133 hska:AccumulatedForeignCurrencyGainOnIntraEntityTransactionsMember 2020-01-01 2020-12-31 0001038133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001038133 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-12-31 0001038133 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0001038133 hska:AccumulatedForeignCurrencyGainOnIntraEntityTransactionsMember 2020-12-31 0001038133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001038133 2019-02-28 2019-02-28 0001038133 hska:InitialPurchasersMember hska:SeniorConvertibleNoteMember us-gaap:ConvertibleDebtMember 2019-09-17 0001038133 hska:SeniorConvertibleNoteMember 2019-09-17 2019-09-17 0001038133 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2020-01-01 2020-12-31 0001038133 us-gaap:LetterOfCreditMember us-gaap:LineOfCreditMember 2020-12-31 0001038133 hska:SeniorConvertibleNoteMember us-gaap:ConvertibleDebtMember 2019-09-17 2019-09-17 0001038133 hska:SeniorConvertibleNoteMember us-gaap:DebtInstrumentRedemptionPeriodOneMember us-gaap:ConvertibleDebtMember 2019-09-17 2019-09-17 0001038133 hska:SeniorConvertibleNoteMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember us-gaap:ConvertibleDebtMember 2019-09-17 2019-09-17 0001038133 hska:SeniorConvertibleNoteMember us-gaap:DebtInstrumentRedemptionPeriodThreeMember us-gaap:ConvertibleDebtMember 2019-09-17 2019-09-17 0001038133 us-gaap:ConvertibleDebtMember 2019-09-17 0001038133 hska:SeniorConvertibleNoteMember us-gaap:ConvertibleDebtMember 2020-12-31 0001038133 hska:SeniorConvertibleNoteMember us-gaap:ConvertibleDebtMember 2020-01-01 2020-12-31 0001038133 hska:SeniorConvertibleNoteMember us-gaap:ConvertibleDebtMember 2019-12-31 0001038133 hska:SeniorConvertibleNoteMember us-gaap:ConvertibleDebtMember 2019-01-01 2019-12-31 0001038133 hska:SeniorConvertibleNoteMember us-gaap:FairValueInputsLevel2Member 2020-12-31 0001038133 hska:SeniorConvertibleNoteMember 2020-01-01 2020-12-31 0001038133 hska:ConvertibleNoteReceivableMember us-gaap:EquityMethodInvesteeMember 2020-12-31 0001038133 hska:ConvertibleNoteReceivableMember us-gaap:EquityMethodInvesteeMember 2020-12-09 2020-12-09 0001038133 us-gaap:OperatingSegmentsMember hska:InternationalSegmentMember 2018-01-01 2018-12-31 0001038133 country:US 2020-01-01 2020-12-31 0001038133 country:US 2019-01-01 2019-12-31 0001038133 country:US 2018-01-01 2018-12-31 0001038133 country:CA 2020-01-01 2020-12-31 0001038133 country:CA 2019-01-01 2019-12-31 0001038133 country:CA 2018-01-01 2018-12-31 0001038133 country:DE 2020-01-01 2020-12-31 0001038133 country:DE 2019-01-01 2019-12-31 0001038133 country:DE 2018-01-01 2018-12-31 0001038133 country:FR 2020-01-01 2020-12-31 0001038133 country:FR 2019-01-01 2019-12-31 0001038133 country:FR 2018-01-01 2018-12-31 0001038133 country:ES 2020-01-01 2020-12-31 0001038133 country:ES 2019-01-01 2019-12-31 0001038133 country:ES 2018-01-01 2018-12-31 0001038133 country:IT 2020-01-01 2020-12-31 0001038133 country:IT 2019-01-01 2019-12-31 0001038133 country:IT 2018-01-01 2018-12-31 0001038133 country:CH 2020-01-01 2020-12-31 0001038133 country:CH 2019-01-01 2019-12-31 0001038133 country:CH 2018-01-01 2018-12-31 0001038133 hska:OtherInternationalMember 2020-01-01 2020-12-31 0001038133 hska:OtherInternationalMember 2019-01-01 2019-12-31 0001038133 hska:OtherInternationalMember 2018-01-01 2018-12-31 0001038133 country:US 2020-12-31 0001038133 country:US 2019-12-31 0001038133 country:US 2018-12-31 0001038133 country:CA 2020-12-31 0001038133 country:CA 2019-12-31 0001038133 country:CA 2018-12-31 0001038133 country:DE 2020-12-31 0001038133 country:DE 2019-12-31 0001038133 country:DE 2018-12-31 0001038133 country:FR 2020-12-31 0001038133 country:FR 2019-12-31 0001038133 country:FR 2018-12-31 0001038133 country:ES 2020-12-31 0001038133 country:ES 2019-12-31 0001038133 country:ES 2018-12-31 0001038133 country:IT 2020-12-31 0001038133 country:IT 2019-12-31 0001038133 country:IT 2018-12-31 0001038133 country:CH 2020-12-31 0001038133 country:CH 2019-12-31 0001038133 country:CH 2018-12-31 0001038133 hska:OtherInternationalMember 2020-12-31 0001038133 hska:OtherInternationalMember 2019-12-31 0001038133 hska:OtherInternationalMember 2018-12-31 0001038133 hska:CovetrusMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001038133 hska:CovetrusMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-12-31 0001038133 hska:CovetrusMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-12-31 0001038133 hska:CovetrusMember srt:NorthAmericaMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001038133 hska:CovetrusMember srt:NorthAmericaMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-12-31 0001038133 hska:CovetrusMember srt:NorthAmericaMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-12-31 0001038133 hska:CovetrusMember hska:InternationalMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001038133 hska:MerckMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001038133 hska:MerckMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-12-31 0001038133 hska:MerckMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-12-31 0001038133 hska:LacunaDiagnosticsIncMember us-gaap:SubsequentEventMember 2021-02-01 2021-02-01 0001038133 hska:LacunaDiagnosticsIncMember hska:PerformanceMetricEarnOutInitialPeriodMember us-gaap:SubsequentEventMember 2021-02-01 0001038133 hska:LacunaDiagnosticsIncMember hska:PerformanceMetricEarnOutInitialPeriodMember us-gaap:SubsequentEventMember 2021-02-01 2021-02-01 0001038133 hska:LacunaDiagnosticsIncMember hska:PerformanceMetricEarnOutSubsequentPeriodMember us-gaap:SubsequentEventMember 2021-02-01 2021-02-01 0001038133 us-gaap:EquityMethodInvesteeMember us-gaap:SubsequentEventMember 2021-02-01 2021-02-01 0001038133 us-gaap:EquityMethodInvesteeMember us-gaap:SubsequentEventMember 2021-02-01 iso4217:USD shares iso4217:USD shares pure iso4217:EUR iso4217:CHF iso4217:CAD iso4217:AUD iso4217:MYR hska:segment hska:plans hska:day hska:payment 0001038133 false FY 2020 186000 769000 105000 192000 0.01 0.01 2500000 2500000 0 0 0 0 0.01 0.01 10250000 13250000 0 0 0 0 0.01 0.01 10250000 13250000 7881928 9475845 7881928 9475845 P3Y P10Y P43Y P2Y P10Y P3Y P7Y P3Y P5Y P5Y P15Y 200000 P1Y P1Y P1Y P1Y P1Y 4.50 7.36 7.37 32.21 32.22 62.50 62.51 69.77 69.78 108.25 4.50 108.25 0 0 P1Y 0.0115434 P68M15D P12M P12M 10-K true 2020-12-31 --12-31 false 000-22427 HESKA CORPORATION DE 77-0192527 3760 Rocky Mountain Avenue Loveland CO 80538 970 493-7272 Common stock, $0.01 par value HSKA NASDAQ Yes No Yes Yes Large Accelerated Filer false false true false 806427745 9477240 <div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Items 10, 11, 12, 13 and 14 of Part III incorporate by reference information from the Registrant's definitive proxy statement to be filed with the Securities and Exchange Commission in connection with the solicitation of proxies for the Registrant's 2021 Annual Meeting of Stockholders to be held on or about May 5, 2021.</span></div> 86334000 89030000 31080000 15161000 40037000 26601000 4794000 3856000 3875000 2219000 5155000 3000000 171275000 139867000 35542000 15469000 5457000 5726000 88276000 36204000 55992000 11472000 5694000 6429000 15789000 14307000 6704000 7424000 6671000 0 8439000 7526000 399839000 244424000 15119000 6600000 18055000 6345000 0 14579000 2087000 1745000 6854000 2930000 42115000 32199000 48459000 45348000 4667000 5966000 554000 1121000 3858000 4413000 11856000 691000 1277000 152000 112786000 89890000 0 170000 0 0 0 0 95000 79000 423650000 290216000 14169000 513000 -150861000 -136444000 287053000 154364000 399839000 244424000 197323000 122661000 127446000 116033000 68212000 70808000 81290000 54449000 56638000 38468000 27678000 24663000 8772000 8240000 3334000 42242000 18204000 24847000 89482000 54122000 52844000 -8192000 327000 3794000 5601000 2910000 -13000 -13793000 -2583000 3807000 1780000 359000 140000 -1541000 -1805000 -2255000 239000 -1446000 -2115000 -14032000 -1137000 5922000 -720000 -594000 -72000 -14752000 -1731000 5850000 -353000 -266000 0 -14399000 -1465000 5850000 -1.66 -0.20 0.81 -1.66 -0.20 0.74 8653000 7446000 7220000 8653000 7446000 7856000 -14752000 -1731000 5850000 40000 -73000 -70000 13696000 163000 -25000 -1096000 -1495000 5895000 -353000 -266000 0 -743000 -1229000 5895000 0 0 7303000 73000 243598000 232000 -143463000 100440000 2634000 2634000 0 0 7303000 73000 243598000 232000 -140829000 103074000 5850000 5850000 318000 3000 2759000 2762000 55000 1000 5450000 5451000 5227000 5227000 45000 45000 0 0 7676000 77000 257034000 277000 -134979000 122409000 -1465000 -1465000 206000 2000 -1620000 -1618000 4968000 4968000 29834000 29834000 236000 236000 0 0 7882000 79000 290216000 513000 -136444000 154364000 -18000 -18000 0 0 7882000 79000 290216000 513000 -136462000 154346000 -14399000 -14399000 85000 1000 2795000 2796000 122000 1000 121785000 121786000 -122000 -1000 1509000 15000 -14000 0 9490000 9490000 622000 622000 13656000 13656000 0 0 9476000 95000 423650000 14169000 -150861000 287053000 -14752000 -1731000 5850000 11385000 4916000 4595000 1985000 1565000 -1541000 -1805000 -2255000 9490000 4968000 5227000 -720000 -594000 -72000 3090000 1842000 0 614000 113000 104000 -91000 560000 8000 5755000 -3683000 1180000 5409000 -918000 -6046000 271000 3580000 4590000 -280000 -1686000 -2020000 0 -226000 -1477000 159000 -6835000 2907000 -656000 3296000 13287000 0 622000 0 14420000 -927000 0 6650000 0 0 450000 0 0 104401000 0 0 0 0 2750000 0 0 8091000 0 1184000 0 686000 1044000 1358000 10000 0 25000 -126597000 -1923000 -12174000 4273000 1829000 4034000 1477000 3447000 1271000 214000 0 0 122000000 0 0 0 0 126000 0 86250000 0 1140000 0 0 0 6750000 3000000 0 12750000 3000000 613000 0 0 291000 1191000 10000 0 3177000 0 123764000 74264000 2627000 793000 4000 -10000 -2696000 75641000 3730000 89030000 13389000 9659000 86334000 89030000 13389000 4437000 827000 1449000 122000000 0 0 0 14420000 0 0 0 5450000 OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Heska Corporation and its wholly-owned subsidiaries ("Heska", the "Company", "we" or "our") sell veterinary and animal health diagnostic and specialty products. Our offerings include Point of Care diagnostic laboratory instruments and supplies; digital imaging diagnostic products, software and services; digital cytology services; vaccines; local and cloud-based data services; allergy testing and immunotherapy; and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. Our core focus is on supporting veterinarians in the canine and feline healthcare space.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation and Consolidation</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the opinion of management, the accompanying Consolidated Financial Statements contain all adjustments, consisting of normal, recurring adjustments, necessary to present fairly the financial position of the Company as of December 31, 2020 and 2019, as well as the results of our operations, statements of stockholders' equity and cash flows for the twelve months ended December 31, 2020, 2019 and 2018.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The audited Consolidated Financial Statements included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Our audited Consolidated Financial Statements include our accounts and the accounts of our wholly-owned subsidiaries since their respective dates of acquisitions. All intercompany accounts and transactions have been eliminated in consolidation. Where our ownership of a subsidiary was less than 100%, the non-controlling interest is reported on our consolidated balance sheets. The non-controlling interest in our consolidated net income is reported as "Net loss attributable to non-controlling interest" on our Consolidated Statements of (Loss) Income. Our audited Consolidated Financial Statements are stated in U.S. Dollars and have been prepared in accordance with accounting principles generally accepted in the U.S. ("GAAP").</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Beginning in the first quarter of 2020, to limit the spread of COVID-19, governments took various actions including the issuance of stay-at-home policies and social distancing procedures and guidelines, causing some businesses to adjust, reduce or suspend business and operating activities. Veterinary care is widely recognized as an "essential" service for pet owners, and veterinarians continued to deliver essential medical care for sick and injured pets. The stay-at-home policies deployed early in 2020 to combat the spread of COVID-19 resulted in a decrease in companion animal clinical visits, including delay of elective procedures and wellness visits and as a result lowers demand for diagnostic testing services. Beginning in the second quarter of 2020, certain local, state and federal governments began to ease the stay-at-home policies and allowed more businesses and facilities to re-open, leading to a recovery in companion animal clinical visits and associated demand for our diagnostic products. The extent to which the continuation, or a possible second-wave outbreak of COVID-19, or an outbreak of other health epidemics could impact our business, results of operations and financial condition, including the potential for write-offs or impairments of assets and suspension of capital investments, will depend on future developments. We are unable to predict with certainty the effects of the COVID-19 pandemic on our customers, suppliers and vendors, as well as the actions of governments, and when and to what extent normal economic and operating conditions can resume; these effects may differ from those assumed in our projected estimates. Even after the COVID-19 pandemic has subsided, we may continue to experience adverse impacts to our business as a result of any economic impact that has occurred or may occur in the future.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Reclassification</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To maintain consistency and comparability, certain amounts in the financial statements have been reclassified to conform to current year presentation.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates are required when establishing the allowance for doubtful accounts and the net realizable value of inventory; determining future costs associated with warranties provided; determining the period over which our obligations are fulfilled under agreements to license product rights and/or technology rights; evaluating long-lived and intangible assets and investments for estimated useful lives and impairment; estimating the useful lives and standalone selling prices of instruments under leasing arrangements; determining the allocation of purchase price under purchase accounting; estimating the expense associated with the granting of stock; determining the need for, and the amount of a valuation allowance on deferred tax assets; determining the fair value of our embedded derivative; and determining the fair value of the liability component associated with the issuance of convertible debt. Our actual results may differ from these estimates and there may be changes to those estimates in future periods. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to a concentration of credit risk consist of cash and cash equivalents and accounts receivable. We maintain the majority of our cash and cash equivalents with financial institutions that management believes are creditworthy in the form of demand deposits. We have no off-balance-sheet concentrations of credit risk such as foreign exchange contracts, options contracts or other foreign currency hedging arrangements. Our accounts receivable balances are due largely from distribution partners, domestic veterinary clinics and individual veterinarians and other animal health companies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Covetrus represented 9% and 19% of our consolidated accounts receivable at December 31, 2020 and 2019, respectively. No other customer accounted for more than 10% of our consolidated accounts receivable at December 31, 2020 or 2019.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We have established an allowance for credit losses based upon factors surrounding the credit risk of specific customers, historical trends and other information.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable and Allowance for Credit Losses</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Accounts receivable are recorded net of an allowance for credit losses. From time to time, our customers are unable to meet their payment obligations. We continuously monitor our customers' credit worthiness and establish allowances for estimated credit losses related to our accounts receivable, net investment in leases, contract assets, and promissory notes. Our allowances are established based on factors surrounding the credit risk of specific customers, historical experience including collections and write-off history, and current economic conditions. Account balances are considered past due if payments have not been received within agreed upon invoice and/or contract terms and the Company may employ collection agencies and legal counsel to pursue recovery of defaulted amounts. Account balances are written off against the allowance after all collection efforts have been exhausted and it is probable the receivable will not be recovered. The Company also performs a qualitative assessment, on a quarterly basis, to monitor economic factors and other uncertainties that may require additional adjustments for the expected credit loss allowance. While such credit losses have historically been within our expectations and the provisions established, there is no assurance that we will continue to experience the same credit loss rates that we have in the past. A significant change in the liquidity or financial position of our customers could have a material adverse impact on the collectability of accounts receivable and our future operating results. The Company will continue to actively monitor the impact of the COVID-19 pandemic on expected credit losses. In 2020, the Company adopted Accounting </span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Standards Update ("ASU") 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">See "Adoption of New Accounting Standards" below for impacts of adoption. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Changes in the allowance for credit losses are summarized as follows (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.845%"><tr><td style="width:1.0%"/><td style="width:65.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.412%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Balances at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">186 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">245 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">215 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Additions from acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">90 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Additions - charged to expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">614 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">113 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">104 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Deductions - write offs, net of recoveries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Balances at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">769 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">186 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">245 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Cash and cash equivalents are stated at cost, which approximates market value, and include short-term, highly liquid investments with original maturities of less than three months. We valued our foreign cash accounts at the spot market foreign exchange rate as of each balance sheet date, with changes due to foreign exchange fluctuations recorded in Accumulated other comprehensive income in the Consolidated Balance Sheets. The majority of our cash and cash equivalents are held in accounts not insured by governmental entities. The foreign cash balances are summarized as follows (denominated in foreign currency, in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.845%"><tr><td style="width:1.0%"/><td style="width:70.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.655%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.658%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">European Union Euros</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,520 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,773 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Swiss Francs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Canadian Dollars</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,993 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Australian Dollars</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Malaysian Ringgit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In accordance with ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(“ASC 820”), the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. Fair value is defined as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Level 1: Quoted market prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Level 2: Quoted prices in active markets for similar assets and liabilities, quoted prices for identically similar assets or liabilities in markets that are not active and models for which all significant inputs are observable either directly or indirectly.</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Level 3: Unobservable inputs reflecting the reporting entity’s own assumptions or external inputs for inactive markets.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company's financial instruments consist of cash and cash equivalents, short-term trade receivables and payables, a long-term note receivable with an embedded derivative asset, and its 3.75% Convertible Senior Notes due 2026 (the "Notes"). The carrying values of cash and cash equivalents and short-term trade receivables and payables approximate fair value because of the short-term nature of the instruments.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The estimated fair value of the Notes disclosed at each reporting period is evaluated through Level 2 inputs with consideration of quoted market prices in less active markets. For additional information regarding the Company's accounting treatment for the issuance of the Notes, including the fair value measurement of the liability component, refer to Note 16. Convertible Notes. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company determined the redemption features of its convertible note receivable represents an embedded derivative. The estimated fair value of the embedded derivative asset is evaluated through Level 3 inputs. The carrying amount of the derivative is recorded at fair value at issuance and will be remeasured each reporting period, with the mark-to-market adjustments to be included in other expense (income). For additional information regarding the Company's accounting treatment for the convertible note receivable, including the fair value measurement of the embedded derivative, refer to Note 17. Convertible Note Receivable. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Property and Equipment</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Property and equipment is stated at cost, net of accumulated depreciation. The costs of additions and improvements are capitalized, while maintenance and repairs are charged to expense as incurred. When an item is sold or retired, the cost and related accumulated depreciation is relieved and the resulting gain or loss, if any, is recognized in the Consolidated Statements of (Loss) Income. We provide for depreciation primarily using the straight-line method by charges to income in amounts that allocate the cost of property and equipment over their estimated useful lives as follows:</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.375%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.425%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Asset Classification</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Estimated<br/>Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Building</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10 to 43 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2 to 10 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3 to 7 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3 to 7 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Leasehold and building improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5 to 15 years</span></td></tr></table></div><div style="margin-top:12pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We capitalize certain costs incurred in connection with developing or obtaining software designated for internal use based on three distinct stages of development. Qualifying costs incurred during the application development stage, which consist primarily of internal payroll and direct fringe benefits and external direct project costs, including labor and travel, are capitalized and amortized on a straight-line basis over the estimated useful life of the asset, which range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjI4MGMyMGMyZWU3NTQ1OThhMDliZjVkMDMxZTRlMDBkL3NlYzoyODBjMjBjMmVlNzU0NTk4YTA5YmY1ZDAzMWU0ZTAwZF8xNDIvZnJhZzoyMzUyYzg5NTViNTM0ZDY4ODZiMWFmZmExYWYyOTViYS90ZXh0cmVnaW9uOjIzNTJjODk1NWI1MzRkNjg4NmIxYWZmYTFhZjI5NWJhXzg2NDQ_48932cf4-838c-40ff-85b0-e8206fe0d04a">three</span> to seven years. Costs incurred during the preliminary project and post-implementation and operation phases are expensed as incurred. These costs are general and administrative in nature and related primarily to the determination of performance requirements, data conversion and training. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Inventories</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost or net realizable value using the first-in, first-out method. Inventory we manufacture includes the cost of material, labor and overhead. We write down the carrying value of inventory for estimated obsolescence by an amount equal to the difference between the cost of inventory and the estimated market value when warranted based on assumptions of future demand, market conditions, remaining shelf life, or product functionality.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Investments in Unconsolidated Affiliates</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Investments in unconsolidated affiliates are measured and recorded as either non-marketable equity securities or equity method investments. Non-marketable equity securities are equity securities without readily determinable fair value that are measured and recorded using a measurement alternative which measures the securities at cost minus impairment, if any, plus or minus changes from qualifying observable price changes. Equity method investments are equity securities in investees we do not control but over which we have the ability to exercise significant influence. When the equity method of accounting is determined to be appropriate, the initial measurement of the investment includes the cost of the investment and all direct transaction costs incurred to acquire the investment. Equity method investments are measured at cost minus impairment, if any, plus or minus our share of equity method investee income or loss, which is recorded as a separate line on the income statement. Both types of investments are evaluated for impairment if a triggering event occurs. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Goodwill, Intangible and Other Long-Lived Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Goodwill is initially valued based on the excess of the purchase price of a business combination over the fair value of acquired net assets recognized and represents the future economic benefits arising from other assets acquired that could not be individually identified and separately recognized. Intangible assets other than goodwill are initially valued at fair value. If a quoted price in an active market for the identical asset is not readily available at the measurement date, the fair value of the intangible asset is estimated based on discounted cash flows using market participant assumptions, which are assumptions that are not specific to the Company. The selection of appropriate valuation methodologies and the estimation of discounted cash flows require significant assumptions about the timing and amounts of future cash flows, risks, appropriate discount rates, and the useful lives of intangible assets. When material, we utilize independent valuation experts to advise and assist us in determining the fair values of the identified intangible assets acquired in connection with a business acquisition and in determining appropriate amortization methods and periods for those intangible assets. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">We assess goodwill for impairment annually, at the reporting unit level, in the fourth quarter and whenever events or circumstances indicate impairment may exist. In evaluating goodwill for impairment, we have the option to first assess the qualitative factors to determine whether it is more-likely-than-not that the estimated fair value of the reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the comparison of the estimated fair value of the reporting unit to the carrying value. The more-likely-than-not threshold is defined as having a likelihood of more than 50 percent. If, after assessing the totality of events or circumstances, we determine that it is more-likely-than-not that the estimated fair value of a reporting is less than its carrying amount, we would then estimate the fair value of the reporting unit and compare it to the carrying value. If the carrying value exceeds the estimated fair value we would recognize an impairment for the difference; otherwise, no further impairment test would be required. In contrast, we can opt to bypass the qualitative assessment for any reporting unit in any period and proceed directly to quantitative analysis. Doing so does not preclude us from performing the qualitative assessment in any subsequent period. Following the acquisition of scil in April 2020, we restructured our operating segments based on how the Chief Operating Decision Maker (“CODM”) manages the business, allocates resources, makes operating decisions and evaluates operating performance. As further discussed in Note 18, our new reporting segments are North America and International. As a result of the change in operating segments, we also revised our reporting units to aggregate our legal entities based on similarities in economic characteristics. Our new reporting units consist of the following: (1) Heska Corporation and Heska Canada, (2) Diamond Animal Health, (3) scil animal care company GmbH, Optomed, CVM, and Heska Australia, and (4) Heska AG. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As a result of the recent global economic disruption and uncertainty due to the COVID-19 pandemic, the </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Company performed a qualitative assessment during the first quarter of 2020. Based on the interim assessment performed, we concluded that there was no triggering event and additionally, no indications of impairment existed. We performed qualitative assessments in the fourth quarters of 2020, 2019, and 2018 and determined that no indications of impairment existed. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We assess the realizability of intangible assets other than goodwill whenever events or changes in circumstances indicate that the carrying value may not be recoverable. If an impairment review is triggered, we evaluate the carrying value of intangible assets based on estimated undiscounted future cash flows over the remaining useful life of the primary asset of the asset group and compare that value to the carrying value of the asset group. The cash flows that are used contain our best estimates, using appropriate and customary assumptions and projections at the time. If the net carrying value of an intangible asset exceeds the related estimated undiscounted future cash flows, an impairment to adjust the intangible asset to its fair value would be reported as a non-cash charge to earnings. If necessary, we would calculate the fair value of an intangible asset using the present value of the estimated future cash flows to be generated by the intangible asset, and applying a risk-adjusted discount rate. We had no impairments of our intangible assets during the years ended December 31, 2020, 2019, and 2018.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We generate revenue through the sale of products, either by outright purchase by our customers or through a subscription agreement whereby our customers receive instruments and pay us a monthly fee for the consumables needed to conduct testing. Subscription placement is the majority of our Point of Care laboratory transactions while outright sales to customers are the majority of both Point of Care imaging diagnostic transactions and the sale of pharmaceuticals and vaccines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For outright sales of products, revenue is recognized when control of the promised product or service is transferred to our customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products or services (the transaction price). Taxes assessed by governmental authorities and collected from the customer are excluded from our revenue recognition. A performance obligation is a promise in a contract to transfer a distinct product or service to a customer and is the unit of account under ASC 606. For instruments, consumables and most software licenses sold by the Company, control transfers to the customer at a point in time. To indicate the transfer of control, the Company must have a present right to payment, legal title must have passed to the customer, the customer must have the significant risks and rewards of ownership and where acceptance is not a formality, the customer must have accepted the product or service. Heska’s principal terms of sale are FOB Shipping Point, or equivalent, and, as such, we primarily transfer control and record revenue for product sales upon shipment. If a performance obligation to the customer with respect to a sales transaction remains unfulfilled following shipment (typically owed installation), revenue recognition for that performance obligation is deferred until such commitments have been fulfilled. For extended warranty and service plans, control transfers to the customer over the term of the arrangement and as such the revenue is recognized ratably based upon the period of time elapsed under the arrangement. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our revenue under subscription agreements relates to operating-type lease ("OTL") arrangements or sales-type lease ("STL") arrangements. Determination of an OTL or STL is primarily determined as a result of the length of the contract as compared to the estimated useful life of the instrument, among other factors. Leases are outside of the scope of ASC 606 and are therefore accounted for in accordance with ASC 842</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">, Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. A STL would result in earlier recognition of instrument revenue as compared to an OTL, which is generally upon installation of the instruments. Instrument lease revenue for our OTL subscription agreements is recognized on a straight-line basis over the life of the lease and is included with the predominant non-lease components in consumables revenue. For instrument only OTL agreements, operating lease income is </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">recognized on a straight-line basis over the term of the lease. The cash collected under both arrangements is over the term of the contract. The OTLs and STLs are not cancellable until after an initial term. See below for additional information on our lease accounting policies. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For contracts with both lease and non-lease components, the Company allocates the contracts' transaction price for each component on a relative standalone selling price basis using our best estimate of the standalone selling price of each distinct product or service in the contract. When available, the method used to estimate the standalone selling price is the price observed in standalone sales to customers. When prices in standalone sales are not available, we use a cost-plus margin approach. Changes in these values can impact the amount of consideration allocated to each component of the contract. Allocation of the transaction price is determined at the contracts' inception. The Company does not adjust the transaction price for the effects of a significant financing component when the period between the transfer of the promised good or service to the customer and payment for that good or service by the customer is expected to be one year or less. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To the extent the transaction price includes variable consideration, such as future payments based on consumable usage over time, we apply judgment to determine if the variable consideration should be constrained. As the variable consideration is highly susceptible to factors outside of the Company’s influence, and the potential values contain a broad range of possible outcomes given all potential amounts of consumption that could occur, it is likely that a significant revenue reversal would occur should the variable consideration be estimated at an amount greater than the minimum stated amount until such a time as the uncertainty is resolved. For our subscription agreements with variable consideration based on consumable usage over time, the variable consideration is allocated to the non-lease components upon resolution of the uncertainty and is included in consumables revenue. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We generate OVP revenue through contract manufacturing agreements with customers. Revenue from these customer contracts is generally recognized upon shipment or acceptance by our customer, under the same guidelines noted above for other outright product sales. Heska assessed the over-time criteria within ASC 606 and concluded that while products within this segment have no alternative use to Heska, as Heska is contractually prohibited to redirect the product to other customers, Heska does not have right to payment for performance to date. Therefore, point in time revenue recognition has been determined to be appropriate.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Recording revenue from the sale of products involves the use of estimates and management's judgment. We must make a determination at the time of sale whether the customer has the ability and intent to make payments in accordance with arrangements. For contracts with multiple performance obligations, we exercise judgment in allocating the transaction price for each performance obligation based on an estimated standalone selling price for each distinct product or service. We do not generally allow return of products or instruments. Distributor rebates are recorded as a reduction to revenue.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Refer to Note 2 for additional disclosures required by ASC 606.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Leases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company acts as a lessee and a lessor. As a lessee, the Company leases buildings, office equipment, and vehicles. As a lessor, the Company enters into sales-type and operating leases as part of its subscription agreements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at inception based on whether control of an identified asset is transferred. For leases where the Company is the lessee, ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The lease terms used to calculate the ROU asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense while the expense for finance leases is recognized as amortization expense and interest expense. The Company has lease agreements which require payments for lease and non-lease components and has elected to account for these as a single lease component for our building and office equipment leases, but as separate components for our vehicle leases. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As a lessor, our subscription agreements relate to both OTL arrangements and STL arrangements. For a STL, instrument revenue is generally recorded upon installation of the instruments and the cost of the customer-leased instruments is removed from inventory and recognized in the Consolidated Statements of (Loss) Income. There is no residual value taken into consideration as it does not meet our capitalization requirements. For our OTL agreements that include both lease and non-lease components, revenue is recognized on a straight-line basis over the term of the lease and is included with the predominant non-lease components in consumables revenue. For instrument only OTL agreements, operating lease income is recognized on a straight-line basis over the term of the lease. For an OTL, the costs of customer-leased instruments are recorded within property and equipment in the accompanying Consolidated Balance Sheets and depreciated over the instrument’s estimated useful life. The depreciation expense is reflected in cost of revenue in the accompanying Consolidated Statements of (Loss) Income. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For leases that commenced before the January 1, 2019 effective date of ASC 842, the Company elected the permitted practical expedients to not reassess the following: (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) initial direct costs for any existing leases. The Company also elected to exclude leases with a term of 12 months or less from the recognized ROU assets and lease liabilities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Stock-based Compensation</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Stock-based compensation expense is measured at the grant date based upon the estimated fair value of the portion of the award that is ultimately expected to vest and is recognized as expense over the applicable requisite service period of the award generally using the straight-line method.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Advertising Costs</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Advertising costs are expensed as incurred and are included in sales and marketing expenses. Advertising expenses were $0.4 million for the year ended December 31, 2020, $0.3 million for the year ended December 31, 2019, and $0.2 million for the year ended December 31, 2018.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company records a current provision for income taxes based on estimated amounts payable or refundable on tax returns filed or to be filed each year. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates, in each tax jurisdiction, expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date. The overall change in deferred tax assets and liabilities for the period measures the deferred tax expense or benefit for the period. Deferred tax assets are reduced by a valuation allowance based on a judgmental assessment of available evidence if the Company is unable to conclude that it is more likely than not that some or all of the deferred tax assets will be realized.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Earnings Per Share</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Translation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The functional currency of certain foreign subsidiaries is the local currency. Accordingly, assets and liabilities of these subsidiaries are translated using the exchange rate in effect at the balance sheet date. Revenue and expense accounts and cash flows are translated using an average of exchange rates in effect during the period. Cumulative translation gains and losses are shown in the Consolidated Balance Sheets as a separate component of stockholders' equity. Exchange gains and losses arising from transactions denominated in foreign currencies (i.e., transaction gains and losses) are recognized as a component of other income (expense) in current operations, as are exchange gains and losses on intercompany transactions expected to be settled in the near term. Gains and losses arising from intercompany foreign currency transactions that are of a long-term investment nature are reported as a component of Accumulated other comprehensive income in the Consolidated Balance Sheets. </span></div><div style="margin-top:15pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Warranty Costs</span></div><div style="margin-top:15pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company generally provides for the estimated cost of hardware and software warranties in the period the related revenue is recognized. The Company assesses the adequacy of its accrued warranty liabilities and adjusts the amounts as necessary based on actual experience and changes in future estimates. Should product failure rates differ from our estimates, actual costs could vary significantly from our expectations. Extended warranties are sold to our customers and revenue is recognized over the term of the warranty agreement, as expected costs are incurred. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Correction of an Immaterial Error</span></div><div style="margin-top:15pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">During the fourth fiscal quarter of 2020, the Company recorded an out-of-period adjustment that impacted the Consolidated Balance Sheets, Consolidated Statements of (Loss) Income and Consolidated Statements of Comprehensive (Loss) Income. The adjustment related to an error in the calculation of non-cash interest expense relating to the Company's Notes. This error resulted in an overstatement of non-cash interest expense of $0.7 million in 2019, $0.6 million in each of the first and second fiscal quarters of 2020 and $0.5 million in the third fiscal quarter of 2020. The error also resulted in an overstatement of Convertible Notes, net, and Deferred Tax Liability of $0.7 million and $0.2 million, respectively as of December 31, 2019; $1.4 million and $0.3 million, respectively, as of March 31, 2020; $2.0 million and $0.4 million, respectively, as of June 30, 2020; and $2.5 million and $0.6 million, respectively, as of September 30, 2020. The Company assessed the materiality of these errors on the previously issued interim and annual financial statements in accordance with SEC Staff Accounting Bulletin No. 99 and No. 108. The Company concluded that the errors were not material to any of the previously issued consolidated financial statements and the impact of correcting these errors in the year ended December 31, 2020 is not material to the consolidated financial statements.</span></div><div style="margin-top:15pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The impact of this adjustment resulted in a fourth quarter period decrease in interest expense of $2.5 million and a decrease in income tax benefit of $0.6 million. The Company also recorded a decrease in Convertible Notes, net, of $2.5 million, and a reduction in Deferred Tax Liability of $0.6 million as of December 31, 2020.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Adoption of New Accounting Pronouncements</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2016-13, Financial Instruments - Credit Losses (Topic 326), which requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected. The income statement reflects the measurement of credit losses for newly recognized financial assets, as well as the increases or decreases of expected credit losses that have taken place during the period. The measurement of expected credit losses is based upon historical experience, current conditions and reasonable and supportable forecasts that affect the collectability of the reported amount. Subsequent to the issuance of ASU 2016-13, the FASB issued ASU 2018-19, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, in November 2018. This ASU clarifies that receivables from operating leases are accounted for using the lease guidance and not as financial instruments. In April 2019, the FASB issued ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments, which further clarifies and improves guidance related to accounting for credit losses. In May 2019, the FASB issued ASU 2019-05, Financial Instruments - Credit Losses (Topic 326). This ASU provides relief to certain entities adopting ASU 2016-13. The amendment provides entities with an option to irrevocably elect the fair value option for certain financial assets. The Company adopted ASU 2016-13 with a cumulative-effect adjustment in retained earnings as of January 1, 2020. The impact of the adoption was not material to the Company's consolidated financial statements. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Accounting Pronouncements Not Yet Adopted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, which is intended to simplify various aspects related to the accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Topic 740,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and also clarifies and amends existing guidance to improve consistent application. This guidance will be effective for interim and annual periods beginning after December 15, 2020, and early adoption is permitted. We evaluated the impact of the standard on our consolidated financial statements and do not expect the standard to have a material impact on our consolidated financial statements and disclosures. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU 2020-01, Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815). The amendments in this ASU clarify the interaction between the accounting for investments in equity securities, investment in equity method and certain derivatives instruments. The ASU is expected to reduce diversity in practice and increase comparability of the accounting for these interactions. This guidance will be effective for fiscal years beginning after December 15, 2020. We evaluated the impact of the standard on our consolidated financial statements and do not expect the standard to have a material impact on our consolidated financial statements and disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40), which simplifies the accounting for certain convertible instruments. The update reduces the number of accounting models for convertible debt instruments and convertible preferred stock. Convertible debt will be accounted for as a single liability measured at its amortized cost and convertible preferred stock will be accounted for as a single equity instrument measured at its historical cost, as long as no other features require bifurcation and recognition as derivatives. The update also requires the if-converted method to be used for convertible instruments and the effect of potential share settlement be included in the diluted earnings per share calculation when an instrument may be settled in cash or shares. The amendments in this update are effective for public business entities for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. The guidance may be early adopted for fiscal years beginning after December 15, 2020,</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:107%">and interim periods within those fiscal years. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company has elected to early adopt ASU 2020-06 as of January 1, 2021. The Notes are a convertible instrument with a cash-conversion feature that is accounted for within the scope of ASC 470-20 and will be impacted by adopting ASU 2020-06. The Company has elected to apply the modified retrospective method wherein the Company will recognize a cumulative-effect adjustment to the opening balance of retained earnings (January 1, 2021). Further, the Company will not restate EPS in the prior periods. The Company calculated the cumulative-effect adjustment as of January 1, 2021 by comparing (i) the historical amortization schedule for the Notes through December 31, 2020 and (ii) an updated amortization schedule wherein the conversion feature within the Notes would not be separated as an equity component and subsequently recognized as non-cash interest expense under ASC 835-30. As a result of ASU 2020-06, while cash interest expense is not impacted, non-cash interest accretion is limited to the amortization of debt issuance costs under ASC 835-30. Therefore, the Company prepared its transition journal entries by (i) reversing the conversion feature amount recorded in APIC and (ii) reversing the difference in non-cash interest expense via retained earnings. The expected impact on retained earnings is $4.3 million.</span></div><div><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASU 2020-10, Codification Improvements, which updates various codification topics by clarifying or improving disclosure requirements to align with the SEC's regulations. This guidance will be effective for annual periods beginning after December 15, 2020, for public entities. The Company will adopt as of the reporting period beginning January 1, 2021. We evaluated the impact of the </span></div>standard on our consolidated financial statements and do not expect the standard to have a material impact on our consolidated financial statements and disclosures. <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the opinion of management, the accompanying Consolidated Financial Statements contain all adjustments, consisting of normal, recurring adjustments, necessary to present fairly the financial position of the Company as of December 31, 2020 and 2019, as well as the results of our operations, statements of stockholders' equity and cash flows for the twelve months ended December 31, 2020, 2019 and 2018.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The audited Consolidated Financial Statements included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Our audited Consolidated Financial Statements include our accounts and the accounts of our wholly-owned subsidiaries since their respective dates of acquisitions. All intercompany accounts and transactions have been eliminated in consolidation. Where our ownership of a subsidiary was less than 100%, the non-controlling interest is reported on our consolidated balance sheets. The non-controlling interest in our consolidated net income is reported as "Net loss attributable to non-controlling interest" on our Consolidated Statements of (Loss) Income. Our audited Consolidated Financial Statements are stated in U.S. Dollars and have been prepared in accordance with accounting principles generally accepted in the U.S. ("GAAP").</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Beginning in the first quarter of 2020, to limit the spread of COVID-19, governments took various actions including the issuance of stay-at-home policies and social distancing procedures and guidelines, causing some businesses to adjust, reduce or suspend business and operating activities. Veterinary care is widely recognized as an "essential" service for pet owners, and veterinarians continued to deliver essential medical care for sick and injured pets. The stay-at-home policies deployed early in 2020 to combat the spread of COVID-19 resulted in a decrease in companion animal clinical visits, including delay of elective procedures and wellness visits and as a result lowers demand for diagnostic testing services. Beginning in the second quarter of 2020, certain local, state and federal governments began to ease the stay-at-home policies and allowed more businesses and facilities to re-open, leading to a recovery in companion animal clinical visits and associated demand for our diagnostic products. The extent to which the continuation, or a possible second-wave outbreak of COVID-19, or an outbreak of other health epidemics could impact our business, results of operations and financial condition, including the potential for write-offs or impairments of assets and suspension of capital investments, will depend on future developments. We are unable to predict with certainty the effects of the COVID-19 pandemic on our customers, suppliers and vendors, as well as the actions of governments, and when and to what extent normal economic and operating conditions can resume; these effects may differ from those assumed in our projected estimates. Even after the COVID-19 pandemic has subsided, we may continue to experience adverse impacts to our business as a result of any economic impact that has occurred or may occur in the future.</span></div> To maintain consistency and comparability, certain amounts in the financial statements have been reclassified to conform to current year presentation. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates are required when establishing the allowance for doubtful accounts and the net realizable value of inventory; determining future costs associated with warranties provided; determining the period over which our obligations are fulfilled under agreements to license product rights and/or technology rights; evaluating long-lived and intangible assets and investments for estimated useful lives and impairment; estimating the useful lives and standalone selling prices of instruments under leasing arrangements; determining the allocation of purchase price under purchase accounting; estimating the expense associated with the granting of stock; determining the need for, and the amount of a valuation allowance on deferred tax assets; determining the fair value of our embedded derivative; and determining the fair value of the liability component associated with the issuance of convertible debt. Our actual results may differ from these estimates and there may be changes to those estimates in future periods. <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to a concentration of credit risk consist of cash and cash equivalents and accounts receivable. We maintain the majority of our cash and cash equivalents with financial institutions that management believes are creditworthy in the form of demand deposits. We have no off-balance-sheet concentrations of credit risk such as foreign exchange contracts, options contracts or other foreign currency hedging arrangements. Our accounts receivable balances are due largely from distribution partners, domestic veterinary clinics and individual veterinarians and other animal health companies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Covetrus represented 9% and 19% of our consolidated accounts receivable at December 31, 2020 and 2019, respectively. No other customer accounted for more than 10% of our consolidated accounts receivable at December 31, 2020 or 2019.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We have established an allowance for credit losses based upon factors surrounding the credit risk of specific customers, historical trends and other information.</span></div> 0.09 0.19 Accounts receivable are recorded net of an allowance for credit losses. From time to time, our customers are unable to meet their payment obligations. We continuously monitor our customers' credit worthiness and establish allowances for estimated credit losses related to our accounts receivable, net investment in leases, contract assets, and promissory notes. Our allowances are established based on factors surrounding the credit risk of specific customers, historical experience including collections and write-off history, and current economic conditions. Account balances are considered past due if payments have not been received within agreed upon invoice and/or contract terms and the Company may employ collection agencies and legal counsel to pursue recovery of defaulted amounts. Account balances are written off against the allowance after all collection efforts have been exhausted and it is probable the receivable will not be recovered. The Company also performs a qualitative assessment, on a quarterly basis, to monitor economic factors and other uncertainties that may require additional adjustments for the expected credit loss allowance. While such credit losses have historically been within our expectations and the provisions established, there is no assurance that we will continue to experience the same credit loss rates that we have in the past. A significant change in the liquidity or financial position of our customers could have a material adverse impact on the collectability of accounts receivable and our future operating results. The Company will continue to actively monitor the impact of the COVID-19 pandemic on expected credit losses. In 2020, the Company adopted Accounting <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Standards Update ("ASU") 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326). </span>See "Adoption of New Accounting Standards" below for impacts of adoption. <div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Changes in the allowance for credit losses are summarized as follows (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.845%"><tr><td style="width:1.0%"/><td style="width:65.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.412%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Balances at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">186 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">245 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">215 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Additions from acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">90 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Additions - charged to expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">614 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">113 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">104 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Deductions - write offs, net of recoveries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Balances at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">769 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">186 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">245 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 186000 245000 215000 90000 0 0 614000 113000 104000 121000 172000 74000 769000 186000 245000 Cash and cash equivalents are stated at cost, which approximates market value, and include short-term, highly liquid investments with original maturities of less than three months. The foreign cash balances are summarized as follows (denominated in foreign currency, in thousands):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.845%"><tr><td style="width:1.0%"/><td style="width:70.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.655%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.658%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">European Union Euros</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,520 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,773 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Swiss Francs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Canadian Dollars</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,993 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Australian Dollars</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Malaysian Ringgit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 8520000 1773000 138000 124000 2993000 88000 159000 54000 364000 0 The Company's financial instruments consist of cash and cash equivalents, short-term trade receivables and payables, a long-term note receivable with an embedded derivative asset, and its 3.75% Convertible Senior Notes due 2026 (the "Notes"). The carrying values of cash and cash equivalents and short-term trade receivables and payables approximate fair value because of the short-term nature of the instruments. <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Property and equipment is stated at cost, net of accumulated depreciation. The costs of additions and improvements are capitalized, while maintenance and repairs are charged to expense as incurred. When an item is sold or retired, the cost and related accumulated depreciation is relieved and the resulting gain or loss, if any, is recognized in the Consolidated Statements of (Loss) Income. We provide for depreciation primarily using the straight-line method by charges to income in amounts that allocate the cost of property and equipment over their estimated useful lives as follows:</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.375%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.425%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Asset Classification</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Estimated<br/>Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Building</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10 to 43 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2 to 10 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3 to 7 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3 to 7 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Leasehold and building improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5 to 15 years</span></td></tr></table></div>We capitalize certain costs incurred in connection with developing or obtaining software designated for internal use based on three distinct stages of development. Qualifying costs incurred during the application development stage, which consist primarily of internal payroll and direct fringe benefits and external direct project costs, including labor and travel, are capitalized and amortized on a straight-line basis over the estimated useful life of the asset, which range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjI4MGMyMGMyZWU3NTQ1OThhMDliZjVkMDMxZTRlMDBkL3NlYzoyODBjMjBjMmVlNzU0NTk4YTA5YmY1ZDAzMWU0ZTAwZF8xNDIvZnJhZzoyMzUyYzg5NTViNTM0ZDY4ODZiMWFmZmExYWYyOTViYS90ZXh0cmVnaW9uOjIzNTJjODk1NWI1MzRkNjg4NmIxYWZmYTFhZjI5NWJhXzg2NDQ_48932cf4-838c-40ff-85b0-e8206fe0d04a">three</span> to seven years. Costs incurred during the preliminary project and post-implementation and operation phases are expensed as incurred. These costs are general and administrative in nature and related primarily to the determination of performance requirements, data conversion and training. We provide for depreciation primarily using the straight-line method by charges to income in amounts that allocate the cost of property and equipment over their estimated useful lives as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.375%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.425%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Asset Classification</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Estimated<br/>Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Building</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10 to 43 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2 to 10 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3 to 7 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3 to 7 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Leasehold and building improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5 to 15 years</span></td></tr></table><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Property and equipment, net, consisted of the following (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.980%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.474%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.475%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,590 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">694 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Building</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12,737 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,845 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">40,411 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">28,777 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,047 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,345 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,773 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,408 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Leasehold and building improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10,728 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10,558 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">671 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Property and equipment, gross</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">73,290 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">49,298 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(37,748)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(33,829)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">35,542 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">15,469 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> P7Y Investments in unconsolidated affiliates are measured and recorded as either non-marketable equity securities or equity method investments. Non-marketable equity securities are equity securities without readily determinable fair value that are measured and recorded using a measurement alternative which measures the securities at cost minus impairment, if any, plus or minus changes from qualifying observable price changes. Equity method investments are equity securities in investees we do not control but over which we have the ability to exercise significant influence. When the equity method of accounting is determined to be appropriate, the initial measurement of the investment includes the cost of the investment and all direct transaction costs incurred to acquire the investment. Equity method investments are measured at cost minus impairment, if any, plus or minus our share of equity method investee income or loss, which is recorded as a separate line on the income statement. Both types of investments are evaluated for impairment if a triggering event occurs. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Goodwill is initially valued based on the excess of the purchase price of a business combination over the fair value of acquired net assets recognized and represents the future economic benefits arising from other assets acquired that could not be individually identified and separately recognized. Intangible assets other than goodwill are initially valued at fair value. If a quoted price in an active market for the identical asset is not readily available at the measurement date, the fair value of the intangible asset is estimated based on discounted cash flows using market participant assumptions, which are assumptions that are not specific to the Company. The selection of appropriate valuation methodologies and the estimation of discounted cash flows require significant assumptions about the timing and amounts of future cash flows, risks, appropriate discount rates, and the useful lives of intangible assets. When material, we utilize independent valuation experts to advise and assist us in determining the fair values of the identified intangible assets acquired in connection with a business acquisition and in determining appropriate amortization methods and periods for those intangible assets. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">We assess goodwill for impairment annually, at the reporting unit level, in the fourth quarter and whenever events or circumstances indicate impairment may exist. In evaluating goodwill for impairment, we have the option to first assess the qualitative factors to determine whether it is more-likely-than-not that the estimated fair value of the reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the comparison of the estimated fair value of the reporting unit to the carrying value. The more-likely-than-not threshold is defined as having a likelihood of more than 50 percent. If, after assessing the totality of events or circumstances, we determine that it is more-likely-than-not that the estimated fair value of a reporting is less than its carrying amount, we would then estimate the fair value of the reporting unit and compare it to the carrying value. If the carrying value exceeds the estimated fair value we would recognize an impairment for the difference; otherwise, no further impairment test would be required. In contrast, we can opt to bypass the qualitative assessment for any reporting unit in any period and proceed directly to quantitative analysis. Doing so does not preclude us from performing the qualitative assessment in any subsequent period. Following the acquisition of scil in April 2020, we restructured our operating segments based on how the Chief Operating Decision Maker (“CODM”) manages the business, allocates resources, makes operating decisions and evaluates operating performance. As further discussed in Note 18, our new reporting segments are North America and International. As a result of the change in operating segments, we also revised our reporting units to aggregate our legal entities based on similarities in economic characteristics. Our new reporting units consist of the following: (1) Heska Corporation and Heska Canada, (2) Diamond Animal Health, (3) scil animal care company GmbH, Optomed, CVM, and Heska Australia, and (4) Heska AG. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As a result of the recent global economic disruption and uncertainty due to the COVID-19 pandemic, the </span></div>Company performed a qualitative assessment during the first quarter of 2020. Based on the interim assessment performed, we concluded that there was no triggering event and additionally, no indications of impairment existed. We performed qualitative assessments in the fourth quarters of 2020, 2019, and 2018 and determined that no indications of impairment existed. We assess the realizability of intangible assets other than goodwill whenever events or changes in circumstances indicate that the carrying value may not be recoverable. If an impairment review is triggered, we evaluate the carrying value of intangible assets based on estimated undiscounted future cash flows over the remaining useful life of the primary asset of the asset group and compare that value to the carrying value of the asset group. The cash flows that are used contain our best estimates, using appropriate and customary assumptions and projections at the time. If the net carrying value of an intangible asset exceeds the related estimated undiscounted future cash flows, an impairment to adjust the intangible asset to its fair value would be reported as a non-cash charge to earnings. If necessary, we would calculate the fair value of an intangible asset using the present value of the estimated future cash flows to be generated by the intangible asset, and applying a risk-adjusted discount rate. 0 0 0 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We generate revenue through the sale of products, either by outright purchase by our customers or through a subscription agreement whereby our customers receive instruments and pay us a monthly fee for the consumables needed to conduct testing. Subscription placement is the majority of our Point of Care laboratory transactions while outright sales to customers are the majority of both Point of Care imaging diagnostic transactions and the sale of pharmaceuticals and vaccines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For outright sales of products, revenue is recognized when control of the promised product or service is transferred to our customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products or services (the transaction price). Taxes assessed by governmental authorities and collected from the customer are excluded from our revenue recognition. A performance obligation is a promise in a contract to transfer a distinct product or service to a customer and is the unit of account under ASC 606. For instruments, consumables and most software licenses sold by the Company, control transfers to the customer at a point in time. To indicate the transfer of control, the Company must have a present right to payment, legal title must have passed to the customer, the customer must have the significant risks and rewards of ownership and where acceptance is not a formality, the customer must have accepted the product or service. Heska’s principal terms of sale are FOB Shipping Point, or equivalent, and, as such, we primarily transfer control and record revenue for product sales upon shipment. If a performance obligation to the customer with respect to a sales transaction remains unfulfilled following shipment (typically owed installation), revenue recognition for that performance obligation is deferred until such commitments have been fulfilled. For extended warranty and service plans, control transfers to the customer over the term of the arrangement and as such the revenue is recognized ratably based upon the period of time elapsed under the arrangement. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our revenue under subscription agreements relates to operating-type lease ("OTL") arrangements or sales-type lease ("STL") arrangements. Determination of an OTL or STL is primarily determined as a result of the length of the contract as compared to the estimated useful life of the instrument, among other factors. Leases are outside of the scope of ASC 606 and are therefore accounted for in accordance with ASC 842</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">, Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. A STL would result in earlier recognition of instrument revenue as compared to an OTL, which is generally upon installation of the instruments. Instrument lease revenue for our OTL subscription agreements is recognized on a straight-line basis over the life of the lease and is included with the predominant non-lease components in consumables revenue. For instrument only OTL agreements, operating lease income is </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">recognized on a straight-line basis over the term of the lease. The cash collected under both arrangements is over the term of the contract. The OTLs and STLs are not cancellable until after an initial term. See below for additional information on our lease accounting policies. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For contracts with both lease and non-lease components, the Company allocates the contracts' transaction price for each component on a relative standalone selling price basis using our best estimate of the standalone selling price of each distinct product or service in the contract. When available, the method used to estimate the standalone selling price is the price observed in standalone sales to customers. When prices in standalone sales are not available, we use a cost-plus margin approach. Changes in these values can impact the amount of consideration allocated to each component of the contract. Allocation of the transaction price is determined at the contracts' inception. The Company does not adjust the transaction price for the effects of a significant financing component when the period between the transfer of the promised good or service to the customer and payment for that good or service by the customer is expected to be one year or less. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To the extent the transaction price includes variable consideration, such as future payments based on consumable usage over time, we apply judgment to determine if the variable consideration should be constrained. As the variable consideration is highly susceptible to factors outside of the Company’s influence, and the potential values contain a broad range of possible outcomes given all potential amounts of consumption that could occur, it is likely that a significant revenue reversal would occur should the variable consideration be estimated at an amount greater than the minimum stated amount until such a time as the uncertainty is resolved. For our subscription agreements with variable consideration based on consumable usage over time, the variable consideration is allocated to the non-lease components upon resolution of the uncertainty and is included in consumables revenue. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We generate OVP revenue through contract manufacturing agreements with customers. Revenue from these customer contracts is generally recognized upon shipment or acceptance by our customer, under the same guidelines noted above for other outright product sales. Heska assessed the over-time criteria within ASC 606 and concluded that while products within this segment have no alternative use to Heska, as Heska is contractually prohibited to redirect the product to other customers, Heska does not have right to payment for performance to date. Therefore, point in time revenue recognition has been determined to be appropriate.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Recording revenue from the sale of products involves the use of estimates and management's judgment. We must make a determination at the time of sale whether the customer has the ability and intent to make payments in accordance with arrangements. For contracts with multiple performance obligations, we exercise judgment in allocating the transaction price for each performance obligation based on an estimated standalone selling price for each distinct product or service. We do not generally allow return of products or instruments. Distributor rebates are recorded as a reduction to revenue.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company acts as a lessee and a lessor. As a lessee, the Company leases buildings, office equipment, and vehicles. As a lessor, the Company enters into sales-type and operating leases as part of its subscription agreements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at inception based on whether control of an identified asset is transferred. For leases where the Company is the lessee, ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The lease terms used to calculate the ROU asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense while the expense for finance leases is recognized as amortization expense and interest expense. The Company has lease agreements which require payments for lease and non-lease components and has elected to account for these as a single lease component for our building and office equipment leases, but as separate components for our vehicle leases. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As a lessor, our subscription agreements relate to both OTL arrangements and STL arrangements. For a STL, instrument revenue is generally recorded upon installation of the instruments and the cost of the customer-leased instruments is removed from inventory and recognized in the Consolidated Statements of (Loss) Income. There is no residual value taken into consideration as it does not meet our capitalization requirements. For our OTL agreements that include both lease and non-lease components, revenue is recognized on a straight-line basis over the term of the lease and is included with the predominant non-lease components in consumables revenue. For instrument only OTL agreements, operating lease income is recognized on a straight-line basis over the term of the lease. For an OTL, the costs of customer-leased instruments are recorded within property and equipment in the accompanying Consolidated Balance Sheets and depreciated over the instrument’s estimated useful life. The depreciation expense is reflected in cost of revenue in the accompanying Consolidated Statements of (Loss) Income. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For leases that commenced before the January 1, 2019 effective date of ASC 842, the Company elected the permitted practical expedients to not reassess the following: (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) initial direct costs for any existing leases. The Company also elected to exclude leases with a term of 12 months or less from the recognized ROU assets and lease liabilities.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company acts as a lessee and a lessor. As a lessee, the Company leases buildings, office equipment, and vehicles. As a lessor, the Company enters into sales-type and operating leases as part of its subscription agreements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at inception based on whether control of an identified asset is transferred. For leases where the Company is the lessee, ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The lease terms used to calculate the ROU asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense while the expense for finance leases is recognized as amortization expense and interest expense. The Company has lease agreements which require payments for lease and non-lease components and has elected to account for these as a single lease component for our building and office equipment leases, but as separate components for our vehicle leases. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As a lessor, our subscription agreements relate to both OTL arrangements and STL arrangements. For a STL, instrument revenue is generally recorded upon installation of the instruments and the cost of the customer-leased instruments is removed from inventory and recognized in the Consolidated Statements of (Loss) Income. There is no residual value taken into consideration as it does not meet our capitalization requirements. For our OTL agreements that include both lease and non-lease components, revenue is recognized on a straight-line basis over the term of the lease and is included with the predominant non-lease components in consumables revenue. For instrument only OTL agreements, operating lease income is recognized on a straight-line basis over the term of the lease. For an OTL, the costs of customer-leased instruments are recorded within property and equipment in the accompanying Consolidated Balance Sheets and depreciated over the instrument’s estimated useful life. The depreciation expense is reflected in cost of revenue in the accompanying Consolidated Statements of (Loss) Income. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For leases that commenced before the January 1, 2019 effective date of ASC 842, the Company elected the permitted practical expedients to not reassess the following: (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) initial direct costs for any existing leases. The Company also elected to exclude leases with a term of 12 months or less from the recognized ROU assets and lease liabilities.</span></div> Stock-based compensation expense is measured at the grant date based upon the estimated fair value of the portion of the award that is ultimately expected to vest and is recognized as expense over the applicable requisite service period of the award generally using the straight-line method. Advertising costs are expensed as incurred and are included in sales and marketing expenses. 400000 300000 200000 The Company records a current provision for income taxes based on estimated amounts payable or refundable on tax returns filed or to be filed each year. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates, in each tax jurisdiction, expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date. The overall change in deferred tax assets and liabilities for the period measures the deferred tax expense or benefit for the period. Deferred tax assets are reduced by a valuation allowance based on a judgmental assessment of available evidence if the Company is unable to conclude that it is more likely than not that some or all of the deferred tax assets will be realized. Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. The functional currency of certain foreign subsidiaries is the local currency. Accordingly, assets and liabilities of these subsidiaries are translated using the exchange rate in effect at the balance sheet date. Revenue and expense accounts and cash flows are translated using an average of exchange rates in effect during the period. Cumulative translation gains and losses are shown in the Consolidated Balance Sheets as a separate component of stockholders' equity. Exchange gains and losses arising from transactions denominated in foreign currencies (i.e., transaction gains and losses) are recognized as a component of other income (expense) in current operations, as are exchange gains and losses on intercompany transactions expected to be settled in the near term. Gains and losses arising from intercompany foreign currency transactions that are of a long-term investment nature are reported as a component of Accumulated other comprehensive income in the Consolidated Balance Sheets. The Company generally provides for the estimated cost of hardware and software warranties in the period the related revenue is recognized. The Company assesses the adequacy of its accrued warranty liabilities and adjusts the amounts as necessary based on actual experience and changes in future estimates. Should product failure rates differ from our estimates, actual costs could vary significantly from our expectations. Extended warranties are sold to our customers and revenue is recognized over the term of the warranty agreement, as expected costs are incurred. 700000 600000 600000 500000 700000 200000 1400000 300000 2000000.0 400000 2500000 600000 -2500000 600000 -2500000 -600000 <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Adoption of New Accounting Pronouncements</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2016-13, Financial Instruments - Credit Losses (Topic 326), which requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected. The income statement reflects the measurement of credit losses for newly recognized financial assets, as well as the increases or decreases of expected credit losses that have taken place during the period. The measurement of expected credit losses is based upon historical experience, current conditions and reasonable and supportable forecasts that affect the collectability of the reported amount. Subsequent to the issuance of ASU 2016-13, the FASB issued ASU 2018-19, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, in November 2018. This ASU clarifies that receivables from operating leases are accounted for using the lease guidance and not as financial instruments. In April 2019, the FASB issued ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments, which further clarifies and improves guidance related to accounting for credit losses. In May 2019, the FASB issued ASU 2019-05, Financial Instruments - Credit Losses (Topic 326). This ASU provides relief to certain entities adopting ASU 2016-13. The amendment provides entities with an option to irrevocably elect the fair value option for certain financial assets. The Company adopted ASU 2016-13 with a cumulative-effect adjustment in retained earnings as of January 1, 2020. The impact of the adoption was not material to the Company's consolidated financial statements. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Accounting Pronouncements Not Yet Adopted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, which is intended to simplify various aspects related to the accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Topic 740,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and also clarifies and amends existing guidance to improve consistent application. This guidance will be effective for interim and annual periods beginning after December 15, 2020, and early adoption is permitted. We evaluated the impact of the standard on our consolidated financial statements and do not expect the standard to have a material impact on our consolidated financial statements and disclosures. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU 2020-01, Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815). The amendments in this ASU clarify the interaction between the accounting for investments in equity securities, investment in equity method and certain derivatives instruments. The ASU is expected to reduce diversity in practice and increase comparability of the accounting for these interactions. This guidance will be effective for fiscal years beginning after December 15, 2020. We evaluated the impact of the standard on our consolidated financial statements and do not expect the standard to have a material impact on our consolidated financial statements and disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40), which simplifies the accounting for certain convertible instruments. The update reduces the number of accounting models for convertible debt instruments and convertible preferred stock. Convertible debt will be accounted for as a single liability measured at its amortized cost and convertible preferred stock will be accounted for as a single equity instrument measured at its historical cost, as long as no other features require bifurcation and recognition as derivatives. The update also requires the if-converted method to be used for convertible instruments and the effect of potential share settlement be included in the diluted earnings per share calculation when an instrument may be settled in cash or shares. The amendments in this update are effective for public business entities for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. The guidance may be early adopted for fiscal years beginning after December 15, 2020,</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:107%">and interim periods within those fiscal years. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company has elected to early adopt ASU 2020-06 as of January 1, 2021. The Notes are a convertible instrument with a cash-conversion feature that is accounted for within the scope of ASC 470-20 and will be impacted by adopting ASU 2020-06. The Company has elected to apply the modified retrospective method wherein the Company will recognize a cumulative-effect adjustment to the opening balance of retained earnings (January 1, 2021). Further, the Company will not restate EPS in the prior periods. The Company calculated the cumulative-effect adjustment as of January 1, 2021 by comparing (i) the historical amortization schedule for the Notes through December 31, 2020 and (ii) an updated amortization schedule wherein the conversion feature within the Notes would not be separated as an equity component and subsequently recognized as non-cash interest expense under ASC 835-30. As a result of ASU 2020-06, while cash interest expense is not impacted, non-cash interest accretion is limited to the amortization of debt issuance costs under ASC 835-30. Therefore, the Company prepared its transition journal entries by (i) reversing the conversion feature amount recorded in APIC and (ii) reversing the difference in non-cash interest expense via retained earnings. The expected impact on retained earnings is $4.3 million.</span></div><div><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASU 2020-10, Codification Improvements, which updates various codification topics by clarifying or improving disclosure requirements to align with the SEC's regulations. This guidance will be effective for annual periods beginning after December 15, 2020, for public entities. The Company will adopt as of the reporting period beginning January 1, 2021. We evaluated the impact of the </span></div>standard on our consolidated financial statements and do not expect the standard to have a material impact on our consolidated financial statements and disclosures. 4300000 REVENUE<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We separate our goods and services among two reportable segments, North America and International. The two segments consist of revenue originating from: </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:14.15pt">North America: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">including the United States, Canada and Mexico</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:14.15pt">International: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">all geographies outside North America, currently consisting primarily of Australia, France, Germany, Italy, Malaysia, Spain and Switzerland</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Refer to Note 18 for further detail regarding the change in reportable segments which required recast of prior period presentation. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table summarizes our segment revenue (in thousands):</span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.916%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.072%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.072%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.076%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">North America Revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    POC Lab Instruments &amp; Other</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,433 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,556 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,375 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    POC Sales-type leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,230 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,890 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,888 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    POC Lab Consumables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,247 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,267 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,111 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    POC Imaging</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,651 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,655 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,832 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    PVD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,810 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,965 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,663 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    OVP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,695 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,090 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,522 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">    Total North America Revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">131,066</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">115,423</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">124,391</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">International Revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    POC Lab Instruments &amp; Other</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,383 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    POC Sales-type leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    POC Operating Leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,012 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    POC Lab Consumables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,354 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    POC Imaging</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,537 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,998 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    PVD</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,584 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,821 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,055 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">    Total International Revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">66,257</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,238</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,055</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Total Revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">197,323</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">122,661</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">127,446</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Remaining Performance Obligations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Remaining performance obligations represent the aggregate transaction price allocated to performance obligations with an original contract term greater than one year which are fully or partially unsatisfied at the end of the period. Remaining performance obligations include noncancelable purchase orders, the non-lease portion of minimum purchase commitments under long-term supply arrangements, extended warranty, service and other long-term contracts. Remaining performance obligations do not include revenue from contracts with customers with an original term of one year or less, revenue from long-term supply arrangements with no minimum purchase requirements, revenue expected from purchases made in excess of the minimum purchase </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">requirements, or revenue from instruments leased to customers. While the remaining performance obligation disclosure is similar in concept to backlog, the definition of remaining performance obligations excludes leases and contracts that provide the customer with the right to cancel or terminate for convenience with no substantial penalty, even if historical experience indicates the likelihood of cancellation or termination is remote. Additionally, the Company has elected to exclude contracts with customers with an original term of one year or less from remaining performance obligations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of December 31, 2020, the aggregate amount of the transaction price allocated to remaining minimum performance obligations was approximately $144.6 million. As of December 31, 2020, the Company expects to recognize revenue as follows (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.808%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,976 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,089 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,992 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,668 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,713 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,129 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,567 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Contract Balances</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled contract assets, deferred revenue, and customer deposits and billings in excess of revenue recognized. In addition, the Company defers certain costs incurred to obtain contracts. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Contract Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Certain unbilled amounts related to long-term contracts for which we provide a free term to the customer are recorded in "Other current assets" and "Other non-current assets" on the accompanying Consolidated Balance Sheets. The collection of these balances occurs over the term of the underlying contract. The balances as of December 31, 2020 were $1.2 million and $4.1 million for current and non-current assets, respectively, shown net of related unearned interest. The balances as of December 31, 2019 were $1.1 million and $3.7 million for current and non-current assets, respectively, shown net of related unearned interest.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Contract Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company receives cash payments from customers for licensing fees or other arrangements that extend for a specified term. These contract liabilities are classified as either current or long-term in the Consolidated Balance Sheets based on the timing of when the Company expects to recognize revenue. As of December 31, 2020 and 2019, contract liabilities were $8.9 million and $8.7 million, respectively, and are included within "Deferred revenue, current, and other" and "Deferred revenue, non-current" in the accompanying Consolidated Balance Sheets. The decrease in the contract liability balance during the year ended December 31, 2020 is approximately $4.2 million of revenue recognized during the period, offset by approximately $3.8 million of additional deferred sales in 2020 and the acquisition of scil contract liabilities of $0.6 million. The decrease in the contract liability balance during the year ended December 31, 2019 is $3.1 million of revenue recognized during the period, offset by $2.2 million of additional deferred sales. Contract liabilities are reported on the accompanying Consolidated Balance Sheets on a contract-by-contract basis. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Contract Costs</span></div>The Company capitalizes certain direct incremental costs incurred to obtain customer contracts, typically sales-related commissions, where the recognition period for the related revenue is greater than one year. Contract costs are classified as current or non-current, and are included in "Other current assets" and "Other non-current assets" in the Consolidated Balance Sheets based on the timing of when the Company expects to recognize the expense. Contract costs are generally amortized into selling and marketing expense with a certain percentage recognized immediately based upon placement of the instrument with the remainder recognized on a straight-line basis (which is consistent with the transfer of control for the related goods or services) over the average term of the underlying contracts, approximately 6 years. Management assesses these costs for impairment at least quarterly on a portfolio basis and as “triggering” events occur that indicate it is more-likely-than-not that an impairment exists. The balance of contract costs as of December 31, 2020 and December 31, 2019 was $3.0 million and $2.7 million, respectively. Amortization expense for the year ended December 31, 2020 was approximately $1.0 million, offset by approximately $1.2 million of additional contract cost capitalization and $0.1 million of the acquisition of scil contract costs. Amortization expense for the year ended December 31, 2019 was approximately $0.9 million, offset by approximately $1.1 million of additional contract costs capitalized. Contract costs are calculated and reported on a portfolio basis. 2 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table summarizes our segment revenue (in thousands):</span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.916%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.072%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.072%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.076%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">North America Revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    POC Lab Instruments &amp; Other</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,433 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,556 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,375 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    POC Sales-type leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,230 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,890 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,888 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    POC Lab Consumables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,247 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,267 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,111 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    POC Imaging</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,651 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,655 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,832 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    PVD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,810 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,965 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,663 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    OVP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,695 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,090 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,522 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">    Total North America Revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">131,066</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">115,423</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">124,391</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">International Revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    POC Lab Instruments &amp; Other</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,383 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    POC Sales-type leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    POC Operating Leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,012 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    POC Lab Consumables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,354 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    POC Imaging</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,537 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,998 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    PVD</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,584 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,821 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,055 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">    Total International Revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">66,257</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,238</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,055</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Total Revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">197,323</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">122,661</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">127,446</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 8433000 6556000 6375000 5230000 6890000 5888000 59247000 53267000 45111000 20651000 21655000 22832000 19810000 10965000 25663000 17695000 16090000 18522000 131066000 115423000 124391000 6383000 96000 0 387000 0 0 1012000 0 0 32354000 323000 0 22537000 3998000 0 3584000 2821000 3055000 66257000 7238000 3055000 197323000 122661000 127446000 144600000 As of December 31, 2020, the Company expects to recognize revenue as follows (in thousands):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.808%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,976 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,089 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,992 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,668 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,713 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,129 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,567 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 32976000 30089000 26992000 22668000 16713000 15129000 144567000 1200000 4100000 1100000 3700000 8900000 8700000 4200000 3800000 3100000 2200000 P6Y 3000000.0 2700000 1000000.0 1200000 900000 1100000 ACQUISITION AND RELATED PARTY ITEMS<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">scil Acquisition</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On April 1, 2020, the Company completed the acquisition of scil animal care company GmbH (“scil”) from Covetrus, Inc. The Company purchased 100% of the capital stock of scil for an aggregate purchase price of $110.3 million in cash. The acquisition represents a key milestone in the Company's long-term strategic plan, creating a global veterinary diagnostics company with leadership positions in key geographic markets. The purchase price exceeded the identifiable net assets, resulting in goodwill of $46.0 million, primarily attributable to the synergies expected from the expanded market opportunities with our offerings and the experienced workforce acquired. Of the goodwill acquired, $37.3 million is allocated to our International segment and $8.7 million is allocated to our North America segment. All of the goodwill is tax deductible for purposes of calculating Controlled Foreign Corporation ("CFC") tested income, which may result in a decrease to the Company's future U.S. federal tax liability.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The acquisition was accounted for using the acquisition method of accounting in accordance with ASC 805, Business Combinations, which requires, among other things, that assets acquired and liabilities assumed be recognized at their fair values as of the acquisition date. As such, the total purchase consideration was allocated to the assets acquired and liabilities assumed based on a preliminary estimate of their fair values as of April 1, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The information below represents the preliminary purchase price allocation of scil (in thousands):</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.214%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.586%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">April 1, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase consideration</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,290 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,889 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,707 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,278 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment in leases, current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,692 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,338 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,320 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,517 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment in leases, non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,027 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in unconsolidated affiliates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Total assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,302 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,221 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,067 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, current, and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,220 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,249 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Net assets acquired</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,290 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of consideration transferred</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,290 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company's preliminary estimates of fair values of the assets acquired and the liabilities assumed are based on the information currently available, and the Company is continuing to evaluate the underlying inputs and assumptions used in its valuations. Accordingly, these preliminary estimates are subject to change during the measurement period, which is up to one year from the date of the acquisition. A decrease in the fair value of assets acquired or an increase in the fair value of liabilities assumed in the acquisition from those valuations would result in a corresponding change in the amount of goodwill from the acquisition. During the fourth quarter, the Company made certain valuation adjustments to provisional amounts previously recognized. These adjustments resulted in a net increase of $0.2 million in goodwill, primarily due to changes in estimated taxes and an increase in accrued liabilities assumed. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Per the tax indemnification included in the purchase agreement of scil animal care company GmbH, the seller has indemnified the Company for $1.1 million related to uncertain tax positions taken in prior years. The outcome of this arrangement will either be settled or expire due to lapse of statute of limitations by 2027. As of December 31, 2020, approximately $0.8 million of the indemnification agreement remains outstanding.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Intangible assets acquired, amortization method and estimated useful life as of April 1, 2020, was as follows (dollars in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.074%"><tr><td style="width:1.0%"/><td style="width:47.342%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Useful Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization Method</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,272 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internally developed software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Backlog</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name subject to amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names not subject to amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,556</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,517 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">scil generated net revenue of $61.3 million and a net loss of $1.1 million for the period from April 1, 2020 to December 31, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company incurred acquisition related costs of approximately $6.3 million and $0.7 million for the years ended December 31, 2020 and 2019, respectively, which are included within general and administrative expenses on our Consolidated Statements of (Loss) Income.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Unaudited Pro Forma Financial Information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following tables present unaudited supplemental pro forma financial information as if the acquisition had occurred on January 1, 2019 (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.850%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.116%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.117%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215,874 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,700 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income before equity in losses of unconsolidated affiliates</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,848)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,159)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income attributable to Heska Corporation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,215)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,487)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The pro forma financial information presented above has been prepared by combining our historical results and the historical results of scil and further reflects the effect of purchase accounting adjustments, including: (i) amortization of acquired intangible assets, (ii) the impact of certain fair value adjustments such as depreciation on the acquired property, plant and equipment, and (iii) historical intercompany sales between the Company and scil. The unaudited pro forma results are presented for informational purposes only and are not necessarily indicative of what actual results of operations would have been if the acquisition had occurred as the beginning of the period presented, nor are they indicative of future results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CVM</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On December 5, 2019, Heska entered into a definitive agreement to purchase 100% of the outstanding shares of CVM Diagnostico Veternario S.L. and CVM Ecografia S.L. (“CVM”, collectively), primarily to expand international operations in Europe. CVM is headquartered in Tudela, outside of Madrid, Spain. CVM mainly </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">operates in Spain. The terms of the agreement transferred control of CVM upon signing, and the transfer of the purchase price of approximately $14.4 million and shares occurred in January 2020. The purchase price exceeded the fair value of the identifiable net assets and, accordingly, $9.0 million was allocated to goodwill within the International segment based on the purchase price allocation, all of which is tax deductible for purposes of calculating CFC tested income. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The fair values allocated to CVM's assets and liabilities as of the acquisition date, as well as the purchase price, are reflected in the table below (in thousands):</span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.214%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.586%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchase Price</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 5, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consideration paid to former owners</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,420 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,226 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,621 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,186 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,608 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Total assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,029 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(471)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of deferred revenue, and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(683)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,109)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(157)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Net assets acqiured</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,461 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,959 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of consideration transferred</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,420 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">During the year ended December 31, 2020, the Company made certain valuation adjustments to provisional amounts previously recognized. These measurement period adjustments resulted in a net $110 thousand increase of goodwill, primarily due to fair value adjustments resulting in a decrease in net identifiable assets acquired. The Company finalized the accounting for the CVM acquisition in the fourth quarter of 2020.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Intangible assets acquired, amortization method and estimated useful life as of December 5, 2019, were as follows (dollars in thousands):</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.634%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.801%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.819%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.804%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Useful Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization Method</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,440 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,608 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CVM generated net revenue of $0.8 million and net income of $0.1 million, for the period from December 6, 2019 to December 31, 2019. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company incurred acquisition related costs of approximately $0.6 million and $0.1 million for the years ended December 31, 2020 and 2019, respectively, which are included within general and administrative expenses on our Consolidated Statements of (Loss) Income. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Unaudited Pro Forma Financial Information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table presents unaudited supplemental pro forma financial information as if the CVM acquisition had occurred on January 1, 2018 (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.276%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.325%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.328%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,434 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,344 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income before equity in losses of unconsolidated affiliates</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(460)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,042 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income attributable to Heska Corporation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(788)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,970 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The pro forma financial information presented above has been prepared by combining our historical results and the historical results of CVM and further reflects the effect of purchase accounting adjustments. The unaudited pro forma results are presented for informational purposes only and are not necessarily indicative of what actual results of operations would have been if the acquisition had occurred as the beginning of the period presented, nor are they indicative of future results of operations. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Optomed</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On February 22, 2019, Heska acquired 70% of the equity of Optomed, a French-based endoscopy company, in exchange for approximately $0.2 million in cash and the assumption of approximately $0.4 million in debt. On October 5, 2020, the Company acquired the remaining 30% minority interest in Optomed for a purchase price of $0.5 million, allowing the Company to assume full control of the business operations. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Purchase Agreement for Certain Assets</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Cuattro, LLC ("Cuattro") is owned by Kevin S. Wilson, the CEO and President of the Company. On December 21, 2018, the Company closed a transaction (the "Asset Acquisition") to acquire certain assets from Cuattro, all related to the North America segment. Pursuant to the Asset Acquisition, dated November 26, 2018, the Company issued 54,763 shares of the Company's common stock, $0.01 par value per share (the "Common Stock"), to Cuattro on the Closing Date, at an aggregate value equal to approximately $5.4 million based on the adjusted closing price per share of the Common Stock as reported on the Nasdaq Stock Market on the Asset Acquisition agreement date. These shares were issued to Cuattro in a private placement in reliance upon an exemption from the registration requirements of the Securities Act pursuant to Section 4(a)(2) thereof and the safe harbor provided by Rule 506 of Regulation D promulgated thereunder. In addition to the Common Stock, the Company paid cash in the amount of $2.8 million to Cuattro as part of the transaction. The total purchase price was determined based on a valuation report from an independent third party. Part of the Asset Acquisition was an agreement to terminate the supply and license agreement that Heska had been operating under since the acquisition of Cuattro Veterinary USA, LLC. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company evaluated the acquisition of the purchased assets under ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and ASU 2017-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and concluded that as substantially all of the fair value of the gross assets acquired is concentrated in an identifiable group of similar assets, the transaction did not meet the requirements to be accounted for as a business combination and therefore was accounted for as an asset </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">acquisition. Accordingly, the $8.2 million purchase price of the purchased assets was allocated entirely to an identifiable intangible asset amortizing on a straight-line basis over a 10-year useful life.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Related Party Activities</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Cuattro charged the Company $0, $6 thousand and $4.6 million during 2020, 2019 and 2018, respectively, primarily related to digital imaging products, pursuant to an underlying supply contract that contained minimum purchase obligations, software and services as well as other operating expenses. Pursuant to the Asset Acquisition, Cuattro was obligated, without further compensation, to assist the Company with the implementation of a third-party image hosting platform and necessary data migration. The implementation and migration were completed, and as of December 31, 2020 there will be no further related party activities with Cuattro.</span></div>CVM management conducts related party activities with Practice Clinicas Veterinarias Moviles, S.L. ("CVM Practice"), which is owned by CVM's management. During the year ended December 31, 2020, the Company fully paid the balance of a loan due to CVM Practice of approximately $1.1 million, which is included in "Payments of related party debt" on the Consolidated Statements of Cash Flows. CVM also leases two warehouses from CVM Practice. CVM Practice charged CVM $31 thousand and $0 during the year ended December 31, 2020 and 2019, respectively, all of which is related to lease payments. The right-of-use asset and lease liability amounts related to the warehouse leases were approximately $0.2 million and $0 as of December 31, 2020 and 2019, respectively. The change from December 31, 2019 to December 31, 2020 is due to a reorganization regarding CVM management and the control that they exercise subsequent to the scil acquisition. 1 110300000 46000000.0 37300000 8700000 110290000 5889000 10707000 11278000 311000 1692000 1338000 19320000 877000 44517000 1027000 55000 291000 97302000 8221000 7067000 356000 3220000 94000 529000 13249000 276000 64290000 46000000 110290000 200000 1100000 800000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Intangible assets acquired, amortization method and estimated useful life as of April 1, 2020, was as follows (dollars in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.074%"><tr><td style="width:1.0%"/><td style="width:47.342%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Useful Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization Method</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,272 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internally developed software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Backlog</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name subject to amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names not subject to amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,556</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,517 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Intangible assets acquired, amortization method and estimated useful life as of December 5, 2019, were as follows (dollars in thousands):</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.634%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.801%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.819%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.804%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Useful Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization Method</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,440 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,608 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> P10Y 36272000 P7Y 353000 P0Y2M12D 210000 P2Y 60000 P0Y9M18D 66000 7556000 44517000 61300000 1100000 6300000 700000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following tables present unaudited supplemental pro forma financial information as if the acquisition had occurred on January 1, 2019 (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.850%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.116%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.117%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215,874 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,700 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income before equity in losses of unconsolidated affiliates</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,848)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,159)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income attributable to Heska Corporation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,215)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,487)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table presents unaudited supplemental pro forma financial information as if the CVM acquisition had occurred on January 1, 2018 (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.276%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.325%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.328%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,434 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,344 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income before equity in losses of unconsolidated affiliates</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(460)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,042 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income attributable to Heska Corporation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(788)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,970 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 215874000 201700000 -14848000 -2159000 -15215000 -2487000 1 14400000 9000000.0 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The fair values allocated to CVM's assets and liabilities as of the acquisition date, as well as the purchase price, are reflected in the table below (in thousands):</span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.214%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.586%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchase Price</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 5, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consideration paid to former owners</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,420 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,226 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,621 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,186 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,608 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Total assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,029 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(471)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of deferred revenue, and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(683)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,109)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(157)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Net assets acqiured</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,461 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,959 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of consideration transferred</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,420 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 14420000 1226000 583000 1621000 1186000 345000 2608000 460000 8029000 94000 471000 54000 683000 1109000 157000 5461000 8959000 14420000 110000 P6Y 2440000 P4Y 111000 57000 2608000 800000 100000 600000 100000 130434000 135344000 -460000 6042000 -788000 5970000 0.70 200000 400000 0.30 500000 54763 0.01 5400000 2800000 8200000 P10Y 0 6000 4600000 1100000 2 31000 0 200000 200000 0 0 INVESTMENTS IN UNCONSOLIDATED AFFILIATES<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The carrying values of investments in unconsolidated affiliates, categorized by type of investment, is as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.807%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.560%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,686 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,406 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-marketable equity security investment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,018 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,018 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in Unconsolidated Affiliates</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,704 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,424 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Equity Method Investment</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On September 24, 2018, we invested approximately $5.1 million, including costs, to acquire an equity interest in a business as part of our product development strategy. As of December 31, 2020, our ownership interest in the business was 29.1%. In connection with the investment, the Company entered into a Manufacturing Supply Agreement that grants the Company global exclusivity to specified products to be delivered under the agreement for a 15-year period that begins upon the Company's receipt and acceptance of an initial order under the agreement. The Company accounts for this investment using the equity method of accounting. Under the equity method, the carrying value of the investment is adjusted for the Company's proportionate share of the investee's reported earnings or losses with the corresponding share of earnings or losses reported as Equity in losses of unconsolidated affiliates, listed below Net income before equity in losses of unconsolidated affiliates within the Consolidated Statements of (Loss) Income. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Non-Marketable Equity Security Investment</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On August 8, 2018, the Company invested approximately $3.0 million, including costs, in exchange for preferred stock. The Company's investment is a non-marketable equity security, recorded using the measurement alternative of cost minus impairment, if any, plus or minus changes resulting from qualifying observable price changes.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As part of the agreement, the Company entered into a Supply and License Agreement, which provides that the investee produce and commercialize products that will enhance the Company's diagnostic portfolio. As part of this agreement, the Company made upfront payment of $1.0 million related to a worldwide exclusive license agreement over a 20-year period, recorded in both short and long-term other assets. In addition, the agreement provides for an additional contingent payment of $10.0 million, relating to the successful achievement of sales milestones. This potential future milestone payment has not yet been accrued as it is not deemed by the Company to be probable at this time. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Both parties in this arrangement are active participants and are exposed to significant risks and rewards dependent on the commercial success of the activities of the collaboration. The parties are actively working on developing and testing the product as well as funding the research and development. Heska classifies the amounts paid for research and development work within the North America segment research and development operating expenses. Expense is recognized ratably when incurred and in accordance with the development plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">. </span></div>Our investments are evaluated for impairment if a triggering event occurs. The Company evaluated both its equity method investment and non-marketable equity security investment for losses other than temporary as of December 31, 2020, and determined that no indications of an impairment existed. <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The carrying values of investments in unconsolidated affiliates, categorized by type of investment, is as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.807%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.560%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,686 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,406 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-marketable equity security investment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,018 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,018 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in Unconsolidated Affiliates</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,704 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,424 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 3686000 4406000 3018000 3018000 6704000 7424000 5100000 0.291 P15Y 3000000.0 1000000.0 P20Y 10000000.0 INCOME TAXES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The components of income before income taxes were as follows (in thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.862%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.474%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.474%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.477%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Domestic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(9,441)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1,872)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,602 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(4,352)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(711)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">205 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(13,793)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2,583)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,807 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Temporary differences that give rise to the components of net deferred tax assets (liabilities) are as follows (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.412%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.414%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,993 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,005 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">295 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">122 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,322 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,858 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Research and development tax credit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,308 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">990 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,571 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,417 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,441 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,052 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">298 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,469 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8,757 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11,676 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Foreign tax credit carryforward</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">64 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">64 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Sales-type leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,324 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1,968)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Convertible debt equity component</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(8,691)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(9,421)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Foreign intangible</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(11,311)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(691)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1,124)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">247 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11,394 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(6,409)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(5,656)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total net deferred tax assets (liabilities)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(6,162)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,738 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The components of the income tax expense (benefit) are as follows (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.845%"><tr><td style="width:1.0%"/><td style="width:60.878%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.419%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.491%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.496%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Current income tax expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(115)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">State</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">339 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">189 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">192 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,465 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">63 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total current expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,780 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">359 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">140 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Deferred income tax (benefit) expense:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">369 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1,610)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1,877)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">State</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">289 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(307)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(378)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2,199)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">112 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total deferred (benefit) expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1,541)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1,805)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2,255)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total income tax expense (benefit)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">239 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1,446)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2,115)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company's income tax (benefit) expense relating to income (loss) for the periods presented differs from the amounts that would result from applying the federal statutory rate to that income (loss) as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.926%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.926%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.272%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Statutory federal tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Non-controlling interest in Optomed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Foreign income inclusion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Non-temporary stock option benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">48 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Meals and entertainment permanent difference</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GILTI permanent difference</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other permanent differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Foreign tax rate differences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Change in tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other deferred differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Transaction costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Executive compensation limit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Research &amp; development credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Equity Investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Change in uncertain tax benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In 2020, we had total income tax expense of $0.2 million, including $0.6 million in domestic deferred income tax expense and $2.2 million in foreign deferred income tax benefit, and $1.8 million in current income tax expense. In 2019, we had total income tax benefit of $1.4 million, including approximately $1.9 million in domestic deferred income tax benefit and $0.1 million of foreign deferred income tax expense, a non-cash benefit, and approximately $0.4 million in current income tax expense. In 2018, we had total income tax benefit of $2.1 million, including $2.3 million in domestic deferred income tax benefit, a non-cash benefit, and $0.1 million in current income tax expense. Income tax expense increased in 2020 from 2019 due to foreign income inclusion, executive compensation limitations and acquisition related costs. Income tax benefit decreased in 2019 from 2018 due to executive compensation limitations and lower excess tax benefits related to stock-based compensation deductions. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Cash paid for income taxes for the years ended December 31, 2020, 2019 and 2018 was $993 thousand, $128 thousand and $36 thousand, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> The Company is subject to income taxes in the U.S. federal jurisdiction, and various foreign, state and local jurisdictions. Tax regulations within each jurisdiction are subject to the interpretation of the related tax laws and regulations and require significant judgment to apply. Although the U.S. and many states generally have statutes of limitations ranging from 3 to 5 years, those statutes could be extended due to the Company’s net operating loss and tax credit carryforward positions in several of the Company's tax jurisdictions. In the U.S., the tax years 2017 - 2019 remain open to examination by the Internal Revenue Service.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of December 31, 2020, the Company had net operating loss carryforwards ("NOL") of approximately $35.0 million, a foreign tax credit of $64 thousand and a domestic research and development tax credit carryforward of approximately $1.3 million. Our federal NOL is expected to expire as follows if unused: $22 million in 2021 through 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$5.4 million in 2024 through 2025 and $0.5 million in 2027 and later. Our foreign NOL of $7.1 million does not have an expiration date. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">The Company considered multiple factors in assessing the need for an increase in the partial valuation allowance against the Company’s deferred tax assets as of December 31, 2020. Significant factors such as employee stock compensation expenses from achievement of Company performance metrics, executive compensation limitations and required capitalization of research and development expenses beginning in 2022 have negatively impacted our future taxable income projections. These future projections indicate a larger portion of the Company’s deferred tax assets will likely expire unrealized. As a result, the Company recorded an additional </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$0.8 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> tax effected increase to the current partial valuation allowance against the Company's worldwide net operating losses and tax credits for the year ended December 31, 2020. As of December 31, 2020, the Company had a deferred tax asset of approximately </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$10.1 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> from net operating losses and tax credits and a net partial valuation allowance of approximately </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$6.4 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> recorded against these deferred tax assets. The Company will continue to closely monitor the need for an additional valuation allowance against its deferred tax assets in each subsequent reporting period which can be impacted by actual operating results compared to the Company's forecast.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ASC Topic 740 prescribes the accounting for uncertainty in income taxes recognized in the financial statements in accordance with the other provisions contained within this guidance. This topic prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by the taxing authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50% likely or being realized upon ultimate audit settlement. In the normal course of business, the Company's tax returns are subject to examination by various taxing authorities. Such examination may result in future tax and interest assessments by these taxing authorities for uncertain tax positions taken in respect to certain matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following provides a reconciliation of unrecognized tax benefits which are included in Other liabilities within the Consolidated Balance Sheets (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.819%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.091%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.880%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.093%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Acquired additions based on prior year tax positions</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,072)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Reductions from lapse in statutes of limitations</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Balance at the end of period</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(808)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The total amount of unrecognized tax benefits, which are included in other liabilities within the combined balance sheets as of December 31, 2020 was approximately $0.8 million, which may impact the effective tax rate if recognized.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">These unrecognized tax benefits were recognized as part of the acquisition of scil animal care company GmbH.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Per the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">tax indemnification included in the purchase agreement, the seller </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">has indemnified the Company for these other liabilities, which would reduce the economic impact to the Company if these positions were settled with tax authorities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">It is expected that the amount of unrecognized tax benefits will change in the next 12 months; however, the Company does not expect the change to have a material impact on the combined financial statements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company recognizes interest and penalties related to uncertain tax positions in income tax (benefit)/expense. Interest and penalties accrued as of December 31, 2020 are $19.0 thousand.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of December 31, 2020, the Company had </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">accumulated undistributed earnings </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">generated by foreign subsidiaries of approximately $2.9 million, which would be subject to U.S. taxes and foreign withholding taxes of approximately $145 thousand if repatriated.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company had previously considered these earnings as a possible cash source through repatriation to the U.S.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of December 31, 2020, the Company has changed its assertion on these earnings and now considers them to be indefinitely reinvested and expects the future U.S. cash generation to be sufficient to meet future U.S. cash needs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If the Company decides to repatriate these foreign earnings, it would need to adjust its income tax provision in the period it determined that the earnings would no longer be indefinitely invested outside the United States.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The components of income before income taxes were as follows (in thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.862%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.474%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.474%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.477%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Domestic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(9,441)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1,872)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,602 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(4,352)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(711)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">205 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(13,793)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2,583)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,807 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The components of the income tax expense (benefit) are as follows (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.845%"><tr><td style="width:1.0%"/><td style="width:60.878%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.419%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.491%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.496%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Current income tax expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(115)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">State</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">339 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">189 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">192 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,465 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">63 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total current expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,780 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">359 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">140 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Deferred income tax (benefit) expense:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">369 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1,610)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1,877)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">State</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">289 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(307)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(378)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2,199)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">112 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total deferred (benefit) expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1,541)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1,805)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2,255)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total income tax expense (benefit)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">239 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1,446)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2,115)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div> -9441000 -1872000 3602000 -4352000 -711000 205000 -13793000 -2583000 3807000 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Temporary differences that give rise to the components of net deferred tax assets (liabilities) are as follows (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.412%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.414%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,993 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,005 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">295 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">122 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,322 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,858 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Research and development tax credit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,308 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">990 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,571 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,417 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,441 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,052 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">298 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,469 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8,757 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11,676 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Foreign tax credit carryforward</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">64 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">64 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Sales-type leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,324 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1,968)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Convertible debt equity component</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(8,691)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(9,421)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Foreign intangible</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(11,311)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(691)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1,124)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">247 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11,394 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(6,409)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(5,656)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total net deferred tax assets (liabilities)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(6,162)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,738 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 2993000 2005000 295000 122000 2322000 1858000 1308000 990000 2571000 1417000 1441000 2052000 298000 3469000 8757000 11676000 64000 64000 1324000 1968000 8691000 9421000 11311000 691000 1124000 179000 247000 11394000 6409000 5656000 6162000 5738000 -24000 0 -115000 339000 189000 192000 1465000 170000 63000 1780000 359000 140000 369000 -1610000 -1877000 289000 -307000 -378000 -2199000 112000 0 -1541000 -1805000 -2255000 239000 -1446000 -2115000 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company's income tax (benefit) expense relating to income (loss) for the periods presented differs from the amounts that would result from applying the federal statutory rate to that income (loss) as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.926%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.926%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.272%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Statutory federal tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Non-controlling interest in Optomed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Foreign income inclusion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Non-temporary stock option benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">48 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Meals and entertainment permanent difference</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GILTI permanent difference</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other permanent differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Foreign tax rate differences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Change in tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other deferred differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Transaction costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Executive compensation limit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Research &amp; development credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Equity Investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Change in uncertain tax benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/></tr></table></div> 0.21 0.21 0.21 -0.04 0.09 -0.08 -0.01 0.02 0 -0.12 0 0 0.06 0.48 0.50 0 -0.02 0.01 0 0.02 0.01 0.01 -0.01 0.01 0.02 0.06 0 0.01 -0.06 0 -0.04 -0.17 0 0.02 0.09 0.21 0.06 0.06 0 0.06 0.07 0 -0.02 -0.20 0 -0.04 0 0 0.03 0 0 -0.01 0 -0.01 -0.02 0.56 -0.56 200000 600000 -2200000 1800000 -1400000 -1900000 100000 400000 -2100000 -2300000 100000 993000 128000 36000 35000000.0 64000 1300000 22000000 5400000 500000 7100000 800000 10100000 6400000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following provides a reconciliation of unrecognized tax benefits which are included in Other liabilities within the Consolidated Balance Sheets (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.819%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.091%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.880%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.093%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Acquired additions based on prior year tax positions</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,072)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Reductions from lapse in statutes of limitations</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Balance at the end of period</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(808)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0 0 1072000 0 358000 0 94000 0 808000 0 800000 19000.0 2900000 145000 LEASES<div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Lessee Accounting </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company leases buildings, office equipment, and vehicles. The following table summarizes the Company's operating and finance lease balances (in thousands): </span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.659%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.165%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.880%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.964%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,457 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,726 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,907 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">81 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total Leased Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7,364 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,807 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating lease liabilities, current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,087 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,745 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating lease liabilities, non-current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,858 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,413 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Deferred revenue, current, and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">295 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">47 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">261 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total Lease Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6,501 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6,242 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For the twelve months ended December 31, 2020, operating lease expense was approximately $2.8 million, including immaterial variable lease costs. For the twelve months ended December 31, 2019, operating lease expense was approximately $2.4 million, including immaterial variable lease costs. The Company had building and other rent expense of $1.9 million for the twelve months ended December 31, 2018 under ASC 840, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Leases.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For the years ended December 31, 2020 and 2019, finance lease amortization expense was $0.3 million and $44 thousand, respectively. For the years ended December 31, 2020 and 2019, finance lease interest expense was $10 thousand and $3 thousand, respectively. The Company's finance leases were not material as of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">December 31, 2018 and for the twelve month period then ended.     </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Supplemental cash flow information related to the Company's operating and finance leases for the years ended December 31, 2020 and 2019, respectively, was as follows (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.653%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.714%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.716%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Twelve Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">    Operating cash outflows - operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,213 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,800 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">    Operating cash outflows - finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">    Financing cash outflows - finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">250 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">36 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ROU assets obtained in exchange for new lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">    Operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">788 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">604 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">    Finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">159 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table presents the weighted average remaining lease term and weighted average discount rate related to the Company's leases: </span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.653%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.714%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.716%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Weighted average remaining lease term:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">    Operating</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.1 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.8 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">    Finance</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.9 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.0 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Weighted average discount rate:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">    Operating</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">    Finance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table presents the maturity of the Company's lease liabilities as of December 31, 2020 (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.807%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.809%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,158 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">294 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,834 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">139 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,949 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">144 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">138 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">132 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6,355 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">574 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">410 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,945 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">556 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Lessor Accounting</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company enters into sales-type leases as part of our subscription agreements. The following table presents the maturity of the Company's lease receivables as of December 31, 2020 (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.301%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.499%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Sales-Type Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,834 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,872 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,220 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,291 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,033 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,424 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total undiscounted future maturities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">20,674 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less: interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">91 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total lease receivables</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">20,583 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table summarizes the profit recognized on the commencement date for sales-type leases and lease income for equipment-only operating leases (in thousands): </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.163%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.685%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.413%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.239%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Twelve Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Sales-type lease revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,617 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6,890 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Sales-type lease cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,951 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,099 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Profit recognized at commencement for sales-type leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,666 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,791 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating lease income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,012 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div> LEASES<div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Lessee Accounting </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company leases buildings, office equipment, and vehicles. The following table summarizes the Company's operating and finance lease balances (in thousands): </span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.659%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.165%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.880%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.964%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,457 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,726 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,907 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">81 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total Leased Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7,364 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,807 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating lease liabilities, current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,087 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,745 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating lease liabilities, non-current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,858 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,413 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Deferred revenue, current, and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">295 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">47 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">261 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total Lease Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6,501 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6,242 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For the twelve months ended December 31, 2020, operating lease expense was approximately $2.8 million, including immaterial variable lease costs. For the twelve months ended December 31, 2019, operating lease expense was approximately $2.4 million, including immaterial variable lease costs. The Company had building and other rent expense of $1.9 million for the twelve months ended December 31, 2018 under ASC 840, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Leases.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For the years ended December 31, 2020 and 2019, finance lease amortization expense was $0.3 million and $44 thousand, respectively. For the years ended December 31, 2020 and 2019, finance lease interest expense was $10 thousand and $3 thousand, respectively. The Company's finance leases were not material as of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">December 31, 2018 and for the twelve month period then ended.     </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Supplemental cash flow information related to the Company's operating and finance leases for the years ended December 31, 2020 and 2019, respectively, was as follows (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.653%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.714%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.716%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Twelve Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">    Operating cash outflows - operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,213 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,800 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">    Operating cash outflows - finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">    Financing cash outflows - finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">250 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">36 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ROU assets obtained in exchange for new lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">    Operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">788 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">604 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">    Finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">159 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table presents the weighted average remaining lease term and weighted average discount rate related to the Company's leases: </span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.653%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.714%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.716%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Weighted average remaining lease term:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">    Operating</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.1 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.8 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">    Finance</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.9 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.0 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Weighted average discount rate:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">    Operating</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">    Finance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table presents the maturity of the Company's lease liabilities as of December 31, 2020 (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.807%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.809%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,158 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">294 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,834 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">139 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,949 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">144 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">138 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">132 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6,355 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">574 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">410 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,945 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">556 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Lessor Accounting</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company enters into sales-type leases as part of our subscription agreements. The following table presents the maturity of the Company's lease receivables as of December 31, 2020 (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.301%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.499%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Sales-Type Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,834 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,872 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,220 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,291 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,033 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,424 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total undiscounted future maturities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">20,674 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less: interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">91 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total lease receivables</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">20,583 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table summarizes the profit recognized on the commencement date for sales-type leases and lease income for equipment-only operating leases (in thousands): </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.163%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.685%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.413%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.239%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Twelve Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Sales-type lease revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,617 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6,890 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Sales-type lease cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,951 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,099 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Profit recognized at commencement for sales-type leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,666 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,791 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating lease income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,012 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div> <div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company leases buildings, office equipment, and vehicles. The following table summarizes the Company's operating and finance lease balances (in thousands): </span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.659%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.165%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.880%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.964%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,457 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,726 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,907 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">81 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total Leased Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7,364 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,807 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating lease liabilities, current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,087 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,745 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating lease liabilities, non-current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,858 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,413 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Deferred revenue, current, and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">295 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">47 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">261 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total Lease Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6,501 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6,242 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 5457000 5726000 1907000 81000 7364000 5807000 2087000 1745000 3858000 4413000 295000 47000 261000 37000 6501000 6242000 2800000 2400000 1900000 300000 44000 10000 3000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Supplemental cash flow information related to the Company's operating and finance leases for the years ended December 31, 2020 and 2019, respectively, was as follows (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.653%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.714%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.716%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Twelve Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">    Operating cash outflows - operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,213 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,800 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">    Operating cash outflows - finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">    Financing cash outflows - finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">250 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">36 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ROU assets obtained in exchange for new lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">    Operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">788 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">604 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">    Finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">159 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table presents the weighted average remaining lease term and weighted average discount rate related to the Company's leases: </span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.653%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.714%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.716%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Weighted average remaining lease term:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">    Operating</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.1 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.8 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">    Finance</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.9 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.0 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Weighted average discount rate:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">    Operating</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">    Finance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> 2213000 1800000 10000 3000 250000 36000 788000 604000 159000 11000 P3Y1M6D P3Y9M18D P2Y10M24D P2Y 0.042 0.044 0.021 0.040 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table presents the maturity of the Company's lease liabilities as of December 31, 2020 (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.807%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.809%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,158 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">294 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,834 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">139 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,949 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">144 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">138 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">132 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6,355 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">574 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">410 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,945 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">556 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 2158000 294000 1834000 139000 1949000 59000 144000 38000 138000 26000 132000 18000 6355000 574000 410000 18000 5945000 556000 The following table presents the maturity of the Company's lease receivables as of December 31, 2020 (in thousands):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.301%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.499%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Sales-Type Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,834 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,872 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,220 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,291 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,033 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,424 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total undiscounted future maturities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">20,674 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less: interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">91 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total lease receivables</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">20,583 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 4834000 4872000 4220000 3291000 2033000 1424000 20674000 91000 20583000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table summarizes the profit recognized on the commencement date for sales-type leases and lease income for equipment-only operating leases (in thousands): </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.163%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.685%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.413%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.239%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Twelve Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Sales-type lease revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,617 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6,890 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Sales-type lease cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,951 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,099 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Profit recognized at commencement for sales-type leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,666 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,791 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating lease income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,012 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div> 5617000 6890000 3951000 5099000 1666000 1791000 1012000 0 EARNINGS PER SHARE<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Basic earnings per share ("EPS") is computed by dividing net income attributable to the Company by the weighted-average number of common shares outstanding during the period. The computation of diluted EPS is similar to the computation of basic EPS except that the numerator is increased to exclude charges that would not have been incurred, and the denominator is increased to include the number of additional common shares that would have been outstanding (using the if-converted and treasury stock methods), if securities containing potentially dilutive common shares (stock options and restricted stock awards but excluding options to purchase fractional shares resulting from the Company's December 2010 1-for-10 reverse stock split) had been converted to common shares, and if such assumed conversion is dilutive.</span></div><div style="margin-top:9.9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following is a reconciliation of the weighted-average shares outstanding used in the calculation of basic and diluted earnings per share ("EPS") for the years ended December 31, 2020, 2019 and 2018 (in thousands, except per share data):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:9.9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.338%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.242%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net (loss) income attributable to Heska Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(14,399)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1,465)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,850 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Basic weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8,653 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7,446 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7,220 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Assumed exercise of dilutive stock options and restricted shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">636 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Diluted weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8,653 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7,446 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7,856 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Basic (loss) earnings per share attributable to Heska Corporation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1.66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(0.20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.81 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Diluted (loss) earnings per share attributable to Heska Corporation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1.66)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(0.20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.74 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following potentially outstanding common shares from convertible preferred stock, convertible senior notes, stock options and restricted stock awards were excluded from the computation of diluted EPS because the effect would have been antidilutive (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.412%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.188%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.415%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible preferred stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and restricted shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">904 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As more fully described in Note 16, our Notes are convertible under certain circumstances, as defined in the indenture, into a combination of cash and shares of our common stock. The Company intends to settle the principal value of the Notes in cash and issue shares of our common stock to settle the intrinsic value of the conversion feature. The Company will use the treasury stock method when calculating the potential dilutive effect of the conversion feature on earnings per share, if any. Potential dilution upon conversion of the Notes occurs when the average market price per share of our common stock is greater than the conversion price of the Notes of $86.63. For the periods presented, all potentially dilutive shares relating to the Notes were not included in the computation of diluted EPS as the effect would have been antidilutive. </span></div>As discussed in Note 12, the Company issued and sold an aggregate of 122,000 shares of its Preferred Stock to certain investors in a private placement offering. The shares were converted into 1,508,964 shares of Public Common Stock, effective on April 21, 2020. The potential dilutive effect of the convertible preferred stock was calculated using the if-converted method for the period the preferred shares were outstanding. For the twelve months ended December 31, 2020, these shares were excluded from the computation of diluted EPS because the effect would have been antidilutive. 10 <div style="margin-top:9.9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following is a reconciliation of the weighted-average shares outstanding used in the calculation of basic and diluted earnings per share ("EPS") for the years ended December 31, 2020, 2019 and 2018 (in thousands, except per share data):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:9.9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.338%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.242%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net (loss) income attributable to Heska Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(14,399)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1,465)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,850 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Basic weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8,653 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7,446 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7,220 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Assumed exercise of dilutive stock options and restricted shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">636 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Diluted weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8,653 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7,446 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7,856 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Basic (loss) earnings per share attributable to Heska Corporation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1.66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(0.20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.81 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Diluted (loss) earnings per share attributable to Heska Corporation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1.66)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(0.20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.74 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> -14399000 -1465000 5850000 8653000 7446000 7220000 0 0 636000 8653000 7446000 7856000 -1.66 -0.20 0.81 -1.66 -0.20 0.74 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following potentially outstanding common shares from convertible preferred stock, convertible senior notes, stock options and restricted stock awards were excluded from the computation of diluted EPS because the effect would have been antidilutive (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.412%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.188%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.415%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible preferred stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and restricted shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">904 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 458000 0 0 118000 0 0 328000 300000 111000 904000 300000 111000 86.63 122000 1508964 GOODWILL AND OTHER INTANGIBLES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following summarizes the changes in goodwill during the years ended December 31, 2020 and 2019 (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.362%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.414%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount, December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,724 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">955 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,679 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill attributable to acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,396 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,396 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount, December 31, 2019</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,724 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,480 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,204 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill attributable to acquisitions (subject to change)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,742 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,258 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement period adjustment to prior year acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">948 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,014 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,962 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount, December 31, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,414 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,862 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,276 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Other intangibles assets, net consisted of the following as of December 31, 2020 and 2019 (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.974%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.474%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.480%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.480%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.015%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets subject to amortization:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships and other</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,989 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,436)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,553 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,205 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,226)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,979 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,669 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,696)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,973 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,200 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(819)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,381 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets not subject to amortization:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,374 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,374 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,229 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,237)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,992 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,517 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,045)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,472 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Amortization expense relating to other intangibles is as follows (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.375%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.560%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.560%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.563%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,196 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,278 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">388 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">    </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The remaining weighted-average amortization period for intangible assets is approximately 8.7 years. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Estimated amortization expense related to intangibles for each of the five years from 2021 through 2025 and thereafter is as follows (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,905 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,868 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,506 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,376 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,347 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">19,616 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total amortization related to finite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">47,618 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8,374 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">55,992 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following summarizes the changes in goodwill during the years ended December 31, 2020 and 2019 (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.362%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.414%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount, December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,724 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">955 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,679 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill attributable to acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,396 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,396 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount, December 31, 2019</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,724 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,480 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,204 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill attributable to acquisitions (subject to change)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,742 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,258 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement period adjustment to prior year acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">948 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,014 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,962 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying amount, December 31, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,414 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,862 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,276 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 25724000 955000 26679000 0 9396000 9396000 0 129000 129000 25724000 10480000 36204000 8742000 37258000 46000000 0 110000 110000 948000 5014000 5962000 35414000 52862000 88276000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Other intangibles assets, net consisted of the following as of December 31, 2020 and 2019 (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.974%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.474%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.480%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.480%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.015%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets subject to amortization:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships and other</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,989 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,436)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,553 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,205 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,226)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,979 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,669 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,696)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,973 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,200 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(819)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,381 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets not subject to amortization:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,374 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,374 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,229 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,237)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,992 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,517 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,045)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,472 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 46989000 6436000 40553000 6205000 2226000 3979000 8669000 1696000 6973000 8200000 819000 7381000 197000 105000 92000 112000 0 112000 8374000 8374000 0 0 64229000 8237000 55992000 14517000 3045000 11472000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Amortization expense relating to other intangibles is as follows (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.375%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.560%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.560%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.563%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,196 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,278 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">388 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 5196000 1278000 388000 P8Y8M12D <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Estimated amortization expense related to intangibles for each of the five years from 2021 through 2025 and thereafter is as follows (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,905 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,868 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,506 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,376 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,347 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">19,616 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total amortization related to finite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">47,618 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8,374 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">55,992 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 5905000 5868000 5506000 5376000 5347000 19616000 47618000 8374000 55992000 PROPERTY AND EQUIPMENT, NET<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Property and equipment, net, consisted of the following (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.980%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.474%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.475%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,590 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">694 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Building</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12,737 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,845 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">40,411 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">28,777 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,047 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,345 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,773 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,408 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Leasehold and building improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10,728 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10,558 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">671 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Property and equipment, gross</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">73,290 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">49,298 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(37,748)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(33,829)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">35,542 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">15,469 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company has subscription agreements whereby its instruments in inventory may be placed at a customer's location on a rental basis. For instruments classified as operating leases, the cost of these instruments is transferred to machinery and equipment and depreciated, typically over a 5 to 7 year period depending on the circumstance under which the instrument is placed with the customer. Our cost of instruments under operating leases as of December 31, 2020 and 2019 was $13.6 million and $8.1 million, respectively, before accumulated depreciation of $4.7 million and $4.6 million, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Depreciation expense for property and equipment was $6.2 million, $3.6 million and $4.2 million for the years ended December 31, 2020, 2019 and 2018, respectively.</span></div> 2590000 694000 12737000 3845000 40411000 28777000 2047000 1345000 4773000 3408000 10728000 10558000 4000 671000 73290000 49298000 37748000 33829000 35542000 15469000 P5Y P7Y 13600000 8100000 4700000 4600000 6200000 3600000 4200000 INVENTORIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Inventories consisted of the following (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.845%"><tr><td style="width:1.0%"/><td style="width:57.014%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.456%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.458%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,454 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,597 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,262 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,730 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,321 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,274 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,037 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,601 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Inventories are measured on a first-in, first-out basis and stated at lower of cost or net realizable value. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Inventories consisted of the following (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.845%"><tr><td style="width:1.0%"/><td style="width:57.014%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.456%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.458%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,454 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,597 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,262 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,730 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,321 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,274 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,037 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,601 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 14454000 14597000 4262000 2730000 21321000 9274000 40037000 26601000 ACCRUED LIABILITIES<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Accrued liabilities consisted of the following (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.845%"><tr><td style="width:1.0%"/><td style="width:57.014%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.456%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.458%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Accrued payroll and employee benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7,949 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,175 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Accrued property taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">659 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">681 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Accrued purchase orders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,549 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">739 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Accrued taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,731 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">586 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,167 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,164 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">18,055 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6,345 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Other accrued liabilities consist of items that are individually less than 5% of total current liabilities.</span></div> <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Accrued liabilities consisted of the following (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.845%"><tr><td style="width:1.0%"/><td style="width:57.014%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.456%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.458%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Accrued payroll and employee benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7,949 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,175 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Accrued property taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">659 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">681 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Accrued purchase orders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,549 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">739 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Accrued taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,731 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">586 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4,167 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,164 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">18,055 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6,345 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 7949000 1175000 659000 681000 1549000 739000 3731000 586000 4167000 3164000 18055000 6345000 0.05 CAPITAL STOCK<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Stock Plans</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We have two stock option plans which authorize granting of stock options, restricted stock awards and stock purchase rights to our employees, officers, directors and consultants. In 1997, the board of directors adopted the 1997 Stock Incentive Plan (the "1997 Plan"), which was later amended in December 2018 to be renamed the "Stock Incentive Plan." In May 2012, stockholders approved an amendment allowing for an increase of 250,000 shares and an annual increase through 2016 based on the number of non-employee directors serving as of our Annual Meeting of Stockholders, subject to a maximum of 45,000 shares per year. The plan was further amended in May 2016, May 2018, and April 2020 to increase the number of shares authorized for issuance by 500,000, 250,000, and 300,000 shares, respectively. In May 2003, the stockholders approved a new plan, the 2003 Equity Incentive Plan (the "2003 Plan"), which allows for the granting of stock options/restricted stock for up to 239,050 shares of the Company's common stock. The number of shares reserved for issuance under both plans as of December 31, 2020 was 151,605. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The stock options granted by the Board of Directors may be either incentive stock options ("ISOs") or non-qualified stock options ("NQs") and may include time-based vesting terms and/or be tied to Company and market-related performance metrics. The exercise price for options under all of the plans may be no less than </span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">100% of the fair value of the underlying common stock. Options granted will expire no later than the tenth anniversary subsequent to the date of grant or three months following termination of employment, except in cases of death or disability, in which case the options will remain exercisable for up to twelve months. Under the terms of the Stock Incentive Plan, in the event we are sold or merged, outstanding options will either be assumed by the surviving corporation or vest immediately.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">We use the Black-Scholes option-pricing model to estimate the fair value of time-vested and performance stock options granted, which includes four key inputs: expected term, expected volatility, risk-free interest rate and expected dividends. Our expected term is estimated based on historical exercise patterns. Our expected volatility input was estimated based on our historical stock price volatility. Our risk-free interest rate input was determined based on the U.S. Treasury yield curve at the time of option issuance. Our expected dividends inputs were zero in all periods as we did not anticipate paying dividends in the foreseeable future. For options tied to market performance, the fair value used in our expense recognition method is measured based on the number of shares granted, and a Monte Carlo simulation model, which incorporates the probability of the achievement of the market-related performance goals as part of the grant date fair value. We recognize forfeitures as they occur.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">Time Vesting Stock Options</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The fair value of each time vesting option grant was estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.691%"><tr><td style="width:1.0%"/><td style="width:50.447%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.534%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.534%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.539%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.64%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.62%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.66%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Expected lives</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.3 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.7 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.9 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">46%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">40%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">40%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0%</span></td></tr></table></div><div style="margin-top:3pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A summary of our time vesting stock option activity is as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.424%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.426%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> Options</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">536,315 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.86 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted at market</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,250 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,307)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.24 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,691)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.25 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84,335)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.64 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464,232 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at end of period</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291,334 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.53 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The total estimated fair value of time vesting stock options granted was computed to be approximately $2.4 million, $2.6 million and $4.4 million during the years ended December 31, 2020, 2019 and 2018, respectively. The amounts are amortized ratably over the vesting periods of the options. The weighted average estimated fair value of options granted was computed to be approximately $28.66, $29.89 and $28.81 during the years ended December 31, 2020, 2019 and 2018, respectively. The total intrinsic value of options </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">exercised was $5.0 million, $12.8 million and $10.5 million during the years ended December 31, 2020, 2019 and 2018, respectively. The cash proceeds from options exercised were $3.4 million, $1.0 million and $3.2 million during the years ended December 31, 2020, 2019 and 2018, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table summarizes information about time vesting stock options outstanding and exercisable at December 31, 2020. </span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.537%"><tr><td style="width:1.0%"/><td style="width:15.489%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.575%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.575%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.575%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.923%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.575%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.163%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.575%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.575%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.841%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options Exercisable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercise Prices</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Options<br/>Outstanding<br/>at<br/>December 31,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Life in Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Outstanding<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Options<br/>Exercisable<br/>at<br/>December 31,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Life in Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise<br/>Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6.23 - $12.78</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,166 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.20</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.59 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,166 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.20</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.59 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$12.79 - $39.76</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,197 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.57</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,197 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.57</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$39.77 - $60.94</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.29</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.94 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$60.95 - $71.84</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,666 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.59</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.21 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,334 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.47</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.03 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$71.85 - $108.25</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,203 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.82</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.45 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,637 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.89</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.98 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6.23 - $108.25</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464,232 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.48</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291,334 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.14</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.53 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of December 31, 2020, there was approximately $3.6 million of total unrecognized compensation cost related to outstanding stock options. That cost is expected to be recognized over a weighted-average period of 1.63 years with all cost to be recognized by the end of August 2023, assuming all options vest according to the vesting schedules in place at December 31, 2020. As of December 31, 2020, the aggregate intrinsic value of outstanding options was approximately $41.1 million and the aggregate intrinsic value of exercisable options was approximately $28.9 million.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">Performance Stock Options</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">On April 16, 2020, the Company granted a total of 240,000 performance-based stock options all with an exercise price of $60.94. Of the options granted,10,000 are tied to market-related vesting conditions and 230,000 are tied to Company performance metrics, including future product launches, future sales targets, operating performance, and EBITDA. Performance and market conditions must be achieved by December 31, 2023 otherwise the stock options are forfeited. All vested but unexercised options will expire April 15, 2030. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">During the year ended December 31, 2020, 20,000 of the performance-based stock options were forfeited, leaving a total of 220,000 options outstanding as of December 31, 2020. The outstanding options had a weighted-average exercise price of $60.94, a weighted-average remaining contractual term of 9.29 years, and an aggregate intrinsic value of approximately $18.6 million. No options were exercisable as of December 31, 2020. For the year ended December 31, 2020, the weighted-average estimated fair value of the options granted was computed to be approximately $25.04 and the total estimated fair value was approximately $6.0 million. As of December 31, 2020, there was approximately $2.4 million of total unrecognized compensation cost that is expected to be recognized over a weighted average period of 1.80 years.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">As of December 31, 2020, we reviewed each of the underlying corporate performance targets and determined that approximately 80,000 shares were related to corporate performance targets in which we did not deem achievement probable. No compensation expense had been recorded at any period prior to December 31, 2020. The unrecognized compensation cost associated with the performance options not deemed probable, based on grant date fair value, is approximately $2.0 million. Any change in the probability determination could accelerate the recognition of this expense.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Restricted Stock Awards</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We have granted unvested restricted stock awards (“restricted stock”) to management and directors pursuant to the Stock Incentive Plan. The restricted stock awards have varying vesting periods, but generally become fully vested between one and four years after the grant date, depending on the specific award, performance targets met for performance based awards granted to management, and vesting period for time based awards. Management performance based awards are granted at the target amount of shares that may be earned and are tied to future sales targets, operating performance, and/or EBITDA. We valued the restricted stock awards related to service and/or company performance targets based on grant date fair value and expense over the period when achievement of those conditions is deemed probable. For restricted stock awards related to market conditions, we utilize a Monte Carlo simulation model to estimate grant date fair value and expense over the requisite period. We recognize forfeitures as they occur. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table summarizes restricted stock transactions for the year ended December 31, 2020:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.795%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.797%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restricted Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value Per Award</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested as of December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335,667 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.29 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,823 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.29 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,140)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.80 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67,830)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.27 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested as of December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291,520 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.44 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The weighted average grant date fair value of awards granted during the year was $87.29, $74.93, and $71.77 for the years ended December 31, 2020, 2019 and 2018, respectively. Fair value of restricted stock vested was $5.0 million, $0.3 million, and $4.4 million for the years ended December 31, 2020, 2019 and 2018, respectively. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of December 31, 2020, there was approximately $5.5 million of total unrecognized compensation cost related to restricted stock awards with probable Company performance targets, as well as market and time vesting conditions. The Company expects to recognize this expense over a weighted average period of 1.4 years. As of December 31, 2020, we reviewed each of the underlying corporate performance targets and determined that approximately 129,000 shares of common stock were related to corporate performance targets in which we did not deem achievement probable. No compensation expense had been recorded at any period prior to December 31, 2020. The unrecognized compensation cost associated with the restricted stock awards not deemed probable, based on grant date fair value, is approximately $10.6 million. Any change in the probability determination could accelerate the recognition of this expense.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Under the 2020 Employee Stock Purchase Plan (the "ESPP"), we are authorized to issue up to 200,000 shares of common stock to our employees, of which 3,859 had been issued as of December 31, 2020. The ESPP provides for the issuance of shares of our common stock to participating employees. At the end of each designated offering period, which occurs every six months on June 30 and December 31, employees can elect to purchase shares of our common stock with contributions of up to 10% of their base pay, accumulated via payroll deductions, at an amount equal to 85% of the lower of our stock price on (i) the first trading day of the offering period, or (ii) the last trading day of the offering period. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We issued 10,069</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10,698 and 10,078 shares under the ESPP for the years ended December 31, 2020, 2019 and 2018, respectively. The weighted-average fair value of the purchase rights granted was $16.19, $18.10 and $18.14 per share for the years ended December 31, 2020, 2019 and 2018, respectively.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.845%"><tr><td style="width:1.0%"/><td style="width:50.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.510%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.355%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.514%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Series X Convertible Preferred Stock</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On March 30, 2020, the Company completed a private placement offering in which the Company issued and sold an aggregate of 122,000 shares of its Series X Convertible Preferred Stock, par value $0.01 per share (the "Preferred Stock"). The shares of Preferred Stock issued and sold were priced at $1,000 per share (the “Stated Value”), resulting in gross proceeds of $122.0 million, less issuance costs of $0.2 million. The Company used approximately $111.0 million of the proceeds from the offering to fund the April 1, 2020 acquisition of scil and plans to use the remaining proceeds for working capital and general corporate purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The offering was made pursuant to the Securities Purchase Agreement (the “Securities Purchase Agreement”), dated as of January 12, 2020, by and among the Company and certain investors, and subsequent amendment (the “Securities Purchase Agreement Amendment”) to the Securities Purchase Agreement, entered into by the Company and each investor on March 30, 2020 (the Securities Purchase Agreement as amended by the Securities Purchase Agreement Amendment, the “Amended Securities Purchase Agreement”).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The shares of Preferred Stock were convertible into shares of the Company’s Common Stock at an initial ratio of approximately 12.4 shares of Common Stock for each share of Preferred Stock (equivalent to a conversion price of approximately $80.85 per share of common stock), at the option of the holders of the Preferred Stock or the Company, subject to the Company possessing sufficient unissued and otherwise unreserved shares of Common Stock under the Company’s Restated Certificate of Incorporation, as amended (the “Certificate of Incorporation”). On April 14, 2020, the Company gave notice of its exercise of its right to convert the 122,000 shares of Preferred Stock into 1,508,964 shares of Public Common Stock (the "Conversion Shares") and the conversion was effective on April 21, 2020. The conversion resulted in dilution of less than 20% of total shares of the Company’s Public Common Stock currently issued and outstanding. A registration statement on Form S-3 (File No. 333-238005) registering the Conversion Shares for resale was filed by us with the SEC on May 5, 2020.</span></div> 2 250000 45000 500000 250000 300000 239050 151605 1 <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.691%"><tr><td style="width:1.0%"/><td style="width:50.447%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.534%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.534%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.539%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.64%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.62%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.66%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Expected lives</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.3 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.7 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.9 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">46%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">40%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">40%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0%</span></td></tr></table> 0.0364 0.0162 0.0266 P5Y3M18D P4Y8M12D P4Y10M24D 0.46 0.40 0.40 0 0 0 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A summary of our time vesting stock option activity is as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.424%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.426%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> Options</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">536,315 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.86 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted at market</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,250 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,307)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.24 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,691)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.25 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84,335)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.64 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464,232 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at end of period</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291,334 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.53 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 536315 54.86 83250 69.27 42307 76.24 28691 69.25 84335 40.64 464232 57.18 291334 46.53 2400000 2600000 4400000 28.66 29.89 28.81 5000000.0 12800000 10500000 3400000 1000000.0 3200000 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table summarizes information about time vesting stock options outstanding and exercisable at December 31, 2020. </span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.537%"><tr><td style="width:1.0%"/><td style="width:15.489%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.575%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.575%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.575%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.923%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.575%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.163%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.575%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.575%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.841%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options Exercisable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercise Prices</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Options<br/>Outstanding<br/>at<br/>December 31,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Life in Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Outstanding<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Options<br/>Exercisable<br/>at<br/>December 31,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Life in Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise<br/>Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6.23 - $12.78</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,166 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.20</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.59 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,166 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.20</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.59 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$12.79 - $39.76</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,197 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.57</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,197 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.57</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$39.77 - $60.94</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.29</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.94 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$60.95 - $71.84</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,666 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.59</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.21 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,334 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.47</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.03 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$71.85 - $108.25</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,203 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.82</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.45 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,637 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.89</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.98 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6.23 - $108.25</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464,232 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.48</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291,334 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.14</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.53 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 86166 P2Y2M12D 7.59 86166 P2Y2M12D 7.59 63197 P4Y6M25D 30.11 63197 P4Y6M25D 30.11 65000 P9Y3M14D 60.94 0 P0Y 0 120666 P7Y7M2D 70.21 71334 P7Y5M19D 70.03 129203 P7Y9M25D 89.45 70637 P6Y10M20D 84.98 464232 P6Y5M23D 57.18 291334 P5Y1M20D 46.53 3600000 P1Y7M17D 41100000 28900000 240000 60.94 230000 20000 220000 60.94 P9Y3M14D 18600000 0 25.04 6000000.0 2400000 P1Y9M18D 80000 2000000.0 P4Y <div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table summarizes restricted stock transactions for the year ended December 31, 2020:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.795%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.797%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restricted Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value Per Award</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested as of December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335,667 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.29 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,823 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.29 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,140)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.80 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67,830)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.27 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested as of December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291,520 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.44 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 335667 74.29 69823 87.29 46140 68.80 67830 73.27 291520 78.44 87.29 74.93 71.77 5000000.0 300000 4400000 5500000 129000 10600000 3859 10069 10698 10078 16.19 18.10 18.14 122000 0.01 1000 122000000.0 200000 111000000.0 12.4 80.85 122000 1508964 ACCUMULATED OTHER COMPREHENSIVE INCOME <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss) consisted of the following (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.091%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.880%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.188%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.416%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Pension Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Foreign Currency Translation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:700;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Gain on Intra-Entity Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Balances at December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(419)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">696 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">277 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">73 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">163 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">236 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Balances at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(346)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">859 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">513 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,013 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8,683 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13,656 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Balances at December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(386)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,872 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,683 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14,169 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency gains and losses related to translation of foreign subsidiary financial statements. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:107%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> The Company has intercompany loans of a long-term investment nature that are denominated in a foreign currency. These transactions are considered to be of a long-term nature if settlement is not planned or anticipated in the foreseeable future.</span></div> <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss) consisted of the following (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.091%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.880%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.188%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.416%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Pension Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Foreign Currency Translation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:700;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Gain on Intra-Entity Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Balances at December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(419)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">696 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">277 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">73 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">163 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">236 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Balances at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(346)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">859 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">513 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,013 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8,683 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13,656 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Balances at December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(386)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,872 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,683 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14,169 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> -419000 696000 0 277000 73000 163000 0 236000 -346000 859000 0 513000 -40000 5013000 8683000 13656000 -386000 5872000 8683000 14169000 COMMITMENTS AND CONTINGENCIES<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Warranties</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company's current terms and conditions of sale include a limited warranty that its products and services will conform to published specifications at the time of shipment and a more extensive warranty related to certain products. The Company also sells a renewal warranty for certain of its products. The typical remedy for breach of warranty is to correct or replace any defective product, and if not possible or practical, the Company will accept the return of the defective product and refund the amount paid. Historically, the Company has incurred minimal warranty costs. The Company's warranty reserve was $0.5 million and $0.3 million as of December 31, 2020 and 2019. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Litigation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">From time to time, the Company may be involved in litigation relating to claims arising out of its operations. The Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred, and the amount can be reasonably estimated.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On February 18, 2020, a former managing director of scil filed a claim disputing the effective date of the termination of his management service agreement and the validity of the Company´s waiver of his two-year post-contractual non-compete obligation. The Company intends to defend itself against the claim. Whether or not this will be successful depends on complex facts and circumstances. The Company is, based on the advice of its legal counsel, confident that it will be successful in evidencing the effective date of the termination of the management service agreement and as such, no accrual has been recorded for this ongoing litigation. Additionally, we are indemnified by the scil acquisition agreement for this claim.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On October 10, 2018, we reached an agreement in principle to settle the complaint that was filed against the Company by Shaun Fauley on March 12, 2015 in the U.S. District Court Northern District of Illinois (the "Court") alleging our transmittal of unauthorized faxes in violation of the federal Telephone Consumer Protection Act of 1991, as amended by the Junk Fax Prevention Act of 2005, as a class action (the "Fauley Complaint"). The settlement, which received the Court's approval on February 28, 2019 and was not </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">subsequently appealed by a class member, required us to make available a total of $6.8 million to pay class members, as well as to pay attorneys' fees and expenses to legal counsel to the class. The Company recorded the loss provision in the third quarter of 2018 in connection with the settlement agreement and does not have insurance coverage for the Fauley Complaint. The payment in respect of the settlement was made in full on April 3, 2019, and all activity related to the Fauley Complaint has ceased.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">At December 31, 2020, the Company was not a party to any other legal proceedings that were expected, individually or in the aggregate, to have a material adverse effect on our business, financial condition or operating results.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Off-Balance Sheet Commitments</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We have no off-balance sheet arrangements or variable interest entities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Purchase Obligations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company has contractual obligations with suppliers for unconditional annual minimum inventory purchases in the amounts of $25.0 million as of December 31, 2020.</span></div> 500000 300000 6800000 25000000.0 INTEREST AND OTHER EXPENSE (INCOME), NET<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Interest and other expense (income), net, consisted of the following (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.845%"><tr><td style="width:1.0%"/><td style="width:41.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.447%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.447%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.450%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(607)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(661)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(261)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6,374 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,089 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">310 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(166)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">482 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Interest and other expense (income), net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,601 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,910 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Refer to Note 1. Summary of Significant Accounting Policies relating to an immaterial out of period error correction of non-cash interest identified and recorded during the fourth fiscal quarter of 2020. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Cash paid for interest was $3.2 million, $0.4 million and $0.2 million for the years ended December 31, 2020, 2019 and 2018, respectively.</span></div> <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Interest and other expense (income), net, consisted of the following (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.845%"><tr><td style="width:1.0%"/><td style="width:41.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.447%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.447%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.450%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(607)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(661)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(261)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6,374 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,089 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">310 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(166)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">482 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Interest and other expense (income), net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,601 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,910 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 607000 661000 261000 6374000 3089000 310000 166000 -482000 62000 -5601000 -2910000 13000 3200000 400000 200000 CONVERTIBLE NOTES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Convertible Notes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On September 17, 2019, the Company issued $86.25 million aggregate principal amount of 3.750% Convertible Senior Notes due 2026, which included the exercise in full of an $11.25 million purchase option, to certain financial institutions as the initial purchasers of the Notes (the "Initial Purchasers"). The Notes are senior unsecured obligations of the Company. The Notes were issued pursuant to an Indenture, dated September 17, 2019 (the “Indenture”), between the Company and U.S. Bank National Association, as trustee.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The net proceeds from the sale of the Notes were approximately $83.7 million after deducting the initial purchasers’ discounts and the offering expenses payable by the Company. The Company used approximately $12.8 million of the net proceeds from the Notes to repay all outstanding indebtedness on its </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">existing Credit Facility with JPMorgan Chase Bank, N.A., and an additional $2.0 million to fully fund a cash collateralized, letter of credit facility under a new Credit Facility. The Company subsequently terminated the Credit Facility with JPMorgan Chase Bank, N.A. on December 31, 2019. The Company expects to use the remainder of the net proceeds from the sale of the Notes to fund our intended expansion efforts, including through acquisitions of complementary businesses or technologies or other strategic transactions, and for working capital and other general corporate purposes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Notes are senior unsecured obligations of the Company and will rank senior in right of payment to any of our indebtedness that is expressly subordinated in right of payment to the Notes; equal in right of payment to any of our unsecured indebtedness that is not so subordinated; effectively junior in right of payment to any of our secured indebtedness to the extent of the value of assets securing such indebtedness; and structurally junior to all indebtedness and other liabilities (including trade payables) of our subsidiaries. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company pays interest on the Notes semiannually in arrears at a rate of 3.750% per annum on March 15 and September 15 of each year. The Notes are convertible based upon an initial conversion rate of 11.5434 shares of the Company’s common stock per $1,000 principal amount of Notes (equivalent to a conversion price of approximately $86.63 per share of common stock). The Notes would convert in full into 995,618 shares of common stock based on the initial conversion rate. The conversion rate will be subject to standard anti-dilution adjustments upon the occurrence of certain events but will not be adjusted for accrued and unpaid interest. The interest rate on the Notes may be increased by up to 0.50% upon the occurrence of certain events of default or non-timely filings until such matter has been cured.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Indenture includes customary covenants, but no financial or operating covenants or restrictions on the payments of dividends, the incurrence of indebtedness or the issuance or repurchase of securities, and sets forth certain events of default and certain types of bankruptcy or insolvency events of default involving the Company after which the Notes become automatically due and payable. The Company can settle any conversions of the Notes in cash, shares of the Company’s common stock or a combination thereof, with the form of consideration determined at the Company’s election. The Company intends to settle the principal value of the Notes in cash and issue shares of the Company’s common stock to settle the intrinsic value of the conversion feature. There can be no guarantee, however, that any settlement will be affected by the Company as currently intended, and the timing and other factors of any settlement, many of which may be outside the Company's control, could impact the actual amounts to be settled in either cash or common stock. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Notes will mature on September 15, 2026, unless earlier repurchased, redeemed or converted. Prior to March 15, 2026, holders may convert all or a portion of their Notes only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on December 31, 2019 (and only during such calendar quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the 5 business day period after any 5 consecutive trading day period (the "Notes measurement period") in which the trading price per $1,000 principal amount of Notes for each trading day of the Notes measurement period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate on each such trading day; (3) with respect to any Notes called for redemption by the Company, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or (4) upon the occurrence of specified corporate events. On and after </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 15, 2026</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> until the close of business on the scheduled trading day immediately preceding the maturity date, holders may convert their Notes at any time, regardless of the foregoing circumstances. Holders of Notes who convert their Notes in connection with a notice of a redemption or a make-whole fundamental change (each as defined in the Indenture) may be entitled to a premium in the form of an increase in the conversion rate of the Notes.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company may not redeem the Notes prior to September 20, 2023. On or after September 20, 2023, the Company may redeem for cash all or part of the Notes if the last reported sale price of the Company’s common stock equals or exceeds 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of the redemption. The redemption price will be 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest, if any. No sinking fund is provided for the Notes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Upon the occurrence of a fundamental change (as defined in the Indenture), holders may require the Company to repurchase all or a portion of their Notes for cash at a price equal to 100% of the principal amount of the Notes to be repurchased plus any accrued but unpaid interest to, but excluding, the fundamental change repurchase date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In accounting for the issuance of the Notes, the Company separated the Notes into liability and equity components. The carrying amount of the liability component was calculated by measuring the fair value of a similar liability that does not have an associated convertible feature. The carrying amount of the equity component, representing the conversion option, which does not meet the criteria for separate accounting as a derivative as it is indexed to the Company's own stock, was determined by deducting the fair value of the liability component from the par value of the Notes. The difference between the principal amount of the Notes and the liability component represents the debt discount, which is recorded as a direct deduction from the related debt liability in the Consolidated Balance Sheet and amortized to interest expense using the effective interest method over the term of the Notes. The effective interest rate of the Notes is 15.3% per annum. The equity component of the Notes is approximately $39.5 million, net of allocated issuance costs of $1.5 million. This is included in additional paid-in capital in the Consolidated Balance Sheet, net of deferred tax impacts of $9.7 million, and is not remeasured as long as it continues to meet the conditions for equity classification. The Company allocated transaction costs related to the Notes using the same proportions as the proceeds from the Notes. Transaction costs attributable to the liability component were recorded as a direct deduction from the related debt liability in the Consolidated Balance Sheet and amortized to interest expense over the term of the Notes, and transaction costs attributable to the equity component were netted with the equity component in shareholders’ equity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, the Company determined that the additional interest that could be due to the holders of the Notes upon an event of default or non-timely filing represented an embedded derivative feature that should be bifurcated from the Notes. The Company concluded that the fair value of this embedded derivative feature was de minimis upon the issuance of the Notes and at December 31, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">During the years ended December 31, 2020 and 2019, no portion of the Notes was converted and the liability component was classified as long-term debt on the Company's Consolidated Balance Sheet as of December 31, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table summarizes the net carrying amount of the Notes as of December 31, 2020 (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.918%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.504%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.507%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount of the Notes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,250 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,250 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,791)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,902)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying amount</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,459 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,348 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Interest expense related to the Notes is comprised of the amortization of debt discount and debt issuance costs and the contractual coupon interest as follows (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.918%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.504%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.507%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense related to contractual coupon interest</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,234 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">925 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense related to amortization of the debt discount</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,111 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,744 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,345 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,669 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Refer to Note 1. Summary of Significant Accounting Policies relating to an immaterial out of period error correction of non-cash interest identified and recorded during the fourth fiscal quarter of 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of December 31, 2020, the remaining period over which the unamortized discount will be amortized is 68.5 months.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The estimated fair value of the Notes was $156.9 million as of December 31, 2020, determined through consideration of quoted market prices in less active markets. The fair value measurement is classified as Level 2 in the fair value hierarchy, which is defined in ASC 820 as inputs other than quoted prices in active markets that are either directly or indirectly observable. Based on our closing stock price of $145.65 on December 31, 2020, the if-converted value exceeded the aggregate principal amount of the Notes by $58.8 million.</span></div> 86250000 0.03750 11250000 83700000 12800000 2000000.0 0.03750 86.63 995618 0.0050 20 30 1.30 5 5 0.98 1.30 20 30 1 1 0.153 39500000 1500000 9700000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following table summarizes the net carrying amount of the Notes as of December 31, 2020 (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.918%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.504%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.507%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount of the Notes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,250 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,250 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,791)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,902)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying amount</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,459 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,348 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 86250000 86250000 37791000 40902000 48459000 45348000 3234000 925000 3111000 1744000 6345000 2669000 156900000 145.65 58800000 CONVERTIBLE NOTE RECEIVABLE<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The carrying value of the note receivable, included in Related party convertible note receivable, net on the Consolidated Balance Sheets, is as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.214%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.880%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.506%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Principal amount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6,650 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(977)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net carrying amount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,673 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On December 9, 2020, our equity method investee (the “Investee”), issued a Convertible Promissory Note to the Company (the “Convertible Promissory Note”) with a principal amount of $6.65 million and a stated interest rate of 3.0% per annum that is payable monthly. The Convertible Promissory Note has a maturity date of December 9, 2023, or otherwise upon qualified redemption event or in the event of a default. Refer to Note 4 for additional information on our equity method investment. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The conversion of the Convertible Promissory Note is contingent upon certain events. Due to the convertible debt features included in the Convertible Promissory Note, it is not an equity security and is therefore not considered an additional investment in our equity method investee. The Company accounted for the transaction as a note receivable, included in Related party convertible note receivable, net on the Consolidated Balance Sheets. The note receivable will be measured at amortized cost, and evaluated for credit losses each reporting period. The Company determined that the redemption features described above met the definition of an embedded derivative that requires bifurcation from the note receivable host. The Company measured the redemption features at fair value, with the residual proceeds paid allocated to the note receivable host, creating a discount to the note receivable. The discount will be amortized over the contractual term of the Promissory Note using the effective interest method. The effective interest rate of the Convertible Promissory Note is 8.69%, and the amortization of the discount will be included as interest income within Interest and other expense (income), net on the Consolidated Statements of Income. </span></div>The fair value of the embedded derivative was $1.0 million at issuance and as of December 31, 2020, and is included in Related party convertible note receivable, net on our Consolidated Balance Sheets. The fair value of the derivative will be remeasured each reporting period, with the mark-to-market adjustment to be included in other expense (income) on the Consolidated Statements of Income. <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The carrying value of the note receivable, included in Related party convertible note receivable, net on the Consolidated Balance Sheets, is as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.214%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.880%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.506%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Principal amount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6,650 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(977)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net carrying amount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,673 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div> 6650000 977000 5673000 6650000 0.030 0.0869 1000000.0 SEGMENT REPORTING<div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On April 1, 2020, Heska completed the acquisition of scil. Following this acquisition, the Company restructured its operating segments based on how the Chief Operating Decision Maker (“CODM”) manages the business, allocates resources, makes operating decisions and evaluates operating performance. The CODM changed how he assesses performance and allocates resources based on geographic regions in order to better align with the global operations of the Company. Based on this change, the Company determined it has two reportable segments and revised prior comparative periods to conform to the current period segment presentation. The Company’s two segments are North America and International.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">The North America segment is comprised of the Company's operations in the United States, Canada and Mexico and the International segment is comprised of geographies outside of North America, which are the Company's operations primarily in Australia, France, Germany, Italy, Malaysia, Spain and Switzerland. Certain expenses incurred at the Company’s headquarters located in the North America segment are allocated to each segment in a manner consistent with where the benefits from the expenses are derived. However, there </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">are certain corporate expenses included in the North America segment that we do not allocate. Such expenses include research and development, certain selling, marketing, general, and administrative costs that support the global organization. Sales and transfers between operating segments are accounted for at market-based transaction prices and are eliminated in consolidation. The Company's sales are determined by the country of origin where the sale occurred. For a description of Heska's previous operating segments, refer to Note 17 to the consolidated financial statements included in Part II. Item 8 of Heska's Annual Report on Form 10-K for the year ended December 31, 2019. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our CODM continues to evaluate segment performance and allocate resources based on Revenue, Cost of Revenue, Gross Profit, Gross Margin and Operating Income. The CODM does not evaluate operating segments using asset information; however, we have included total asset information by segment below as there was a material change in total assets by segment as of December 31, 2020 due to the acquisition of scil.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Summarized financial information concerning the Company's reportable segments is shown in the following tables (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.691%"><tr><td style="width:1.0%"/><td style="width:50.138%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.463%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.392%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.288%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Total</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,066 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,257 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,323 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,163 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,870 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,033 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,903 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,387 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,290 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Gross margin</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,977)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,215)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,192)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,871)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,922)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,793)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in unconsolidated affiliates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,704 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,704 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238,550 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,289 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399,839 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156,931 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,122 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,053 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital Expenditures</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,735 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,650 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,385 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.691%"><tr><td style="width:1.0%"/><td style="width:50.138%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.463%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.392%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.288%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> <br/> <br/>Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,423 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,238 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,661 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,089 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,123 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,212 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,334 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,115 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,449 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Gross margin</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,426 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,099)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,343)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,240)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,583)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in unconsolidated affiliates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,424 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,424 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219,402 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,022 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244,424 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,835 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,699 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,534 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital Expenditures</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,005 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,044 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,788 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,916 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.691%"><tr><td style="width:1.0%"/><td style="width:50.138%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.463%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.392%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.288%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Year Ended December 31, 2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> <br/> <br/>Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,391 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,055 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,446 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,555 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,253 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,808 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,836 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,638 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Gross margin</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,622 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,794 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,717 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,807 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in unconsolidated affiliates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,018 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,018 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,663 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,789 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156,452 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,770 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,639 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,409 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital Expenditures</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,329 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,358 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,586 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,595 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-indent:36pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company measures its geographic revenue information based on the country of origin where the sale occurred. The geographic classification is independent of where the customer resides or where the customer is physically located while using the Company's product. Total revenue by principal geographic area was as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.190%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.646%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.650%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,244 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,485 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,965 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,822 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,938 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,543 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,615 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,473 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,995 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">759 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Italy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,850 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,343 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,820 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,056 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,911 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,323 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,661 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,446 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Total long-lived assets by principal geographic areas were as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.190%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.646%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.650%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,805 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,712 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,933 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,630 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,205 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Italy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,944 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,542 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,469 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,981 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Revenue from Covetrus represented approximately</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 6%, 14% and 15% of our consolidated revenue for the years ended December 31, 2020, 2019 and 2018, respectively. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Consolidated revenue from Covetrus attributable to our North America segment represented approximately 5%, 14% and 15%, respectively, whereas revenue from Covetrus attributable to our International segment represented 1% for 2020.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Revenue from Merck entities, including Merck Animal Health, represented approximately 5%, 1% and 12% for the years ended December 31, 2020, 2019 and 2018, respectively, all included in our North America Segment. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No other customer accounted for more than 10% of our consolidated revenue for the years ended December 31, 2020, 2019 or 2018.</span> 2 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Summarized financial information concerning the Company's reportable segments is shown in the following tables (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.691%"><tr><td style="width:1.0%"/><td style="width:50.138%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.463%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.392%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.288%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Total</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,066 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,257 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,323 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,163 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,870 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,033 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,903 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,387 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,290 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Gross margin</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,977)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,215)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,192)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,871)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,922)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,793)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in unconsolidated affiliates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,704 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,704 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238,550 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,289 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399,839 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156,931 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,122 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,053 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital Expenditures</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,735 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,650 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,385 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.691%"><tr><td style="width:1.0%"/><td style="width:50.138%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.463%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.392%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.288%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> <br/> <br/>Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,423 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,238 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,661 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,089 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,123 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,212 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,334 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,115 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,449 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Gross margin</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,426 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,099)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,343)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,240)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,583)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in unconsolidated affiliates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,424 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,424 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219,402 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,022 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244,424 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,835 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,699 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,534 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital Expenditures</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,005 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,044 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,788 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,916 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.691%"><tr><td style="width:1.0%"/><td style="width:50.138%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.463%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.392%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.288%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Year Ended December 31, 2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> <br/> <br/>Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,391 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,055 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,446 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,555 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,253 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,808 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,836 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,638 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Gross margin</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,622 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,794 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,717 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,807 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in unconsolidated affiliates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,018 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,018 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,663 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,789 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156,452 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,770 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,639 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,409 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital Expenditures</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,329 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,358 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,586 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,595 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 131066000 66257000 197323000 70163000 45870000 116033000 60903000 20387000 81290000 0.46 0.31 0.41 -4977000 -3215000 -8192000 -7871000 -5922000 -13793000 6704000 0 6704000 238550000 161289000 399839000 156931000 130122000 287053000 443000 243000 686000 4735000 6650000 11385000 115423000 7238000 122661000 63089000 5123000 68212000 52334000 2115000 54449000 0.45 0.29 0.44 1426000 -1099000 327000 -1343000 -1240000 -2583000 7424000 0 7424000 219402000 25022000 244424000 133835000 20699000 154534000 1005000 39000 1044000 4788000 128000 4916000 124391000 3055000 127446000 68555000 2253000 70808000 55836000 802000 56638000 0.45 0.26 0.44 3622000 172000 3794000 3717000 90000 3807000 8018000 0 8018000 152663000 3789000 156452000 118770000 3639000 122409000 1329000 29000 1358000 4586000 9000 4595000 Total revenue by principal geographic area was as follows (in thousands):<div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.190%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.646%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.650%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,244 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,485 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,965 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,822 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,938 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,543 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,615 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,473 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,995 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">759 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Italy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,850 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,343 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,820 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,056 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,911 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,323 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,661 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,446 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Total long-lived assets by principal geographic areas were as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.190%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.646%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.650%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,805 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,712 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,933 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,630 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,205 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Italy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,944 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,542 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,469 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,981 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 120244000 113485000 123965000 10822000 1938000 425000 29543000 0 0 12615000 3473000 0 12995000 759000 0 5850000 0 0 3343000 2820000 3056000 1911000 186000 0 197323000 122661000 127446000 11805000 14712000 15933000 643000 0 11000 14630000 0 0 4205000 152000 0 1209000 391000 0 1944000 0 0 46000 33000 37000 1060000 181000 0 35542000 15469000 15981000 0.06 0.14 0.15 0.05 0.14 0.15 0.01 0.05 0.01 0.12 SUBSEQUENT EVENTS<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Lacuna Diagnostics, Inc. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On February 1, 2021 the Company completed the acquisition of Lacuna Diagnostics, Inc. ("Lacuna"), a veterinary digital cytology company, to broaden the Company's point of care diagnostic offering. In exchange for all the outstanding shares of Lacuna, the Company paid total consideration of $4.3 million upon closing. The Company expects to account for this transaction as a business combination however, does not have that accounting complete as of the date of this filing due to the limited time that has passed since the date of transaction. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As additional consideration for the shares, the Company agreed to a contingent earn-out of an additional $2 million based on the achievement of certain performance metrics within a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjI4MGMyMGMyZWU3NTQ1OThhMDliZjVkMDMxZTRlMDBkL3NlYzoyODBjMjBjMmVlNzU0NTk4YTA5YmY1ZDAzMWU0ZTAwZF8yMTEvZnJhZzoyMTM0Y2JhY2EwODA0ZWVhODkyNzU5NjI3YmQ4NDY1OC90ZXh0cmVnaW9uOjIxMzRjYmFjYTA4MDRlZWE4OTI3NTk2MjdiZDg0NjU4XzU0OTc1NTgxNTg2MTY_1ed66c8e-3c9b-4de0-802c-33cccdb3050a">twelve</span> month period ("Initial Earn Out Period"), reducing to $1 million if such metrics were met in a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjI4MGMyMGMyZWU3NTQ1OThhMDliZjVkMDMxZTRlMDBkL3NlYzoyODBjMjBjMmVlNzU0NTk4YTA5YmY1ZDAzMWU0ZTAwZF8yMTEvZnJhZzoyMTM0Y2JhY2EwODA0ZWVhODkyNzU5NjI3YmQ4NDY1OC90ZXh0cmVnaW9uOjIxMzRjYmFjYTA4MDRlZWE4OTI3NTk2MjdiZDg0NjU4XzU0OTc1NTgxNTg2Mjk_e2905d73-c60a-410e-9269-5b22a5dac918">twelve</span> month period subsequent to the Initial Earn Out Period. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Note Receivable</span></div>On February 1, 2021, one of our equity investees ("Investee"), for which we account for as a nonmarketable equity security, issued a Promissory Note to the Company (the “Promissory Note”) with a principal amount of $9.0 million and a stated interest rate of 10.0% per annum that is payable monthly. The Promissory Note has a maturity date of December 1, 2024. The Promissory Note provides for interest only payments through December 1, 2023. Beginning on January 1, 2024, the Promissory Note requires repayment of the principal and interest over twelve consecutive monthly payments. Additionally, the Investee issued a warrant to the Company to acquire securities. The warrant expires December 31, 2034. Refer to Note 4 for additional information on our equity investments. 4300000 2000000 1000000 9000000.0 0.100 12 XML 21 R1.htm IDEA: XBRL DOCUMENT v3.20.4
Cover - USD ($)
12 Months Ended
Dec. 31, 2020
Feb. 25, 2021
Jun. 30, 2020
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2020    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 000-22427    
Entity Registrant Name HESKA CORPORATION    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 77-0192527    
Entity Address, Address Line One 3760 Rocky Mountain Avenue    
Entity Address, City or Town Loveland    
Entity Address, State or Province CO    
Entity Address, Postal Zip Code 80538    
City Area Code 970    
Local Phone Number 493-7272    
Title of 12(b) Security Common stock, $0.01 par value    
Trading Symbol HSKA    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Entity Shell Company false    
Entity Public Float     $ 806,427,745
Entity Common Stock, Shares Outstanding   9,477,240  
Documents Incorporated by Reference
DOCUMENTS INCORPORATED BY REFERENCE
Items 10, 11, 12, 13 and 14 of Part III incorporate by reference information from the Registrant's definitive proxy statement to be filed with the Securities and Exchange Commission in connection with the solicitation of proxies for the Registrant's 2021 Annual Meeting of Stockholders to be held on or about May 5, 2021.
   
Entity Central Index Key 0001038133    
Amendment Flag false    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2020    
XML 22 R2.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 86,334 $ 89,030
Accounts receivable, net of allowance for losses of $769 and $186, respectively 31,080 15,161
Inventories 40,037 26,601
Net investment in leases, current, net of allowance for losses of $192 and $105, respectively 4,794 3,856
Prepaid expenses 3,875 2,219
Other current assets 5,155 3,000
Total current assets 171,275 139,867
Property and equipment, net 35,542 15,469
Operating lease right-of-use assets 5,457 5,726
Goodwill 88,276 36,204
Net intangible assets 55,992 11,472
Deferred tax asset, net 5,694 6,429
Net investment in leases, non-current 15,789 14,307
Investments in unconsolidated affiliates 6,704 7,424
Related party convertible note receivable, net 6,671 0
Other non-current assets 8,439 7,526
Total assets 399,839 244,424
Current liabilities:    
Accounts payable 15,119 6,600
Accrued liabilities 18,055 6,345
Accrued purchase consideration payable 0 14,579
Operating lease liabilities, current 2,087 1,745
Deferred revenue, current, and other 6,854 2,930
Total current liabilities 42,115 32,199
Convertible note, non-current, net 48,459 45,348
Deferred revenue, non-current 4,667 5,966
Other long-term borrowings 554 1,121
Operating lease liabilities, non-current 3,858 4,413
Deferred tax liability 11,856 691
Other liabilities 1,277 152
Total liabilities 112,786 89,890
Redeemable non-controlling interest and mezzanine equity 0 170
Stockholders' equity:    
Preferred stock, $.01 par value, 2,500,000 shares authorized, none issued or outstanding 0 0
Common stock, $.01 par value, 13,250,000 and 10,250,00 shares authorized, respectively, none issued or outstanding 0 0
Public common stock, $.01 par value, 13,250,000 and 10,250,000 shares authorized, 9,475,845 and 7,881,928 shares issued and outstanding, respectively 95 79
Additional paid-in capital 423,650 290,216
Accumulated other comprehensive income 14,169 513
Accumulated deficit (150,861) (136,444)
Total stockholders' equity 287,053 154,364
Total liabilities, mezzanine equity and stockholders' equity $ 399,839 $ 244,424
XML 23 R3.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Allowance for doubtful accounts $ 769 $ 186
Net investment in leases, current $ 192 $ 105
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, shares authorized 2,500,000 2,500,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding 0 0
Common Stock    
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized 13,250,000 10,250,000
Common stock, shares issued 0 0
Common stock, shares outstanding 0 0
Public Common Stock    
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized 13,250,000 10,250,000
Common stock, shares issued 9,475,845 7,881,928
Common stock, shares outstanding 9,475,845 7,881,928
XML 24 R4.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Revenues [Abstract]      
Revenue, net $ 197,323 $ 122,661 $ 127,446
Cost of revenue 116,033 68,212 70,808
Gross profit 81,290 54,449 56,638
Operating expenses:      
Selling and marketing 38,468 27,678 24,663
Research and development 8,772 8,240 3,334
General and administrative 42,242 18,204 24,847
Total operating expenses 89,482 54,122 52,844
Operating income (loss) (8,192) 327 3,794
Interest and other expense (income), net 5,601 2,910 (13)
Income (loss) before income taxes and equity in losses of unconsolidated affiliates (13,793) (2,583) 3,807
Income tax expense (benefit):      
Current income tax expense 1,780 359 140
Deferred income tax benefit (1,541) (1,805) (2,255)
Total income tax expense (benefit) 239 (1,446) (2,115)
Net (loss) income before equity in losses of unconsolidated affiliates (14,032) (1,137) 5,922
Equity in losses of unconsolidated affiliates (720) (594) (72)
Net (loss) income after equity in losses of unconsolidated affiliates (14,752) (1,731) 5,850
Net loss attributable to redeemable non-controlling interest (353) (266) 0
Net (loss) income attributable to Heska Corporation $ (14,399) $ (1,465) $ 5,850
Earnings Per Share [Abstract]      
Basic earnings per share attributable to Heska Corporation (in dollars per share) $ (1.66) $ (0.20) $ 0.81
Diluted earnings per share attributable to Heska Corporation (in dollars per share) $ (1.66) $ (0.20) $ 0.74
Weighted average outstanding shares used to compute basic (loss) earnings per share attributable to Heska Corporation 8,653 7,446 7,220
Weighted average outstanding shares used to compute diluted (loss) earnings per share attributable to Heska Corporation 8,653 7,446 7,856
XML 25 R5.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]      
Net (loss) income after equity in losses of unconsolidated affiliates $ (14,752) $ (1,731) $ 5,850
Other comprehensive (loss) income:      
Minimum pension liability (40) 73 70
Translation adjustments and gains (losses) from intra-entity transactions 13,696 163 (25)
Comprehensive (loss) income (1,096) (1,495) 5,895
Comprehensive loss attributable to redeemable non-controlling interest (353) (266) 0
Comprehensive (loss) income attributable to Heska Corporation $ (743) $ (1,229) $ 5,895
XML 26 R6.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Preferred Stock
Preferred Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
    Common Stock
    Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
  Additional Paid-in Capital
  Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income
Cumulative Effect, Period of Adoption, Adjusted Balance
    Accumulated Deficit
    Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
    Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning balance (in shares) at Dec. 31, 2017       0 0 7,303 7,303              
Beginning balance at Dec. 31, 2017 $ 100,440 $ 2,634 $ 103,074 $ 0 $ 0 $ 73 $ 73 $ 243,598 $ 243,598 $ 232 $ 232 $ (143,463) $ 2,634 $ (140,829)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net (loss) income attributable to Heska Corporation 5,850                     5,850    
Issuance of common stock, net of shares withheld for employee taxes (in shares)           318                
Issuance of common stock, net of shares withheld for employee taxes 2,762         $ 3   2,759            
Issuance of common stock related to acquisition of assets from Cuattro, LLC (in shares)           55                
Issuance of common stock related to acquisition of assets from Cuattro, LLC 5,451         $ 1   5,450            
Stock-based compensation 5,227             5,227            
Other comprehensive income 45                 45        
Ending balance at Dec. 31, 2018 122,409     $ 0   $ 77   257,034   277   (134,979)    
Ending balance (in shares) at Dec. 31, 2018       0   7,676                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net (loss) income attributable to Heska Corporation (1,465)                     (1,465)    
Issuance of common stock, net of shares withheld for employee taxes (in shares)           206                
Issuance of common stock, net of shares withheld for employee taxes (1,618)         $ 2   (1,620)            
Stock-based compensation 4,968             4,968            
Convertible notes, equity 29,834             29,834            
Other comprehensive income 236                 236        
Ending balance at Dec. 31, 2019 154,364 $ (18) $ 154,346 $ 0 $ 0 $ 79 $ 79 290,216 $ 290,216 513 $ 513 (136,444) $ (18) $ (136,462)
Ending balance (in shares) at Dec. 31, 2019       0 0 7,882 7,882              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net (loss) income attributable to Heska Corporation (14,399)                     (14,399)    
Issuance of common stock, net of shares withheld for employee taxes (in shares)           85                
Issuance of common stock, net of shares withheld for employee taxes 2,796         $ 1   2,795            
Issuance of preferred stock (in shares)       122                    
Issuance of preferred stock 121,786     $ 1       121,785            
Conversion to common stock (in shares)       (122)   1,509                
Conversion to common stock 0     $ (1)   $ 15   (14)            
Stock-based compensation 9,490             9,490            
Purchase of minority interest (622)             (622)            
Other comprehensive income 13,656                 13,656        
Ending balance at Dec. 31, 2020 $ 287,053     $ 0   $ 95   $ 423,650   $ 14,169   $ (150,861)    
Ending balance (in shares) at Dec. 31, 2020       0   9,476                
XML 27 R7.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF CASH FLOWS
€ in Thousands, SFr in Thousands, RM in Thousands, $ in Thousands, $ in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net (loss) income after equity in losses from unconsolidated affiliates $ (14,752) $ (1,731) $ 5,850
Adjustments to reconcile net (loss) income to cash (used in) provided by operating activities:      
Depreciation and amortization 11,385 4,916 4,595
Non-cash impact of operating leases 1,985 1,565  
Deferred income tax benefit (1,541) (1,805) (2,255)
Stock-based compensation 9,490 4,968 5,227
Equity in losses of unconsolidated affiliates 720 594 72
Accretion of discounts and issuance costs 3,090 1,842 0
Provision for credit losses 614 113 104
Other (gains) losses (91) 560 8
Changes in operating assets and liabilities (net of effect of acquisitions):      
Accounts receivable (5,755) 3,683 (1,180)
Inventories (5,409) 918 6,046
Other assets (271) (3,580) (4,590)
Accounts payable (280) (1,686) (2,020)
Due to related parties 0 (226) (1,477)
Other liabilities 159 (6,835) 2,907
Net cash (used in) provided by operating activities (656) 3,296 13,287
CASH FLOWS FROM INVESTING ACTIVITIES:      
Investment in subsidiary, net of cash acquired 0 (622) 0
Convertible note receivable issuance (6,650) 0 0
Purchase of minority interest (450) 0 0
Acquisition of intangible asset 0 0 (2,750)
Investments in unconsolidated affiliates 0 0 (8,091)
Real estate asset acquisition 0 (1,184) 0
Purchases of property and equipment (686) (1,044) (1,358)
Proceeds from disposition of property and equipment 10 0 25
Net cash used in investing activities (126,597) (1,923) (12,174)
CASH FLOWS FROM FINANCING ACTIVITIES:      
Proceeds from issuance of common stock 4,273 1,829 4,034
Repurchase of common stock (1,477) (3,447) (1,271)
Payment of preferred stock issuance costs (214) 0 0
Preferred Stock Proceeds 122,000 0 0
Distributions to non-controlling interest members 0 0 (126)
Convertible debt proceeds 0 86,250 0
Payments of related party debts (1,140) 0 0
Borrowing on line of credit 0 6,750 3,000
Repayments of line of credit borrowings 0 (12,750) (3,000)
Borrowings of other debts 613 0 0
Repayments of other debt (291) (1,191) (10)
Payment of debt issuance costs 0 (3,177) 0
Net cash provided by financing activities 123,764 74,264 2,627
NET EFFECT OF EXCHANGE RATE CHANGES ON CASH 793 4 (10)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (2,696) 75,641 3,730
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR 89,030 13,389 9,659
CASH AND CASH EQUIVALENTS, END OF YEAR 86,334 89,030 13,389
NON-CASH TRANSACTIONS:      
Transfers of equipment between inventory and property and equipment, net 4,437 827 1,449
Non-cash conversion of preferred stock to common stock 122,000 0 0
Consideration payable for CVM Acquisition 0 14,420 0
Common stock issued as partial consideration of Cuattro acquisition transactions (See Note 3) 0 0 5,450
Scil Animal Care Company      
CASH FLOWS FROM INVESTING ACTIVITIES:      
Acquisition of scil, net of cash acquired (104,401) 0 0
CVM      
CASH FLOWS FROM INVESTING ACTIVITIES:      
Acquisition of scil, net of cash acquired $ (14,420) $ 927 $ 0
XML 28 R8.htm IDEA: XBRL DOCUMENT v3.20.4
OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
12 Months Ended
Dec. 31, 2020
Accounting Policies [Abstract]  
OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Heska Corporation and its wholly-owned subsidiaries ("Heska", the "Company", "we" or "our") sell veterinary and animal health diagnostic and specialty products. Our offerings include Point of Care diagnostic laboratory instruments and supplies; digital imaging diagnostic products, software and services; digital cytology services; vaccines; local and cloud-based data services; allergy testing and immunotherapy; and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. Our core focus is on supporting veterinarians in the canine and feline healthcare space.
Basis of Presentation and Consolidation
In the opinion of management, the accompanying Consolidated Financial Statements contain all adjustments, consisting of normal, recurring adjustments, necessary to present fairly the financial position of the Company as of December 31, 2020 and 2019, as well as the results of our operations, statements of stockholders' equity and cash flows for the twelve months ended December 31, 2020, 2019 and 2018.
The audited Consolidated Financial Statements included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Our audited Consolidated Financial Statements include our accounts and the accounts of our wholly-owned subsidiaries since their respective dates of acquisitions. All intercompany accounts and transactions have been eliminated in consolidation. Where our ownership of a subsidiary was less than 100%, the non-controlling interest is reported on our consolidated balance sheets. The non-controlling interest in our consolidated net income is reported as "Net loss attributable to non-controlling interest" on our Consolidated Statements of (Loss) Income. Our audited Consolidated Financial Statements are stated in U.S. Dollars and have been prepared in accordance with accounting principles generally accepted in the U.S. ("GAAP").
Beginning in the first quarter of 2020, to limit the spread of COVID-19, governments took various actions including the issuance of stay-at-home policies and social distancing procedures and guidelines, causing some businesses to adjust, reduce or suspend business and operating activities. Veterinary care is widely recognized as an "essential" service for pet owners, and veterinarians continued to deliver essential medical care for sick and injured pets. The stay-at-home policies deployed early in 2020 to combat the spread of COVID-19 resulted in a decrease in companion animal clinical visits, including delay of elective procedures and wellness visits and as a result lowers demand for diagnostic testing services. Beginning in the second quarter of 2020, certain local, state and federal governments began to ease the stay-at-home policies and allowed more businesses and facilities to re-open, leading to a recovery in companion animal clinical visits and associated demand for our diagnostic products. The extent to which the continuation, or a possible second-wave outbreak of COVID-19, or an outbreak of other health epidemics could impact our business, results of operations and financial condition, including the potential for write-offs or impairments of assets and suspension of capital investments, will depend on future developments. We are unable to predict with certainty the effects of the COVID-19 pandemic on our customers, suppliers and vendors, as well as the actions of governments, and when and to what extent normal economic and operating conditions can resume; these effects may differ from those assumed in our projected estimates. Even after the COVID-19 pandemic has subsided, we may continue to experience adverse impacts to our business as a result of any economic impact that has occurred or may occur in the future.
Reclassification
To maintain consistency and comparability, certain amounts in the financial statements have been reclassified to conform to current year presentation.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates are required when establishing the allowance for doubtful accounts and the net realizable value of inventory; determining future costs associated with warranties provided; determining the period over which our obligations are fulfilled under agreements to license product rights and/or technology rights; evaluating long-lived and intangible assets and investments for estimated useful lives and impairment; estimating the useful lives and standalone selling prices of instruments under leasing arrangements; determining the allocation of purchase price under purchase accounting; estimating the expense associated with the granting of stock; determining the need for, and the amount of a valuation allowance on deferred tax assets; determining the fair value of our embedded derivative; and determining the fair value of the liability component associated with the issuance of convertible debt. Our actual results may differ from these estimates and there may be changes to those estimates in future periods.
Concentration of Credit Risk
Financial instruments that potentially subject us to a concentration of credit risk consist of cash and cash equivalents and accounts receivable. We maintain the majority of our cash and cash equivalents with financial institutions that management believes are creditworthy in the form of demand deposits. We have no off-balance-sheet concentrations of credit risk such as foreign exchange contracts, options contracts or other foreign currency hedging arrangements. Our accounts receivable balances are due largely from distribution partners, domestic veterinary clinics and individual veterinarians and other animal health companies.

Covetrus represented 9% and 19% of our consolidated accounts receivable at December 31, 2020 and 2019, respectively. No other customer accounted for more than 10% of our consolidated accounts receivable at December 31, 2020 or 2019.
We have established an allowance for credit losses based upon factors surrounding the credit risk of specific customers, historical trends and other information.
Accounts Receivable and Allowance for Credit Losses
Accounts receivable are recorded net of an allowance for credit losses. From time to time, our customers are unable to meet their payment obligations. We continuously monitor our customers' credit worthiness and establish allowances for estimated credit losses related to our accounts receivable, net investment in leases, contract assets, and promissory notes. Our allowances are established based on factors surrounding the credit risk of specific customers, historical experience including collections and write-off history, and current economic conditions. Account balances are considered past due if payments have not been received within agreed upon invoice and/or contract terms and the Company may employ collection agencies and legal counsel to pursue recovery of defaulted amounts. Account balances are written off against the allowance after all collection efforts have been exhausted and it is probable the receivable will not be recovered. The Company also performs a qualitative assessment, on a quarterly basis, to monitor economic factors and other uncertainties that may require additional adjustments for the expected credit loss allowance. While such credit losses have historically been within our expectations and the provisions established, there is no assurance that we will continue to experience the same credit loss rates that we have in the past. A significant change in the liquidity or financial position of our customers could have a material adverse impact on the collectability of accounts receivable and our future operating results. The Company will continue to actively monitor the impact of the COVID-19 pandemic on expected credit losses. In 2020, the Company adopted Accounting
Standards Update ("ASU") 2016-13, Financial Instruments - Credit Losses (Topic 326). See "Adoption of New Accounting Standards" below for impacts of adoption.
Changes in the allowance for credit losses are summarized as follows (in thousands):

Years Ended December 31,
202020192018
Balances at beginning of period$186 $245 $215 
Additions from acquisition90 — — 
Additions - charged to expense614 113 104 
Deductions - write offs, net of recoveries(121)(172)(74)
Balances at end of period$769 $186 $245 
Cash and Cash Equivalents
Cash and cash equivalents are stated at cost, which approximates market value, and include short-term, highly liquid investments with original maturities of less than three months. We valued our foreign cash accounts at the spot market foreign exchange rate as of each balance sheet date, with changes due to foreign exchange fluctuations recorded in Accumulated other comprehensive income in the Consolidated Balance Sheets. The majority of our cash and cash equivalents are held in accounts not insured by governmental entities. The foreign cash balances are summarized as follows (denominated in foreign currency, in thousands):

As of December 31,
20202019
European Union Euros8,520 1,773 
Swiss Francs138 124 
Canadian Dollars2,993 88 
Australian Dollars159 54 
Malaysian Ringgit364 — 
Fair Value of Financial Instruments
In accordance with ASC 820, Fair Value Measurements (“ASC 820”), the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. Fair value is defined as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:
Level 1: Quoted market prices in active markets for identical assets or liabilities.
Level 2: Quoted prices in active markets for similar assets and liabilities, quoted prices for identically similar assets or liabilities in markets that are not active and models for which all significant inputs are observable either directly or indirectly.
Level 3: Unobservable inputs reflecting the reporting entity’s own assumptions or external inputs for inactive markets.
The Company's financial instruments consist of cash and cash equivalents, short-term trade receivables and payables, a long-term note receivable with an embedded derivative asset, and its 3.75% Convertible Senior Notes due 2026 (the "Notes"). The carrying values of cash and cash equivalents and short-term trade receivables and payables approximate fair value because of the short-term nature of the instruments.
The estimated fair value of the Notes disclosed at each reporting period is evaluated through Level 2 inputs with consideration of quoted market prices in less active markets. For additional information regarding the Company's accounting treatment for the issuance of the Notes, including the fair value measurement of the liability component, refer to Note 16. Convertible Notes.
The Company determined the redemption features of its convertible note receivable represents an embedded derivative. The estimated fair value of the embedded derivative asset is evaluated through Level 3 inputs. The carrying amount of the derivative is recorded at fair value at issuance and will be remeasured each reporting period, with the mark-to-market adjustments to be included in other expense (income). For additional information regarding the Company's accounting treatment for the convertible note receivable, including the fair value measurement of the embedded derivative, refer to Note 17. Convertible Note Receivable.
Property and Equipment
Property and equipment is stated at cost, net of accumulated depreciation. The costs of additions and improvements are capitalized, while maintenance and repairs are charged to expense as incurred. When an item is sold or retired, the cost and related accumulated depreciation is relieved and the resulting gain or loss, if any, is recognized in the Consolidated Statements of (Loss) Income. We provide for depreciation primarily using the straight-line method by charges to income in amounts that allocate the cost of property and equipment over their estimated useful lives as follows:
Asset ClassificationEstimated
Useful Life
Building10 to 43 years
Machinery and equipment2 to 10 years
Office furniture and equipment3 to 7 years
Computer hardware and software3 to 7 years
Leasehold and building improvements5 to 15 years

We capitalize certain costs incurred in connection with developing or obtaining software designated for internal use based on three distinct stages of development. Qualifying costs incurred during the application development stage, which consist primarily of internal payroll and direct fringe benefits and external direct project costs, including labor and travel, are capitalized and amortized on a straight-line basis over the estimated useful life of the asset, which range from three to seven years. Costs incurred during the preliminary project and post-implementation and operation phases are expensed as incurred. These costs are general and administrative in nature and related primarily to the determination of performance requirements, data conversion and training.
Inventories
Inventories are stated at the lower of cost or net realizable value using the first-in, first-out method. Inventory we manufacture includes the cost of material, labor and overhead. We write down the carrying value of inventory for estimated obsolescence by an amount equal to the difference between the cost of inventory and the estimated market value when warranted based on assumptions of future demand, market conditions, remaining shelf life, or product functionality.
Investments in Unconsolidated Affiliates
Investments in unconsolidated affiliates are measured and recorded as either non-marketable equity securities or equity method investments. Non-marketable equity securities are equity securities without readily determinable fair value that are measured and recorded using a measurement alternative which measures the securities at cost minus impairment, if any, plus or minus changes from qualifying observable price changes. Equity method investments are equity securities in investees we do not control but over which we have the ability to exercise significant influence. When the equity method of accounting is determined to be appropriate, the initial measurement of the investment includes the cost of the investment and all direct transaction costs incurred to acquire the investment. Equity method investments are measured at cost minus impairment, if any, plus or minus our share of equity method investee income or loss, which is recorded as a separate line on the income statement. Both types of investments are evaluated for impairment if a triggering event occurs.
Goodwill, Intangible and Other Long-Lived Assets

Goodwill is initially valued based on the excess of the purchase price of a business combination over the fair value of acquired net assets recognized and represents the future economic benefits arising from other assets acquired that could not be individually identified and separately recognized. Intangible assets other than goodwill are initially valued at fair value. If a quoted price in an active market for the identical asset is not readily available at the measurement date, the fair value of the intangible asset is estimated based on discounted cash flows using market participant assumptions, which are assumptions that are not specific to the Company. The selection of appropriate valuation methodologies and the estimation of discounted cash flows require significant assumptions about the timing and amounts of future cash flows, risks, appropriate discount rates, and the useful lives of intangible assets. When material, we utilize independent valuation experts to advise and assist us in determining the fair values of the identified intangible assets acquired in connection with a business acquisition and in determining appropriate amortization methods and periods for those intangible assets.

We assess goodwill for impairment annually, at the reporting unit level, in the fourth quarter and whenever events or circumstances indicate impairment may exist. In evaluating goodwill for impairment, we have the option to first assess the qualitative factors to determine whether it is more-likely-than-not that the estimated fair value of the reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the comparison of the estimated fair value of the reporting unit to the carrying value. The more-likely-than-not threshold is defined as having a likelihood of more than 50 percent. If, after assessing the totality of events or circumstances, we determine that it is more-likely-than-not that the estimated fair value of a reporting is less than its carrying amount, we would then estimate the fair value of the reporting unit and compare it to the carrying value. If the carrying value exceeds the estimated fair value we would recognize an impairment for the difference; otherwise, no further impairment test would be required. In contrast, we can opt to bypass the qualitative assessment for any reporting unit in any period and proceed directly to quantitative analysis. Doing so does not preclude us from performing the qualitative assessment in any subsequent period. Following the acquisition of scil in April 2020, we restructured our operating segments based on how the Chief Operating Decision Maker (“CODM”) manages the business, allocates resources, makes operating decisions and evaluates operating performance. As further discussed in Note 18, our new reporting segments are North America and International. As a result of the change in operating segments, we also revised our reporting units to aggregate our legal entities based on similarities in economic characteristics. Our new reporting units consist of the following: (1) Heska Corporation and Heska Canada, (2) Diamond Animal Health, (3) scil animal care company GmbH, Optomed, CVM, and Heska Australia, and (4) Heska AG.
As a result of the recent global economic disruption and uncertainty due to the COVID-19 pandemic, the
Company performed a qualitative assessment during the first quarter of 2020. Based on the interim assessment performed, we concluded that there was no triggering event and additionally, no indications of impairment existed. We performed qualitative assessments in the fourth quarters of 2020, 2019, and 2018 and determined that no indications of impairment existed.

We assess the realizability of intangible assets other than goodwill whenever events or changes in circumstances indicate that the carrying value may not be recoverable. If an impairment review is triggered, we evaluate the carrying value of intangible assets based on estimated undiscounted future cash flows over the remaining useful life of the primary asset of the asset group and compare that value to the carrying value of the asset group. The cash flows that are used contain our best estimates, using appropriate and customary assumptions and projections at the time. If the net carrying value of an intangible asset exceeds the related estimated undiscounted future cash flows, an impairment to adjust the intangible asset to its fair value would be reported as a non-cash charge to earnings. If necessary, we would calculate the fair value of an intangible asset using the present value of the estimated future cash flows to be generated by the intangible asset, and applying a risk-adjusted discount rate. We had no impairments of our intangible assets during the years ended December 31, 2020, 2019, and 2018.
Revenue Recognition

We generate revenue through the sale of products, either by outright purchase by our customers or through a subscription agreement whereby our customers receive instruments and pay us a monthly fee for the consumables needed to conduct testing. Subscription placement is the majority of our Point of Care laboratory transactions while outright sales to customers are the majority of both Point of Care imaging diagnostic transactions and the sale of pharmaceuticals and vaccines.

For outright sales of products, revenue is recognized when control of the promised product or service is transferred to our customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products or services (the transaction price). Taxes assessed by governmental authorities and collected from the customer are excluded from our revenue recognition. A performance obligation is a promise in a contract to transfer a distinct product or service to a customer and is the unit of account under ASC 606. For instruments, consumables and most software licenses sold by the Company, control transfers to the customer at a point in time. To indicate the transfer of control, the Company must have a present right to payment, legal title must have passed to the customer, the customer must have the significant risks and rewards of ownership and where acceptance is not a formality, the customer must have accepted the product or service. Heska’s principal terms of sale are FOB Shipping Point, or equivalent, and, as such, we primarily transfer control and record revenue for product sales upon shipment. If a performance obligation to the customer with respect to a sales transaction remains unfulfilled following shipment (typically owed installation), revenue recognition for that performance obligation is deferred until such commitments have been fulfilled. For extended warranty and service plans, control transfers to the customer over the term of the arrangement and as such the revenue is recognized ratably based upon the period of time elapsed under the arrangement.

Our revenue under subscription agreements relates to operating-type lease ("OTL") arrangements or sales-type lease ("STL") arrangements. Determination of an OTL or STL is primarily determined as a result of the length of the contract as compared to the estimated useful life of the instrument, among other factors. Leases are outside of the scope of ASC 606 and are therefore accounted for in accordance with ASC 842, Leases. A STL would result in earlier recognition of instrument revenue as compared to an OTL, which is generally upon installation of the instruments. Instrument lease revenue for our OTL subscription agreements is recognized on a straight-line basis over the life of the lease and is included with the predominant non-lease components in consumables revenue. For instrument only OTL agreements, operating lease income is
recognized on a straight-line basis over the term of the lease. The cash collected under both arrangements is over the term of the contract. The OTLs and STLs are not cancellable until after an initial term. See below for additional information on our lease accounting policies.
For contracts with both lease and non-lease components, the Company allocates the contracts' transaction price for each component on a relative standalone selling price basis using our best estimate of the standalone selling price of each distinct product or service in the contract. When available, the method used to estimate the standalone selling price is the price observed in standalone sales to customers. When prices in standalone sales are not available, we use a cost-plus margin approach. Changes in these values can impact the amount of consideration allocated to each component of the contract. Allocation of the transaction price is determined at the contracts' inception. The Company does not adjust the transaction price for the effects of a significant financing component when the period between the transfer of the promised good or service to the customer and payment for that good or service by the customer is expected to be one year or less.

To the extent the transaction price includes variable consideration, such as future payments based on consumable usage over time, we apply judgment to determine if the variable consideration should be constrained. As the variable consideration is highly susceptible to factors outside of the Company’s influence, and the potential values contain a broad range of possible outcomes given all potential amounts of consumption that could occur, it is likely that a significant revenue reversal would occur should the variable consideration be estimated at an amount greater than the minimum stated amount until such a time as the uncertainty is resolved. For our subscription agreements with variable consideration based on consumable usage over time, the variable consideration is allocated to the non-lease components upon resolution of the uncertainty and is included in consumables revenue.

We generate OVP revenue through contract manufacturing agreements with customers. Revenue from these customer contracts is generally recognized upon shipment or acceptance by our customer, under the same guidelines noted above for other outright product sales. Heska assessed the over-time criteria within ASC 606 and concluded that while products within this segment have no alternative use to Heska, as Heska is contractually prohibited to redirect the product to other customers, Heska does not have right to payment for performance to date. Therefore, point in time revenue recognition has been determined to be appropriate.
Recording revenue from the sale of products involves the use of estimates and management's judgment. We must make a determination at the time of sale whether the customer has the ability and intent to make payments in accordance with arrangements. For contracts with multiple performance obligations, we exercise judgment in allocating the transaction price for each performance obligation based on an estimated standalone selling price for each distinct product or service. We do not generally allow return of products or instruments. Distributor rebates are recorded as a reduction to revenue.

Refer to Note 2 for additional disclosures required by ASC 606.

Leases

The Company acts as a lessee and a lessor. As a lessee, the Company leases buildings, office equipment, and vehicles. As a lessor, the Company enters into sales-type and operating leases as part of its subscription agreements.

The Company determines if an arrangement is a lease at inception based on whether control of an identified asset is transferred. For leases where the Company is the lessee, ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based
on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The lease terms used to calculate the ROU asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense while the expense for finance leases is recognized as amortization expense and interest expense. The Company has lease agreements which require payments for lease and non-lease components and has elected to account for these as a single lease component for our building and office equipment leases, but as separate components for our vehicle leases.

As a lessor, our subscription agreements relate to both OTL arrangements and STL arrangements. For a STL, instrument revenue is generally recorded upon installation of the instruments and the cost of the customer-leased instruments is removed from inventory and recognized in the Consolidated Statements of (Loss) Income. There is no residual value taken into consideration as it does not meet our capitalization requirements. For our OTL agreements that include both lease and non-lease components, revenue is recognized on a straight-line basis over the term of the lease and is included with the predominant non-lease components in consumables revenue. For instrument only OTL agreements, operating lease income is recognized on a straight-line basis over the term of the lease. For an OTL, the costs of customer-leased instruments are recorded within property and equipment in the accompanying Consolidated Balance Sheets and depreciated over the instrument’s estimated useful life. The depreciation expense is reflected in cost of revenue in the accompanying Consolidated Statements of (Loss) Income.

For leases that commenced before the January 1, 2019 effective date of ASC 842, the Company elected the permitted practical expedients to not reassess the following: (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) initial direct costs for any existing leases. The Company also elected to exclude leases with a term of 12 months or less from the recognized ROU assets and lease liabilities.
Stock-based Compensation
Stock-based compensation expense is measured at the grant date based upon the estimated fair value of the portion of the award that is ultimately expected to vest and is recognized as expense over the applicable requisite service period of the award generally using the straight-line method.
Advertising Costs
Advertising costs are expensed as incurred and are included in sales and marketing expenses. Advertising expenses were $0.4 million for the year ended December 31, 2020, $0.3 million for the year ended December 31, 2019, and $0.2 million for the year ended December 31, 2018.
Income Taxes

The Company records a current provision for income taxes based on estimated amounts payable or refundable on tax returns filed or to be filed each year. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates, in each tax jurisdiction, expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date. The overall change in deferred tax assets and liabilities for the period measures the deferred tax expense or benefit for the period. Deferred tax assets are reduced by a valuation allowance based on a judgmental assessment of available evidence if the Company is unable to conclude that it is more likely than not that some or all of the deferred tax assets will be realized.
Earnings Per Share
Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued.
Foreign Currency Translation

The functional currency of certain foreign subsidiaries is the local currency. Accordingly, assets and liabilities of these subsidiaries are translated using the exchange rate in effect at the balance sheet date. Revenue and expense accounts and cash flows are translated using an average of exchange rates in effect during the period. Cumulative translation gains and losses are shown in the Consolidated Balance Sheets as a separate component of stockholders' equity. Exchange gains and losses arising from transactions denominated in foreign currencies (i.e., transaction gains and losses) are recognized as a component of other income (expense) in current operations, as are exchange gains and losses on intercompany transactions expected to be settled in the near term. Gains and losses arising from intercompany foreign currency transactions that are of a long-term investment nature are reported as a component of Accumulated other comprehensive income in the Consolidated Balance Sheets.
Warranty Costs
The Company generally provides for the estimated cost of hardware and software warranties in the period the related revenue is recognized. The Company assesses the adequacy of its accrued warranty liabilities and adjusts the amounts as necessary based on actual experience and changes in future estimates. Should product failure rates differ from our estimates, actual costs could vary significantly from our expectations. Extended warranties are sold to our customers and revenue is recognized over the term of the warranty agreement, as expected costs are incurred.
Correction of an Immaterial Error
During the fourth fiscal quarter of 2020, the Company recorded an out-of-period adjustment that impacted the Consolidated Balance Sheets, Consolidated Statements of (Loss) Income and Consolidated Statements of Comprehensive (Loss) Income. The adjustment related to an error in the calculation of non-cash interest expense relating to the Company's Notes. This error resulted in an overstatement of non-cash interest expense of $0.7 million in 2019, $0.6 million in each of the first and second fiscal quarters of 2020 and $0.5 million in the third fiscal quarter of 2020. The error also resulted in an overstatement of Convertible Notes, net, and Deferred Tax Liability of $0.7 million and $0.2 million, respectively as of December 31, 2019; $1.4 million and $0.3 million, respectively, as of March 31, 2020; $2.0 million and $0.4 million, respectively, as of June 30, 2020; and $2.5 million and $0.6 million, respectively, as of September 30, 2020. The Company assessed the materiality of these errors on the previously issued interim and annual financial statements in accordance with SEC Staff Accounting Bulletin No. 99 and No. 108. The Company concluded that the errors were not material to any of the previously issued consolidated financial statements and the impact of correcting these errors in the year ended December 31, 2020 is not material to the consolidated financial statements.
The impact of this adjustment resulted in a fourth quarter period decrease in interest expense of $2.5 million and a decrease in income tax benefit of $0.6 million. The Company also recorded a decrease in Convertible Notes, net, of $2.5 million, and a reduction in Deferred Tax Liability of $0.6 million as of December 31, 2020.
Adoption of New Accounting Pronouncements
In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2016-13, Financial Instruments - Credit Losses (Topic 326), which requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected. The income statement reflects the measurement of credit losses for newly recognized financial assets, as well as the increases or decreases of expected credit losses that have taken place during the period. The measurement of expected credit losses is based upon historical experience, current conditions and reasonable and supportable forecasts that affect the collectability of the reported amount. Subsequent to the issuance of ASU 2016-13, the FASB issued ASU 2018-19, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, in November 2018. This ASU clarifies that receivables from operating leases are accounted for using the lease guidance and not as financial instruments. In April 2019, the FASB issued ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments, which further clarifies and improves guidance related to accounting for credit losses. In May 2019, the FASB issued ASU 2019-05, Financial Instruments - Credit Losses (Topic 326). This ASU provides relief to certain entities adopting ASU 2016-13. The amendment provides entities with an option to irrevocably elect the fair value option for certain financial assets. The Company adopted ASU 2016-13 with a cumulative-effect adjustment in retained earnings as of January 1, 2020. The impact of the adoption was not material to the Company's consolidated financial statements.
Accounting Pronouncements Not Yet Adopted    

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which is intended to simplify various aspects related to the accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740, and also clarifies and amends existing guidance to improve consistent application. This guidance will be effective for interim and annual periods beginning after December 15, 2020, and early adoption is permitted. We evaluated the impact of the standard on our consolidated financial statements and do not expect the standard to have a material impact on our consolidated financial statements and disclosures.

In January 2020, the FASB issued ASU 2020-01, Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815). The amendments in this ASU clarify the interaction between the accounting for investments in equity securities, investment in equity method and certain derivatives instruments. The ASU is expected to reduce diversity in practice and increase comparability of the accounting for these interactions. This guidance will be effective for fiscal years beginning after December 15, 2020. We evaluated the impact of the standard on our consolidated financial statements and do not expect the standard to have a material impact on our consolidated financial statements and disclosures.

In August 2020, the FASB issued ASU 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40), which simplifies the accounting for certain convertible instruments. The update reduces the number of accounting models for convertible debt instruments and convertible preferred stock. Convertible debt will be accounted for as a single liability measured at its amortized cost and convertible preferred stock will be accounted for as a single equity instrument measured at its historical cost, as long as no other features require bifurcation and recognition as derivatives. The update also requires the if-converted method to be used for convertible instruments and the effect of potential share settlement be included in the diluted earnings per share calculation when an instrument may be settled in cash or shares. The amendments in this update are effective for public business entities for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. The guidance may be early adopted for fiscal years beginning after December 15, 2020,
and interim periods within those fiscal years.

The Company has elected to early adopt ASU 2020-06 as of January 1, 2021. The Notes are a convertible instrument with a cash-conversion feature that is accounted for within the scope of ASC 470-20 and will be impacted by adopting ASU 2020-06. The Company has elected to apply the modified retrospective method wherein the Company will recognize a cumulative-effect adjustment to the opening balance of retained earnings (January 1, 2021). Further, the Company will not restate EPS in the prior periods. The Company calculated the cumulative-effect adjustment as of January 1, 2021 by comparing (i) the historical amortization schedule for the Notes through December 31, 2020 and (ii) an updated amortization schedule wherein the conversion feature within the Notes would not be separated as an equity component and subsequently recognized as non-cash interest expense under ASC 835-30. As a result of ASU 2020-06, while cash interest expense is not impacted, non-cash interest accretion is limited to the amortization of debt issuance costs under ASC 835-30. Therefore, the Company prepared its transition journal entries by (i) reversing the conversion feature amount recorded in APIC and (ii) reversing the difference in non-cash interest expense via retained earnings. The expected impact on retained earnings is $4.3 million.

In October 2020, the FASB issued ASU 2020-10, Codification Improvements, which updates various codification topics by clarifying or improving disclosure requirements to align with the SEC's regulations. This guidance will be effective for annual periods beginning after December 15, 2020, for public entities. The Company will adopt as of the reporting period beginning January 1, 2021. We evaluated the impact of the
standard on our consolidated financial statements and do not expect the standard to have a material impact on our consolidated financial statements and disclosures.
XML 29 R9.htm IDEA: XBRL DOCUMENT v3.20.4
REVENUE
12 Months Ended
Dec. 31, 2020
Revenue from Contract with Customer [Abstract]  
REVENUE REVENUE
We separate our goods and services among two reportable segments, North America and International. The two segments consist of revenue originating from:

North America: including the United States, Canada and Mexico
International: all geographies outside North America, currently consisting primarily of Australia, France, Germany, Italy, Malaysia, Spain and Switzerland

Refer to Note 18 for further detail regarding the change in reportable segments which required recast of prior period presentation.
The following table summarizes our segment revenue (in thousands):

Year Ended December 31,
202020192018
North America Revenue:
    POC Lab Instruments & Other$8,433 $6,556 $6,375 
    POC Sales-type leases5,230 6,890 5,888 
    POC Lab Consumables59,247 53,267 45,111 
    POC Imaging20,651 21,655 22,832 
    PVD19,810 10,965 25,663 
    OVP17,695 16,090 18,522 
    Total North America Revenue$131,066 $115,423 $124,391 
International Revenue:
    POC Lab Instruments & Other$6,383 $96 $— 
    POC Sales-type leases387 — — 
    POC Operating Leases1,012 — — 
    POC Lab Consumables32,354 323 — 
    POC Imaging22,537 3,998 — 
    PVD3,584 2,821 3,055 
    Total International Revenue$66,257 $7,238 $3,055 
Total Revenue$197,323 $122,661 $127,446 

Remaining Performance Obligations

Remaining performance obligations represent the aggregate transaction price allocated to performance obligations with an original contract term greater than one year which are fully or partially unsatisfied at the end of the period. Remaining performance obligations include noncancelable purchase orders, the non-lease portion of minimum purchase commitments under long-term supply arrangements, extended warranty, service and other long-term contracts. Remaining performance obligations do not include revenue from contracts with customers with an original term of one year or less, revenue from long-term supply arrangements with no minimum purchase requirements, revenue expected from purchases made in excess of the minimum purchase
requirements, or revenue from instruments leased to customers. While the remaining performance obligation disclosure is similar in concept to backlog, the definition of remaining performance obligations excludes leases and contracts that provide the customer with the right to cancel or terminate for convenience with no substantial penalty, even if historical experience indicates the likelihood of cancellation or termination is remote. Additionally, the Company has elected to exclude contracts with customers with an original term of one year or less from remaining performance obligations.

As of December 31, 2020, the aggregate amount of the transaction price allocated to remaining minimum performance obligations was approximately $144.6 million. As of December 31, 2020, the Company expects to recognize revenue as follows (in thousands):

Year Ending December 31,Revenue
2021$32,976 
202230,089 
202326,992 
202422,668 
202516,713 
Thereafter15,129 
$144,567 

Contract Balances

The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled contract assets, deferred revenue, and customer deposits and billings in excess of revenue recognized. In addition, the Company defers certain costs incurred to obtain contracts.

Contract Assets

Certain unbilled amounts related to long-term contracts for which we provide a free term to the customer are recorded in "Other current assets" and "Other non-current assets" on the accompanying Consolidated Balance Sheets. The collection of these balances occurs over the term of the underlying contract. The balances as of December 31, 2020 were $1.2 million and $4.1 million for current and non-current assets, respectively, shown net of related unearned interest. The balances as of December 31, 2019 were $1.1 million and $3.7 million for current and non-current assets, respectively, shown net of related unearned interest.
Contract Liabilities

The Company receives cash payments from customers for licensing fees or other arrangements that extend for a specified term. These contract liabilities are classified as either current or long-term in the Consolidated Balance Sheets based on the timing of when the Company expects to recognize revenue. As of December 31, 2020 and 2019, contract liabilities were $8.9 million and $8.7 million, respectively, and are included within "Deferred revenue, current, and other" and "Deferred revenue, non-current" in the accompanying Consolidated Balance Sheets. The decrease in the contract liability balance during the year ended December 31, 2020 is approximately $4.2 million of revenue recognized during the period, offset by approximately $3.8 million of additional deferred sales in 2020 and the acquisition of scil contract liabilities of $0.6 million. The decrease in the contract liability balance during the year ended December 31, 2019 is $3.1 million of revenue recognized during the period, offset by $2.2 million of additional deferred sales. Contract liabilities are reported on the accompanying Consolidated Balance Sheets on a contract-by-contract basis.

Contract Costs
The Company capitalizes certain direct incremental costs incurred to obtain customer contracts, typically sales-related commissions, where the recognition period for the related revenue is greater than one year. Contract costs are classified as current or non-current, and are included in "Other current assets" and "Other non-current assets" in the Consolidated Balance Sheets based on the timing of when the Company expects to recognize the expense. Contract costs are generally amortized into selling and marketing expense with a certain percentage recognized immediately based upon placement of the instrument with the remainder recognized on a straight-line basis (which is consistent with the transfer of control for the related goods or services) over the average term of the underlying contracts, approximately 6 years. Management assesses these costs for impairment at least quarterly on a portfolio basis and as “triggering” events occur that indicate it is more-likely-than-not that an impairment exists. The balance of contract costs as of December 31, 2020 and December 31, 2019 was $3.0 million and $2.7 million, respectively. Amortization expense for the year ended December 31, 2020 was approximately $1.0 million, offset by approximately $1.2 million of additional contract cost capitalization and $0.1 million of the acquisition of scil contract costs. Amortization expense for the year ended December 31, 2019 was approximately $0.9 million, offset by approximately $1.1 million of additional contract costs capitalized. Contract costs are calculated and reported on a portfolio basis.
XML 30 R10.htm IDEA: XBRL DOCUMENT v3.20.4
ACQUISITION AND RELATED PARTY ITEMS
12 Months Ended
Dec. 31, 2020
Business Combinations and Related Party Disclosure [Abstract]  
ACQUISITION AND RELATED PARTY ITEMS ACQUISITION AND RELATED PARTY ITEMS
scil Acquisition
On April 1, 2020, the Company completed the acquisition of scil animal care company GmbH (“scil”) from Covetrus, Inc. The Company purchased 100% of the capital stock of scil for an aggregate purchase price of $110.3 million in cash. The acquisition represents a key milestone in the Company's long-term strategic plan, creating a global veterinary diagnostics company with leadership positions in key geographic markets. The purchase price exceeded the identifiable net assets, resulting in goodwill of $46.0 million, primarily attributable to the synergies expected from the expanded market opportunities with our offerings and the experienced workforce acquired. Of the goodwill acquired, $37.3 million is allocated to our International segment and $8.7 million is allocated to our North America segment. All of the goodwill is tax deductible for purposes of calculating Controlled Foreign Corporation ("CFC") tested income, which may result in a decrease to the Company's future U.S. federal tax liability.
The acquisition was accounted for using the acquisition method of accounting in accordance with ASC 805, Business Combinations, which requires, among other things, that assets acquired and liabilities assumed be recognized at their fair values as of the acquisition date. As such, the total purchase consideration was allocated to the assets acquired and liabilities assumed based on a preliminary estimate of their fair values as of April 1, 2020.

The information below represents the preliminary purchase price allocation of scil (in thousands):


April 1, 2020
Total purchase consideration$110,290 
Cash and cash equivalents5,889 
Accounts receivable 10,707 
Inventories11,278 
Net investment in leases, current311 
Prepaid expenses1,692 
Other current assets1,338 
Property and equipment, net19,320 
Operating lease right-of-use assets877 
Other intangible assets, net44,517 
Net investment in leases, non-current1,027 
Investments in unconsolidated affiliates55 
Other non-current assets291 
    Total assets acquired97,302 
Accounts payable8,221 
Accrued liabilities7,067 
Operating lease liabilities, current356 
Deferred revenue, current, and other3,220 
Deferred revenue, non-current94 
Operating lease liabilities, non-current529 
Deferred tax liability13,249 
Other liabilities276 
    Net assets acquired64,290 
Goodwill46,000 
Total fair value of consideration transferred$110,290 

The Company's preliminary estimates of fair values of the assets acquired and the liabilities assumed are based on the information currently available, and the Company is continuing to evaluate the underlying inputs and assumptions used in its valuations. Accordingly, these preliminary estimates are subject to change during the measurement period, which is up to one year from the date of the acquisition. A decrease in the fair value of assets acquired or an increase in the fair value of liabilities assumed in the acquisition from those valuations would result in a corresponding change in the amount of goodwill from the acquisition. During the fourth quarter, the Company made certain valuation adjustments to provisional amounts previously recognized. These adjustments resulted in a net increase of $0.2 million in goodwill, primarily due to changes in estimated taxes and an increase in accrued liabilities assumed.
Per the tax indemnification included in the purchase agreement of scil animal care company GmbH, the seller has indemnified the Company for $1.1 million related to uncertain tax positions taken in prior years. The outcome of this arrangement will either be settled or expire due to lapse of statute of limitations by 2027. As of December 31, 2020, approximately $0.8 million of the indemnification agreement remains outstanding.
Intangible assets acquired, amortization method and estimated useful life as of April 1, 2020, was as follows (dollars in thousands):

Useful LifeAmortization MethodFair Value
Customer relationships10 yearsStraight-line$36,272 
Internally developed software7 yearsStraight-line353
Backlog0.2 yearsStraight-line210
Non-compete agreements2 yearsStraight-line60
Trade name subject to amortization0.8 yearsStraight-line66
Trademarks and trade names not subject to amortizationn/aIndefinite7,556
Total intangible assets acquired$44,517 

scil generated net revenue of $61.3 million and a net loss of $1.1 million for the period from April 1, 2020 to December 31, 2020.

The Company incurred acquisition related costs of approximately $6.3 million and $0.7 million for the years ended December 31, 2020 and 2019, respectively, which are included within general and administrative expenses on our Consolidated Statements of (Loss) Income.

Unaudited Pro Forma Financial Information

The following tables present unaudited supplemental pro forma financial information as if the acquisition had occurred on January 1, 2019 (in thousands):
Year Ended December 31,
20202019
Revenue, net$215,874 $201,700 
Net (loss) income before equity in losses of unconsolidated affiliates$(14,848)$(2,159)
Net (loss) income attributable to Heska Corporation$(15,215)$(2,487)

The pro forma financial information presented above has been prepared by combining our historical results and the historical results of scil and further reflects the effect of purchase accounting adjustments, including: (i) amortization of acquired intangible assets, (ii) the impact of certain fair value adjustments such as depreciation on the acquired property, plant and equipment, and (iii) historical intercompany sales between the Company and scil. The unaudited pro forma results are presented for informational purposes only and are not necessarily indicative of what actual results of operations would have been if the acquisition had occurred as the beginning of the period presented, nor are they indicative of future results of operations.

CVM
On December 5, 2019, Heska entered into a definitive agreement to purchase 100% of the outstanding shares of CVM Diagnostico Veternario S.L. and CVM Ecografia S.L. (“CVM”, collectively), primarily to expand international operations in Europe. CVM is headquartered in Tudela, outside of Madrid, Spain. CVM mainly
operates in Spain. The terms of the agreement transferred control of CVM upon signing, and the transfer of the purchase price of approximately $14.4 million and shares occurred in January 2020. The purchase price exceeded the fair value of the identifiable net assets and, accordingly, $9.0 million was allocated to goodwill within the International segment based on the purchase price allocation, all of which is tax deductible for purposes of calculating CFC tested income.
The fair values allocated to CVM's assets and liabilities as of the acquisition date, as well as the purchase price, are reflected in the table below (in thousands):

Purchase PriceDecember 5, 2019
Consideration paid to former owners$14,420 
Cash and cash equivalents1,226 
Accounts receivable583 
Inventories1,621 
Other current assets1,186 
Property and equipment345 
Other intangible assets2,608 
Other non-current assets460 
    Total assets acquired8,029 
Accounts payable(94)
Accrued liabilities(471)
Current portion of deferred revenue, and other(54)
Deferred tax liability(683)
Other long-term borrowings(1,109)
Other liabilities(157)
    Net assets acqiured5,461 
Goodwill8,959 
Total fair value of consideration transferred$14,420 

During the year ended December 31, 2020, the Company made certain valuation adjustments to provisional amounts previously recognized. These measurement period adjustments resulted in a net $110 thousand increase of goodwill, primarily due to fair value adjustments resulting in a decrease in net identifiable assets acquired. The Company finalized the accounting for the CVM acquisition in the fourth quarter of 2020.
Intangible assets acquired, amortization method and estimated useful life as of December 5, 2019, were as follows (dollars in thousands):
Useful LifeAmortization MethodFair Value
Customer relationships6 yearsStraight-line$2,440 
Trade name4 yearsStraight-line111 
Developed technologyn/aIndefinite57 
$2,608 
CVM generated net revenue of $0.8 million and net income of $0.1 million, for the period from December 6, 2019 to December 31, 2019.
The Company incurred acquisition related costs of approximately $0.6 million and $0.1 million for the years ended December 31, 2020 and 2019, respectively, which are included within general and administrative expenses on our Consolidated Statements of (Loss) Income.
Unaudited Pro Forma Financial Information

The following table presents unaudited supplemental pro forma financial information as if the CVM acquisition had occurred on January 1, 2018 (in thousands):
Year Ended December 31,
20192018
Revenue, net$130,434 $135,344 
Net (loss) income before equity in losses of unconsolidated affiliates$(460)$6,042 
Net (loss) income attributable to Heska Corporation$(788)$5,970 

The pro forma financial information presented above has been prepared by combining our historical results and the historical results of CVM and further reflects the effect of purchase accounting adjustments. The unaudited pro forma results are presented for informational purposes only and are not necessarily indicative of what actual results of operations would have been if the acquisition had occurred as the beginning of the period presented, nor are they indicative of future results of operations.
Optomed
On February 22, 2019, Heska acquired 70% of the equity of Optomed, a French-based endoscopy company, in exchange for approximately $0.2 million in cash and the assumption of approximately $0.4 million in debt. On October 5, 2020, the Company acquired the remaining 30% minority interest in Optomed for a purchase price of $0.5 million, allowing the Company to assume full control of the business operations.
Purchase Agreement for Certain Assets
Cuattro, LLC ("Cuattro") is owned by Kevin S. Wilson, the CEO and President of the Company. On December 21, 2018, the Company closed a transaction (the "Asset Acquisition") to acquire certain assets from Cuattro, all related to the North America segment. Pursuant to the Asset Acquisition, dated November 26, 2018, the Company issued 54,763 shares of the Company's common stock, $0.01 par value per share (the "Common Stock"), to Cuattro on the Closing Date, at an aggregate value equal to approximately $5.4 million based on the adjusted closing price per share of the Common Stock as reported on the Nasdaq Stock Market on the Asset Acquisition agreement date. These shares were issued to Cuattro in a private placement in reliance upon an exemption from the registration requirements of the Securities Act pursuant to Section 4(a)(2) thereof and the safe harbor provided by Rule 506 of Regulation D promulgated thereunder. In addition to the Common Stock, the Company paid cash in the amount of $2.8 million to Cuattro as part of the transaction. The total purchase price was determined based on a valuation report from an independent third party. Part of the Asset Acquisition was an agreement to terminate the supply and license agreement that Heska had been operating under since the acquisition of Cuattro Veterinary USA, LLC.
The Company evaluated the acquisition of the purchased assets under ASC 805, Business Combinations and ASU 2017-01, Business Combinations (Topic 805) and concluded that as substantially all of the fair value of the gross assets acquired is concentrated in an identifiable group of similar assets, the transaction did not meet the requirements to be accounted for as a business combination and therefore was accounted for as an asset
acquisition. Accordingly, the $8.2 million purchase price of the purchased assets was allocated entirely to an identifiable intangible asset amortizing on a straight-line basis over a 10-year useful life.
Related Party Activities
Cuattro charged the Company $0, $6 thousand and $4.6 million during 2020, 2019 and 2018, respectively, primarily related to digital imaging products, pursuant to an underlying supply contract that contained minimum purchase obligations, software and services as well as other operating expenses. Pursuant to the Asset Acquisition, Cuattro was obligated, without further compensation, to assist the Company with the implementation of a third-party image hosting platform and necessary data migration. The implementation and migration were completed, and as of December 31, 2020 there will be no further related party activities with Cuattro.
CVM management conducts related party activities with Practice Clinicas Veterinarias Moviles, S.L. ("CVM Practice"), which is owned by CVM's management. During the year ended December 31, 2020, the Company fully paid the balance of a loan due to CVM Practice of approximately $1.1 million, which is included in "Payments of related party debt" on the Consolidated Statements of Cash Flows. CVM also leases two warehouses from CVM Practice. CVM Practice charged CVM $31 thousand and $0 during the year ended December 31, 2020 and 2019, respectively, all of which is related to lease payments. The right-of-use asset and lease liability amounts related to the warehouse leases were approximately $0.2 million and $0 as of December 31, 2020 and 2019, respectively. The change from December 31, 2019 to December 31, 2020 is due to a reorganization regarding CVM management and the control that they exercise subsequent to the scil acquisition.
XML 31 R11.htm IDEA: XBRL DOCUMENT v3.20.4
INVESTMENTS IN UNCONSOLIDATED AFFILIATES
12 Months Ended
Dec. 31, 2020
Equity Method Investments and Joint Ventures [Abstract]  
INVESTMENTS IN UNCONSOLIDATED AFFILIATES INVESTMENTS IN UNCONSOLIDATED AFFILIATES
The carrying values of investments in unconsolidated affiliates, categorized by type of investment, is as follows (in thousands):
December 31, 2020December 31, 2019
Equity method investment$3,686 $4,406 
Non-marketable equity security investment3,018 3,018 
Investment in Unconsolidated Affiliates$6,704 $7,424 
Equity Method Investment
On September 24, 2018, we invested approximately $5.1 million, including costs, to acquire an equity interest in a business as part of our product development strategy. As of December 31, 2020, our ownership interest in the business was 29.1%. In connection with the investment, the Company entered into a Manufacturing Supply Agreement that grants the Company global exclusivity to specified products to be delivered under the agreement for a 15-year period that begins upon the Company's receipt and acceptance of an initial order under the agreement. The Company accounts for this investment using the equity method of accounting. Under the equity method, the carrying value of the investment is adjusted for the Company's proportionate share of the investee's reported earnings or losses with the corresponding share of earnings or losses reported as Equity in losses of unconsolidated affiliates, listed below Net income before equity in losses of unconsolidated affiliates within the Consolidated Statements of (Loss) Income.
Non-Marketable Equity Security Investment
On August 8, 2018, the Company invested approximately $3.0 million, including costs, in exchange for preferred stock. The Company's investment is a non-marketable equity security, recorded using the measurement alternative of cost minus impairment, if any, plus or minus changes resulting from qualifying observable price changes.
As part of the agreement, the Company entered into a Supply and License Agreement, which provides that the investee produce and commercialize products that will enhance the Company's diagnostic portfolio. As part of this agreement, the Company made upfront payment of $1.0 million related to a worldwide exclusive license agreement over a 20-year period, recorded in both short and long-term other assets. In addition, the agreement provides for an additional contingent payment of $10.0 million, relating to the successful achievement of sales milestones. This potential future milestone payment has not yet been accrued as it is not deemed by the Company to be probable at this time.
Both parties in this arrangement are active participants and are exposed to significant risks and rewards dependent on the commercial success of the activities of the collaboration. The parties are actively working on developing and testing the product as well as funding the research and development. Heska classifies the amounts paid for research and development work within the North America segment research and development operating expenses. Expense is recognized ratably when incurred and in accordance with the development plan.
Our investments are evaluated for impairment if a triggering event occurs. The Company evaluated both its equity method investment and non-marketable equity security investment for losses other than temporary as of December 31, 2020, and determined that no indications of an impairment existed.
XML 32 R12.htm IDEA: XBRL DOCUMENT v3.20.4
INCOME TAXES
12 Months Ended
Dec. 31, 2020
Income Tax Disclosure [Abstract]  
INCOME TAXES INCOME TAXES
The components of income before income taxes were as follows (in thousands):

 Year Ended December 31,
 202020192018
Domestic$(9,441)$(1,872)$3,602 
Foreign(4,352)(711)205 
 $(13,793)$(2,583)$3,807 
Temporary differences that give rise to the components of net deferred tax assets (liabilities) are as follows (in thousands):

 December 31,
 20202019
Inventory$2,993 $2,005 
Accrued compensation295 122 
Stock options2,322 1,858 
Research and development tax credit1,308 990 
Research and development expense2,571 1,417 
Deferred revenue1,441 2,052 
Property and equipment298 3,469 
Net operating loss carryforwards8,757 11,676 
Foreign tax credit carryforward64 64 
Sales-type leases1,324 (1,968)
Convertible debt equity component(8,691)(9,421)
Foreign intangible(11,311)(691)
Other(1,124)(179)
247 11,394 
Valuation allowance(6,409)(5,656)
Total net deferred tax assets (liabilities)$(6,162)$5,738 

The components of the income tax expense (benefit) are as follows (in thousands):

 Year Ended December 31,
 202020192018
Current income tax expense:   
Federal$(24)$— $(115)
State339 189 192 
Foreign1,465 170 63 
Total current expense$1,780 $359 $140 
Deferred income tax (benefit) expense:   
Federal$369 $(1,610)$(1,877)
State289 (307)(378)
Foreign(2,199)112 — 
Total deferred (benefit) expense(1,541)(1,805)(2,255)
Total income tax expense (benefit)$239 $(1,446)$(2,115)
The Company's income tax (benefit) expense relating to income (loss) for the periods presented differs from the amounts that would result from applying the federal statutory rate to that income (loss) as follows:

Year Ended December 31,
202020192018
Statutory federal tax rate21 %21 %21 %
State income taxes, net of federal benefit(4)%%(8)%
Non-controlling interest in Optomed%(2)%— %
Foreign income inclusion(12)%— %— %
Non-temporary stock option benefit%48 %(50)%
Meals and entertainment permanent difference— %(2)%%
GILTI permanent difference— %%%
Other permanent differences%(1)%%
Foreign tax rate differences%%— %
Change in tax rate%(6)%— %
Change in valuation allowance(4)%(17)%— %
Other deferred differences(2)%(9)%(21)%
Transaction costs(6)%(6)%— %
Executive compensation limit(6)%(7)%— %
Research & development credit%20 %— %
Equity Investment(4)%— %— %
Change in uncertain tax benefits%— %— %
Other(1)%— %(1)%
Effective income tax rate(2)%56 %(56)%

In 2020, we had total income tax expense of $0.2 million, including $0.6 million in domestic deferred income tax expense and $2.2 million in foreign deferred income tax benefit, and $1.8 million in current income tax expense. In 2019, we had total income tax benefit of $1.4 million, including approximately $1.9 million in domestic deferred income tax benefit and $0.1 million of foreign deferred income tax expense, a non-cash benefit, and approximately $0.4 million in current income tax expense. In 2018, we had total income tax benefit of $2.1 million, including $2.3 million in domestic deferred income tax benefit, a non-cash benefit, and $0.1 million in current income tax expense. Income tax expense increased in 2020 from 2019 due to foreign income inclusion, executive compensation limitations and acquisition related costs. Income tax benefit decreased in 2019 from 2018 due to executive compensation limitations and lower excess tax benefits related to stock-based compensation deductions.

Cash paid for income taxes for the years ended December 31, 2020, 2019 and 2018 was $993 thousand, $128 thousand and $36 thousand, respectively.
The Company is subject to income taxes in the U.S. federal jurisdiction, and various foreign, state and local jurisdictions. Tax regulations within each jurisdiction are subject to the interpretation of the related tax laws and regulations and require significant judgment to apply. Although the U.S. and many states generally have statutes of limitations ranging from 3 to 5 years, those statutes could be extended due to the Company’s net operating loss and tax credit carryforward positions in several of the Company's tax jurisdictions. In the U.S., the tax years 2017 - 2019 remain open to examination by the Internal Revenue Service.

As of December 31, 2020, the Company had net operating loss carryforwards ("NOL") of approximately $35.0 million, a foreign tax credit of $64 thousand and a domestic research and development tax credit carryforward of approximately $1.3 million. Our federal NOL is expected to expire as follows if unused: $22 million in 2021 through 2022, $5.4 million in 2024 through 2025 and $0.5 million in 2027 and later. Our foreign NOL of $7.1 million does not have an expiration date.

The Company considered multiple factors in assessing the need for an increase in the partial valuation allowance against the Company’s deferred tax assets as of December 31, 2020. Significant factors such as employee stock compensation expenses from achievement of Company performance metrics, executive compensation limitations and required capitalization of research and development expenses beginning in 2022 have negatively impacted our future taxable income projections. These future projections indicate a larger portion of the Company’s deferred tax assets will likely expire unrealized. As a result, the Company recorded an additional $0.8 million tax effected increase to the current partial valuation allowance against the Company's worldwide net operating losses and tax credits for the year ended December 31, 2020. As of December 31, 2020, the Company had a deferred tax asset of approximately $10.1 million from net operating losses and tax credits and a net partial valuation allowance of approximately $6.4 million recorded against these deferred tax assets. The Company will continue to closely monitor the need for an additional valuation allowance against its deferred tax assets in each subsequent reporting period which can be impacted by actual operating results compared to the Company's forecast.

ASC Topic 740 prescribes the accounting for uncertainty in income taxes recognized in the financial statements in accordance with the other provisions contained within this guidance. This topic prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by the taxing authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50% likely or being realized upon ultimate audit settlement. In the normal course of business, the Company's tax returns are subject to examination by various taxing authorities. Such examination may result in future tax and interest assessments by these taxing authorities for uncertain tax positions taken in respect to certain matters.

The following provides a reconciliation of unrecognized tax benefits which are included in Other liabilities within the Consolidated Balance Sheets (in thousands):
Year Ended December 31,
20202019
Balance at beginning of period$— $— 
Acquired additions based on prior year tax positions
(1,072)— 
Reductions from lapse in statutes of limitations
358 — 
Currency Translation Adjustment$(94)— 
Balance at the end of period
$(808)$— 
The total amount of unrecognized tax benefits, which are included in other liabilities within the combined balance sheets as of December 31, 2020 was approximately $0.8 million, which may impact the effective tax rate if recognized. These unrecognized tax benefits were recognized as part of the acquisition of scil animal care company GmbH. Per the tax indemnification included in the purchase agreement, the seller has indemnified the Company for these other liabilities, which would reduce the economic impact to the Company if these positions were settled with tax authorities. It is expected that the amount of unrecognized tax benefits will change in the next 12 months; however, the Company does not expect the change to have a material impact on the combined financial statements. The Company recognizes interest and penalties related to uncertain tax positions in income tax (benefit)/expense. Interest and penalties accrued as of December 31, 2020 are $19.0 thousand.

As of December 31, 2020, the Company had accumulated undistributed earnings generated by foreign subsidiaries of approximately $2.9 million, which would be subject to U.S. taxes and foreign withholding taxes of approximately $145 thousand if repatriated. The Company had previously considered these earnings as a possible cash source through repatriation to the U.S. As of December 31, 2020, the Company has changed its assertion on these earnings and now considers them to be indefinitely reinvested and expects the future U.S. cash generation to be sufficient to meet future U.S. cash needs. If the Company decides to repatriate these foreign earnings, it would need to adjust its income tax provision in the period it determined that the earnings would no longer be indefinitely invested outside the United States.
XML 33 R13.htm IDEA: XBRL DOCUMENT v3.20.4
LEASES
12 Months Ended
Dec. 31, 2020
Leases [Abstract]  
LEASES LEASES
Lessee Accounting

The Company leases buildings, office equipment, and vehicles. The following table summarizes the Company's operating and finance lease balances (in thousands):

LeasesBalance Sheet LocationDecember 31, 2020December 31, 2019
Assets
OperatingOperating lease right-of-use assets$5,457 $5,726 
FinanceProperty and equipment, net1,907 81 
Total Leased Assets$7,364 $5,807 
Liabilities
OperatingOperating lease liabilities, current$2,087 $1,745 
Operating lease liabilities, non-current3,858 4,413 
FinanceDeferred revenue, current, and other295 47 
Other liabilities261 37 
Total Lease Liabilities$6,501 $6,242 

For the twelve months ended December 31, 2020, operating lease expense was approximately $2.8 million, including immaterial variable lease costs. For the twelve months ended December 31, 2019, operating lease expense was approximately $2.4 million, including immaterial variable lease costs. The Company had building and other rent expense of $1.9 million for the twelve months ended December 31, 2018 under ASC 840, Leases.
For the years ended December 31, 2020 and 2019, finance lease amortization expense was $0.3 million and $44 thousand, respectively. For the years ended December 31, 2020 and 2019, finance lease interest expense was $10 thousand and $3 thousand, respectively. The Company's finance leases were not material as of December 31, 2018 and for the twelve month period then ended.     


Supplemental cash flow information related to the Company's operating and finance leases for the years ended December 31, 2020 and 2019, respectively, was as follows (in thousands):
Twelve Months Ended
December 31,
20202019
Cash paid for amounts included in the measurement of lease liabilities:
    Operating cash outflows - operating leases$2,213 $1,800 
    Operating cash outflows - finance leases$10 $
    Financing cash outflows - finance leases$250 $36 
ROU assets obtained in exchange for new lease obligations:
    Operating leases$788 $604 
    Finance leases$159 $11 

The following table presents the weighted average remaining lease term and weighted average discount rate related to the Company's leases:

December 31,
20202019
Weighted average remaining lease term:
    Operating3.1 years3.8 years
    Finance2.9 years2.0 years
Weighted average discount rate:
    Operating4.2 %4.4 %
    Finance2.1 %4.0 %
The following table presents the maturity of the Company's lease liabilities as of December 31, 2020 (in thousands):

Year Ending December 31,Operating LeasesFinance Leases
2021$2,158 $294 
20221,834 139 
20231,949 59 
2024144 38 
2025138 26 
Thereafter132 18 
Total lease payments6,355 574 
Less: imputed interest410 18 
Total lease liabilities$5,945 $556 

Lessor Accounting
The Company enters into sales-type leases as part of our subscription agreements. The following table presents the maturity of the Company's lease receivables as of December 31, 2020 (in thousands):

Year Ending December 31,Sales-Type Leases
2021$4,834 
20224,872 
20234,220 
20243,291 
20252,033 
Thereafter1,424 
Total undiscounted future maturities20,674 
Less: interest91 
Total lease receivables$20,583 
The following table summarizes the profit recognized on the commencement date for sales-type leases and lease income for equipment-only operating leases (in thousands):


Twelve Months Ended
December 31,
20202019
Sales-type lease revenue$5,617 $6,890 
Sales-type lease cost of revenue3,951 5,099 
Profit recognized at commencement for sales-type leases$1,666 $1,791 
Operating lease income$1,012 $— 
LEASES LEASES
Lessee Accounting

The Company leases buildings, office equipment, and vehicles. The following table summarizes the Company's operating and finance lease balances (in thousands):

LeasesBalance Sheet LocationDecember 31, 2020December 31, 2019
Assets
OperatingOperating lease right-of-use assets$5,457 $5,726 
FinanceProperty and equipment, net1,907 81 
Total Leased Assets$7,364 $5,807 
Liabilities
OperatingOperating lease liabilities, current$2,087 $1,745 
Operating lease liabilities, non-current3,858 4,413 
FinanceDeferred revenue, current, and other295 47 
Other liabilities261 37 
Total Lease Liabilities$6,501 $6,242 

For the twelve months ended December 31, 2020, operating lease expense was approximately $2.8 million, including immaterial variable lease costs. For the twelve months ended December 31, 2019, operating lease expense was approximately $2.4 million, including immaterial variable lease costs. The Company had building and other rent expense of $1.9 million for the twelve months ended December 31, 2018 under ASC 840, Leases.
For the years ended December 31, 2020 and 2019, finance lease amortization expense was $0.3 million and $44 thousand, respectively. For the years ended December 31, 2020 and 2019, finance lease interest expense was $10 thousand and $3 thousand, respectively. The Company's finance leases were not material as of December 31, 2018 and for the twelve month period then ended.     


Supplemental cash flow information related to the Company's operating and finance leases for the years ended December 31, 2020 and 2019, respectively, was as follows (in thousands):
Twelve Months Ended
December 31,
20202019
Cash paid for amounts included in the measurement of lease liabilities:
    Operating cash outflows - operating leases$2,213 $1,800 
    Operating cash outflows - finance leases$10 $
    Financing cash outflows - finance leases$250 $36 
ROU assets obtained in exchange for new lease obligations:
    Operating leases$788 $604 
    Finance leases$159 $11 

The following table presents the weighted average remaining lease term and weighted average discount rate related to the Company's leases:

December 31,
20202019
Weighted average remaining lease term:
    Operating3.1 years3.8 years
    Finance2.9 years2.0 years
Weighted average discount rate:
    Operating4.2 %4.4 %
    Finance2.1 %4.0 %
The following table presents the maturity of the Company's lease liabilities as of December 31, 2020 (in thousands):

Year Ending December 31,Operating LeasesFinance Leases
2021$2,158 $294 
20221,834 139 
20231,949 59 
2024144 38 
2025138 26 
Thereafter132 18 
Total lease payments6,355 574 
Less: imputed interest410 18 
Total lease liabilities$5,945 $556 

Lessor Accounting
The Company enters into sales-type leases as part of our subscription agreements. The following table presents the maturity of the Company's lease receivables as of December 31, 2020 (in thousands):

Year Ending December 31,Sales-Type Leases
2021$4,834 
20224,872 
20234,220 
20243,291 
20252,033 
Thereafter1,424 
Total undiscounted future maturities20,674 
Less: interest91 
Total lease receivables$20,583 
The following table summarizes the profit recognized on the commencement date for sales-type leases and lease income for equipment-only operating leases (in thousands):


Twelve Months Ended
December 31,
20202019
Sales-type lease revenue$5,617 $6,890 
Sales-type lease cost of revenue3,951 5,099 
Profit recognized at commencement for sales-type leases$1,666 $1,791 
Operating lease income$1,012 $— 
XML 34 R14.htm IDEA: XBRL DOCUMENT v3.20.4
EARNINGS PER SHARE
12 Months Ended
Dec. 31, 2020
Earnings Per Share [Abstract]  
EARNINGS PER SHARE EARNINGS PER SHARE
Basic earnings per share ("EPS") is computed by dividing net income attributable to the Company by the weighted-average number of common shares outstanding during the period. The computation of diluted EPS is similar to the computation of basic EPS except that the numerator is increased to exclude charges that would not have been incurred, and the denominator is increased to include the number of additional common shares that would have been outstanding (using the if-converted and treasury stock methods), if securities containing potentially dilutive common shares (stock options and restricted stock awards but excluding options to purchase fractional shares resulting from the Company's December 2010 1-for-10 reverse stock split) had been converted to common shares, and if such assumed conversion is dilutive.
The following is a reconciliation of the weighted-average shares outstanding used in the calculation of basic and diluted earnings per share ("EPS") for the years ended December 31, 2020, 2019 and 2018 (in thousands, except per share data):

Years ended December 31,
202020192018
Net (loss) income attributable to Heska Corporation$(14,399)$(1,465)$5,850 
Basic weighted-average common shares outstanding8,653 7,446 7,220 
Assumed exercise of dilutive stock options and restricted shares— — 636 
Diluted weighted-average common shares outstanding8,653 7,446 7,856 
Basic (loss) earnings per share attributable to Heska Corporation$(1.66)$(0.20)$0.81 
Diluted (loss) earnings per share attributable to Heska Corporation$(1.66)$(0.20)$0.74 
The following potentially outstanding common shares from convertible preferred stock, convertible senior notes, stock options and restricted stock awards were excluded from the computation of diluted EPS because the effect would have been antidilutive (in thousands):

Years ended December 31,
202020192018
Convertible preferred stock458 — — 
Convertible senior notes118 — — 
Stock options and restricted shares328 300 111 
904 300 111 

As more fully described in Note 16, our Notes are convertible under certain circumstances, as defined in the indenture, into a combination of cash and shares of our common stock. The Company intends to settle the principal value of the Notes in cash and issue shares of our common stock to settle the intrinsic value of the conversion feature. The Company will use the treasury stock method when calculating the potential dilutive effect of the conversion feature on earnings per share, if any. Potential dilution upon conversion of the Notes occurs when the average market price per share of our common stock is greater than the conversion price of the Notes of $86.63. For the periods presented, all potentially dilutive shares relating to the Notes were not included in the computation of diluted EPS as the effect would have been antidilutive.
As discussed in Note 12, the Company issued and sold an aggregate of 122,000 shares of its Preferred Stock to certain investors in a private placement offering. The shares were converted into 1,508,964 shares of Public Common Stock, effective on April 21, 2020. The potential dilutive effect of the convertible preferred stock was calculated using the if-converted method for the period the preferred shares were outstanding. For the twelve months ended December 31, 2020, these shares were excluded from the computation of diluted EPS because the effect would have been antidilutive.
XML 35 R15.htm IDEA: XBRL DOCUMENT v3.20.4
GOODWILL AND OTHER INTANGIBLES
12 Months Ended
Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
GOOWILL AND OTHER INTANGIBLES GOODWILL AND OTHER INTANGIBLES
The following summarizes the changes in goodwill during the years ended December 31, 2020 and 2019 (in thousands):
North AmericaInternationalTotal
Carrying amount, December 31, 2018$25,724 $955 $26,679 
Goodwill attributable to acquisitions— 9,396 9,396 
Foreign currency adjustments— 129 129 
Carrying amount, December 31, 2019$25,724 $10,480 $36,204 
Goodwill attributable to acquisitions (subject to change)8,742 37,258 46,000 
Measurement period adjustment to prior year acquisition— 110 110 
Foreign currency adjustments948 5,014 5,962 
Carrying amount, December 31, 2020$35,414 $52,862 $88,276 

Other intangibles assets, net consisted of the following as of December 31, 2020 and 2019 (in thousands):

20202019
Gross Carrying AmountAccumulated AmortizationNet Carrying AmountGross Carrying AmountAccumulated AmortizationNet Carrying Amount
Intangible assets subject to amortization:
Customer relationships and other$46,989 $(6,436)$40,553 $6,205 $(2,226)$3,979 
Developed technology8,669 (1,696)6,973 8,200 (819)7,381 
Trade names197 (105)92 112 — 112 
Intangible assets not subject to amortization:
Trade names8,374 — 8,374 — — — 
Total intangible assets$64,229 $(8,237)$55,992 $14,517 $(3,045)$11,472 

Amortization expense relating to other intangibles is as follows (in thousands):

Years Ended December 31,
202020192018
Amortization expense$5,196 $1,278 $388 
    
The remaining weighted-average amortization period for intangible assets is approximately 8.7 years.
Estimated amortization expense related to intangibles for each of the five years from 2021 through 2025 and thereafter is as follows (in thousands):

Year Ending December 31,
2021$5,905 
20225,868 
20235,506 
20245,376 
20255,347 
Thereafter19,616 
Total amortization related to finite-lived intangible assets47,618 
Indefinite-lived intangible assets8,374 
Net intangible assets$55,992 
XML 36 R16.htm IDEA: XBRL DOCUMENT v3.20.4
PROPERTY AND EQUIPMENT
12 Months Ended
Dec. 31, 2020
Property, Plant and Equipment [Abstract]  
PROPERTY AND EQUIPMENT PROPERTY AND EQUIPMENT, NET
Property and equipment, net, consisted of the following (in thousands):
 December 31,
 20202019
Land$2,590 $694 
Building12,737 3,845 
Machinery and equipment40,411 28,777 
Office furniture and equipment2,047 1,345 
Computer hardware and software4,773 3,408 
Leasehold and building improvements10,728 10,558 
Construction in progress671 
Property and equipment, gross73,290 49,298 
Less accumulated depreciation(37,748)(33,829)
Total property and equipment, net$35,542 $15,469 
The Company has subscription agreements whereby its instruments in inventory may be placed at a customer's location on a rental basis. For instruments classified as operating leases, the cost of these instruments is transferred to machinery and equipment and depreciated, typically over a 5 to 7 year period depending on the circumstance under which the instrument is placed with the customer. Our cost of instruments under operating leases as of December 31, 2020 and 2019 was $13.6 million and $8.1 million, respectively, before accumulated depreciation of $4.7 million and $4.6 million, respectively.
Depreciation expense for property and equipment was $6.2 million, $3.6 million and $4.2 million for the years ended December 31, 2020, 2019 and 2018, respectively.
XML 37 R17.htm IDEA: XBRL DOCUMENT v3.20.4
INVENTORIES
12 Months Ended
Dec. 31, 2020
Inventory Disclosure [Abstract]  
INVENTORIES INVENTORIES
Inventories consisted of the following (in thousands):
December 31,
20202019
Raw materials$14,454 $14,597 
Work in process4,262 2,730 
Finished goods21,321 9,274 
Total inventories$40,037 $26,601 
Inventories are measured on a first-in, first-out basis and stated at lower of cost or net realizable value.
XML 38 R18.htm IDEA: XBRL DOCUMENT v3.20.4
ACCRUED LIABILITIES
12 Months Ended
Dec. 31, 2020
Payables and Accruals [Abstract]  
ACCRUED LIABILITIES ACCRUED LIABILITIES
Accrued liabilities consisted of the following (in thousands):
December 31,
20202019
Accrued payroll and employee benefits$7,949 $1,175 
Accrued property taxes659 681 
Accrued purchase orders1,549 739 
Accrued taxes3,731 586 
Other4,167 3,164 
Total accrued liabilities$18,055 $6,345 

Other accrued liabilities consist of items that are individually less than 5% of total current liabilities.
XML 39 R19.htm IDEA: XBRL DOCUMENT v3.20.4
CAPITAL STOCK
12 Months Ended
Dec. 31, 2020
Share-based Payment Arrangement [Abstract]  
CAPITAL STOCK CAPITAL STOCK
Stock Plans
We have two stock option plans which authorize granting of stock options, restricted stock awards and stock purchase rights to our employees, officers, directors and consultants. In 1997, the board of directors adopted the 1997 Stock Incentive Plan (the "1997 Plan"), which was later amended in December 2018 to be renamed the "Stock Incentive Plan." In May 2012, stockholders approved an amendment allowing for an increase of 250,000 shares and an annual increase through 2016 based on the number of non-employee directors serving as of our Annual Meeting of Stockholders, subject to a maximum of 45,000 shares per year. The plan was further amended in May 2016, May 2018, and April 2020 to increase the number of shares authorized for issuance by 500,000, 250,000, and 300,000 shares, respectively. In May 2003, the stockholders approved a new plan, the 2003 Equity Incentive Plan (the "2003 Plan"), which allows for the granting of stock options/restricted stock for up to 239,050 shares of the Company's common stock. The number of shares reserved for issuance under both plans as of December 31, 2020 was 151,605.
Stock Options
The stock options granted by the Board of Directors may be either incentive stock options ("ISOs") or non-qualified stock options ("NQs") and may include time-based vesting terms and/or be tied to Company and market-related performance metrics. The exercise price for options under all of the plans may be no less than
100% of the fair value of the underlying common stock. Options granted will expire no later than the tenth anniversary subsequent to the date of grant or three months following termination of employment, except in cases of death or disability, in which case the options will remain exercisable for up to twelve months. Under the terms of the Stock Incentive Plan, in the event we are sold or merged, outstanding options will either be assumed by the surviving corporation or vest immediately.
We use the Black-Scholes option-pricing model to estimate the fair value of time-vested and performance stock options granted, which includes four key inputs: expected term, expected volatility, risk-free interest rate and expected dividends. Our expected term is estimated based on historical exercise patterns. Our expected volatility input was estimated based on our historical stock price volatility. Our risk-free interest rate input was determined based on the U.S. Treasury yield curve at the time of option issuance. Our expected dividends inputs were zero in all periods as we did not anticipate paying dividends in the foreseeable future. For options tied to market performance, the fair value used in our expense recognition method is measured based on the number of shares granted, and a Monte Carlo simulation model, which incorporates the probability of the achievement of the market-related performance goals as part of the grant date fair value. We recognize forfeitures as they occur.

Time Vesting Stock Options
The fair value of each time vesting option grant was estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions:

 202020192018
Risk-free interest rate3.64%1.62%2.66%
Expected lives5.3 years4.7 years4.9 years
Expected volatility46%40%40%
Expected dividend yield0%0%0%

A summary of our time vesting stock option activity is as follows:

 Year Ended December 31,
 2020
  OptionsWeighted Average Exercise Price
Outstanding at beginning of period536,315 $54.86 
Granted at market83,250 $69.27 
Forfeited(42,307)$76.24 
Expired(28,691)$69.25 
Exercised(84,335)$40.64 
Outstanding at end of period464,232 $57.18 
Exercisable at end of period291,334 $46.53 

The total estimated fair value of time vesting stock options granted was computed to be approximately $2.4 million, $2.6 million and $4.4 million during the years ended December 31, 2020, 2019 and 2018, respectively. The amounts are amortized ratably over the vesting periods of the options. The weighted average estimated fair value of options granted was computed to be approximately $28.66, $29.89 and $28.81 during the years ended December 31, 2020, 2019 and 2018, respectively. The total intrinsic value of options
exercised was $5.0 million, $12.8 million and $10.5 million during the years ended December 31, 2020, 2019 and 2018, respectively. The cash proceeds from options exercised were $3.4 million, $1.0 million and $3.2 million during the years ended December 31, 2020, 2019 and 2018, respectively.
The following table summarizes information about time vesting stock options outstanding and exercisable at December 31, 2020.
Options OutstandingOptions Exercisable
Exercise PricesNumber of
Options
Outstanding
at
December 31,
2020
Weighted
Average
Remaining
Contractual
Life in Years
Weighted
Average
Outstanding
Price
Number of
Options
Exercisable
at
December 31,
2020
Weighted
Average
Remaining
Contractual
Life in Years
Weighted
Average
Exercise
Price
$6.23 - $12.7886,166 2.20$7.59 86,166 2.20$7.59 
$12.79 - $39.7663,197 4.57$30.11 63,197 4.57$30.11 
$39.77 - $60.9465,000 9.29$60.94 — 0$— 
$60.95 - $71.84120,666 7.59$70.21 71,334 7.47$70.03 
$71.85 - $108.25129,203 7.82$89.45 70,637 6.89$84.98 
$6.23 - $108.25464,232 6.48$57.18 291,334 5.14$46.53 
As of December 31, 2020, there was approximately $3.6 million of total unrecognized compensation cost related to outstanding stock options. That cost is expected to be recognized over a weighted-average period of 1.63 years with all cost to be recognized by the end of August 2023, assuming all options vest according to the vesting schedules in place at December 31, 2020. As of December 31, 2020, the aggregate intrinsic value of outstanding options was approximately $41.1 million and the aggregate intrinsic value of exercisable options was approximately $28.9 million.
Performance Stock Options
On April 16, 2020, the Company granted a total of 240,000 performance-based stock options all with an exercise price of $60.94. Of the options granted,10,000 are tied to market-related vesting conditions and 230,000 are tied to Company performance metrics, including future product launches, future sales targets, operating performance, and EBITDA. Performance and market conditions must be achieved by December 31, 2023 otherwise the stock options are forfeited. All vested but unexercised options will expire April 15, 2030.
During the year ended December 31, 2020, 20,000 of the performance-based stock options were forfeited, leaving a total of 220,000 options outstanding as of December 31, 2020. The outstanding options had a weighted-average exercise price of $60.94, a weighted-average remaining contractual term of 9.29 years, and an aggregate intrinsic value of approximately $18.6 million. No options were exercisable as of December 31, 2020. For the year ended December 31, 2020, the weighted-average estimated fair value of the options granted was computed to be approximately $25.04 and the total estimated fair value was approximately $6.0 million. As of December 31, 2020, there was approximately $2.4 million of total unrecognized compensation cost that is expected to be recognized over a weighted average period of 1.80 years.
As of December 31, 2020, we reviewed each of the underlying corporate performance targets and determined that approximately 80,000 shares were related to corporate performance targets in which we did not deem achievement probable. No compensation expense had been recorded at any period prior to December 31, 2020. The unrecognized compensation cost associated with the performance options not deemed probable, based on grant date fair value, is approximately $2.0 million. Any change in the probability determination could accelerate the recognition of this expense.
Restricted Stock Awards
We have granted unvested restricted stock awards (“restricted stock”) to management and directors pursuant to the Stock Incentive Plan. The restricted stock awards have varying vesting periods, but generally become fully vested between one and four years after the grant date, depending on the specific award, performance targets met for performance based awards granted to management, and vesting period for time based awards. Management performance based awards are granted at the target amount of shares that may be earned and are tied to future sales targets, operating performance, and/or EBITDA. We valued the restricted stock awards related to service and/or company performance targets based on grant date fair value and expense over the period when achievement of those conditions is deemed probable. For restricted stock awards related to market conditions, we utilize a Monte Carlo simulation model to estimate grant date fair value and expense over the requisite period. We recognize forfeitures as they occur.
The following table summarizes restricted stock transactions for the year ended December 31, 2020:

Restricted StockWeighted-Average Grant Date Fair Value Per Award
Non-vested as of December 31, 2019335,667 $74.29 
Granted69,823 $87.29 
Vested(46,140)$68.80 
Forfeited(67,830)$73.27 
Non-vested as of December 31, 2020291,520 $78.44 
The weighted average grant date fair value of awards granted during the year was $87.29, $74.93, and $71.77 for the years ended December 31, 2020, 2019 and 2018, respectively. Fair value of restricted stock vested was $5.0 million, $0.3 million, and $4.4 million for the years ended December 31, 2020, 2019 and 2018, respectively.
As of December 31, 2020, there was approximately $5.5 million of total unrecognized compensation cost related to restricted stock awards with probable Company performance targets, as well as market and time vesting conditions. The Company expects to recognize this expense over a weighted average period of 1.4 years. As of December 31, 2020, we reviewed each of the underlying corporate performance targets and determined that approximately 129,000 shares of common stock were related to corporate performance targets in which we did not deem achievement probable. No compensation expense had been recorded at any period prior to December 31, 2020. The unrecognized compensation cost associated with the restricted stock awards not deemed probable, based on grant date fair value, is approximately $10.6 million. Any change in the probability determination could accelerate the recognition of this expense.
Employee Stock Purchase Plan
Under the 2020 Employee Stock Purchase Plan (the "ESPP"), we are authorized to issue up to 200,000 shares of common stock to our employees, of which 3,859 had been issued as of December 31, 2020. The ESPP provides for the issuance of shares of our common stock to participating employees. At the end of each designated offering period, which occurs every six months on June 30 and December 31, employees can elect to purchase shares of our common stock with contributions of up to 10% of their base pay, accumulated via payroll deductions, at an amount equal to 85% of the lower of our stock price on (i) the first trading day of the offering period, or (ii) the last trading day of the offering period.
We issued 10,069, 10,698 and 10,078 shares under the ESPP for the years ended December 31, 2020, 2019 and 2018, respectively. The weighted-average fair value of the purchase rights granted was $16.19, $18.10 and $18.14 per share for the years ended December 31, 2020, 2019 and 2018, respectively.
Series X Convertible Preferred Stock
On March 30, 2020, the Company completed a private placement offering in which the Company issued and sold an aggregate of 122,000 shares of its Series X Convertible Preferred Stock, par value $0.01 per share (the "Preferred Stock"). The shares of Preferred Stock issued and sold were priced at $1,000 per share (the “Stated Value”), resulting in gross proceeds of $122.0 million, less issuance costs of $0.2 million. The Company used approximately $111.0 million of the proceeds from the offering to fund the April 1, 2020 acquisition of scil and plans to use the remaining proceeds for working capital and general corporate purposes.

The offering was made pursuant to the Securities Purchase Agreement (the “Securities Purchase Agreement”), dated as of January 12, 2020, by and among the Company and certain investors, and subsequent amendment (the “Securities Purchase Agreement Amendment”) to the Securities Purchase Agreement, entered into by the Company and each investor on March 30, 2020 (the Securities Purchase Agreement as amended by the Securities Purchase Agreement Amendment, the “Amended Securities Purchase Agreement”).

The shares of Preferred Stock were convertible into shares of the Company’s Common Stock at an initial ratio of approximately 12.4 shares of Common Stock for each share of Preferred Stock (equivalent to a conversion price of approximately $80.85 per share of common stock), at the option of the holders of the Preferred Stock or the Company, subject to the Company possessing sufficient unissued and otherwise unreserved shares of Common Stock under the Company’s Restated Certificate of Incorporation, as amended (the “Certificate of Incorporation”). On April 14, 2020, the Company gave notice of its exercise of its right to convert the 122,000 shares of Preferred Stock into 1,508,964 shares of Public Common Stock (the "Conversion Shares") and the conversion was effective on April 21, 2020. The conversion resulted in dilution of less than 20% of total shares of the Company’s Public Common Stock currently issued and outstanding. A registration statement on Form S-3 (File No. 333-238005) registering the Conversion Shares for resale was filed by us with the SEC on May 5, 2020.
XML 40 R20.htm IDEA: XBRL DOCUMENT v3.20.4
ACCUMULATED OTHER COMPREHENSIVE INCOME
12 Months Ended
Dec. 31, 2020
Equity [Abstract]  
ACCUMULATED OTHER COMPREHENSIVE INCOME ACCUMULATED OTHER COMPREHENSIVE INCOME
Accumulated other comprehensive income (loss) consisted of the following (in thousands):

Pension Adjustments
Foreign Currency Translation1
Foreign Currency Gain on Intra-Entity Transactions2
Total Accumulated Other Comprehensive Income
Balances at December 31, 2018$(419)$696 $— $277 
Other comprehensive income73 163 — 236 
Balances at December 31, 2019(346)859 — 513 
Other comprehensive (loss) income(40)5,013 8,683 13,656 
Balances at December 31, 2020$(386)$5,872 $8,683 $14,169 
1 Foreign currency gains and losses related to translation of foreign subsidiary financial statements.
2 The Company has intercompany loans of a long-term investment nature that are denominated in a foreign currency. These transactions are considered to be of a long-term nature if settlement is not planned or anticipated in the foreseeable future.
XML 41 R21.htm IDEA: XBRL DOCUMENT v3.20.4
COMMITMENTS AND CONTINGENCIES
12 Months Ended
Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES COMMITMENTS AND CONTINGENCIES
Warranties
The Company's current terms and conditions of sale include a limited warranty that its products and services will conform to published specifications at the time of shipment and a more extensive warranty related to certain products. The Company also sells a renewal warranty for certain of its products. The typical remedy for breach of warranty is to correct or replace any defective product, and if not possible or practical, the Company will accept the return of the defective product and refund the amount paid. Historically, the Company has incurred minimal warranty costs. The Company's warranty reserve was $0.5 million and $0.3 million as of December 31, 2020 and 2019.

Litigation
From time to time, the Company may be involved in litigation relating to claims arising out of its operations. The Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred, and the amount can be reasonably estimated.
On February 18, 2020, a former managing director of scil filed a claim disputing the effective date of the termination of his management service agreement and the validity of the Company´s waiver of his two-year post-contractual non-compete obligation. The Company intends to defend itself against the claim. Whether or not this will be successful depends on complex facts and circumstances. The Company is, based on the advice of its legal counsel, confident that it will be successful in evidencing the effective date of the termination of the management service agreement and as such, no accrual has been recorded for this ongoing litigation. Additionally, we are indemnified by the scil acquisition agreement for this claim.

On October 10, 2018, we reached an agreement in principle to settle the complaint that was filed against the Company by Shaun Fauley on March 12, 2015 in the U.S. District Court Northern District of Illinois (the "Court") alleging our transmittal of unauthorized faxes in violation of the federal Telephone Consumer Protection Act of 1991, as amended by the Junk Fax Prevention Act of 2005, as a class action (the "Fauley Complaint"). The settlement, which received the Court's approval on February 28, 2019 and was not
subsequently appealed by a class member, required us to make available a total of $6.8 million to pay class members, as well as to pay attorneys' fees and expenses to legal counsel to the class. The Company recorded the loss provision in the third quarter of 2018 in connection with the settlement agreement and does not have insurance coverage for the Fauley Complaint. The payment in respect of the settlement was made in full on April 3, 2019, and all activity related to the Fauley Complaint has ceased.
At December 31, 2020, the Company was not a party to any other legal proceedings that were expected, individually or in the aggregate, to have a material adverse effect on our business, financial condition or operating results.
Off-Balance Sheet Commitments
We have no off-balance sheet arrangements or variable interest entities.

Purchase Obligations

The Company has contractual obligations with suppliers for unconditional annual minimum inventory purchases in the amounts of $25.0 million as of December 31, 2020.
XML 42 R22.htm IDEA: XBRL DOCUMENT v3.20.4
INTEREST AND OTHER (INCOME) EXPENSE, NET
12 Months Ended
Dec. 31, 2020
Other Income and Expenses [Abstract]  
INTEREST AND OTHER (INCOME) EXPENSE, NET INTEREST AND OTHER EXPENSE (INCOME), NET
Interest and other expense (income), net, consisted of the following (in thousands):

 Year Ended December 31,
 202020192018
Interest income$(607)$(661)$(261)
Interest expense1
6,374 3,089 310 
Other (income) expense, net(166)482 (62)
Interest and other expense (income), net$5,601 $2,910 $(13)
1 Refer to Note 1. Summary of Significant Accounting Policies relating to an immaterial out of period error correction of non-cash interest identified and recorded during the fourth fiscal quarter of 2020.
Cash paid for interest was $3.2 million, $0.4 million and $0.2 million for the years ended December 31, 2020, 2019 and 2018, respectively.
XML 43 R23.htm IDEA: XBRL DOCUMENT v3.20.4
CREDIT FACILITY AND LONG-TERM DEBT
12 Months Ended
Dec. 31, 2020
Debt Disclosure [Abstract]  
CREDIT FACILITY AND LONG-TERM DEBT CONVERTIBLE NOTES
Convertible Notes

On September 17, 2019, the Company issued $86.25 million aggregate principal amount of 3.750% Convertible Senior Notes due 2026, which included the exercise in full of an $11.25 million purchase option, to certain financial institutions as the initial purchasers of the Notes (the "Initial Purchasers"). The Notes are senior unsecured obligations of the Company. The Notes were issued pursuant to an Indenture, dated September 17, 2019 (the “Indenture”), between the Company and U.S. Bank National Association, as trustee.

The net proceeds from the sale of the Notes were approximately $83.7 million after deducting the initial purchasers’ discounts and the offering expenses payable by the Company. The Company used approximately $12.8 million of the net proceeds from the Notes to repay all outstanding indebtedness on its
existing Credit Facility with JPMorgan Chase Bank, N.A., and an additional $2.0 million to fully fund a cash collateralized, letter of credit facility under a new Credit Facility. The Company subsequently terminated the Credit Facility with JPMorgan Chase Bank, N.A. on December 31, 2019. The Company expects to use the remainder of the net proceeds from the sale of the Notes to fund our intended expansion efforts, including through acquisitions of complementary businesses or technologies or other strategic transactions, and for working capital and other general corporate purposes.

The Notes are senior unsecured obligations of the Company and will rank senior in right of payment to any of our indebtedness that is expressly subordinated in right of payment to the Notes; equal in right of payment to any of our unsecured indebtedness that is not so subordinated; effectively junior in right of payment to any of our secured indebtedness to the extent of the value of assets securing such indebtedness; and structurally junior to all indebtedness and other liabilities (including trade payables) of our subsidiaries.

The Company pays interest on the Notes semiannually in arrears at a rate of 3.750% per annum on March 15 and September 15 of each year. The Notes are convertible based upon an initial conversion rate of 11.5434 shares of the Company’s common stock per $1,000 principal amount of Notes (equivalent to a conversion price of approximately $86.63 per share of common stock). The Notes would convert in full into 995,618 shares of common stock based on the initial conversion rate. The conversion rate will be subject to standard anti-dilution adjustments upon the occurrence of certain events but will not be adjusted for accrued and unpaid interest. The interest rate on the Notes may be increased by up to 0.50% upon the occurrence of certain events of default or non-timely filings until such matter has been cured.

The Indenture includes customary covenants, but no financial or operating covenants or restrictions on the payments of dividends, the incurrence of indebtedness or the issuance or repurchase of securities, and sets forth certain events of default and certain types of bankruptcy or insolvency events of default involving the Company after which the Notes become automatically due and payable. The Company can settle any conversions of the Notes in cash, shares of the Company’s common stock or a combination thereof, with the form of consideration determined at the Company’s election. The Company intends to settle the principal value of the Notes in cash and issue shares of the Company’s common stock to settle the intrinsic value of the conversion feature. There can be no guarantee, however, that any settlement will be affected by the Company as currently intended, and the timing and other factors of any settlement, many of which may be outside the Company's control, could impact the actual amounts to be settled in either cash or common stock.

The Notes will mature on September 15, 2026, unless earlier repurchased, redeemed or converted. Prior to March 15, 2026, holders may convert all or a portion of their Notes only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on December 31, 2019 (and only during such calendar quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the 5 business day period after any 5 consecutive trading day period (the "Notes measurement period") in which the trading price per $1,000 principal amount of Notes for each trading day of the Notes measurement period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate on each such trading day; (3) with respect to any Notes called for redemption by the Company, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or (4) upon the occurrence of specified corporate events. On and after March 15, 2026 until the close of business on the scheduled trading day immediately preceding the maturity date, holders may convert their Notes at any time, regardless of the foregoing circumstances. Holders of Notes who convert their Notes in connection with a notice of a redemption or a make-whole fundamental change (each as defined in the Indenture) may be entitled to a premium in the form of an increase in the conversion rate of the Notes.
The Company may not redeem the Notes prior to September 20, 2023. On or after September 20, 2023, the Company may redeem for cash all or part of the Notes if the last reported sale price of the Company’s common stock equals or exceeds 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of the redemption. The redemption price will be 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest, if any. No sinking fund is provided for the Notes.

Upon the occurrence of a fundamental change (as defined in the Indenture), holders may require the Company to repurchase all or a portion of their Notes for cash at a price equal to 100% of the principal amount of the Notes to be repurchased plus any accrued but unpaid interest to, but excluding, the fundamental change repurchase date.

In accounting for the issuance of the Notes, the Company separated the Notes into liability and equity components. The carrying amount of the liability component was calculated by measuring the fair value of a similar liability that does not have an associated convertible feature. The carrying amount of the equity component, representing the conversion option, which does not meet the criteria for separate accounting as a derivative as it is indexed to the Company's own stock, was determined by deducting the fair value of the liability component from the par value of the Notes. The difference between the principal amount of the Notes and the liability component represents the debt discount, which is recorded as a direct deduction from the related debt liability in the Consolidated Balance Sheet and amortized to interest expense using the effective interest method over the term of the Notes. The effective interest rate of the Notes is 15.3% per annum. The equity component of the Notes is approximately $39.5 million, net of allocated issuance costs of $1.5 million. This is included in additional paid-in capital in the Consolidated Balance Sheet, net of deferred tax impacts of $9.7 million, and is not remeasured as long as it continues to meet the conditions for equity classification. The Company allocated transaction costs related to the Notes using the same proportions as the proceeds from the Notes. Transaction costs attributable to the liability component were recorded as a direct deduction from the related debt liability in the Consolidated Balance Sheet and amortized to interest expense over the term of the Notes, and transaction costs attributable to the equity component were netted with the equity component in shareholders’ equity.

In addition, the Company determined that the additional interest that could be due to the holders of the Notes upon an event of default or non-timely filing represented an embedded derivative feature that should be bifurcated from the Notes. The Company concluded that the fair value of this embedded derivative feature was de minimis upon the issuance of the Notes and at December 31, 2020.

During the years ended December 31, 2020 and 2019, no portion of the Notes was converted and the liability component was classified as long-term debt on the Company's Consolidated Balance Sheet as of December 31, 2020.

The following table summarizes the net carrying amount of the Notes as of December 31, 2020 (in thousands):

December 31, 2020December 31, 2019
Principal amount of the Notes$86,250 $86,250 
Unamortized debt discount(37,791)(40,902)
Net carrying amount$48,459 $45,348 
Interest expense related to the Notes is comprised of the amortization of debt discount and debt issuance costs and the contractual coupon interest as follows (in thousands):

Twelve Months Ended December 31, 2020Twelve Months Ended December 31, 2019
Interest expense related to contractual coupon interest$3,234 $925 
Interest expense related to amortization of the debt discount1
3,111 1,744 
Total interest expense$6,345 $2,669 
1 Refer to Note 1. Summary of Significant Accounting Policies relating to an immaterial out of period error correction of non-cash interest identified and recorded during the fourth fiscal quarter of 2020.

As of December 31, 2020, the remaining period over which the unamortized discount will be amortized is 68.5 months.

The estimated fair value of the Notes was $156.9 million as of December 31, 2020, determined through consideration of quoted market prices in less active markets. The fair value measurement is classified as Level 2 in the fair value hierarchy, which is defined in ASC 820 as inputs other than quoted prices in active markets that are either directly or indirectly observable. Based on our closing stock price of $145.65 on December 31, 2020, the if-converted value exceeded the aggregate principal amount of the Notes by $58.8 million.
XML 44 R24.htm IDEA: XBRL DOCUMENT v3.20.4
CONVERTIBLE NOTE RECEIVABLE
12 Months Ended
Dec. 31, 2020
Debt Disclosure [Abstract]  
CONVERTIBLE NOTE RECEIVABLE CONVERTIBLE NOTE RECEIVABLE
The carrying value of the note receivable, included in Related party convertible note receivable, net on the Consolidated Balance Sheets, is as follows (in thousands):
December 31, 2020
Principal amount$6,650 
Unamortized discount(977)
Net carrying amount$5,673 

On December 9, 2020, our equity method investee (the “Investee”), issued a Convertible Promissory Note to the Company (the “Convertible Promissory Note”) with a principal amount of $6.65 million and a stated interest rate of 3.0% per annum that is payable monthly. The Convertible Promissory Note has a maturity date of December 9, 2023, or otherwise upon qualified redemption event or in the event of a default. Refer to Note 4 for additional information on our equity method investment.

The conversion of the Convertible Promissory Note is contingent upon certain events. Due to the convertible debt features included in the Convertible Promissory Note, it is not an equity security and is therefore not considered an additional investment in our equity method investee. The Company accounted for the transaction as a note receivable, included in Related party convertible note receivable, net on the Consolidated Balance Sheets. The note receivable will be measured at amortized cost, and evaluated for credit losses each reporting period. The Company determined that the redemption features described above met the definition of an embedded derivative that requires bifurcation from the note receivable host. The Company measured the redemption features at fair value, with the residual proceeds paid allocated to the note receivable host, creating a discount to the note receivable. The discount will be amortized over the contractual term of the Promissory Note using the effective interest method. The effective interest rate of the Convertible Promissory Note is 8.69%, and the amortization of the discount will be included as interest income within Interest and other expense (income), net on the Consolidated Statements of Income.
The fair value of the embedded derivative was $1.0 million at issuance and as of December 31, 2020, and is included in Related party convertible note receivable, net on our Consolidated Balance Sheets. The fair value of the derivative will be remeasured each reporting period, with the mark-to-market adjustment to be included in other expense (income) on the Consolidated Statements of Income.
XML 45 R25.htm IDEA: XBRL DOCUMENT v3.20.4
SEGMENT REPORTING
12 Months Ended
Dec. 31, 2020
Segment Reporting [Abstract]  
SEGMENT REPORTING SEGMENT REPORTING
On April 1, 2020, Heska completed the acquisition of scil. Following this acquisition, the Company restructured its operating segments based on how the Chief Operating Decision Maker (“CODM”) manages the business, allocates resources, makes operating decisions and evaluates operating performance. The CODM changed how he assesses performance and allocates resources based on geographic regions in order to better align with the global operations of the Company. Based on this change, the Company determined it has two reportable segments and revised prior comparative periods to conform to the current period segment presentation. The Company’s two segments are North America and International.
The North America segment is comprised of the Company's operations in the United States, Canada and Mexico and the International segment is comprised of geographies outside of North America, which are the Company's operations primarily in Australia, France, Germany, Italy, Malaysia, Spain and Switzerland. Certain expenses incurred at the Company’s headquarters located in the North America segment are allocated to each segment in a manner consistent with where the benefits from the expenses are derived. However, there
are certain corporate expenses included in the North America segment that we do not allocate. Such expenses include research and development, certain selling, marketing, general, and administrative costs that support the global organization. Sales and transfers between operating segments are accounted for at market-based transaction prices and are eliminated in consolidation. The Company's sales are determined by the country of origin where the sale occurred. For a description of Heska's previous operating segments, refer to Note 17 to the consolidated financial statements included in Part II. Item 8 of Heska's Annual Report on Form 10-K for the year ended December 31, 2019.

Our CODM continues to evaluate segment performance and allocate resources based on Revenue, Cost of Revenue, Gross Profit, Gross Margin and Operating Income. The CODM does not evaluate operating segments using asset information; however, we have included total asset information by segment below as there was a material change in total assets by segment as of December 31, 2020 due to the acquisition of scil.

Summarized financial information concerning the Company's reportable segments is shown in the following tables (in thousands):
Year Ended December 31, 2020North AmericaInternational
 
 
Total
Total revenue$131,066 $66,257 $197,323 
Cost of revenue70,163 45,870 116,033 
Gross profit60,903 20,387 81,290 
   Gross margin46%31%41%
Operating loss(4,977)(3,215)(8,192)
Income (loss) before income taxes(7,871)(5,922)(13,793)
Investments in unconsolidated affiliates6,704 — 6,704 
Total Assets238,550 161,289 399,839 
Net Assets156,931 130,122 287,053 
Capital Expenditures443 243 686 
Depreciation and Amortization4,735 6,650 11,385 

Year Ended December 31, 2019North AmericaInternational 
 
Total
Total revenue$115,423 $7,238 $122,661 
Cost of revenue63,089 5,123 68,212 
Gross profit52,334 2,115 54,449 
   Gross margin45%29%44%
Operating income (loss)1,426 (1,099)327 
Income (loss) before income taxes(1,343)(1,240)(2,583)
Investments in unconsolidated affiliates7,424 — 7,424 
Total Assets219,402 25,022 244,424 
Net Assets133,835 20,699 154,534 
Capital Expenditures1,005 39 1,044 
Depreciation and Amortization4,788 128 4,916 
Year Ended December 31, 2018North AmericaInternational 
 
Total
Total revenue$124,391 $3,055 $127,446 
Cost of revenue68,555 2,253 70,808 
Gross profit55,836 802 56,638 
   Gross margin45%26%44%
Operating income3,622 172 3,794 
Income before income taxes3,717 90 3,807 
Investments in unconsolidated affiliates8,018 — 8,018 
Total Assets152,663 3,789 156,452 
Net Assets118,770 3,639 122,409 
Capital Expenditures1,329 29 1,358 
Depreciation and Amortization4,586 4,595 

The Company measures its geographic revenue information based on the country of origin where the sale occurred. The geographic classification is independent of where the customer resides or where the customer is physically located while using the Company's product. Total revenue by principal geographic area was as follows (in thousands):
 For the Year Ended December 31,
 202020192018
United States$120,244 $113,485 $123,965 
Canada10,822 1,938 425 
Germany29,543 — — 
France12,615 3,473 — 
Spain12,995 759 — 
Italy5,850 — — 
Switzerland3,343 2,820 3,056 
Other International1,911 186 — 
Total$197,323 $122,661 $127,446 
Total long-lived assets by principal geographic areas were as follows (in thousands):
 As of December 31,
 202020192018
United States$11,805 $14,712 $15,933 
Canada643 — 11 
Germany14,630 — — 
France4,205 152 — 
Spain1,209 391 — 
Italy1,944 — — 
Switzerland46 33 37 
Other International1,060 181 — 
Total$35,542 $15,469 $15,981 
Revenue from Covetrus represented approximately 6%, 14% and 15% of our consolidated revenue for the years ended December 31, 2020, 2019 and 2018, respectively. Consolidated revenue from Covetrus attributable to our North America segment represented approximately 5%, 14% and 15%, respectively, whereas revenue from Covetrus attributable to our International segment represented 1% for 2020. Revenue from Merck entities, including Merck Animal Health, represented approximately 5%, 1% and 12% for the years ended December 31, 2020, 2019 and 2018, respectively, all included in our North America Segment. No other customer accounted for more than 10% of our consolidated revenue for the years ended December 31, 2020, 2019 or 2018.
XML 46 R26.htm IDEA: XBRL DOCUMENT v3.20.4
SUBSEQUENT EVENTS
12 Months Ended
Dec. 31, 2020
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS SUBSEQUENT EVENTS
Lacuna Diagnostics, Inc.
On February 1, 2021 the Company completed the acquisition of Lacuna Diagnostics, Inc. ("Lacuna"), a veterinary digital cytology company, to broaden the Company's point of care diagnostic offering. In exchange for all the outstanding shares of Lacuna, the Company paid total consideration of $4.3 million upon closing. The Company expects to account for this transaction as a business combination however, does not have that accounting complete as of the date of this filing due to the limited time that has passed since the date of transaction.
As additional consideration for the shares, the Company agreed to a contingent earn-out of an additional $2 million based on the achievement of certain performance metrics within a twelve month period ("Initial Earn Out Period"), reducing to $1 million if such metrics were met in a twelve month period subsequent to the Initial Earn Out Period.
Note Receivable
On February 1, 2021, one of our equity investees ("Investee"), for which we account for as a nonmarketable equity security, issued a Promissory Note to the Company (the “Promissory Note”) with a principal amount of $9.0 million and a stated interest rate of 10.0% per annum that is payable monthly. The Promissory Note has a maturity date of December 1, 2024. The Promissory Note provides for interest only payments through December 1, 2023. Beginning on January 1, 2024, the Promissory Note requires repayment of the principal and interest over twelve consecutive monthly payments. Additionally, the Investee issued a warrant to the Company to acquire securities. The warrant expires December 31, 2034. Refer to Note 4 for additional information on our equity investments.
XML 47 R27.htm IDEA: XBRL DOCUMENT v3.20.4
OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
12 Months Ended
Dec. 31, 2020
Accounting Policies [Abstract]  
Basis of Presentation and Consolidation
In the opinion of management, the accompanying Consolidated Financial Statements contain all adjustments, consisting of normal, recurring adjustments, necessary to present fairly the financial position of the Company as of December 31, 2020 and 2019, as well as the results of our operations, statements of stockholders' equity and cash flows for the twelve months ended December 31, 2020, 2019 and 2018.
The audited Consolidated Financial Statements included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Our audited Consolidated Financial Statements include our accounts and the accounts of our wholly-owned subsidiaries since their respective dates of acquisitions. All intercompany accounts and transactions have been eliminated in consolidation. Where our ownership of a subsidiary was less than 100%, the non-controlling interest is reported on our consolidated balance sheets. The non-controlling interest in our consolidated net income is reported as "Net loss attributable to non-controlling interest" on our Consolidated Statements of (Loss) Income. Our audited Consolidated Financial Statements are stated in U.S. Dollars and have been prepared in accordance with accounting principles generally accepted in the U.S. ("GAAP").
Beginning in the first quarter of 2020, to limit the spread of COVID-19, governments took various actions including the issuance of stay-at-home policies and social distancing procedures and guidelines, causing some businesses to adjust, reduce or suspend business and operating activities. Veterinary care is widely recognized as an "essential" service for pet owners, and veterinarians continued to deliver essential medical care for sick and injured pets. The stay-at-home policies deployed early in 2020 to combat the spread of COVID-19 resulted in a decrease in companion animal clinical visits, including delay of elective procedures and wellness visits and as a result lowers demand for diagnostic testing services. Beginning in the second quarter of 2020, certain local, state and federal governments began to ease the stay-at-home policies and allowed more businesses and facilities to re-open, leading to a recovery in companion animal clinical visits and associated demand for our diagnostic products. The extent to which the continuation, or a possible second-wave outbreak of COVID-19, or an outbreak of other health epidemics could impact our business, results of operations and financial condition, including the potential for write-offs or impairments of assets and suspension of capital investments, will depend on future developments. We are unable to predict with certainty the effects of the COVID-19 pandemic on our customers, suppliers and vendors, as well as the actions of governments, and when and to what extent normal economic and operating conditions can resume; these effects may differ from those assumed in our projected estimates. Even after the COVID-19 pandemic has subsided, we may continue to experience adverse impacts to our business as a result of any economic impact that has occurred or may occur in the future.
Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates are required when establishing the allowance for doubtful accounts and the net realizable value of inventory; determining future costs associated with warranties provided; determining the period over which our obligations are fulfilled under agreements to license product rights and/or technology rights; evaluating long-lived and intangible assets and investments for estimated useful lives and impairment; estimating the useful lives and standalone selling prices of instruments under leasing arrangements; determining the allocation of purchase price under purchase accounting; estimating the expense associated with the granting of stock; determining the need for, and the amount of a valuation allowance on deferred tax assets; determining the fair value of our embedded derivative; and determining the fair value of the liability component associated with the issuance of convertible debt. Our actual results may differ from these estimates and there may be changes to those estimates in future periods.
Concentration of Credit Risk
Financial instruments that potentially subject us to a concentration of credit risk consist of cash and cash equivalents and accounts receivable. We maintain the majority of our cash and cash equivalents with financial institutions that management believes are creditworthy in the form of demand deposits. We have no off-balance-sheet concentrations of credit risk such as foreign exchange contracts, options contracts or other foreign currency hedging arrangements. Our accounts receivable balances are due largely from distribution partners, domestic veterinary clinics and individual veterinarians and other animal health companies.

Covetrus represented 9% and 19% of our consolidated accounts receivable at December 31, 2020 and 2019, respectively. No other customer accounted for more than 10% of our consolidated accounts receivable at December 31, 2020 or 2019.
We have established an allowance for credit losses based upon factors surrounding the credit risk of specific customers, historical trends and other information.
Accounts Receivable and Allowance for Doubtful Accounts Accounts receivable are recorded net of an allowance for credit losses. From time to time, our customers are unable to meet their payment obligations. We continuously monitor our customers' credit worthiness and establish allowances for estimated credit losses related to our accounts receivable, net investment in leases, contract assets, and promissory notes. Our allowances are established based on factors surrounding the credit risk of specific customers, historical experience including collections and write-off history, and current economic conditions. Account balances are considered past due if payments have not been received within agreed upon invoice and/or contract terms and the Company may employ collection agencies and legal counsel to pursue recovery of defaulted amounts. Account balances are written off against the allowance after all collection efforts have been exhausted and it is probable the receivable will not be recovered. The Company also performs a qualitative assessment, on a quarterly basis, to monitor economic factors and other uncertainties that may require additional adjustments for the expected credit loss allowance. While such credit losses have historically been within our expectations and the provisions established, there is no assurance that we will continue to experience the same credit loss rates that we have in the past. A significant change in the liquidity or financial position of our customers could have a material adverse impact on the collectability of accounts receivable and our future operating results. The Company will continue to actively monitor the impact of the COVID-19 pandemic on expected credit losses. In 2020, the Company adopted Accounting Standards Update ("ASU") 2016-13, Financial Instruments - Credit Losses (Topic 326). See "Adoption of New Accounting Standards" below for impacts of adoption.
Cash and Cash Equivalents Cash and cash equivalents are stated at cost, which approximates market value, and include short-term, highly liquid investments with original maturities of less than three months.
Fair Value of Financial Instruments The Company's financial instruments consist of cash and cash equivalents, short-term trade receivables and payables, a long-term note receivable with an embedded derivative asset, and its 3.75% Convertible Senior Notes due 2026 (the "Notes"). The carrying values of cash and cash equivalents and short-term trade receivables and payables approximate fair value because of the short-term nature of the instruments.
Property and Equipment
Property and equipment is stated at cost, net of accumulated depreciation. The costs of additions and improvements are capitalized, while maintenance and repairs are charged to expense as incurred. When an item is sold or retired, the cost and related accumulated depreciation is relieved and the resulting gain or loss, if any, is recognized in the Consolidated Statements of (Loss) Income. We provide for depreciation primarily using the straight-line method by charges to income in amounts that allocate the cost of property and equipment over their estimated useful lives as follows:
Asset ClassificationEstimated
Useful Life
Building10 to 43 years
Machinery and equipment2 to 10 years
Office furniture and equipment3 to 7 years
Computer hardware and software3 to 7 years
Leasehold and building improvements5 to 15 years
We capitalize certain costs incurred in connection with developing or obtaining software designated for internal use based on three distinct stages of development. Qualifying costs incurred during the application development stage, which consist primarily of internal payroll and direct fringe benefits and external direct project costs, including labor and travel, are capitalized and amortized on a straight-line basis over the estimated useful life of the asset, which range from three to seven years. Costs incurred during the preliminary project and post-implementation and operation phases are expensed as incurred. These costs are general and administrative in nature and related primarily to the determination of performance requirements, data conversion and training.
Investments in Unconsolidated Affiliates Investments in unconsolidated affiliates are measured and recorded as either non-marketable equity securities or equity method investments. Non-marketable equity securities are equity securities without readily determinable fair value that are measured and recorded using a measurement alternative which measures the securities at cost minus impairment, if any, plus or minus changes from qualifying observable price changes. Equity method investments are equity securities in investees we do not control but over which we have the ability to exercise significant influence. When the equity method of accounting is determined to be appropriate, the initial measurement of the investment includes the cost of the investment and all direct transaction costs incurred to acquire the investment. Equity method investments are measured at cost minus impairment, if any, plus or minus our share of equity method investee income or loss, which is recorded as a separate line on the income statement. Both types of investments are evaluated for impairment if a triggering event occurs.
Goodwill, Intangible and Other Long-Lived Assets
Goodwill is initially valued based on the excess of the purchase price of a business combination over the fair value of acquired net assets recognized and represents the future economic benefits arising from other assets acquired that could not be individually identified and separately recognized. Intangible assets other than goodwill are initially valued at fair value. If a quoted price in an active market for the identical asset is not readily available at the measurement date, the fair value of the intangible asset is estimated based on discounted cash flows using market participant assumptions, which are assumptions that are not specific to the Company. The selection of appropriate valuation methodologies and the estimation of discounted cash flows require significant assumptions about the timing and amounts of future cash flows, risks, appropriate discount rates, and the useful lives of intangible assets. When material, we utilize independent valuation experts to advise and assist us in determining the fair values of the identified intangible assets acquired in connection with a business acquisition and in determining appropriate amortization methods and periods for those intangible assets.

We assess goodwill for impairment annually, at the reporting unit level, in the fourth quarter and whenever events or circumstances indicate impairment may exist. In evaluating goodwill for impairment, we have the option to first assess the qualitative factors to determine whether it is more-likely-than-not that the estimated fair value of the reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the comparison of the estimated fair value of the reporting unit to the carrying value. The more-likely-than-not threshold is defined as having a likelihood of more than 50 percent. If, after assessing the totality of events or circumstances, we determine that it is more-likely-than-not that the estimated fair value of a reporting is less than its carrying amount, we would then estimate the fair value of the reporting unit and compare it to the carrying value. If the carrying value exceeds the estimated fair value we would recognize an impairment for the difference; otherwise, no further impairment test would be required. In contrast, we can opt to bypass the qualitative assessment for any reporting unit in any period and proceed directly to quantitative analysis. Doing so does not preclude us from performing the qualitative assessment in any subsequent period. Following the acquisition of scil in April 2020, we restructured our operating segments based on how the Chief Operating Decision Maker (“CODM”) manages the business, allocates resources, makes operating decisions and evaluates operating performance. As further discussed in Note 18, our new reporting segments are North America and International. As a result of the change in operating segments, we also revised our reporting units to aggregate our legal entities based on similarities in economic characteristics. Our new reporting units consist of the following: (1) Heska Corporation and Heska Canada, (2) Diamond Animal Health, (3) scil animal care company GmbH, Optomed, CVM, and Heska Australia, and (4) Heska AG.
As a result of the recent global economic disruption and uncertainty due to the COVID-19 pandemic, the
Company performed a qualitative assessment during the first quarter of 2020. Based on the interim assessment performed, we concluded that there was no triggering event and additionally, no indications of impairment existed. We performed qualitative assessments in the fourth quarters of 2020, 2019, and 2018 and determined that no indications of impairment existed. We assess the realizability of intangible assets other than goodwill whenever events or changes in circumstances indicate that the carrying value may not be recoverable. If an impairment review is triggered, we evaluate the carrying value of intangible assets based on estimated undiscounted future cash flows over the remaining useful life of the primary asset of the asset group and compare that value to the carrying value of the asset group. The cash flows that are used contain our best estimates, using appropriate and customary assumptions and projections at the time. If the net carrying value of an intangible asset exceeds the related estimated undiscounted future cash flows, an impairment to adjust the intangible asset to its fair value would be reported as a non-cash charge to earnings. If necessary, we would calculate the fair value of an intangible asset using the present value of the estimated future cash flows to be generated by the intangible asset, and applying a risk-adjusted discount rate.
Revenue Recognition
We generate revenue through the sale of products, either by outright purchase by our customers or through a subscription agreement whereby our customers receive instruments and pay us a monthly fee for the consumables needed to conduct testing. Subscription placement is the majority of our Point of Care laboratory transactions while outright sales to customers are the majority of both Point of Care imaging diagnostic transactions and the sale of pharmaceuticals and vaccines.

For outright sales of products, revenue is recognized when control of the promised product or service is transferred to our customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products or services (the transaction price). Taxes assessed by governmental authorities and collected from the customer are excluded from our revenue recognition. A performance obligation is a promise in a contract to transfer a distinct product or service to a customer and is the unit of account under ASC 606. For instruments, consumables and most software licenses sold by the Company, control transfers to the customer at a point in time. To indicate the transfer of control, the Company must have a present right to payment, legal title must have passed to the customer, the customer must have the significant risks and rewards of ownership and where acceptance is not a formality, the customer must have accepted the product or service. Heska’s principal terms of sale are FOB Shipping Point, or equivalent, and, as such, we primarily transfer control and record revenue for product sales upon shipment. If a performance obligation to the customer with respect to a sales transaction remains unfulfilled following shipment (typically owed installation), revenue recognition for that performance obligation is deferred until such commitments have been fulfilled. For extended warranty and service plans, control transfers to the customer over the term of the arrangement and as such the revenue is recognized ratably based upon the period of time elapsed under the arrangement.

Our revenue under subscription agreements relates to operating-type lease ("OTL") arrangements or sales-type lease ("STL") arrangements. Determination of an OTL or STL is primarily determined as a result of the length of the contract as compared to the estimated useful life of the instrument, among other factors. Leases are outside of the scope of ASC 606 and are therefore accounted for in accordance with ASC 842, Leases. A STL would result in earlier recognition of instrument revenue as compared to an OTL, which is generally upon installation of the instruments. Instrument lease revenue for our OTL subscription agreements is recognized on a straight-line basis over the life of the lease and is included with the predominant non-lease components in consumables revenue. For instrument only OTL agreements, operating lease income is
recognized on a straight-line basis over the term of the lease. The cash collected under both arrangements is over the term of the contract. The OTLs and STLs are not cancellable until after an initial term. See below for additional information on our lease accounting policies.
For contracts with both lease and non-lease components, the Company allocates the contracts' transaction price for each component on a relative standalone selling price basis using our best estimate of the standalone selling price of each distinct product or service in the contract. When available, the method used to estimate the standalone selling price is the price observed in standalone sales to customers. When prices in standalone sales are not available, we use a cost-plus margin approach. Changes in these values can impact the amount of consideration allocated to each component of the contract. Allocation of the transaction price is determined at the contracts' inception. The Company does not adjust the transaction price for the effects of a significant financing component when the period between the transfer of the promised good or service to the customer and payment for that good or service by the customer is expected to be one year or less.

To the extent the transaction price includes variable consideration, such as future payments based on consumable usage over time, we apply judgment to determine if the variable consideration should be constrained. As the variable consideration is highly susceptible to factors outside of the Company’s influence, and the potential values contain a broad range of possible outcomes given all potential amounts of consumption that could occur, it is likely that a significant revenue reversal would occur should the variable consideration be estimated at an amount greater than the minimum stated amount until such a time as the uncertainty is resolved. For our subscription agreements with variable consideration based on consumable usage over time, the variable consideration is allocated to the non-lease components upon resolution of the uncertainty and is included in consumables revenue.

We generate OVP revenue through contract manufacturing agreements with customers. Revenue from these customer contracts is generally recognized upon shipment or acceptance by our customer, under the same guidelines noted above for other outright product sales. Heska assessed the over-time criteria within ASC 606 and concluded that while products within this segment have no alternative use to Heska, as Heska is contractually prohibited to redirect the product to other customers, Heska does not have right to payment for performance to date. Therefore, point in time revenue recognition has been determined to be appropriate.
Recording revenue from the sale of products involves the use of estimates and management's judgment. We must make a determination at the time of sale whether the customer has the ability and intent to make payments in accordance with arrangements. For contracts with multiple performance obligations, we exercise judgment in allocating the transaction price for each performance obligation based on an estimated standalone selling price for each distinct product or service. We do not generally allow return of products or instruments. Distributor rebates are recorded as a reduction to revenue.
Stock-Based Compensation Stock-based compensation expense is measured at the grant date based upon the estimated fair value of the portion of the award that is ultimately expected to vest and is recognized as expense over the applicable requisite service period of the award generally using the straight-line method.
Advertising Costs Advertising costs are expensed as incurred and are included in sales and marketing expenses.
Income Taxes The Company records a current provision for income taxes based on estimated amounts payable or refundable on tax returns filed or to be filed each year. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates, in each tax jurisdiction, expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date. The overall change in deferred tax assets and liabilities for the period measures the deferred tax expense or benefit for the period. Deferred tax assets are reduced by a valuation allowance based on a judgmental assessment of available evidence if the Company is unable to conclude that it is more likely than not that some or all of the deferred tax assets will be realized.
Earnings Per Share Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued.
Foreign Currency Translation The functional currency of certain foreign subsidiaries is the local currency. Accordingly, assets and liabilities of these subsidiaries are translated using the exchange rate in effect at the balance sheet date. Revenue and expense accounts and cash flows are translated using an average of exchange rates in effect during the period. Cumulative translation gains and losses are shown in the Consolidated Balance Sheets as a separate component of stockholders' equity. Exchange gains and losses arising from transactions denominated in foreign currencies (i.e., transaction gains and losses) are recognized as a component of other income (expense) in current operations, as are exchange gains and losses on intercompany transactions expected to be settled in the near term. Gains and losses arising from intercompany foreign currency transactions that are of a long-term investment nature are reported as a component of Accumulated other comprehensive income in the Consolidated Balance Sheets.
Warranty Costs The Company generally provides for the estimated cost of hardware and software warranties in the period the related revenue is recognized. The Company assesses the adequacy of its accrued warranty liabilities and adjusts the amounts as necessary based on actual experience and changes in future estimates. Should product failure rates differ from our estimates, actual costs could vary significantly from our expectations. Extended warranties are sold to our customers and revenue is recognized over the term of the warranty agreement, as expected costs are incurred.
Recent Accounting Pronouncements
Adoption of New Accounting Pronouncements
In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2016-13, Financial Instruments - Credit Losses (Topic 326), which requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected. The income statement reflects the measurement of credit losses for newly recognized financial assets, as well as the increases or decreases of expected credit losses that have taken place during the period. The measurement of expected credit losses is based upon historical experience, current conditions and reasonable and supportable forecasts that affect the collectability of the reported amount. Subsequent to the issuance of ASU 2016-13, the FASB issued ASU 2018-19, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, in November 2018. This ASU clarifies that receivables from operating leases are accounted for using the lease guidance and not as financial instruments. In April 2019, the FASB issued ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments, which further clarifies and improves guidance related to accounting for credit losses. In May 2019, the FASB issued ASU 2019-05, Financial Instruments - Credit Losses (Topic 326). This ASU provides relief to certain entities adopting ASU 2016-13. The amendment provides entities with an option to irrevocably elect the fair value option for certain financial assets. The Company adopted ASU 2016-13 with a cumulative-effect adjustment in retained earnings as of January 1, 2020. The impact of the adoption was not material to the Company's consolidated financial statements.
Accounting Pronouncements Not Yet Adopted    

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which is intended to simplify various aspects related to the accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740, and also clarifies and amends existing guidance to improve consistent application. This guidance will be effective for interim and annual periods beginning after December 15, 2020, and early adoption is permitted. We evaluated the impact of the standard on our consolidated financial statements and do not expect the standard to have a material impact on our consolidated financial statements and disclosures.

In January 2020, the FASB issued ASU 2020-01, Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815). The amendments in this ASU clarify the interaction between the accounting for investments in equity securities, investment in equity method and certain derivatives instruments. The ASU is expected to reduce diversity in practice and increase comparability of the accounting for these interactions. This guidance will be effective for fiscal years beginning after December 15, 2020. We evaluated the impact of the standard on our consolidated financial statements and do not expect the standard to have a material impact on our consolidated financial statements and disclosures.

In August 2020, the FASB issued ASU 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40), which simplifies the accounting for certain convertible instruments. The update reduces the number of accounting models for convertible debt instruments and convertible preferred stock. Convertible debt will be accounted for as a single liability measured at its amortized cost and convertible preferred stock will be accounted for as a single equity instrument measured at its historical cost, as long as no other features require bifurcation and recognition as derivatives. The update also requires the if-converted method to be used for convertible instruments and the effect of potential share settlement be included in the diluted earnings per share calculation when an instrument may be settled in cash or shares. The amendments in this update are effective for public business entities for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. The guidance may be early adopted for fiscal years beginning after December 15, 2020,
and interim periods within those fiscal years.

The Company has elected to early adopt ASU 2020-06 as of January 1, 2021. The Notes are a convertible instrument with a cash-conversion feature that is accounted for within the scope of ASC 470-20 and will be impacted by adopting ASU 2020-06. The Company has elected to apply the modified retrospective method wherein the Company will recognize a cumulative-effect adjustment to the opening balance of retained earnings (January 1, 2021). Further, the Company will not restate EPS in the prior periods. The Company calculated the cumulative-effect adjustment as of January 1, 2021 by comparing (i) the historical amortization schedule for the Notes through December 31, 2020 and (ii) an updated amortization schedule wherein the conversion feature within the Notes would not be separated as an equity component and subsequently recognized as non-cash interest expense under ASC 835-30. As a result of ASU 2020-06, while cash interest expense is not impacted, non-cash interest accretion is limited to the amortization of debt issuance costs under ASC 835-30. Therefore, the Company prepared its transition journal entries by (i) reversing the conversion feature amount recorded in APIC and (ii) reversing the difference in non-cash interest expense via retained earnings. The expected impact on retained earnings is $4.3 million.

In October 2020, the FASB issued ASU 2020-10, Codification Improvements, which updates various codification topics by clarifying or improving disclosure requirements to align with the SEC's regulations. This guidance will be effective for annual periods beginning after December 15, 2020, for public entities. The Company will adopt as of the reporting period beginning January 1, 2021. We evaluated the impact of the
standard on our consolidated financial statements and do not expect the standard to have a material impact on our consolidated financial statements and disclosures.
Reclassification, Comparability Adjustment To maintain consistency and comparability, certain amounts in the financial statements have been reclassified to conform to current year presentation.
Lessee, Leases
The Company acts as a lessee and a lessor. As a lessee, the Company leases buildings, office equipment, and vehicles. As a lessor, the Company enters into sales-type and operating leases as part of its subscription agreements.

The Company determines if an arrangement is a lease at inception based on whether control of an identified asset is transferred. For leases where the Company is the lessee, ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based
on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The lease terms used to calculate the ROU asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense while the expense for finance leases is recognized as amortization expense and interest expense. The Company has lease agreements which require payments for lease and non-lease components and has elected to account for these as a single lease component for our building and office equipment leases, but as separate components for our vehicle leases.

As a lessor, our subscription agreements relate to both OTL arrangements and STL arrangements. For a STL, instrument revenue is generally recorded upon installation of the instruments and the cost of the customer-leased instruments is removed from inventory and recognized in the Consolidated Statements of (Loss) Income. There is no residual value taken into consideration as it does not meet our capitalization requirements. For our OTL agreements that include both lease and non-lease components, revenue is recognized on a straight-line basis over the term of the lease and is included with the predominant non-lease components in consumables revenue. For instrument only OTL agreements, operating lease income is recognized on a straight-line basis over the term of the lease. For an OTL, the costs of customer-leased instruments are recorded within property and equipment in the accompanying Consolidated Balance Sheets and depreciated over the instrument’s estimated useful life. The depreciation expense is reflected in cost of revenue in the accompanying Consolidated Statements of (Loss) Income.

For leases that commenced before the January 1, 2019 effective date of ASC 842, the Company elected the permitted practical expedients to not reassess the following: (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) initial direct costs for any existing leases. The Company also elected to exclude leases with a term of 12 months or less from the recognized ROU assets and lease liabilities.
Lessor, Leases
The Company acts as a lessee and a lessor. As a lessee, the Company leases buildings, office equipment, and vehicles. As a lessor, the Company enters into sales-type and operating leases as part of its subscription agreements.

The Company determines if an arrangement is a lease at inception based on whether control of an identified asset is transferred. For leases where the Company is the lessee, ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based
on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The lease terms used to calculate the ROU asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense while the expense for finance leases is recognized as amortization expense and interest expense. The Company has lease agreements which require payments for lease and non-lease components and has elected to account for these as a single lease component for our building and office equipment leases, but as separate components for our vehicle leases.

As a lessor, our subscription agreements relate to both OTL arrangements and STL arrangements. For a STL, instrument revenue is generally recorded upon installation of the instruments and the cost of the customer-leased instruments is removed from inventory and recognized in the Consolidated Statements of (Loss) Income. There is no residual value taken into consideration as it does not meet our capitalization requirements. For our OTL agreements that include both lease and non-lease components, revenue is recognized on a straight-line basis over the term of the lease and is included with the predominant non-lease components in consumables revenue. For instrument only OTL agreements, operating lease income is recognized on a straight-line basis over the term of the lease. For an OTL, the costs of customer-leased instruments are recorded within property and equipment in the accompanying Consolidated Balance Sheets and depreciated over the instrument’s estimated useful life. The depreciation expense is reflected in cost of revenue in the accompanying Consolidated Statements of (Loss) Income.

For leases that commenced before the January 1, 2019 effective date of ASC 842, the Company elected the permitted practical expedients to not reassess the following: (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) initial direct costs for any existing leases. The Company also elected to exclude leases with a term of 12 months or less from the recognized ROU assets and lease liabilities.
XML 48 R28.htm IDEA: XBRL DOCUMENT v3.20.4
OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2020
Accounting Policies [Abstract]  
Changes in allowance for doubtful accounts
Changes in the allowance for credit losses are summarized as follows (in thousands):

Years Ended December 31,
202020192018
Balances at beginning of period$186 $245 $215 
Additions from acquisition90 — — 
Additions - charged to expense614 113 104 
Deductions - write offs, net of recoveries(121)(172)(74)
Balances at end of period$769 $186 $245 
Schedule of cash and cash equivalents The foreign cash balances are summarized as follows (denominated in foreign currency, in thousands):
As of December 31,
20202019
European Union Euros8,520 1,773 
Swiss Francs138 124 
Canadian Dollars2,993 88 
Australian Dollars159 54 
Malaysian Ringgit364 — 
Schedule of property and equipment We provide for depreciation primarily using the straight-line method by charges to income in amounts that allocate the cost of property and equipment over their estimated useful lives as follows:
Asset ClassificationEstimated
Useful Life
Building10 to 43 years
Machinery and equipment2 to 10 years
Office furniture and equipment3 to 7 years
Computer hardware and software3 to 7 years
Leasehold and building improvements5 to 15 years
Property and equipment, net, consisted of the following (in thousands):
 December 31,
 20202019
Land$2,590 $694 
Building12,737 3,845 
Machinery and equipment40,411 28,777 
Office furniture and equipment2,047 1,345 
Computer hardware and software4,773 3,408 
Leasehold and building improvements10,728 10,558 
Construction in progress671 
Property and equipment, gross73,290 49,298 
Less accumulated depreciation(37,748)(33,829)
Total property and equipment, net$35,542 $15,469 
XML 49 R29.htm IDEA: XBRL DOCUMENT v3.20.4
REVENUE (Tables)
12 Months Ended
Dec. 31, 2020
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue
The following table summarizes our segment revenue (in thousands):

Year Ended December 31,
202020192018
North America Revenue:
    POC Lab Instruments & Other$8,433 $6,556 $6,375 
    POC Sales-type leases5,230 6,890 5,888 
    POC Lab Consumables59,247 53,267 45,111 
    POC Imaging20,651 21,655 22,832 
    PVD19,810 10,965 25,663 
    OVP17,695 16,090 18,522 
    Total North America Revenue$131,066 $115,423 $124,391 
International Revenue:
    POC Lab Instruments & Other$6,383 $96 $— 
    POC Sales-type leases387 — — 
    POC Operating Leases1,012 — — 
    POC Lab Consumables32,354 323 — 
    POC Imaging22,537 3,998 — 
    PVD3,584 2,821 3,055 
    Total International Revenue$66,257 $7,238 $3,055 
Total Revenue$197,323 $122,661 $127,446 
Schedule of Timing of Revenue Expected to be Recognized As of December 31, 2020, the Company expects to recognize revenue as follows (in thousands):
Year Ending December 31,Revenue
2021$32,976 
202230,089 
202326,992 
202422,668 
202516,713 
Thereafter15,129 
$144,567 
XML 50 R30.htm IDEA: XBRL DOCUMENT v3.20.4
ACQUISITION AND RELATED PARTY ITEMS ACQUISITION AND RELATED PARTY ITEMS (Tables)
12 Months Ended
Dec. 31, 2020
Business Combinations and Related Party Disclosure [Abstract]  
Schedule of aggregate consideration and allocation of purchase price
The fair values allocated to CVM's assets and liabilities as of the acquisition date, as well as the purchase price, are reflected in the table below (in thousands):

Purchase PriceDecember 5, 2019
Consideration paid to former owners$14,420 
Cash and cash equivalents1,226 
Accounts receivable583 
Inventories1,621 
Other current assets1,186 
Property and equipment345 
Other intangible assets2,608 
Other non-current assets460 
    Total assets acquired8,029 
Accounts payable(94)
Accrued liabilities(471)
Current portion of deferred revenue, and other(54)
Deferred tax liability(683)
Other long-term borrowings(1,109)
Other liabilities(157)
    Net assets acqiured5,461 
Goodwill8,959 
Total fair value of consideration transferred$14,420 
Schedule of intangible assets acquired
Intangible assets acquired, amortization method and estimated useful life as of April 1, 2020, was as follows (dollars in thousands):

Useful LifeAmortization MethodFair Value
Customer relationships10 yearsStraight-line$36,272 
Internally developed software7 yearsStraight-line353
Backlog0.2 yearsStraight-line210
Non-compete agreements2 yearsStraight-line60
Trade name subject to amortization0.8 yearsStraight-line66
Trademarks and trade names not subject to amortizationn/aIndefinite7,556
Total intangible assets acquired$44,517 
Intangible assets acquired, amortization method and estimated useful life as of December 5, 2019, were as follows (dollars in thousands):
Useful LifeAmortization MethodFair Value
Customer relationships6 yearsStraight-line$2,440 
Trade name4 yearsStraight-line111 
Developed technologyn/aIndefinite57 
$2,608 
Business acquisition, pro forma information
The following tables present unaudited supplemental pro forma financial information as if the acquisition had occurred on January 1, 2019 (in thousands):
Year Ended December 31,
20202019
Revenue, net$215,874 $201,700 
Net (loss) income before equity in losses of unconsolidated affiliates$(14,848)$(2,159)
Net (loss) income attributable to Heska Corporation$(15,215)$(2,487)
The following table presents unaudited supplemental pro forma financial information as if the CVM acquisition had occurred on January 1, 2018 (in thousands):
Year Ended December 31,
20192018
Revenue, net$130,434 $135,344 
Net (loss) income before equity in losses of unconsolidated affiliates$(460)$6,042 
Net (loss) income attributable to Heska Corporation$(788)$5,970 
XML 51 R31.htm IDEA: XBRL DOCUMENT v3.20.4
INVESTMENTS IN UNCONSOLIDATED AFFILIATES (Tables)
12 Months Ended
Dec. 31, 2020
Equity Method Investments and Joint Ventures [Abstract]  
Carrying values of investments in unconsolidated entities
The carrying values of investments in unconsolidated affiliates, categorized by type of investment, is as follows (in thousands):
December 31, 2020December 31, 2019
Equity method investment$3,686 $4,406 
Non-marketable equity security investment3,018 3,018 
Investment in Unconsolidated Affiliates$6,704 $7,424 
XML 52 R32.htm IDEA: XBRL DOCUMENT v3.20.4
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2020
Income Tax Disclosure [Abstract]  
Schedule of components of income tax expense
The components of income before income taxes were as follows (in thousands):

 Year Ended December 31,
 202020192018
Domestic$(9,441)$(1,872)$3,602 
Foreign(4,352)(711)205 
 $(13,793)$(2,583)$3,807 
The components of the income tax expense (benefit) are as follows (in thousands):

 Year Ended December 31,
 202020192018
Current income tax expense:   
Federal$(24)$— $(115)
State339 189 192 
Foreign1,465 170 63 
Total current expense$1,780 $359 $140 
Deferred income tax (benefit) expense:   
Federal$369 $(1,610)$(1,877)
State289 (307)(378)
Foreign(2,199)112 — 
Total deferred (benefit) expense(1,541)(1,805)(2,255)
Total income tax expense (benefit)$239 $(1,446)$(2,115)
Temporary differences to the components of deferred tax assets
Temporary differences that give rise to the components of net deferred tax assets (liabilities) are as follows (in thousands):

 December 31,
 20202019
Inventory$2,993 $2,005 
Accrued compensation295 122 
Stock options2,322 1,858 
Research and development tax credit1,308 990 
Research and development expense2,571 1,417 
Deferred revenue1,441 2,052 
Property and equipment298 3,469 
Net operating loss carryforwards8,757 11,676 
Foreign tax credit carryforward64 64 
Sales-type leases1,324 (1,968)
Convertible debt equity component(8,691)(9,421)
Foreign intangible(11,311)(691)
Other(1,124)(179)
247 11,394 
Valuation allowance(6,409)(5,656)
Total net deferred tax assets (liabilities)$(6,162)$5,738 
Effective income tax rate
The Company's income tax (benefit) expense relating to income (loss) for the periods presented differs from the amounts that would result from applying the federal statutory rate to that income (loss) as follows:

Year Ended December 31,
202020192018
Statutory federal tax rate21 %21 %21 %
State income taxes, net of federal benefit(4)%%(8)%
Non-controlling interest in Optomed%(2)%— %
Foreign income inclusion(12)%— %— %
Non-temporary stock option benefit%48 %(50)%
Meals and entertainment permanent difference— %(2)%%
GILTI permanent difference— %%%
Other permanent differences%(1)%%
Foreign tax rate differences%%— %
Change in tax rate%(6)%— %
Change in valuation allowance(4)%(17)%— %
Other deferred differences(2)%(9)%(21)%
Transaction costs(6)%(6)%— %
Executive compensation limit(6)%(7)%— %
Research & development credit%20 %— %
Equity Investment(4)%— %— %
Change in uncertain tax benefits%— %— %
Other(1)%— %(1)%
Effective income tax rate(2)%56 %(56)%
Schedule of unrecognized tax benefits roll forward
The following provides a reconciliation of unrecognized tax benefits which are included in Other liabilities within the Consolidated Balance Sheets (in thousands):
Year Ended December 31,
20202019
Balance at beginning of period$— $— 
Acquired additions based on prior year tax positions
(1,072)— 
Reductions from lapse in statutes of limitations
358 — 
Currency Translation Adjustment$(94)— 
Balance at the end of period
$(808)$— 
XML 53 R33.htm IDEA: XBRL DOCUMENT v3.20.4
LEASES (Tables)
12 Months Ended
Dec. 31, 2020
Leases [Abstract]  
Assets and Liabilities, Lessee
The Company leases buildings, office equipment, and vehicles. The following table summarizes the Company's operating and finance lease balances (in thousands):

LeasesBalance Sheet LocationDecember 31, 2020December 31, 2019
Assets
OperatingOperating lease right-of-use assets$5,457 $5,726 
FinanceProperty and equipment, net1,907 81 
Total Leased Assets$7,364 $5,807 
Liabilities
OperatingOperating lease liabilities, current$2,087 $1,745 
Operating lease liabilities, non-current3,858 4,413 
FinanceDeferred revenue, current, and other295 47 
Other liabilities261 37 
Total Lease Liabilities$6,501 $6,242 
Lease, Cost
Supplemental cash flow information related to the Company's operating and finance leases for the years ended December 31, 2020 and 2019, respectively, was as follows (in thousands):
Twelve Months Ended
December 31,
20202019
Cash paid for amounts included in the measurement of lease liabilities:
    Operating cash outflows - operating leases$2,213 $1,800 
    Operating cash outflows - finance leases$10 $
    Financing cash outflows - finance leases$250 $36 
ROU assets obtained in exchange for new lease obligations:
    Operating leases$788 $604 
    Finance leases$159 $11 

The following table presents the weighted average remaining lease term and weighted average discount rate related to the Company's leases:

December 31,
20202019
Weighted average remaining lease term:
    Operating3.1 years3.8 years
    Finance2.9 years2.0 years
Weighted average discount rate:
    Operating4.2 %4.4 %
    Finance2.1 %4.0 %
Lessee, Operating Lease, Liability, Maturity
The following table presents the maturity of the Company's lease liabilities as of December 31, 2020 (in thousands):

Year Ending December 31,Operating LeasesFinance Leases
2021$2,158 $294 
20221,834 139 
20231,949 59 
2024144 38 
2025138 26 
Thereafter132 18 
Total lease payments6,355 574 
Less: imputed interest410 18 
Total lease liabilities$5,945 $556 
Lessor, Operating Lease, Payments to be Received, Maturity The following table presents the maturity of the Company's lease receivables as of December 31, 2020 (in thousands):
Year Ending December 31,Sales-Type Leases
2021$4,834 
20224,872 
20234,220 
20243,291 
20252,033 
Thereafter1,424 
Total undiscounted future maturities20,674 
Less: interest91 
Total lease receivables$20,583 
Sales-type Lease, Lease Income
The following table summarizes the profit recognized on the commencement date for sales-type leases and lease income for equipment-only operating leases (in thousands):


Twelve Months Ended
December 31,
20202019
Sales-type lease revenue$5,617 $6,890 
Sales-type lease cost of revenue3,951 5,099 
Profit recognized at commencement for sales-type leases$1,666 $1,791 
Operating lease income$1,012 $— 
XML 54 R34.htm IDEA: XBRL DOCUMENT v3.20.4
EARNINGS PER SHARE (Tables)
12 Months Ended
Dec. 31, 2020
Earnings Per Share [Abstract]  
Reconciliation of basic and diluted earnings per share
The following is a reconciliation of the weighted-average shares outstanding used in the calculation of basic and diluted earnings per share ("EPS") for the years ended December 31, 2020, 2019 and 2018 (in thousands, except per share data):

Years ended December 31,
202020192018
Net (loss) income attributable to Heska Corporation$(14,399)$(1,465)$5,850 
Basic weighted-average common shares outstanding8,653 7,446 7,220 
Assumed exercise of dilutive stock options and restricted shares— — 636 
Diluted weighted-average common shares outstanding8,653 7,446 7,856 
Basic (loss) earnings per share attributable to Heska Corporation$(1.66)$(0.20)$0.81 
Diluted (loss) earnings per share attributable to Heska Corporation$(1.66)$(0.20)$0.74 
Schedule of antidilutive securities excluded from computation of earnings per share
The following potentially outstanding common shares from convertible preferred stock, convertible senior notes, stock options and restricted stock awards were excluded from the computation of diluted EPS because the effect would have been antidilutive (in thousands):

Years ended December 31,
202020192018
Convertible preferred stock458 — — 
Convertible senior notes118 — — 
Stock options and restricted shares328 300 111 
904 300 111 
XML 55 R35.htm IDEA: XBRL DOCUMENT v3.20.4
GOODWILL AND OTHER INTANGIBLES (Tables)
12 Months Ended
Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of changes in goodwill
The following summarizes the changes in goodwill during the years ended December 31, 2020 and 2019 (in thousands):
North AmericaInternationalTotal
Carrying amount, December 31, 2018$25,724 $955 $26,679 
Goodwill attributable to acquisitions— 9,396 9,396 
Foreign currency adjustments— 129 129 
Carrying amount, December 31, 2019$25,724 $10,480 $36,204 
Goodwill attributable to acquisitions (subject to change)8,742 37,258 46,000 
Measurement period adjustment to prior year acquisition— 110 110 
Foreign currency adjustments948 5,014 5,962 
Carrying amount, December 31, 2020$35,414 $52,862 $88,276 
Schedule of other intangible assets
Other intangibles assets, net consisted of the following as of December 31, 2020 and 2019 (in thousands):

20202019
Gross Carrying AmountAccumulated AmortizationNet Carrying AmountGross Carrying AmountAccumulated AmortizationNet Carrying Amount
Intangible assets subject to amortization:
Customer relationships and other$46,989 $(6,436)$40,553 $6,205 $(2,226)$3,979 
Developed technology8,669 (1,696)6,973 8,200 (819)7,381 
Trade names197 (105)92 112 — 112 
Intangible assets not subject to amortization:
Trade names8,374 — 8,374 — — — 
Total intangible assets$64,229 $(8,237)$55,992 $14,517 $(3,045)$11,472 
Schedule of amortization expense on intangible assets
Amortization expense relating to other intangibles is as follows (in thousands):

Years Ended December 31,
202020192018
Amortization expense$5,196 $1,278 $388 
Schedule of estimated future amortization expense
Estimated amortization expense related to intangibles for each of the five years from 2021 through 2025 and thereafter is as follows (in thousands):

Year Ending December 31,
2021$5,905 
20225,868 
20235,506 
20245,376 
20255,347 
Thereafter19,616 
Total amortization related to finite-lived intangible assets47,618 
Indefinite-lived intangible assets8,374 
Net intangible assets$55,992 
XML 56 R36.htm IDEA: XBRL DOCUMENT v3.20.4
PROPERTY AND EQUIPMENT (Tables)
12 Months Ended
Dec. 31, 2020
Property, Plant and Equipment [Abstract]  
Schedule of property and equipment We provide for depreciation primarily using the straight-line method by charges to income in amounts that allocate the cost of property and equipment over their estimated useful lives as follows:
Asset ClassificationEstimated
Useful Life
Building10 to 43 years
Machinery and equipment2 to 10 years
Office furniture and equipment3 to 7 years
Computer hardware and software3 to 7 years
Leasehold and building improvements5 to 15 years
Property and equipment, net, consisted of the following (in thousands):
 December 31,
 20202019
Land$2,590 $694 
Building12,737 3,845 
Machinery and equipment40,411 28,777 
Office furniture and equipment2,047 1,345 
Computer hardware and software4,773 3,408 
Leasehold and building improvements10,728 10,558 
Construction in progress671 
Property and equipment, gross73,290 49,298 
Less accumulated depreciation(37,748)(33,829)
Total property and equipment, net$35,542 $15,469 
XML 57 R37.htm IDEA: XBRL DOCUMENT v3.20.4
INVENTORIES (Tables)
12 Months Ended
Dec. 31, 2020
Inventory Disclosure [Abstract]  
Schedule of inventory
Inventories consisted of the following (in thousands):
December 31,
20202019
Raw materials$14,454 $14,597 
Work in process4,262 2,730 
Finished goods21,321 9,274 
Total inventories$40,037 $26,601 
XML 58 R38.htm IDEA: XBRL DOCUMENT v3.20.4
ACCRUED LIABILITIES (Tables)
12 Months Ended
Dec. 31, 2020
Payables and Accruals [Abstract]  
Schedule of accrued liabilities
Accrued liabilities consisted of the following (in thousands):
December 31,
20202019
Accrued payroll and employee benefits$7,949 $1,175 
Accrued property taxes659 681 
Accrued purchase orders1,549 739 
Accrued taxes3,731 586 
Other4,167 3,164 
Total accrued liabilities$18,055 $6,345 
XML 59 R39.htm IDEA: XBRL DOCUMENT v3.20.4
CAPITAL STOCK (Tables)
12 Months Ended
Dec. 31, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of weighted average valuation assumptions
 202020192018
Risk-free interest rate3.64%1.62%2.66%
Expected lives5.3 years4.7 years4.9 years
Expected volatility46%40%40%
Expected dividend yield0%0%0%
Schedule of stock options plans
A summary of our time vesting stock option activity is as follows:

 Year Ended December 31,
 2020
  OptionsWeighted Average Exercise Price
Outstanding at beginning of period536,315 $54.86 
Granted at market83,250 $69.27 
Forfeited(42,307)$76.24 
Expired(28,691)$69.25 
Exercised(84,335)$40.64 
Outstanding at end of period464,232 $57.18 
Exercisable at end of period291,334 $46.53 
Schedule of shares authorized under stock options plans by exercise price range
The following table summarizes information about time vesting stock options outstanding and exercisable at December 31, 2020.
Options OutstandingOptions Exercisable
Exercise PricesNumber of
Options
Outstanding
at
December 31,
2020
Weighted
Average
Remaining
Contractual
Life in Years
Weighted
Average
Outstanding
Price
Number of
Options
Exercisable
at
December 31,
2020
Weighted
Average
Remaining
Contractual
Life in Years
Weighted
Average
Exercise
Price
$6.23 - $12.7886,166 2.20$7.59 86,166 2.20$7.59 
$12.79 - $39.7663,197 4.57$30.11 63,197 4.57$30.11 
$39.77 - $60.9465,000 9.29$60.94 — 0$— 
$60.95 - $71.84120,666 7.59$70.21 71,334 7.47$70.03 
$71.85 - $108.25129,203 7.82$89.45 70,637 6.89$84.98 
$6.23 - $108.25464,232 6.48$57.18 291,334 5.14$46.53 
Schedule of restricted stock transactions
The following table summarizes restricted stock transactions for the year ended December 31, 2020:

Restricted StockWeighted-Average Grant Date Fair Value Per Award
Non-vested as of December 31, 2019335,667 $74.29 
Granted69,823 $87.29 
Vested(46,140)$68.80 
Forfeited(67,830)$73.27 
Non-vested as of December 31, 2020291,520 $78.44 
XML 60 R40.htm IDEA: XBRL DOCUMENT v3.20.4
ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)
12 Months Ended
Dec. 31, 2020
Equity [Abstract]  
Schedule of accumulated other comprehensive income (loss)
Accumulated other comprehensive income (loss) consisted of the following (in thousands):

Pension Adjustments
Foreign Currency Translation1
Foreign Currency Gain on Intra-Entity Transactions2
Total Accumulated Other Comprehensive Income
Balances at December 31, 2018$(419)$696 $— $277 
Other comprehensive income73 163 — 236 
Balances at December 31, 2019(346)859 — 513 
Other comprehensive (loss) income(40)5,013 8,683 13,656 
Balances at December 31, 2020$(386)$5,872 $8,683 $14,169 
XML 61 R41.htm IDEA: XBRL DOCUMENT v3.20.4
INTEREST AND OTHER (INCOME) EXPENSE, NET (Tables)
12 Months Ended
Dec. 31, 2020
Other Income and Expenses [Abstract]  
Schedule of interest expense (income) and other income, net
Interest and other expense (income), net, consisted of the following (in thousands):

 Year Ended December 31,
 202020192018
Interest income$(607)$(661)$(261)
Interest expense1
6,374 3,089 310 
Other (income) expense, net(166)482 (62)
Interest and other expense (income), net$5,601 $2,910 $(13)
XML 62 R42.htm IDEA: XBRL DOCUMENT v3.20.4
CREDIT FACILITY AND LONG-TERM DEBT CREDIT FACILITY AND LONG-TERM DEBT (Tables)
12 Months Ended
Dec. 31, 2020
Debt Disclosure [Abstract]  
Convertible Debt
The following table summarizes the net carrying amount of the Notes as of December 31, 2020 (in thousands):

December 31, 2020December 31, 2019
Principal amount of the Notes$86,250 $86,250 
Unamortized debt discount(37,791)(40,902)
Net carrying amount$48,459 $45,348 
XML 63 R43.htm IDEA: XBRL DOCUMENT v3.20.4
CONVERTIBLE NOTE RECEIVABLE (Tables)
12 Months Ended
Dec. 31, 2020
Debt Disclosure [Abstract]  
Schedule of Related Party Transactions
The carrying value of the note receivable, included in Related party convertible note receivable, net on the Consolidated Balance Sheets, is as follows (in thousands):
December 31, 2020
Principal amount$6,650 
Unamortized discount(977)
Net carrying amount$5,673 
XML 64 R44.htm IDEA: XBRL DOCUMENT v3.20.4
SEGMENT REPORTING (Tables)
12 Months Ended
Dec. 31, 2020
Segment Reporting [Abstract]  
Reconciliation of other significant reconciling items from segments to consolidated
Summarized financial information concerning the Company's reportable segments is shown in the following tables (in thousands):
Year Ended December 31, 2020North AmericaInternational
 
 
Total
Total revenue$131,066 $66,257 $197,323 
Cost of revenue70,163 45,870 116,033 
Gross profit60,903 20,387 81,290 
   Gross margin46%31%41%
Operating loss(4,977)(3,215)(8,192)
Income (loss) before income taxes(7,871)(5,922)(13,793)
Investments in unconsolidated affiliates6,704 — 6,704 
Total Assets238,550 161,289 399,839 
Net Assets156,931 130,122 287,053 
Capital Expenditures443 243 686 
Depreciation and Amortization4,735 6,650 11,385 

Year Ended December 31, 2019North AmericaInternational 
 
Total
Total revenue$115,423 $7,238 $122,661 
Cost of revenue63,089 5,123 68,212 
Gross profit52,334 2,115 54,449 
   Gross margin45%29%44%
Operating income (loss)1,426 (1,099)327 
Income (loss) before income taxes(1,343)(1,240)(2,583)
Investments in unconsolidated affiliates7,424 — 7,424 
Total Assets219,402 25,022 244,424 
Net Assets133,835 20,699 154,534 
Capital Expenditures1,005 39 1,044 
Depreciation and Amortization4,788 128 4,916 
Year Ended December 31, 2018North AmericaInternational 
 
Total
Total revenue$124,391 $3,055 $127,446 
Cost of revenue68,555 2,253 70,808 
Gross profit55,836 802 56,638 
   Gross margin45%26%44%
Operating income3,622 172 3,794 
Income before income taxes3,717 90 3,807 
Investments in unconsolidated affiliates8,018 — 8,018 
Total Assets152,663 3,789 156,452 
Net Assets118,770 3,639 122,409 
Capital Expenditures1,329 29 1,358 
Depreciation and Amortization4,586 4,595 
Schedule of revenue from external customers and long-lived assets, by geographical areas Total revenue by principal geographic area was as follows (in thousands):
 For the Year Ended December 31,
 202020192018
United States$120,244 $113,485 $123,965 
Canada10,822 1,938 425 
Germany29,543 — — 
France12,615 3,473 — 
Spain12,995 759 — 
Italy5,850 — — 
Switzerland3,343 2,820 3,056 
Other International1,911 186 — 
Total$197,323 $122,661 $127,446 
Total long-lived assets by principal geographic areas were as follows (in thousands):
 As of December 31,
 202020192018
United States$11,805 $14,712 $15,933 
Canada643 — 11 
Germany14,630 — — 
France4,205 152 — 
Spain1,209 391 — 
Italy1,944 — — 
Switzerland46 33 37 
Other International1,060 181 — 
Total$35,542 $15,469 $15,981 
XML 65 R45.htm IDEA: XBRL DOCUMENT v3.20.4
OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)
€ in Thousands, SFr in Thousands, RM in Thousands, $ in Thousands, $ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2020
USD ($)
Sep. 30, 2020
USD ($)
Jun. 30, 2020
USD ($)
Mar. 31, 2020
USD ($)
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Jan. 01, 2021
USD ($)
Dec. 31, 2020
EUR (€)
Dec. 31, 2020
CHF (SFr)
Dec. 31, 2020
CAD ($)
Dec. 31, 2020
AUD ($)
Dec. 31, 2020
MYR (RM)
Dec. 31, 2019
EUR (€)
Dec. 31, 2019
CHF (SFr)
Dec. 31, 2019
CAD ($)
Dec. 31, 2019
AUD ($)
Dec. 31, 2019
MYR (RM)
Dec. 31, 2017
USD ($)
Allowance for Doubtful Accounts Receivable [Roll Forward]                                      
Balances at beginning of period       $ 186,000 $ 186,000 $ 245,000 $ 215,000                        
Additions from acquisition         90,000 0 0                        
Additions - charged to expense         614,000 113,000 104,000                        
Deductions - write offs, net of recoveries         (121,000) (172,000) (74,000)                        
Balances at end of period $ 769,000       769,000 186,000 245,000                        
Cash and cash equivalents 86,334,000       86,334,000 89,030,000 13,389,000   € 8,520 SFr 138 $ 2,993 $ 159 RM 364 € 1,773 SFr 124 $ 88 $ 54 RM 0 $ 9,659,000
Impairment of intangible assets (excluding goodwill)         0 0 0                        
Advertising expense         400,000 300,000 200,000                        
Operating lease right-of-use assets 5,457,000       5,457,000 5,726,000                          
Operating lease liability 5,945,000       5,945,000                            
Interest expense         6,374,000 3,089,000 310,000                        
Deferred tax liability 11,856,000       11,856,000 691,000                          
Income tax expense (benefit)         239,000 (1,446,000) (2,115,000)                        
Stockholders' equity 287,053,000       287,053,000 154,364,000 122,409,000                       100,440,000
Cumulative Effect, Period of Adoption, Adjustment                                      
Allowance for Doubtful Accounts Receivable [Roll Forward]                                      
Stockholders' equity           (18,000)                         2,634,000
Revision of Prior Period, Error Correction, Adjustment | Noncash Debt Interest Expense Calculation                                      
Allowance for Doubtful Accounts Receivable [Roll Forward]                                      
Interest expense (2,500,000) $ 500,000 $ 600,000 600,000   700,000                          
Convertible notes (2,500,000) 2,500,000 2,000,000.0 1,400,000 (2,500,000) 700,000                          
Deferred tax liability (600,000) $ 600,000 $ 400,000 $ 300,000 (600,000) 200,000                          
Income tax expense (benefit) 600,000                                    
    Accumulated Deficit                                      
Allowance for Doubtful Accounts Receivable [Roll Forward]                                      
Stockholders' equity $ (150,861,000)       $ (150,861,000) (136,444,000) $ (134,979,000)                       (143,463,000)
    Accumulated Deficit | Cumulative Effect, Period of Adoption, Adjustment                                      
Allowance for Doubtful Accounts Receivable [Roll Forward]                                      
Stockholders' equity           $ (18,000)                         $ 2,634,000
    Accumulated Deficit | ASU 2020-06 | Cumulative Effect, Period of Adoption, Adjustment | Subsequent Event                                      
Allowance for Doubtful Accounts Receivable [Roll Forward]                                      
Stockholders' equity               $ 4,300,000                      
Building | Minimum                                      
Allowance for Doubtful Accounts Receivable [Roll Forward]                                      
Property plant and equipment, useful life         10 years                            
Building | Maximum                                      
Allowance for Doubtful Accounts Receivable [Roll Forward]                                      
Property plant and equipment, useful life         43 years                            
Machinery and equipment | Minimum                                      
Allowance for Doubtful Accounts Receivable [Roll Forward]                                      
Property plant and equipment, useful life         2 years                            
Machinery and equipment | Maximum                                      
Allowance for Doubtful Accounts Receivable [Roll Forward]                                      
Property plant and equipment, useful life         10 years                            
Office furniture & equipment | Minimum                                      
Allowance for Doubtful Accounts Receivable [Roll Forward]                                      
Property plant and equipment, useful life         3 years                            
Office furniture & equipment | Maximum                                      
Allowance for Doubtful Accounts Receivable [Roll Forward]                                      
Property plant and equipment, useful life         7 years                            
Computer hardware & software | Minimum                                      
Allowance for Doubtful Accounts Receivable [Roll Forward]                                      
Property plant and equipment, useful life         3 years                            
Computer hardware & software | Maximum                                      
Allowance for Doubtful Accounts Receivable [Roll Forward]                                      
Property plant and equipment, useful life         5 years                            
Leasehold and building improvements | Minimum                                      
Allowance for Doubtful Accounts Receivable [Roll Forward]                                      
Property plant and equipment, useful life         5 years                            
Leasehold and building improvements | Maximum                                      
Allowance for Doubtful Accounts Receivable [Roll Forward]                                      
Property plant and equipment, useful life         15 years                            
Software Development | Minimum                                      
Allowance for Doubtful Accounts Receivable [Roll Forward]                                      
Property plant and equipment, useful life         3 years                            
Software Development | Maximum                                      
Allowance for Doubtful Accounts Receivable [Roll Forward]                                      
Property plant and equipment, useful life         7 years                            
Customer Concentration Risk | Accounts Receivable | Henry Schein                                      
Property, Plant and Equipment [Line Items]                                      
Concentration risk, percentage         9.00% 19.00%                          
XML 66 R46.htm IDEA: XBRL DOCUMENT v3.20.4
REVENUE (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2020
USD ($)
segment
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Number of reportable segments | segment 2    
Revenue, net $ 197,323 $ 122,661 $ 127,446
Contract receivables, current 1,200 1,100  
Contract receivables, noncurrent 4,100 3,700  
Current portion of deferred revenue, and other 8,900 8,700  
Contract liabilities, revenue recognized 4,200 3,100  
Contract liabilities, increase due to additional deferred sales $ 3,800 2,200  
Contract cost average term 6 years    
Capitalized contract costs $ 3,000 2,700  
Capitalized contract costs, amortization 1,000 900  
Capitalized contract costs during the period 1,200 1,100  
North America Segment | Operating Segments      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Revenue, net 131,066 115,423 124,391
International Segment | Operating Segments      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Revenue, net 66,257 7,238 3,055
POC Lab Instruments & Other | North America Segment | Operating Segments      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Revenue, net 8,433 6,556 6,375
POC Lab Instruments & Other | International Segment | Operating Segments      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Revenue, net 6,383 96 0
POC Sales-type leases | North America Segment | Operating Segments      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Revenue, net 5,230 6,890 5,888
POC Sales-type leases | International Segment | Operating Segments      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Revenue, net 387 0 0
POC Operating Leases | International Segment | Operating Segments      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Revenue, net 1,012 0 0
POC Lab Consumables | North America Segment | Operating Segments      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Revenue, net 59,247 53,267 45,111
POC Lab Consumables | International Segment | Operating Segments      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Revenue, net 32,354 323 0
POC Imaging | North America Segment | Operating Segments      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Revenue, net 20,651 21,655 22,832
POC Imaging | International Segment | Operating Segments      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Revenue, net 22,537 3,998 0
PVD | North America Segment | Operating Segments      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Revenue, net 19,810 10,965 25,663
PVD | International Segment | Operating Segments      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Revenue, net 3,584 2,821 3,055
OVP | North America Segment | Operating Segments      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Revenue, net 17,695 16,090 18,522
OVP | International Segment | Operating Segments      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Revenue, net $ 66,257 $ 7,238 $ 3,055
XML 67 R47.htm IDEA: XBRL DOCUMENT v3.20.4
REVENUE - Performance Obligations (Details)
$ in Thousands
Dec. 31, 2020
USD ($)
Revenue from Contract with Customer [Abstract]  
Remaining performance obligation $ 144,567
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-01-01  
Revenue from Contract with Customer [Abstract]  
Remaining performance obligation $ 32,976
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Expected timing of satisfaction 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01  
Revenue from Contract with Customer [Abstract]  
Remaining performance obligation $ 30,089
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Expected timing of satisfaction 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01  
Revenue from Contract with Customer [Abstract]  
Remaining performance obligation $ 26,992
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Expected timing of satisfaction 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01  
Revenue from Contract with Customer [Abstract]  
Remaining performance obligation $ 22,668
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Expected timing of satisfaction 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01  
Revenue from Contract with Customer [Abstract]  
Remaining performance obligation $ 16,713
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Expected timing of satisfaction 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01  
Revenue from Contract with Customer [Abstract]  
Remaining performance obligation $ 15,129
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Expected timing of satisfaction
XML 68 R48.htm IDEA: XBRL DOCUMENT v3.20.4
ACQUISITION AND RELATED PARTY ITEMS - Additional Information (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 6 Months Ended 12 Months Ended
Oct. 05, 2020
USD ($)
Apr. 01, 2020
USD ($)
Mar. 30, 2020
USD ($)
Dec. 05, 2019
USD ($)
Feb. 22, 2019
USD ($)
Dec. 21, 2018
USD ($)
$ / shares
shares
Dec. 31, 2019
USD ($)
Sep. 30, 2020
USD ($)
Dec. 31, 2020
USD ($)
segment
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Business Acquisition [Line Items]                      
Goodwill             $ 36,204   $ 88,276 $ 36,204 $ 26,679
Acquired additions based on prior year tax positions                 1,072 0  
Unrecognized tax benefits             0   808 0 0
Cash paid for amounts included in the measurement of lease liabilities:                 2,213 1,800  
Operating lease right-of-use assets             5,726   5,457 5,726  
Operating lease liability                 5,945    
Common stock, par value (in dollars per share) | $ / shares           $ 0.01          
Repayments of related party debt                 $ 1,140 0 0
Cuattro, LLC                      
Business Acquisition [Line Items]                      
Consideration transferred shares issued | shares           54,763          
Shares issued as consideration, value           $ 5,400          
Payments for asset acquisition           2,800          
Asset acquisition, consideration transferred           $ 8,200          
Acquired finite-lived intangible assets, weighted average useful life           10 years          
CVM Practice | Affiliated Entity                      
Business Acquisition [Line Items]                      
Number of warehouses | segment                 2    
Cash paid for amounts included in the measurement of lease liabilities:                 $ 31 0  
Operating lease right-of-use assets             0   200 0  
Operating lease liability             0   200 0  
Repayments of related party debt                 1,100    
Cuattro, LLC | Heska Imaging                      
Business Acquisition [Line Items]                      
Related party - amount of transaction                 0 6 4,600
Scil Animal Care Company                      
Business Acquisition [Line Items]                      
Percentage of voting interest acquired   100.00%                  
Payments to acquire business   $ 110,300 $ 111,000                
Purchase price   110,290                  
Goodwill   46,000                  
Goodwill, period increase (decrease)                 200    
Acquired additions based on prior year tax positions                 1,100    
Unrecognized tax benefits                 800    
Revenue of acquiree since acquisition date               $ 61,300      
Earnings or loss of acquiree since acquisition date               $ 1,100      
Acquisition related costs                 6,300 700  
Revenue, net                 215,874 201,700  
Net (loss) income attributable to Heska Corporation                 (15,215) (2,487)  
Scil Animal Care Company | International Segment                      
Business Acquisition [Line Items]                      
Goodwill   37,300                  
Scil Animal Care Company | North America Segment                      
Business Acquisition [Line Items]                      
Goodwill   $ 8,700                  
CVM                      
Business Acquisition [Line Items]                      
Percentage of voting interest acquired       100.00%              
Purchase price       $ 14,400              
Goodwill       $ 8,959              
Goodwill, period increase (decrease)                 110    
Revenue of acquiree since acquisition date             800        
Earnings or loss of acquiree since acquisition date             $ 100        
Acquisition related costs                 $ 600 100  
Revenue, net                   130,434 135,344
Net (loss) income attributable to Heska Corporation                   $ (788) $ 5,970
Optomed                      
Business Acquisition [Line Items]                      
Percentage of voting interest acquired 30.00%       70.00%            
Payments to acquire business $ 500       $ 200            
Debt assumed in acquisition         $ 400            
XML 69 R49.htm IDEA: XBRL DOCUMENT v3.20.4
ACQUISITION AND RELATED PARTY ITEMS - Fair Values of Assets and Liabilties at Scil Acquisition Date (Details) - USD ($)
$ in Thousands
Apr. 01, 2020
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract]        
Goodwill   $ 88,276 $ 36,204 $ 26,679
Scil Animal Care Company        
Purchase Price        
Total fair value of consideration transferred $ 110,290      
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract]        
Cash and cash equivalents 5,889      
Accounts receivable 10,707      
Inventories 11,278      
Net investment in leases, current 311      
Prepaid expenses 1,692      
Other current assets 1,338      
Property and equipment 19,320      
Operating lease right-of-use assets 877      
Other intangible assets 44,517      
Net investment in leases, non-current 1,027      
Investments in unconsolidated affiliates 55      
Other non-current assets 291      
Total assets acquired 97,302      
Accounts payable 8,221      
Accrued liabilities 7,067      
Operating lease liabilities, current 356      
Current portion of deferred revenue, and other 3,220      
Deferred revenue, non-current 94      
Operating lease liabilities, non-current 529      
Deferred tax liability 13,249      
Other liabilities 276      
Net assets acqiured 64,290      
Goodwill $ 46,000      
XML 70 R50.htm IDEA: XBRL DOCUMENT v3.20.4
ACQUISITION AND RELATED PARTY ITEMS - Fair Value of Assets and Liabilities at CVM Acquisition Date (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 05, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Purchase Price        
Consideration payable for CVM Acquisition   $ 0 $ 14,420 $ 0
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract]        
Goodwill   $ 88,276 $ 36,204 $ 26,679
CVM        
Purchase Price        
Consideration payable for CVM Acquisition $ 14,420      
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract]        
Cash and cash equivalents 1,226      
Accounts receivable 583      
Inventories 1,621      
Other current assets 1,186      
Property and equipment 345      
Other intangible assets 2,608      
Other non-current assets 460      
Total assets acquired 8,029      
Accounts payable (94)      
Accrued liabilities (471)      
Current portion of deferred revenue, and other (54)      
Deferred tax liability (683)      
Other long-term borrowings (1,109)      
Other liabilities (157)      
Net assets acqiured 5,461      
Goodwill 8,959      
Total fair value of consideration transferred $ 14,420      
XML 71 R51.htm IDEA: XBRL DOCUMENT v3.20.4
ACQUISITION AND RELATED PARTY ITEMS - Intangible Assets Acquired, Amortization Method (Details) - USD ($)
$ in Thousands
Apr. 01, 2020
Dec. 05, 2019
Dec. 31, 2020
Dec. 31, 2019
Business Acquisition [Line Items]        
Total intangible assets acquired     $ 64,229 $ 14,517
Scil Animal Care Company        
Business Acquisition [Line Items]        
Total intangible assets acquired $ 44,517      
Scil Animal Care Company | Trade names        
Business Acquisition [Line Items]        
Fair Value $ 7,556      
CVM        
Business Acquisition [Line Items]        
Total intangible assets acquired   $ 2,608    
CVM | Developed technology        
Business Acquisition [Line Items]        
Indefinite-lived intangible assets acquired   $ 57    
Customer Relationships | Scil Animal Care Company        
Business Acquisition [Line Items]        
Acquired finite-lived intangible assets, weighted average useful life 10 years      
Fair Value $ 36,272      
Customer Relationships | CVM        
Business Acquisition [Line Items]        
Acquired finite-lived intangible assets, weighted average useful life   6 years    
Fair Value   $ 2,440    
Software Development | Scil Animal Care Company        
Business Acquisition [Line Items]        
Acquired finite-lived intangible assets, weighted average useful life 7 years      
Fair Value $ 353      
Backlog | Scil Animal Care Company        
Business Acquisition [Line Items]        
Acquired finite-lived intangible assets, weighted average useful life 2 months 12 days      
Fair Value $ 210      
Non-compete agreements | Scil Animal Care Company        
Business Acquisition [Line Items]        
Acquired finite-lived intangible assets, weighted average useful life 2 years      
Fair Value $ 60      
Trade names | Scil Animal Care Company        
Business Acquisition [Line Items]        
Acquired finite-lived intangible assets, weighted average useful life 9 months 18 days      
Fair Value $ 66      
Trade names | CVM        
Business Acquisition [Line Items]        
Acquired finite-lived intangible assets, weighted average useful life   4 years    
Fair Value   $ 111    
XML 72 R52.htm IDEA: XBRL DOCUMENT v3.20.4
ACQUISITION AND RELATED PARTY ITEMS - Unaudited Pro Forma Financial Information (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Scil Animal Care Company      
Business Acquisition [Line Items]      
Revenue, net $ 215,874 $ 201,700  
Business Acquisition, Pro Forma Net Income (Loss), Including Portion Attributable To Noncontrolling Interest (14,848) (2,159)  
Net (loss) income attributable to Heska Corporation $ (15,215) (2,487)  
CVM      
Business Acquisition [Line Items]      
Revenue, net   130,434 $ 135,344
Business Acquisition, Pro Forma Net Income (Loss), Including Portion Attributable To Noncontrolling Interest   (460) 6,042
Net (loss) income attributable to Heska Corporation   $ (788) $ 5,970
XML 73 R53.htm IDEA: XBRL DOCUMENT v3.20.4
INVESTMENTS IN UNCONSOLIDATED AFFILIATES (Details) - USD ($)
$ in Thousands
12 Months Ended
Sep. 24, 2018
Aug. 08, 2018
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Schedule of Equity Method Investments [Line Items]          
Investments in unconsolidated affiliates     $ 3,686 $ 4,406  
Non-marketable equity security investment     3,018 3,018  
Investments     6,704 7,424 $ 8,018
Payments to acquire equity method investments     $ 0 $ 0 $ 8,091
General Fluidics Corporation          
Schedule of Equity Method Investments [Line Items]          
Supply commitment term 15 years        
General Fluidics Corporation          
Schedule of Equity Method Investments [Line Items]          
Payments to acquire equity method investments $ 5,100        
Ownership percentage     29.10%    
MBio Diagnostics, Inc.          
Schedule of Equity Method Investments [Line Items]          
Payments to acquire non-marketable securities   $ 3,000      
Intangible asset acquired   $ 1,000      
Intangible assets acquired, useful life   20 years      
Contingent consideration on milestones   $ 10,000      
XML 74 R54.htm IDEA: XBRL DOCUMENT v3.20.4
INCOME TAXES (Details) - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Operating Loss Carryforwards [Line Items]      
Income tax expense (benefit) $ 239,000 $ (1,446,000) $ (2,115,000)
Deferred income tax benefit (1,541,000) (1,805,000) (2,255,000)
Current income tax expense (benefit) 1,780,000 359,000 140,000
Valuation allowance, deferred tax asset, increase (decrease), amount 800,000    
Deferred tax assets, operating loss carryforwards 10,100,000    
Deferred tax assets, valuation allowance 6,409,000 5,656,000  
Cash paid for income taxes 993,000 128,000 36,000
Unrecognized tax benefits 808,000 0 0
Unrecognized tax benefits, income tax penalties and interest expense 19,000.0    
Undistributed earnings of foreign subsisdiaries 2,900,000    
Foreign earnings repatriated 145,000    
Tax Years 2018 Through 2022      
Operating Loss Carryforwards [Line Items]      
Operating loss carryforwards 22,000,000    
Tax Years 2024 Through 2025      
Operating Loss Carryforwards [Line Items]      
Operating loss carryforwards 5,400,000    
Tax Year 2027 and later      
Operating Loss Carryforwards [Line Items]      
Operating loss carryforwards 500,000    
Domestic Tax Authority      
Operating Loss Carryforwards [Line Items]      
Deferred income tax benefit 600,000 (1,900,000) $ (2,300,000)
Operating loss carryforwards 35,000,000.0    
Domestic Tax Authority | Research Tax Credit Carryforward      
Operating Loss Carryforwards [Line Items]      
Operating loss carryforwards 1,300,000    
Foreign Tax Authority      
Operating Loss Carryforwards [Line Items]      
Deferred income tax benefit (2,200,000) $ 100,000  
Operating loss carryforwards 64,000    
Deferred tax assets, operating loss carryforwards, not subject to expiration $ 7,100,000    
XML 75 R55.htm IDEA: XBRL DOCUMENT v3.20.4
INCOME TAXES - COMPONENTS OF INCOME (LOSS) BEFORE TAXES (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Income Tax Disclosure [Abstract]      
Domestic $ (9,441) $ (1,872) $ 3,602
Foreign (4,352) (711) 205
Income (loss) before income taxes $ (13,793) $ (2,583) $ 3,807
XML 76 R56.htm IDEA: XBRL DOCUMENT v3.20.4
INCOME TAXES - TEMPORARY DIFFERENCES TO THE COMPONENTS OF DEFERRED TAX ASSETS (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Income Tax Disclosure [Abstract]    
Inventory $ 2,993 $ 2,005
Accrued compensation 295 122
Stock and Stock Options 2,322 1,858
Research and development tax credit 1,308 990
Research and development expense 2,571 1,417
Deferred revenue 1,441 2,052
Property and equipment 298 3,469
Net operating loss carryforwards – domestic 8,757 11,676
Foreign tax credit carryforward 64 64
Sales-type leases 1,324  
Sales-type leases   1,968
Convertible debt equity component (8,691) (9,421)
Foreign intangible (11,311) (691)
Other (1,124) (179)
Deferred tax assets, gross 247 11,394
Valuation allowance 6,409 5,656
Total net deferred tax assets (liabilities) $ (6,162)  
Total net deferred tax assets (liabilities)   $ 5,738
XML 77 R57.htm IDEA: XBRL DOCUMENT v3.20.4
INCOME TAXES - COMPONENTS OF INCOME TAX EXPENSE (BENEFIT) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Current income tax expense:      
Federal $ (24) $ 0 $ (115)
State 339 189 192
Foreign 1,465 170 63
Total current expense 1,780 359 140
Deferred income tax (benefit) expense:      
Federal 369 (1,610) (1,877)
State 289 (307) (378)
Foreign (2,199) 112 0
Total deferred (benefit) expense 1,541 1,805 2,255
Income tax expense (benefit) $ 239 $ (1,446) $ (2,115)
XML 78 R58.htm IDEA: XBRL DOCUMENT v3.20.4
INCOME TAXES - EFFECTIVE INCOME TAX RECONCILIATION (Details)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Income Tax Contingency [Line Items]      
Statutory federal tax rate 21.00% 21.00% 21.00%
State income taxes, net of federal benefit (4.00%) 9.00% (8.00%)
Foreign income inclusion (12.00%) 0.00% 0.00%
Non-temporary stock option benefit 6.00% 48.00% 50.00%
Meals and entertainment permanent difference 0.00% (2.00%) 1.00%
GILTI permanent difference 0 0.02 0.01
Other permanent differences 1.00% (1.00%) 1.00%
Foreign tax rate differences 2.00% 6.00% 0.00%
Change in tax rate 1.00% (6.00%) 0.00%
Change in valuation allowance (4.00%) (17.00%) 0.00%
Other deferred differences (2.00%) (9.00%) (21.00%)
Transaction costs (6.00%) (6.00%) 0.00%
Executive compensation limit (6.00%) (7.00%) 0.00%
Research & development credit 2.00% 20.00% 0.00%
Equity Investment (4.00%) 0.00% 0.00%
Change in uncertain tax benefits 3.00% 0.00% 0.00%
Other (1.00%) 0.00% (1.00%)
Effective income tax rate (2.00%) 56.00% (56.00%)
Optomed      
Income Tax Contingency [Line Items]      
Non-controlling interest in Optomed 1.00% (2.00%) 0.00%
XML 79 R59.htm IDEA: XBRL DOCUMENT v3.20.4
INCOME TAXES - UNRECOGNIZED TAX BENEFITS ROLL FORWARD (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]    
Balance at beginning of period $ 0 $ 0
Acquired additions based on prior year tax positions (1,072) 0
Reductions from lapse in statutes of limitations 358 0
Currency Translation Adjustment (94) 0
Balance at the end of period $ (808) $ 0
XML 80 R60.htm IDEA: XBRL DOCUMENT v3.20.4
LEASES - Operating and Financing Lease Balances (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Leases [Abstract]    
Operating lease right-of-use assets $ 5,457 $ 5,726
Property and equipment, net 1,907 81
Total Leased Assets 7,364 5,807
Operating lease liabilities, current 2,087 1,745
Operating lease liabilities, non-current 3,858 4,413
Deferred revenue, current, and other 295 47
Other liabilities 261 37
Total Lease Liabilities $ 6,501 $ 6,242
XML 81 R61.htm IDEA: XBRL DOCUMENT v3.20.4
LEASES - Additional Information (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Leases [Abstract]      
Finance lease amortization expense $ 300 $ 44  
Finance lease, interest expense 10 3  
Operating lease, expense $ 2,800 $ 2,400 $ 1,900
XML 82 R62.htm IDEA: XBRL DOCUMENT v3.20.4
LEASES - Supplemental Cash Flow Information (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Cash paid for amounts included in the measurement of lease liabilities:    
Cash paid for amounts included in the measurement of lease liabilities: $ 2,213 $ 1,800
Operating cash outflows - finance leases 10 3
Financing cash outflows - finance leases 250 36
ROU assets obtained in exchange for new lease obligations:    
ROU assets obtained in exchange for new lease obligations: 788 604
Finance leases $ 159 $ 11
XML 83 R63.htm IDEA: XBRL DOCUMENT v3.20.4
LEASES - Weighted Average Remaining Lease Term and Weighted Average Discount Rate (Details)
Dec. 31, 2020
Dec. 31, 2019
Weighted average remaining lease term:    
Operating 3 years 1 month 6 days 3 years 9 months 18 days
Finance 2 years 10 months 24 days 2 years
Weighted average discount rate:    
Operating 4.20% 4.40%
Finance 2.10% 4.00%
XML 84 R64.htm IDEA: XBRL DOCUMENT v3.20.4
LEASES - Lessee Accounting (Details)
$ in Thousands
Dec. 31, 2020
USD ($)
Operating Leases  
2021 $ 2,158
2022 1,834
2023 1,949
2024 144
2025 138
Thereafter 132
Total lease payments 6,355
Less: imputed interest 410
Operating lease liability 5,945
Finance Leases  
2021 294
2022 139
2023 59
2024 38
2025 26
Thereafter 18
Total lease payments 574
Less: imputed interest 18
Total lease liabilities $ 556
XML 85 R65.htm IDEA: XBRL DOCUMENT v3.20.4
LEASES - Lessor Accounting (Details)
$ in Thousands
Dec. 31, 2020
USD ($)
Lessor, Operating Lease, Payments, Fiscal Year Maturity [Abstract]  
2021 $ 4,834
2022 4,872
2023 4,220
2024 3,291
2025 2,033
Thereafter 1,424
Total undiscounted future maturities 20,674
Less: interest 91
Total lease receivables $ 20,583
XML 86 R66.htm IDEA: XBRL DOCUMENT v3.20.4
LEASES - Sales-type Leases and Lease Income (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Leases [Abstract]    
Sales-type lease revenue $ 5,617 $ 6,890
Sales-type lease cost of revenue 3,951 5,099
Profit recognized at commencement for sales-type leases 1,666 1,791
Operating lease income $ 1,012 $ 0
XML 87 R67.htm IDEA: XBRL DOCUMENT v3.20.4
EARNINGS PER SHARE (Details)
$ / shares in Units, $ in Thousands
12 Months Ended
Apr. 14, 2020
shares
Dec. 31, 2020
USD ($)
$ / shares
shares
Dec. 31, 2019
USD ($)
$ / shares
shares
Dec. 31, 2018
USD ($)
$ / shares
shares
Sep. 17, 2019
$ / shares
Earnings Per Share [Abstract]          
Reverse stock split conversion ratio   10      
Net (loss) income attributable to Heska Corporation | $   $ (14,399) $ (1,465) $ 5,850  
Basic weighted-average common shares outstanding (In shares)   8,653,000 7,446,000 7,220,000  
Assumed exercise of dilutive stock options and restricted stock awards (in shares)   0 0 636,000  
Diluted weighted-average common shares outstanding (in shares)   8,653,000 7,446,000 7,856,000  
Basic earnings per share attributable to Heska Corporation (in dollars per share) | $ / shares   $ (1.66) $ (0.20) $ 0.81  
Diluted earnings per share attributable to Heska Corporation (in dollars per share) | $ / shares   $ (1.66) $ (0.20) $ 0.74  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Stock options and restricted units excluded from computation of earnings per share   904,000 300,000 111,000  
Series X Convertible Preferred Stock          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Conversion to common stock (in shares) 122,000        
Common Stock          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Conversion to common stock (in shares) 1,508,964        
Convertible Preferred Stock          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Stock options and restricted units excluded from computation of earnings per share   458,000 0 0  
Senior Convertible Note          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Stock options and restricted units excluded from computation of earnings per share   118,000 0 0  
Stock Options And Restricted Units          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Stock options and restricted units excluded from computation of earnings per share   328,000 300,000 111,000  
Senior Convertible Note | Convertible Debt          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Debt instrument, convertible, conversion price (in dollars per share) | $ / shares         $ 86.63
XML 88 R68.htm IDEA: XBRL DOCUMENT v3.20.4
GOODWILL AND OTHER INTANGIBLES (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Goodwill [Roll Forward]      
Carrying amount $ 36,204 $ 26,679  
Goodwill attributable to acquisitions (subject to change) 46,000 9,396  
Measurement period adjustment to prior year acquisition 110    
Foreign currency adjustments 5,962 129  
Carrying amount 88,276 36,204 $ 26,679
Finite-Lived Intangible Assets, Net [Abstract]      
Accumulated Amortization (8,237) (3,045)  
Other intangible assets, net 47,618    
Indefinite-lived Intangible Assets [Line Items]      
Indefinite-lived intangible assets 8,374    
Intangible Assets, Net (Excluding Goodwill) [Abstract]      
Total intangible assets acquired 64,229 14,517  
Accumulated Amortization (8,237) (3,045)  
Net intangible assets 55,992 11,472  
Amortization expense $ 5,196 1,278 388
Finite-lived intangible assets, remaining amortization period 8 years 8 months 12 days    
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]      
2021 $ 5,905    
2022 5,868    
2023 5,506    
2024 5,376    
2025 5,347    
Thereafter 19,616    
Net Carrying Amount 47,618    
Indefinite-lived intangible assets 8,374    
Net intangible assets 55,992 11,472  
North America Segment | Operating Segments      
Goodwill [Roll Forward]      
Carrying amount 25,724 25,724  
Goodwill attributable to acquisitions (subject to change) 8,742 0  
Measurement period adjustment to prior year acquisition 0    
Foreign currency adjustments 948 0  
Carrying amount 35,414 25,724 25,724
International Segment | Operating Segments      
Goodwill [Roll Forward]      
Carrying amount 10,480 955  
Goodwill attributable to acquisitions (subject to change) 37,258 9,396  
Measurement period adjustment to prior year acquisition 110    
Foreign currency adjustments 5,014 129  
Carrying amount 52,862 10,480 $ 955
Trade names      
Indefinite-lived Intangible Assets [Line Items]      
Indefinite-lived intangible assets 8,374 0  
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]      
Indefinite-lived intangible assets 8,374 0  
Customer relationships and other      
Finite-Lived Intangible Assets, Net [Abstract]      
Gross Carrying Amount 46,989 6,205  
Accumulated Amortization (6,436) (2,226)  
Other intangible assets, net 40,553 3,979  
Intangible Assets, Net (Excluding Goodwill) [Abstract]      
Accumulated Amortization (6,436) (2,226)  
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]      
Net Carrying Amount 40,553 3,979  
Developed technology      
Finite-Lived Intangible Assets, Net [Abstract]      
Gross Carrying Amount 8,669 8,200  
Accumulated Amortization (1,696) (819)  
Other intangible assets, net 6,973 7,381  
Intangible Assets, Net (Excluding Goodwill) [Abstract]      
Accumulated Amortization (1,696) (819)  
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]      
Net Carrying Amount 6,973 7,381  
Trade names      
Finite-Lived Intangible Assets, Net [Abstract]      
Gross Carrying Amount 197 112  
Accumulated Amortization (105) 0  
Other intangible assets, net 92 112  
Intangible Assets, Net (Excluding Goodwill) [Abstract]      
Accumulated Amortization (105) 0  
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]      
Net Carrying Amount $ 92 $ 112  
XML 89 R69.htm IDEA: XBRL DOCUMENT v3.20.4
PROPERTY AND EQUIPMENT (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Property, Plant and Equipment [Line Items]      
Property and equipment, gross $ 73,290 $ 49,298  
Less accumulated depreciation (37,748) (33,829)  
Total property and equipment, net 35,542 15,469  
Transfers of equipment between inventory and property and equipment, net 4,437 827 $ 1,449
Depreciation and amortization 6,200 3,600 $ 4,200
Land      
Property, Plant and Equipment [Line Items]      
Property and equipment, gross 2,590 694  
Building      
Property, Plant and Equipment [Line Items]      
Property and equipment, gross $ 12,737 3,845  
Building | Minimum      
Property, Plant and Equipment [Line Items]      
Property plant and equipment, useful life 10 years    
Building | Maximum      
Property, Plant and Equipment [Line Items]      
Property plant and equipment, useful life 43 years    
Machinery and equipment      
Property, Plant and Equipment [Line Items]      
Property and equipment, gross $ 40,411 28,777  
Machinery and equipment | Minimum      
Property, Plant and Equipment [Line Items]      
Property plant and equipment, useful life 2 years    
Machinery and equipment | Maximum      
Property, Plant and Equipment [Line Items]      
Property plant and equipment, useful life 10 years    
Office furniture & equipment      
Property, Plant and Equipment [Line Items]      
Property and equipment, gross $ 2,047 1,345  
Office furniture & equipment | Minimum      
Property, Plant and Equipment [Line Items]      
Property plant and equipment, useful life 3 years    
Office furniture & equipment | Maximum      
Property, Plant and Equipment [Line Items]      
Property plant and equipment, useful life 7 years    
Computer hardware & software      
Property, Plant and Equipment [Line Items]      
Property and equipment, gross $ 4,773 3,408  
Computer hardware & software | Minimum      
Property, Plant and Equipment [Line Items]      
Property plant and equipment, useful life 3 years    
Computer hardware & software | Maximum      
Property, Plant and Equipment [Line Items]      
Property plant and equipment, useful life 5 years    
Leasehold and building improvements      
Property, Plant and Equipment [Line Items]      
Property and equipment, gross $ 10,728 10,558  
Leasehold and building improvements | Minimum      
Property, Plant and Equipment [Line Items]      
Property plant and equipment, useful life 5 years    
Leasehold and building improvements | Maximum      
Property, Plant and Equipment [Line Items]      
Property plant and equipment, useful life 15 years    
Construction in progress      
Property, Plant and Equipment [Line Items]      
Property and equipment, gross $ 4 671  
Machinery and equipment | Minimum      
Property, Plant and Equipment [Line Items]      
Property plant and equipment, useful life 5 years    
Machinery and equipment | Maximum      
Property, Plant and Equipment [Line Items]      
Property plant and equipment, useful life 7 years    
Leased Equipment      
Property, Plant and Equipment [Line Items]      
Property and equipment, gross $ 13,600 8,100  
Less accumulated depreciation $ (4,700) $ (4,600)  
XML 90 R70.htm IDEA: XBRL DOCUMENT v3.20.4
INVENTORIES (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Inventory Disclosure [Abstract]    
Raw materials $ 14,454 $ 14,597
Work in process 4,262 2,730
Finished goods 21,321 9,274
Total inventory, net $ 40,037 $ 26,601
XML 91 R71.htm IDEA: XBRL DOCUMENT v3.20.4
ACCRUED LIABILITIES (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Payables and Accruals [Abstract]    
Accrued payroll and employee benefits $ 7,949 $ 1,175
Accrued property taxes 659 681
Accrued settlement 1,549 739
Accrued taxes 3,731 586
Other 4,167 3,164
Accrued liabilities $ 18,055 $ 6,345
Current percentage of total liabilities 5.00%  
XML 92 R72.htm IDEA: XBRL DOCUMENT v3.20.4
CAPITAL STOCK - NARRATIVE (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Apr. 16, 2020
$ / shares
shares
Apr. 14, 2020
shares
Apr. 01, 2020
USD ($)
Mar. 30, 2020
USD ($)
$ / shares
shares
Apr. 30, 2020
shares
May 31, 2018
shares
May 31, 2016
shares
May 31, 2012
shares
Dec. 31, 2020
USD ($)
plans
$ / shares
shares
Dec. 31, 2019
USD ($)
$ / shares
shares
Dec. 31, 2018
USD ($)
$ / shares
shares
May 31, 2003
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Number of stock option plans | plans                 2      
Expected dividend rate (as a percent)                 0.00% 0.00% 0.00%  
Reverse stock split conversion ratio                 10      
Fair value of stock options granted during period | $                 $ 2,400 $ 2,600 $ 4,400  
Weighted average grant date fair value | $ / shares                 $ 28.66 $ 29.89 $ 28.81  
Intrinsic value of options exercised | $                 $ 5,000 $ 12,800 $ 10,500  
Proceeds from stock options exercised | $                 3,400 $ 1,000 $ 3,200  
Unrecognized compensation costs, not probable | $                 $ 10,600      
Weighted average purchase price of shares purchased | $ / shares                 $ 16.19 $ 18.10 $ 18.14  
Preferred stock, shares issued (in shares)                 0 0    
Preferred stock, par value (in dollars per share) | $ / shares                 $ 0.01 $ 0.01    
Payments of stock issuance costs | $                 $ 214 $ 0 $ 0  
Series X Convertible Preferred Stock                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Conversion to common stock (in shares)   122,000                    
Common Stock                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Common stock, shares issued                 0 0    
Conversion to common stock (in shares)   1,508,964                    
Scil Animal Care Company                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Payments to acquire business | $     $ 110,300 $ 111,000                
Preferred Stock                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Preferred stock, shares issued (in shares)       122,000                
Preferred stock, par value (in dollars per share) | $ / shares       $ 0.01                
Sale of stock, price per share (in dollars per share) | $ / shares       $ 1,000                
Sale of stock, consideration received per transaction | $       $ 122,000                
Payments of stock issuance costs | $       $ 200                
Convertible preferred stock, shares issuable upon conversion (in shares)       12.4                
Preferred stock, convertible, conversion price (in dollars per share) | $ / shares       $ 80.85                
Conversion to common stock (in shares)                 (122,000)      
Restricted Stock                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | $                 $ 5,500      
Restricted Stock | Minimum                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Award vesting period (in years)                 1 year      
Restricted Stock | Maximum                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Award vesting period (in years)                 4 years      
Stock options and restricted shares                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Intrinsic value of options exercised | $                 $ 28,900      
Total unrecognized compensation expense related to outstanding stock options | $                 $ 3,600      
Period for recognition of unrecognized compensation expense                 1 year 7 months 17 days      
Intrinsic value of options outstanding | $                 $ 41,100      
Granted at Market (in dollars per share) | $ / shares                 $ 69.27      
Forfeitures in period (in shares)                 42,307      
Options outstanding (in shares)                 464,232 536,315    
Outstanding exercise price (in dollars per share) | $ / shares                 $ 57.18 $ 54.86    
Exercises in period (in shares)                 84,335      
Incentive Stock Options                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Percent of fair value for options granted                 100.00%      
Performance Shares                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Fair value of stock options granted during period | $                 $ 6,000      
Total unrecognized compensation expense related to outstanding stock options | $                 $ 2,400      
Period for recognition of unrecognized compensation expense                 1 year 9 months 18 days      
Intrinsic value of options outstanding | $                 $ 18,600      
Grants in period (in shares) 240,000                      
Granted at Market (in dollars per share) | $ / shares $ 60.94               $ 25.04      
Forfeitures in period (in shares)                 20,000      
Options outstanding (in shares)                 220,000      
Outstanding exercise price (in dollars per share) | $ / shares                 $ 60.94      
Weighted average remaining contractual term (in years)                 9 years 3 months 14 days      
Exercises in period (in shares)                 0      
Performance shares not meeting performance targets (in shares)                 80,000      
Unrecognized compensation costs, not probable | $                 $ 2,000      
Performance Shares | Share-based Payment Arrangement, Tranche One                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Grants in period (in shares) 230,000                      
Employee Stock                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Shares issued during period                 10,069 10,698 10,078  
Share Purchase Plan 1997                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Increase in number of share to be repurchased         300,000 250,000 500,000 250,000        
Number of shares authorized to be repurchased annually               45,000        
Remaining number of shares authorized to be repurchased                 151,605      
Common stock, shares issued                 3,859      
Share Purchase Plan 2003                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Number of shares authorized                       239,050
Restricted Stock                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Shares not meeting performance targets                 129,000      
Weighted average purchase price of shares purchased | $ / shares                 $ 87.29 $ 74.93 $ 71.77  
Restricted stock vested, fair value | $                 $ 5,000 $ 300 $ 4,400  
XML 93 R73.htm IDEA: XBRL DOCUMENT v3.20.4
CAPITAL STOCK - OPTION ACTIVITY (Details) - $ / shares
12 Months Ended
Apr. 16, 2020
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Risk-free interest rate (as a percent)   3.64% 1.62% 2.66%
Expected lives (in years)   5 years 3 months 18 days 4 years 8 months 12 days 4 years 10 months 24 days
Expected volatility (as a percent)   46.00% 40.00% 40.00%
Expected dividend rate (as a percent)   0.00% 0.00% 0.00%
Stock options and restricted shares        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]        
Outstanding at beginning of period   536,315    
Granted at market   83,250    
Forfeited   (42,307)    
Expired   (28,691)    
Exercised   (84,335)    
Outstanding at end of period   464,232 536,315  
Exercisable at end of period   291,334    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]        
Outstanding at beginning of period (in dollars per share)   $ 54.86    
Granted at Market (in dollars per share)   69.27    
Forfeited (in dollars per share)   76.24    
Expired (in dollars per share)   69.25    
Exercised (in dollars per share)   40.64    
Outstanding at ending of period (in dollars per share)   57.18 $ 54.86  
Exercisable at end of period (in dollars per share)   $ 46.53    
Performance Shares        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]        
Forfeited   (20,000)    
Exercised   0    
Outstanding at end of period   220,000    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]        
Granted at Market (in dollars per share) $ 60.94 $ 25.04    
Outstanding at ending of period (in dollars per share)   $ 60.94    
XML 94 R74.htm IDEA: XBRL DOCUMENT v3.20.4
CAPITAL STOCK- SUMMARY OF INFORMATION BY EXERCISE PRICE RANGE (Details)
12 Months Ended
Dec. 31, 2020
$ / shares
shares
$6.23 - $12.78  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Number of Options Outstanding at December 31, 2020 | shares 86,166
Weighted Average Remaining Contractual Life in Years 2 years 2 months 12 days
Options Outstanding - Weighted Average Exercise Price (in dollars per share) $ 7.59
Number of Options Exercisable at December 31, 2020 | shares 86,166
Weighted Average Remaining Contractual Life in Years 2 years 2 months 12 days
Options Exercisable - Weighted Average Exercise Price (in dollars per share) $ 7.59
Exercise price, lower range limit 4.50
Exercise price, upper range limit $ 7.36
$12.79 - $39.76  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Number of Options Outstanding at December 31, 2020 | shares 63,197
Weighted Average Remaining Contractual Life in Years 4 years 6 months 25 days
Options Outstanding - Weighted Average Exercise Price (in dollars per share) $ 30.11
Number of Options Exercisable at December 31, 2020 | shares 63,197
Weighted Average Remaining Contractual Life in Years 4 years 6 months 25 days
Options Exercisable - Weighted Average Exercise Price (in dollars per share) $ 30.11
Exercise price, lower range limit 7.37
Exercise price, upper range limit $ 32.21
$39.77 - $60.94  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Number of Options Outstanding at December 31, 2020 | shares 65,000
Weighted Average Remaining Contractual Life in Years 9 years 3 months 14 days
Options Outstanding - Weighted Average Exercise Price (in dollars per share) $ 60.94
Number of Options Exercisable at December 31, 2020 | shares 0
Weighted Average Remaining Contractual Life in Years 0 years
Options Exercisable - Weighted Average Exercise Price (in dollars per share) $ 0
Exercise price, lower range limit 32.22
Exercise price, upper range limit $ 62.50
$60.95 - $71.84  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Number of Options Outstanding at December 31, 2020 | shares 120,666
Weighted Average Remaining Contractual Life in Years 7 years 7 months 2 days
Options Outstanding - Weighted Average Exercise Price (in dollars per share) $ 70.21
Number of Options Exercisable at December 31, 2020 | shares 71,334
Weighted Average Remaining Contractual Life in Years 7 years 5 months 19 days
Options Exercisable - Weighted Average Exercise Price (in dollars per share) $ 70.03
Exercise price, lower range limit 62.51
Exercise price, upper range limit $ 69.77
$71.85 - $108.25  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Number of Options Outstanding at December 31, 2020 | shares 129,203
Weighted Average Remaining Contractual Life in Years 7 years 9 months 25 days
Options Outstanding - Weighted Average Exercise Price (in dollars per share) $ 89.45
Number of Options Exercisable at December 31, 2020 | shares 70,637
Weighted Average Remaining Contractual Life in Years 6 years 10 months 20 days
Options Exercisable - Weighted Average Exercise Price (in dollars per share) $ 84.98
Exercise price, lower range limit 69.78
Exercise price, upper range limit $ 108.25
$6.23 - $108.25  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Number of Options Outstanding at December 31, 2020 | shares 464,232
Weighted Average Remaining Contractual Life in Years 6 years 5 months 23 days
Options Outstanding - Weighted Average Exercise Price (in dollars per share) $ 57.18
Number of Options Exercisable at December 31, 2020 | shares 291,334
Weighted Average Remaining Contractual Life in Years 5 years 1 month 20 days
Options Exercisable - Weighted Average Exercise Price (in dollars per share) $ 46.53
Exercise price, lower range limit 4.50
Exercise price, upper range limit $ 108.25
XML 95 R75.htm IDEA: XBRL DOCUMENT v3.20.4
CAPITAL STOCK CAPITAL STOCK - RESTRICTED STOCK (Details) - $ / shares
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Granted (in dollars per share) $ 16.19 $ 18.10 $ 18.14
Restricted Stock      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Non-vested, period start (in shares) 335,667    
Granted (in shares) 69,823    
Vested (in shares) (46,140)    
Forfeited (in shares) (67,830)    
Non-vested, period end (in shares) 291,520 335,667  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Nonvested, at period start (in dollars per share) $ 74.29    
Granted (in dollars per share) 87.29 $ 74.93 $ 71.77
Vested (in dollars per share) 68.80    
Forfeited (in dollars per share) 73.27    
Nonvested, at period end (in dollars per share) $ 78.44 $ 74.29  
XML 96 R76.htm IDEA: XBRL DOCUMENT v3.20.4
ACCUMULATED OTHER COMPREHENSIVE INCOME (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]    
Beginning balance $ 154,364 $ 122,409
Ending balance 287,053 154,364
Total Accumulated Other Comprehensive Income    
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]    
Beginning balance 513 277
Other comprehensive (loss) income 13,656 236
Ending balance 14,169 513
Pension Adjustments    
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]    
Beginning balance (346) (419)
Other comprehensive (loss) income (40) 73
Ending balance (386) (346)
Foreign Currency Translation    
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]    
Beginning balance 859 696
Other comprehensive (loss) income 5,013 163
Ending balance 5,872 859
Foreign Currency Gain on Intra-Entity Transactions    
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]    
Beginning balance 0 0
Other comprehensive (loss) income 8,683 0
Ending balance $ 8,683 $ 0
XML 97 R77.htm IDEA: XBRL DOCUMENT v3.20.4
COMMITMENTS AND CONTINGENCIES (Details) - USD ($)
$ in Millions
Feb. 28, 2019
Dec. 31, 2020
Dec. 31, 2019
Commitments and Contingencies Disclosure [Abstract]      
Warranty reserve   $ 0.5 $ 0.3
Litigation settlement, amount awarded to other party $ 6.8    
Purchase commitment, remaining minimum amount committed   $ 25.0  
XML 98 R78.htm IDEA: XBRL DOCUMENT v3.20.4
INTEREST AND OTHER (INCOME) EXPENSE, NET (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Other Income and Expenses [Abstract]      
Interest income $ (607) $ (661) $ (261)
Interest expense 6,374 3,089 310
Other (income) expense, net (166) 482 (62)
Interest and other expense (income) 5,601 2,910 (13)
Cash paid for interest $ 3,200 $ 400 $ 200
XML 99 R79.htm IDEA: XBRL DOCUMENT v3.20.4
CREDIT FACILITY AND LONG-TERM DEBT CREDIT FACILITY AND LONG-TERM DEBT - Narrative (Details)
12 Months Ended
Sep. 17, 2019
USD ($)
day
$ / shares
shares
Dec. 31, 2020
USD ($)
$ / shares
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Debt Instrument [Line Items]        
Proceeds from convertible debt   $ 0 $ 86,250,000 $ 0
Debt instrument, convertible, conversion ratio   0.0115434    
Convertible notes, equity     29,834,000  
Debt instrument, convertible, remaining discount amortization period   68 months 15 days    
Share price (in dollars per share) | $ / shares   $ 145.65    
Line of Credit | Revolving Credit Facility        
Debt Instrument [Line Items]        
Repayments of debt   $ 12,800,000    
Line of Credit | Letter of Credit        
Debt Instrument [Line Items]        
Debt instrument, collateral amount   2,000,000.0    
Convertible Debt        
Debt Instrument [Line Items]        
Debt instrument, interest rate, effective percentage 15.30%      
Senior Convertible Note        
Debt Instrument [Line Items]        
Proceeds from convertible debt $ 83,700,000      
Debt instrument, convertible, if-converted value in excess of principal   58,800,000    
Senior Convertible Note | Convertible Debt        
Debt Instrument [Line Items]        
Face amount $ 86,250,000 86,250,000 86,250,000  
Debt instrument, interest rate, stated percentage 3.75%      
Debt instrument, convertible, conversion price (in dollars per share) | $ / shares $ 86.63      
Debt instrument, shares issuable upon conversion (in shares) | shares 995,618      
Debt instrument, debt default, maximum rate increase 0.50%      
Debt instrument, convertible, carrying amount of equity component   39,500,000    
Debt instrument, debt issuance costs, net   1,500,000    
Convertible notes, equity   9,700,000    
Interest expense, debt   6,345,000 $ 2,669,000  
Fair Value, Inputs, Level 2 | Senior Convertible Note        
Debt Instrument [Line Items]        
Convertible debt, fair value disclosures   $ 156,900,000    
Initial Purchasers | Senior Convertible Note | Convertible Debt        
Debt Instrument [Line Items]        
Face amount $ 11,250,000      
Debt Instrument, Redemption, Period One | Senior Convertible Note | Convertible Debt        
Debt Instrument [Line Items]        
Debt instrument, convertible, threshold trading days | day 20      
Debt instrument, convertible, threshold consecutive trading days | day 30      
Debt instrument, convertible, threshold percentage of stock price trigger 130.00%      
Debt Instrument, Redemption, Period Two | Senior Convertible Note | Convertible Debt        
Debt Instrument [Line Items]        
Debt instrument, convertible, threshold consecutive trading days | day 5      
Debt instrument, convertible, threshold percentage of stock price trigger 98.00%      
Debt instrument, convertible, threshold business trading days | day 5      
Debt Instrument, Redemption, Period Three | Senior Convertible Note | Convertible Debt        
Debt Instrument [Line Items]        
Debt instrument, convertible, threshold trading days | day 20      
Debt instrument, convertible, threshold consecutive trading days | day 30      
Debt instrument, convertible, threshold percentage of stock price trigger 130.00%      
Debt instrument, redemption price, percentage 100.00%      
XML 100 R80.htm IDEA: XBRL DOCUMENT v3.20.4
CREDIT FACILITY AND LONG-TERM DEBT CREDIT FACILITY AND LONG-TERM DEBT - Carrying Amount of Debt (Details) - Convertible Debt - Senior Convertible Note - USD ($)
Dec. 31, 2020
Dec. 31, 2019
Sep. 17, 2019
Debt Instrument [Line Items]      
Principal amount of the Notes $ 86,250,000 $ 86,250,000 $ 86,250,000
Unamortized debt discount (37,791,000) (40,902,000)  
Net carrying amount $ 48,459,000 $ 45,348,000  
XML 101 R81.htm IDEA: XBRL DOCUMENT v3.20.4
CREDIT FACILITY AND LONG-TERM DEBT CREDIT FACILITY AND LONG-TERM DEBT - Interest Expense Related to the Notes (Details) - Senior Convertible Note - Convertible Debt - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Debt Instrument [Line Items]    
Interest expense related to contractual coupon interest $ 3,234 $ 925
Interest expense related to amortization of the debt discount 3,111 1,744
Total interest expense related to debt $ 6,345 $ 2,669
XML 102 R82.htm IDEA: XBRL DOCUMENT v3.20.4
CONVERTIBLE NOTE RECEIVABLE (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Debt Instrument [Line Items]    
Net carrying amount $ 6,671 $ 0
Equity Method Investee | Convertible Note Receivable    
Debt Instrument [Line Items]    
Principal amount 6,650  
Unamortized discount (977)  
Net carrying amount $ 5,673  
XML 103 R83.htm IDEA: XBRL DOCUMENT v3.20.4
CONVERTIBLE NOTE RECEIVABLE - Additional Information (Details) - USD ($)
12 Months Ended
Dec. 09, 2020
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Debt Instrument [Line Items]        
Principal amount   $ 6,650,000 $ 0 $ 0
Equity Method Investee | Convertible Note Receivable        
Debt Instrument [Line Items]        
Principal amount $ 6,650,000      
Related party transaction, rate 3.00%      
Related party transaction, effective interest rate 8.69%      
Embedded derivative, fair value of embedded derivative asset   $ 1,000,000.0    
XML 104 R84.htm IDEA: XBRL DOCUMENT v3.20.4
SEGMENT REPORTING (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2020
USD ($)
segment
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Segment Reporting [Abstract]      
Number of reportable segments | segment 2    
Segment Reporting, Other Significant Reconciling Item [Line Items]      
Total revenue $ 197,323 $ 122,661 $ 127,446
Cost of revenue 116,033 68,212 70,808
Gross profit $ 81,290 $ 54,449 $ 56,638
Gross margin 41.00% 44.00% 44.00%
Operating income (loss) $ (8,192) $ 327 $ 3,794
Income (loss) before income taxes (13,793) (2,583) 3,807
Investments in unconsolidated affiliates 6,704 7,424 8,018
Total Assets 399,839 244,424 156,452
Net Assets 287,053 154,534 122,409
Capital Expenditures 686 1,044 1,358
Depreciation and Amortization 11,385 4,916 4,595
Total long-lived assets 35,542 15,469 15,981
North America Segment | Operating Segments      
Segment Reporting, Other Significant Reconciling Item [Line Items]      
Total revenue 131,066 115,423 124,391
Cost of revenue 70,163 63,089 68,555
Gross profit $ 60,903 $ 52,334 $ 55,836
Gross margin 46.00% 45.00% 45.00%
Operating income (loss) $ (4,977) $ 1,426 $ 3,622
Income (loss) before income taxes (7,871) (1,343) 3,717
Investments in unconsolidated affiliates 6,704 7,424 8,018
Total Assets 238,550 219,402 152,663
Net Assets 156,931 133,835 118,770
Capital Expenditures 443 1,005 1,329
Depreciation and Amortization 4,735 4,788 4,586
International Segment | Operating Segments      
Segment Reporting, Other Significant Reconciling Item [Line Items]      
Total revenue 66,257 7,238 3,055
Cost of revenue 45,870 5,123 2,253
Gross profit $ 20,387 $ 2,115 $ 802
Gross margin 31.00% 29.00% 26.00%
Operating income (loss) $ (3,215) $ (1,099) $ 172
Income (loss) before income taxes (5,922) (1,240) 90
Investments in unconsolidated affiliates 0 0 0
Total Assets 161,289 25,022 3,789
Net Assets 130,122 20,699 3,639
Capital Expenditures 243 39 29
Depreciation and Amortization $ 6,650 $ 128 $ 9
Customer Concentration Risk | Sales Revenue, Net | Merck      
Segment Reporting, Other Significant Reconciling Item [Line Items]      
Concentration risk, percentage 5.00% 1.00% 12.00%
Customer Concentration Risk | Sales Revenue, Net | Covetrus      
Segment Reporting, Other Significant Reconciling Item [Line Items]      
Concentration risk, percentage 6.00% 14.00% 15.00%
United States      
Segment Reporting, Other Significant Reconciling Item [Line Items]      
Total revenue $ 120,244 $ 113,485 $ 123,965
Total long-lived assets 11,805 14,712 15,933
Canada      
Segment Reporting, Other Significant Reconciling Item [Line Items]      
Total revenue 10,822 1,938 425
Total long-lived assets 643 0 11
Germany      
Segment Reporting, Other Significant Reconciling Item [Line Items]      
Total revenue 29,543 0 0
Total long-lived assets 14,630 0 0
France      
Segment Reporting, Other Significant Reconciling Item [Line Items]      
Total revenue 12,615 3,473 0
Total long-lived assets 4,205 152 0
Spain      
Segment Reporting, Other Significant Reconciling Item [Line Items]      
Total revenue 12,995 759 0
Total long-lived assets 1,209 391 0
Italy      
Segment Reporting, Other Significant Reconciling Item [Line Items]      
Total revenue 5,850 0 0
Total long-lived assets 1,944 0 0
Switzerland      
Segment Reporting, Other Significant Reconciling Item [Line Items]      
Total revenue 3,343 2,820 3,056
Total long-lived assets 46 33 37
Other International      
Segment Reporting, Other Significant Reconciling Item [Line Items]      
Total revenue 1,911 186 0
Total long-lived assets $ 1,060 $ 181 $ 0
North America | Customer Concentration Risk | Sales Revenue, Net | Covetrus      
Segment Reporting, Other Significant Reconciling Item [Line Items]      
Concentration risk, percentage 5.00% 14.00% 15.00%
International | Customer Concentration Risk | Sales Revenue, Net | Covetrus      
Segment Reporting, Other Significant Reconciling Item [Line Items]      
Concentration risk, percentage 1.00%    
XML 105 R85.htm IDEA: XBRL DOCUMENT v3.20.4
SUBSEQUENT EVENTS (Details)
12 Months Ended
Feb. 01, 2021
USD ($)
payment
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Subsequent Event [Line Items]        
Principal amount   $ 6,650,000 $ 0 $ 0
Subsequent Event | Equity Method Investee        
Subsequent Event [Line Items]        
Number of consecutive monthly payments | payment 12      
Principal amount $ 9,000,000.0      
Related party transaction, rate 10.00%      
Lacuna Diagnostics, Inc. | Subsequent Event        
Subsequent Event [Line Items]        
Total fair value of consideration transferred $ 4,300,000      
Lacuna Diagnostics, Inc. | Subsequent Event | Performance Metric Earn Out, Initial Period        
Subsequent Event [Line Items]        
Business combination, contingent consideration, liability $ 2,000,000      
Business combination, earn-out period 12 months      
Lacuna Diagnostics, Inc. | Subsequent Event | Performance Metric Earn Out, Subsequent Period        
Subsequent Event [Line Items]        
Business combination, earn-out period 12 months      
Business combination, contingent consideration arrangements, change in range of outcomes, contingent consideration, liability, value, low $ 1,000,000      
EXCEL 106 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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�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end XML 107 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 108 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 109 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.4 html 379 618 1 false 117 0 false 13 false false R1.htm 0001001 - Document - Cover Sheet http://Heska.com/role/Cover Cover Cover 1 false false R2.htm 1001002 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://Heska.com/role/CONSOLIDATEDBALANCESHEETS CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 1002003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://Heska.com/role/CONSOLIDATEDBALANCESHEETSParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 1003004 - Statement - CONSOLIDATED STATEMENTS OF INCOME Sheet http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME CONSOLIDATED STATEMENTS OF INCOME Statements 4 false false R5.htm 1004005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Sheet http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Statements 5 false false R6.htm 1005006 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Sheet http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Statements 6 false false R7.htm 1006007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 7 false false R8.htm 2101101 - Disclosure - OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 2105102 - Disclosure - REVENUE Sheet http://Heska.com/role/REVENUE REVENUE Notes 9 false false R10.htm 2109103 - Disclosure - ACQUISITION AND RELATED PARTY ITEMS Sheet http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMS ACQUISITION AND RELATED PARTY ITEMS Notes 10 false false R11.htm 2116104 - Disclosure - INVESTMENTS IN UNCONSOLIDATED AFFILIATES Sheet http://Heska.com/role/INVESTMENTSINUNCONSOLIDATEDAFFILIATES INVESTMENTS IN UNCONSOLIDATED AFFILIATES Notes 11 false false R12.htm 2119105 - Disclosure - INCOME TAXES Sheet http://Heska.com/role/INCOMETAXES INCOME TAXES Notes 12 false false R13.htm 2127106 - Disclosure - LEASES Sheet http://Heska.com/role/LEASES LEASES Notes 13 false false R14.htm 2136107 - Disclosure - EARNINGS PER SHARE Sheet http://Heska.com/role/EARNINGSPERSHARE EARNINGS PER SHARE Notes 14 false false R15.htm 2139108 - Disclosure - GOODWILL AND OTHER INTANGIBLES Sheet http://Heska.com/role/GOODWILLANDOTHERINTANGIBLES GOODWILL AND OTHER INTANGIBLES Notes 15 false false R16.htm 2142109 - Disclosure - PROPERTY AND EQUIPMENT Sheet http://Heska.com/role/PROPERTYANDEQUIPMENT PROPERTY AND EQUIPMENT Notes 16 false false R17.htm 2145110 - Disclosure - INVENTORIES Sheet http://Heska.com/role/INVENTORIES INVENTORIES Notes 17 false false R18.htm 2148111 - Disclosure - ACCRUED LIABILITIES Sheet http://Heska.com/role/ACCRUEDLIABILITIES ACCRUED LIABILITIES Notes 18 false false R19.htm 2151112 - Disclosure - CAPITAL STOCK Sheet http://Heska.com/role/CAPITALSTOCK CAPITAL STOCK Notes 19 false false R20.htm 2157113 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME Sheet http://Heska.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME ACCUMULATED OTHER COMPREHENSIVE INCOME Notes 20 false false R21.htm 2160114 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://Heska.com/role/COMMITMENTSANDCONTINGENCIES COMMITMENTS AND CONTINGENCIES Notes 21 false false R22.htm 2162115 - Disclosure - INTEREST AND OTHER (INCOME) EXPENSE, NET Sheet http://Heska.com/role/INTERESTANDOTHERINCOMEEXPENSENET INTEREST AND OTHER (INCOME) EXPENSE, NET Notes 22 false false R23.htm 2165116 - Disclosure - CREDIT FACILITY AND LONG-TERM DEBT Sheet http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBT CREDIT FACILITY AND LONG-TERM DEBT Notes 23 false false R24.htm 2170117 - Disclosure - CONVERTIBLE NOTE RECEIVABLE Sheet http://Heska.com/role/CONVERTIBLENOTERECEIVABLE CONVERTIBLE NOTE RECEIVABLE Notes 24 false false R25.htm 2174118 - Disclosure - SEGMENT REPORTING Sheet http://Heska.com/role/SEGMENTREPORTING SEGMENT REPORTING Notes 25 false false R26.htm 2177119 - Disclosure - SUBSEQUENT EVENTS Sheet http://Heska.com/role/SUBSEQUENTEVENTS SUBSEQUENT EVENTS Notes 26 false false R27.htm 2202201 - Disclosure - OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 27 false false R28.htm 2303301 - Disclosure - OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES 28 false false R29.htm 2306302 - Disclosure - REVENUE (Tables) Sheet http://Heska.com/role/REVENUETables REVENUE (Tables) Tables http://Heska.com/role/REVENUE 29 false false R30.htm 2310303 - Disclosure - ACQUISITION AND RELATED PARTY ITEMS ACQUISITION AND RELATED PARTY ITEMS (Tables) Sheet http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSACQUISITIONANDRELATEDPARTYITEMSTables ACQUISITION AND RELATED PARTY ITEMS ACQUISITION AND RELATED PARTY ITEMS (Tables) Tables 30 false false R31.htm 2317304 - Disclosure - INVESTMENTS IN UNCONSOLIDATED AFFILIATES (Tables) Sheet http://Heska.com/role/INVESTMENTSINUNCONSOLIDATEDAFFILIATESTables INVESTMENTS IN UNCONSOLIDATED AFFILIATES (Tables) Tables http://Heska.com/role/INVESTMENTSINUNCONSOLIDATEDAFFILIATES 31 false false R32.htm 2320305 - Disclosure - INCOME TAXES (Tables) Sheet http://Heska.com/role/INCOMETAXESTables INCOME TAXES (Tables) Tables http://Heska.com/role/INCOMETAXES 32 false false R33.htm 2328306 - Disclosure - LEASES (Tables) Sheet http://Heska.com/role/LEASESTables LEASES (Tables) Tables http://Heska.com/role/LEASES 33 false false R34.htm 2337307 - Disclosure - EARNINGS PER SHARE (Tables) Sheet http://Heska.com/role/EARNINGSPERSHARETables EARNINGS PER SHARE (Tables) Tables http://Heska.com/role/EARNINGSPERSHARE 34 false false R35.htm 2340308 - Disclosure - GOODWILL AND OTHER INTANGIBLES (Tables) Sheet http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESTables GOODWILL AND OTHER INTANGIBLES (Tables) Tables http://Heska.com/role/GOODWILLANDOTHERINTANGIBLES 35 false false R36.htm 2343309 - Disclosure - PROPERTY AND EQUIPMENT (Tables) Sheet http://Heska.com/role/PROPERTYANDEQUIPMENTTables PROPERTY AND EQUIPMENT (Tables) Tables http://Heska.com/role/PROPERTYANDEQUIPMENT 36 false false R37.htm 2346310 - Disclosure - INVENTORIES (Tables) Sheet http://Heska.com/role/INVENTORIESTables INVENTORIES (Tables) Tables http://Heska.com/role/INVENTORIES 37 false false R38.htm 2349311 - Disclosure - ACCRUED LIABILITIES (Tables) Sheet http://Heska.com/role/ACCRUEDLIABILITIESTables ACCRUED LIABILITIES (Tables) Tables http://Heska.com/role/ACCRUEDLIABILITIES 38 false false R39.htm 2352312 - Disclosure - CAPITAL STOCK (Tables) Sheet http://Heska.com/role/CAPITALSTOCKTables CAPITAL STOCK (Tables) Tables http://Heska.com/role/CAPITALSTOCK 39 false false R40.htm 2358313 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables) Sheet http://Heska.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables) Tables http://Heska.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME 40 false false R41.htm 2363314 - Disclosure - INTEREST AND OTHER (INCOME) EXPENSE, NET (Tables) Sheet http://Heska.com/role/INTERESTANDOTHERINCOMEEXPENSENETTables INTEREST AND OTHER (INCOME) EXPENSE, NET (Tables) Tables http://Heska.com/role/INTERESTANDOTHERINCOMEEXPENSENET 41 false false R42.htm 2366315 - Disclosure - CREDIT FACILITY AND LONG-TERM DEBT CREDIT FACILITY AND LONG-TERM DEBT (Tables) Sheet http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTTables CREDIT FACILITY AND LONG-TERM DEBT CREDIT FACILITY AND LONG-TERM DEBT (Tables) Tables 42 false false R43.htm 2371316 - Disclosure - CONVERTIBLE NOTE RECEIVABLE (Tables) Sheet http://Heska.com/role/CONVERTIBLENOTERECEIVABLETables CONVERTIBLE NOTE RECEIVABLE (Tables) Tables http://Heska.com/role/CONVERTIBLENOTERECEIVABLE 43 false false R44.htm 2375317 - Disclosure - SEGMENT REPORTING (Tables) Sheet http://Heska.com/role/SEGMENTREPORTINGTables SEGMENT REPORTING (Tables) Tables http://Heska.com/role/SEGMENTREPORTING 44 false false R45.htm 2404401 - Disclosure - OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables 45 false false R46.htm 2407402 - Disclosure - REVENUE (Details) Sheet http://Heska.com/role/REVENUEDetails REVENUE (Details) Details http://Heska.com/role/REVENUETables 46 false false R47.htm 2408403 - Disclosure - REVENUE - Performance Obligations (Details) Sheet http://Heska.com/role/REVENUEPerformanceObligationsDetails REVENUE - Performance Obligations (Details) Details 47 false false R48.htm 2411404 - Disclosure - ACQUISITION AND RELATED PARTY ITEMS - Additional Information (Details) Sheet http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails ACQUISITION AND RELATED PARTY ITEMS - Additional Information (Details) Details 48 false false R49.htm 2412405 - Disclosure - ACQUISITION AND RELATED PARTY ITEMS - Fair Values of Assets and Liabilties at Scil Acquisition Date (Details) Sheet http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails ACQUISITION AND RELATED PARTY ITEMS - Fair Values of Assets and Liabilties at Scil Acquisition Date (Details) Details 49 false false R50.htm 2413406 - Disclosure - ACQUISITION AND RELATED PARTY ITEMS - Fair Value of Assets and Liabilities at CVM Acquisition Date (Details) Sheet http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails ACQUISITION AND RELATED PARTY ITEMS - Fair Value of Assets and Liabilities at CVM Acquisition Date (Details) Details 50 false false R51.htm 2414407 - Disclosure - ACQUISITION AND RELATED PARTY ITEMS - Intangible Assets Acquired, Amortization Method (Details) Sheet http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSIntangibleAssetsAcquiredAmortizationMethodDetails ACQUISITION AND RELATED PARTY ITEMS - Intangible Assets Acquired, Amortization Method (Details) Details 51 false false R52.htm 2415408 - Disclosure - ACQUISITION AND RELATED PARTY ITEMS - Unaudited Pro Forma Financial Information (Details) Sheet http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSUnauditedProFormaFinancialInformationDetails ACQUISITION AND RELATED PARTY ITEMS - Unaudited Pro Forma Financial Information (Details) Details 52 false false R53.htm 2418409 - Disclosure - INVESTMENTS IN UNCONSOLIDATED AFFILIATES (Details) Sheet http://Heska.com/role/INVESTMENTSINUNCONSOLIDATEDAFFILIATESDetails INVESTMENTS IN UNCONSOLIDATED AFFILIATES (Details) Details http://Heska.com/role/INVESTMENTSINUNCONSOLIDATEDAFFILIATESTables 53 false false R54.htm 2421410 - Disclosure - INCOME TAXES (Details) Sheet http://Heska.com/role/INCOMETAXESDetails INCOME TAXES (Details) Details http://Heska.com/role/INCOMETAXESTables 54 false false R55.htm 2422411 - Disclosure - INCOME TAXES - COMPONENTS OF INCOME (LOSS) BEFORE TAXES (Details) Sheet http://Heska.com/role/INCOMETAXESCOMPONENTSOFINCOMELOSSBEFORETAXESDetails INCOME TAXES - COMPONENTS OF INCOME (LOSS) BEFORE TAXES (Details) Details 55 false false R56.htm 2423412 - Disclosure - INCOME TAXES - TEMPORARY DIFFERENCES TO THE COMPONENTS OF DEFERRED TAX ASSETS (Details) Sheet http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails INCOME TAXES - TEMPORARY DIFFERENCES TO THE COMPONENTS OF DEFERRED TAX ASSETS (Details) Details 56 false false R57.htm 2424413 - Disclosure - INCOME TAXES - COMPONENTS OF INCOME TAX EXPENSE (BENEFIT) (Details) Sheet http://Heska.com/role/INCOMETAXESCOMPONENTSOFINCOMETAXEXPENSEBENEFITDetails INCOME TAXES - COMPONENTS OF INCOME TAX EXPENSE (BENEFIT) (Details) Details 57 false false R58.htm 2425414 - Disclosure - INCOME TAXES - EFFECTIVE INCOME TAX RECONCILIATION (Details) Sheet http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails INCOME TAXES - EFFECTIVE INCOME TAX RECONCILIATION (Details) Details 58 false false R59.htm 2426415 - Disclosure - INCOME TAXES - UNRECOGNIZED TAX BENEFITS ROLL FORWARD (Details) Sheet http://Heska.com/role/INCOMETAXESUNRECOGNIZEDTAXBENEFITSROLLFORWARDDetails INCOME TAXES - UNRECOGNIZED TAX BENEFITS ROLL FORWARD (Details) Details 59 false false R60.htm 2429416 - Disclosure - LEASES - Operating and Financing Lease Balances (Details) Sheet http://Heska.com/role/LEASESOperatingandFinancingLeaseBalancesDetails LEASES - Operating and Financing Lease Balances (Details) Details 60 false false R61.htm 2430417 - Disclosure - LEASES - Additional Information (Details) Sheet http://Heska.com/role/LEASESAdditionalInformationDetails LEASES - Additional Information (Details) Details 61 false false R62.htm 2431418 - Disclosure - LEASES - Supplemental Cash Flow Information (Details) Sheet http://Heska.com/role/LEASESSupplementalCashFlowInformationDetails LEASES - Supplemental Cash Flow Information (Details) Details 62 false false R63.htm 2432419 - Disclosure - LEASES - Weighted Average Remaining Lease Term and Weighted Average Discount Rate (Details) Sheet http://Heska.com/role/LEASESWeightedAverageRemainingLeaseTermandWeightedAverageDiscountRateDetails LEASES - Weighted Average Remaining Lease Term and Weighted Average Discount Rate (Details) Details 63 false false R64.htm 2433420 - Disclosure - LEASES - Lessee Accounting (Details) Sheet http://Heska.com/role/LEASESLesseeAccountingDetails LEASES - Lessee Accounting (Details) Details 64 false false R65.htm 2434421 - Disclosure - LEASES - Lessor Accounting (Details) Sheet http://Heska.com/role/LEASESLessorAccountingDetails LEASES - Lessor Accounting (Details) Details 65 false false R66.htm 2435422 - Disclosure - LEASES - Sales-type Leases and Lease Income (Details) Sheet http://Heska.com/role/LEASESSalestypeLeasesandLeaseIncomeDetails LEASES - Sales-type Leases and Lease Income (Details) Details 66 false false R67.htm 2438423 - Disclosure - EARNINGS PER SHARE (Details) Sheet http://Heska.com/role/EARNINGSPERSHAREDetails EARNINGS PER SHARE (Details) Details http://Heska.com/role/EARNINGSPERSHARETables 67 false false R68.htm 2441424 - Disclosure - GOODWILL AND OTHER INTANGIBLES (Details) Sheet http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails GOODWILL AND OTHER INTANGIBLES (Details) Details http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESTables 68 false false R69.htm 2444425 - Disclosure - PROPERTY AND EQUIPMENT (Details) Sheet http://Heska.com/role/PROPERTYANDEQUIPMENTDetails PROPERTY AND EQUIPMENT (Details) Details http://Heska.com/role/PROPERTYANDEQUIPMENTTables 69 false false R70.htm 2447426 - Disclosure - INVENTORIES (Details) Sheet http://Heska.com/role/INVENTORIESDetails INVENTORIES (Details) Details http://Heska.com/role/INVENTORIESTables 70 false false R71.htm 2450427 - Disclosure - ACCRUED LIABILITIES (Details) Sheet http://Heska.com/role/ACCRUEDLIABILITIESDetails ACCRUED LIABILITIES (Details) Details http://Heska.com/role/ACCRUEDLIABILITIESTables 71 false false R72.htm 2453428 - Disclosure - CAPITAL STOCK - NARRATIVE (Details) Sheet http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails CAPITAL STOCK - NARRATIVE (Details) Details 72 false false R73.htm 2454429 - Disclosure - CAPITAL STOCK - OPTION ACTIVITY (Details) Sheet http://Heska.com/role/CAPITALSTOCKOPTIONACTIVITYDetails CAPITAL STOCK - OPTION ACTIVITY (Details) Details 73 false false R74.htm 2455430 - Disclosure - CAPITAL STOCK- SUMMARY OF INFORMATION BY EXERCISE PRICE RANGE (Details) Sheet http://Heska.com/role/CAPITALSTOCKSUMMARYOFINFORMATIONBYEXERCISEPRICERANGEDetails CAPITAL STOCK- SUMMARY OF INFORMATION BY EXERCISE PRICE RANGE (Details) Details 74 false false R75.htm 2456431 - Disclosure - CAPITAL STOCK CAPITAL STOCK - RESTRICTED STOCK (Details) Sheet http://Heska.com/role/CAPITALSTOCKCAPITALSTOCKRESTRICTEDSTOCKDetails CAPITAL STOCK CAPITAL STOCK - RESTRICTED STOCK (Details) Details 75 false false R76.htm 2459432 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (Details) Sheet http://Heska.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEDetails ACCUMULATED OTHER COMPREHENSIVE INCOME (Details) Details http://Heska.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables 76 false false R77.htm 2461433 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) Sheet http://Heska.com/role/COMMITMENTSANDCONTINGENCIESDetails COMMITMENTS AND CONTINGENCIES (Details) Details http://Heska.com/role/COMMITMENTSANDCONTINGENCIES 77 false false R78.htm 2464434 - Disclosure - INTEREST AND OTHER (INCOME) EXPENSE, NET (Details) Sheet http://Heska.com/role/INTERESTANDOTHERINCOMEEXPENSENETDetails INTEREST AND OTHER (INCOME) EXPENSE, NET (Details) Details http://Heska.com/role/INTERESTANDOTHERINCOMEEXPENSENETTables 78 false false R79.htm 2467435 - Disclosure - CREDIT FACILITY AND LONG-TERM DEBT CREDIT FACILITY AND LONG-TERM DEBT - Narrative (Details) Sheet http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails CREDIT FACILITY AND LONG-TERM DEBT CREDIT FACILITY AND LONG-TERM DEBT - Narrative (Details) Details http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTTables 79 false false R80.htm 2468436 - Disclosure - CREDIT FACILITY AND LONG-TERM DEBT CREDIT FACILITY AND LONG-TERM DEBT - Carrying Amount of Debt (Details) Sheet http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTCarryingAmountofDebtDetails CREDIT FACILITY AND LONG-TERM DEBT CREDIT FACILITY AND LONG-TERM DEBT - Carrying Amount of Debt (Details) Details 80 false false R81.htm 2469437 - Disclosure - CREDIT FACILITY AND LONG-TERM DEBT CREDIT FACILITY AND LONG-TERM DEBT - Interest Expense Related to the Notes (Details) Notes http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTInterestExpenseRelatedtotheNotesDetails CREDIT FACILITY AND LONG-TERM DEBT CREDIT FACILITY AND LONG-TERM DEBT - Interest Expense Related to the Notes (Details) Details 81 false false R82.htm 2472438 - Disclosure - CONVERTIBLE NOTE RECEIVABLE (Details) Sheet http://Heska.com/role/CONVERTIBLENOTERECEIVABLEDetails CONVERTIBLE NOTE RECEIVABLE (Details) Details http://Heska.com/role/CONVERTIBLENOTERECEIVABLETables 82 false false R83.htm 2473439 - Disclosure - CONVERTIBLE NOTE RECEIVABLE - Additional Information (Details) Sheet http://Heska.com/role/CONVERTIBLENOTERECEIVABLEAdditionalInformationDetails CONVERTIBLE NOTE RECEIVABLE - Additional Information (Details) Details 83 false false R84.htm 2476440 - Disclosure - SEGMENT REPORTING (Details) Sheet http://Heska.com/role/SEGMENTREPORTINGDetails SEGMENT REPORTING (Details) Details http://Heska.com/role/SEGMENTREPORTINGTables 84 false false R85.htm 2478441 - Disclosure - SUBSEQUENT EVENTS (Details) Sheet http://Heska.com/role/SUBSEQUENTEVENTSDetails SUBSEQUENT EVENTS (Details) Details http://Heska.com/role/SUBSEQUENTEVENTS 85 false false All Reports Book All Reports hska-20201231.htm heska-12312020xex1015.htm heska-12312020xex1032.htm heska-12312020xex10x31.htm heska-12312020xex211.htm heska-12312020xex231.htm heska-12312020xex232.htm heska-12312020xex31x1.htm heska-12312020xex42.htm heska-12312020xexx1030.htm heska-12312020xexx31x2.htm heska-12312020xexx32x1.htm hska-20201231.xsd hska-20201231_cal.xml hska-20201231_def.xml hska-20201231_lab.xml hska-20201231_pre.xml hska-20201231_g1.jpg hska-20201231_g2.jpg http://xbrl.sec.gov/dei/2020-01-31 http://xbrl.sec.gov/country/2020-01-31 http://fasb.org/us-gaap/2020-01-31 http://fasb.org/srt/2020-01-31 true true JSON 112 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "hska-20201231.htm": { "axisCustom": 1, "axisStandard": 38, "contextCount": 379, "dts": { "calculationLink": { "local": [ "hska-20201231_cal.xml" ] }, "definitionLink": { "local": [ "hska-20201231_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "hska-20201231.htm" ] }, "labelLink": { "local": [ "hska-20201231_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "hska-20201231_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml" ] }, "schema": { "local": [ "hska-20201231.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd" ] } }, "elementCount": 857, "entityCount": 1, "hidden": { "http://Heska.com/20201231": 2, "http://fasb.org/us-gaap/2020-01-31": 63, "http://xbrl.sec.gov/dei/2020-01-31": 4, "total": 69 }, "keyCustom": 70, "keyStandard": 548, "memberCustom": 53, "memberStandard": 57, "nsprefix": "hska", "nsuri": "http://Heska.com/20201231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover", "role": "http://Heska.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2109103 - Disclosure - ACQUISITION AND RELATED PARTY ITEMS", "role": "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMS", "shortName": "ACQUISITION AND RELATED PARTY ITEMS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2116104 - Disclosure - INVESTMENTS IN UNCONSOLIDATED AFFILIATES", "role": "http://Heska.com/role/INVESTMENTSINUNCONSOLIDATEDAFFILIATES", "shortName": "INVESTMENTS IN UNCONSOLIDATED AFFILIATES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2119105 - Disclosure - INCOME TAXES", "role": "http://Heska.com/role/INCOMETAXES", "shortName": "INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2127106 - Disclosure - LEASES", "role": "http://Heska.com/role/LEASES", "shortName": "LEASES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2136107 - Disclosure - EARNINGS PER SHARE", "role": "http://Heska.com/role/EARNINGSPERSHARE", "shortName": "EARNINGS PER SHARE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2139108 - Disclosure - GOODWILL AND OTHER INTANGIBLES", "role": "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLES", "shortName": "GOODWILL AND OTHER INTANGIBLES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2142109 - Disclosure - PROPERTY AND EQUIPMENT", "role": "http://Heska.com/role/PROPERTYANDEQUIPMENT", "shortName": "PROPERTY AND EQUIPMENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2145110 - Disclosure - INVENTORIES", "role": "http://Heska.com/role/INVENTORIES", "shortName": "INVENTORIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2148111 - Disclosure - ACCRUED LIABILITIES", "role": "http://Heska.com/role/ACCRUEDLIABILITIES", "shortName": "ACCRUED LIABILITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2151112 - Disclosure - CAPITAL STOCK", "role": "http://Heska.com/role/CAPITALSTOCK", "shortName": "CAPITAL STOCK", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ibe400f3fad3045a18918ff3e0e51c171_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1001002 - Statement - CONSOLIDATED BALANCE SHEETS", "role": "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS", "shortName": "CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ibe400f3fad3045a18918ff3e0e51c171_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2157113 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME", "role": "http://Heska.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME", "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2160114 - Disclosure - COMMITMENTS AND CONTINGENCIES", "role": "http://Heska.com/role/COMMITMENTSANDCONTINGENCIES", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InterestAndOtherIncomeTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2162115 - Disclosure - INTEREST AND OTHER (INCOME) EXPENSE, NET", "role": "http://Heska.com/role/INTERESTANDOTHERINCOMEEXPENSENET", "shortName": "INTEREST AND OTHER (INCOME) EXPENSE, NET", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InterestAndOtherIncomeTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2165116 - Disclosure - CREDIT FACILITY AND LONG-TERM DEBT", "role": "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBT", "shortName": "CREDIT FACILITY AND LONG-TERM DEBT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2170117 - Disclosure - CONVERTIBLE NOTE RECEIVABLE", "role": "http://Heska.com/role/CONVERTIBLENOTERECEIVABLE", "shortName": "CONVERTIBLE NOTE RECEIVABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2174118 - Disclosure - SEGMENT REPORTING", "role": "http://Heska.com/role/SEGMENTREPORTING", "shortName": "SEGMENT REPORTING", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2177119 - Disclosure - SUBSEQUENT EVENTS", "role": "http://Heska.com/role/SUBSEQUENTEVENTS", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2202201 - Disclosure - OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "role": "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies", "shortName": "OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2303301 - Disclosure - OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "role": "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables", "shortName": "OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2306302 - Disclosure - REVENUE (Tables)", "role": "http://Heska.com/role/REVENUETables", "shortName": "REVENUE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ibe400f3fad3045a18918ff3e0e51c171_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)", "role": "http://Heska.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2310303 - Disclosure - ACQUISITION AND RELATED PARTY ITEMS ACQUISITION AND RELATED PARTY ITEMS (Tables)", "role": "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSACQUISITIONANDRELATEDPARTYITEMSTables", "shortName": "ACQUISITION AND RELATED PARTY ITEMS ACQUISITION AND RELATED PARTY ITEMS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2317304 - Disclosure - INVESTMENTS IN UNCONSOLIDATED AFFILIATES (Tables)", "role": "http://Heska.com/role/INVESTMENTSINUNCONSOLIDATEDAFFILIATESTables", "shortName": "INVESTMENTS IN UNCONSOLIDATED AFFILIATES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2320305 - Disclosure - INCOME TAXES (Tables)", "role": "http://Heska.com/role/INCOMETAXESTables", "shortName": "INCOME TAXES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "hska:AssetsAndLiabilitiesLesseeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2328306 - Disclosure - LEASES (Tables)", "role": "http://Heska.com/role/LEASESTables", "shortName": "LEASES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "hska:AssetsAndLiabilitiesLesseeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2337307 - Disclosure - EARNINGS PER SHARE (Tables)", "role": "http://Heska.com/role/EARNINGSPERSHARETables", "shortName": "EARNINGS PER SHARE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2340308 - Disclosure - GOODWILL AND OTHER INTANGIBLES (Tables)", "role": "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESTables", "shortName": "GOODWILL AND OTHER INTANGIBLES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2343309 - Disclosure - PROPERTY AND EQUIPMENT (Tables)", "role": "http://Heska.com/role/PROPERTYANDEQUIPMENTTables", "shortName": "PROPERTY AND EQUIPMENT (Tables)", "subGroupType": "tables", "uniqueAnchor": null }, "R37": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2346310 - Disclosure - INVENTORIES (Tables)", "role": "http://Heska.com/role/INVENTORIESTables", "shortName": "INVENTORIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2349311 - Disclosure - ACCRUED LIABILITIES (Tables)", "role": "http://Heska.com/role/ACCRUEDLIABILITIESTables", "shortName": "ACCRUED LIABILITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2352312 - Disclosure - CAPITAL STOCK (Tables)", "role": "http://Heska.com/role/CAPITALSTOCKTables", "shortName": "CAPITAL STOCK (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003004 - Statement - CONSOLIDATED STATEMENTS OF INCOME", "role": "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME", "shortName": "CONSOLIDATED STATEMENTS OF INCOME", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:SellingAndMarketingExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2358313 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)", "role": "http://Heska.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables", "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "hska:InterestExpenseIncomeandOtherIncomeNetTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2363314 - Disclosure - INTEREST AND OTHER (INCOME) EXPENSE, NET (Tables)", "role": "http://Heska.com/role/INTERESTANDOTHERINCOMEEXPENSENETTables", "shortName": "INTEREST AND OTHER (INCOME) EXPENSE, NET (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "hska:InterestExpenseIncomeandOtherIncomeNetTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConvertibleDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2366315 - Disclosure - CREDIT FACILITY AND LONG-TERM DEBT CREDIT FACILITY AND LONG-TERM DEBT (Tables)", "role": "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTTables", "shortName": "CREDIT FACILITY AND LONG-TERM DEBT CREDIT FACILITY AND LONG-TERM DEBT (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConvertibleDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2371316 - Disclosure - CONVERTIBLE NOTE RECEIVABLE (Tables)", "role": "http://Heska.com/role/CONVERTIBLENOTERECEIVABLETables", "shortName": "CONVERTIBLE NOTE RECEIVABLE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2375317 - Disclosure - SEGMENT REPORTING (Tables)", "role": "http://Heska.com/role/SEGMENTREPORTINGTables", "shortName": "SEGMENT REPORTING (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i101f2c87a99d42fb88d21c0b0c403d78_I20181231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2404401 - Disclosure - OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "role": "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails", "shortName": "OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ibc78c6e146284324a226cd84f8234be3_I20171231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407402 - Disclosure - REVENUE (Details)", "role": "http://Heska.com/role/REVENUEDetails", "shortName": "REVENUE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ibe400f3fad3045a18918ff3e0e51c171_I20201231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetNetCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ibe400f3fad3045a18918ff3e0e51c171_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408403 - Disclosure - REVENUE - Performance Obligations (Details)", "role": "http://Heska.com/role/REVENUEPerformanceObligationsDetails", "shortName": "REVENUE - Performance Obligations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ibe400f3fad3045a18918ff3e0e51c171_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ia396796044924e569a662d56ee164ed1_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411404 - Disclosure - ACQUISITION AND RELATED PARTY ITEMS - Additional Information (Details)", "role": "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails", "shortName": "ACQUISITION AND RELATED PARTY ITEMS - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "if88361bdc23d4c9d8b97cf0cc9f1d216_I20181221", "decimals": "INF", "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ibe400f3fad3045a18918ff3e0e51c171_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2412405 - Disclosure - ACQUISITION AND RELATED PARTY ITEMS - Fair Values of Assets and Liabilties at Scil Acquisition Date (Details)", "role": "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails", "shortName": "ACQUISITION AND RELATED PARTY ITEMS - Fair Values of Assets and Liabilties at Scil Acquisition Date (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "icd24b871cff042dba4cf261458bb14d4_I20200401", "decimals": "-3", "lang": "en-US", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "role": "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME", "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2413406 - Disclosure - ACQUISITION AND RELATED PARTY ITEMS - Fair Value of Assets and Liabilities at CVM Acquisition Date (Details)", "role": "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails", "shortName": "ACQUISITION AND RELATED PARTY ITEMS - Fair Value of Assets and Liabilities at CVM Acquisition Date (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i82eb7dcd6a3d45b291f6a61245a42f26_D20191205-20191205", "decimals": "-3", "lang": "en-US", "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ibe400f3fad3045a18918ff3e0e51c171_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2414407 - Disclosure - ACQUISITION AND RELATED PARTY ITEMS - Intangible Assets Acquired, Amortization Method (Details)", "role": "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSIntangibleAssetsAcquiredAmortizationMethodDetails", "shortName": "ACQUISITION AND RELATED PARTY ITEMS - Intangible Assets Acquired, Amortization Method (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "icd24b871cff042dba4cf261458bb14d4_I20200401", "decimals": "-3", "lang": "en-US", "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ie67e897015c640849f96a6c40f3820d2_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2415408 - Disclosure - ACQUISITION AND RELATED PARTY ITEMS - Unaudited Pro Forma Financial Information (Details)", "role": "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSUnauditedProFormaFinancialInformationDetails", "shortName": "ACQUISITION AND RELATED PARTY ITEMS - Unaudited Pro Forma Financial Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ie67e897015c640849f96a6c40f3820d2_D20200101-20201231", "decimals": "-3", "lang": "en-US", "name": "hska:BusinessAcquisitionProFormaNetIncomeLossIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:EquityMethodInvestmentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ibe400f3fad3045a18918ff3e0e51c171_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2418409 - Disclosure - INVESTMENTS IN UNCONSOLIDATED AFFILIATES (Details)", "role": "http://Heska.com/role/INVESTMENTSINUNCONSOLIDATEDAFFILIATESDetails", "shortName": "INVESTMENTS IN UNCONSOLIDATED AFFILIATES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:EquityMethodInvestmentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ibe400f3fad3045a18918ff3e0e51c171_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxExpenseBenefit", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2421410 - Disclosure - INCOME TAXES (Details)", "role": "http://Heska.com/role/INCOMETAXESDetails", "shortName": "INCOME TAXES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2422411 - Disclosure - INCOME TAXES - COMPONENTS OF INCOME (LOSS) BEFORE TAXES (Details)", "role": "http://Heska.com/role/INCOMETAXESCOMPONENTSOFINCOMELOSSBEFORETAXESDetails", "shortName": "INCOME TAXES - COMPONENTS OF INCOME (LOSS) BEFORE TAXES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ibe400f3fad3045a18918ff3e0e51c171_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DeferredTaxAssetsInventory", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2423412 - Disclosure - INCOME TAXES - TEMPORARY DIFFERENCES TO THE COMPONENTS OF DEFERRED TAX ASSETS (Details)", "role": "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails", "shortName": "INCOME TAXES - TEMPORARY DIFFERENCES TO THE COMPONENTS OF DEFERRED TAX ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ibe400f3fad3045a18918ff3e0e51c171_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DeferredTaxAssetsInventory", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2424413 - Disclosure - INCOME TAXES - COMPONENTS OF INCOME TAX EXPENSE (BENEFIT) (Details)", "role": "http://Heska.com/role/INCOMETAXESCOMPONENTSOFINCOMETAXEXPENSEBENEFITDetails", "shortName": "INCOME TAXES - COMPONENTS OF INCOME TAX EXPENSE (BENEFIT) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2425414 - Disclosure - INCOME TAXES - EFFECTIVE INCOME TAX RECONCILIATION (Details)", "role": "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails", "shortName": "INCOME TAXES - EFFECTIVE INCOME TAX RECONCILIATION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ia396796044924e569a662d56ee164ed1_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2426415 - Disclosure - INCOME TAXES - UNRECOGNIZED TAX BENEFITS ROLL FORWARD (Details)", "role": "http://Heska.com/role/INCOMETAXESUNRECOGNIZEDTAXBENEFITSROLLFORWARDDetails", "shortName": "INCOME TAXES - UNRECOGNIZED TAX BENEFITS ROLL FORWARD (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ia91fb6d0759b4fbf96a4d9220c7cb7e5_I20171231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:SharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005006 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY", "role": "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ia91fb6d0759b4fbf96a4d9220c7cb7e5_I20171231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:SharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ibe400f3fad3045a18918ff3e0e51c171_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2429416 - Disclosure - LEASES - Operating and Financing Lease Balances (Details)", "role": "http://Heska.com/role/LEASESOperatingandFinancingLeaseBalancesDetails", "shortName": "LEASES - Operating and Financing Lease Balances (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "hska:AssetsAndLiabilitiesLesseeTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ibe400f3fad3045a18918ff3e0e51c171_I20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:FinanceLeaseRightOfUseAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2430417 - Disclosure - LEASES - Additional Information (Details)", "role": "http://Heska.com/role/LEASESAdditionalInformationDetails", "shortName": "LEASES - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2431418 - Disclosure - LEASES - Supplemental Cash Flow Information (Details)", "role": "http://Heska.com/role/LEASESSupplementalCashFlowInformationDetails", "shortName": "LEASES - Supplemental Cash Flow Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:FinanceLeaseInterestPaymentOnLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ibe400f3fad3045a18918ff3e0e51c171_I20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2432419 - Disclosure - LEASES - Weighted Average Remaining Lease Term and Weighted Average Discount Rate (Details)", "role": "http://Heska.com/role/LEASESWeightedAverageRemainingLeaseTermandWeightedAverageDiscountRateDetails", "shortName": "LEASES - Weighted Average Remaining Lease Term and Weighted Average Discount Rate (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ibe400f3fad3045a18918ff3e0e51c171_I20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ibe400f3fad3045a18918ff3e0e51c171_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2433420 - Disclosure - LEASES - Lessee Accounting (Details)", "role": "http://Heska.com/role/LEASESLesseeAccountingDetails", "shortName": "LEASES - Lessee Accounting (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ibe400f3fad3045a18918ff3e0e51c171_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ibe400f3fad3045a18918ff3e0e51c171_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2434421 - Disclosure - LEASES - Lessor Accounting (Details)", "role": "http://Heska.com/role/LEASESLessorAccountingDetails", "shortName": "LEASES - Lessor Accounting (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ibe400f3fad3045a18918ff3e0e51c171_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SalesTypeLeaseLeaseIncomeTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:SalesTypeLeaseRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2435422 - Disclosure - LEASES - Sales-type Leases and Lease Income (Details)", "role": "http://Heska.com/role/LEASESSalestypeLeasesandLeaseIncomeDetails", "shortName": "LEASES - Sales-type Leases and Lease Income (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SalesTypeLeaseLeaseIncomeTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:SalesTypeLeaseRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteStockSplitConversionRatio1", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2438423 - Disclosure - EARNINGS PER SHARE (Details)", "role": "http://Heska.com/role/EARNINGSPERSHAREDetails", "shortName": "EARNINGS PER SHARE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ia396796044924e569a662d56ee164ed1_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2441424 - Disclosure - GOODWILL AND OTHER INTANGIBLES (Details)", "role": "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails", "shortName": "GOODWILL AND OTHER INTANGIBLES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:GoodwillAcquiredDuringPeriod", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ibe400f3fad3045a18918ff3e0e51c171_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2444425 - Disclosure - PROPERTY AND EQUIPMENT (Details)", "role": "http://Heska.com/role/PROPERTYANDEQUIPMENTDetails", "shortName": "PROPERTY AND EQUIPMENT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ibe400f3fad3045a18918ff3e0e51c171_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "role": "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "-3", "lang": "en-US", "name": "hska:OperatingLeaseNoncashImpacts", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ibe400f3fad3045a18918ff3e0e51c171_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2447426 - Disclosure - INVENTORIES (Details)", "role": "http://Heska.com/role/INVENTORIESDetails", "shortName": "INVENTORIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ibe400f3fad3045a18918ff3e0e51c171_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ibe400f3fad3045a18918ff3e0e51c171_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2450427 - Disclosure - ACCRUED LIABILITIES (Details)", "role": "http://Heska.com/role/ACCRUEDLIABILITIESDetails", "shortName": "ACCRUED LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ibe400f3fad3045a18918ff3e0e51c171_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "hska:SharebasedCompensationArrangementbySharebasedPaymentAwardNumberOfOptionPlans", "reportCount": 1, "unique": true, "unitRef": "plans", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2453428 - Disclosure - CAPITAL STOCK - NARRATIVE (Details)", "role": "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails", "shortName": "CAPITAL STOCK - NARRATIVE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "hska:SharebasedCompensationArrangementbySharebasedPaymentAwardNumberOfOptionPlans", "reportCount": 1, "unique": true, "unitRef": "plans", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "4", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2454429 - Disclosure - CAPITAL STOCK - OPTION ACTIVITY (Details)", "role": "http://Heska.com/role/CAPITALSTOCKOPTIONACTIVITYDetails", "shortName": "CAPITAL STOCK - OPTION ACTIVITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "4", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "id1a8b5ae940140cdb44b4b0971d687d8_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2455430 - Disclosure - CAPITAL STOCK- SUMMARY OF INFORMATION BY EXERCISE PRICE RANGE (Details)", "role": "http://Heska.com/role/CAPITALSTOCKSUMMARYOFINFORMATIONBYEXERCISEPRICERANGEDetails", "shortName": "CAPITAL STOCK- SUMMARY OF INFORMATION BY EXERCISE PRICE RANGE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "id1a8b5ae940140cdb44b4b0971d687d8_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2456431 - Disclosure - CAPITAL STOCK CAPITAL STOCK - RESTRICTED STOCK (Details)", "role": "http://Heska.com/role/CAPITALSTOCKCAPITALSTOCKRESTRICTEDSTOCKDetails", "shortName": "CAPITAL STOCK CAPITAL STOCK - RESTRICTED STOCK (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ib9d7968fd1344f669b8e00fc4737675a_D20200101-20201231", "decimals": "INF", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ia396796044924e569a662d56ee164ed1_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2459432 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (Details)", "role": "http://Heska.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEDetails", "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i2dd0703fef8646f7a117f14338d3a7fe_I20181231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ibe400f3fad3045a18918ff3e0e51c171_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ProductWarrantyAccrual", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2461433 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)", "role": "http://Heska.com/role/COMMITMENTSANDCONTINGENCIESDetails", "shortName": "COMMITMENTS AND CONTINGENCIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ibe400f3fad3045a18918ff3e0e51c171_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ProductWarrantyAccrual", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "hska:InterestExpenseIncomeandOtherIncomeNetTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InterestIncomeDepositsWithFinancialInstitutions", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2464434 - Disclosure - INTEREST AND OTHER (INCOME) EXPENSE, NET (Details)", "role": "http://Heska.com/role/INTERESTANDOTHERINCOMEEXPENSENETDetails", "shortName": "INTEREST AND OTHER (INCOME) EXPENSE, NET (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "hska:InterestExpenseIncomeandOtherIncomeNetTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InterestIncomeDepositsWithFinancialInstitutions", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProceedsFromConvertibleDebt", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2467435 - Disclosure - CREDIT FACILITY AND LONG-TERM DEBT CREDIT FACILITY AND LONG-TERM DEBT - Narrative (Details)", "role": "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails", "shortName": "CREDIT FACILITY AND LONG-TERM DEBT CREDIT FACILITY AND LONG-TERM DEBT - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ibe400f3fad3045a18918ff3e0e51c171_I20201231", "decimals": "2", "lang": "en-US", "name": "us-gaap:SharePrice", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2101101 - Disclosure - OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "role": "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES", "shortName": "OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ConvertibleDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i3125bc189a8a400d906fee204859d995_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2468436 - Disclosure - CREDIT FACILITY AND LONG-TERM DEBT CREDIT FACILITY AND LONG-TERM DEBT - Carrying Amount of Debt (Details)", "role": "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTCarryingAmountofDebtDetails", "shortName": "CREDIT FACILITY AND LONG-TERM DEBT CREDIT FACILITY AND LONG-TERM DEBT - Carrying Amount of Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ConvertibleDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i3125bc189a8a400d906fee204859d995_I20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DebtInstrumentUnamortizedDiscount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i348be3a21fad4bf397864387c4906b6d_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InterestExpenseDebtExcludingAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2469437 - Disclosure - CREDIT FACILITY AND LONG-TERM DEBT CREDIT FACILITY AND LONG-TERM DEBT - Interest Expense Related to the Notes (Details)", "role": "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTInterestExpenseRelatedtotheNotesDetails", "shortName": "CREDIT FACILITY AND LONG-TERM DEBT CREDIT FACILITY AND LONG-TERM DEBT - Interest Expense Related to the Notes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i348be3a21fad4bf397864387c4906b6d_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InterestExpenseDebtExcludingAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ibe400f3fad3045a18918ff3e0e51c171_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NotesReceivableRelatedParties", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2472438 - Disclosure - CONVERTIBLE NOTE RECEIVABLE (Details)", "role": "http://Heska.com/role/CONVERTIBLENOTERECEIVABLEDetails", "shortName": "CONVERTIBLE NOTE RECEIVABLE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i8a0d6b9aded346e983aab0fc32098f07_I20201231", "decimals": "-3", "lang": "en-US", "name": "hska:NotesReceivableRelatedPartiesFaceAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OriginationOfNotesReceivableFromRelatedParties", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2473439 - Disclosure - CONVERTIBLE NOTE RECEIVABLE - Additional Information (Details)", "role": "http://Heska.com/role/CONVERTIBLENOTERECEIVABLEAdditionalInformationDetails", "shortName": "CONVERTIBLE NOTE RECEIVABLE - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i88822bbb7f68456a88d2238f7ec7a6da_D20201209-20201209", "decimals": "INF", "lang": "en-US", "name": "us-gaap:OriginationOfNotesReceivableFromRelatedParties", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R84": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2476440 - Disclosure - SEGMENT REPORTING (Details)", "role": "http://Heska.com/role/SEGMENTREPORTINGDetails", "shortName": "SEGMENT REPORTING (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "2", "lang": "en-US", "name": "hska:GrossMargin", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R85": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OriginationOfNotesReceivableFromRelatedParties", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2478441 - Disclosure - SUBSEQUENT EVENTS (Details)", "role": "http://Heska.com/role/SUBSEQUENTEVENTSDetails", "shortName": "SUBSEQUENT EVENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "ia132c6cf50754a5cb5f38aed7b4d0817_I20210201", "decimals": "INF", "lang": "en-US", "name": "hska:RelatedPartyTransactionNumberOfConsecutiveMonthlyPayments", "reportCount": 1, "unique": true, "unitRef": "payment", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2105102 - Disclosure - REVENUE", "role": "http://Heska.com/role/REVENUE", "shortName": "REVENUE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hska-20201231.htm", "contextRef": "i5e9c241d2b32433a90080d8b4b09428e_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 117, "tag": { "country_CA": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CANADA", "terseLabel": "Canada" } } }, "localname": "CA", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "domainItemType" }, "country_CH": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SWITZERLAND", "terseLabel": "Switzerland" } } }, "localname": "CH", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "domainItemType" }, "country_DE": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "GERMANY", "terseLabel": "Germany" } } }, "localname": "DE", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "domainItemType" }, "country_ES": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SPAIN", "terseLabel": "Spain" } } }, "localname": "ES", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "domainItemType" }, "country_FR": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FRANCE", "terseLabel": "France" } } }, "localname": "FR", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "domainItemType" }, "country_IT": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ITALY", "terseLabel": "Italy" } } }, "localname": "IT", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "United States" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Heska.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Heska.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Heska.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r693", "r694", "r695" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report", "terseLabel": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Heska.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Heska.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Heska.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Heska.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r696" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Heska.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Heska.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r691" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]", "terseLabel": "Documents Incorporated by Reference" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Heska.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Heska.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Heska.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Heska.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Heska.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r697" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Heska.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Heska.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Heska.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]", "terseLabel": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails", "http://Heska.com/role/PROPERTYANDEQUIPMENTDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r697" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Heska.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Heska.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r697" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Heska.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Heska.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r698" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Heska.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float", "terseLabel": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Heska.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r697" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Heska.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r697" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Heska.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r697" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Heska.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r697" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Heska.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers", "terseLabel": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Heska.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer", "terseLabel": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Heska.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r693", "r694", "r695" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag", "terseLabel": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Heska.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]", "terseLabel": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails", "http://Heska.com/role/PROPERTYANDEQUIPMENTDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Heska.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r690" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Heska.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r692" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Heska.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://Heska.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "hska_AccountingStandardsUpdate202006Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2020-06", "label": "Accounting Standards Update 2020-06 [Member]", "terseLabel": "ASU 2020-06" } } }, "localname": "AccountingStandardsUpdate202006Member", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" ], "xbrltype": "domainItemType" }, "hska_AccountsReceivableAllowanceForCreditLossIncreaseFromAcquisition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accounts Receivable, Allowance For Credit Loss, Increase From Acquisition", "label": "Accounts Receivable, Allowance For Credit Loss, Increase From Acquisition", "terseLabel": "Additions from acquisition" } } }, "localname": "AccountsReceivableAllowanceForCreditLossIncreaseFromAcquisition", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" ], "xbrltype": "monetaryItemType" }, "hska_AccruedDebtIssuanceCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accrued Debt Issuance Costs", "label": "Accrued Debt Issuance Costs", "terseLabel": "Non-cash conversion of preferred stock to common stock" } } }, "localname": "AccruedDebtIssuanceCosts", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "hska_AccruedPurchasesCurrent": { "auth_ref": [], "calculation": { "http://Heska.com/role/ACCRUEDLIABILITIESDetails": { "order": 4.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued Purchases, Current", "label": "Accrued Purchases, Current", "verboseLabel": "Accrued taxes" } } }, "localname": "AccruedPurchasesCurrent", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/ACCRUEDLIABILITIESDetails" ], "xbrltype": "monetaryItemType" }, "hska_AccumulatedForeignCurrencyGainOnIntraEntityTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accumulated Foreign Currency Gain On Intra-Entity Transactions", "label": "Accumulated Foreign Currency Gain On Intra-Entity Transactions [Member]", "terseLabel": "Foreign Currency Gain on Intra-Entity Transactions" } } }, "localname": "AccumulatedForeignCurrencyGainOnIntraEntityTransactionsMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEDetails" ], "xbrltype": "domainItemType" }, "hska_AdjustmentsToAdditionalPaidInCapitalPurchaseOfMinorityInterest": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Adjustments To Additional Paid In Capital, Purchase Of Minority Interest", "label": "Adjustments To Additional Paid In Capital, Purchase Of Minority Interest", "negatedTerseLabel": "Purchase of minority interest" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalPurchaseOfMinorityInterest", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "hska_AllowanceforDoubtfulAccountsReceivableWriteoffsNetofRecoveries": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Allowance for Doubtful Accounts Receivable, Write-offs Net of Recoveries", "label": "Allowance for Doubtful Accounts Receivable, Write-offs Net of Recoveries", "negatedTerseLabel": "Deductions - write offs, net of recoveries" } } }, "localname": "AllowanceforDoubtfulAccountsReceivableWriteoffsNetofRecoveries", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" ], "xbrltype": "monetaryItemType" }, "hska_AssetAcquisitionAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Asset Acquisition [Axis]", "label": "Asset Acquisition [Axis]", "terseLabel": "Asset Acquisition [Axis]" } } }, "localname": "AssetAcquisitionAxis", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "hska_AssetAcquisitionConsiderationTransferred": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Asset Acquisition, Consideration Transferred", "label": "Asset Acquisition, Consideration Transferred", "terseLabel": "Asset acquisition, consideration transferred" } } }, "localname": "AssetAcquisitionConsiderationTransferred", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "hska_AssetAcquisitionConsiderationTransferredEquityInstrumentsIssuedOrIssuable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Asset Acquisition, Consideration Transferred, Equity Instruments Issued Or Issuable", "label": "Asset Acquisition, Consideration Transferred, Equity Instruments Issued Or Issuable", "terseLabel": "Consideration transferred shares issued" } } }, "localname": "AssetAcquisitionConsiderationTransferredEquityInstrumentsIssuedOrIssuable", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "hska_AssetAcquisitionConsiderationTransferredEquityIssuedValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Asset Acquisition, Consideration Transferred, Equity Issued, Value", "label": "Asset Acquisition, Consideration Transferred, Equity Issued, Value", "terseLabel": "Shares issued as consideration, value" } } }, "localname": "AssetAcquisitionConsiderationTransferredEquityIssuedValue", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "hska_AssetAcquisitionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Domain] for Asset Acquisition [Axis]", "label": "Asset Acquisition [Domain]", "terseLabel": "Asset Acquisition [Domain]" } } }, "localname": "AssetAcquisitionDomain", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "hska_AssetsAndLiabilitiesLesseeTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets and Liabilities, Lessee", "label": "Assets and Liabilities, Lessee [Table Text Block]", "terseLabel": "Assets and Liabilities, Lessee" } } }, "localname": "AssetsAndLiabilitiesLesseeTableTextBlock", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/LEASESTables" ], "xbrltype": "textBlockItemType" }, "hska_BusinessAcquisitionProFormaNetIncomeLossIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Acquisition, Pro Forma Net Income (Loss), Including Portion Attributable To Noncontrolling Interest", "label": "Business Acquisition, Pro Forma Net Income (Loss), Including Portion Attributable To Noncontrolling Interest", "terseLabel": "Business Acquisition, Pro Forma Net Income (Loss), Including Portion Attributable To Noncontrolling Interest" } } }, "localname": "BusinessAcquisitionProFormaNetIncomeLossIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSUnauditedProFormaFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "hska_BusinessCombinationAchievementOfPerformanceMetricsContingentEarnOut": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Achievement Of Performance Metrics Contingent Earn-out", "label": "Business Combination, Achievement Of Performance Metrics Contingent Earn-out", "terseLabel": "Business combination, achievement of performance metrics contingent earn-out" } } }, "localname": "BusinessCombinationAchievementOfPerformanceMetricsContingentEarnOut", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "monetaryItemType" }, "hska_BusinessCombinationAchievementOfPerformanceMetricsSubsequentToContingentEarnOut": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Achievement Of Performance Metrics Subsequent To Contingent Earn-out", "label": "Business Combination, Achievement Of Performance Metrics Subsequent To Contingent Earn-out", "terseLabel": "Business combination, achievement of performance metrics subsequent to contingent earn-out" } } }, "localname": "BusinessCombinationAchievementOfPerformanceMetricsSubsequentToContingentEarnOut", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "monetaryItemType" }, "hska_BusinessCombinationEarnOutPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Combination, Earn-out Period", "label": "Business Combination, Earn-out Period", "terseLabel": "Business combination, earn-out period" } } }, "localname": "BusinessCombinationEarnOutPeriod", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "durationItemType" }, "hska_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities": { "auth_ref": [], "calculation": { "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 }, "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities", "negatedTerseLabel": "Accrued liabilities", "terseLabel": "Accrued liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails" ], "xbrltype": "monetaryItemType" }, "hska_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentInvestmentInLeases": { "auth_ref": [], "calculation": { "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Investment In Leases", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Investment In Leases", "terseLabel": "Net investment in leases, current" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentInvestmentInLeases", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails" ], "xbrltype": "monetaryItemType" }, "hska_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentInUnconsolidatedInvestments": { "auth_ref": [], "calculation": { "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Investment In Unconsolidated Investments", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Investment In Unconsolidated Investments", "terseLabel": "Investments in unconsolidated affiliates" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentInUnconsolidatedInvestments", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails" ], "xbrltype": "monetaryItemType" }, "hska_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentInvestmentInLeases": { "auth_ref": [], "calculation": { "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails": { "order": 10.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Investment In Leases", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Investment In Leases", "terseLabel": "Net investment in leases, non-current" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentInvestmentInLeases", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails" ], "xbrltype": "monetaryItemType" }, "hska_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLeaseLiability": { "auth_ref": [], "calculation": { "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails": { "order": 8.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Operating Lease, Liability", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Operating Lease, Liability", "terseLabel": "Operating lease liabilities, non-current" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLeaseLiability", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails" ], "xbrltype": "monetaryItemType" }, "hska_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilityCurrent": { "auth_ref": [], "calculation": { "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Liability, Current", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Liability, Current", "terseLabel": "Operating lease liabilities, current" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilityCurrent", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails" ], "xbrltype": "monetaryItemType" }, "hska_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset": { "auth_ref": [], "calculation": { "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails": { "order": 6.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Right-Of-Use Asset", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Right-Of-Use Asset", "terseLabel": "Operating lease right-of-use assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails" ], "xbrltype": "monetaryItemType" }, "hska_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPrepaidExpenses": { "auth_ref": [], "calculation": { "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails": { "order": 8.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Prepaid Expenses", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Prepaid Expenses", "terseLabel": "Prepaid expenses" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPrepaidExpenses", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails" ], "xbrltype": "monetaryItemType" }, "hska_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLongtermDebtOther": { "auth_ref": [], "calculation": { "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails": { "order": 5.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Long-term Debt, Other", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Long-term Debt, Other", "negatedTerseLabel": "Other long-term borrowings" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLongtermDebtOther", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails" ], "xbrltype": "monetaryItemType" }, "hska_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentLiabilitiesDeferredRevenue": { "auth_ref": [], "calculation": { "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails": { "order": 5.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Deferred Revenue", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Deferred Revenue", "terseLabel": "Deferred revenue, non-current" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentLiabilitiesDeferredRevenue", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails" ], "xbrltype": "monetaryItemType" }, "hska_BusinessCombinationSubsequentToInitialEarnOutPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Combination, Subsequent To Initial Earn-out Period", "label": "Business Combination, Subsequent To Initial Earn-out Period", "terseLabel": "Business combination, subsequent to initial earn-out period" } } }, "localname": "BusinessCombinationSubsequentToInitialEarnOutPeriod", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "durationItemType" }, "hska_BusinessCombinationsandRelatedPartyDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Combinations and Related Party Disclosure [Abstract]", "label": "Business Combinations and Related Party Disclosure [Abstract]" } } }, "localname": "BusinessCombinationsandRelatedPartyDisclosureAbstract", "nsuri": "http://Heska.com/20201231", "xbrltype": "stringItemType" }, "hska_CVMMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CVM [Member]", "label": "CVM [Member]", "terseLabel": "CVM" } } }, "localname": "CVMMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSIntangibleAssetsAcquiredAmortizationMethodDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSUnauditedProFormaFinancialInformationDetails", "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "domainItemType" }, "hska_CVMPracticeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CVM Practice", "label": "CVM Practice [Member]", "terseLabel": "CVM Practice" } } }, "localname": "CVMPracticeMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "hska_CapitalizedContractCostsAverageTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Capitalized Contract Costs, Average Term", "label": "Capitalized Contract Costs, Average Term", "terseLabel": "Contract cost average term" } } }, "localname": "CapitalizedContractCostsAverageTerm", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/REVENUEDetails" ], "xbrltype": "durationItemType" }, "hska_CapitalizedContractCostsDuringThePeriod": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Capitalized Contract Costs During The Period", "label": "Capitalized Contract Costs During The Period", "terseLabel": "Capitalized contract costs during the period" } } }, "localname": "CapitalizedContractCostsDuringThePeriod", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/REVENUEDetails" ], "xbrltype": "monetaryItemType" }, "hska_CashFlowLesseeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cash Flow, Lessee", "label": "Cash Flow, Lessee [Abstract]", "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:" } } }, "localname": "CashFlowLesseeAbstract", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/LEASESSupplementalCashFlowInformationDetails" ], "xbrltype": "stringItemType" }, "hska_ComputerHardwareAndSoftwareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Computer Hardware And Software [Member]", "label": "Computer Hardware And Software [Member]", "terseLabel": "Computer hardware & software" } } }, "localname": "ComputerHardwareAndSoftwareMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails", "http://Heska.com/role/PROPERTYANDEQUIPMENTDetails" ], "xbrltype": "domainItemType" }, "hska_ContractwithCustomerLiabilityIncreaseDueToAdditionalDeferredSales": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Contract with Customer, Liability, Increase Due To Additional Deferred Sales", "label": "Contract with Customer, Liability, Increase Due To Additional Deferred Sales", "terseLabel": "Contract liabilities, increase due to additional deferred sales" } } }, "localname": "ContractwithCustomerLiabilityIncreaseDueToAdditionalDeferredSales", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/REVENUEDetails" ], "xbrltype": "monetaryItemType" }, "hska_ConvertibleNoteReceivableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Note Receivable", "label": "Convertible Note Receivable [Member]", "terseLabel": "Convertible Note Receivable" } } }, "localname": "ConvertibleNoteReceivableMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CONVERTIBLENOTERECEIVABLEAdditionalInformationDetails", "http://Heska.com/role/CONVERTIBLENOTERECEIVABLEDetails" ], "xbrltype": "domainItemType" }, "hska_ConvertiblePreferredStockSharesIssuableUponConversion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Preferred Stock, Shares Issuable Upon Conversion", "label": "Convertible Preferred Stock, Shares Issuable Upon Conversion", "terseLabel": "Convertible preferred stock, shares issuable upon conversion (in shares)" } } }, "localname": "ConvertiblePreferredStockSharesIssuableUponConversion", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "pureItemType" }, "hska_ConvertiblePromissoryNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Promissory Note", "label": "Convertible Promissory Note [Member]", "terseLabel": "Convertible Promissory Note" } } }, "localname": "ConvertiblePromissoryNoteMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "domainItemType" }, "hska_CovetrusMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Covetrus", "label": "Covetrus [Member]", "terseLabel": "Covetrus" } } }, "localname": "CovetrusMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "domainItemType" }, "hska_CuattroLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cuattro, LLC [Member]", "label": "Cuattro, LLC [Member]", "terseLabel": "Cuattro, LLC" } } }, "localname": "CuattroLLCMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "hska_CustomerRelationshipsAndOtherMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer Relationships And Other [Member]", "label": "Customer Relationships And Other [Member]", "terseLabel": "Customer relationships and other" } } }, "localname": "CustomerRelationshipsAndOtherMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails" ], "xbrltype": "domainItemType" }, "hska_DebtInstrumentConvertibleThresholdBusinessTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Convertible, Threshold Business Trading Days", "label": "Debt Instrument, Convertible, Threshold Business Trading Days", "terseLabel": "Debt instrument, convertible, threshold business trading days" } } }, "localname": "DebtInstrumentConvertibleThresholdBusinessTradingDays", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails" ], "xbrltype": "integerItemType" }, "hska_DebtInstrumentDebtDefaultMaximumRateIncrease": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Debt Default, Maximum Rate Increase", "label": "Debt Instrument, Debt Default, Maximum Rate Increase", "terseLabel": "Debt instrument, debt default, maximum rate increase" } } }, "localname": "DebtInstrumentDebtDefaultMaximumRateIncrease", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails" ], "xbrltype": "percentItemType" }, "hska_DebtInstrumentSharesIssuableUponConversion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Shares Issuable Upon Conversion", "label": "Debt Instrument, Shares Issuable Upon Conversion", "terseLabel": "Debt instrument, shares issuable upon conversion (in shares)" } } }, "localname": "DebtInstrumentSharesIssuableUponConversion", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails" ], "xbrltype": "sharesItemType" }, "hska_DeferredTaxAssetsLeasingArrangements": { "auth_ref": [], "calculation": { "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails": { "order": 10.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Leasing Arrangements", "label": "Deferred Tax Assets, Leasing Arrangements", "terseLabel": "Sales-type leases" } } }, "localname": "DeferredTaxAssetsLeasingArrangements", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails" ], "xbrltype": "monetaryItemType" }, "hska_DeferredTaxAssetsNetExcludingForeignIntangible": { "auth_ref": [], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Net, Excluding Foreign Intangible", "label": "Deferred Tax Assets, Net, Excluding Foreign Intangible", "terseLabel": "Deferred tax asset, net" } } }, "localname": "DeferredTaxAssetsNetExcludingForeignIntangible", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "hska_DeferredTaxLiabilitiesConvertibleDebtEquityComponent": { "auth_ref": [], "calculation": { "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails": { "order": 12.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Liabilities, Convertible Debt Equity Component", "label": "Deferred Tax Liabilities, Convertible Debt Equity Component", "negatedTerseLabel": "Convertible debt equity component" } } }, "localname": "DeferredTaxLiabilitiesConvertibleDebtEquityComponent", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails" ], "xbrltype": "monetaryItemType" }, "hska_DeferredTaxLiabilitiesForeignIntangible": { "auth_ref": [], "calculation": { "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails": { "order": 13.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Liabilities, Foreign Intangible", "label": "Deferred Tax Liabilities, Foreign Intangible", "negatedTerseLabel": "Foreign intangible" } } }, "localname": "DeferredTaxLiabilitiesForeignIntangible", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails" ], "xbrltype": "monetaryItemType" }, "hska_EffectiveIncomeTaxRateReconciliationEquityMethodInvestment": { "auth_ref": [], "calculation": { "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails": { "order": 8.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Equity Method Investment", "label": "Effective Income Tax Rate Reconciliation, Equity Method Investment", "terseLabel": "Equity Investment" } } }, "localname": "EffectiveIncomeTaxRateReconciliationEquityMethodInvestment", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails" ], "xbrltype": "percentItemType" }, "hska_EffectiveIncomeTaxRateReconciliationExecutiveCompensationLimitPercent": { "auth_ref": [], "calculation": { "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails": { "order": 9.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": -1.0 } }, "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Executive Compensation Limit, Percent", "label": "Effective Income Tax Rate Reconciliation, Executive Compensation Limit, Percent", "negatedTerseLabel": "Executive compensation limit" } } }, "localname": "EffectiveIncomeTaxRateReconciliationExecutiveCompensationLimitPercent", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails" ], "xbrltype": "percentItemType" }, "hska_EffectiveIncomeTaxRateReconciliationForeignIncomeInclusionPercent": { "auth_ref": [], "calculation": { "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails": { "order": 7.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Foreign Income Inclusion, Percent", "label": "Effective Income Tax Rate Reconciliation, Foreign Income Inclusion, Percent", "terseLabel": "Foreign income inclusion" } } }, "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeInclusionPercent", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails" ], "xbrltype": "percentItemType" }, "hska_EffectiveIncomeTaxRateReconciliationOtherDeferredDifferencesPercent": { "auth_ref": [], "calculation": { "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails": { "order": 17.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": -1.0 } }, "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Other Deferred Differences, Percent", "label": "Effective Income Tax Rate Reconciliation, Other Deferred Differences, Percent", "negatedTerseLabel": "Other deferred differences" } } }, "localname": "EffectiveIncomeTaxRateReconciliationOtherDeferredDifferencesPercent", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails" ], "xbrltype": "percentItemType" }, "hska_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent": { "auth_ref": [], "calculation": { "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails": { "order": 18.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Transaction Costs, Percent", "label": "Effective Income Tax Rate Reconciliation, Transaction Costs, Percent", "negatedTerseLabel": "Transaction costs" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTransactionCostsPercent", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails" ], "xbrltype": "percentItemType" }, "hska_EliLillyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Eli Lilly [Member]", "label": "Eli Lilly [Member]", "terseLabel": "Eli Lilly" } } }, "localname": "EliLillyMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" ], "xbrltype": "domainItemType" }, "hska_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationNotYetRecognizedEquityInstrumentsOtherThanOptionsNotProbableAwards": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Employee Service Share-Based Compensation, Nonvested Awards, Compensation Not Yet Recognized, Equity Instruments Other Than Options, Not Probable Awards", "label": "Employee Service Share-Based Compensation, Nonvested Awards, Compensation Not Yet Recognized, Equity Instruments Other Than Options, Not Probable Awards", "terseLabel": "Unrecognized compensation costs, not probable" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationNotYetRecognizedEquityInstrumentsOtherThanOptionsNotProbableAwards", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "monetaryItemType" }, "hska_EmployeeStockPurchasePlanPurchasePriceGreaterOfMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employee Stock Purchase Plan, Purchase Price, Greater Of [Member]", "label": "Employee Stock Purchase Plan, Purchase Price, Greater Of [Member]", "terseLabel": "Employee Stock Purchase Plan, Purchase Price, Greater Of" } } }, "localname": "EmployeeStockPurchasePlanPurchasePriceGreaterOfMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "domainItemType" }, "hska_ExercisePriceRangeFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Range Five [Member]", "label": "Exercise Price Range Five [Member]", "terseLabel": "$71.85 - $108.25" } } }, "localname": "ExercisePriceRangeFiveMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CAPITALSTOCKSUMMARYOFINFORMATIONBYEXERCISEPRICERANGEDetails" ], "xbrltype": "domainItemType" }, "hska_ExercisePriceRangeFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Range Four [Member]", "label": "Exercise Price Range Four [Member]", "terseLabel": "$60.95 - $71.84" } } }, "localname": "ExercisePriceRangeFourMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CAPITALSTOCKSUMMARYOFINFORMATIONBYEXERCISEPRICERANGEDetails" ], "xbrltype": "domainItemType" }, "hska_ExercisePriceRangeOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Range One [Member]", "label": "Exercise Price Range One [Member]", "terseLabel": "$6.23 - $12.78" } } }, "localname": "ExercisePriceRangeOneMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CAPITALSTOCKSUMMARYOFINFORMATIONBYEXERCISEPRICERANGEDetails" ], "xbrltype": "domainItemType" }, "hska_ExercisePriceRangeSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Range Six", "label": "Exercise Price Range Six [Member]", "terseLabel": "$6.23 - $108.25" } } }, "localname": "ExercisePriceRangeSixMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CAPITALSTOCKSUMMARYOFINFORMATIONBYEXERCISEPRICERANGEDetails" ], "xbrltype": "domainItemType" }, "hska_ExercisePriceRangeThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Range Three [Member]", "label": "Exercise Price Range Three [Member]", "terseLabel": "$39.77 - $60.94" } } }, "localname": "ExercisePriceRangeThreeMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CAPITALSTOCKSUMMARYOFINFORMATIONBYEXERCISEPRICERANGEDetails" ], "xbrltype": "domainItemType" }, "hska_ExercisePriceRangeTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Range Two [Member]", "label": "Exercise Price Range Two [Member]", "terseLabel": "$12.79 - $39.76" } } }, "localname": "ExercisePriceRangeTwoMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CAPITALSTOCKSUMMARYOFINFORMATIONBYEXERCISEPRICERANGEDetails" ], "xbrltype": "domainItemType" }, "hska_GeneralFluidicsCorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "General Fluidics Corporation [Member]", "label": "General Fluidics Corporation [Member]", "terseLabel": "General Fluidics Corporation" } } }, "localname": "GeneralFluidicsCorporationMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/INVESTMENTSINUNCONSOLIDATEDAFFILIATESDetails" ], "xbrltype": "domainItemType" }, "hska_GrossMargin": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross Margin", "label": "Gross Margin", "terseLabel": "Gross margin" } } }, "localname": "GrossMargin", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "percentItemType" }, "hska_HenryScheinMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Henry Schein [Member]", "label": "Henry Schein [Member]", "terseLabel": "Henry Schein" } } }, "localname": "HenryScheinMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" ], "xbrltype": "domainItemType" }, "hska_HeskaImagingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Heska Imaging [Member]", "label": "Heska Imaging [Member]", "terseLabel": "Heska Imaging" } } }, "localname": "HeskaImagingMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails", "http://Heska.com/role/PROPERTYANDEQUIPMENTDetails" ], "xbrltype": "domainItemType" }, "hska_IncentiveStockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Incentive Stock Options [Member]", "label": "Incentive Stock Options [Member]", "terseLabel": "Incentive Stock Options" } } }, "localname": "IncentiveStockOptionsMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "domainItemType" }, "hska_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsIncomeTaxesNoncontrollingInterestNetOfTaxes": { "auth_ref": [], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Income (Loss) From Continuing Operations Before Equity Method Investments, Income Taxes, Noncontrolling Interest, Net Of Taxes", "label": "Income (Loss) From Continuing Operations Before Equity Method Investments, Income Taxes, Noncontrolling Interest, Net Of Taxes", "totalLabel": "Net (loss) income before equity in losses of unconsolidated affiliates" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsIncomeTaxesNoncontrollingInterestNetOfTaxes", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "monetaryItemType" }, "hska_InitialPurchasersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Initial Purchasers [Member]", "label": "Initial Purchasers [Member]", "terseLabel": "Initial Purchasers" } } }, "localname": "InitialPurchasersMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails" ], "xbrltype": "domainItemType" }, "hska_InterestExpenseIncomeandOtherIncomeNetTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest Expense (Income) and Other Income, Net", "label": "Interest Expense (Income) and Other Income, Net [Table Text Block]", "terseLabel": "Schedule of interest expense (income) and other income, net" } } }, "localname": "InterestExpenseIncomeandOtherIncomeNetTableTextBlock", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/INTERESTANDOTHERINCOMEEXPENSENETTables" ], "xbrltype": "textBlockItemType" }, "hska_InterestandOtherExpenseNet": { "auth_ref": [], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Table of interest and other income expense", "label": "Interest and other (income) expense, net", "terseLabel": "Interest and other expense (income), net" } } }, "localname": "InterestandOtherExpenseNet", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "monetaryItemType" }, "hska_InternationalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "International", "label": "International [Member]", "terseLabel": "International" } } }, "localname": "InternationalMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "domainItemType" }, "hska_InternationalSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "International Segment", "label": "International Segment [Member]", "terseLabel": "International Segment" } } }, "localname": "InternationalSegmentMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails", "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails", "http://Heska.com/role/REVENUEDetails", "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "domainItemType" }, "hska_InventoryTransferredToMachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Inventory Transferred To Machinery And Equipment [Member]", "label": "Inventory Transferred To Machinery And Equipment [Member]", "terseLabel": "Machinery and equipment" } } }, "localname": "InventoryTransferredToMachineryAndEquipmentMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/PROPERTYANDEQUIPMENTDetails" ], "xbrltype": "domainItemType" }, "hska_LacunaDiagnosticsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lacuna Diagnostics, Inc.", "label": "Lacuna Diagnostics, Inc. [Member]", "terseLabel": "Lacuna Diagnostics, Inc." } } }, "localname": "LacunaDiagnosticsIncMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "domainItemType" }, "hska_LeaseLiability": { "auth_ref": [], "calculation": { "http://Heska.com/role/LEASESOperatingandFinancingLeaseBalancesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Lease, Liability", "label": "Lease, Liability", "totalLabel": "Total Lease Liabilities" } } }, "localname": "LeaseLiability", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/LEASESOperatingandFinancingLeaseBalancesDetails" ], "xbrltype": "monetaryItemType" }, "hska_LeaseRightOfUseAsset": { "auth_ref": [], "calculation": { "http://Heska.com/role/LEASESOperatingandFinancingLeaseBalancesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Lease, Right-of-Use Asset", "label": "Lease, Right-of-Use Asset", "totalLabel": "Total Leased Assets" } } }, "localname": "LeaseRightOfUseAsset", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/LEASESOperatingandFinancingLeaseBalancesDetails" ], "xbrltype": "monetaryItemType" }, "hska_LeasedEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Leased Equipment [Member]", "label": "Leased Equipment [Member]", "terseLabel": "Leased Equipment" } } }, "localname": "LeasedEquipmentMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/PROPERTYANDEQUIPMENTDetails" ], "xbrltype": "domainItemType" }, "hska_LeaseholdandBuildingImprovementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Leasehold and Building Improvements [Member]", "label": "Leasehold and Building Improvements [Member]", "terseLabel": "Leasehold and building improvements" } } }, "localname": "LeaseholdandBuildingImprovementsMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails", "http://Heska.com/role/PROPERTYANDEQUIPMENTDetails" ], "xbrltype": "domainItemType" }, "hska_LeasesWeightedAverageDiscountRateAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Leases, Weighted Average Discount Rate", "label": "Leases, Weighted Average Discount Rate [Abstract]", "terseLabel": "Weighted average discount rate:" } } }, "localname": "LeasesWeightedAverageDiscountRateAbstract", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/LEASESWeightedAverageRemainingLeaseTermandWeightedAverageDiscountRateDetails" ], "xbrltype": "stringItemType" }, "hska_LessorOperatingLeasePaymentToBeReceivedUndiscountedExcessAmount": { "auth_ref": [], "calculation": { "http://Heska.com/role/LEASESLessorAccountingDetails_1": { "order": 2.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Lessor, Operating Lease, Payment to be Received, Undiscounted Excess Amount", "label": "Lessor, Operating Lease, Payment to be Received, Undiscounted Excess Amount", "terseLabel": "Less: interest" } } }, "localname": "LessorOperatingLeasePaymentToBeReceivedUndiscountedExcessAmount", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/LEASESLessorAccountingDetails" ], "xbrltype": "monetaryItemType" }, "hska_LessorOperatingLeasesReceivables": { "auth_ref": [], "calculation": { "http://Heska.com/role/LEASESLessorAccountingDetails_1": { "order": 1.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Lessor, Operating Leases, Receivables", "label": "Lessor, Operating Leases, Receivables", "terseLabel": "Total lease receivables" } } }, "localname": "LessorOperatingLeasesReceivables", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/LEASESLessorAccountingDetails" ], "xbrltype": "monetaryItemType" }, "hska_LoansAndLeasesReceivableNetOfDeferredIncomeNoncurrent": { "auth_ref": [], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Loans And Leases Receivable, Net Of Deferred Income, Noncurrent", "label": "Loans And Leases Receivable, Net Of Deferred Income, Noncurrent", "terseLabel": "Net investment in leases, non-current" } } }, "localname": "LoansAndLeasesReceivableNetOfDeferredIncomeNoncurrent", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "hska_MBioDiagnosticsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "MBio Diagnostics, Inc. [Member]", "label": "MBio Diagnostics, Inc. [Member]", "terseLabel": "MBio Diagnostics, Inc." } } }, "localname": "MBioDiagnosticsInc.Member", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/INVESTMENTSINUNCONSOLIDATEDAFFILIATESDetails" ], "xbrltype": "domainItemType" }, "hska_MerckMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Merck [Member]", "label": "Merck [Member]", "terseLabel": "Merck" } } }, "localname": "MerckMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails", "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "domainItemType" }, "hska_NonMarketableEquitySecurityInvestment": { "auth_ref": [], "calculation": { "http://Heska.com/role/INVESTMENTSINUNCONSOLIDATEDAFFILIATESDetails": { "order": 2.0, "parentTag": "us-gaap_Investments", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Non-Marketable Equity Security Investment", "label": "Non-Marketable Equity Security Investment", "terseLabel": "Non-marketable equity security investment" } } }, "localname": "NonMarketableEquitySecurityInvestment", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/INVESTMENTSINUNCONSOLIDATEDAFFILIATESDetails" ], "xbrltype": "monetaryItemType" }, "hska_NonMarketableEquitySecurityInvestmentConsiderationTransferredContingentConsiderationAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Non-Marketable Equity Security Investment, Consideration Transferred, Contingent Consideration Amount", "label": "Non-Marketable Equity Security Investment, Consideration Transferred, Contingent Consideration Amount", "terseLabel": "Contingent consideration on milestones" } } }, "localname": "NonMarketableEquitySecurityInvestmentConsiderationTransferredContingentConsiderationAmount", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/INVESTMENTSINUNCONSOLIDATEDAFFILIATESDetails" ], "xbrltype": "monetaryItemType" }, "hska_NonMarketableEquitySecurityInvestmentIntangibleAssetsAcquired": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Non-Marketable Equity Security Investment, Intangible Assets Acquired", "label": "Non-Marketable Equity Security Investment, Intangible Assets Acquired", "terseLabel": "Intangible asset acquired" } } }, "localname": "NonMarketableEquitySecurityInvestmentIntangibleAssetsAcquired", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/INVESTMENTSINUNCONSOLIDATEDAFFILIATESDetails" ], "xbrltype": "monetaryItemType" }, "hska_NonMarketableEquitySecurityInvestmentIntangibleAssetsAcquiredUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non-Marketable Equity Security Investment, Intangible Assets Acquired, Useful Life", "label": "Non-Marketable Equity Security Investment, Intangible Assets Acquired, Useful Life", "terseLabel": "Intangible assets acquired, useful life" } } }, "localname": "NonMarketableEquitySecurityInvestmentIntangibleAssetsAcquiredUsefulLife", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/INVESTMENTSINUNCONSOLIDATEDAFFILIATESDetails" ], "xbrltype": "durationItemType" }, "hska_NoncashDebtInterestExpenseCalculationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Noncash Debt Interest Expense Calculation", "label": "Noncash Debt Interest Expense Calculation [Member]", "terseLabel": "Noncash Debt Interest Expense Calculation" } } }, "localname": "NoncashDebtInterestExpenseCalculationMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" ], "xbrltype": "domainItemType" }, "hska_NoncashorPartNoncashAcquisitionNoncashFinancialorEquityInstrumentConsiderationSharesIssuedValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Shares Issued, Value", "label": "Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Shares Issued, Value", "terseLabel": "Common stock issued as partial consideration of Cuattro acquisition transactions (See Note 3)" } } }, "localname": "NoncashorPartNoncashAcquisitionNoncashFinancialorEquityInstrumentConsiderationSharesIssuedValue", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "hska_NorthAmericaSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "North America Segment", "label": "North America Segment [Member]", "terseLabel": "North America Segment" } } }, "localname": "NorthAmericaSegmentMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails", "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails", "http://Heska.com/role/REVENUEDetails", "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "domainItemType" }, "hska_NotesReceivableRelatedPartiesFaceAmount": { "auth_ref": [], "calculation": { "http://Heska.com/role/CONVERTIBLENOTERECEIVABLEDetails": { "order": 1.0, "parentTag": "us-gaap_NotesReceivableRelatedParties", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Notes Receivable, Related Parties, Face Amount", "label": "Notes Receivable, Related Parties, Face Amount", "terseLabel": "Principal amount" } } }, "localname": "NotesReceivableRelatedPartiesFaceAmount", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CONVERTIBLENOTERECEIVABLEDetails" ], "xbrltype": "monetaryItemType" }, "hska_NotesReceivableRelatedPartiesUnamortizedDiscount": { "auth_ref": [], "calculation": { "http://Heska.com/role/CONVERTIBLENOTERECEIVABLEDetails": { "order": 2.0, "parentTag": "us-gaap_NotesReceivableRelatedParties", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Notes Receivable, Related Parties, Unamortized Discount", "label": "Notes Receivable, Related Parties, Unamortized Discount", "negatedTerseLabel": "Unamortized discount" } } }, "localname": "NotesReceivableRelatedPartiesUnamortizedDiscount", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CONVERTIBLENOTERECEIVABLEDetails" ], "xbrltype": "monetaryItemType" }, "hska_NumberOfWarehouses": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Warehouses", "label": "Number Of Warehouses", "terseLabel": "Number of warehouses" } } }, "localname": "NumberOfWarehouses", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "hska_OVPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "OVP", "label": "OVP [Member]", "terseLabel": "OVP" } } }, "localname": "OVPMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/REVENUEDetails" ], "xbrltype": "domainItemType" }, "hska_OfficeFurnitureAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Office Furniture And Equipment [Member]", "label": "Office Furniture And Equipment [Member]", "terseLabel": "Office furniture & equipment" } } }, "localname": "OfficeFurnitureAndEquipmentMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails", "http://Heska.com/role/PROPERTYANDEQUIPMENTDetails" ], "xbrltype": "domainItemType" }, "hska_OperatingLeaseNoncashImpacts": { "auth_ref": [], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating Lease, Non-cash Impacts", "label": "Operating Lease, Non-cash Impacts", "terseLabel": "Non-cash impact of operating leases" } } }, "localname": "OperatingLeaseNoncashImpacts", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "hska_OptomedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Optomed [Member]", "label": "Optomed [Member]", "terseLabel": "Optomed" } } }, "localname": "OptomedMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails", "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails" ], "xbrltype": "domainItemType" }, "hska_OtherInternationalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other International", "label": "Other International [Member]", "terseLabel": "Other International" } } }, "localname": "OtherInternationalMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "domainItemType" }, "hska_OtherRevenueOtherPharmaceuticalsVaccinesAndDiagnosticTestsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Revenue, Other Pharmaceuticals, Vaccines And Diagnostic Tests [Member]", "label": "Other Revenue, Other Pharmaceuticals, Vaccines And Diagnostic Tests [Member]", "terseLabel": "PVD" } } }, "localname": "OtherRevenueOtherPharmaceuticalsVaccinesAndDiagnosticTestsMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/REVENUEDetails" ], "xbrltype": "domainItemType" }, "hska_PaymentsForAssetAcquisitions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Payments For Asset Acquisitions", "label": "Payments For Asset Acquisitions", "terseLabel": "Payments for asset acquisition" } } }, "localname": "PaymentsForAssetAcquisitions", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "hska_PaymentsToAcquireNonMarketableSecurities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments To Acquire Non-Marketable Securities", "label": "Payments To Acquire Non-Marketable Securities", "terseLabel": "Payments to acquire non-marketable securities" } } }, "localname": "PaymentsToAcquireNonMarketableSecurities", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/INVESTMENTSINUNCONSOLIDATEDAFFILIATESDetails" ], "xbrltype": "monetaryItemType" }, "hska_PercentageOfTotalLiabilitiesCurrent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage Of Total Liabilities, Current", "label": "Percentage Of Total Liabilities, Current", "terseLabel": "Current percentage of total liabilities" } } }, "localname": "PercentageOfTotalLiabilitiesCurrent", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/ACCRUEDLIABILITIESDetails" ], "xbrltype": "percentItemType" }, "hska_PerformanceMetricEarnOutInitialPeriodMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Performance Metric Earn Out, Initial Period", "label": "Performance Metric Earn Out, Initial Period [Member]", "terseLabel": "Performance Metric Earn Out, Initial Period" } } }, "localname": "PerformanceMetricEarnOutInitialPeriodMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "domainItemType" }, "hska_PerformanceMetricEarnOutSubsequentPeriodMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Performance Metric Earn Out, Subsequent Period", "label": "Performance Metric Earn Out, Subsequent Period [Member]", "terseLabel": "Performance Metric Earn Out, Subsequent Period" } } }, "localname": "PerformanceMetricEarnOutSubsequentPeriodMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "domainItemType" }, "hska_PointOfCareLaboratoryRevenueConsumablesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Point Of Care Laboratory Revenue, Consumables [Member]", "label": "Point Of Care Laboratory Revenue, Consumables [Member]", "terseLabel": "POC Lab Consumables" } } }, "localname": "PointOfCareLaboratoryRevenueConsumablesMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/REVENUEDetails" ], "xbrltype": "domainItemType" }, "hska_PointOfCareLaboratoryRevenueImagingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Point Of Care Laboratory Revenue, Imaging", "label": "Point Of Care Laboratory Revenue, Imaging [Member]", "terseLabel": "POC Imaging" } } }, "localname": "PointOfCareLaboratoryRevenueImagingMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/REVENUEDetails" ], "xbrltype": "domainItemType" }, "hska_PointOfCareLaboratoryRevenueLabInstrumentsAndOtherMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Point Of Care Laboratory Revenue, Lab Instruments And Other", "label": "Point Of Care Laboratory Revenue, Lab Instruments And Other [Member]", "terseLabel": "POC Lab Instruments & Other" } } }, "localname": "PointOfCareLaboratoryRevenueLabInstrumentsAndOtherMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/REVENUEDetails" ], "xbrltype": "domainItemType" }, "hska_PointOfCareLaboratoryRevenueOperatingLeasesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Point Of Care Laboratory Revenue, Operating Leases", "label": "Point Of Care Laboratory Revenue, Operating Leases [Member]", "terseLabel": "POC Operating Leases" } } }, "localname": "PointOfCareLaboratoryRevenueOperatingLeasesMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/REVENUEDetails" ], "xbrltype": "domainItemType" }, "hska_PointOfCareLaboratoryRevenueSalesTypeLeasesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Point Of Care Laboratory Revenue, Sales-Type Leases [Member]", "label": "Point Of Care Laboratory Revenue, Sales-Type Leases [Member]", "terseLabel": "POC Sales-type leases" } } }, "localname": "PointOfCareLaboratoryRevenueSalesTypeLeasesMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/REVENUEDetails" ], "xbrltype": "domainItemType" }, "hska_PreferredStockConvertibleConversionPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred Stock, Convertible, Conversion Price", "label": "Preferred Stock, Convertible, Conversion Price", "terseLabel": "Preferred stock, convertible, conversion price (in dollars per share)" } } }, "localname": "PreferredStockConvertibleConversionPrice", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "perShareItemType" }, "hska_PublicAndCommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Public And Common Stock [Member]", "label": "Public And Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "PublicAndCommonStockMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "hska_PublicCommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Public Common Stock [Member]", "label": "Public Common Stock [Member]", "terseLabel": "Public Common Stock" } } }, "localname": "PublicCommonStockMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "domainItemType" }, "hska_PublicCommonStockValueIssued": { "auth_ref": [], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Public Common Stock, Value, Issued", "label": "Public Common Stock, Value, Issued", "terseLabel": "Public common stock, $.01 par value, 13,250,000 and 10,250,000 shares authorized, 9,475,845 and 7,881,928 shares issued and outstanding, respectively" } } }, "localname": "PublicCommonStockValueIssued", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "hska_RelatedPartyTransactionEffectiveInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transaction, Effective Interest Rate", "label": "Related Party Transaction, Effective Interest Rate", "terseLabel": "Related party transaction, effective interest rate" } } }, "localname": "RelatedPartyTransactionEffectiveInterestRate", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CONVERTIBLENOTERECEIVABLEAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "hska_RelatedPartyTransactionNumberOfConsecutiveMonthlyPayments": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transaction, Number Of Consecutive Monthly Payments", "label": "Related Party Transaction, Number Of Consecutive Monthly Payments", "terseLabel": "Number of consecutive monthly payments" } } }, "localname": "RelatedPartyTransactionNumberOfConsecutiveMonthlyPayments", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "integerItemType" }, "hska_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right-Of-Use Asset Obtained In Exchange For Lease Liability", "label": "Right-Of-Use Asset Obtained In Exchange For Lease Liability [Abstract]", "terseLabel": "ROU assets obtained in exchange for new lease obligations:" } } }, "localname": "RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/LEASESSupplementalCashFlowInformationDetails" ], "xbrltype": "stringItemType" }, "hska_ScilAnimalCareCompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Scil Animal Care Company", "label": "Scil Animal Care Company [Member]", "terseLabel": "Scil Animal Care Company" } } }, "localname": "ScilAnimalCareCompanyMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSIntangibleAssetsAcquiredAmortizationMethodDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSUnauditedProFormaFinancialInformationDetails", "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails", "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "domainItemType" }, "hska_SeniorConvertibleNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Convertible Note [Member]", "label": "Senior Convertible Note [Member]", "terseLabel": "Senior Convertible Note" } } }, "localname": "SeniorConvertibleNoteMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTCarryingAmountofDebtDetails", "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTInterestExpenseRelatedtotheNotesDetails", "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails", "http://Heska.com/role/EARNINGSPERSHAREDetails" ], "xbrltype": "domainItemType" }, "hska_SeriesXConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series X Convertible Preferred Stock [Member]", "label": "Series X Convertible Preferred Stock [Member]", "terseLabel": "Series X Convertible Preferred Stock" } } }, "localname": "SeriesXConvertiblePreferredStockMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails", "http://Heska.com/role/EARNINGSPERSHAREDetails" ], "xbrltype": "domainItemType" }, "hska_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsSharesNotMeetingPerformanceTargets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement By Share-based Payment Award, Options, Shares Not Meeting Performance Targets", "label": "Share-Based Compensation Arrangement By Share-based Payment Award, Options, Shares Not Meeting Performance Targets", "terseLabel": "Performance shares not meeting performance targets (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsSharesNotMeetingPerformanceTargets", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "sharesItemType" }, "hska_ShareBasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesNotMeetingPerformanceTargets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Shares Not Meeting Performance Targets", "label": "Share-Based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Shares Not Meeting Performance Targets", "terseLabel": "Shares not meeting performance targets" } } }, "localname": "ShareBasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsSharesNotMeetingPerformanceTargets", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "sharesItemType" }, "hska_SharePurchasePlan1997Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Purchase Plan 1997 [Member]", "label": "Share Purchase Plan 1997 [Member]", "terseLabel": "Share Purchase Plan 1997" } } }, "localname": "SharePurchasePlan1997Member", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "domainItemType" }, "hska_SharePurchasePlan2003Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Purchase Plan 2003 [Member]", "label": "Share Purchase Plan 2003 [Member]", "terseLabel": "Share Purchase Plan 2003" } } }, "localname": "SharePurchasePlan2003Member", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "domainItemType" }, "hska_SharebasedCompensationArrangementBySharebasedPaymentAwardMonthlyWithholdingForCompensationPayment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement By Share-based Payment Award, Monthly Withholding For Compensation Payment", "label": "Share-based Compensation Arrangement By Share-based Payment Award, Monthly Withholding For Compensation Payment", "terseLabel": "Monthly withholding for compensation payment" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardMonthlyWithholdingForCompensationPayment", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "monetaryItemType" }, "hska_SharebasedCompensationArrangementbySharebasedPaymentAwardAccumulationPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Accumulation Period", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Accumulation Period", "terseLabel": "Accumulation period" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardAccumulationPeriod", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "durationItemType" }, "hska_SharebasedCompensationArrangementbySharebasedPaymentAwardAnnualRequirementForPlanEligibility": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Annual Requirement For Plan Eligibility", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Annual Requirement For Plan Eligibility", "terseLabel": "Annual month requirement for plan eligibility" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardAnnualRequirementForPlanEligibility", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "durationItemType" }, "hska_SharebasedCompensationArrangementbySharebasedPaymentAwardMaximumPercentOfAnnualBaseEarningsWithholdingForPurchasesOfStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Percent Of Annual Base Earnings Withholding For Purchases Of Stock", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Percent Of Annual Base Earnings Withholding For Purchases Of Stock", "terseLabel": "Maximum percent of annual base earnings withholding for purchases of stock" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardMaximumPercentOfAnnualBaseEarningsWithholdingForPurchasesOfStock", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "percentItemType" }, "hska_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberOfOptionPlans": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Number Of Option Plans", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number Of Option Plans", "terseLabel": "Number of stock option plans" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardNumberOfOptionPlans", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "integerItemType" }, "hska_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberOfSharesAuthorizedToBePurchasedAnnually": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Number Of Shares Authorized To Be Purchased Annually", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number Of Shares Authorized To Be Purchased Annually", "terseLabel": "Number of shares authorized to be repurchased annually" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardNumberOfSharesAuthorizedToBePurchasedAnnually", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "sharesItemType" }, "hska_SharebasedCompensationArrangementbySharebasedPaymentAwardOfferingPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Offering Period", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Offering Period", "terseLabel": "Offering period" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardOfferingPeriod", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "durationItemType" }, "hska_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsGrantsExercisePricePercentofFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants, Exercise Price, Percent of Fair Value", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants, Exercise Price, Percent of Fair Value", "terseLabel": "Percent of fair value for options granted" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsGrantsExercisePricePercentofFairValue", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "percentItemType" }, "hska_SharebasedCompensationArrangementbySharebasedPaymentAwardWeeklyRequirementForPlanEligibility": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Weekly Requirement For Plan Eligibility", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Weekly Requirement For Plan Eligibility", "terseLabel": "Weekly hours requirement for plan eligibility" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardWeeklyRequirementForPlanEligibility", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "integerItemType" }, "hska_StockOptionsAndRestrictedUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Options And Restricted Units [Member]", "label": "Stock Options And Restricted Units [Member]", "terseLabel": "Stock Options And Restricted Units" } } }, "localname": "StockOptionsAndRestrictedUnitsMember", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/EARNINGSPERSHAREDetails" ], "xbrltype": "domainItemType" }, "hska_StockRepurchaseProgramIncreaseInRemainingAuthorizedRepurchaseAmount": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Repurchase Program, Increase In Remaining Authorized Repurchase Amount", "label": "Stock Repurchase Program, Increase In Remaining Authorized Repurchase Amount", "terseLabel": "Increase in authorized repurchase amount" } } }, "localname": "StockRepurchaseProgramIncreaseInRemainingAuthorizedRepurchaseAmount", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "sharesItemType" }, "hska_SupplyCommitmentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Supply Commitment, Term", "label": "Supply Commitment, Term", "terseLabel": "Supply commitment term" } } }, "localname": "SupplyCommitmentTerm", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/INVESTMENTSINUNCONSOLIDATEDAFFILIATESDetails" ], "xbrltype": "durationItemType" }, "hska_TaxYear2027Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax Year 2027 [Member]", "label": "Tax Year 2027 [Member]", "terseLabel": "Tax Year 2027 and later" } } }, "localname": "TaxYear2027Member", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/INCOMETAXESDetails" ], "xbrltype": "domainItemType" }, "hska_TaxYears2018through2022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax Years 2018 through 2022 [Member]", "label": "Tax Years 2018 through 2022 [Member]", "terseLabel": "Tax Years 2018 Through 2022" } } }, "localname": "TaxYears2018through2022Member", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/INCOMETAXESDetails" ], "xbrltype": "domainItemType" }, "hska_TaxYears2024Through2025Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax Years 2024 Through 2025 [Member]", "label": "Tax Years 2024 Through 2025 [Member]", "terseLabel": "Tax Years 2024 Through 2025" } } }, "localname": "TaxYears2024Through2025Member", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/INCOMETAXESDetails" ], "xbrltype": "domainItemType" }, "hska_UnrealizedGainLossOnForeignCurrencyTranslation": { "auth_ref": [], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Unrealized gain loss on foreign currency transactions", "label": "Unrealized (gain) loss on foreign currency translation", "terseLabel": "Other (gains) losses" } } }, "localname": "UnrealizedGainLossOnForeignCurrencyTranslation", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "hska_WeightedAverageRemainingLeaseTermAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Remaining Lease Term", "label": "Weighted Average Remaining Lease Term [Abstract]", "terseLabel": "Weighted average remaining lease term:" } } }, "localname": "WeightedAverageRemainingLeaseTermAbstract", "nsuri": "http://Heska.com/20201231", "presentation": [ "http://Heska.com/role/LEASESWeightedAverageRemainingLeaseTermandWeightedAverageDiscountRateDetails" ], "xbrltype": "stringItemType" }, "srt_AffiliatedEntityMember": { "auth_ref": [ "r362", "r570", "r571", "r572", "r688" ], "lang": { "en-us": { "role": { "label": "Affiliated Entity [Member]", "terseLabel": "Affiliated Entity" } } }, "localname": "AffiliatedEntityMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r190", "r203", "r204", "r205", "r206", "r208", "r210", "r214" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails", "http://Heska.com/role/REVENUEDetails", "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r190", "r203", "r204", "r205", "r206", "r208", "r210", "r214" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails", "http://Heska.com/role/REVENUEDetails", "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r60", "r129" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails", "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails", "http://Heska.com/role/INVESTMENTSINUNCONSOLIDATEDAFFILIATESDetails" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember": { "auth_ref": [ "r140", "r147", "r243", "r409", "r410", "r411", "r453", "r454" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption, Adjusted Balance [Member]", "terseLabel": "Cumulative Effect, Period of Adoption, Adjusted Balance" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": { "auth_ref": [ "r140", "r147", "r243", "r409", "r410", "r411", "r453", "r454" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]", "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAxis": { "auth_ref": [ "r140", "r147", "r243", "r409", "r410", "r411", "r453", "r454" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption [Axis]", "terseLabel": "Cumulative Effect, Period of Adoption [Axis]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionDomain": { "auth_ref": [ "r140", "r147", "r243", "r409", "r410", "r411", "r453", "r454" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption [Domain]", "terseLabel": "Cumulative Effect, Period of Adoption [Domain]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" ], "xbrltype": "domainItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment, Name [Domain]", "terseLabel": "Investment, Name [Domain]" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails", "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails", "http://Heska.com/role/INVESTMENTSINUNCONSOLIDATEDAFFILIATESDetails" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r220", "r343", "r349", "r654" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]", "terseLabel": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails", "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r365", "r367", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r651", "r655" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails", "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails", "http://Heska.com/role/PROPERTYANDEQUIPMENTDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r365", "r367", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r651", "r655" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails", "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails", "http://Heska.com/role/PROPERTYANDEQUIPMENTDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r220", "r343", "r349", "r654" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]", "terseLabel": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails", "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "domainItemType" }, "srt_NorthAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "North America [Member]", "terseLabel": "North America" } } }, "localname": "NorthAmericaMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r216", "r343", "r347", "r588", "r650", "r652" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://Heska.com/role/REVENUEDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r216", "r343", "r347", "r588", "r650", "r652" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://Heska.com/role/REVENUEDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r353", "r365", "r367", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r651", "r655" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Range [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails", "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails", "http://Heska.com/role/PROPERTYANDEQUIPMENTDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r353", "r365", "r367", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r651", "r655" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Range [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails", "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails", "http://Heska.com/role/PROPERTYANDEQUIPMENTDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails", "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails", "http://Heska.com/role/INVESTMENTSINUNCONSOLIDATEDAFFILIATESDetails" ], "xbrltype": "domainItemType" }, "srt_RestatementAxis": { "auth_ref": [ "r136", "r137", "r138", "r139", "r141", "r142", "r145", "r146", "r147", "r149", "r150", "r151", "r152", "r153", "r166", "r244", "r245", "r412", "r454", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Axis]", "terseLabel": "Revision of Prior Period [Axis]" } } }, "localname": "RestatementAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" ], "xbrltype": "stringItemType" }, "srt_RestatementDomain": { "auth_ref": [ "r136", "r137", "r138", "r139", "r141", "r142", "r145", "r146", "r147", "r149", "r150", "r151", "r152", "r153", "r166", "r244", "r245", "r412", "r454", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Domain]", "terseLabel": "Revision of Prior Period [Domain]" } } }, "localname": "RestatementDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" ], "xbrltype": "domainItemType" }, "srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember": { "auth_ref": [ "r145", "r146", "r149", "r150", "r152", "r153" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period, Error Correction, Adjustment [Member]", "terseLabel": "Revision of Prior Period, Error Correction, Adjustment" } } }, "localname": "RevisionOfPriorPeriodErrorCorrectionAdjustmentMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r234" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]", "terseLabel": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails", "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails", "http://Heska.com/role/INVESTMENTSINUNCONSOLIDATEDAFFILIATESDetails" ], "xbrltype": "stringItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r217", "r218", "r343", "r348", "r653", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r217", "r218", "r343", "r348", "r653", "r674", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r42" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.", "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]", "terseLabel": "ACCRUED LIABILITIES" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACCRUEDLIABILITIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r41" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]", "terseLabel": "Accounts Receivable" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r6", "r25", "r222", "r223" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable, net of allowance for losses of $769 and $186, respectively" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent": { "auth_ref": [ "r12", "r44", "r417" ], "calculation": { "http://Heska.com/role/ACCRUEDLIABILITIESDetails": { "order": 2.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrual for Taxes Other than Income Taxes, Current", "terseLabel": "Accrued property taxes" } } }, "localname": "AccrualForTaxesOtherThanIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACCRUEDLIABILITIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r44" ], "calculation": { "http://Heska.com/role/ACCRUEDLIABILITIESDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued liabilities", "totalLabel": "Accrued liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACCRUEDLIABILITIESDetails", "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "auth_ref": [ "r64", "r69", "r70", "r506" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "terseLabel": "Pension Adjustments" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r39", "r282" ], "calculation": { "http://Heska.com/role/PROPERTYANDEQUIPMENTDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedTerseLabel": "Less accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/PROPERTYANDEQUIPMENTDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease": { "auth_ref": [ "r280" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in accumulated depreciation, depletion and amortization of property, plant and equipment.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant and Equipment, Period Increase (Decrease)", "terseLabel": "Depreciation and amortization" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/PROPERTYANDEQUIPMENTDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r28", "r67", "r68", "r69", "r635", "r663", "r667" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive income" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r524", "r525", "r526", "r527", "r528", "r530" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r66", "r69", "r70", "r136", "r137", "r139", "r506", "r658", "r659" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Total Accumulated Other Comprehensive Income" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r62", "r69", "r70", "r506", "r525", "r526", "r527", "r528", "r530" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "terseLabel": "Foreign Currency Translation" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r266" ], "lang": { "en-us": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life", "terseLabel": "Acquired finite-lived intangible assets, weighted average useful life" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSIntangibleAssetsAcquiredAmortizationMethodDetails" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r26", "r412" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r136", "r137", "r139", "r409", "r410", "r411" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForErrorCorrectionDomain": { "auth_ref": [ "r138", "r145", "r146", "r149", "r150", "r152", "r153" ], "lang": { "en-us": { "role": { "documentation": "Type of error correction.", "label": "Error Correction, Type [Domain]", "terseLabel": "Error Correction, Type [Domain]" } } }, "localname": "AdjustmentsForErrorCorrectionDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r141", "r142", "r143", "r144", "r240", "r241", "r242", "r243", "r244", "r245", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r451", "r452", "r453", "r454", "r590", "r591", "r592", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667" ], "lang": { "en-us": { "role": { "documentation": "Information by amendment to accounting standards.", "label": "Accounting Standards Update [Axis]", "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net (loss) income to cash (used in) provided by operating activities:" } } }, "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt": { "auth_ref": [ "r299" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.", "label": "Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt", "terseLabel": "Convertible notes, equity" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r368", "r370", "r414", "r415" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Stock-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "auth_ref": [ "r418" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for advertising cost.", "label": "Advertising Cost [Policy Text Block]", "terseLabel": "Advertising Costs" } } }, "localname": "AdvertisingCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_AdvertisingExpense": { "auth_ref": [ "r419" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.", "label": "Advertising Expense", "terseLabel": "Advertising expense" } } }, "localname": "AdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r228", "r246", "r247", "r249" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Accounts Receivable, Allowance for Credit Loss", "periodEndLabel": "Balances at end of period", "periodStartLabel": "Balances at beginning of period", "terseLabel": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]", "terseLabel": "Allowance for Doubtful Accounts Receivable [Roll Forward]" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableRollforward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r94", "r115", "r534" ], "calculation": { "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTInterestExpenseRelatedtotheNotesDetails": { "order": 2.0, "parentTag": "us-gaap_InterestExpenseDebt", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization of Debt Discount (Premium)", "terseLabel": "Interest expense related to amortization of the debt discount" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTInterestExpenseRelatedtotheNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "auth_ref": [ "r115", "r536" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.", "label": "Amortization of Debt Issuance Costs and Discounts", "terseLabel": "Accretion of discounts and issuance costs" } } }, "localname": "AmortizationOfFinancingCostsAndDiscounts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r115", "r263", "r273" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization expense" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r163" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Stock options and restricted units excluded from computation of earnings per share" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/EARNINGSPERSHAREDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r163" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/EARNINGSPERSHAREDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/EARNINGSPERSHAREDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r163" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/EARNINGSPERSHAREDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r127", "r198", "r205", "r212", "r237", "r501", "r507", "r518", "r608", "r632" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "terseLabel": "Total Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS", "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r8", "r10", "r59", "r127", "r237", "r501", "r507", "r518" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNet": { "auth_ref": [ "r3", "r670", "r671", "r672", "r673" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net assets (liabilities).", "label": "Net Assets", "terseLabel": "Net Assets" } } }, "localname": "AssetsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r372", "r403" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKCAPITALSTOCKRESTRICTEDSTOCKDetails", "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails", "http://Heska.com/role/CAPITALSTOCKOPTIONACTIVITYDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation and Consolidation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BuildingMember": { "auth_ref": [ "r281" ], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.", "label": "Building [Member]", "terseLabel": "Building" } } }, "localname": "BuildingMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails", "http://Heska.com/role/PROPERTYANDEQUIPMENTDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r364", "r366" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSIntangibleAssetsAcquiredAmortizationMethodDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSUnauditedProFormaFinancialInformationDetails", "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails", "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://Heska.com/role/PROPERTYANDEQUIPMENTDetails", "http://Heska.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r364", "r366", "r474", "r475" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSIntangibleAssetsAcquiredAmortizationMethodDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSUnauditedProFormaFinancialInformationDetails", "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails", "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://Heska.com/role/PROPERTYANDEQUIPMENTDetails", "http://Heska.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSIntangibleAssetsAcquiredAmortizationMethodDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSUnauditedProFormaFinancialInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "auth_ref": [ "r470" ], "lang": { "en-us": { "role": { "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.", "label": "Business Acquisition, Percentage of Voting Interests Acquired", "terseLabel": "Percentage of voting interest acquired" } } }, "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "auth_ref": [ "r472", "r473" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.", "label": "Business Acquisition, Pro Forma Information [Table Text Block]", "terseLabel": "Business acquisition, pro forma information" } } }, "localname": "BusinessAcquisitionProFormaInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSACQUISITIONANDRELATEDPARTYITEMSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": { "auth_ref": [ "r472", "r473" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.", "label": "Business Acquisition, Pro Forma Net Income (Loss)", "terseLabel": "Net (loss) income attributable to Heska Corporation" } } }, "localname": "BusinessAcquisitionsProFormaNetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSUnauditedProFormaFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "auth_ref": [ "r472", "r473" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.", "label": "Business Acquisition, Pro Forma Revenue", "terseLabel": "Revenue, net" } } }, "localname": "BusinessAcquisitionsProFormaRevenue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSUnauditedProFormaFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "auth_ref": [ "r469" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.", "label": "Business Combination, Acquisition Related Costs", "terseLabel": "Acquisition related costs" } } }, "localname": "BusinessCombinationAcquisitionRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r485", "r486", "r489" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "netLabel": "Purchase price", "terseLabel": "Total fair value of consideration transferred" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails", "http://Heska.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombinationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination [Abstract]", "terseLabel": "Purchase Price" } } }, "localname": "BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombinationAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": { "auth_ref": [ "r483", "r485", "r486", "r491" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.", "label": "Business Combination, Consideration Transferred, Liabilities Incurred", "terseLabel": "Debt assumed in acquisition" } } }, "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": { "auth_ref": [ "r114", "r493" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.", "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability", "terseLabel": "Consideration payable for CVM Acquisition" } } }, "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails", "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueLow": { "auth_ref": [ "r494" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the amount of any change recognized during the period in the low-end of the estimated range of outcomes (undiscounted) of a liability assumed in a business combination arising from an item of contingent consideration.", "label": "Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, Low", "terseLabel": "Business combination, contingent consideration arrangements, change in range of outcomes, contingent consideration, liability, value, low" } } }, "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueLow", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "auth_ref": [ "r484", "r487", "r492" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.", "label": "Business Combination, Contingent Consideration, Liability", "terseLabel": "Business combination, contingent consideration, liability" } } }, "localname": "BusinessCombinationContingentConsiderationLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": { "auth_ref": [ "r484", "r488" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.", "label": "Business Combination, Contingent Consideration, Liability, Current", "terseLabel": "Accrued purchase consideration payable" } } }, "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r495" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "verboseLabel": "ACQUISITION AND RELATED PARTY ITEMS" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMS" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual": { "auth_ref": [ "r471" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.", "label": "Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual", "terseLabel": "Earnings or loss of acquiree since acquisition date" } } }, "localname": "BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual": { "auth_ref": [ "r471" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.", "label": "Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual", "terseLabel": "Revenue of acquiree since acquisition date" } } }, "localname": "BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "auth_ref": [ "r477" ], "calculation": { "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0 }, "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets", "totalLabel": "Total assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r477" ], "calculation": { "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails": { "order": 5.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 }, "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails": { "order": 7.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents", "terseLabel": "Cash and cash equivalents" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": { "auth_ref": [ "r477" ], "calculation": { "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 }, "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other", "terseLabel": "Other current assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "auth_ref": [ "r477" ], "calculation": { "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 }, "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails": { "order": 9.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables", "terseLabel": "Accounts receivable" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "auth_ref": [ "r477" ], "calculation": { "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 }, "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails": { "order": 9.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable", "negatedTerseLabel": "Accounts payable", "terseLabel": "Accounts payable" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": { "auth_ref": [ "r477" ], "calculation": { "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 }, "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails": { "order": 7.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue", "negatedTerseLabel": "Current portion of deferred revenue, and other", "terseLabel": "Current portion of deferred revenue, and other" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "auth_ref": [ "r477" ], "calculation": { "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails": { "order": 7.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 }, "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails": { "order": 6.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities", "negatedTerseLabel": "Deferred tax liability", "terseLabel": "Deferred tax liability" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r477" ], "calculation": { "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails": { "order": 6.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 }, "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails": { "order": 11.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill", "terseLabel": "Other intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "auth_ref": [ "r476", "r477" ], "calculation": { "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 }, "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails": { "order": 12.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of inventory recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory", "terseLabel": "Inventories" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "auth_ref": [ "r476", "r477" ], "calculation": { "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net", "totalLabel": "Net assets acqiured" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": { "auth_ref": [ "r477" ], "calculation": { "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails": { "order": 6.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 }, "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other", "negatedTerseLabel": "Other liabilities", "terseLabel": "Other liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": { "auth_ref": [ "r477" ], "calculation": { "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails": { "order": 7.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 }, "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets", "terseLabel": "Other non-current assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r476", "r477" ], "calculation": { "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 }, "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails": { "order": 5.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment", "terseLabel": "Property and equipment" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract]", "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract]" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": { "auth_ref": [ "r477" ], "calculation": { "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net", "totalLabel": "Total fair value of consideration transferred" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalExpendituresIncurredButNotYetPaid": { "auth_ref": [ "r120", "r121", "r122" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.", "label": "Capital Expenditures Incurred but Not yet Paid", "terseLabel": "Capital Expenditures" } } }, "localname": "CapitalExpendituresIncurredButNotYetPaid", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedContractCostAmortization": { "auth_ref": [ "r254" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.", "label": "Capitalized Contract Cost, Amortization", "terseLabel": "Capitalized contract costs, amortization" } } }, "localname": "CapitalizedContractCostAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/REVENUEDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedContractCostNet": { "auth_ref": [ "r253" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.", "label": "Capitalized Contract Cost, Net", "terseLabel": "Capitalized contract costs" } } }, "localname": "CapitalizedContractCostNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/REVENUEDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r4", "r35", "r117" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r15", "r118", "r124" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r111", "r117", "r123" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "CASH AND CASH EQUIVALENTS, END OF YEAR", "periodStartLabel": "CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r111", "r523" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r126", "r127", "r156", "r157", "r158", "r160", "r162", "r171", "r172", "r173", "r237", "r518" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails", "http://Heska.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://Heska.com/role/EARNINGSPERSHAREDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r289", "r290", "r291", "r293" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/COMMITMENTSANDCONTINGENCIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Common Stock, Capital Shares Reserved for Future Issuance", "terseLabel": "Remaining number of shares authorized to be repurchased" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r136", "r137" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails", "http://Heska.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://Heska.com/role/EARNINGSPERSHAREDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails", "http://Heska.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails", "http://Heska.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r24", "r313" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r24" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $.01 par value, 13,250,000 and 10,250,00 shares authorized, respectively, none issued or outstanding" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The change in equity (net assets) of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income [Member]", "terseLabel": "Accumulated Other Comprehensive Income" } } }, "localname": "ComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r73", "r75", "r76", "r86", "r621", "r646" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive (loss) income attributable to Heska Corporation" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]", "terseLabel": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]" } } }, "localname": "ComprehensiveIncomeNetOfTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r73", "r75", "r85", "r499", "r500", "r511", "r620", "r645" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "terseLabel": "Comprehensive loss attributable to redeemable non-controlling interest" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r73", "r75", "r84", "r498", "r511", "r619", "r644" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Comprehensive (loss) income" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "auth_ref": [ "r83", "r97", "r618", "r643" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.", "label": "Comprehensive Income (Loss) Note [Text Block]", "terseLabel": "ACCUMULATED OTHER COMPREHENSIVE INCOME" } } }, "localname": "ComprehensiveIncomeNoteTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r180", "r181", "r220", "r516", "r517" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails", "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r180", "r181", "r220", "r516", "r517", "r669" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails", "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r180", "r181", "r220", "r516", "r517", "r669" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails", "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r176", "r630" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentration of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r180", "r181", "r220", "r516", "r517" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Concentration risk, percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails", "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r180", "r181", "r220", "r516", "r517" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails", "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConstructionInProgressMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.", "label": "Construction in Progress [Member]", "terseLabel": "Construction in progress" } } }, "localname": "ConstructionInProgressMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/PROPERTYANDEQUIPMENTDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ContingentConsiderationByTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of contingent consideration.", "label": "Contingent Consideration by Type [Axis]", "terseLabel": "Contingent Consideration by Type [Axis]" } } }, "localname": "ContingentConsiderationByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ContingentConsiderationTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of contingent payment arrangement.", "label": "Contingent Consideration Type [Domain]", "terseLabel": "Contingent Consideration Type [Domain]" } } }, "localname": "ContingentConsiderationTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ContractWithCustomerAssetNetCurrent": { "auth_ref": [ "r321", "r323", "r344" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.", "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current", "terseLabel": "Contract receivables, current" } } }, "localname": "ContractWithCustomerAssetNetCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/REVENUEDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerAssetNetNoncurrent": { "auth_ref": [ "r321", "r323", "r344" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as noncurrent.", "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent", "terseLabel": "Contract receivables, noncurrent" } } }, "localname": "ContractWithCustomerAssetNetNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/REVENUEDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r321", "r322", "r344" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability", "terseLabel": "Current portion of deferred revenue, and other" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/REVENUEDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r321", "r322", "r344" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract with Customer, Liability, Current", "terseLabel": "Deferred revenue, current, and other" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityNoncurrent": { "auth_ref": [ "r321", "r322", "r344" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.", "label": "Contract with Customer, Liability, Noncurrent", "terseLabel": "Deferred revenue, non-current" } } }, "localname": "ContractWithCustomerLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r345" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract with Customer, Liability, Revenue Recognized", "terseLabel": "Contract liabilities, revenue recognized" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/REVENUEDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebt": { "auth_ref": [ "r20", "r610", "r633" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.", "label": "Convertible Debt", "terseLabel": "Convertible notes" } } }, "localname": "ConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtFairValueDisclosures": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Convertible Debt, Fair Value Disclosures", "terseLabel": "Convertible debt, fair value disclosures" } } }, "localname": "ConvertibleDebtFairValueDisclosures", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtMember": { "auth_ref": [ "r298" ], "lang": { "en-us": { "role": { "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Convertible Debt [Member]", "terseLabel": "Convertible Debt" } } }, "localname": "ConvertibleDebtMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTCarryingAmountofDebtDetails", "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTInterestExpenseRelatedtotheNotesDetails", "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails", "http://Heska.com/role/EARNINGSPERSHAREDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleDebtNoncurrent": { "auth_ref": [ "r48" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.", "label": "Convertible Debt, Noncurrent", "terseLabel": "Convertible note, non-current, net" } } }, "localname": "ConvertibleDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of borrowings which can be exchanged for a specified number of another security at the option of the issuer or the holder. Disclosures include, but are not limited to, principal amount, amortized premium or discount, and amount of liability and equity components.", "label": "Convertible Debt [Table Text Block]", "terseLabel": "Convertible Debt" } } }, "localname": "ConvertibleDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.", "label": "Convertible Preferred Stock [Member]", "terseLabel": "Convertible Preferred Stock" } } }, "localname": "ConvertiblePreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/EARNINGSPERSHAREDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsSoldSalesTypeLease": { "auth_ref": [ "r169", "r564" ], "calculation": { "http://Heska.com/role/LEASESSalestypeLeasesandLeaseIncomeDetails": { "order": 1.0, "parentTag": "us-gaap_SalesTypeLeaseSellingProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cost of goods sold for sales-type financing lease.", "label": "Cost of Goods Sold, Sales-type Lease", "terseLabel": "Sales-type lease cost of revenue" } } }, "localname": "CostOfGoodsSoldSalesTypeLease", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESSalestypeLeasesandLeaseIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r91", "r127", "r237", "r518" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Revenue", "terseLabel": "Cost of revenue" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME", "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "auth_ref": [ "r128", "r447", "r457" ], "calculation": { "http://Heska.com/role/INCOMETAXESCOMPONENTSOFINCOMETAXEXPENSEBENEFITDetails": { "order": 1.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Federal Tax Expense (Benefit)", "terseLabel": "Federal" } } }, "localname": "CurrentFederalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESCOMPONENTSOFINCOMETAXEXPENSEBENEFITDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "auth_ref": [ "r133", "r447" ], "calculation": { "http://Heska.com/role/INCOMETAXESCOMPONENTSOFINCOMETAXEXPENSEBENEFITDetails": { "order": 3.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Foreign Tax Expense (Benefit)", "verboseLabel": "Foreign" } } }, "localname": "CurrentForeignTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESCOMPONENTSOFINCOMETAXEXPENSEBENEFITDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r128", "r447", "r457", "r459" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 }, "http://Heska.com/role/INCOMETAXESCOMPONENTSOFINCOMETAXEXPENSEBENEFITDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Current Income Tax Expense (Benefit)", "terseLabel": "Current income tax expense", "totalLabel": "Total current expense", "verboseLabel": "Current income tax expense (benefit)" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME", "http://Heska.com/role/INCOMETAXESCOMPONENTSOFINCOMETAXEXPENSEBENEFITDetails", "http://Heska.com/role/INCOMETAXESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Current income tax expense:" } } }, "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESCOMPONENTSOFINCOMETAXEXPENSEBENEFITDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r128", "r447", "r457" ], "calculation": { "http://Heska.com/role/INCOMETAXESCOMPONENTSOFINCOMETAXEXPENSEBENEFITDetails": { "order": 2.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current State and Local Tax Expense (Benefit)", "terseLabel": "State" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESCOMPONENTSOFINCOMETAXEXPENSEBENEFITDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r179", "r220" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer Concentration Risk" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails", "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r481" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "terseLabel": "Customer Relationships" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSIntangibleAssetsAcquiredAmortizationMethodDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r308" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "CREDIT FACILITY AND LONG-TERM DEBT" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBT" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r18", "r19", "r20", "r609", "r610", "r631" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTCarryingAmountofDebtDetails", "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTInterestExpenseRelatedtotheNotesDetails", "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails", "http://Heska.com/role/EARNINGSPERSHAREDetails", "http://Heska.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentCollateralAmount": { "auth_ref": [ "r626" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets pledged to secure a debt instrument.", "label": "Debt Instrument, Collateral Amount", "terseLabel": "Debt instrument, collateral amount" } } }, "localname": "DebtInstrumentCollateralAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent": { "auth_ref": [ "r300" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.", "label": "Debt Instrument, Convertible, Carrying Amount of Equity Component", "terseLabel": "Debt instrument, convertible, carrying amount of equity component" } } }, "localname": "DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r304" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Debt instrument, convertible, conversion price (in dollars per share)" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails", "http://Heska.com/role/EARNINGSPERSHAREDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentConvertibleConversionRatio1": { "auth_ref": [ "r47", "r314", "r315", "r317" ], "lang": { "en-us": { "role": { "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.", "label": "Debt Instrument, Convertible, Conversion Ratio", "terseLabel": "Debt instrument, convertible, conversion ratio" } } }, "localname": "DebtInstrumentConvertibleConversionRatio1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails" ], "xbrltype": "pureItemType" }, "us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal": { "auth_ref": [ "r305" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount by which the convertible debt's if-converted value exceeds its principle amount at the balance sheet date, regardless of whether the instrument is currently convertible. This element applies to public companies only.", "label": "Debt Instrument, Convertible, If-converted Value in Excess of Principal", "terseLabel": "Debt instrument, convertible, if-converted value in excess of principal" } } }, "localname": "DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1": { "auth_ref": [ "r303" ], "lang": { "en-us": { "role": { "documentation": "Remaining amortization period for discount on the liability component of convertible debt which may be settled in cash upon conversion, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Convertible, Remaining Discount Amortization Period", "terseLabel": "Debt instrument, convertible, remaining discount amortization period" } } }, "localname": "DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.", "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days", "terseLabel": "Debt instrument, convertible, threshold consecutive trading days" } } }, "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.", "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger", "terseLabel": "Debt instrument, convertible, threshold percentage of stock price trigger" } } }, "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.", "label": "Debt Instrument, Convertible, Threshold Trading Days", "terseLabel": "Debt instrument, convertible, threshold trading days" } } }, "localname": "DebtInstrumentConvertibleThresholdTradingDays", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r535", "r537" ], "calculation": { "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTCarryingAmountofDebtDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Face amount", "verboseLabel": "Principal amount of the Notes" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTCarryingAmountofDebtDetails", "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails", "http://Heska.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r46", "r306", "r535" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument, Interest Rate, Effective Percentage", "terseLabel": "Debt instrument, interest rate, effective percentage" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r46" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Debt instrument, interest rate, stated percentage" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails", "http://Heska.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONVERTIBLENOTERECEIVABLEAdditionalInformationDetails", "http://Heska.com/role/CONVERTIBLENOTERECEIVABLEDetails", "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTCarryingAmountofDebtDetails", "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTInterestExpenseRelatedtotheNotesDetails", "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTCarryingAmountofDebtDetails", "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTInterestExpenseRelatedtotheNotesDetails", "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails", "http://Heska.com/role/EARNINGSPERSHAREDetails", "http://Heska.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodAxis": { "auth_ref": [ "r627" ], "lang": { "en-us": { "role": { "documentation": "Information about timing of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period [Axis]", "terseLabel": "Debt Instrument, Redemption, Period [Axis]" } } }, "localname": "DebtInstrumentRedemptionPeriodAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodDomain": { "auth_ref": [ "r627" ], "lang": { "en-us": { "role": { "documentation": "Period as defined under terms of the debt agreement for debt redemption features.", "label": "Debt Instrument, Redemption, Period [Domain]", "terseLabel": "Debt Instrument, Redemption, Period [Domain]" } } }, "localname": "DebtInstrumentRedemptionPeriodDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodOneMember": { "auth_ref": [ "r627" ], "lang": { "en-us": { "role": { "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period One [Member]", "terseLabel": "Debt Instrument, Redemption, Period One" } } }, "localname": "DebtInstrumentRedemptionPeriodOneMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodThreeMember": { "auth_ref": [ "r627" ], "lang": { "en-us": { "role": { "documentation": "Period three representing third most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period Three [Member]", "terseLabel": "Debt Instrument, Redemption, Period Three" } } }, "localname": "DebtInstrumentRedemptionPeriodThreeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": { "auth_ref": [ "r627" ], "lang": { "en-us": { "role": { "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period Two [Member]", "terseLabel": "Debt Instrument, Redemption, Period Two" } } }, "localname": "DebtInstrumentRedemptionPeriodTwoMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPricePercentage": { "auth_ref": [ "r627" ], "lang": { "en-us": { "role": { "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.", "label": "Debt Instrument, Redemption Price, Percentage", "terseLabel": "Debt instrument, redemption price, percentage" } } }, "localname": "DebtInstrumentRedemptionPricePercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r48", "r130", "r314", "r316", "r317", "r318", "r534", "r535", "r537", "r628" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONVERTIBLENOTERECEIVABLEAdditionalInformationDetails", "http://Heska.com/role/CONVERTIBLENOTERECEIVABLEDetails", "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTCarryingAmountofDebtDetails", "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTInterestExpenseRelatedtotheNotesDetails", "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r534", "r537" ], "calculation": { "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTCarryingAmountofDebtDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebt", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument, Unamortized Discount", "negatedTerseLabel": "Unamortized debt discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTCarryingAmountofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": { "auth_ref": [ "r301", "r536" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.", "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net", "terseLabel": "Debt instrument, debt issuance costs, net" } } }, "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "auth_ref": [ "r128", "r448", "r457" ], "calculation": { "http://Heska.com/role/INCOMETAXESCOMPONENTSOFINCOMETAXEXPENSEBENEFITDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Federal Income Tax Expense (Benefit)", "verboseLabel": "Federal" } } }, "localname": "DeferredFederalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESCOMPONENTSOFINCOMETAXEXPENSEBENEFITDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "auth_ref": [ "r128", "r448", "r457" ], "calculation": { "http://Heska.com/role/INCOMETAXESCOMPONENTSOFINCOMETAXEXPENSEBENEFITDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Foreign Income Tax Expense (Benefit)", "verboseLabel": "Foreign" } } }, "localname": "DeferredForeignIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESCOMPONENTSOFINCOMETAXEXPENSEBENEFITDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r115", "r128", "r448", "r457", "r458", "r459" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 }, "http://Heska.com/role/INCOMETAXESCOMPONENTSOFINCOMETAXEXPENSEBENEFITDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "negatedTotalLabel": "Total deferred (benefit) expense", "netLabel": "Deferred income tax benefit", "verboseLabel": "Deferred income tax benefit" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME", "http://Heska.com/role/INCOMETAXESCOMPONENTSOFINCOMETAXEXPENSEBENEFITDetails", "http://Heska.com/role/INCOMETAXESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Deferred income tax (benefit) expense:" } } }, "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESCOMPONENTSOFINCOMETAXEXPENSEBENEFITDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r425", "r426" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "terseLabel": "Deferred tax liability" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS", "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "auth_ref": [ "r128", "r448", "r457" ], "calculation": { "http://Heska.com/role/INCOMETAXESCOMPONENTSOFINCOMETAXEXPENSEBENEFITDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred State and Local Income Tax Expense (Benefit)", "verboseLabel": "State" } } }, "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESCOMPONENTSOFINCOMETAXEXPENSEBENEFITDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsDeferredIncome": { "auth_ref": [ "r445", "r446" ], "calculation": { "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails": { "order": 6.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.", "label": "Deferred Tax Assets, Deferred Income", "terseLabel": "Deferred revenue" } } }, "localname": "DeferredTaxAssetsDeferredIncome", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r438" ], "calculation": { "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Gross", "terseLabel": "Deferred tax assets, gross" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": { "auth_ref": [ "r445", "r446" ], "calculation": { "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails": { "order": 5.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.", "label": "Deferred Tax Assets, in Process Research and Development", "terseLabel": "Research and development expense" } } }, "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsInventory": { "auth_ref": [ "r445", "r446" ], "calculation": { "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.", "label": "Deferred Tax Assets, Inventory", "terseLabel": "Inventory" } } }, "localname": "DeferredTaxAssetsInventory", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "auth_ref": [ "r440" ], "calculation": { "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.", "label": "Deferred Tax Assets, Net", "totalLabel": "Total net deferred tax assets (liabilities)" } } }, "localname": "DeferredTaxAssetsLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r445", "r446" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards", "terseLabel": "Deferred tax assets, operating loss carryforwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": { "auth_ref": [ "r445", "r446" ], "calculation": { "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails": { "order": 8.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards, Domestic", "terseLabel": "Net operating loss carryforwards \u2013 domestic" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.", "label": "Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration", "terseLabel": "Deferred tax assets, operating loss carryforwards, not subject to expiration" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": { "auth_ref": [], "calculation": { "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails": { "order": 7.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.", "label": "Deferred Tax Assets, Property, Plant and Equipment", "terseLabel": "Property and equipment" } } }, "localname": "DeferredTaxAssetsPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign": { "auth_ref": [ "r443", "r445", "r446" ], "calculation": { "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails": { "order": 9.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign tax credit carryforwards.", "label": "Deferred Tax Assets, Tax Credit Carryforwards, Foreign", "terseLabel": "Foreign tax credit carryforward" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwardsForeign", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": { "auth_ref": [ "r443", "r445", "r446" ], "calculation": { "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.", "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research", "terseLabel": "Research and development tax credit" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation": { "auth_ref": [ "r445", "r446" ], "calculation": { "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation.", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation", "terseLabel": "Accrued compensation" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "auth_ref": [ "r445", "r446" ], "calculation": { "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost", "terseLabel": "Stock and Stock Options" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r439" ], "calculation": { "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "terseLabel": "Deferred tax assets, valuation allowance", "verboseLabel": "Valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESDetails", "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilities": { "auth_ref": [ "r426", "r440" ], "calculation": { "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.", "label": "Deferred Tax Liabilities, Net", "negatedTotalLabel": "Total net deferred tax assets (liabilities)" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": { "auth_ref": [ "r445", "r446" ], "calculation": { "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails": { "order": 11.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.", "label": "Deferred Tax Liabilities, Leasing Arrangements", "terseLabel": "Sales-type leases" } } }, "localname": "DeferredTaxLiabilitiesLeasingArrangements", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesOther": { "auth_ref": [ "r445", "r446" ], "calculation": { "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails": { "order": 14.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.", "label": "Deferred Tax Liabilities, Other", "negatedLabel": "Other" } } }, "localname": "DeferredTaxLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESTEMPORARYDIFFERENCESTOTHECOMPONENTSOFDEFERREDTAXASSETSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r115", "r280" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation, Depletion and Amortization, Nonproduction", "terseLabel": "Depreciation and amortization", "verboseLabel": "Depreciation and Amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DevelopedTechnologyRightsMember": { "auth_ref": [ "r482" ], "lang": { "en-us": { "role": { "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.", "label": "Developed Technology Rights [Member]", "terseLabel": "Developed technology" } } }, "localname": "DevelopedTechnologyRightsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSIntangibleAssetsAcquiredAmortizationMethodDetails", "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r343" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Disaggregation of Revenue" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/REVENUETables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-based Payment Arrangement [Text Block]", "terseLabel": "CAPITAL STOCK" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCK" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement [Abstract]", "terseLabel": "Disclosure of Compensation Related Costs, Share-based Payments [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DomesticCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.", "label": "Domestic Tax Authority [Member]", "terseLabel": "Domestic Tax Authority" } } }, "localname": "DomesticCountryMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r87", "r145", "r146", "r147", "r148", "r149", "r154", "r156", "r160", "r161", "r162", "r166", "r167", "r622", "r647" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "verboseLabel": "Basic earnings per share attributable to Heska Corporation (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME", "http://Heska.com/role/EARNINGSPERSHAREDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r87", "r145", "r146", "r147", "r148", "r149", "r156", "r160", "r161", "r162", "r166", "r167", "r622", "r647" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "verboseLabel": "Diluted earnings per share attributable to Heska Corporation (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME", "http://Heska.com/role/EARNINGSPERSHAREDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r124", "r163", "r164" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Earnings Per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r163", "r164", "r165", "r168" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "EARNINGS PER SHARE" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/EARNINGSPERSHARE" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": { "auth_ref": [ "r523" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.", "label": "Effect of Exchange Rate on Cash and Cash Equivalents", "terseLabel": "NET EFFECT OF EXCHANGE RATE CHANGES ON CASH" } } }, "localname": "EffectOfExchangeRateOnCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r428" ], "calculation": { "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "totalLabel": "Effective income tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r428", "r461" ], "calculation": { "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails": { "order": 5.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "Statutory federal tax rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r428", "r461" ], "calculation": { "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails": { "order": 13.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent", "terseLabel": "Change in valuation allowance" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": { "auth_ref": [ "r428", "r461" ], "calculation": { "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails": { "order": 4.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.", "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent", "terseLabel": "Change in tax rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense": { "auth_ref": [ "r428", "r461" ], "calculation": { "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails": { "order": 16.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": -1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.", "label": "Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Percent", "negatedTerseLabel": "Non-controlling interest in Optomed" } } }, "localname": "EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment": { "auth_ref": [ "r428", "r461" ], "calculation": { "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails": { "order": 1.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to meals and entertainment expense.", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Percent", "terseLabel": "Meals and entertainment permanent difference" } } }, "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther": { "auth_ref": [ "r428", "r461" ], "calculation": { "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails": { "order": 12.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent", "terseLabel": "Other permanent differences" } } }, "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": { "auth_ref": [ "r428", "r461" ], "calculation": { "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails": { "order": 14.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": -1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent", "terseLabel": "Non-temporary stock option benefit" } } }, "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": { "auth_ref": [ "r428", "r461" ], "calculation": { "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails": { "order": 10.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.", "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent", "verboseLabel": "Other" } } }, "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings": { "auth_ref": [ "r428", "r461" ], "calculation": { "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails": { "order": 3.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the repatriation of foreign earnings.", "label": "Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent", "terseLabel": "Foreign tax rate differences" } } }, "localname": "EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r428", "r461" ], "calculation": { "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails": { "order": 11.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent", "terseLabel": "State income taxes, net of federal benefit" } } }, "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies": { "auth_ref": [ "r428", "r461" ], "calculation": { "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails": { "order": 2.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax contingencies. Includes, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.", "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Percent", "terseLabel": "Change in uncertain tax benefits" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxContingencies", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": { "auth_ref": [ "r428", "r461" ], "calculation": { "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails": { "order": 6.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": -1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent", "negatedTerseLabel": "Research & development credit" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent": { "auth_ref": [ "r428" ], "calculation": { "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails": { "order": 15.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to Tax Cuts and Jobs Act.", "label": "Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act, Percent", "terseLabel": "GILTI permanent difference" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails" ], "xbrltype": "pureItemType" }, "us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeAsset": { "auth_ref": [ "r512" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as an asset.", "label": "Embedded Derivative, Fair Value of Embedded Derivative Asset", "terseLabel": "Embedded derivative, fair value of embedded derivative asset" } } }, "localname": "EmbeddedDerivativeFairValueOfEmbeddedDerivativeAsset", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONVERTIBLENOTERECEIVABLEAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r44" ], "calculation": { "http://Heska.com/role/ACCRUEDLIABILITIESDetails": { "order": 1.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Accrued payroll and employee benefits" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACCRUEDLIABILITIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r402" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Period for recognition of unrecognized compensation expense" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r402" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount", "terseLabel": "Total unrecognized compensation expense related to outstanding stock options" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.", "label": "Employee Stock [Member]", "terseLabel": "Employee Stock" } } }, "localname": "EmployeeStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails", "http://Heska.com/role/CAPITALSTOCKOPTIONACTIVITYDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r401" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-based Payment Arrangement, Option [Member]", "terseLabel": "Stock options and restricted shares" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails", "http://Heska.com/role/CAPITALSTOCKOPTIONACTIVITYDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]", "terseLabel": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r136", "r137", "r139", "r142", "r150", "r153", "r170", "r243", "r313", "r319", "r409", "r410", "r411", "r453", "r454", "r524", "r525", "r526", "r527", "r528", "r530", "r658", "r659", "r660" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEDetails", "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails", "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvesteeMember": { "auth_ref": [ "r232", "r595", "r597", "r599", "r601", "r603", "r605" ], "lang": { "en-us": { "role": { "documentation": "An entity that issued voting stock held by an investor and that is accounted for under the equity method of accounting by the investor.", "label": "Equity Method Investee [Member]", "terseLabel": "Equity Method Investee" } } }, "localname": "EquityMethodInvesteeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONVERTIBLENOTERECEIVABLEAdditionalInformationDetails", "http://Heska.com/role/CONVERTIBLENOTERECEIVABLEDetails", "http://Heska.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r234" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Ownership percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INVESTMENTSINUNCONSOLIDATEDAFFILIATESDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r36", "r199", "r233" ], "calculation": { "http://Heska.com/role/INVESTMENTSINUNCONSOLIDATEDAFFILIATESDetails": { "order": 1.0, "parentTag": "us-gaap_Investments", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Method Investments", "terseLabel": "Investments in unconsolidated affiliates" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INVESTMENTSINUNCONSOLIDATEDAFFILIATESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Method Investments and Joint Ventures [Abstract]", "terseLabel": "Equity Method Investments and Joint Ventures [Abstract]" } } }, "localname": "EquityMethodInvestmentsAndJointVenturesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": { "auth_ref": [ "r239" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.", "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]", "terseLabel": "INVESTMENTS IN UNCONSOLIDATED AFFILIATES" } } }, "localname": "EquityMethodInvestmentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INVESTMENTSINUNCONSOLIDATEDAFFILIATES" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityMethodInvestmentsPolicy": { "auth_ref": [ "r36", "r110", "r124", "r235", "r518" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.", "label": "Equity Method Investments [Policy Text Block]", "terseLabel": "Investments in Unconsolidated Affiliates" } } }, "localname": "EquityMethodInvestmentsPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityMethodInvestmentsTextBlock": { "auth_ref": [ "r238" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.", "label": "Equity Method Investments [Table Text Block]", "terseLabel": "Carrying values of investments in unconsolidated entities" } } }, "localname": "EquityMethodInvestmentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INVESTMENTSINUNCONSOLIDATEDAFFILIATESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis": { "auth_ref": [ "r138", "r145", "r146", "r149", "r150", "r152", "r153" ], "lang": { "en-us": { "role": { "documentation": "Information by type of error correction.", "label": "Error Correction, Type [Axis]", "terseLabel": "Error Correction, Type [Axis]" } } }, "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r363", "r513", "r578", "r579", "r580" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r354", "r355", "r360", "r363", "r513", "r579" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Fair Value, Inputs, Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r363", "r578", "r579", "r580" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r124", "r514", "r515" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueOptionQuantitativeDisclosuresTextBlock": { "auth_ref": [ "r519", "r520", "r521", "r522" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information about asset and liability measured at fair value under fair value option.", "label": "Fair Value Option, Disclosures [Table Text Block]", "terseLabel": "Schedule of pricing models" } } }, "localname": "FairValueOptionQuantitativeDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinanceLeaseInterestExpense": { "auth_ref": [ "r542", "r547", "r555" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense on finance lease liability.", "label": "Finance Lease, Interest Expense", "terseLabel": "Finance lease, interest expense" } } }, "localname": "FinanceLeaseInterestExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseInterestPaymentOnLiability": { "auth_ref": [ "r544", "r549" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest paid on finance lease liability.", "label": "Finance Lease, Interest Payment on Liability", "terseLabel": "Operating cash outflows - finance leases" } } }, "localname": "FinanceLeaseInterestPaymentOnLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, Payment, Due [Abstract]", "terseLabel": "Finance Leases" } } }, "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESLesseeAccountingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinanceLeaseLiability": { "auth_ref": [ "r541", "r554" ], "calculation": { "http://Heska.com/role/LEASESLesseeAccountingDetails": { "order": 1.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.", "label": "Finance Lease, Liability", "terseLabel": "Total lease liabilities" } } }, "localname": "FinanceLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESLesseeAccountingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityCurrent": { "auth_ref": [ "r541" ], "calculation": { "http://Heska.com/role/LEASESOperatingandFinancingLeaseBalancesDetails": { "order": 2.0, "parentTag": "hska_LeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.", "label": "Finance Lease, Liability, Current", "terseLabel": "Deferred revenue, current, and other" } } }, "localname": "FinanceLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESOperatingandFinancingLeaseBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "auth_ref": [ "r541" ], "calculation": { "http://Heska.com/role/LEASESOperatingandFinancingLeaseBalancesDetails": { "order": 4.0, "parentTag": "hska_LeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.", "label": "Finance Lease, Liability, Noncurrent", "terseLabel": "Other liabilities" } } }, "localname": "FinanceLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESOperatingandFinancingLeaseBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDue": { "auth_ref": [ "r554" ], "calculation": { "http://Heska.com/role/LEASESLesseeAccountingDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://Heska.com/role/LEASESLesseeAccountingDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.", "label": "Finance Lease, Liability, Payment, Due", "totalLabel": "Total lease payments" } } }, "localname": "FinanceLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESLesseeAccountingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r554" ], "calculation": { "http://Heska.com/role/LEASESLesseeAccountingDetails_1": { "order": 3.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESLesseeAccountingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r554" ], "calculation": { "http://Heska.com/role/LEASESLesseeAccountingDetails_1": { "order": 6.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year One", "terseLabel": "2021" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESLesseeAccountingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r554" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Five", "terseLabel": "2025" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESLesseeAccountingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r554" ], "calculation": { "http://Heska.com/role/LEASESLesseeAccountingDetails_1": { "order": 1.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Four", "terseLabel": "2024" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESLesseeAccountingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r554" ], "calculation": { "http://Heska.com/role/LEASESLesseeAccountingDetails_1": { "order": 5.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Three", "terseLabel": "2023" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESLesseeAccountingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r554" ], "calculation": { "http://Heska.com/role/LEASESLesseeAccountingDetails_1": { "order": 4.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Two", "terseLabel": "2022" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESLesseeAccountingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r554" ], "calculation": { "http://Heska.com/role/LEASESLesseeAccountingDetails": { "order": 2.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.", "label": "Finance Lease, Liability, Undiscounted Excess Amount", "terseLabel": "Less: imputed interest" } } }, "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESLesseeAccountingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeasePrincipalPayments": { "auth_ref": [ "r543", "r549" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for principal payment on finance lease.", "label": "Finance Lease, Principal Payments", "terseLabel": "Financing cash outflows - finance leases" } } }, "localname": "FinanceLeasePrincipalPayments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAsset": { "auth_ref": [ "r540" ], "calculation": { "http://Heska.com/role/LEASESOperatingandFinancingLeaseBalancesDetails": { "order": 2.0, "parentTag": "hska_LeaseRightOfUseAsset", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.", "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization", "terseLabel": "Property and equipment, net" } } }, "localname": "FinanceLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESOperatingandFinancingLeaseBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAssetAmortization": { "auth_ref": [ "r542", "r547", "r555" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.", "label": "Finance Lease, Right-of-Use Asset, Amortization", "terseLabel": "Finance lease amortization expense" } } }, "localname": "FinanceLeaseRightOfUseAssetAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r552", "r555" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for finance lease calculated at point in time.", "label": "Finance Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Finance" } } }, "localname": "FinanceLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESWeightedAverageRemainingLeaseTermandWeightedAverageDiscountRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r551", "r555" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Finance Lease, Weighted Average Remaining Lease Term", "terseLabel": "Finance" } } }, "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESWeightedAverageRemainingLeaseTermandWeightedAverageDiscountRateDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r272" ], "calculation": { "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails_1": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedTerseLabel": "Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "auth_ref": [], "calculation": { "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails": { "order": 6.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r274" ], "calculation": { "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails": { "order": 5.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "terseLabel": "2021" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.", "label": "Finite-lived Intangible Assets Amortization Expense [Table Text Block]", "terseLabel": "Schedule of amortization expense on intangible assets" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r274" ], "calculation": { "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails": { "order": 4.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "terseLabel": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r274" ], "calculation": { "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "terseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r274" ], "calculation": { "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "terseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r274" ], "calculation": { "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails": { "order": 3.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "terseLabel": "2022" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r264", "r268", "r272", "r276", "r589", "r593" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSIntangibleAssetsAcquiredAmortizationMethodDetails", "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]", "terseLabel": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]" } } }, "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r272", "r593" ], "calculation": { "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails_1": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Gross Carrying Amount" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r264", "r271" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSIntangibleAssetsAcquiredAmortizationMethodDetails", "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r272", "r589" ], "calculation": { "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails": { "order": 1.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0 }, "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "terseLabel": "Other intangible assets, net", "totalLabel": "Net Carrying Amount" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Net [Abstract]", "terseLabel": "Finite-Lived Intangible Assets, Net [Abstract]" } } }, "localname": "FiniteLivedIntangibleAssetsNetAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": { "auth_ref": [ "r589" ], "lang": { "en-us": { "role": { "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Assets, Remaining Amortization Period", "terseLabel": "Finite-lived intangible assets, remaining amortization period" } } }, "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FinitelivedIntangibleAssetsAcquired1": { "auth_ref": [ "r265" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.", "label": "Finite-lived Intangible Assets Acquired", "terseLabel": "Fair Value" } } }, "localname": "FinitelivedIntangibleAssetsAcquired1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSIntangibleAssetsAcquiredAmortizationMethodDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.", "label": "Foreign Tax Authority [Member]", "terseLabel": "Foreign Tax Authority" } } }, "localname": "ForeignCountryMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r124", "r532" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "terseLabel": "Foreign Currency Translation" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ForeignEarningsRepatriated": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign earnings repatriated from subsidiaries outside the country of domicile.", "label": "Foreign Earnings Repatriated", "terseLabel": "Foreign earnings repatriated" } } }, "localname": "ForeignEarningsRepatriated", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r92" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r255", "r256", "r607" ], "calculation": { "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 }, "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "Carrying amount", "periodStartLabel": "Carrying amount", "terseLabel": "Goodwill", "verboseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails", "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS", "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAcquiredDuringPeriod": { "auth_ref": [ "r257" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.", "label": "Goodwill, Acquired During Period", "terseLabel": "Goodwill attributable to acquisitions (subject to change)" } } }, "localname": "GoodwillAcquiredDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]", "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r279" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "terseLabel": "GOOWILL AND OTHER INTANGIBLES" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLES" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "auth_ref": [ "r124", "r260", "r269" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.", "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]", "terseLabel": "Goodwill, Intangible and Other Long-Lived Assets" } } }, "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r258" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Foreign Currency Translation Gain (Loss)", "terseLabel": "Foreign currency adjustments" } } }, "localname": "GoodwillForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillPeriodIncreaseDecrease": { "auth_ref": [ "r260" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Period Increase (Decrease)", "terseLabel": "Goodwill, period increase (decrease)" } } }, "localname": "GoodwillPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillPurchaseAccountingAdjustments": { "auth_ref": [ "r259", "r468" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Purchase Accounting Adjustments", "terseLabel": "Measurement period adjustment to prior year acquisition" } } }, "localname": "GoodwillPurchaseAccountingAdjustments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Goodwill [Roll Forward]", "terseLabel": "Goodwill [Roll Forward]" } } }, "localname": "GoodwillRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r90", "r127", "r198", "r204", "r208", "r211", "r214", "r237", "r518" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "terseLabel": "Gross profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME", "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r115", "r277" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.", "label": "Impairment of Intangible Assets (Excluding Goodwill)", "terseLabel": "Impairment of intangible assets (excluding goodwill)" } } }, "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "auth_ref": [ "r132", "r460" ], "calculation": { "http://Heska.com/role/INCOMETAXESCOMPONENTSOFINCOMELOSSBEFORETAXESDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic", "terseLabel": "Domestic" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESCOMPONENTSOFINCOMELOSSBEFORETAXESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r80", "r198", "r204", "r208", "r211", "r214", "r606", "r616", "r625", "r648" ], "calculation": { "http://Heska.com/role/INCOMETAXESCOMPONENTSOFINCOMELOSSBEFORETAXESDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Income (loss) before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESCOMPONENTSOFINCOMELOSSBEFORETAXESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": { "auth_ref": [ "r132", "r460" ], "calculation": { "http://Heska.com/role/INCOMETAXESCOMPONENTSOFINCOMELOSSBEFORETAXESDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign", "terseLabel": "Foreign" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESCOMPONENTSOFINCOMELOSSBEFORETAXESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r132", "r198", "r204", "r208", "r211", "r214" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": { "order": 1.0, "parentTag": "hska_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsIncomeTaxesNoncontrollingInterestNetOfTaxes", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.", "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest", "terseLabel": "Income (loss) before income taxes", "totalLabel": "Income (loss) before income taxes and equity in losses of unconsolidated affiliates" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME", "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r81", "r115", "r195", "r233", "r615", "r641" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Income (Loss) from Equity Method Investments", "negatedTerseLabel": "Equity in losses of unconsolidated affiliates", "terseLabel": "Equity in losses of unconsolidated affiliates" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r431" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]", "terseLabel": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]", "terseLabel": "Income Tax Authority [Domain]" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxContingencyLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Tax Contingency [Line Items]", "terseLabel": "Income Tax Contingency [Line Items]" } } }, "localname": "IncomeTaxContingencyLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxContingencyTable": { "auth_ref": [ "r432", "r435", "r437", "r450" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.", "label": "Income Tax Contingency [Table]", "terseLabel": "Income Tax Contingency [Table]" } } }, "localname": "IncomeTaxContingencyTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESEFFECTIVEINCOMETAXRECONCILIATIONDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]", "terseLabel": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r429", "r436", "r442", "r455", "r462", "r464", "r465", "r467" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXES" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r128", "r152", "r153", "r196", "r427", "r456", "r463", "r649" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": { "order": 2.0, "parentTag": "hska_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsIncomeTaxesNoncontrollingInterestNetOfTaxes", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Income tax expense (benefit)", "totalLabel": "Total income tax expense (benefit)" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME", "http://Heska.com/role/INCOMETAXESCOMPONENTSOFINCOMETAXEXPENSEBENEFITDetails", "http://Heska.com/role/INCOMETAXESDetails", "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxExpenseBenefitIntraperiodTaxAllocationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Expense (Benefit), Intraperiod Tax Allocation [Abstract]", "terseLabel": "Income tax expense (benefit):" } } }, "localname": "IncomeTaxExpenseBenefitIntraperiodTaxAllocationAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r77", "r124", "r423", "r424", "r436", "r437", "r441", "r449", "r675" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r112", "r119" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "terseLabel": "Cash paid for income taxes" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableTrade": { "auth_ref": [ "r114" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.", "label": "Increase (Decrease) in Accounts Payable, Trade", "verboseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayableTrade", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r114" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedTerseLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDueToRelatedParties": { "auth_ref": [ "r114" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence.", "label": "Increase (Decrease) in Due to Related Parties", "terseLabel": "Due to related parties" } } }, "localname": "IncreaseDecreaseInDueToRelatedParties", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r114" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedTerseLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities (net of effect of acquisitions):" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r114" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other assets" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": { "auth_ref": [ "r114" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating liabilities classified as other.", "label": "Increase (Decrease) in Other Operating Liabilities", "terseLabel": "Other liabilities" } } }, "localname": "IncreaseDecreaseInOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r267", "r275" ], "lang": { "en-us": { "role": { "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets [Axis]", "terseLabel": "Indefinite-lived Intangible Assets [Axis]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSIntangibleAssetsAcquiredAmortizationMethodDetails", "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Indefinite-lived Intangible Assets [Line Items]", "terseLabel": "Indefinite-lived Intangible Assets [Line Items]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r275" ], "calculation": { "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails": { "order": 2.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)", "terseLabel": "Indefinite-lived intangible assets" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r267", "r275" ], "lang": { "en-us": { "role": { "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.", "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSIntangibleAssetsAcquiredAmortizationMethodDetails", "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IndefinitelivedIntangibleAssetsAcquired": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in assets, excluding financial assets and goodwill, lacking physical substance with an indefinite life, from an acquisition.", "label": "Indefinite-lived Intangible Assets Acquired", "terseLabel": "Indefinite-lived intangible assets acquired" } } }, "localname": "IndefinitelivedIntangibleAssetsAcquired", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSIntangibleAssetsAcquiredAmortizationMethodDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsGrossExcludingGoodwill": { "auth_ref": [], "calculation": { "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails_1": { "order": 2.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.", "label": "Intangible Assets, Gross (Excluding Goodwill)", "terseLabel": "Total intangible assets acquired" } } }, "localname": "IntangibleAssetsGrossExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSIntangibleAssetsAcquiredAmortizationMethodDetails", "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r262", "r270" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Net intangible assets", "totalLabel": "Net intangible assets" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS", "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Intangible Assets, Net (Excluding Goodwill) [Abstract]", "terseLabel": "Intangible Assets, Net (Excluding Goodwill) [Abstract]" } } }, "localname": "IntangibleAssetsNetExcludingGoodwillAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InterestAndOtherIncomeTextBlock": { "auth_ref": [ "r352" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for interest and other income.", "label": "Interest and Other Income [Text Block]", "terseLabel": "INTEREST AND OTHER (INCOME) EXPENSE, NET" } } }, "localname": "InterestAndOtherIncomeTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INTERESTANDOTHERINCOMEEXPENSENET" ], "xbrltype": "textBlockItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r79", "r192", "r533", "r536", "r624" ], "calculation": { "http://Heska.com/role/INTERESTANDOTHERINCOMEEXPENSENETDetails": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "terseLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INTERESTANDOTHERINCOMEEXPENSENETDetails", "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r94", "r307" ], "calculation": { "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTInterestExpenseRelatedtotheNotesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest Expense, Debt", "terseLabel": "Interest expense, debt", "totalLabel": "Total interest expense related to debt" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTInterestExpenseRelatedtotheNotesDetails", "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebtExcludingAmortization": { "auth_ref": [ "r96" ], "calculation": { "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTInterestExpenseRelatedtotheNotesDetails": { "order": 1.0, "parentTag": "us-gaap_InterestExpenseDebt", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.", "label": "Interest Expense, Debt, Excluding Amortization", "terseLabel": "Interest expense related to contractual coupon interest" } } }, "localname": "InterestExpenseDebtExcludingAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTInterestExpenseRelatedtotheNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeDepositsWithFinancialInstitutions": { "auth_ref": [ "r623" ], "calculation": { "http://Heska.com/role/INTERESTANDOTHERINCOMEEXPENSENETDetails": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Interest income derived from funds deposited with both domestic and foreign financial institutions including funds in money market and other accounts.", "label": "Interest Income, Deposits with Financial Institutions", "negatedTerseLabel": "Interest income" } } }, "localname": "InterestIncomeDepositsWithFinancialInstitutions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INTERESTANDOTHERINCOMEEXPENSENETDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaid": { "auth_ref": [ "r119" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.", "label": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities", "terseLabel": "Cash paid for interest" } } }, "localname": "InterestPaid", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INTERESTANDOTHERINCOMEEXPENSENETDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r250" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "terseLabel": "INVENTORIES" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INVENTORIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r54" ], "calculation": { "http://Heska.com/role/INVENTORIESDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Inventory, Finished Goods, Gross", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INVENTORIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r5", "r57" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://Heska.com/role/INVENTORIESDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventories", "totalLabel": "Total inventory, net" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS", "http://Heska.com/role/INVENTORIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterials": { "auth_ref": [ "r56" ], "calculation": { "http://Heska.com/role/INVENTORIESDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Raw Materials, Gross", "terseLabel": "Raw materials" } } }, "localname": "InventoryRawMaterials", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INVENTORIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcess": { "auth_ref": [ "r55" ], "calculation": { "http://Heska.com/role/INVENTORIESDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.", "label": "Inventory, Work in Process, Gross", "terseLabel": "Work in process" } } }, "localname": "InventoryWorkInProcess", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INVENTORIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Investments": { "auth_ref": [ "r639" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://Heska.com/role/INVESTMENTSINUNCONSOLIDATEDAFFILIATESDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.", "label": "Investments", "terseLabel": "Investments in unconsolidated affiliates", "totalLabel": "Investments" } } }, "localname": "Investments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS", "http://Heska.com/role/INVESTMENTSINUNCONSOLIDATEDAFFILIATESDetails", "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LandMember": { "auth_ref": [ "r347" ], "lang": { "en-us": { "role": { "documentation": "Part of earth's surface not covered by water.", "label": "Land [Member]", "terseLabel": "Land" } } }, "localname": "LandMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/PROPERTYANDEQUIPMENTDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r553" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "Lease, Cost" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]", "terseLabel": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r546" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee, Leases [Policy Text Block]", "terseLabel": "Lessee, Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r554" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Lessee, Operating Lease, Liability, Maturity" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r554" ], "calculation": { "http://Heska.com/role/LEASESLesseeAccountingDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://Heska.com/role/LEASESLesseeAccountingDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESLesseeAccountingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r554" ], "calculation": { "http://Heska.com/role/LEASESLesseeAccountingDetails_1": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESLesseeAccountingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r554" ], "calculation": { "http://Heska.com/role/LEASESLesseeAccountingDetails_1": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "2021" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESLesseeAccountingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r554" ], "calculation": { "http://Heska.com/role/LEASESLesseeAccountingDetails_1": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESLesseeAccountingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r554" ], "calculation": { "http://Heska.com/role/LEASESLesseeAccountingDetails_1": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESLesseeAccountingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r554" ], "calculation": { "http://Heska.com/role/LEASESLesseeAccountingDetails_1": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESLesseeAccountingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r554" ], "calculation": { "http://Heska.com/role/LEASESLesseeAccountingDetails_1": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESLesseeAccountingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r554" ], "calculation": { "http://Heska.com/role/LEASESLesseeAccountingDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "terseLabel": "Less: imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESLesseeAccountingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r556" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "LEASES" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASES" ], "xbrltype": "textBlockItemType" }, "us-gaap_LessorLeasesPolicyTextBlock": { "auth_ref": [ "r560", "r562", "r563", "r566" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangements entered into by lessor.", "label": "Lessor, Leases [Policy Text Block]", "terseLabel": "Lessor, Leases" } } }, "localname": "LessorLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lessor, Operating Lease, Payments, Fiscal Year Maturity [Abstract]", "terseLabel": "Lessor, Operating Lease, Payments, Fiscal Year Maturity [Abstract]" } } }, "localname": "LessorOperatingLeasePaymentsFiscalYearMaturityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESLessorAccountingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceived": { "auth_ref": [ "r561" ], "calculation": { "http://Heska.com/role/LEASESLessorAccountingDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://Heska.com/role/LEASESLessorAccountingDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payments to be received by lessor for operating lease.", "label": "Lessor, Operating Lease, Payments to be Received", "totalLabel": "Total undiscounted future maturities" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceived", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESLessorAccountingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears": { "auth_ref": [ "r561" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessor, Operating Lease, Payment to be Received, Year Five", "terseLabel": "2025" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedFiveYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESLessorAccountingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears": { "auth_ref": [ "r561" ], "calculation": { "http://Heska.com/role/LEASESLessorAccountingDetails": { "order": 5.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessor, Operating Lease, Payment to be Received, Year Four", "terseLabel": "2024" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedFourYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESLessorAccountingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock": { "auth_ref": [ "r561" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity of undiscounted cash flows to be received by lessor on annual basis for operating lease.", "label": "Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Table Text Block]", "terseLabel": "Lessor, Operating Lease, Payments to be Received, Maturity" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths": { "auth_ref": [ "r561" ], "calculation": { "http://Heska.com/role/LEASESLessorAccountingDetails": { "order": 2.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessor, Operating Lease, Payment to be Received, Year One", "terseLabel": "2021" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESLessorAccountingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter": { "auth_ref": [ "r561" ], "calculation": { "http://Heska.com/role/LEASESLessorAccountingDetails": { "order": 6.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessor, Operating Lease, Payment to be Received, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedThereafter", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESLessorAccountingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears": { "auth_ref": [ "r561" ], "calculation": { "http://Heska.com/role/LEASESLessorAccountingDetails": { "order": 4.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessor, Operating Lease, Payment to be Received, Year Three", "terseLabel": "2023" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedThreeYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESLessorAccountingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears": { "auth_ref": [ "r561" ], "calculation": { "http://Heska.com/role/LEASESLessorAccountingDetails": { "order": 3.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessor, Operating Lease, Payment to be Received, Year Two", "terseLabel": "2022" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedTwoYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESLessorAccountingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LetterOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).", "label": "Letter of Credit [Member]", "terseLabel": "Letter of Credit" } } }, "localname": "LetterOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r43", "r127", "r206", "r237", "r502", "r507", "r508", "r518" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "terseLabel": "Liabilities" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r31", "r127", "r237", "r518", "r612", "r637" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities, mezzanine equity and stockholders' equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r45", "r127", "r237", "r502", "r507", "r508", "r518" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]", "terseLabel": "Line of Credit" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LitigationSettlementAmountAwardedToOtherParty": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount awarded to other party in judgment or settlement of litigation.", "label": "Litigation Settlement, Amount Awarded to Other Party", "terseLabel": "Litigation settlement, amount awarded to other party" } } }, "localname": "LitigationSettlementAmountAwardedToOtherParty", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/COMMITMENTSANDCONTINGENCIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LoansAndLeasesReceivableNetOfDeferredIncome": { "auth_ref": [ "r222", "r228" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allowance and after deduction of deferred interest and fees, unamortized costs and premiums and discounts from face amounts, of loans and leases held in portfolio, including but not limited to, commercial and consumer loans. Excludes loans and leases covered under loss sharing agreements.", "label": "Loans and Leases Receivable, Net of Deferred Income", "terseLabel": "Net investment in leases, current, net of allowance for losses of $192 and $105, respectively" } } }, "localname": "LoansAndLeasesReceivableNetOfDeferredIncome", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r20", "r302", "r610", "r633" ], "calculation": { "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTCarryingAmountofDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt", "totalLabel": "Net carrying amount" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTCarryingAmountofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTCarryingAmountofDebtDetails", "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTInterestExpenseRelatedtotheNotesDetails", "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails", "http://Heska.com/role/EARNINGSPERSHAREDetails", "http://Heska.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r48", "r297" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTCarryingAmountofDebtDetails", "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTInterestExpenseRelatedtotheNotesDetails", "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails", "http://Heska.com/role/EARNINGSPERSHAREDetails", "http://Heska.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingencyAccrualCarryingValueCurrent": { "auth_ref": [ "r292" ], "calculation": { "http://Heska.com/role/ACCRUEDLIABILITIESDetails": { "order": 3.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer.", "label": "Loss Contingency, Accrual, Current", "terseLabel": "Accrued settlement" } } }, "localname": "LossContingencyAccrualCarryingValueCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACCRUEDLIABILITIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment [Member]", "terseLabel": "Machinery and equipment" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails", "http://Heska.com/role/PROPERTYANDEQUIPMENTDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r111" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r111" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r111", "r113", "r116" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash (used in) provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r2", "r71", "r74", "r82", "r116", "r127", "r141", "r145", "r146", "r147", "r148", "r152", "r153", "r159", "r198", "r204", "r208", "r211", "r214", "r237", "r518", "r617", "r642" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net (loss) income attributable to Heska Corporation", "totalLabel": "Net (loss) income attributable to Heska Corporation" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME", "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://Heska.com/role/EARNINGSPERSHAREDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r71", "r74", "r152", "r153", "r504", "r510" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "terseLabel": "Net loss attributable to redeemable non-controlling interest" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentInLeaseCurrent": { "auth_ref": [ "r557", "r558" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net investment in sales-type and direct financing lease, classified as current.", "label": "Net Investment in Lease, Current", "terseLabel": "Net investment in leases, current" } } }, "localname": "NetInvestmentInLeaseCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncompeteAgreementsMember": { "auth_ref": [ "r479" ], "lang": { "en-us": { "role": { "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.", "label": "Noncompete Agreements [Member]", "terseLabel": "Non-compete agreements" } } }, "localname": "NoncompeteAgreementsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSIntangibleAssetsAcquiredAmortizationMethodDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NoncurrentAssets": { "auth_ref": [ "r218" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.", "label": "Long-Lived Assets", "periodEndLabel": "Total long-lived assets" } } }, "localname": "NoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r93" ], "calculation": { "http://Heska.com/role/INTERESTANDOTHERINCOMEEXPENSENETDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "negatedTotalLabel": "Interest and other expense (income)" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INTERESTANDOTHERINCOMEEXPENSENETDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesReceivableRelatedParties": { "auth_ref": [ "r134", "r571", "r640" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 9.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://Heska.com/role/CONVERTIBLENOTERECEIVABLEDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "For an unclassified balance sheet, amounts due from parties associated with the reporting entity as evidenced by a written promise to pay.", "label": "Notes Receivable, Related Parties", "terseLabel": "Related party convertible note receivable, net", "totalLabel": "Net carrying amount" } } }, "localname": "NotesReceivableRelatedParties", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS", "http://Heska.com/role/CONVERTIBLENOTERECEIVABLEDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [ "r186" ], "lang": { "en-us": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number of Reportable Segments", "terseLabel": "Number of reportable segments" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/REVENUEDetails", "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r198", "r204", "r208", "r211", "r214" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "terseLabel": "Operating income (loss)", "totalLabel": "Operating income (loss)" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME", "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r548", "r555" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease, Cost", "terseLabel": "Operating lease, expense" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLeaseIncome": { "auth_ref": [ "r169", "r559", "r565" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.", "label": "Operating Lease, Lease Income", "terseLabel": "Operating lease income" } } }, "localname": "OperatingLeaseLeaseIncome", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESSalestypeLeasesandLeaseIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]", "terseLabel": "Operating Leases" } } }, "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESLesseeAccountingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r541" ], "calculation": { "http://Heska.com/role/LEASESLesseeAccountingDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "terseLabel": "Operating lease liability" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails", "http://Heska.com/role/LEASESLesseeAccountingDetails", "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r541" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://Heska.com/role/LEASESOperatingandFinancingLeaseBalancesDetails": { "order": 3.0, "parentTag": "hska_LeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Operating lease liabilities, current" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS", "http://Heska.com/role/LEASESOperatingandFinancingLeaseBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r541" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://Heska.com/role/LEASESOperatingandFinancingLeaseBalancesDetails": { "order": 1.0, "parentTag": "hska_LeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating lease liabilities, non-current" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS", "http://Heska.com/role/LEASESOperatingandFinancingLeaseBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r545", "r549" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails", "http://Heska.com/role/LEASESSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r540" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://Heska.com/role/LEASESOperatingandFinancingLeaseBalancesDetails": { "order": 1.0, "parentTag": "hska_LeaseRightOfUseAsset", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails", "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS", "http://Heska.com/role/LEASESOperatingandFinancingLeaseBalancesDetails", "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r552", "r555" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Operating" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESWeightedAverageRemainingLeaseTermandWeightedAverageDiscountRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r551", "r555" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Operating" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESWeightedAverageRemainingLeaseTermandWeightedAverageDiscountRateDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLeasesOfLessorDisclosureTextBlock": { "auth_ref": [ "r538", "r539", "r567" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for lessor's operating leases.", "label": "Lessor, Operating Leases [Text Block]", "terseLabel": "LEASES" } } }, "localname": "OperatingLeasesOfLessorDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASES" ], "xbrltype": "textBlockItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r443" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards", "terseLabel": "Operating loss carryforwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Operating Loss Carryforwards [Line Items]", "terseLabel": "Operating Loss Carryforwards [Line Items]" } } }, "localname": "OperatingLossCarryforwardsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsTable": { "auth_ref": [ "r444" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.", "label": "Operating Loss Carryforwards [Table]", "terseLabel": "Operating Loss Carryforwards [Table]" } } }, "localname": "OperatingLossCarryforwardsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r203", "r204", "r205", "r206", "r208", "r214" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating Segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails", "http://Heska.com/role/REVENUEDetails", "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrderOrProductionBacklogMember": { "auth_ref": [ "r480" ], "lang": { "en-us": { "role": { "documentation": "Orders, production or production backlog arising from contracts such as purchase or sales orders acquired in a business combination.", "label": "Order or Production Backlog [Member]", "terseLabel": "Backlog" } } }, "localname": "OrderOrProductionBacklogMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSIntangibleAssetsAcquiredAmortizationMethodDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OriginationOfNotesReceivableFromRelatedParties": { "auth_ref": [ "r99" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a loan, supported by a promissory note, granted to related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth.", "label": "Origination of Notes Receivable from Related Parties", "negatedTerseLabel": "Convertible note receivable issuance", "terseLabel": "Principal amount" } } }, "localname": "OriginationOfNotesReceivableFromRelatedParties", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://Heska.com/role/CONVERTIBLENOTERECEIVABLEAdditionalInformationDetails", "http://Heska.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r11", "r12", "r13", "r44" ], "calculation": { "http://Heska.com/role/ACCRUEDLIABILITIESDetails": { "order": 5.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "terseLabel": "Other" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACCRUEDLIABILITIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r58" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r40" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 10.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other non-current assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r61" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 3.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "terseLabel": "Translation adjustments and gains (losses) from intra-entity transactions" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r72", "r75", "r78", "r83", "r313", "r524", "r529", "r530", "r618", "r643" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Other comprehensive (loss) income" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]", "terseLabel": "Other comprehensive (loss) income:" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "auth_ref": [ "r65", "r67" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "negatedTerseLabel": "Minimum pension liability" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax": { "auth_ref": [ "r63", "r67", "r361" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.", "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax", "terseLabel": "Other comprehensive income" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIncomeAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Income and Expenses [Abstract]", "terseLabel": "Other Income and Expenses [Abstract]" } } }, "localname": "OtherIncomeAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r49" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 7.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLongTermDebtNoncurrent": { "auth_ref": [ "r48" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt classified as other, payable after one year or the operating cycle, if longer.", "label": "Other Long-term Debt, Noncurrent", "terseLabel": "Other long-term borrowings" } } }, "localname": "OtherLongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r95" ], "calculation": { "http://Heska.com/role/INTERESTANDOTHERINCOMEEXPENSENETDetails": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "negatedTerseLabel": "Other (income) expense, net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INTERESTANDOTHERINCOMEEXPENSENETDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]", "terseLabel": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r105" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedTerseLabel": "Repurchase of common stock" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r107" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Payments of Debt Issuance Costs", "negatedTerseLabel": "Payment of debt issuance costs" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r108" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "Payments of Stock Issuance Costs", "negatedTerseLabel": "Payment of preferred stock issuance costs", "terseLabel": "Payments of stock issuance costs" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails", "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries": { "auth_ref": [ "r100" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the purchase of noncontrolling interest during the period.", "label": "Payments to Acquire Additional Interest in Subsidiaries", "negatedTerseLabel": "Purchase of minority interest" } } }, "localname": "PaymentsToAcquireAdditionalInterestInSubsidiaries", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r100", "r490" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "terseLabel": "Payments to acquire business" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails", "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r100" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedTerseLabel": "Acquisition of scil, net of cash acquired" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireEquityMethodInvestments": { "auth_ref": [ "r100" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.", "label": "Payments to Acquire Equity Method Investments", "negatedTerseLabel": "Investments in unconsolidated affiliates", "terseLabel": "Payments to acquire equity method investments" } } }, "localname": "PaymentsToAcquireEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://Heska.com/role/INVESTMENTSINUNCONSOLIDATEDAFFILIATESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r101" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedTerseLabel": "Acquisition of intangible asset" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireOtherInvestments": { "auth_ref": [ "r102" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to acquire investments classified as other.", "label": "Payments to Acquire Other Investments", "negatedTerseLabel": "Investment in subsidiary, net of cash acquired" } } }, "localname": "PaymentsToAcquireOtherInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment": { "auth_ref": [ "r101" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from the acquisition of or improvements to long-lived, physical assets used to produce goods and services and not intended for resale, classified as other.", "label": "Payments to Acquire Other Property, Plant, and Equipment", "negatedLabel": "Purchases of property and equipment" } } }, "localname": "PaymentsToAcquireOtherPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireRealEstate": { "auth_ref": [ "r101" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow from the acquisition of a piece of land, anything permanently fixed to it, including buildings, structures on it and so forth; includes real estate intended to generate income for the owner; excludes real estate acquired for use by the owner.", "label": "Payments to Acquire Real Estate", "negatedTerseLabel": "Real estate asset acquisition" } } }, "localname": "PaymentsToAcquireRealEstate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToMinorityShareholders": { "auth_ref": [ "r108" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.", "label": "Payments to Noncontrolling Interests", "negatedTerseLabel": "Distributions to non-controlling interest members" } } }, "localname": "PaymentsToMinorityShareholders", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PerformanceSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement awarded for meeting performance target.", "label": "Performance Shares [Member]", "terseLabel": "Performance Shares" } } }, "localname": "PerformanceSharesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails", "http://Heska.com/role/CAPITALSTOCKOPTIONACTIVITYDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r372", "r403" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]", "terseLabel": "Preferred Stock" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails", "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails", "http://Heska.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued (in shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails", "http://Heska.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r23" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $.01 par value, 2,500,000 shares authorized, none issued or outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r7", "r9", "r251", "r252" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense, Current", "terseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.", "label": "Reclassification, Comparability Adjustment [Policy Text Block]", "terseLabel": "Reclassification, Comparability Adjustment" } } }, "localname": "PriorPeriodReclassificationAdjustmentDescription", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ProceedsFromConvertibleDebt": { "auth_ref": [ "r104" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Proceeds from Convertible Debt", "terseLabel": "Convertible debt proceeds", "verboseLabel": "Proceeds from convertible debt" } } }, "localname": "ProceedsFromConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r103" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Proceeds from issuance of common stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock": { "auth_ref": [ "r103" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.", "label": "Proceeds from Issuance of Preferred Stock and Preference Stock", "terseLabel": "Preferred Stock Proceeds" } } }, "localname": "ProceedsFromIssuanceOfPreferredStockAndPreferenceStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLinesOfCredit": { "auth_ref": [ "r104", "r131" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "Proceeds from Lines of Credit", "terseLabel": "Borrowing on line of credit" } } }, "localname": "ProceedsFromLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromOtherDebt": { "auth_ref": [ "r104" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from debt classified as other.", "label": "Proceeds from Other Debt", "terseLabel": "Borrowings of other debts" } } }, "localname": "ProceedsFromOtherDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "auth_ref": [ "r98" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.", "label": "Proceeds from Sale of Property, Plant, and Equipment", "terseLabel": "Proceeds from disposition of property and equipment" } } }, "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r103", "r404" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from stock options exercised" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrual": { "auth_ref": [ "r295", "r296", "r613" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.", "label": "Standard and Extended Product Warranty Accrual", "terseLabel": "Warranty reserve" } } }, "localname": "ProductWarrantyAccrual", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/COMMITMENTSANDCONTINGENCIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r2", "r71", "r74", "r109", "r127", "r141", "r152", "r153", "r198", "r204", "r208", "r211", "r214", "r237", "r498", "r503", "r505", "r510", "r511", "r518", "r625" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net (loss) income after equity in losses from unconsolidated affiliates", "totalLabel": "Net (loss) income after equity in losses of unconsolidated affiliates", "verboseLabel": "Net (loss) income after equity in losses of unconsolidated affiliates" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME", "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]", "terseLabel": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r39", "r283" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Property, Plant and Equipment, Type [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails", "http://Heska.com/role/PROPERTYANDEQUIPMENTDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r286", "r676", "r677", "r678" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "PROPERTY AND EQUIPMENT" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/PROPERTYANDEQUIPMENT" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r38", "r281" ], "calculation": { "http://Heska.com/role/PROPERTYANDEQUIPMENTDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Property and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/PROPERTYANDEQUIPMENTDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails", "http://Heska.com/role/PROPERTYANDEQUIPMENTDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r16", "r17", "r283", "r638" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://Heska.com/role/PROPERTYANDEQUIPMENTDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and equipment, net", "totalLabel": "Total property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS", "http://Heska.com/role/PROPERTYANDEQUIPMENTDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r37", "r124", "r283", "r676", "r677" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r16", "r283" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Schedule of property and equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables", "http://Heska.com/role/PROPERTYANDEQUIPMENTTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTransfersAndChanges": { "auth_ref": [ "r284" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of physical assets used in the normal conduct of business and not intended for resale, from reclassification, impairment, donation, or changes classified as other. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Transfers and Changes", "terseLabel": "Transfers of equipment between inventory and property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentTransfersAndChanges", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://Heska.com/role/PROPERTYANDEQUIPMENTDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r16", "r281" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Property, Plant and Equipment, Type [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails", "http://Heska.com/role/PROPERTYANDEQUIPMENTDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Property plant and equipment, useful life" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails", "http://Heska.com/role/PROPERTYANDEQUIPMENTDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r88", "r248" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "terseLabel": "Additions - charged to expense" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProvisionForLoanLossesExpensed": { "auth_ref": [ "r248", "r614" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of credit loss expense (reversal of expense) for financing receivable.", "label": "Financing Receivable, Credit Loss, Expense (Reversal)", "terseLabel": "Provision for credit losses" } } }, "localname": "ProvisionForLoanLossesExpensed", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted": { "auth_ref": [ "r21", "r611", "r634" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Minimum amount to be expended to satisfy the terms of arrangements in which the entity has agreed to expend funds to procure goods or services, excluding long-term purchase commitments or unconditional purchase obligations.", "label": "Purchase Commitment, Remaining Minimum Amount Committed", "terseLabel": "Purchase commitment, remaining minimum amount committed" } } }, "localname": "PurchaseCommitmentRemainingMinimumAmountCommitted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/COMMITMENTSANDCONTINGENCIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]", "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable": { "auth_ref": [ "r206", "r208" ], "lang": { "en-us": { "role": { "documentation": "Identification, description, and amounts of all significant reconciling items in the reconciliation of a significant segment item of information disclosed (for example, liabilities) other than profit (loss), revenues, or assets, between reportable segments in total and the entity's consolidated total for that significant segment item disclosed.", "label": "Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table]", "terseLabel": "Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table]" } } }, "localname": "ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock": { "auth_ref": [ "r206", "r208" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of each significant reconciling item, other than profit (loss), revenues, or assets, in the reconciliation of totals of such items in reportable segments to the entity's corresponding consolidated amount.", "label": "Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table Text Block]", "terseLabel": "Reconciliation of other significant reconciling items from segments to consolidated" } } }, "localname": "ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/SEGMENTREPORTINGTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]", "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]" } } }, "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESUNRECOGNIZEDTAXBENEFITSROLLFORWARDDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": { "auth_ref": [ "r309", "r310", "r311", "r312" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.", "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount", "terseLabel": "Redeemable non-controlling interest and mezzanine equity" } } }, "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r362", "r570", "r571" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails", "http://Heska.com/role/CONVERTIBLENOTERECEIVABLEAdditionalInformationDetails", "http://Heska.com/role/CONVERTIBLENOTERECEIVABLEDetails", "http://Heska.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "auth_ref": [ "r570", "r572" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transactions with related party during the financial reporting period.", "label": "Related Party Transaction, Amounts of Transaction", "terseLabel": "Related party - amount of transaction" } } }, "localname": "RelatedPartyTransactionAmountsOfTransaction", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r362", "r570", "r571", "r572" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]", "terseLabel": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONVERTIBLENOTERECEIVABLEAdditionalInformationDetails", "http://Heska.com/role/CONVERTIBLENOTERECEIVABLEDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r362" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]", "terseLabel": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONVERTIBLENOTERECEIVABLEAdditionalInformationDetails", "http://Heska.com/role/CONVERTIBLENOTERECEIVABLEDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties.", "label": "Related Party Transaction, Rate", "terseLabel": "Related party transaction, rate" } } }, "localname": "RelatedPartyTransactionRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONVERTIBLENOTERECEIVABLEAdditionalInformationDetails", "http://Heska.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "percentItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r362", "r570", "r572", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]", "terseLabel": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails", "http://Heska.com/role/CONVERTIBLENOTERECEIVABLEAdditionalInformationDetails", "http://Heska.com/role/CONVERTIBLENOTERECEIVABLEDetails", "http://Heska.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r568", "r569", "r571", "r573", "r574" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "CONVERTIBLE NOTE RECEIVABLE" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONVERTIBLENOTERECEIVABLE" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfDebt": { "auth_ref": [ "r106" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.", "label": "Repayments of Debt", "terseLabel": "Repayments of debt" } } }, "localname": "RepaymentsOfDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfLinesOfCredit": { "auth_ref": [ "r106", "r131" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "Repayments of Lines of Credit", "negatedTerseLabel": "Repayments of line of credit borrowings" } } }, "localname": "RepaymentsOfLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfOtherDebt": { "auth_ref": [ "r106" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for the payment of debt classified as other.", "label": "Repayments of Other Debt", "negatedTerseLabel": "Repayments of other debt" } } }, "localname": "RepaymentsOfOtherDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "auth_ref": [ "r106" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.", "label": "Repayments of Related Party Debt", "negatedTerseLabel": "Payments of related party debts", "terseLabel": "Repayments of related party debt" } } }, "localname": "RepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails", "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r420", "r689" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchMember": { "auth_ref": [ "r444" ], "lang": { "en-us": { "role": { "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes.", "label": "Research Tax Credit Carryforward [Member]", "terseLabel": "Research Tax Credit Carryforward" } } }, "localname": "ResearchMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r163" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]", "terseLabel": "Restricted Stock" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "Restricted Stock" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKCAPITALSTOCKRESTRICTEDSTOCKDetails", "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r27", "r319", "r412", "r636", "r662", "r667" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r136", "r137", "r139", "r142", "r150", "r153", "r243", "r409", "r410", "r411", "r453", "r454", "r658", "r660" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]", "terseLabel": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r189", "r190", "r203", "r209", "r210", "r216", "r217", "r220", "r342", "r343", "r588" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Revenue, net", "verboseLabel": "Total revenue" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME", "http://Heska.com/role/REVENUEDetails", "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r125", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r351" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue from Contract with Customer [Policy Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r324", "r325", "r326", "r327", "r328", "r329", "r332", "r333", "r346", "r351" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "REVENUE" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/REVENUE" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue, Initial Application Period Cumulative Effect Transition [Line Items]", "terseLabel": "Revenue, Initial Application Period Cumulative Effect Transition [Line Items]" } } }, "localname": "RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/REVENUEDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable": { "auth_ref": [ "r350" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information when using transition method for cumulative effect in initial period of application for revenue from contract with customer.", "label": "Revenue, Initial Application Period Cumulative Effect Transition [Table]", "terseLabel": "Revenue, Initial Application Period Cumulative Effect Transition [Table]" } } }, "localname": "RevenueInitialApplicationPeriodCumulativeEffectTransitionTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/REVENUEDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r330" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Amount", "terseLabel": "Remaining performance obligation" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/REVENUEPerformanceObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/REVENUEPerformanceObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": { "auth_ref": [ "r331" ], "lang": { "en-us": { "role": { "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period", "terseLabel": "Expected timing of satisfaction" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/REVENUEPerformanceObligationsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": { "auth_ref": [ "r331" ], "lang": { "en-us": { "role": { "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in CCYY-MM-DD format.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/REVENUEPerformanceObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/REVENUEPerformanceObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock": { "auth_ref": [ "r331" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of expected timing for satisfying remaining performance obligation.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]", "terseLabel": "Schedule of Timing of Revenue Expected to be Recognized" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/REVENUETables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]", "terseLabel": "Revenues [Abstract]" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "stringItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": { "auth_ref": [ "r550", "r555" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability", "terseLabel": "Finance leases" } } }, "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r550", "r555" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "ROU assets obtained in exchange for new lease obligations:" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockConsiderationReceivedPerTransaction": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.", "label": "Sale of Stock, Consideration Received Per Transaction", "terseLabel": "Sale of stock, consideration received per transaction" } } }, "localname": "SaleOfStockConsiderationReceivedPerTransaction", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share", "terseLabel": "Sale of stock, price per share (in dollars per share)" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r180", "r220" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]", "terseLabel": "Sales Revenue, Net" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SalesTypeLeaseLeaseIncomeTableTextBlock": { "auth_ref": [ "r169", "r565" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of components of income from sales-type lease.", "label": "Sales-type Lease, Lease Income [Table Text Block]", "terseLabel": "Sales-type Lease, Lease Income" } } }, "localname": "SalesTypeLeaseLeaseIncomeTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SalesTypeLeaseRevenue": { "auth_ref": [ "r169", "r564" ], "calculation": { "http://Heska.com/role/LEASESSalestypeLeasesandLeaseIncomeDetails": { "order": 2.0, "parentTag": "us-gaap_SalesTypeLeaseSellingProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of sales-type lease revenue.", "label": "Sales-type Lease, Revenue", "terseLabel": "Sales-type lease revenue" } } }, "localname": "SalesTypeLeaseRevenue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESSalestypeLeasesandLeaseIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeLeaseSellingProfitLoss": { "auth_ref": [ "r169", "r564" ], "calculation": { "http://Heska.com/role/LEASESSalestypeLeasesandLeaseIncomeDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of profit (loss) recognized at commencement from sales-type lease.", "label": "Sales-type Lease, Selling Profit (Loss)", "totalLabel": "Profit recognized at commencement for sales-type leases" } } }, "localname": "SalesTypeLeaseSellingProfitLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/LEASESSalestypeLeasesandLeaseIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "auth_ref": [ "r53" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]", "terseLabel": "Changes in allowance for doubtful accounts" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accrued liabilities.", "label": "Schedule of Accrued Liabilities [Table Text Block]", "terseLabel": "Schedule of accrued liabilities" } } }, "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACCRUEDLIABILITIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r69", "r529", "r530" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of accumulated other comprehensive income (loss)" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r163" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/EARNINGSPERSHAREDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r163" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Schedule of antidilutive securities excluded from computation of earnings per share" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/EARNINGSPERSHARETables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r474", "r475" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValueofAssetsandLiabilitiesatCVMAcquisitionDateDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSFairValuesofAssetsandLiabiltiesatScilAcquisitionDateDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSIntangibleAssetsAcquiredAmortizationMethodDetails", "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSUnauditedProFormaFinancialInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": { "auth_ref": [ "r474", "r475" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.", "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]", "terseLabel": "Schedule of aggregate consideration and allocation of purchase price" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSACQUISITIONANDRELATEDPARTYITEMSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of cash and cash equivalents.", "label": "Schedule of Cash and Cash Equivalents [Table Text Block]", "terseLabel": "Schedule of cash and cash equivalents" } } }, "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r449" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "terseLabel": "Schedule of components of income tax expense" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r440" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "terseLabel": "Temporary differences to the components of deferred tax assets" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r162" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Reconciliation of basic and diluted earnings per share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/EARNINGSPERSHARETables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r428" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Effective income tax rate" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of Equity Method Investments [Line Items]", "terseLabel": "Schedule of Equity Method Investments [Line Items]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INVESTMENTSINUNCONSOLIDATEDAFFILIATESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsTable": { "auth_ref": [ "r2", "r127", "r236", "r237", "r518" ], "lang": { "en-us": { "role": { "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.", "label": "Schedule of Equity Method Investments [Table]", "terseLabel": "Schedule of Equity Method Investments [Table]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INVESTMENTSINUNCONSOLIDATEDAFFILIATESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock": { "auth_ref": [ "r264" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.", "label": "Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]", "terseLabel": "Schedule of intangible assets acquired" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSACQUISITIONANDRELATEDPARTYITEMSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r264", "r271", "r589" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r264", "r271" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of other intangible assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r260", "r261" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]", "terseLabel": "Schedule of changes in goodwill" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r275", "r278" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.", "label": "Schedule of Indefinite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r14", "r32", "r33", "r34" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Schedule of inventory" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INVENTORIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r39", "r283" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails", "http://Heska.com/role/PROPERTYANDEQUIPMENTDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.", "label": "Schedule of Related Party Transactions [Table Text Block]", "terseLabel": "Schedule of Related Party Transactions" } } }, "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONVERTIBLENOTERECEIVABLETables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": { "auth_ref": [ "r89", "r219" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]", "terseLabel": "Schedule of revenue from external customers and long-lived assets, by geographical areas" } } }, "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/SEGMENTREPORTINGTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r198", "r201", "r207", "r260" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r372", "r403" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKCAPITALSTOCKRESTRICTEDSTOCKDetails", "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails", "http://Heska.com/role/CAPITALSTOCKOPTIONACTIVITYDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": { "auth_ref": [ "r403" ], "lang": { "en-us": { "role": { "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Table]", "terseLabel": "Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKSUMMARYOFINFORMATIONBYEXERCISEPRICERANGEDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": { "auth_ref": [ "r403" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]", "terseLabel": "Schedule of shares authorized under stock options plans by exercise price range" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r377", "r389", "r392" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Schedule of stock options plans" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": { "auth_ref": [ "r396" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]", "terseLabel": "Schedule of weighted average valuation assumptions" } } }, "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.", "label": "Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]", "terseLabel": "Schedule of restricted stock transactions" } } }, "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": { "auth_ref": [ "r435", "r450" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in unrecognized tax benefits.", "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]", "terseLabel": "Schedule of unrecognized tax benefits roll forward" } } }, "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r271" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Schedule of estimated future amortization expense" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r185", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r203", "r204", "r205", "r206", "r208", "r209", "r210", "r211", "r212", "r214", "r220", "r650" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails", "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails", "http://Heska.com/role/REVENUEDetails", "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r185", "r187", "r188", "r198", "r202", "r208", "r212", "r213", "r214", "r215", "r216", "r219", "r220", "r221" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "SEGMENT REPORTING" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/SEGMENTREPORTING" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting, Other Significant Reconciling Item [Line Items]", "terseLabel": "Segment Reporting, Other Significant Reconciling Item [Line Items]" } } }, "localname": "SegmentReportingOtherSignificantReconcilingItemLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Selling and Marketing Expense", "terseLabel": "Selling and marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r114" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "terseLabel": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r373" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "terseLabel": "Award vesting period (in years)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r382" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedTerseLabel": "Forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKCAPITALSTOCKRESTRICTEDSTOCKDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r387" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Forfeited (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKCAPITALSTOCKRESTRICTEDSTOCKDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r385" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKCAPITALSTOCKRESTRICTEDSTOCKDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r385" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average purchase price of shares purchased", "verboseLabel": "Granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKCAPITALSTOCKRESTRICTEDSTOCKDetails", "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r384" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Non-vested, period end (in shares)", "periodStartLabel": "Non-vested, period start (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKCAPITALSTOCKRESTRICTEDSTOCKDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKCAPITALSTOCKRESTRICTEDSTOCKDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r384" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Nonvested, at period end (in dollars per share)", "periodStartLabel": "Nonvested, at period start (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKCAPITALSTOCKRESTRICTEDSTOCKDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKCAPITALSTOCKRESTRICTEDSTOCKDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r386" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedTerseLabel": "Vested (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKCAPITALSTOCKRESTRICTEDSTOCKDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": { "auth_ref": [ "r391" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value", "terseLabel": "Restricted stock vested, fair value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r386" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Vested (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKCAPITALSTOCKRESTRICTEDSTOCKDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r399" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "verboseLabel": "Expected dividend rate (as a percent)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails", "http://Heska.com/role/CAPITALSTOCKOPTIONACTIVITYDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r398" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Expected volatility (as a percent)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKOPTIONACTIVITYDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r400" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk-free interest rate (as a percent)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKOPTIONACTIVITYDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKCAPITALSTOCKRESTRICTEDSTOCKDetails", "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails", "http://Heska.com/role/CAPITALSTOCKOPTIONACTIVITYDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized", "terseLabel": "Increase in number of share to be repurchased" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r374" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized", "terseLabel": "Number of shares authorized" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r379" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number", "terseLabel": "Exercisable at end of period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKOPTIONACTIVITYDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r379" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "terseLabel": "Exercisable at end of period (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKOPTIONACTIVITYDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "auth_ref": [ "r391" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value", "terseLabel": "Intrinsic value of options exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": { "auth_ref": [ "r383" ], "lang": { "en-us": { "role": { "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period", "negatedLabel": "Expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKOPTIONACTIVITYDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r382" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period", "negatedLabel": "Forfeited", "terseLabel": "Forfeitures in period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails", "http://Heska.com/role/CAPITALSTOCKOPTIONACTIVITYDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "auth_ref": [ "r380" ], "lang": { "en-us": { "role": { "documentation": "Net number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures", "terseLabel": "Granted at market" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKOPTIONACTIVITYDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Grants in period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r390" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average grant date fair value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r403" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value", "terseLabel": "Intrinsic value of options outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r378", "r403" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Outstanding at end of period", "periodStartLabel": "Outstanding at beginning of period", "terseLabel": "Options outstanding (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails", "http://Heska.com/role/CAPITALSTOCKOPTIONACTIVITYDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKOPTIONACTIVITYDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKOPTIONACTIVITYDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": { "auth_ref": [ "r403" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period", "terseLabel": "Shares issued during period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r369", "r375" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Equity Award [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKCAPITALSTOCKRESTRICTEDSTOCKDetails", "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails", "http://Heska.com/role/CAPITALSTOCKOPTIONACTIVITYDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Exercised (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKOPTIONACTIVITYDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price", "terseLabel": "Expired (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKOPTIONACTIVITYDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "terseLabel": "Forfeited (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKOPTIONACTIVITYDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Granted at Market (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails", "http://Heska.com/role/CAPITALSTOCKOPTIONACTIVITYDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationAwardTrancheOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.", "label": "Share-based Payment Arrangement, Tranche One [Member]", "terseLabel": "Share-based Payment Arrangement, Tranche One" } } }, "localname": "ShareBasedCompensationAwardTrancheOneMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r124", "r372", "r376" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-based Payment Arrangement [Policy Text Block]", "terseLabel": "Stock-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "auth_ref": [ "r395" ], "lang": { "en-us": { "role": { "documentation": "Information by range of option prices pertaining to options granted.", "label": "Exercise Price Range [Axis]", "terseLabel": "Exercise Price Range [Axis]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKSUMMARYOFINFORMATIONBYEXERCISEPRICERANGEDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "auth_ref": [ "r401" ], "lang": { "en-us": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Exercise Price Range [Domain]", "terseLabel": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKSUMMARYOFINFORMATIONBYEXERCISEPRICERANGEDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]", "terseLabel": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKSUMMARYOFINFORMATIONBYEXERCISEPRICERANGEDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": { "auth_ref": [ "r401" ], "lang": { "en-us": { "role": { "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit", "terseLabel": "Exercise price, lower range limit" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKSUMMARYOFINFORMATIONBYEXERCISEPRICERANGEDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": { "auth_ref": [ "r388" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable", "terseLabel": "Number of Options Exercisable at December\u00a031, 2020" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKSUMMARYOFINFORMATIONBYEXERCISEPRICERANGEDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": { "auth_ref": [ "r378" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding", "terseLabel": "Number of Options Outstanding at December\u00a031, 2020" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKSUMMARYOFINFORMATIONBYEXERCISEPRICERANGEDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": { "auth_ref": [ "r401" ], "lang": { "en-us": { "role": { "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit", "terseLabel": "Exercise price, upper range limit" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKSUMMARYOFINFORMATIONBYEXERCISEPRICERANGEDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Share price (in dollars per share)" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CREDITFACILITYANDLONGTERMDEBTCREDITFACILITYANDLONGTERMDEBTNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r397", "r413" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected lives (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKOPTIONACTIVITYDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r393" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted average remaining contractual term (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": { "auth_ref": [ "r379" ], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price", "terseLabel": "Options Exercisable - Weighted Average Exercise Price (in dollars per share)" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKSUMMARYOFINFORMATIONBYEXERCISEPRICERANGEDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r394" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted Average Remaining Contractual Life in Years" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKSUMMARYOFINFORMATIONBYEXERCISEPRICERANGEDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": { "auth_ref": [ "r378" ], "lang": { "en-us": { "role": { "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Outstanding at ending of period (in dollars per share)", "periodStartLabel": "Outstanding at beginning of period (in dollars per share)", "terseLabel": "Outstanding exercise price (in dollars per share)", "verboseLabel": "Options Outstanding - Weighted Average Exercise Price (in dollars per share)" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails", "http://Heska.com/role/CAPITALSTOCKOPTIONACTIVITYDetails", "http://Heska.com/role/CAPITALSTOCKSUMMARYOFINFORMATIONBYEXERCISEPRICERANGEDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r393" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted Average Remaining Contractual Life in Years" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKSUMMARYOFINFORMATIONBYEXERCISEPRICERANGEDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r135" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_SoftwareDevelopmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Internally developed software for sale, licensing or long-term internal use.", "label": "Software Development [Member]", "terseLabel": "Software Development" } } }, "localname": "SoftwareDevelopmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSIntangibleAssetsAcquiredAmortizationMethodDetails", "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StandardProductWarrantyPolicy": { "auth_ref": [ "r124", "r294" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.", "label": "Standard Product Warranty, Policy [Policy Text Block]", "terseLabel": "Warranty Costs" } } }, "localname": "StandardProductWarrantyPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r1", "r185", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r203", "r204", "r205", "r206", "r208", "r209", "r210", "r211", "r212", "r214", "r220", "r260", "r285", "r287", "r288", "r650" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails", "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails", "http://Heska.com/role/REVENUEDetails", "http://Heska.com/role/SEGMENTREPORTINGDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r22", "r23", "r24", "r126", "r127", "r156", "r157", "r158", "r160", "r162", "r171", "r172", "r173", "r237", "r313", "r518" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails", "http://Heska.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://Heska.com/role/EARNINGSPERSHAREDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r52", "r136", "r137", "r139", "r142", "r150", "r153", "r170", "r243", "r313", "r319", "r409", "r410", "r411", "r453", "r454", "r524", "r525", "r526", "r527", "r528", "r530", "r658", "r659", "r660" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEDetails", "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails", "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r136", "r137", "r139", "r170", "r588" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, before forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Granted, Value, Share-based Payment Arrangement, before Forfeiture", "terseLabel": "Fair value of stock options granted during period" } } }, "localname": "StockGrantedDuringPeriodValueSharebasedCompensationGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r23", "r24", "r319" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Stock Issued During Period, Shares, Acquisitions", "terseLabel": "Issuance of common stock related to acquisition of assets from Cuattro, LLC (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r51", "r313", "r314", "r319" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities", "terseLabel": "Conversion to common stock (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails", "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://Heska.com/role/EARNINGSPERSHAREDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r23", "r24", "r313", "r319" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Issuance of preferred stock (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r23", "r24", "r313", "r319" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Issuance of common stock, net of shares withheld for employee taxes (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r23", "r24", "r313", "r319", "r381" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period", "negatedTerseLabel": "Exercised", "terseLabel": "Exercises in period (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails", "http://Heska.com/role/CAPITALSTOCKOPTIONACTIVITYDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [ "r52", "r313", "r319" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued pursuant to acquisitions during the period.", "label": "Stock Issued During Period, Value, Acquisitions", "terseLabel": "Issuance of common stock related to acquisition of assets from Cuattro, LLC" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r52", "r313", "r319" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Stock Issued During Period, Value, Conversion of Convertible Securities", "terseLabel": "Conversion to common stock" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r23", "r24", "r313", "r319" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Issuance of preferred stock" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r23", "r24", "r319", "r371", "r390" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Issuance of common stock, net of shares withheld for employee taxes" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r24", "r29", "r30", "r127", "r230", "r237", "r518" ], "calculation": { "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total stockholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders' equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r127", "r136", "r137", "r139", "r142", "r150", "r237", "r243", "r319", "r409", "r410", "r411", "r453", "r454", "r496", "r497", "r509", "r518", "r524", "r525", "r530", "r659", "r660" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "terseLabel": "Stockholders' equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEDetails", "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": { "auth_ref": [ "r320" ], "lang": { "en-us": { "role": { "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.", "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio", "terseLabel": "Reverse stock split conversion ratio" } } }, "localname": "StockholdersEquityNoteStockSplitConversionRatio1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails", "http://Heska.com/role/EARNINGSPERSHAREDetails" ], "xbrltype": "pureItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]", "terseLabel": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r531", "r576" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails", "http://Heska.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r531", "r576" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]", "terseLabel": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r531", "r576" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails", "http://Heska.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r531", "r576" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails", "http://Heska.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]", "terseLabel": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r575", "r577" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/SUBSEQUENTEVENTS" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "NON-CASH TRANSACTIONS:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardAxis": { "auth_ref": [ "r444" ], "lang": { "en-us": { "role": { "documentation": "Information by specific tax credit related to an unused tax credit.", "label": "Tax Credit Carryforward [Axis]", "terseLabel": "Tax Credit Carryforward [Axis]" } } }, "localname": "TaxCreditCarryforwardAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardNameDomain": { "auth_ref": [ "r444" ], "lang": { "en-us": { "role": { "documentation": "The name of the tax credit carryforward.", "label": "Tax Credit Carryforward, Name [Domain]", "terseLabel": "Tax Credit Carryforward, Name [Domain]" } } }, "localname": "TaxCreditCarryforwardNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TaxPeriodAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information about the period subject to enacted tax laws.", "label": "Tax Period [Axis]", "terseLabel": "Tax Period [Axis]" } } }, "localname": "TaxPeriodAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxPeriodDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identified tax period.", "label": "Tax Period [Domain]", "terseLabel": "Tax Period [Domain]" } } }, "localname": "TaxPeriodDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "auth_ref": [ "r224", "r225", "r226", "r227", "r229", "r231" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for accounts receivable.", "label": "Accounts Receivable [Policy Text Block]", "terseLabel": "Accounts Receivable and Allowance for Doubtful Accounts" } } }, "localname": "TradeAndOtherAccountsReceivablePolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_TradeNamesMember": { "auth_ref": [ "r478" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trade Names [Member]", "terseLabel": "Trade names" } } }, "localname": "TradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSIntangibleAssetsAcquiredAmortizationMethodDetails", "http://Heska.com/role/GOODWILLANDOTHERINTANGIBLESDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [ "r141", "r142", "r143", "r144", "r240", "r241", "r242", "r243", "r244", "r245", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r451", "r452", "r453", "r454", "r590", "r591", "r592", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667" ], "lang": { "en-us": { "role": { "documentation": "Amendment to accounting standards.", "label": "Accounting Standards Update [Domain]", "terseLabel": "Type of Adoption [Domain]" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UndistributedEarningsOfForeignSubsidiaries": { "auth_ref": [ "r421", "r466", "r629", "r668" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.", "label": "Undistributed Earnings of Foreign Subsidiaries", "terseLabel": "Undistributed earnings of foreign subsisdiaries" } } }, "localname": "UndistributedEarningsOfForeignSubsidiaries", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r422", "r433" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "negatedPeriodEndLabel": "Balance at the end of period", "negatedPeriodStartLabel": "Balance at beginning of period", "terseLabel": "Unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails", "http://Heska.com/role/INCOMETAXESDetails", "http://Heska.com/role/INCOMETAXESUNRECOGNIZEDTAXBENEFITSROLLFORWARDDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromAcquisition": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from acquisitions.", "label": "Unrecognized Tax Benefits, Decrease Resulting from Acquisition", "negatedTerseLabel": "Acquired additions based on prior year tax positions", "terseLabel": "Acquired additions based on prior year tax positions" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromAcquisition", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/ACQUISITIONANDRELATEDPARTYITEMSAdditionalInformationDetails", "http://Heska.com/role/INCOMETAXESUNRECOGNIZEDTAXBENEFITSROLLFORWARDDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation": { "auth_ref": [ "r433" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from foreign currency translation.", "label": "Unrecognized Tax Benefits, Decrease Resulting from Foreign Currency Translation", "negatedTerseLabel": "Currency Translation Adjustment" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESUNRECOGNIZEDTAXBENEFITSROLLFORWARDDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": { "auth_ref": [ "r430" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense", "terseLabel": "Unrecognized tax benefits, income tax penalties and interest expense" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": { "auth_ref": [ "r434" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.", "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations", "terseLabel": "Reductions from lapse in statutes of limitations" } } }, "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESUNRECOGNIZEDTAXBENEFITSROLLFORWARDDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r174", "r175", "r177", "r178", "r182", "r183", "r184" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/OPERATIONSANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r440" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount", "terseLabel": "Valuation allowance, deferred tax asset, increase (decrease), amount" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/INCOMETAXESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VestingAxis": { "auth_ref": [ "r403" ], "lang": { "en-us": { "role": { "documentation": "Information by vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Axis]", "terseLabel": "Vesting [Axis]" } } }, "localname": "VestingAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VestingDomain": { "auth_ref": [ "r403" ], "lang": { "en-us": { "role": { "documentation": "Vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Domain]", "terseLabel": "Vesting [Domain]" } } }, "localname": "VestingDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CAPITALSTOCKNARRATIVEDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": { "auth_ref": [ "r162" ], "calculation": { "http://Heska.com/role/EARNINGSPERSHAREDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.", "label": "Weighted Average Number Diluted Shares Outstanding Adjustment", "terseLabel": "Assumed exercise of dilutive stock options and restricted stock awards (in shares)" } } }, "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/EARNINGSPERSHAREDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r155", "r162" ], "calculation": { "http://Heska.com/role/EARNINGSPERSHAREDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted average outstanding shares used to compute diluted (loss) earnings per share attributable to Heska Corporation", "totalLabel": "Diluted weighted-average common shares outstanding (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME", "http://Heska.com/role/EARNINGSPERSHAREDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r154", "r162" ], "calculation": { "http://Heska.com/role/EARNINGSPERSHAREDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted average outstanding shares used to compute basic (loss) earnings per share attributable to Heska Corporation", "verboseLabel": "Basic weighted-average common shares outstanding (In shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://Heska.com/role/CONSOLIDATEDSTATEMENTSOFINCOME", "http://Heska.com/role/EARNINGSPERSHAREDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 13 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "21D", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=SL94080555-108585" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h)(1)(i))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r135": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e22044-107793" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258" }, "r168": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=121640914&loc=SL77927221-108306" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(25))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599" }, "r221": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e4975-111524" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953423-111524" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5212-111524" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5033-111524" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5093-111524" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=117311354&loc=d3e32014-111567" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(b)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r239": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "323", "URI": "http://asc.fasb.org/topic&trid=2196965" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=68051541&loc=SL49131252-203054" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=68051541&loc=SL49131252-203054" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b),(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r279": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r286": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "http://asc.fasb.org/topic&trid=2155823" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r291": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r293": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(5)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109126253&loc=d3e4852-112606" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=51819886&loc=SL6014347-161799" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=77885760&loc=SL35686385-199418" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031898-161870" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031898-161870" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031898-161870" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870" }, "r308": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(12)(c)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(16)(c)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "14", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "15", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 4.C)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130533-203044" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130561-203045" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130564-203045" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(i)(1)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048" }, "r351": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r352": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "610", "URI": "http://asc.fasb.org/topic&trid=49130413" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(4)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907" }, "r416": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "720", "URI": "http://asc.fasb.org/extlink&oid=6419918&loc=d3e35281-107843" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(b)", "Topic": "720", "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121573983&loc=d3e28200-109314" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "217", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121610041&loc=d3e36027-109320" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r467": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e961-128460" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e1043-128460" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(3)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "b", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(3)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479" }, "r495": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613674-111683" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13279-108611" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14172-108612" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14210-108612" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14217-108612" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3,4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r532": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "http://asc.fasb.org/topic&trid=2175825" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "Note 1", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121580752&loc=d3e38371-112697" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "Note 3", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121580752&loc=d3e38371-112697" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918666-209980" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971" }, "r556": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/subtopic&trid=77888251" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121561866&loc=SL77919306-209978" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121561866&loc=SL77919308-209978" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121561866&loc=SL77919311-209978" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL77919352-209981" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL77919396-209981" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL117410129-209981" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL117410129-209981" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL77919372-209981" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL77919372-209981" }, "r566": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "14", "Topic": "842", "URI": "http://asc.fasb.org/section&trid=77888298" }, "r567": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/subtopic&trid=77888252" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r574": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r577": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(17))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(24))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(25))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.4)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(d)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Subparagraph": "(b)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6479915&loc=d3e66715-112838" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(h))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i),(j),(k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.3)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(20))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(21))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i-k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6487024&loc=d3e29054-158556" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=118262037&loc=d3e9915-115836" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e604008-122996" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580" }, "r690": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r691": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r692": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r693": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r694": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r695": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r696": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r697": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r698": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "17B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(22))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(23))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "8", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r97": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "220", "URI": "http://asc.fasb.org/topic&trid=2134417" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" } }, "version": "2.1" } ZIP 113 0001038133-21-000011-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001038133-21-000011-xbrl.zip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

0S)^,I>!VSQI*FC)Q.B-[D/I\-JSY^XJ'BC@,$1C@U$@_B:E M&+6*!@.%2KE/2VFOSIXV0G \Y^F_<4JMB%@./J\G'GS/]19YEDPE!4;+4%&G MHI0+.1=*!E/I4WNZM67/W?4]MBCQ.\7GQ E4SEA5! BI.J)8N4^-\*[.GI\9 M9WPP.20CIYGOEO(M;O/9B^?GN/):OABS;F6T0*% MC&3$@#8Y'-%BFFUSSD>?3*?LR#W&Q=S.Z6F7-Y_R89[PK._"^0=7@;KQ0;IN,QWIL]X^D82C(N-%2>C\7RGMAX//V.>R%>?3$^> M\AL>'[S^?3X]#+'M#,_X.D=,9;+71L4.159.P49,D,.)BF'P+IFEJ=[ MLFILX/9:*;LK5ETK"D^*ELB08QM4_>H^M"Q9N#V^G-[)1W33#", MDI$32X9E%"?GO?6&+&1AN.G#(.' [6MQ^QD>\JPE#HMLX4YN:*+(:/)9H4L$ M$!%#<629H08;?-"#&!E(W3L5DEC[Y)3Q-5EHB6--Q6((T3NLOL"@0@92]TY^ MY.!"UCD6[S6PR]$7ZQ')A5#D^3YTJ1E(?2U2MUMU?-0:P]U)Z=%V="ZY4(D> MP-><;8K9%Z^5RSF:,DB/@="]DAV:#<64VSX>!FS;Q:@$IPIR=%A(V4%V#(3N ME^2(UI#X8V7; MC"D4%;8Q-I309HD!QWCM";1_CBKRO>>RDWH#H1RB56KP.H M7+.*3M+#5(J+H6(?-AP9R+Q^9%Z1U"BV5D!+XI0!@TT0BR4LV2K(D=(@-08R M]T9F%%3BB&/(24LB:"I:;6.-K=5!#$GUH0!I)63^"S8M)N+.V+-X_.0 IT=8 M^'@NM_QP]BN6TKA_7Y ;X8OQ9";/[_)LW:VLG^H#8NLBDZIU -IQ5$%9TL0U M&@XTS+,,'.^]*+'!9H?6*O09(L0(50.@'3*R8<"6K%6Y/EL0^!!/0QD70<9H+4U!JW)M?4=H( ) MC"-5Q9LJ#ZX.,J"'BG)%W940Q?.Q300(5I=D*"2+;+42WS<$Z5Y2:34AE*S/ MFE56"10H!JPF2:)B*D6)K:B'$-I'*JTDP%G%I HE6TR$J"![S+YD22*,49:& M +<$*BTZLHX7EX:'JY]A^ONLP.0:G047J@L)*(<<*@?TH)2P/18UA-R!W+T5 M 9**0' ZVH@:? V9.+)PVY.H2U)#:.)1;MK(I, MHG#[T"QI(/<:+^U9C1Y)F&-%3>1*$B<=,G@$KMIIFSGF-.B1@=7]$R)1.ZXF M8/!!06*?DH,2,4:V[-@-O2 &5O=1@5@'&$NME2Q88;-*R!B,"9GEOT&!+)]5 M'Z[E2JQ:M7WU4H$X3P8AJRQ2&G2H,4+6A@(U=PVU#@ID8'7_%(C*VB6?.3LL M4&I![\%;$DI[G0W708$,K.Z? G%DE=-.Y00:6BO!ZFPN(K1M"J#BT!OS[NGJ M.]X)(G IY+VR[!&T\4BM9#%Z1YJS"690'P.C^Z4\$F 6W<$!0H5D8E8Q*14S M^U0QX; 48F!TSU1'< #,XJ.5*@[)D M@\4R1Y> @LE6)S)8A-LZ>AR68PYL[I': (Y:&9$565,3'*(GL-8::F0(&H?& M4P.;>Z0TC!?Q7!,ICPBB,K)W;?0."95WV(O-^-:1S?U81OQW$2 N!%LUJ$BI M@LF80L&@2DQ78WT?T\U>^1'^2"ME:[2U5(*A1@2I"0(5)GDMN M8-V266<&UHFOB[XFDY&S,5#%B_KJT'D3G:DQ!#NP;LFLLP/K[HW:AFXF<"L5 M2^ DT#IRQ:1H7G%*>LDQ5B[@99SU,X'(NZ7_SD>S48-APMC$<_*Z/#^>'2$AZVL MX\'DZ#6.3Y8_&'$)&P47AB*^ AO,B;A$:TDEP.JC8[)5<"&LEN%\I@'.9AH& MD*XY&@]7'HV_=.C73)"VFMK,B9TNX%DD!FO*[%+5WF=7UM_:5E6HO59$NAEK M+Y)9QYJ5!0^@0QM$%%=L:ZN_%E=\-[AQ QV)[SXUJG?""1-3B05RM4BY%*H9 M2[*J)EBU-.PC-LL24!B5(5MRH%*!6I N!74)V>5::U(]"M*/1/7.^>?1&R9Q MX3A^,3.G\K$&](@G8X>7WG@L;J M&9:MA6(*>J@.'&)&=(; !L4^IM.]V>\RPW:FQ-.=Z=D(*24PYI48S)3-F4&.XZQ7:G2+R-1\OKQ3(0Z[2)N(V>;;%HV4%S M8S50L-0*UBKE6'M$K,TQ<1W(M4;D\AFM#UH#0@5E28283R#1D;0+^70SK(OD MDKQ_70#W[= MNLD1FM.B8N66,$(3#;?1&?)H"5PV25>/7AO)<\!4XT]+X!L2W0#)GUK2IZ#\ M95'XQT._IBC<@.'H27LLX)67ASXJ*H4Y0>6_$WXW*QV_9"BOEXSRWJ$HN01J MT4$OQ%23"P3!J1"LYH%1MYV,]))&HOVMJZ+;JBZ0-62P)3FOK8<:,.- HR6F M'F=COTR[7 [&D\/)BY.GHQ<'?SE^TDMF<73:HD[!&(1D0DJYQ;P"7)G\V9X^ MC5!^;5?MK9=D\5?&;SGM %,L9)WHSA# VI2JR,ULH@9G5,9\*OZ5,::?L.V\ M;D*!;C@!4*8S9@D)P&*M=M25),L&5IR,Y .*,D7)IUF?[[@J:'0#+%>QJ$O M_+E%73KT*RRJ1H->[F=;O Q84D)6-8F&*[9UW51G)1"JKR'V%BRJ%3VHY:34 MA(J+XN!:'5NJDI*53(8PJU"A^K/IPH9&-\!RE0&J2\#\16< M1R-H9 7-O2 MO-4B>D[9E&S8F,)0,YUNBAFU,>=KKH']DSOP%6Y( MNQP#%A>KMU"LRL"8+:G*Q=?2HU8LQZUB]K60YJ0ERQ<8_&^6GTOJ/4@\^OYG M?H&'#Q=??05VLJ+6:Q2(&4#5B(".HH=@P$LJE:+VIT4'O6B!\C=AR8IVKP,* M$$,RITD"Y>#9>! _RL(-VY^]8_XN+%E)RP],9#U&AU@BE-*"#^?"7#%)2@+< M@XCS<;7;H=P$>M*8LCO%\>QT#=OLQY.+KYPBVYAUO];1X:B]<(KYUU+H+]CZ MX->M)]-V287O8E *6)VB*)[& )@(B5P)(L>+UAA0Y_4OZ?\[\^=F5A*0C[JF MH()3$,BGHE.V6 E%JZC"/= I S?60'TQH<_R&9_-VFM\_R_P)=H]YS%,\?'1X/*)1F3V83%^W M3O_R$3>O5U-GX&IZ]=*A7S-%[5S(OI+-H9436FSU9ZQ*RJ(WR.GUE1D]A/M& M5$%.-I6(3C%JL*EU&*P*'&463*.!GECNGWC3OY=%.JU916] (C"PMAAM-HAH MO#<^Q7,\Y4]W_F =\5R":6[].)I\[%<^VQR7;V\>\/;WBH!?//1K:CDPL_%% M / *LJ&LBM@TD\%)^!=#4I)A"SQ@)BT"!6[:!- M6?<@=^L3R*O*JW1,JFK+SH)1.8D!8X[52G V%$M/AHA[ _)*1GA+2CD'G8PF M@&!,+)(EB2$36"PVUQZXZX^UED50VL5W]X\%R^F'O1C?83 S8&)?7%4Z M@_448ZN--9@PQE9[U(,@NY:FN9IH6ET"C\9HB 70VDRV!'(NUNC1:;Q#:-ZF M::Y(&NGHHU&^K2L0X0BT/E0HJV< M1?C&&B!J6OG&%CT \6;:H2L@4\4IMEVLBPJQ*"2<0AO4B3XX5YRW4?(%'7HPE[]<<[GRQ\H'/I@RC>8/<#H]J9/I6YS2 MY4]^RC/&:3GH"Q6L!HPIAJ R2,HHN89!EL!7<^.#6G\J""9/%M_W0KHOS^T) M"K,69.8'T\GQBX.V+TI/,*F43\#,NQQ+%1CQ[^*X<'A/3H^GDJ'6;.9XO9A9W MZD.3SY_@DQ8)D_$;GL[;@N4G4ZX\E?#U;#XIK^[B>(NI MP-%#3,4% %TR&+'0MD HFR(6VZ,,_2Z38S49/Y2:(Y.S,5MPGC$0J5J*HH&6L"K1)FK1S>8@GJV7%BH:.?:[6L(^JE4Y4B\5; M7U7VRK(OV(=9];O-BM5,P_ND4QO@Q, B/54NE$+-A*D*.XP9(LA%5C0=L?-Z M42)_?TQ/>3:?CMHF9<_'HYMND+2:4%(A>5>2YHH$$6Q"FW4,'-M_U?>AWNKO M08_5Q!0RT6&KNS.L +A&")Q=]=9:W6IOAYBR+O1827!1EK0RZ)+6" %L-MIE M16B(O#%PWIXKZ;"NK/AY,GXQY^G1!N?Y[LEK_L-461=K(;$*1<=B_6)6A-''SYLLJBA.W^PKJ3XL/_: MHGWB3ET8]B68IF+Y_UGA&"9T^BK++3X]]&L6[+..T7%;ZQ0 8LR!M":HH*MH MB&+O!KP?#?_HJ&U#>T?!=*A=J35RA@RNV&P!$K3Q!!T\0CGO>+1^T?QT"=1X M-CD5U5# 0/5-@9[,#=AB+ M!P1*%KW*G/- BC7W*S?""O(1%2:OHN2/+IN,"I+UWA=64'(?ZFD&>GPVVUG! M=I9;30@B"OK(>0&43??'&8$F%/53 ]67%%VTO M=-9H]#.[5=T?T\[\@*<]P2VQH1QM:^83(8'/.K3-'1E;(\B":GU%9 ]Q6Z+, M*R;H''RH[ A0[BI&YWU""!5M9;YC]K:"/9ANQ-Q MPX\#)Q] :LI<3 4JM*E M)OBP+<\ VYI9FVO+0\@8FUF#2CD&8Y,"8W,%\7FTH&11I"]J%8"5\)T2-KVUHK5)&(;OUM:LVQ6J9=E9*AZDA:Y$44 M@Q*9J"B(I _( MOZV]63JC^2L?[G_RKK8C=$2<)"@:$F0L$UW!N-5K@5)1%TR=\QN M;@.=98Y" "02]Y4R 5B5,>36=$*@"M%HO<83!%^$SA:6@]&8IR<7#^R)(6D2 M2()KNS%H2$YG0HK%)*M<;9V6[I@AW3I42[0J[X,';X-7: &JCQ*=K(N./.I: MJ ?=?*X$U6D?UUI'A1\=3T6>'T^YAX85:LFFAL)$%92GML-?:!T+DFU;+/5@ MS&'MT5JB;6DLZ-O"&Q+34A21T2C'UA;76IKYNV1;I\MR>/IOG-);7,#U;%+G M[6%/;$NIH@M1B:"UF!5FC^"*CVU[57)AC>O>>H/6$FTK 4MFZV(FK< D'3-8 MG0$@^%:Y>*=LZV?&&1],#DD2W7/1OGGT>CIYPU VYB-*@VMI):?05T/:E/Y M9'JZ>^+I&L_=R2VEY:LOG:WHDN3MVONJ(/H4D]$E6T@:0N;3+=_7G$VKQ/R+ MJ([OKD#U7K(IU6PH%*-#+J =8,[!:>5;LX VVW='8OY'F=:_4: <-/L KF:) M](IR+3E1J*[$XJSK06'76B+T=?']>#PZA>>U?*?9AQM_)-=_/.73+[-XZ?S] MYZ^<_]Y.\'EAYSG;ZD-,ED"U8?1@C(DZB+!C9\)B<:=1[G1QISQ87]SOMY;G MGR"\:-SRY'A:#@3I1@B=T@TT%+ZTL-)TREUQ8>7BT*4X5I ,T:GHT_X<1S_@^-&8U Y8LREMFGB9" %%N7%.8-W[*P_ M:[=TAF,<#-N7N$GY MH^QER_JJTFANFP";E*' (MZ5$JVA:+D2YQZ4W*[0H&ZFL%9SB!XSAF#!A8BV ME"I:D@G9<>E5@]'/0+,Y+NW$;_AB=[^[F)QK38*-DIS<9 B>,+=E6;X421#8 M8EK_U.\3^,Z??GCT^G!RPAM6L5F];2EOY8]S*L4 +3T+K!07KN!K\KX'.R>MAVTM,6R1ED3+(2<1X: * M90 Q-Y6")A\#]6 MW&E;VC:&U6HNY-7%*N#%L[.S[>?>M]ZSQ-,+\#1U,?OQ MY.$[GI:1B(WIJ/"%$>A%S/O]BSOCOM3:H-(:76@[R0NBDCO'2)E!Q=J*X57J MD<_L/<"K=[PZLFI;<"5'%A2ZU%I8)QVURR$0KG&7CU608/?MI"=6;A(Y)RK( M&UU 94D!2;GD0DB* [(>K/SV %Z]E1=C;6BK.&OPXNE-PAS1U.(-94NU!VN? M;I4$!U/N2S0706;!(BDER-I%H7-DW;8<3=YI2X.=WR;$J[?T6@/*"2LJ:A4$ M/DH\5\09O0J%4@\2J=NDP:/)<5\:.#GQUDJ2L)2Q@N 92PYB]Y9+BBY;-1CZ M+2*\>CLG:QU4%U4)!:HEI% S%VLA!0 .@YU?8L'H35\".J40V5L3@PZ0HI7$ M+!AT53PZ6)N&]/PV$5Z]G4/6CITK%2L!HA5VD CY:H%%Z]D>K!&]318\&[WK MB9D;3UYR6$3'8P\]L#>/567G7QE0&KYPCD$NJ@#>8< MK>5J+'[8.\B?[QWDUY4-?S /\H2G=3(]PG'A4V;<1C6,]E>#\=*A7[,9=39, MKA C)4"+J%2NRE!2,1KC=8]@_)5GK3OR91 _;^FGB$\%VH,KC)(/1+I*=-#< M...I. N8*=J,:)*J52*$YM"CZ+ ^,*Y@V%4\NE*);)8H[V(6^5;0(_K(CKQU MZR_>5H?>S2R#5LEEIRI%0' >VE8'XJXY&1VB=GT81/GB!5%?B_G'W5IO:=>_ M%0RJN,(Y)&N21Q AGK(N*+\"*-/VQ>AMA=1C);UH MD^13CJQ4+1!L\,%A#ZQV7?!9O8T5'P3'JMO0-5#Q:3&V@48%KSSKVMN8N (; M6^9XA"0IIJ9@BC.02DQ0%WH%2 RA7NPB^&ZX'-I=RA3RA*:%X$Q,U'>*2!$'KM<_DC&/?@PJM50G* M&RJ?M(J-) X2JR"W#:(YZ$ID7$R93>R_&+E4LGP7)4@"\8B2AP=%U!9))X6(5Q-A&-CO$5= TL:0(6BBM:%6@MJ-.!J_R/<;4*XDKC6 M4 %CK9(L&WS"%$N.N4:C!%AESF8VE5W?E;_/SK?Z:RTRYB=M3'PRY@];_7UL MN,&G+7)N(\PI>V%A[]>4&TEFS464AA8/65DEW2S+:^TI>A_+69@3=+H!IB^* M>Q>!^HM9!;NX3I^>::]XM@.ALMIJ$N MK!8NH\/[X]$1'C[ *3? <7QR%Q&53)T$P2 Y7@#?%M[71#$YR]GG8OLP3W3S MO>S^QN/95D212L8O:D8MHQA]@JIL$=64_&*;H/461U?TW?=+.3XZ/I1C::-M M <7T(X_EP7Q197*?7A[/YNTL-SK@'9T=7A!+C<[8-CD!H$JLI!QX;]DK.-L>I==X+:+J!; >3:8\ M>C%^<"QZ:5Q.'N-HO#/>',^G^'#QO19@8KFA5A W8W-$*BA;N48/O@;4.E0Q M0QO)8JAWTE."DHR/$:%K[ M+YLQUAZ-XZQ]G%O]D(_.+$Y51U6UAY0B)D;=MM!QV3@(YDZC?4O1/5 0]"*" V8;$%\.6KPZ#Q5*#YA]NM?9;7VT?IF-AVF&GR,5;"*8+DF M1:@\LL^.E!CO7<3M]K/2Y>&%!8ISBFJT$7SBY*ID.)*A,HI3C3W8";)7$?1F MMK&+)K2Y:>.M!G EB>D10Z&LO76J]A[#=J!!L&WH$O%M#D;9@1,R0;K3#8U^1YLO;3VT?IFNJNC+2F0 4H M"C%&FUFD5Y5PK"+>2=QN/2M=(EZ>!!T-FJ FL)ZSYJ@1;+)>Y8*V]WBM5P2] M$0PA>R11N,P@LHA:![*8$8,AY!QS'UI#KW$LO!'(=,&:O>)<4FH5"E@AM!64 M53LD,/IL=-V8V)T_N&GLOF"PVG0F7FVP^M*A7[.4RB:GK0-'& &MQ> R$JNH MVMJ/L[* I)(.ZTKUGR?C%W.>'FUPGG]V*]\W/)V/\B&W Y95<]?.M;G8)+A= M[<723!Z/)M,+G[H]F7]URY!6-/A@CR#B6C^0@/S[>/F=[T MX)]*G0Y+L-FLV+7U>V2+ALH:*7L+6@R8?4YT/B,FW.O6G81+Y<,29KTN(O07 MCN3BH5^S4Y8-KH92HP4+$B?1.'$?R1F=3*FU3P-%?^Y1?I:48J<^F#*-EN9. M3L_V",OH4&[$IW6\;R:';T;C%Y=:G#(] MT,[K19V?>2X7<\5/7!2 >?3O]T]HXN-(23'Q#;QJ9,$;&DTFNGY M];W;Y-@P1\?J)('K!5I@A<$:<87U%TW6A175'9)#-IG?'QF^J.Y]='=D/8J, M" A1"R+==+C# CO400-DCF:Y1AAN2/%'2/&$AWPH:F/27DY/X>%K%UAW[[<\ M'],F*LX,5]>]P A\T[!UWPRM2#4CW_2TT./ZAJQ_%5E_OQW+AJP?[\3T? V- MK;:J&:9EJZ[C6*8=Z;X;!=0%#F1%7"0B1V3^R$S M;<-GFLMU;"W.K=_+1K0#O^;)-"G5%QVFHW%9T!7Z62MD,;6B%CK#MI?S-3QI#BJWJ\ M'&3A(FM:Z+37M\WW.$]BJZC /U&.3^=CFQV"N'D:&90;!&E0S%2%8 M:9$E<4B!R8'-:C::N.YJS* E8/F H" SD[I:FQ M1'[_Q*+M4LJJVJ;+ \OS ]7VS,!F/M,-[ QK>;;/+1ZM@=B"M%1OZ3N>]7,V M&L0!DR)M@)%^^>35I]/G):.@5T8-/-4P0FZJD>4:4<3@,TU5@?\$SAJHM4O? MN>6HD]AK/8HBU?*99W(G\#GF,[C,,#S+,D3?OS7 [^7NW%+04G6=@$6,<5?% MDKC<=:D'JQ-$V*!578=NRX_^Z!M8-CP+'=/S =50L A_9MFZ8 M 5L'(^#2=VXY:&G8:J1JV.7I\\'MANJ#N^X9J!:GF& M;AF!';D G)X1L>>#ED^W&-C)W38MBYO..C2(6OK.+0^LXM!RT=E44Z[%;$ FZJ.@@H MA@%J@1J$NFD[0I]['FCYA#NW%+1DD1-@]T-7YZ!]:ZIKV+9O>P'C-@]LIC\? MM#P\>UYHZ9@6,U5',S L'I1RT >8!3*F::BZ9EG/2+9\NIU;4E=M[EJZHUJN MQVW0R@$N+4.S+:YZ4>3I&G\^:/F$.[<4M#0C50TCKH,TXIG,-KS0\6P6>-Q! M=N>O0_G.QUJ>F%^F.]WS0\NEV;CEH MZ7/FVR$WW( QT]68Y]G<@6/G:9&O>>8SLEL^X8^ SG#7==:EK@&;RT&..K_H&1K!ZAN;K MP?H#Z%(V$BJDN)%7N:6EJNQMTH<$.;>:83,08Z.&AX MH6LY?@C<;G6S2I>\!XML4^1SP]8\@SMJ:+J6ZNLZL"QNJZK)/6ZRU6V\NNP] M6%PG54\UM=#S/! +5#,R M<*#%"V=.I_:UML[;%HL9%83Y-O""J2#P(W_.7" M'L YL'PX E$4N8;O:BO<%F_)>[! +.)!P#3+\[30#TW/8KZIVC[S;&R[SMS( M67LL>K(]6!P6.=P.0F9XAJ-JH'D:S'0#Q[),2[=T,W3TM<>BQ<8Y/0D617;D MFX%O:$Z@FLRP7-_P50,^T7T6Z(:U]ECT5'NP0"RRN:8[@6$$H>I3*Q/#,E3& M04#25.XXYMICT9/MP>*P2&6FH7*0334G,M70PMXRKAGZ/ "I2#/XVF/18J.( MGD9',_S(]((P,D!*A0/FJKH/F^([FN.K=JBM/18]U1XL$(M\6'.NNPPKV)N@ M) ,8F8ZF68:M&H[N\+7'HB?;@P5BD0J\-PP=4S4",[0=QD/5CIBG1B&W+&W] ML6BQ,3I/@D6ZJ6FV UQ85;G)+>9JFJHZMN4;CN8!8UY[+'JJ/5AD?UT6AKKM M:%S50Y/9'G,#('^F>Z:J8ZF>M<>B)]N#!=J+@M .;--250,#!P,O-$+;=U7+ MC3PS"-2UQZ+%1L \34U-0]<"UXDL;OBFX5FN%ZDVMWW+U S;]U:X-?B2]V"1 M*;!&?-XI'N@-GL6!F)Z:X]%3[8'B\.B0/>X:GB1H3NJ"9S8 MM?PP\KU MT);XV&P]EBTV/B2)\$B6&G#TL+ ,RT4D9AOPG)['I"^$_FJ;ZX] M%CW5'BP0BS3'\E3/BSR,WG>M "LM,V[8KA=&=A 9:X]%3[8'B\,BUP^P+H4? M\D S@0LP4XT,C9D6#QPU#.RUQ:)?%I?Q)/#D\\@Q0M\-3,I81.J85>BZ<&(UY/G<#->017Y/XSQZ[S/+=<5%F0YZW*P'N9M>\ MS,<+JSZXFZ4!QW[>N,LG<7'U=O*6I\%@R/*KZ0*(IRSAQ0F_YNF8'_&%U?.> M,X$YM<3E2MRY^#E&O4::!="N KYPUPR8[CLFBT!# 7!QC+.:Q+UNB'A52#A MY<3ZNJ'M6[;CX[^FY@8L4/W(4AV'&;KE6MZ:Q/IN2'@E2'@I$N;ELM5S?=L,PP(!00^_/LKRPH?_U5:VIR853DQRY%; M;!\ G^ENI,*YT3S7B[AO, #]R ^-2%771&[9G)C?\,0LJ9@H#S05'3 AQS*P MW-4M4\,"^KIO&9;]#)+R-R?FV9Z8I4AE@>6H)@M +PY-T]94W^>ZCQ73(I.A M7W_]I;*[_1XV9^:YG)DEM6:P,,!+AW?>DWLC7 ^- *+>:8NF.YD6YSH&C;5%7;"==%K]C0[]+I=TF% M"@V=.0X@K>E;9L0C-XI WK=4+U3]T [71:[C,YUIMF$& MH)O:JFOY@:-A%*T>B*9<&DH.W>J'5:/?:M^J%FL[P7_'<1'/M!'\P()QRO9B MUD^SHHR#XC -%D56IV._X/\=PW3W@6+GM$N>N>")&3E0D?Y(1CYSZ5\Q$#J6 M9V!9^2A4S= S/=OW;(.IW(D<+=)\"C#:T,]]L(3-!V&Z\%,![R(PIPU.-(>/ M/(^R?,@ EWJ@V,7!/LO3XW%YF,)L6?*1=NOY$'4KXFJ&3O]*4*YJ1Q:W0Q4T M)-.)/*8Y;F"&NN;IONFP#>!M"':-41BH6C,9QWXZEFGX&@M,U_89<[$/DL>= M#77_>D+Z9:>JF=:C#M9:$KAM.WIHJ)J/! Y_6*BZ1JA93-,8RK%K1.#+(K,U MZ7?]J\AK#+R(:&O$)CC3FER&G!7CG(LS)[^LQJB^JW['0>;2*],,/; #C(^R M3&8%OA6!D,Q#QS>!=_P+CB9S'\ MG8?\R,WMN;&\#]/SL[+,AJ]LF-V\@4KF)[RZQ<]R6)MND"4)&Q7\5?7#ZS N M1@F;P+HG("MTZ:;7USPOT>4FARRS4?/^VZI8@Q)6N@RK\>77V_35'V5X]SO/ MW?;4^[]6M[7ZNS]H;#$^3!17X?^VC*V9=Y&OKXU*A3K3*W]3Z;_7\ON$1^7] MW^:TM?=^#:\\Y\L1"T,0+U[IHUM%FUYV?-KLNHD9/HY>JN_A?;/\5?7 ",B] M&[%AG$Q>_>,,3GBA'/$;Y20#T>4?G0*.=+> Q*)"XOX&W^EX<3HUQM!O@Z, M0WLKR5G0\*>CP[/]/>7T;.<,<]+OH;15F>WI_NZGD\.SP_U39>=H3]G_S^[[ MG:-W^\KN<:]W>'IZ>'RTQ%=0'_4*7U@Q -HIL[2C[&WO;BNZ:IG>#$#4U/\' M'<1'G7WY"5*L=P\4_.(MT_%]#XY/>LH_ 9;3+#T:4WB+(M'[A$=8\)A[@6YJ MH>X;NFD8#-#!53&0U%<]4W?GIJ(H*4/V'?+XU5X6C(>2FV[)F%3C\\3?RZX_ MZ"?7YT9O'%[N7U^\\RZ/+P_-WKO>!/]>WO9NX0_P\_)T;=/ZM'9E7E^MF.=#\^UB[V= M;[TOG]2+LYV;BP/W]H-^,3G_$MC'>X>W1_KGRXMWY];1\-/-T=[^S<6[@^'1 MV8YZO/?IYN++G^;1WKG:>_?I.GSWV0S?_RNYT)-K_S(S>Y?[QL67HZN+RRL= MQE5[9V^OSK^<:[T]N.?L;7*QUU>/+O^\N?CL&KVS/W5XEG9TUO_6^]8SO[J! M'JJV9G9]E85=TP]8%[B]LY.K MWI?>S<7EX.KB+!P>?=N1]WR&9UGIQ5EF]+X< J[U;WKZP>#BK*=>['W28(ZW M,,;M^;>WP^-W)\F1#BMQX-Y\.-LI>Z?J[8>S/ZVC_E=;]6%+#;\;N:;1-34> M=CU=#[I!Z 66;W,U4-6M-W__F^>8]NM[P5"2^2(HN)8!ER%S[!P=?=KYH)SL M?SP^.5,^?CHY_;1S=*:<'2L@4)V!U*1HAG)\HFC6B_"EHGF&^0,+I>(R;3U*M/GUDMJ=TR\DERQ7R@%7HKB ?50FG.4*3T,> M+EZ<:>-"B#&/,.(@9!-\)D_GP8.P2^X+^\Q:XL-/RSW:T=X5O,,G$^2?;[W+ MP/QJ.JJO!H;7U;S [IK,9EW/\XQNX&(3%#W0/>8\,9JW=VUZQW;'.>QA>4!4 M= X;NMDTVC0?-B6";>H:H06;YD1AUV?,Z_J^R4RLQ&IXL&E[/"#STM__IMGJ M:PS4F,;JCH+[,?NILD)JX'QP.3[9"+(;0?8Y";(12XJYDBR9G,GKN/;2[/FP M=]O;V[\]?@?/V.L91WMOX]Z7?:-W>6Z<7WXRX!G?+BXO!L=?#F>DV5%\_@VE MWGWSXNQ/M? M[WIN& %_

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

;O/S^S.K^>7C<>N;N/7C_VM^WCW>>=<>ROH/Z375!R>M M$4YV_S/UBT%7XER5:UZ*62LL8"$?3N1OUXA4N9X M*UYSNOM_O*3$H6W/OI'*AG_YU>'#XH3=][QG< M^WX?S8(/WGR8PH

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

(MT() G@(-CHENU':B]6V];012#X.S"V^OGAF\4NL$HN!W,'8X\=" M)Q&P3.](RWY\T*EYUMT?:WMB+3NK0<\*&XW@Y>6:6[G@3/FB+$Q.5!:Q"3)H M,:MVL.ZP#SL.=1I8V[S6Q;*MQ)AI$LZLLZ5 >4@%W*='CS0B/S@WAB8>#IPW]H41=UYH1&:$2]@Z+XS,P]S5FQ-7.B4% 9'DI !\Y"3UG>29(2 M>;IZ-<-#_^BLTZ/$&Z$)^3[,TCL35YIO=%XD*J2;6A53W'=LE)A5Z>-,TR[5 M\76] ^W=OOSO?JW \E1$V%R\V[!>_YWUBF/7]DW#Q\:F^"[U?VYC?%B0W&D M,.DA"I$-0DN1T@=-E!2G=BYZ0#9ZGEB2TR< MW-RRGF>^E[,FK!0BBMY?MWO8?.V)%]_B-+AXD%@VK,@YEFVMD.-\-=B->QDG MK:QNM805BQF6U=Q%[2T%V^W27VE;V6T"(=88I!%-/Q*$;$JWR8S-6DXZ[.$A M8L_ J:-4G1S,_RU9FS]9[T[^PP&A.)IZV@H1!/2%LT5<8ZZTN4M1U@?8=Q)( M21=+S^0-/5VHO)45(]PFWQB#HP)C@?@?!'LBKZ9;W64K;)T;H78]\G($88"MCRJWIX%DTHFK.4 M?'F?-'#"5![]!L'J;VFM1T5W]VK*M&S59[#& [.#.^8HL6(AN?XS*V"$KBD^( M!Q_""$-G"I%8;3-LF1N,5?G4\CB0Y>YSXL1>-M(20:GD2,>R&TU?[S'71/" M\R4CPG'033U_!:XLP#\(S1X]%3C( W+ 8=PP&6X%MI5?>G9G'43$S'M*2"[D M< N&DJQJ"[&-A$9R>Q@\B@R97@5ICT $Z$ HC7E4X%5%\/D_QITD6!@3DHA\ M8#LS0U1L./]T;)^%)PJ:D#-OJ,"F0YT"%2B6P>S?/&BBS'^= M<@IQK5>=;2G3Q7R)GG12#&],",5EXWU0%CC-R%7_>&W_C%AOQ2X>._8W:F)? MZN_>Q"B %H@>$"/P39/2_7O(T>N8;6NV>*3#"@9D4@85B,VF M<&UAG2D/N 0H%!!%MPR_-]248C(=P6$(@3T-J/WC?BCBGBP5.*WYNXQHAZP$ M)\Z"TGGD/U>5^+M\MNWJG)WRYO:M5.#?:Z+\,Y_B%LA1@EM;0QU7:9]?M5]9 MO]_G$T-#=-TC]NJ,^5(] $V7;59,O M6+@Z0-(/:#B\0 Y+*R++V\4626K65+?Z\XBCZ/?; M\&<&^_1UGZP\)JTP-OYA)L)\O;)H2E6)H;6N19_,_=OT^6YJ_8SR#&D M]F-WRY"Q%9T,CYU8=9;)1N_6^3YUR"0\SOF,XO#"\)HF49"0@3?&5>*=/IWY MV+\>*X/*:\Q=W?VL!*V:Y_/AUM"\H0H9_3&/4"0Q?:4"+LBHD.@HZ17O\T5S MZU&.AM]'.VE&+SN7B2*/:RF>$+;TM_8+/6OR)@=MC#N%4<',Q,-HJ$!9#;28 MI%87?>+'4;\BB6?(#OYS;[U7NUE\J<#UB4!T'-R=J$2(;8!R.Q("E=#/T6 U M%U 'WIWSO!Y'9R1&%"TL9+X5O.2.A\YL-.F*12"/;$..+,^$I:F6Z=X8:4NO MAV^R_%B]F5C-/E9.'A=]RWINPV9;P5(PZQ-3?5:,("UV:SZ-E(HY@QSQW*4" MFK4^@P,D'RJ0/#S/3#PV!9*3W6++6L'5X.0)X1_,!'YSTLL))/Y0-148%5[8 MWX^@,+"!DSX00KY?3 7P.C$H!C_*9<1;T,W4A_P+K&';A*V!Q/@@6P7AK)?_ M+.30A&KP_$76-G\_<>Q2_3[>M?9TUH[G%S<)GP"U+SI"JQ/D:A#QI7NM]N9T MO0H**]HQX+31W&Q%!/GEV#4G[V/\$S'&]^]-IR&$<&8Y\XDLMF[[+6NMV7EN M)YX7BSJ']>DLY@GL^P&W[-E@9H/%%6M&<_O[<^X='9_871>?=[1+E;8[V;?S M[TI;'VNM=NTWU#RFDW!=$/U6F1'9((+@@5L37)%S'&B!IN*AJ8 4>WBD\T!& MN"R3XA.[%U(^VIP'KQ0L0H\30HB-EFO?T_+&#.S?6>A\M;;JS'"(')C)H_\H M;9@'"P M0E1IX%HV2$DRCWS>]-M@<^U-7%.2"M2?\KNYD"6 ,PK([)Q.W/D*%\.M8[ = M;6-.%;.Q!05*/MV.,D7 1'=;? 8R3B;@*4\4/>?WK!SI\]]-%1+$/I,[LSZA M(I3YATDP+$9]H,8P"QV]0^QP3,;7:V-6-\B2XN/Z.HNN_.'NC3]=!.*%O-F/=/5S&\)1CPA3&<_U]=/=*2>9K Z:7HC"RU M#IMRSM$_D6&8L&A(]$9,<;.0HQ'<7+J62?Z0X[#L8WQJ45;%'=5"XVH"BZ=RDV;S%4(7 Y*7-3%8D(V\""^O=_%> \#/TB \W M=TZ:ZG/B(/=&9?(F"383=NHT/;O0AAFK:0]SD.\-G&>E^]OE /.0U)PPGJBI MH:%3Z:X3VR;J=*7*]\R7T*N:5(".=P"NZ^OJUJ?N>"(N-8"6-NZ%?[W &;IA,5A?3Q,ZDL)% M4)\9AS$3[-7[RY5.=06T.+L>3I#XH04)3@R0Y]_4EMY3!^<*'/3)=I#[5;73 MS1O ,A7 :;B=V!C<7CH9S^0,73G.E+K>=F:9@_-NSC72NG$K:^FSM&MO@L6P M*YB4K3#E#=OKRG;L*0O)E?8S"H)9=9^W]17)$.B.-RT'VXW*XPO';R, M;Q)V?%W]$R)4DSRD=6U*5MBO M)Q]"77\1-T,%0F0:! E-0(BX(Z3',02R6DLT""K :Q,J[.C*\H4@XY-.=PS]9LV<,UM M=_5@V&HDT9I@CO]"4'>?0Q_M6FAO5DAX*1SAG3-A?^$B\.-*@9_C8L1C)2,, M1Y&&W]OE0;/DWK?PU:RYU5V0VI3Q_^?//_XB?_+=$%BI_Y^=F!;.8/;.BF'+ M,"(4V784 ^CJB#3;_SKU8\P9$0KO; .8=O9%0&N;!M4J,A5$!8C0-LB92^N7 MR<<^]-C-MG4&*MS[P;V8K7Z6"F3"KP2.R7E!)3JQ!';;X>-KH_X(;:2MDW3! MM2?!;X-@I),K%(;@N9YQ*XMHLQJB9A0%,MX1^])6BPH$AT9LJ;OE;E3>L"8] MZ@YD*:'TPND)M+/0T=S9051D#<<;JV5VO7<3UX[U3;3?8[]I3>K3&EG(^$IS M#^#2C\T:)?AJ5?1OK^BZ4_X[&Y"@ U!?X[QWR;SX3 MUXK8K3Y8CC2?I ):>R1](?_,Z@!0#35\3X2_8/Z#U"J_U]*PR.C)H*5^G]5E M$X>Y]4KH2^8Q--X$Y[R*Q-EN-"(NE8_R.ED)C]R7&7MQMK'K)/>K72Z3;]SN M707[Y\@E4 <((V(,PN"I*#'G L_+[AQSRCE!^]->#JCM&/^L9?N($8H * MO&^+A3J(Q9[./(ES1*4I!B=W;XKK?O\L208Z.#8LY& M0IV-=6+]I[L0!:^WY11O%Q92^+I=?J-PPA_(*"K@['4:T3_-X@$7F^GB]3 W M_KCWAF\AJD_QGN/S?=ZC.TKZ0#L/1)_\ '2K+Z8NDS_";W 8Q)<;T(]^.6DX M7,Q[09#X;-96<=2;Q'/O$T?,-V=\&=Z._*3F-)$/KI#8A#C6-]1]:FPX+7EV M?>?BU;;GEY]Q)%K31-ZX^XI)>,%W73#[GOY3L9!AUOO=WAV]HB?(JO1Y7RYY7V M HC")$I(,/<01"0N[$W$^K>'$<+"I@8'ZO0F8Z10*H5;HYL, 2QDZ.(SW2#[>5/ M'VL(WN_T'B[()QLPZ[0]/^XO7BKOQ\5T,W@"393.7CE5Q]M7Y+4J6K1QQ^OV MS;5UGL?:K+B2H\6%E[U15EF66(H^L8[K\-;OF[FYF"RM5 MG7K'Q_N3F/=T0 C"$-().S@!RZ% 6E&FSX\I!F/FI=(2VM//N4G?>7(Z";;?-V5J0%X;[_.W" M!+<5T0/TLV_@UZA R?DV2@0LKH(H_<>XX>B1^6;/\!C!XH@79,B?'"2VPK#J MB7N\F:)@'M#$EAZNK([-Y.&DON9@>;)BA*6N_NYB"NTF,X51!02QZ'GT/J$2 MY*5:[DTK$]"9-Y#-$ I(2]&Q2#)_5(UR+2.247$,=9)Q!S,"I1C0SU(!$U8@31BMOA?SSB,_]D'@42=VV0VK?#_:F -P?#:F+V+J^@B,R3R*6/PDA8Y6&]6QW1"M9$Z^R$U^ZB32NQ(1G#=>%7RCPKAWIW%1^0% MI7.YS:OVB4IGW**3W;S9.FQ(\^+@X_BFLTK,OE;_<'4"$HWBQ'RK(#11F@(Q M^THKJ<6YOVE[.Y"<-%MW/)#RN<)E3>&*\@Z&V9# MTMIQNX&!DJ=3 Y7:R0 G )P!&',+?NS:\@QZBJ&+/<7$O,Z[KHL*/&Z_M"G1 M<45BX5FRMD"RGC_J -(9R8[HH\@D-E$8OHI5=*F7.&R:WY%YIR_;<:Y1HV[U MZJKD7>&=SER!)D<_CBK,6$H_Y2S$,+JI\0%4QMM_NVW5% 0'I81$HGV75YZF M&UQDINT6S'K@]CEGZRV\RT?71%L5AL>9J50:&RH@-?ZM:K]6\7G;P\[D7=>PQ1C*9V0)?5/B2)N:*;8N!5_DXX*W M64F;=<1\VJ$I??B5"G@?2#CDH^$^_BX+-YAYL5] 8C=RIJ%^)7]0ZVU"SQ)P2-L#DX*DH^UN+!JA28F"F[I.!.4QAS MP-Z.5),3:CRG+F"[:G9AQW9&/U=ZVI2[C@NL]G%7,RM;96IQZ%LXUJF@ET/G M!)K63L]APOVAQPBQ!I6#?C:W)XO0(L[6;]XA;Z@T'!4WN:="1PN+1&(-D2.T MEN0HBM S\S7VM/"=O+/;>GIIR0H9P5HSUR.6..VBY$W)]I%!B2O>%M:ZY+E1 M*B!)!:2'Z\@]H;1Q^-C1'F3GWA"X)I0K\8&PU(%Y;*4%5HIJ&8>Q$MR0DC+- M"JDO^9*\\JT6+\AN*PV6/E7<^@RM@98QK\G/PL;Z9Z438VL$@A-I*('\)IKFKBW"#'71*&T_5F+<"1TV9L MRKO*;(!WL$Y.C,L3R$\UWJS1;BIM:QKKZ\LGP5%+W9Q.QTRM>PD8J?V361]1 MHUOX>]BV-5EL@1XN^@%ZB*@]8'Y0GVXH. M>Z-;ETOO5E^L?B?(I.[_][L')VQ5CS@P5"<85-6F@EU/"RUT5WB1Q6%UQ:(S MN;/M*U.]0W(0<.(NC?0XH@/ZWB >>@?RL)00V##F;BWYU'U\^7UJR!T'*E"8 M?IW33\XP];8X#1H$%B->%(;E&?0(LI';-H7QQY10[4/1'+1UZ\&6MFOV<;X+ MJJ@9>@&@]#8-^F6/7$P4C!L6DST&+5C%G/*>*TW**JI>#6HCG8RF'-[+HG05 MV,]#'AJ.$B+:8C^XN^N?+_V:\6Y\[&8T:1LJA/KT59Z8'".\R1E@!SMK.M2L MLX&UU?;3[!DL$DK^_LS0 LE2Q[\$.4SB"IYC/NF&5^".S7U+C*W^I.;]:E5I MY"?@K@=28DAYY%KH3.7^8C,5^$" S7+8!GDUK3W+'7X1'/)T?UL9)(]I?LJ8 ME<-M$PON!4+MWC Y0VLUU+D=BV MN6GN@T)5>H68JA+/UA\JCS/K+#HRY6X$FF> $$*,U/"@NB;XO.B(VE1NGIK M[,*N?$@*]*S3RWQ3V!Q[YT3 ]4^-WU#B@#)ACPIPKXORUV1J.R9]2]8075_T ME5!,-O!QJ?R8W!VT$*.9H#6BH,!5^,;GL-)#=._KAJ#SD7[<94CW(E*:EU@K M7BDRM=]D+V07FNLFO$4%* Q*5."@=>R\?S$*.SRG\:HTJ)OMN*M"^5KD\).[ MO(_QGVA?0U>0TT0J\(IM+\$^;:C!W$^XR'QBV"_HZ;LO3SXYL'T#!XEY-6P6 M.JXZJT@YB[O,;8+S3+L^,'?5TR_O\YR:T@#V+$,3S4BDW0JKN0C[H." J>L5 M;;=T7DEO>.\$Q1?IAARU;T&]/]T2VP/RB)Z.3,5VY^ S%\:-[B6?*Z M\OI7U>$?T\V)X0@60HMOMMY<(M.RPG8F=_7I,5_;\<)IAXPS$Y](%9DV%=%.]YM+V1--("H%*C,^?+#!9+.UC-B5)'#-= K.+D:M^ M>D?TR_K\XF7.'2QZ67A-[I;*J(GWQKJV=)ZZ(Z&M-=V@:?K8E+O">HY]]K(, MPW?KR2G]DJ8#^V42 /(1.F8W5W2-O);I693^= %2 5G+P>[BE; 8?'2\].>U M];?7AM)MZBX,B.U3@8)8^58-V5(3^@)&0NC/"X?AN$L7MIHP!]>:XSN-@C(I MS$]"QZ\VH9R?A)"BH]!=4 ["BB7AZ5QLEUPZEH@ &?>X=''Q%[W+NY+.4 MMJL*@+@$S",%Z^B&+XC?Y1M?@VZ22$G+LYNCNE-Y622#=Q@/%$%XHUELK&PM M1#26/_,PUN13W,A-?<0@_"6T3^#,)>:@?K=;,QNM[M_2!=%])4%"9RP1'W9+<%ZPBFVPG]B_7M/YHR]>:_,S MY47YFL;TS?Z9ZO),C@*K=T,N3I%-;9+B7]Z7S.31'=>D8T_'<$-G4L!I=A'C M7'2M9W:Z67CY I9K(-/VY3N=EHRF30EB84A&@$ 2%;C4_GDF"582D);D=JJT MARZIB^XS/SA3)#^_<0!+8NE61PB_<-AYOT_Y\C9O=5^:$M:[%12G^*XC5>V) MH7JP@-P_G@$N8#Z 5$.S68QXP!JY)$WH@)7!?A=C$Q26H*BQ!'K4)?F>7BKP M^S-&N",X1!94(/GBW ;Q&)KR,*&NJY@1!/F,L ,_]^@N__X^ I0'Q%)_H%E- M?T+'ON9BL[OR<.)_N'6)YO_C14SD$4;D":B#2U;,5H^6\!]/&$.?!GF16%&4 MZVEML)W6GVL,3WYT\R-48\]G2\&LVI-=C&20<(:#/J0]UQHL%+%"!=0;8&D5 M^Y%@!T.I0(K^)Y!#D($ES? +!.3#_7R0,4B5__G&HB8^OS>CB0J4]S0? MT3BS25*'FR?.2E6+4134$*/,D T7H:ZAR(CI,Z(U(H76(G7Q M\V*B@CE)):F[CY).&=R:C4'6&)=3=-OD$;6RZ_WV;;^-6>%MZ!;0\(5_ZSJ>;N_YL7#D3YOC? M3.OH%VYYOEL=O$F/53B/:\JSG?=YJ?*O['G2SRZVB>V)(,3!09KSJZIC&(>W%9+E;D4>3M?D.6@R ?V8 ^?;\*9[A5?C% M+!LWRZ>3M5$H^Y-ZWMY7'B2PTIY_E@F@.Q/'>RB, F%$%1OK(%BCSX3K%,,C M?(> 1%?AXQ",?VRO0F91-YLGZT1FE+^08)%^!H61!EQ%^-/FM.NPYDW$=A[L MAO@/]D*'PO1G2_8/=RS"#,R7=WVKY^.E=#\-[9RYM+JV6%U=]5C]J/CK9&WK M%P=-.9,-[&PPJT3B94(9/@WGLZQ\IG_,,2ZQPK;C2<5[8Y*1LMQ&Y%G[GW=M MMK?P.N0'B@)$X67<9!/[BJU0DLR$VRY+?'O2E\::/=?M\XD^&L"R3[RT@Z_@ ME^QJY3!R/&;F"3=L%*Z-TQ'IVNSPFMU&T-_UM$ N54 WN M@ * MHT/TJX53R/1MQ_T$T%C"]^$?[.5ON2+=>\5VS%<6": M.?KI39_F=EHE3J+S1SX1JZ.F$ MBJUY>$K'7Y.S2W O*,@[P._R5OM\@") SY^,>).^:S"R2&'HP/'A>P;F,Z[U M(]_72+Z_\W%XYZ#+:C\D2'/*&3)Y]:KA@VTD9A>(F=QDN416U=?T^9 MPGEVZJ%_2!18'] X?%_>@G6KD=3,*26->&0LT>$C!#7/WC#(MZHD+_;W8Y4" M+1-.*28-4@$K%#VB&8E5A9XDF1 %'BH+ZP;.D ^6\HTT+?).&A"O MM@]XV!Y#O"6=)9R=A8QN--P("FVH8D*]SPFA@6 M;8)%QEXR(VH/\C7P';!RI9](OT Y>WR3>>"X"@_^B:EQGJ"V/E.7V[/Y"R][ M29N4,51ISR/H;71<(/?98=/B0J=)Y91\7K9HX\INVL3U*BR7I [JAFGBX^%M M3>(M2COW6?)["I-MD'&SX>&WWSUD#=6.*:?Y'#IELL/UW(?V(E]$./0@QH4* MC XW3[_O:2G2;9BZ5$84S;DUGOU4TJ[V0D1+?F]Y'?_=!4NW4>Z.:NGH62@/IBU M=>YID(/26:Z0@KS/CHKAPGNEZ&SHS$LD]L;+0+#(E$]UO?E!$(NG&F5OHA;[ MUXXO1C[7_"K'H:]L!GL\Y\EA,4*V9RHR1'Z;LJU%M>\%$R8@Y=98D/_LOH^I M)]CC9%4(;3-*8LU39P>*=CR8+1X8N/LR?*G*?)607Q]^5NN@%L\]%38,+%E' M5*15IPL"_1 '.OO'_^G__O%G7\);M?DS-K0B)T;1T"5=VNA QF\Z-YH8JB/J MPP[_\Y4>QIP,6I#3!+XZ4/?JYU=[D UB)"OB'7<)MTJD"W:ZB1CL[5^H#>D) M_MMA$6Q=0+Z=AAEY=8W[^/;:K,X"X M\&Q01&SV-0+\9,U^1];V.NA/OP<'U31H3N1@?%,)#$1E@@'>B>#O.HL\M P" M=--W$^,(5\\W]<P.QTE)AT4:A1:>_V2V4I MD:Z%B8ZCXCSKG6VT_1,OS+]+/OG1DV[N@Y09G5L1*/Z> Q\F>H/]T2?1$ME& M]')[) DIK5W^V3J#VEIJ0BG1\ EMI1@/%H&MRKZY^M%Y<_$:R MZW*W0[*YP/GGB?PI[0(I,/_DNPX_+#] )Q,W=Q"UM2"/ORYJN;!AVAN@I(LO M(5? PXB.06U$XU;V,FUGS]4[?@5WVNQR:ACX!K8D/ R0CENB73;X[RHVYRDEJ'B?61UWU\(Y69 M66YA_;'Q\^PQ5KKY")N-<71QKJCD2WEC\O=,Y_4=-M4F]G/8Z:AMLCQ:K.)0 M:67"])KY^^ TV2NL8L_Y -DK]OPS#LEN9 3O[M>]QUDUB_@$<@&$EO'[/1JJNAVF(P%R77>Q0\(F%IXD3C7 M>C#XW/D,@92)7EB>(^>5!_6B+J*N8,73"^-;6TJ=RDPO1/N'!>?ZY#>.*08ORTI>*,P.)EQ*7AQCFJ^X[Q*=J?;OQ^8=/(3-/Q+(! MNAU)X ?QY!V2:(8! 8:3,K*??>QJEPG48W>)[Y^T'&&QD<#Q[:7BG:@D^Q,.$^7U4%9;(&13_%>S\5U]4-A7XXWD,J1%4 M*Q(QI:W MD;^+V%'NMHG%EZR'W5>'(ZD \RL"Z!FN3<=CL-R@4TWL_9.HU841I<(K_\'R MMT/E YC=F19'6,W;P/[N,T=#MD4(H.W2K"$)9,CO([B[;2+&FC[A#[+AJ !) M.6*VC7P$(4,%ZD-A%*CF'R+*TFZ!;8='_]DES25416++)'1^>(U^SN"TJ]EN M:A6BE-_@J+E.@21=N%SW3&%3/O<#7&).\&1 DU9V%/)DB7D1I0$D1$%09A!= M"Z'VCY@G_R'*"-78B&I.'&4'M;_5QXB=)ER$DIZ+)6!6XM&45!7;A3^YS2GT M&L?KC"W;/ 7"%[6M:Y@;F)E$Y*;K,!0/J0(Q_UWSA;6P6"(#Z)+5X'Q$$=+) MM":%[XESNBNCTO)HM52):[UT?O%7.[[D0L^M):@[6HJTJ;I)ZEBBWFS_AP;5 MAR@?H%#[WTIE_XJY#?>!8U=WR0+N0[#))I3I5M94E QEN=K%+)LZ7>5ZO,YH MX6_\-?VY2M%-PQ>V;<;JK"9/V.:AE9#56LB:+E9G4:>2)??AY0^R56K= ??% MSTB4KKX7^Q)*6_%I/ ;O=O%M?]5)UY\28*^I2YEWL&P(Y/'9,#>\ESZ]_ MY+ST3!%@TF"D.)!4"5[%) &<:?>C.271#:U!$2;^\%F9%P&.2F<-G(Q4N!B* M?_BS)C ^F;CY"%REHIS1B&Y4)7TS\VB6UDROOT&E2_ZHA\"-SJ%,XB%5C="% MP^TKZ<2(&2\26_7L;K-:U' +RV20F-&=BZ[W/[X/P#_5 ,GB_5>TQ%:,N$MA MCH[D1!^;X\E=KR9ND;X:]S>:[US&GD85V',.F7V1M]P=6]D 82&I M8'O,3D]Q#57H,6&1'5;":9'/0KC>.(1RQNQ?F=4DL?7/.=]OOKO2NZPL6G[] MD*PX.7WI_HCV\2.H WI!^^4H]6\C^3M/U*'YV)S*8PX['!KJQQ/4PKAEHC"T'(?LMN:PI!)]2;'7K5*CPFPRG4''CI\IM MA]X_L9P8DS2P#_F-6_W#9@!)\0]$V!_ZS\>7:)TKW Z5C'^X6KF'J,L$O::& M5A[1MO'L4UV773L5:! I.K$>\B4KM]$&&@_)&WR$8YX3C<5F-YZNVGTH?21, M3+N_'][_)8C['E-A,Y;5(?FNE/5N6\^89B.L+/#!FT&X05Z+Y[CVA_=Q4=6U MGAV

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ɬ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end

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